<SEC-DOCUMENT>0001601830-25-000166.txt : 20251105
<SEC-HEADER>0001601830-25-000166.hdr.sgml : 20251105
<ACCEPTANCE-DATETIME>20251105064025
ACCESSION NUMBER:		0001601830-25-000166
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		86
CONFORMED PERIOD OF REPORT:	20250930
FILED AS OF DATE:		20251105
DATE AS OF CHANGE:		20251105

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RECURSION PHARMACEUTICALS, INC.
		CENTRAL INDEX KEY:			0001601830
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				464099738
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40323
		FILM NUMBER:		251451649

	BUSINESS ADDRESS:	
		STREET 1:		41S RIO GRANDE STREET
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84101
		BUSINESS PHONE:		(385) 269-0203

	MAIL ADDRESS:	
		STREET 1:		41S RIO GRANDE STREET
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84101

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Recursion Pharmaceuticals, LLC
		DATE OF NAME CHANGE:	20140305
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>rxrx-20250930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:84e2dd81-95f3-479b-879b-c1ea33e5483d,g:a06efc1c-9b19-4722-bcb5-747c44bbab78,d:5bc8ea8f307049f2861df48b957318f8-->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ecd="http://xbrl.sec.gov/ecd/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:rxrx="http://www.recursion.com/20250930" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>rxrx-20250930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-26">0001601830</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-27">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-28">2025</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-29">Q3</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="f-30">12/31</ix:nonNumeric><ix:nonNumeric contextRef="c-65" name="rxrx:LicenseAgreementTradingPeriodUsedForEquityValueDetermination" id="f-388">P7D</ix:nonNumeric><ix:nonNumeric contextRef="c-65" name="rxrx:LicenseAgreementAmountOfTimePriorToThePaymentDate" id="f-389">P5D</ix:nonNumeric><ix:nonNumeric contextRef="c-221" name="ecd:TrdArrDuration" format="ixt-sec:durday" id="f-899">457</ix:nonNumeric><ix:nonNumeric contextRef="c-223" name="ecd:TrdArrDuration" format="ixt-sec:durday" id="f-900">456</ix:nonNumeric><ix:nonNumeric contextRef="c-225" name="ecd:TrdArrDuration" format="ixt-sec:durday" id="f-901">455</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="rxrx-20250930.xsd"/></ix:references><ix:resources><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="contract"><xbrli:measure>rxrx:contract</xbrli:measure></xbrli:unit><xbrli:unit id="inprocessresearchanddevelopmentasset"><xbrli:measure>rxrx:inProcessResearchAndDevelopmentAsset</xbrli:measure></xbrli:unit><xbrli:unit id="vote"><xbrli:measure>rxrx:vote</xbrli:measure></xbrli:unit><xbrli:unit id="class"><xbrli:measure>rxrx:class</xbrli:measure></xbrli:unit><xbrli:unit id="candidate"><xbrli:measure>rxrx:candidate</xbrli:measure></xbrli:unit><xbrli:unit id="performance_obligation"><xbrli:measure>rxrx:performance_obligation</xbrli:measure></xbrli:unit><xbrli:unit id="phenomap"><xbrli:measure>rxrx:phenomap</xbrli:measure></xbrli:unit><xbrli:unit id="program"><xbrli:measure>rxrx:program</xbrli:measure></xbrli:unit><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rxrx:ExchangeableStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rxrx:ExchangeableStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:TempusLabsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-01</xbrli:startDate><xbrli:endDate>2023-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:TempusLabsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:TempusLabsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-06-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">rxrx:REVenturesIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">rxrx:REVenturesIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">rxrx:REVenturesIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">rxrx:REVenturesIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-08-01</xbrli:startDate><xbrli:endDate>2025-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rxrx:AlphaBiotechnologyGmbHAlphaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">rxrx:ExscientiaGmbHMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rxrx:AlphaBiotechnologyGmbHAlphaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rxrx:ExscientiaPlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-11-01</xbrli:startDate><xbrli:endDate>2024-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rxrx:ExscientiaPlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-11-01</xbrli:startDate><xbrli:endDate>2024-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-11-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rxrx:ExscientiaPlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rxrx:ExscientiaPlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rxrx:ExscientiaPlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rxrx:ExscientiaPlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rxrx:ExscientiaPlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rxrx:LeaseDescriptionAxis">rxrx:ViennaFacilitiesOfExscientiaGmbHMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-03-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-03-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rxrx:LeaseDescriptionAxis">rxrx:SchrodingerLeasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-10-07</xbrli:startDate><xbrli:endDate>2025-10-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rxrx:AtTheMarketOfferingProgramCitiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-01</xbrli:startDate><xbrli:endDate>2025-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rxrx:AtTheMarketOfferingProgramCitiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rxrx:AtTheMarketOfferingProgramCitiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rxrx:AtTheMarketOfferingProgramJefferiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-01</xbrli:startDate><xbrli:endDate>2023-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rxrx:AtTheMarketOfferingProgramJefferiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-01</xbrli:startDate><xbrli:endDate>2025-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rxrx:AtTheMarketOfferingProgramJefferiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rxrx:PublicOfferingOfCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-06-26</xbrli:startDate><xbrli:endDate>2024-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rxrx:PublicOfferingOfCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rxrx:PublicOfferingOfCommonStockUnderwritingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-06-26</xbrli:startDate><xbrli:endDate>2024-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rxrx:PublicOfferingOfCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-06-26</xbrli:startDate><xbrli:endDate>2024-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-06-26</xbrli:startDate><xbrli:endDate>2024-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rxrx:ValenceDiscoveryIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rxrx:ExchangeableStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2023-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rxrx:ExchangeableStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rxrx:ValenceDiscoveryIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2023-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">rxrx:CEOAndAffiliatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:SanofiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:SanofiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:SanofiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rxrx:MilestoneTypeAxis">rxrx:ResearchMilestonesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:SanofiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rxrx:MilestoneTypeAxis">rxrx:DevelopmentAndRegulatoryMilestonesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:SanofiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:SanofiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-11-01</xbrli:startDate><xbrli:endDate>2024-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:SanofiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:MerckKGaAMerckMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rxrx:MilestoneTypeAxis">rxrx:DiscoveryDevelopmentAndSalesMilestonesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:MerckKGaAMerckMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:MerckKGaAMerckMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-11-01</xbrli:startDate><xbrli:endDate>2024-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:MerckKGaAMerckMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:RocheAndGenentechMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:RocheAndGenentechMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-09-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rxrx:RevenueRemainingPerformanceObligationAxis">rxrx:PhenomapsCreationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:RocheAndGenentechMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rxrx:RevenueRemainingPerformanceObligationAxis">rxrx:PhenomapsRawImagesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:RocheAndGenentechMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rxrx:RevenueRemainingPerformanceObligationAxis">rxrx:DevelopedAndCommercializedProgramsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:RocheAndGenentechMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:RocheAndGenentechMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rxrx:RevenueRemainingPerformanceObligationAxis">rxrx:GastrointestinalCancerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:RocheAndGenentechMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rxrx:RevenueRemainingPerformanceObligationAxis">rxrx:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:RocheAndGenentechMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxrx:A2021EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxrx:A2024InducementEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">rxrx:TempusAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">rxrx:TempusAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">rxrx:TempusAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">rxrx:TempusAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">rxrx:ContingentStockRelatingToREVentures1AgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">rxrx:ContingentStockRelatingToREVentures1AgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">rxrx:ContingentStockRelatingToREVentures1AgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">rxrx:ContingentStockRelatingToREVentures1AgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-183"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-184"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-185"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-186"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-187"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-188"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-189"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-190"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-191"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-192"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-193"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-194"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-195"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-196"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-197"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-198"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rxrx:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-199"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rxrx:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-200"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rxrx:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rxrx:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rxrx:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rxrx:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:RocheAndGenentechMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-10-27</xbrli:startDate><xbrli:endDate>2025-10-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rxrx:AtTheMarketOfferingProgramCitiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-10-01</xbrli:startDate><xbrli:endDate>2025-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rxrx:AtTheMarketOfferingProgramCitiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-01</xbrli:startDate><xbrli:endDate>2025-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">rxrx:BlakeBorgesonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">rxrx:BlakeBorgesonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">rxrx:NajatKhanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-224"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">rxrx:NajatKhanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">rxrx:BenTaylorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">rxrx:BenTaylorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i5bc8ea8f307049f2861df48b957318f8_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"><tr><td style="width:1.0pt"/><td style="width:511.00pt"/><td style="width:1.0pt"/></tr><tr style="height:314pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;text-align:center"><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-Q</ix:nonNumeric></span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Mark One)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="f-2">&#9746;</ix:nonNumeric></span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">  </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div><div><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-3">September&#160;30, 2025</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">or</span></div><div style="text-align:center"><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-4">&#9744;</ix:nonNumeric></span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For the transition period from  </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">            </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">            </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">        </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:130%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:center"><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-40323</ix:nonNumeric></span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:130%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-6">RECURSION PHARMACEUTICALS, INC.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-7">Delaware</ix:nonNumeric>                                                                                             </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-8">46-4099738</ix:nonNumeric></span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">                </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:130%">(State or other jurisdiction of incorporation or organization)                                 (I.R.S. Employer Identification No.)</span></div><div style="padding-left:18pt;padding-right:18pt;text-align:center;text-indent:36pt"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-9">41 S Rio Grande Street</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-10">Salt Lake City,</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" id="f-11">UT</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-12">84101</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Address of principal executive offices) (Zip code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-13">385</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-14">269 - 0203</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Registrant&#8217;s telephone number, including area code)</span></div></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"><tr><td style="width:1.0pt"/><td style="width:201.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:97.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:208.00pt"/><td style="width:1.0pt"/></tr><tr style="height:14pt"><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Securities registered pursuant to Section 12(b) of the Act:</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Trading symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-15">Class A Common Stock, par value $0.00001</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-16">RXRX</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-17">Nasdaq Global Select Market</ix:nonNumeric> </span></div></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"><tr><td style="width:1.0pt"/><td style="width:511.00pt"/><td style="width:1.0pt"/></tr><tr style="height:126pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;         <ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-18">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">x</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">    No &#9744;</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). </span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;          <ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-19">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">x</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">   No &#9744;</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and "emerging growth company" in Rule 12b-2 of the Exchange Act.</span></div></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"><tr><td style="width:1.0pt"/><td style="width:103.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:22.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:223.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:132.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:22.00pt"/><td style="width:1.0pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-20">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="f-21">&#9744;</ix:nonNumeric></span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-22">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"><tr><td style="width:1.0pt"/><td style="width:511.00pt"/><td style="width:1.0pt"/></tr><tr style="height:92pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.       </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).   Yes </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-23">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">   No </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">As of October&#160;31, 2025, there were <ix:nonFraction unitRef="shares" contextRef="c-2" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-24">514,895,802</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-25">5,747,334</ix:nonFraction> of the registrant&#8217;s Class A and B common stock outstanding, respectively.</span></div></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div></div></div><div id="i5bc8ea8f307049f2861df48b957318f8_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:79.309%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.772%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_13">Part I </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_13">Financial Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_13">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1. </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_16">Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_16">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2. </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_82">Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_82">26</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3. </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_112">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_112">34</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_115">Controls and Procedures </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_115">35</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_118">Part II </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_118">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_118">37</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_121">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_121">37</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1A. </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_124">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_124">37</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_127">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_127">37</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6. </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_136">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_136">39</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_139">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_139">40</a></span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div id="i5bc8ea8f307049f2861df48b957318f8_10"></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cautionary Note Regarding Forward-Looking Statements</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q contains &#8220;forward-looking statements&#8221; about us and our industry within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts are forward-looking statements. In some cases, you can identify forward-looking statements by terms such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;would,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;could,&#8221; &#8220;intend,&#8221; &#8220;target,&#8221; &#8220;project,&#8221; &#8220;contemplate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; or &#8220;continue&#8221; or the negative of these terms or other similar expressions. Forward-looking statements contained in this report may include without limitation those regarding: </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our research and development programs;</span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">the initiation, timing, progress, results, and cost of our current and future preclinical and clinical studies, including statements regarding the design of, and the timing of initiation and completion of, studies and related preparatory work, as well as the period during which the results of the studies will become available and key milestones will be met; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our ability to use our combined assets from our recent business combination to create a fully integrated, technology-first drug discovery platform;</span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">the timing and likelihood of our ability to shift our wet-lab from a source of data generation to a model for validating data from AI-generated results; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">the ability and willingness of our collaborators to continue research and development activities relating to our development candidates and investigational medicines; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">future agreements with third parties in connection with the commercialization of our investigational medicines and any other approved product; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">the timing, scope, and likelihood of regulatory filings and approvals, including the timing of Investigational New Drug applications and final approval by the U.S. Food and Drug Administration, or FDA, of our current drug candidates and any other future drug candidates, as well as our ability to maintain any such approvals; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">the timing, scope, or likelihood of foreign regulatory filings and approvals, including our ability to maintain any such approvals; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">the size of the potential market opportunity for TechBio companies, including the expected impact of AI-enabled technologies;</span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">the size of the potential market opportunity for our drug candidates, including our estimates of the number of patients who suffer from the diseases we are targeting; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our ability to identify viable new drug candidates for clinical development and the rate at which we expect to identify such candidates, whether through an inferential approach or otherwise; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our expectation that the assets that will drive the most value for us are those that we will identify in the future using our datasets and tools; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our ability to develop and advance our current drug candidates and programs into, and successfully complete, clinical studies; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our ability to reduce the time or cost or increase the likelihood of success of our research and development relative to the traditional drug discovery paradigm, including the use of data sets from our partners to accelerate the development of our AI-enabled technologies; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our ability to improve, and the rate of improvement in, our infrastructure, datasets, biology, technology tools, and drug discovery platform, and our ability to realize benefits from such improvements; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our ability to effectively use machine learning and artificial intelligence in our drug development process;</span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our ability to leverage our collaborations and partnerships to develop our products and grow our business;</span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our expectations related to the performance and benefits of our BioHive-2 supercomputer, Recursion OS, and our digital chemistry platform;</span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our ability to realize a return on our investment of resources and cash in our drug discovery collaborations; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our ability to scale like a technology company and to add more programs to our pipeline each year; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our ability to acquire and generate datasets to train and develop our AI-enabled technologies;</span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our ability to successfully compete in a highly competitive market; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our manufacturing, commercialization, and marketing capabilities and strategies; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our plans relating to commercializing our drug candidates, if approved, including the geographic areas of focus and sales strategy; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our expectations regarding the approval and use of our drug candidates in combination with other drugs; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">the rate and degree of market acceptance and clinical utility of our current drug candidates, if approved, and other drug candidates we may develop; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our competitive position and the success of competing approaches that are or may become available, including with respect to our AI-enabled technologies; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our estimates of the number of patients that we will enroll in our clinical trials and the timing of their enrollment; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">the beneficial characteristics, safety, efficacy, and therapeutic effects of our drug candidates; </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_7">Table of Contents</a></span></div></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our plans for further development of our drug candidates, including additional indications we may pursue; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our ability to adequately protect and enforce our intellectual property and proprietary technology, including the scope of protection we are able to establish and maintain for intellectual property rights covering our current drug candidates and other drug candidates we may develop, receipt of patent protection, the extensions of existing patent terms where available, the validity of intellectual property rights held by third parties, the protection of our trade secrets, and our ability not to infringe, misappropriate or otherwise violate any third-party intellectual property rights; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">the impact of any intellectual property disputes and our ability to defend against claims of infringement, misappropriation, or other violations of intellectual property rights; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our ability to keep pace with new technological developments, including with respect to AI; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our ability to utilize third-party open source software and cloud-based infrastructure, on which we are dependent; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">the adequacy of our insurance policies and the scope of their coverage; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">the potential impact of a pandemic, epidemic, or outbreak of an infectious disease, such as COVID-19, or natural disaster, global political instability, or warfare, and the effect of such outbreak or natural disaster, global political instability, or warfare on our business and financial results; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our ability to maintain our technical operations infrastructure to avoid errors, delays, or cybersecurity breaches; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our continued reliance on third parties to conduct additional clinical trials of our drug candidates, and for the manufacture of our drug candidates for preclinical studies and clinical trials; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our ability to obtain, and negotiate favorable terms of, any collaboration, licensing or other arrangements that may be necessary or desirable to research, develop, manufacture, or commercialize our platform and drug candidates; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">the pricing and reimbursement of our current drug candidates and other drug candidates we may develop, if approved; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our estimates regarding expenses, future revenue, capital requirements, and need for additional financing;</span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our financial performance; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">the period over which we estimate our existing cash and cash equivalents will be sufficient to fund our future operating expenses and capital expenditure requirements; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our ability to raise substantial additional funding; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">the impact of current and future laws and regulations, and our ability to comply with all regulations that we are, or may become, subject to; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">the need to hire additional personnel and our ability to attract and retain such personnel; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">the impact of any current or future litigation, which may arise during the ordinary course of business and be costly to defend; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our ability to maintain effective internal control over financial reporting and disclosure controls and procedures, including our ability to remediate the material weakness in internal control over financial reporting;</span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our anticipated use of our existing resources and the net proceeds from our public offerings; and </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">other risks and uncertainties, including those listed in the section titled &#8220;Risk Factors.&#8221; </span></div><div style="text-indent:4.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We have based these forward-looking statements largely on our current expectations and projections about our business, the industry in which we operate, and financial trends that we believe may affect our business, financial condition, results of operations, and prospects. These forward-looking statements are not guarantees of future performance or development. These statements speak only as of the date of this report and are subject to a number of risks, uncertainties and assumptions described in the section titled &#8220;Risk Factors&#8221; and elsewhere in this report. Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, you should not rely on these forward-looking statements as predictions of future events. The events and circumstances reflected in our forward-looking statements may not be achieved or occur and actual results could differ materially from those projected in the forward-looking statements. Except as required by applicable law, we undertake no obligation to update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, or otherwise.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In addition, statements that &#8220;we believe&#8221; and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this report. While we believe such information forms a reasonable basis for such statements, the information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and you are cautioned not to unduly rely upon them.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii</span></div></div></div><div id="i5bc8ea8f307049f2861df48b957318f8_13"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I - FINANCIAL INFORMATION</span></div><div><span><br/></span></div><div id="i5bc8ea8f307049f2861df48b957318f8_16"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Financial Statements.</span></div><div><span><br/></span></div><div id="i5bc8ea8f307049f2861df48b957318f8_19"></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recursion Pharmaceuticals, Inc. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets (unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share and per share amounts)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"/><td style="width:71.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.657%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.658%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">September 30,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-31">659,836</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-32">594,350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RestrictedCashCurrent" format="ixt:num-dot-decimal" scale="3" id="f-33">3,136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RestrictedCashCurrent" format="ixt:num-dot-decimal" scale="3" id="f-34">3,045</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-35">21,910</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-36">49,166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid data assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PrepaidExpenseCurrent" format="ixt:fixed-zero" scale="3" id="f-37">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PrepaidExpenseCurrent" format="ixt:num-dot-decimal" scale="3" id="f-38">29,601</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-39">29,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-40">38,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-41">714,105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-42">714,269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash, non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-43">4,173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-44">5,629</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-45">111,706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-46">141,063</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-47">47,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-48">65,877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-49">21,726</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-50">26,273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-51">322,344</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-52">335,855</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-53">162,042</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-54">148,873</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="3" id="f-55">957</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-56">1,934</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets, non-current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-57">14,661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-58">8,825</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-59">1,399,526</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-60">1,448,598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities and stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-61">13,935</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-62">21,613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-63">53,102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-64">81,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued data liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="rxrx:AccruedDataCurrent" format="ixt:num-dot-decimal" scale="3" id="f-65">20,258</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="rxrx:AccruedDataCurrent" format="ixt:fixed-zero" scale="3" id="f-66">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-67">47,364</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-68">61,767</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-69">11,525</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-70">13,795</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Notes payable and financing lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-71">8,919</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-72">8,425</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-73">155,103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-74">187,472</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue, non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-75">111,204</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-76">118,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities, non-current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-77">50,028</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-78">67,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Notes payable and financing lease liabilities, non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="3" id="f-79">11,902</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="3" id="f-80">19,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="f-81">23,312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="f-82">16,575</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities, non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-83">1,029</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-84">4,732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-85">352,578</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-86">413,816</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commitments and contingencies (Note&#160;7)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-4" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-87"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-5" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-88"></ix:nonFraction></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-89"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-90">0.00001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-91"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-92">2,000,000,000</ix:nonFraction></ix:nonFraction> shares (Class A <ix:nonFraction unitRef="shares" contextRef="c-6" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-93"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-94">1,989,032,117</ix:nonFraction></ix:nonFraction> and Class B <ix:nonFraction unitRef="shares" contextRef="c-8" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-95"><ix:nonFraction unitRef="shares" contextRef="c-9" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-96">10,967,883</ix:nonFraction></ix:nonFraction>) authorized as of September&#160;30, 2025 and December&#160;31, 2024; <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-97"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-98">491,800,501</ix:nonFraction></ix:nonFraction> shares (Class A <ix:nonFraction unitRef="shares" contextRef="c-6" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-99"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-100">485,213,547</ix:nonFraction></ix:nonFraction>, Class B <ix:nonFraction unitRef="shares" contextRef="c-9" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-101"><ix:nonFraction unitRef="shares" contextRef="c-9" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-102">5,967,334</ix:nonFraction></ix:nonFraction> and Exchangeable <ix:nonFraction unitRef="shares" contextRef="c-10" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-103"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-104">619,620</ix:nonFraction></ix:nonFraction>) and <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-105"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-106">396,802,394</ix:nonFraction></ix:nonFraction> shares (Class A <ix:nonFraction unitRef="shares" contextRef="c-7" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-107"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-108">389,547,223</ix:nonFraction></ix:nonFraction>, Class B <ix:nonFraction unitRef="shares" contextRef="c-8" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-109"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-110">6,958,575</ix:nonFraction></ix:nonFraction> and Exchangeable <ix:nonFraction unitRef="shares" contextRef="c-11" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-111"><ix:nonFraction unitRef="shares" contextRef="c-11" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-112">296,596</ix:nonFraction></ix:nonFraction>) issued and outstanding as of September&#160;30, 2025 and December&#160;31, 2024, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-113">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-114">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="f-115">2,980,729</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="f-116">2,473,698</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-117">1,967,879</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-118">1,431,283</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-119">34,093</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-120">7,637</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-121">1,046,948</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-122">1,034,782</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-123">1,399,526</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-124">1,448,598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See the accompanying notes to these c</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ondensed </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_7">Table of Contents</a></span></div></div><div style="text-align:center"><span><br/></span></div><div id="i5bc8ea8f307049f2861df48b957318f8_22"></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recursion Pharmaceuticals, Inc. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Operations (unaudited)</span></div><div style="text-align:center"><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">in thousands, except share and per share amounts)</span></div><div style="text-align:center"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:44.727%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.759%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.759%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.996%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.955%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.104%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-125">4,983</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-126">26,082</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-127">38,905</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-128">53,977</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-129">192</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-130">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-131">238</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-132">316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-133">5,175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-134">26,082</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-135">39,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-136">54,293</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating costs and expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="f-137">14,687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="f-138">12,079</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="f-139">56,678</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="f-140">32,444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-141">121,062</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-142">74,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-143">379,331</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-144">216,087</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-145">41,628</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-146">37,757</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-147">142,932</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-148">100,998</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total operating costs and expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-149">177,377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-150">124,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-151">578,941</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-152">349,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-153">172,202</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-154">98,354</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-155">539,798</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-156">295,236</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-157">9,952</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-158">2,679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-159">3,005</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-160">9,347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loss before income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-161">162,250</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-162">95,675</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-163">536,793</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-164">285,889</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="f-165">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="f-166">167</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="f-167">156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-168">1,134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-169">162,253</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-170">95,842</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-171">536,637</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-172">284,755</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Per share data</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net loss per share of Class A, B and Exchangeable common stock, basic and diluted</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-20" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-173"><ix:nonFraction unitRef="usdPerShare" contextRef="c-20" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-174">0.36</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-21" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-175"><ix:nonFraction unitRef="usdPerShare" contextRef="c-21" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-176">0.34</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-177"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-178">1.27</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-22" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-179"><ix:nonFraction unitRef="usdPerShare" contextRef="c-22" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-180">1.12</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average shares (Class A, B and Exchangeable) outstanding, basic and diluted</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-20" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-181"><ix:nonFraction unitRef="shares" contextRef="c-20" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-182">446,988,046</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-21" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-183"><ix:nonFraction unitRef="shares" contextRef="c-21" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-184">282,583,048</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-185"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-186">422,642,653</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-22" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-187"><ix:nonFraction unitRef="shares" contextRef="c-22" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-188">253,447,099</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See the accompanying notes to these c</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ondensed</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i5bc8ea8f307049f2861df48b957318f8_25"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recursion Pharmaceuticals, Inc. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Comprehensive Loss (unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands) </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.499%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nine months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">September 30,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-189">162,253</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-190">95,842</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-191">536,637</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-192">284,755</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other comprehensive income (loss):</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-193">9,527</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:fixed-zero" scale="0" id="f-194">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-195">41,730</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:fixed-zero" scale="0" id="f-196">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other comprehensive income (loss)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-197">9,527</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:fixed-zero" scale="3" id="f-198">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-199">41,730</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:fixed-zero" scale="3" id="f-200">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Comprehensive loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-201">171,780</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-202">95,842</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-203">494,907</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-204">284,755</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See the accompanying notes to these condensed consolidated financial statements</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i5bc8ea8f307049f2861df48b957318f8_28"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recursion Pharmaceuticals, Inc. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Stockholders&#8217; Equity (unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share amounts)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:34.246%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.945%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.945%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.945%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.712%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.538%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Common Stock </span></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in-Capital</span></div></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accumulated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Deficit</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accumulated other comprehensive income (loss)</span></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stockholders&#8217;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Equity</span></div></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Class A, B and Exchangeable)</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance as of June 30, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-24" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-205">432,830,642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-206">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-207">2,681,111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-208">1,805,589</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-209">43,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-210">919,146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-211">162,253</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-212">162,253</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-213">9,527</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-214">9,527</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock option exercises and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-31" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-215">2,871,306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="f-216">401</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="f-217">37</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="f-218">438</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-219">25,244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-220">25,244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock sales issuances, net of issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-31" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-221">52,243,578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-222">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-223">254,460</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-224">254,461</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Class A shares issued for asset acquisition</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-31" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" format="ixt:num-dot-decimal" scale="0" id="f-225">3,854,975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="f-226">20,315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="f-227">20,315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance as of September 30, 2025</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-33" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-228">491,800,501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-229">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-230">2,980,729</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-231">1,967,879</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-232">34,093</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-233">1,046,948</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:34.246%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.945%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.945%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.945%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.712%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.538%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Common Stock </span></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in-Capital</span></div></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accumulated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Deficit</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accumulated other comprehensive income (loss)</span></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stockholders&#8217;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Equity</span></div></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Class A, B and Exchangeable)</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance as of December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-37" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-234">396,802,394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-235">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-236">2,473,698</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-237">1,431,283</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-238">7,637</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-239">1,034,782</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-240">536,637</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-241">536,637</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-242">41,730</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-243">41,730</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock option exercises and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-43" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-244">11,645,465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-245">3,772</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="f-246">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-247">3,813</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-248">87,460</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-249">87,460</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock sales issuances, net of issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-43" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-250">79,497,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-251">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-252">395,484</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-253">395,485</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Class A shares issued for asset acquisition</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-43" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" format="ixt:num-dot-decimal" scale="0" id="f-254">3,854,975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="f-255">20,315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="f-256">20,315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance as of September 30, 2025</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-33" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-257">491,800,501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-258">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-259">2,980,729</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-260">1,967,879</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-261">34,093</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-262">1,046,948</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See the accompanying notes to these c</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ondensed </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consolidated financial statements</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recursion Pharmaceuticals, Inc. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Stockholders&#8217; Equity (unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share amounts)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:29.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.633%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Common Stock</span></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in-Capital</span></div></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accumulated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Deficit</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accumulated other comprehensive income (loss)</span></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stockholders&#8217;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Equity</span></div></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Class A, B and Exchangeable)</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance as of June 30, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-45" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-263">280,968,276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-264">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-265">1,740,981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-266">1,156,535</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="f-267">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-268">584,449</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-269">95,842</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-270">95,842</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock option exercises and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-51" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-271">2,689,679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="f-272">732</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="f-273">732</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-274">18,252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-275">18,252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock sales issuances, net of issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-51" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-276">2,466,324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-277">16,968</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-278">16,968</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance as of September 30, 2024</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-53" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-279">286,124,279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-280">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-281">1,776,933</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-282">1,252,377</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="f-283">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-284">524,559</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:29.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.633%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Common Stock</span></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in-Capital</span></div></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accumulated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Deficit</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accumulated other comprehensive income (loss)</span></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stockholders&#8217;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Equity</span></div></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Class A, B and Exchangeable)</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance as of December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-58" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-285">234,270,384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-286">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-287">1,431,056</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-288">967,622</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="f-289">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-290">463,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-291">284,755</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-292">284,755</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock option exercises and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-63" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-293">7,827,268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-294">5,586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-295">5,586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-296">50,904</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-297">50,904</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock sales issuances, net of issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-63" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-298">44,026,627</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-299">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-300">289,387</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-301">289,388</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance as of September 30, 2024</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-53" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-302">286,124,279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-303">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-304">1,776,933</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-305">1,252,377</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="f-306">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-307">524,559</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See the accompanying notes to these condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i5bc8ea8f307049f2861df48b957318f8_31"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recursion Pharmaceuticals, Inc. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows (unaudited) (in thousands) </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"><tr><td style="width:1.0%"/><td style="width:65.019%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.870%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.811%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from operating activities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-308">536,637</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-309">284,755</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-310">64,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-311">23,543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-312">87,460</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-313">50,904</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:TangibleAssetImpairmentCharges" format="ixt:num-dot-decimal" scale="3" id="f-314">5,956</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:TangibleAssetImpairmentCharges" scale="3" id="f-315">108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="f-316">17,019</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="f-317">11,155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on disposal of a business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="3" id="f-318">4,502</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="3" id="f-319">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired IPR&amp;D</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" format="ixt:num-dot-decimal" scale="3" id="f-320">22,082</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" format="ixt:fixed-zero" scale="3" id="f-321">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-322">6,655</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="f-323">650</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables and assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:num-dot-decimal" scale="3" id="f-324">33,775</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:num-dot-decimal" scale="3" id="f-325">4,173</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid data assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="rxrx:IncreaseDecreaseInPrepaidDataAssets" format="ixt:num-dot-decimal" scale="3" id="f-326">29,601</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="rxrx:IncreaseDecreaseInPrepaidDataAssets" format="ixt:num-dot-decimal" scale="3" id="f-327">2,930</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued data liability</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="rxrx:IncreaseDecreaseInAccruedDataLiability" format="ixt:num-dot-decimal" scale="3" id="f-328">20,258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="rxrx:IncreaseDecreaseInAccruedDataLiability" format="ixt:fixed-zero" scale="3" id="f-329">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="f-330">30,014</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="f-331">22,374</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="f-332">7,035</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="f-333">1,687</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued development expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="rxrx:IncreaseDecreaseInAccruedDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-334">4,210</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="rxrx:IncreaseDecreaseInAccruedDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-335">2,623</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-336">23,246</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-337">5,001</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="rxrx:IncreaseDecreaseInLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-338">16,124</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="rxrx:IncreaseDecreaseInLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-339">11,121</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash used in operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-340">325,735</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-341">243,744</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from investing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-342">5,225</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-343">12,397</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of an intangible asset</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="f-344">2,158</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:PaymentsToAcquireIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="f-345">3,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease in cash related to disposal of a business</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" format="ixt:num-dot-decimal" scale="3" id="f-346">4,438</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" format="ixt:fixed-zero" scale="3" id="f-347">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireInvestments" format="ixt:num-dot-decimal" scale="3" id="f-348">3,806</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:PaymentsToAcquireInvestments" format="ixt:fixed-zero" scale="3" id="f-349">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-350">15,627</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-351">15,397</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from financing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of common shares, net of issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-352">395,484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-353">289,387</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from equity incentive plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" format="ixt:num-dot-decimal" scale="3" id="f-354">3,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" format="ixt:num-dot-decimal" scale="3" id="f-355">6,433</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayment of long-term debt and finance lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities" format="ixt:num-dot-decimal" scale="3" id="f-356">6,258</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities" format="ixt:num-dot-decimal" scale="3" id="f-357">2,339</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of an intangible asset</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="rxrx:PaymentsToAcquireIntangibleAssetsFinancialActivities" format="ixt:num-dot-decimal" scale="3" id="f-358">3,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="rxrx:PaymentsToAcquireIntangibleAssetsFinancialActivities" format="ixt:fixed-zero" scale="3" id="f-359">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-360">389,526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-361">293,481</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Effect of exchange rate changes on cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-362">15,957</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="f-363">66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net change in cash, cash equivalents and restricted cash</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-364">64,121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-365">34,406</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash, beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-366">603,024</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-367">401,425</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash, cash equivalents and restricted cash, end of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-368">667,145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-369">435,831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental schedule of non-cash investing and financing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of shares for the acquisition of an asset</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssued1" format="ixt:num-dot-decimal" scale="3" id="f-370">20,315</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:StockIssued1" format="ixt:fixed-zero" scale="3" id="f-371">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="f-372">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="f-373">236</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of an equity investment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="rxrx:PurchaseOfAnEquityInvestmentNonCash" format="ixt:num-dot-decimal" scale="3" id="f-374">4,438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="rxrx:PurchaseOfAnEquityInvestmentNonCash" format="ixt:fixed-zero" scale="3" id="f-375">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of an intangible asset</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1" format="ixt:fixed-zero" scale="3" id="f-376">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1" format="ixt:num-dot-decimal" scale="3" id="f-377">6,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See the accompanying notes to these condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i5bc8ea8f307049f2861df48b957318f8_34"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recursion Pharmaceuticals, Inc. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div id="i5bc8ea8f307049f2861df48b957318f8_37"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 1.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:NatureOfOperations" id="f-378" continuedAt="f-378-1" escape="true">Description of the Business </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-378-1"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recursion Pharmaceuticals, Inc. (&#8220;Recursion&#8221; or the &#8220;Company&#8221;) is a clinical stage TechBio company decoding biology and chemistry to industrialize drug discovery. The Recursion Operating System (OS), a platform built across diverse technologies, enables the Company to map and navigate trillions of biological and chemical relationships within the Recursion Data Universe, one of the world&#8217;s largest proprietary biological and chemical datasets. The Company integrates physical and digital components as iterative loops of atoms and bits scaling wet lab biology and chemistry data organized into virtuous cycles with computational tools to rapidly translate </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in silico </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">hypotheses into validated insights and novel chemistry.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2025, the Company had an accumulated deficit of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-8" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="9" id="f-379">2.0</ix:nonFraction> billion. The Company expects to incur substantial operating losses in future periods and will require additional capital to advance its drug candidates. The Company does not expect to generate significant revenue until the Company successfully completes significant drug development milestones or in collaboration&#160;with third parties, which the Company expects will take a number of years. In order to commercialize its drug candidates, the Company or its partners need to complete clinical development and comply with comprehensive regulatory requirements. The Company is subject to a number of risks and uncertainties similar to those of other companies of the same size within the biotechnology industry, such as the uncertainty of clinical trial outcomes, uncertainty of additional funding and a history of operating losses. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has funded its operations to date primarily through the issuance of Class A common stock (see Note 8, &#8220;Common Stock&#8221; for additional details). Additionally, the Company has received payments from its strategic partnerships (see Note 9, &#8220;Collaborative Development Contracts&#8221; for additional details). Recursion will likely be required to raise additional capital. As of September&#160;30, 2025, the Company did not have any unconditional outstanding commitments for additional funding. If the Company is unable to access additional funds when needed, it may not be able to continue the development of its products or the Company could be required to delay, scale back or abandon some or all of its development programs and other operations. The Company&#8217;s ability to access capital when needed is not assured and, if not achieved on a timely basis, could materially harm its business, financial condition and results of operations. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recursion believes that the Company&#8217;s existing cash and cash equivalents will be sufficient to fund the Company&#8217;s operating expenses and capital expenditures for at least the next 12 months.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="i5bc8ea8f307049f2861df48b957318f8_40"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2. <ix:nonNumeric contextRef="c-1" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="f-380" continuedAt="f-380-1" escape="true">Basis of Presentation</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-380-1" continuedAt="f-380-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="f-381" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited interim condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC). Accordingly, certain information and footnote disclosures normally included in annual financial statements prepared in accordance with generally accepted accounting principles in the United States (U.S. GAAP) have been condensed or omitted. These unaudited interim condensed consolidated financial statements should be read in conjunction with the Company&#8217;s audited consolidated financial statements and notes for the year ended December&#160;31, 2024. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is management&#8217;s opinion that these condensed consolidated financial statements include all normal and recurring adjustments necessary for a fair statement of the financial position, results of operations and cash flows for the periods presented. Revenue and net loss for any interim period are not necessarily indicative of future or annual results.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-382" continuedAt="f-382-1" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2025, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2025-06, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for internal-use software costs (Topic 350)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The new standard amends specific aspects of the accounting for internal-use software costs including the criteria for capitalizing software costs. It also amends the related disclosure requirements. This standard will be effective for Recursion starting the annual period ending </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_7">Table of Contents</a></span></div></div><ix:continuation id="f-382-1" continuedAt="f-382-2"><ix:continuation id="f-380-2" continuedAt="f-380-3"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;15, 2028 and for interim reporting periods within that annual reporting period. Early adoption is permitted. The amendments can be applied on a prospective, modified prospective or retrospective basis. Recursion is currently assessing the impact of adopting this guidance on its consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2024-03, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Income Statement Expenses (Topic 220)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The standard requires new disclosures in the notes to the financial statements about certain caption expenses presented on the face of the Income Statement including information on: purchases of inventory; employee compensation; depreciation and intangible asset amortization. Recursion must also disclose a qualitative description of the amounts remaining in expense captions that are not separately disaggregated. This standard will be effective for Recursion starting the annual period ending December 31, 2027 and for interim reporting periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The amendments can be applied on a prospective or retrospective basis. Recursion is currently assessing the impact of adopting this guidance on its consolidated financial statements. </span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div><ix:continuation id="f-382-2" continuedAt="f-382-3"><ix:continuation id="f-380-3" continuedAt="f-380-4"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU No. 2023-09, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740)</span></ix:continuation></ix:continuation><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-382-3"><ix:continuation id="f-380-4">. The new standard updates disclosure requirements for Accounting Standards Codification (ASC) 740 primarily by requiring additional information in the income tax rate reconciliation and additional disclosures about income taxes paid. This standard will be effective for Recursion starting the annual period ending December 31, 2025. The amendments can be applied on a prospective or retrospective basis. The Company is in process of evaluating the impact of adoption of ASU 2023-09 on the Company's consolidated financial statements and disclosures. We do not expect the adoption of this ASU to have a material impact on our consolidated financial statements.</ix:continuation></ix:continuation> </span></div><div><span><br/></span></div><div><span><br/></span></div><div id="i5bc8ea8f307049f2861df48b957318f8_43"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 3.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="rxrx:SupplementalBalanceSheetAndIncomeStatementInformationTextBlock" id="f-383" continuedAt="f-383-1" escape="true">Supplemental Financial Information </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-383-1" continuedAt="f-383-2"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tempus agreement</span></div><div><span><br/></span></div><div><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">November 2023</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Recursion entered into a </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-65" name="rxrx:LicenseAgreementTerm" format="ixt-sec:durwordsen" id="f-384" continuedAt="f-384-1">five</ix:nonNumeric></span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-384-1">-year</ix:continuation> agreement </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(the Tempus Agreement) </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with Tempus AI, Inc. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;Tempus&#8221;) t</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o purchase access to their records of patient-centric multimodal oncology data and use rights for therapeutic development purposes. This data will be used to improve the training of Recursion&#8217;s artificial intelligence and machine learning models and is expected to accelerate Recursion&#8217;s drug discovery process. Recursion is making annual payments, ranging between </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-5" name="rxrx:LicenseAgreementAnnualPayments" format="ixt:num-dot-decimal" scale="6" id="f-385">22.0</ix:nonFraction>&#160;million</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-5" name="rxrx:LicenseAgreementAnnualPayments" format="ixt:num-dot-decimal" scale="6" id="f-386">42.0</ix:nonFraction>&#160;million</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, up to </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-5" name="rxrx:LicenseAgreementAggregatePayments" format="ixt:num-dot-decimal" scale="6" id="f-387">160.0</ix:nonFraction>&#160;million</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in aggregate, to Tempus in cash or equity at the Company&#8217;s option. The equity value is determined by using the <span style="-sec-ix-hidden:f-388">seven</span>-trading day period dollar volume-weighted average price (VWAP) for Recursion Class A common stock ending on the day immediately preceding the date that is <span style="-sec-ix-hidden:f-389">five</span> business days prior to the payment date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recursion is expensing the record purchases based on a contractually agreed price as &#8220;Research and Development&#8221; expenses in the Condensed Consolidated Statements of Operations as the records are downloaded. To the extent that the Recursion payments to Tempus are greater than or less than the records purchased amount, Recursion records the applicable amount to &#8220;Prepaid data assets&#8221; or &#8220;Accrued data liability&#8221; on the Condensed Consolidated Balance Sheet, respectively. The expense for the record purchases was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="rxrx:LicenseAgreementIncreaseDecreaseAccruedLiabilities" scale="6" id="f-390">49.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-5" name="rxrx:LicenseAgreementIncreaseDecreaseAccruedLiabilities" scale="6" id="f-391">2.9</ix:nonFraction> million for the nine months ended September 30, 2025 and 2024. There was <ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-5" name="rxrx:LicenseAgreementIncreaseDecreaseAccruedLiabilities" format="ixt:fixed-zero" scale="0" id="f-392"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="rxrx:LicenseAgreementIncreaseDecreaseAccruedLiabilities" format="ixt:fixed-zero" scale="0" id="f-393">no</ix:nonFraction></ix:nonFraction> expense recorded for the three months ended September 30, 2025 and 2024</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_7">Table of Contents</a></span></div></div><div><span><br/></span></div><ix:continuation id="f-383-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" id="f-394" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accrued Expenses and Other Liabilities</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.660%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.521%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-395">24,056</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-396">50,853</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="rxrx:AccruedDevelopmentCostsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-397">2,497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="rxrx:AccruedDevelopmentCostsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-398">5,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued early discovery expenses</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="rxrx:AccruedEarlyDiscoveryExpensesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-399">7,840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="rxrx:AccruedEarlyDiscoveryExpensesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-400">3,095</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-401">1,956</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="f-402">787</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Materials received not invoiced</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="rxrx:MaterialsReceivedNotInvoiced" format="ixt:num-dot-decimal" scale="3" id="f-403">1,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="rxrx:MaterialsReceivedNotInvoiced" format="ixt:num-dot-decimal" scale="3" id="f-404">1,590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued license fees</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="rxrx:AccruedLicenseFeeCurrent" format="ixt:num-dot-decimal" scale="3" id="f-405">3,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="rxrx:AccruedLicenseFeeCurrent" format="ixt:num-dot-decimal" scale="3" id="f-406">3,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued other expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-407">12,547</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-408">16,735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expense and other liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-409">53,102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-410">81,872</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restructuring</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2025, Recursion announced a reduction in personnel program to help streamline the Company's operating strategy and post-integration efficiencies. These changes resulted in a workforce reduction of approximately <ix:nonFraction unitRef="number" contextRef="c-68" decimals="2" name="us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent" scale="-2" id="f-411">20</ix:nonFraction>%. The Company estimates that it will incur approximately $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="f-412">9.5</ix:nonFraction> million in charges for the workforce reduction, consisting of severance payments and employee benefits. Recursion expects to incur all of these expenses in the year ending December&#160;31, 2025. Recursion records these costs in &#8220;General and Administrative&#8221; on the Condensed Consolidated Statement of Operations as incurred. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="f-413" continuedAt="f-413-1" escape="true">The following summarizes the activity related to these restructuring actions and the related accrual as of September&#160;30, 2025:</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-413-1"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"><tr><td style="width:1.0%"/><td style="width:77.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.212%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:fixed-zero" scale="3" id="f-414">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="f-415">8,516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsForRestructuring" format="ixt:num-dot-decimal" scale="3" id="f-416">7,717</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2025</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RestructuringReserve" scale="3" id="f-417">799</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock" id="f-418" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Income, Net</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.490%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:InvestmentIncomeNonoperating" format="ixt:num-dot-decimal" scale="3" id="f-419">5,540</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:InvestmentIncomeNonoperating" format="ixt:num-dot-decimal" scale="3" id="f-420">3,826</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InvestmentIncomeNonoperating" format="ixt:num-dot-decimal" scale="3" id="f-421">16,541</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:InvestmentIncomeNonoperating" format="ixt:num-dot-decimal" scale="3" id="f-422">11,138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:InterestExpenseNonoperating" scale="3" id="f-423">833</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:InterestExpenseNonoperating" scale="3" id="f-424">553</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestExpenseNonoperating" format="ixt:num-dot-decimal" scale="3" id="f-425">1,821</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:InterestExpenseNonoperating" scale="3" id="f-426">967</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="3" id="f-427">4,707</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="3" id="f-428">3,273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="3" id="f-429">14,720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="3" id="f-430">10,171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September 30, 2025 and 2024, interest income primarily related to earnings on cash and cash equivalents in money market funds. Interest expense primarily related to the Company&#8217;s supercomputer financing lease. Interest income, net was included in &#8220;Other income (loss), net&#8221; on the Condensed Consolidated Statements of Operations.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="i5bc8ea8f307049f2861df48b957318f8_46"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 4. <ix:nonNumeric contextRef="c-1" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="f-431" continuedAt="f-431-1" escape="true">Acquisitions</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-431-1" continuedAt="f-431-2"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RE Ventures I</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2025, Recursion acquired Rallybio&#8217;s interest in the joint venture, RE Ventures I, such that Recursion now owns <ix:nonFraction unitRef="number" contextRef="c-69" decimals="2" name="rxrx:AssetAcquisitionEquityOwnershipPercentage" scale="-2" id="f-432">100</ix:nonFraction>% of the interest in RE Ventures I for total consideration of $<ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-5" name="us-gaap:AssetAcquisitionConsiderationTransferred" scale="6" id="f-433">20.2</ix:nonFraction> million. Recursion determined that this </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_7">Table of Contents</a></span></div></div><ix:continuation id="f-431-2" continuedAt="f-431-3"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">transaction met the criteria for as an asset acquisition since the lead asset, ENPP1 (Rec-102), an inhibitor program for the treatment of hypophosphatasia (HPP), represented substantially all of the fair value of the gross assets acquired. For the three months ended September 30, 2025, Recursion recorded an expense of $<ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-5" name="us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment" scale="6" id="f-434">20.2</ix:nonFraction> million, representing an acquired in-process research and development (IPR&amp;D) asset with no alternative future use, to &#8220;Research and Development&#8221; on the Condensed Consolidated Statements of Operations. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to closing, in August 2025, Recursion issued additional consideration as part of a required milestone payment related to the RE Ventures I transaction for the initiation of an additional preclinical study. This included the settlement of the previously recorded contingent consideration liability. As a result, Recursion recorded an additional expense of $<ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-3" name="us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment" scale="6" id="f-435">2.4</ix:nonFraction> million acquired IPR&amp;D, which was recorded to &#8220;Research and Development&#8221; on the Condensed Consolidated Statements of Operations. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:AssetAcquisitionTableTextBlock" id="f-436" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the total consideration transferred at acquisition date:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recursion Class A common stock</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-3" name="us-gaap:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" format="ixt:num-dot-decimal" scale="3" id="f-437">7,815</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liability</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-3" name="us-gaap:AssetAcquisitionConsiderationTransferredContingentConsideration" format="ixt:num-dot-decimal" scale="3" id="f-438">11,875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transactions costs</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-3" name="us-gaap:AssetAcquisitionConsiderationTransferredTransactionCost" scale="3" id="f-439">292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-3" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="3" id="f-440">171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-3" name="us-gaap:AssetAcquisitionConsiderationTransferred" format="ixt:num-dot-decimal" scale="3" id="f-441">20,153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:AssetAcquisitionContingentConsiderationTableTextBlock" id="f-442" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the consideration transferred for the milestone:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recursion Class A common stock</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-3" name="rxrx:AssetAcquisitionContingentConsiderationEquityInterestIssuedAndIssuable" format="ixt:num-dot-decimal" scale="3" id="f-443">12,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-3" name="rxrx:AssetAcquisitionContingentConsiderationCashPaid" format="ixt:num-dot-decimal" scale="3" id="f-444">1,768</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-3" name="us-gaap:AssetAcquisitionConsiderationTransferredContingentConsideration" format="ixt:num-dot-decimal" scale="3" id="f-445">14,268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the agreement, Rallybio is eligible to receive additional milestone payments under certain conditions. Milestone payment obligations that are incurred prior to regulatory approval of the compound will be expensed as acquired IPR&amp;D when recognized.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sale of Exscientia GmbH</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2025, Recursion completed the sale of its Austrian operations (Exscientia GmbH) to a newly formed company, Alpha Biotechnology GmbH (Alpha). As part of the sale, Recursion obtained a <ix:nonFraction unitRef="number" contextRef="c-73" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-446">49</ix:nonFraction>% equity interest in Alpha. Recursion entered into this transaction as part of focusing its efforts and moderating spend. Alpha is a company leveraging a patient-tissue platform for the development of precision therapeutics for the treatment of hematological and solid cancers. For the nine months ended September 30, 2025, Recursion recorded a loss on the disposal of Exscientia GmbH of $<ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-5" sign="-" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="f-447">4.5</ix:nonFraction> million, which was classified as &#8220;Other income (loss), net&#8221; on the Condensed Consolidated Statement of Operations. Recursion also recorded a $<ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-5" name="us-gaap:EquityMethodInvestments" scale="6" id="f-448">4.4</ix:nonFraction> million investment on the Condensed Consolidated Balance Sheet within &#8220;Other assets, non-current&#8221; related to its <ix:nonFraction unitRef="number" contextRef="c-73" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-449">49</ix:nonFraction>% equity interest in Alpha, which was determined to be an equity method investment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Exscientia plc</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, Recursion acquired all of the outstanding equity interests of Exscientia plc (&#8220;Exscientia&#8221;), a United Kingdom based public company that was registered on the Nasdaq Global Select Market. Exscientia is a drug design company utilizing its artificial intelligence platform to efficiently design and develop differentiated medicines for diseases with high unmet patient needs. Their focus is on utilizing their platform to develop best in class molecules with improvements to known or likely points of failure to improve the probability of developmental success. The Company believes the combination of the Recursion and Exscientia platforms and pipelines will position it to be a leader of the AI-enabled drug discovery and development space.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_7">Table of Contents</a></span></div></div><ix:continuation id="f-431-3" continuedAt="f-431-4"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition of Exscientia was accounted for as a business combination using the acquisition method of accounting. The consideration transferred of approximately $<ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="f-450">630.1</ix:nonFraction> million consisted of $<ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" scale="6" id="f-451">616.9</ix:nonFraction> million in Recursion Class A shares and $<ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-5" name="rxrx:BusinessCombinationConsiderationTransferredEquityInterestsIssuable" scale="6" id="f-452">13.2</ix:nonFraction> million related to the portion of Exscientia share based awards that were replaced with Recursion share based awards that is attributable to pre-combination service. Approximately <ix:nonFraction unitRef="shares" contextRef="c-76" decimals="-5" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" scale="6" id="f-453">102.1</ix:nonFraction> million Recursion Class A shares were issued in exchange for Exscientia ordinary shares using a fixed exchange ratio of one Exscientia ordinary share converts to <ix:nonFraction unitRef="shares" contextRef="c-77" decimals="INF" name="rxrx:BusinessCombinationEquityInterestIssuedOrIssuableSharesOfAcquirerStockPerShareOfAcquireeStockOutstanding" scale="0" id="f-454">0.7729</ix:nonFraction> Recursion Class A shares (the &#8220;Exchange Ratio&#8221;). In addition, Recursion replaced all outstanding Exscientia share based awards with Recursion share based awards wherein the vesting schedule and other applicable terms were carried over except for the exercise price of share options which were adjusted using the <ix:nonFraction unitRef="shares" contextRef="c-77" decimals="INF" name="rxrx:BusinessCombinationEquityInterestIssuedOrIssuableSharesOfAcquirerStockPerShareOfAcquireeStockOutstanding" scale="0" id="f-455">0.7729</ix:nonFraction> exchange ratio. This included Exscientia&#8217;s stock options and restricted stock units. Recursion used $<ix:nonFraction unitRef="usdPerShare" contextRef="c-78" decimals="2" name="us-gaap:SharePrice" scale="0" id="f-456">6.04</ix:nonFraction>, the Company&#8217;s share price on November&#160;20, 2024 to calculate the consideration transferred. See Note 10, &#8220;Stock-Based Compensation&#8221; for additional information on the Exscientia share based awards.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the nine months ended September 30, 2025, Recursion updated the deferred tax liabilities from the acquisition, which were incomplete as of December&#160;31, 2024. As a result, Recursion adjusted the provisional deferred tax liabilities to reflect the additional information obtained about the facts and circumstances that existed as of the acquisition date. As a result, deferred tax liabilities and goodwill increased by $<ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="f-457"><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-5" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" id="f-458">6.0</ix:nonFraction></ix:nonFraction> million. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="f-459" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of assets acquired and liabilities assumed as of the acquisition date:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:79.427%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.373%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(in thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-460">277,104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="rxrx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables" format="ixt:num-dot-decimal" scale="3" id="f-461">48,408</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" format="ixt:num-dot-decimal" scale="3" id="f-462">12,843</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-463">61,961</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="rxrx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="f-464">20,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Intangible assets, technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="f-465">182,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Intangible assets, indefinite-lived</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="f-466">129,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" format="ixt:num-dot-decimal" scale="3" id="f-467">1,934</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other assets, non-current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="3" id="f-468">930</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Accounts payable and accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(<ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="f-469">40,780</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(<ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="rxrx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-470">21,679</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(<ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="f-471">120,905</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(<ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-472">23,077</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(<ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" format="ixt:num-dot-decimal" scale="3" id="f-473">1,572</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Total identifiable net assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="f-474">526,438</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-475">103,686</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Total assets acquired and liabilities assumed</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="f-476">630,124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquired contract liabilities in the scope of ASC 606 are an exception to the ASC 805 fair value measurement principle and were measured as if Recursion had originated the acquired contract. <ix:nonFraction unitRef="contract" contextRef="c-80" decimals="INF" name="rxrx:NumberOfAcquiredCustomerContractsWithContractLiabilities" format="ixt-sec:numwordsen" scale="0" id="f-477">Two</ix:nonFraction> acquired customer contracts had contract liabilities and for each contract Recursion reassessed the identification of performance obligations, determination of transaction price, allocation of transaction price and measure of progress for each performance obligation as if Recursion has been party to the original contract and recognized the resulting contract liability as a liability assumed. No contract assets in the scope of ASC 606 were acquired.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The intangible assets of Exscientia consist of the Exscientia artificial intelligence platform and <ix:nonFraction unitRef="inprocessresearchanddevelopmentasset" contextRef="c-80" decimals="INF" name="rxrx:NumberOfInProcessResearchAndDevelopmentAssets" format="ixt-sec:numwordsen" scale="0" id="f-478">four</ix:nonFraction> clinical stage oncology in process research and development (IPR&amp;D) assets. The operating system is a critical tool used for both designing molecules for fulfilling collaboration agreements and Exscientia&#8217;s own research and development projects. The fair value of each intangible asset was valued based on the present value of future discounted cash flows prepared under the multi-period excess earnings method with the significant inputs being the estimates of future revenues, future expenses, the discount rate of <ix:nonFraction unitRef="number" contextRef="c-76" decimals="3" name="rxrx:FiniteLivedIntangibleAssetDiscountRate" scale="-2" id="f-479">10.5</ix:nonFraction>% and probabilities of technological and regulatory success. The platform asset is being amortized on a straight line basis ove</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">r a <ix:nonNumeric contextRef="c-81" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:durwordsen" id="f-480">six year</ix:nonNumeric> useful life. The IPR&amp;D assets </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_7">Table of Contents</a></span></div></div><ix:continuation id="f-431-4"><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">have been assigned an indefinite useful life and will be tested for impairme</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nt prospectively and, if regulatory approval is achieved, will be assigned a useful life and amortization will commence.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill was calculated based on the excess of the consideration transferred over net assets acquired. The goodwill recognized represents the assembled workforce, future research and development projects enabled by the platform that do not yet have sufficient substance to meet the definition of in-process research and development assets and expected synergies such as the integration of Recursion and Exscientia platforms. The goodwill is not deductible for tax purposes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recursion&#8217;s consolidated statement of operations for the nine months ended September 30, 2025 includes $<ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-5" name="us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" scale="6" id="f-481">16.8</ix:nonFraction> million of revenue and $<ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-5" sign="-" name="us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" scale="6" id="f-482">139.4</ix:nonFraction> million of operating loss from Exscientia operations. As the business combination occurred in November 2024, Recursion is still finalizing the allocation of the purchase price to assets acquired and liabilities assumed. The preliminary purchase price allocation reflected in the September&#160;30, 2025 balance sheet is based on the current best estimate of management and subject to change. The Company will finalize the amounts recognized as the information necessary to complete the analysis is obtained and management estimates are further refined. The primary areas subject to finalization are the valuation of intangible assets, right-of-use assets, property and equipment and the valuation of tax assets and liabilities. The Company expects to finalize the purchase price allocation soon but will do so no later than one year from the acquisition date. External specialists have been engaged to assist with certain elements of applying the acquisition method of accounting.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pro forma financial information </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:BusinessAcquisitionProFormaInformationTextBlock" id="f-483" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following pro forma summary presents consolidated revenue and earnings of Recursion as if the Exscientia business combination had occurred on January&#160;1, 2023</span><span style="color:#008080;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:51.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.795%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.797%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Three months ended September 30, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Nine months ended September 30, 2024</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(in thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-3" name="us-gaap:BusinessAcquisitionsProFormaRevenue" format="ixt:num-dot-decimal" scale="3" id="f-484">32,048</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-3" name="us-gaap:BusinessAcquisitionsProFormaRevenue" format="ixt:num-dot-decimal" scale="3" id="f-485">75,643</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Operating loss</span></td><td style="border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(<ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-3" sign="-" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-486">202,645</ix:nonFraction>)</span></td><td style="border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td style="border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(<ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-3" sign="-" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-487">512,213</ix:nonFraction>)</span></td><td style="border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pro forma amounts have been calculated after converting the Exscientia financial information to U.S. GAAP, applying Recursion accounting policies and applying the acquisition method of accounting at January&#160;1, 2023. The pro forma financial information is not necessarily indicative of what the consolidated results of operations would have been had the acquisition been completed on January&#160;1, 2023. In addition, the pro forma financial information is not a projection of the future results of operations of the combined company nor does it reflect the expected realization of any cost savings or synergies associated with the acquisition.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="i5bc8ea8f307049f2861df48b957318f8_49"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 5.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeFinanceLeasesTextBlock" id="f-489" continuedAt="f-489-1" escape="true"><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeasesTextBlock" id="f-488" continuedAt="f-488-1" escape="true">Leases </ix:nonNumeric></ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-489-1" continuedAt="f-489-2"><ix:continuation id="f-488-1" continuedAt="f-488-2"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into various long-term real estate operating leases primarily related to office, research and development and operating activities and an equipment financing lease related to the supercomputer. The Company&#8217;s leases have remaining terms from under <ix:nonNumeric contextRef="c-84" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" format="ixt-sec:durwordsen" id="f-490">one year</ix:nonNumeric> to <ix:nonNumeric contextRef="c-85" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" format="ixt-sec:durwordsen" id="f-491">eight years</ix:nonNumeric> and some of those leases include options that provide Recursion with the ability to extend the lease term, generally for <ix:nonNumeric contextRef="c-4" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:duryear" id="f-492">5</ix:nonNumeric> years. The options are included in the lease term when it is reasonably certain that the option will be exercised. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September 30, 2025, Recursion entered into lease modifications and terminations resulting in a decrease to the right-of-use asset and lease liability of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="rxrx:LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications" format="ixt:num-dot-decimal" scale="6" id="f-493"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="rxrx:IncreaseDecreaseInOperatingLeaseRightOfUseAssets" format="ixt:num-dot-decimal" scale="6" id="f-494">10.1</ix:nonFraction></ix:nonFraction>&#160;million.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This impact included the lease surrender of the Vienna facilities of Exscientia GmbH in </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 2025</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which resulted in a $<ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-5" sign="-" name="rxrx:IncreaseDecreaseInOperatingLeaseRightOfUseAssets" scale="6" id="f-495"><ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-5" sign="-" name="rxrx:LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications" scale="6" id="f-496">5.2</ix:nonFraction></ix:nonFraction> million reduction to both the right-of-use asset and lease liability. In connection with this surrender, the Company also incurred a lease termination fee of $<ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-5" name="rxrx:TerminationOfLeaseFee" scale="6" id="f-497">5.2</ix:nonFraction> million, which was classified as &#8220;Other income (loss), net&#8221; on the Condensed Consolidated Statement of Operations. Additionally, the Company entered into a lease modification related to the Schrodinger leases to decrease the lease terms, which now ended during the second quarter of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This resulted in a decrease to both the right-of-use asset and lease liability by $<ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-5" sign="-" name="rxrx:IncreaseDecreaseInOperatingLeaseRightOfUseAssets" scale="6" id="f-498"><ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-5" sign="-" name="rxrx:LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications" scale="6" id="f-499">4.9</ix:nonFraction></ix:nonFraction> million. As a part of the lease modifications and termination, Recursion recorded leasehold impairments of $<ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-5" name="us-gaap:ImpairmentOfLeasehold" scale="6" id="f-500">6.0</ix:nonFraction> million. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended September 30, 2024,</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Recursion entered into operating lease modifications and additions resulting in an increase to the right-of-use asset and lease liability of $<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-5" name="rxrx:IncreaseDecreaseInOperatingLeaseRightOfUseAssets" scale="6" id="f-501"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-5" name="rxrx:LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications" scale="6" id="f-502">19.5</ix:nonFraction></ix:nonFraction> million. The modifications had </span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_7">Table of Contents</a></span></div></div><ix:continuation id="f-489-2"><ix:continuation id="f-488-2"><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">no impact to the Condensed Consolidated Statements of Operations. For the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended September 30, 2024,</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Recursion entered into finance lease additions resulting in an increase to the right-of-use asset and lease liability of $<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-5" name="rxrx:LesseeFinanceLeaseIncreaseDecreaseInFinanceLeaseLiabilityDueToLeaseModifications" scale="6" id="f-503"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-5" name="rxrx:IncreaseDecreaseInRightOfUseAssetsForFinanceLeases" scale="6" id="f-504">29.3</ix:nonFraction></ix:nonFraction> million. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LeaseCostTableTextBlock" id="f-505" escape="true"><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases were:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.666%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.199%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amount included in the measurement of lease liabilities: </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="f-506">14,756</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="f-507">10,742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from financing leases</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" format="ixt:num-dot-decimal" scale="3" id="f-508">1,368</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="f-509">379</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from financing leases</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" format="ixt:num-dot-decimal" scale="3" id="f-510">6,174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" format="ixt:num-dot-decimal" scale="3" id="f-511">2,261</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets additions, modifications and termination:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="rxrx:IncreaseDecreaseInOperatingLeaseRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="f-512">10,084</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="rxrx:IncreaseDecreaseInOperatingLeaseRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="f-513">19,455</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing leases</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="rxrx:IncreaseDecreaseInRightOfUseAssetsForFinanceLeases" format="ixt:fixed-zero" scale="3" id="f-514">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="rxrx:IncreaseDecreaseInRightOfUseAssetsForFinanceLeases" format="ixt:num-dot-decimal" scale="3" id="f-515">29,342</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="i5bc8ea8f307049f2861df48b957318f8_52"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 6.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="f-516" continuedAt="f-516-1" escape="true">Goodwill and Intangible Assets </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-516-1"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfGoodwillTextBlock" id="f-517" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in the carrying amount of goodwill: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.836%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-518">148,873</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="f-519">5,947</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-520">7,222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2025</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-521">162,042</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="INF" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="f-522"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="INF" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="f-523"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="INF" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="f-524"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="INF" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="f-525">No</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> goodwill impairment was recorded during the three and nine months ended September 30, 2025 and 2024.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets, Net</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" id="f-527" escape="true"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="f-526" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes intangible assets:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:21.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.888%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross carrying amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net carrying amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross carrying amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net carrying amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Definite-lived technology intangible assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-528">236,443</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-529">57,806</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-530">178,637</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-531">224,362</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-532">24,544</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-533">199,818</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Definite-lived licensed intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-534">11,508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-535">5,679</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-536">5,829</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-537">9,350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-538">2,088</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-539">7,262</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-540">137,878</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-541">137,878</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-542">128,775</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-543">128,775</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-544">385,829</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-545">63,485</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-546">322,344</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-547">362,487</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-548">26,632</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-549">335,855</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense was $<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-550">13.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-551">37.4</ix:nonFraction> million during the three and nine months ended September 30, 2025, respectively. Amortization expense was $<ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-552">4.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-553">11.3</ix:nonFraction> million during the three and nine months ended September 30, 2024, respectively. Amortization expense was included in &#8220;Research and Development&#8221; and &#8220;Cost of Revenue&#8221; in the Condensed Consolidated Statements of Operations. <ix:nonFraction unitRef="usd" contextRef="c-20" decimals="INF" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" format="ixt:fixed-zero" scale="0" id="f-554"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="INF" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" format="ixt:fixed-zero" scale="0" id="f-555"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="INF" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" format="ixt:fixed-zero" scale="0" id="f-556"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="INF" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" format="ixt:fixed-zero" scale="0" id="f-557">No</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> indefinite-lived intangible asset impairment charges were recorded during the three and nine months ended September 30, 2025 and 2024.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><div id="i5bc8ea8f307049f2861df48b957318f8_55"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Or Note 7. <ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="f-558" continuedAt="f-558-1" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-558-1" continuedAt="f-558-2"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Obligations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company enters into contracts with clinical research organizations, drug manufacturers and other vendors&#160;for preclinical and clinical research studies, research and development supplies and other services and products for operating purposes. These contracts generally provide for termination on notice and are cancellable contracts.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indemnification</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has agreed to indemnify its officers and directors for certain events or occurrences, while the officer or director is or was serving at the Company&#8217;s request in such capacity. The Company purchases directors and officers liability insurance coverage that provides for reimbursement to the Company for covered obligations and this is intended to limit the Company&#8217;s exposure and enable it to recover a portion of any amount it pays under its indemnification obligations. The Company had <ix:nonFraction unitRef="usd" contextRef="c-4" decimals="INF" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:fixed-zero" scale="0" id="f-559"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="INF" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:fixed-zero" scale="0" id="f-560">no</ix:nonFraction></ix:nonFraction> liabilities recorded for these agreements as of September&#160;30, 2025 and December&#160;31, 2024, as no amounts were probable. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Agreements </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has signed employment agreements with certain key employees pursuant to which, if their employment is terminated following a change of control of the Company, the employees are entitled to receive certain benefits, including accelerated vesting of equity incentives. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Matters</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may, from time to time, be involved in various legal proceedings arising in the normal course of business. An unfavorable resolution of any such matter could materially affect the Company&#8217;s future financial position, results of operations or cash flows. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April 2024</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a putative class action complaint was filed in the U.S. District Court for the District of New Jersey against Exscientia plc, Andrew Hopkins, Ben R. Taylor and David Nicholson (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Campanile v. Exscientia plc, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Case No. 1:24-cv-05692). In </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June 2024</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a separate complaint was filed against the same defendants in the U.S. District Court for the District of New Jersey (Case 1:24-cv-07181). Both complaints allege that the defendants violated federal securities laws by, among other things, making materially false and misleading statements regarding Exscientia&#8217;s business, operations and prospects. The complaints seek unspecified compensatory damages, as well as an award of reasonable attorneys&#8217; fees and other costs, on behalf of persons and/or entities which purchased Exscientia securities between </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 2022</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 2024</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The cases were consolidated and plaintiffs filed an amended complaint on November 11, 2024 against Exscientia plc, Andrew Hopkins and David Nicholson, and the Company moved to dismiss on January 21, 2025. On </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">October&#160;7, 2025</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that motion to dismiss was granted and the District Court dismissed the plaintiff&#8217;s claims without prejudice; permitting leave to re-file the complaint within <ix:nonNumeric contextRef="c-93" name="rxrx:DurationOfTimeForPlaintiffToRefileClaim" format="ixt-sec:durday" id="f-561">30</ix:nonNumeric> days. As of </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;30, 2025</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company had <ix:nonFraction unitRef="usd" contextRef="c-4" decimals="INF" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:fixed-zero" scale="0" id="f-562">no</ix:nonFraction> liability recorded for these events as an unfavorable outcome was not probable.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, the Company entered into a lease agreement for laboratory and office space (the Industry Lease) with Industry Office SLC, LLC (the landlord). In March 2023, the Company sent a letter to the landlord detailing numerous construction delays and irregularities, deficiencies and deviations from applicable structural drawings and/or non-conforming conditions with applicable building codes (collectively, the Claims). On June&#160;23, 2023, the landlord filed a lawsuit against the Company (Industry Office SLC, LLC v. Recursion Pharmaceuticals, Inc., Case No. 230904627) amended in October 2023, in the Third District Court for Salt Lake County, State of Utah (the Court), alleging anticipatory repudiation, breach of contract and breach of the implied covenant of good faith and fair dealing and seeks monetary damages and attorney&#8217;s fees. As of September&#160;30, 2025, the Company had <ix:nonFraction unitRef="usd" contextRef="c-4" decimals="INF" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:fixed-zero" scale="0" id="f-563">no</ix:nonFraction> liability recorded for these events as an unfavorable outcome was not probable. In September 2023, the Company filed claims in the Court against the landlord alleging, among other things, breach of contract and fraudulent misrepresentation (the Counterclaims). In October 2023, the landlord filed an answer and denied the Company&#8217;s allegations asserted in the Counterclaims. In </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">October 2025</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company filed a motion for summary judgment against the Claims and in favor of a number of its Counterclaims, which remains pending. The Company is unable to estimate the possible amount or range of damages associated with the Counterclaims.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_7">Table of Contents</a></span></div></div><div><span><br/></span></div><ix:continuation id="f-558-2"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pledged Assets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2025, assets pledged as collateral against finance leases totaled $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="rxrx:FinanceLeasesAssetsPledgedAsCollateral" scale="6" id="f-564">19.5</ix:nonFraction> million. Assets pledged as collateral are Lab Equipment reported in &#8220;Property and Equipment, net&#8221; on the Condensed Consolidated Balance Sheet. As of September&#160;30, 2025, the liabilities associated with collateral pledged were solely comprised of a finance lease and had a carrying value of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:FinanceLeaseLiability" scale="6" id="f-565">20.5</ix:nonFraction> million. The collateral pledged under the lease agreement may only be operated by the Company within the continental United States and must maintain a good title. The assets cannot be sold, disposed of or repledged by the Company.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="i5bc8ea8f307049f2861df48b957318f8_58"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 8. <ix:nonNumeric contextRef="c-1" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="f-566" continuedAt="f-566-1" escape="true">Common Stock </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-566-1" continuedAt="f-566-2"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each share of Class A common stock entitles the holder to <ix:nonFraction unitRef="vote" contextRef="c-6" decimals="INF" name="rxrx:CommonStockVotePerShare" format="ixt-sec:numwordsen" scale="0" id="f-567">one</ix:nonFraction> vote per share and each share of Class B common stock entitles the holder to <ix:nonFraction unitRef="vote" contextRef="c-9" decimals="INF" name="rxrx:CommonStockVotePerShare" scale="0" id="f-568">10</ix:nonFraction> votes per share on all matters submitted to a vote of the Company&#8217;s stockholders. Common stockholders are entitled to receive dividends, as may be declared by the Company&#8217;s Board of Directors. As of September&#160;30, 2025 and December&#160;31, 2024, <ix:nonFraction unitRef="usd" contextRef="c-94" decimals="INF" name="us-gaap:DividendsStock" format="ixt:fixed-zero" scale="0" id="f-569"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="INF" name="us-gaap:DividendsStock" format="ixt:fixed-zero" scale="0" id="f-570">no</ix:nonFraction></ix:nonFraction> dividends had been declared. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">At-The-Market Offering (Citi)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 2025</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, following the termination of the Jefferies Sales Agreement, the Company entered into a Sales Agreement (the Citi Sales Agreement) with Citigroup Capital Markets Inc. (Citi) to provide for the offering, issuance and sale of up to an aggregate amount of $<ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-6" name="rxrx:SaleOfStockValueAuthorized" scale="6" id="f-571">500</ix:nonFraction> million of its Class A common stock from time to time in &#8220;at-the-market&#8221; offerings (the Citi ATM Offering). The Citi ATM Offering was made under a prospectus supplement dated February&#160;28, 2025 and related prospectus filed with the Securities and Exchange Commission pursuant to the Company&#8217;s automatically effective shelf registration statement on Form S-3 (Registration No. 333-284878). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September 30, 2025, the Company sold <ix:nonFraction unitRef="shares" contextRef="c-96" decimals="-5" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="6" id="f-572">74.6</ix:nonFraction>&#160;million shares and received net proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="f-573">358.2</ix:nonFraction> million under the agreement. As of&#160;September&#160;30, 2025, an amount of $<ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-5" name="rxrx:SaleOfStockValueRemainingAuthorized" scale="6" id="f-574">136.4</ix:nonFraction> million remained available for future sales under the Sales Agreement. The remaining amount was fully utilized during October 2025, see Note 15, &#8220;Subsequent Events</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; for additional details.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">At-The-Market Offering (Jefferies)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">August 2023</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company entered into an Open Market Sales Agreement (the &#8220;Jefferies Sales Agreement&#8221;) with Jefferies LLC ( &#8220;Jefferies&#8221;), to provide for the offering, issuance and sale of up to an aggregate amount of $<ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-5" name="rxrx:SaleOfStockValueAuthorized" scale="6" id="f-575">300.0</ix:nonFraction> million of its Class A common stock from time to time in &#8220;at-the-market&#8221; (ATM) offerings. In </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 2025</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company terminated the Jefferies Sales Agreement. In total, the Company sold <ix:nonFraction unitRef="shares" contextRef="c-99" decimals="-5" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="6" id="f-576">26.8</ix:nonFraction>&#160;million shares and received net proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="f-577">199.1</ix:nonFraction> million under the agreement through its termination. Of the total sales and net proceeds, the Company sold <ix:nonFraction unitRef="shares" contextRef="c-100" decimals="-5" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="6" id="f-578">4.9</ix:nonFraction>&#160;million shares and received net proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="f-579">36.9</ix:nonFraction> million under the agreement in 2025,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">prior to its termination. The Company paid Jefferies a commission of up to <ix:nonFraction unitRef="number" contextRef="c-99" decimals="2" name="rxrx:SaleOfStockPercentageOfCommission" scale="-2" id="f-580">3</ix:nonFraction>% of the aggregate gross proceeds received from all sales of Class A common stock. The Jefferies ATM Offering was made under a prospectus supplement dated August&#160;8, 2023 and related prospectus filed with the Securities and Exchange Commission pursuant to the Company&#8217;s automatically effective shelf registration statement on Form S-3ASR (Registration No. 333-264845). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Public Offering of Common Stock</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2024, the Company closed its public offering of Class A common stock and issued <ix:nonFraction unitRef="shares" contextRef="c-101" decimals="-5" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="6" id="f-581">35.4</ix:nonFraction>&#160;million shares at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-102" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-582">6.50</ix:nonFraction> per share for net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="f-583">216.4</ix:nonFraction> million, after deducting transaction costs of $<ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-5" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="6" id="f-584">13.6</ix:nonFraction> million. In connection with the public offering of Class A common stock, the Company entered into an underwriting agreement for the offering and sale of <ix:nonFraction unitRef="shares" contextRef="c-103" decimals="-5" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="6" id="f-585">30.8</ix:nonFraction>&#160;million shares. The Company also granted the Underwriters a <ix:nonNumeric contextRef="c-104" name="rxrx:SaleOfStockUnderwritersOptionPeriodFromTheDateOfTheAgreement" format="ixt-sec:durday" id="f-586">30</ix:nonNumeric> day option from the date of the underwriting agreement to purchase up to an additional <ix:nonFraction unitRef="shares" contextRef="c-105" decimals="-5" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="6" id="f-587">4.6</ix:nonFraction>&#160;million shares of Class A Common Stock, which was exercised in full. The public offering was made pursuant to the Company's effective registration statement on Form S-3 (File No. 333-264845) and a related prospectus supplement and accompanying prospectus dated June&#160;26, 2024.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_7">Table of Contents</a></span></div></div><div><span><br/></span></div><ix:continuation id="f-566-2" continuedAt="f-566-3"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Valence Acquisition Exchangeable Shares</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May 2023</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, in connection with the acquisition of Valence, the Company entered into an agreement to issue up to <ix:nonFraction unitRef="shares" contextRef="c-106" decimals="-5" name="rxrx:BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares" format="ixt:num-dot-decimal" scale="6" id="f-588">5.9</ix:nonFraction>&#160;million shares of Class A common stock (the &#8220;Exchangeable Shares&#8221;), that may be issued upon exchange, retraction or redemption of exchangeable shares of a subsidiary of Recursion. Each exchangeable share of the subsidiary of Recursion entitles the holder to exchange those shares on a <ix:nonFraction unitRef="number" contextRef="c-107" decimals="INF" name="rxrx:CommonStockConversionRatio" format="ixt-sec:numwordsen" scale="0" id="f-589">one</ix:nonFraction>-for-one basis for Recursion&#8217;s Class A common stock. The shares are entitled to receive dividends economically equivalent to dividends declared by Recursion, are non-voting and are subject to customary adjustments for stock splits or other reorganizations. In addition, the Company may require all outstanding exchangeable shares to be exchanged into an equal number of Class A common stock upon the occurrence of certain events and at any time following the seventh anniversary of the closing of the Valence acquisition. The exchangeable shares are substantially the economic equivalent of the Class A shares and classified as common stock within the Company&#8217;s stockholders&#8217; equity. The Company&#8217;s calculation of weighted-average shares outstanding includes the exchangeable shares. As of September&#160;30, 2025, <ix:nonFraction unitRef="shares" contextRef="c-108" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="6" id="f-590">5.0</ix:nonFraction>&#160;million Exchangeable shares have been redeemed for Class A shares.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Registration Rights Agreements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Tempus agreement</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">November 2023</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, in connection with the Tempus Agreement, the Company agreed to prepare and file a registration statement (or a prospectus supplement to an effective registration statement on Form S-3ASR that will become automatically effective upon filing with the SEC pursuant to Rule 462(e)) with the SEC, for resale of the shares of Class A common stock issued or issuable under the Tempus Agreement. A prospectus supplement to a registration statement (File No. 333-264845) was subsequently filed in December 2023 to register shares issued to Tempus for the initial license fee under the Tempus Agreement for resale. In December 2024, a prospectus supplement to a registration statement (File No. 333-264845) was filed to register shares issued to Tempus in payment for the 2024 annual fee. Such registration statement (File No. 333-264845) expired.  A new registration statement (333-284878) was filed in February 2025 and a prospectus supplement covering all shares that have been issued under the Tempus Agreement and remained held by Tempus was filed in May 2025.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After registration of any shares issued to Tempus under the Tempus Agreement, the Company has agreed to use commercially reasonable efforts to keep such registration statement effective until such date that all shares issued to Tempus covered by such registration statement have been sold or are able to be publicly sold by relying on Rule 144 of the Securities Act without registration.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Acquisitions</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, in connection with the acquisition of Exscientia, the Company filed a Registration Statement on Form S-8 (File No. 333-283347) to register the shares of Class A common stock issuable upon exercise or settlement, as applicable, of Recursion stock options and RSUs issued under the assumed Exscientia plans and the Inducement awards. The Company has agreed to use commercially reasonable efforts to maintain the effectiveness of such registration statement as long as such Recursion stock options and RSUs issued under the assumed Exscientia plans remain outstanding.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2023, in connection with the acquisition of Valence, the Company entered into a Registration Agreement providing for the registration for resale of the shares of Class A common stock and Exchange Shares issued or issuable in such transaction. A registration statement on Form S-3ASR (File No. 333-272281) was filed to register the shares for resale by the holders. The registration statement must remain effective for a period of not less than <ix:nonNumeric contextRef="c-109" name="rxrx:RegistrationRightsAgreementTerm" format="ixt-sec:durwordsen" id="f-591">three years</ix:nonNumeric>. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Class A and B Common Shares Authorization</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, the Company&#8217;s Board of Directors authorized <ix:nonFraction unitRef="class" contextRef="c-110" decimals="INF" name="rxrx:NumberOfClassesOfCommonStockAuthorized" format="ixt-sec:numwordsen" scale="0" id="f-592">two</ix:nonFraction> classes of common stock, Class A and Class B. The rights of the holders of Class A and B common stock are identical, except with respect to voting and conversion. Each share of Class A common stock is entitled to <ix:nonFraction unitRef="vote" contextRef="c-6" decimals="INF" name="rxrx:CommonStockVotePerShare" format="ixt-sec:numwordsen" scale="0" id="f-593">one</ix:nonFraction> vote per share. Each share of Class B common stock is entitled to <ix:nonFraction unitRef="vote" contextRef="c-9" decimals="INF" name="rxrx:CommonStockVotePerShare" scale="0" id="f-594">10</ix:nonFraction> votes per share and is convertible at any time into <ix:nonFraction unitRef="number" contextRef="c-6" decimals="INF" name="rxrx:CommonStockConversionRatio" format="ixt-sec:numwordsen" scale="0" id="f-595">one</ix:nonFraction> share of Class A common stock.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All Class B common stock is held by Christopher Gibson, Ph.D., the Company&#8217;s Chief Executive Officer (CEO), or his affiliates. As of September&#160;30, 2025, Dr. Gibson and his affiliates held outstanding shares of Class B common </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_7">Table of Contents</a></span></div></div><ix:continuation id="f-566-3"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">stock representing approximately <ix:nonFraction unitRef="number" contextRef="c-111" decimals="2" name="rxrx:AffiliatedHoldersOwnershipPercentage" scale="-2" id="f-596">12</ix:nonFraction>% of the voting power of the Company&#8217;s outstanding shares. This voting power may increase over time as Dr. Gibson vests in and exercises equity awards outstanding. If all the exchangeable equity awards held by Dr. Gibson had been fully vested, exercised and exchanged for shares of Class B common stock as of September&#160;30, 2025, Dr. Gibson and his affiliates would hold approximately <ix:nonFraction unitRef="number" contextRef="c-111" decimals="2" name="rxrx:AffiliatedHoldersPotentialOwnershipPercentageWhenOutstandingEquityAwardsVest" scale="-2" id="f-597">13</ix:nonFraction>% of the voting power of the Company&#8217;s outstanding shares. As a result, Dr. Gibson will be able to significantly influence any action requiring the approval of Recursion stockholders, including the election of the Board of Directors; the adoption of amendments to the Company&#8217;s certificate of incorporation and bylaws; and the approval of any merger, consolidation, sale of all or substantially all of the Company&#8217;s assets, or other major corporate transaction.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="i5bc8ea8f307049f2861df48b957318f8_61"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note&#160;9. <ix:nonNumeric contextRef="c-1" name="us-gaap:CollaborativeArrangementDisclosureTextBlock" id="f-598" continuedAt="f-598-1" escape="true">Collaborative Development Contracts </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-598-1" continuedAt="f-598-2"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sanofi</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Description</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">January 2022</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company and Sanofi entered into a collaboration agreement to develop an AI-driven pipeline of precision-engineered medicines. The research is focused on up to <ix:nonFraction unitRef="candidate" contextRef="c-112" decimals="INF" name="rxrx:ContractWithCustomerNumberOfNovelSmallMoleculeCandidates" scale="0" id="f-599">15</ix:nonFraction> novel small molecule candidates across oncology and immunology and utilizes the Company&#8217;s AI platform. The Company is leading small molecule drug design and lead optimization activities with Sanofi assuming responsibility for preclinical and clinical development, manufacturing and commercialization.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Pricing</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company received a $<ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-5" name="us-gaap:ContractWithCustomerLiability" scale="6" id="f-600">100.0</ix:nonFraction> million non-refundable upfront payment. In </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April 2025</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Recursion received a $<ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-5" name="rxrx:CollaborativeArrangementMilestonePaymentReceived" scale="6" id="f-601">7.0</ix:nonFraction> million payment related to the achievement of a milestone for one of the performance obligations. The Company has also received multiple other milestone payments related to this agreement totaling approximately $<ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="f-602">30.0</ix:nonFraction> million. These related to the advancement of several of the discovery programs within the collaboration and the addition of an existing Company program into the collaboration. Recursion is eligible for additional milestone payments based on performance progress of the collaboration and tiered royalties ranging from high-single-digits to mid-teens. Recursion could earn a maximum of $<ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-5" name="us-gaap:ContractWithCustomerLiability" scale="6" id="f-603">555.0</ix:nonFraction> million from all research milestones and $<ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-8" name="us-gaap:ContractWithCustomerLiability" scale="9" id="f-604">1.8</ix:nonFraction> billion from all development and regulatory milestones.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Accounting</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">November 2024</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Recursion acquired Exscientia as part of an acquisition. See Note 4, &#8220;Acquisitions&#8221; for additional information. As such, the initial Recursion accounting analysis for this transaction was done as of the business combination date as if Recursion had originated the contract. This agreement represents a transaction with a customer and therefore is accounted for in accordance with ASC 606. Recursion has determined that it has at least <ix:nonFraction unitRef="performance_obligation" contextRef="c-117" decimals="INF" name="rxrx:RevenuePerformanceObligationNumberOfObligations" format="ixt-sec:numwordsen" scale="0" id="f-605">eight</ix:nonFraction> performance obligations related to the small molecule projects. These performance obligations are for performing research and development services for Sanofi to design small molecules and perform lead optimization activities. The performance obligations also include potential licenses related to the intellectual property. The Company concluded that licenses within the contract are not distinct from the research and development services as they are interrelated due to the fact that the research and development services significantly impact the potential licenses. Any additional services are considered customer options and will be considered as separate contracts for accounting purposes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has determined the transaction price to be $<ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="f-606">152.9</ix:nonFraction> million, for the initial performance obligations, comprised of the upfront payment, several milestones that have been achieved and estimated additional target exercises. Prior to the three months ended June 30, 2025, Recursion had fully constrained the $<ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-5" name="rxrx:CollaborativeArrangementMilestonePaymentReceived" scale="6" id="f-607">7.0</ix:nonFraction> million variable consideration milestone. Recursion is now recognizing the milestone as part of the transaction price over the completion period for the related performance obligation. Recursion has fully constrained the amounts of remaining variable consideration to be received from potential milestones considering the stage of development and the risks associated with the remaining development required to achieve each milestone. Recursion will re-evaluate the transaction price each reporting period. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction price was generally allocated to the performance obligations based on the estimated relative stand-alone selling price of each performance obligation as determined using an expected cost plus margin approach. The milestone fees were allocated to related performance obligation as the terms of the variable consideration related specifically to Recursion&#8217;s efforts to satisfy the related performance obligation. The Company recognizes revenue over time based on costs incurred relative to total expected costs to perform the research and development services. Recursion determined that this method provides a faithful depiction of the transfer of control to the </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_7">Table of Contents</a></span></div></div><ix:continuation id="f-598-2" continuedAt="f-598-3"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">customer. This method of recognizing revenue requires the Company to make estimates of total costs to provide the services required under the performance obligations. Significant inputs used to determine the total costs included the number of projects to be performed, the number of substitutions related to those projects, length of time required, service hours performed by Company employees and materials costs. A significant change in these estimates could have a material effect on the timing and amount of revenue recognized in future periods. Recursion is unable to estimate the completion date of the performance obligations due to the current stage of work.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Merck KGaA (Merck)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Description</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September 2023</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company and Merck entered into a collaboration agreement to discover novel small molecule drug candidates across oncology, neuroinflammation and immunology. The collaboration utilizes the Company&#8217;s AI platform and the Company is performing drug design and discovery while Merck will be assuming responsibility for the preclinical and clinical development.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Pricing</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company received a $<ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-5" name="us-gaap:ContractWithCustomerLiability" scale="6" id="f-608">20.1</ix:nonFraction> million non-refundable upfront payment. Recursion is eligible for additional milestone payments based on performance progress of the collaboration and tiered royalties from the mid-single-digits to low-double-digits. The Company could earn a maximum of $<ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-5" name="us-gaap:ContractWithCustomerLiability" scale="6" id="f-609">73.0</ix:nonFraction> million for discovery, development and sales milestones per project.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Accounting</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">November 2024</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Recursion acquired Exscientia as part of an acquisition. See Note 4, &#8220;Acquisitions&#8221; for additional information. As such, the initial Recursion accounting analysis for this transaction was done as of the business combination date as if Recursion had originated the contract. This agreement represents a transaction with a customer and therefore is accounted for in accordance with ASC 606. Recursion has determined that it has <ix:nonFraction unitRef="performance_obligation" contextRef="c-121" decimals="INF" name="rxrx:RevenuePerformanceObligationNumberOfObligations" format="ixt-sec:numwordsen" scale="0" id="f-610">three</ix:nonFraction> performance obligations related to each project in the partnership. These performance obligations are for performing research and development services for Merck to design small molecules and perform lead optimization activities. The performance obligations also include potential licenses related to the intellectual property. The Company concluded that licenses within the contract are not distinct from the research and development services as they are interrelated due to the fact that the research and development services significantly impact the potential licenses. Any additional services are considered customer options and will be considered as separate contracts for accounting purposes. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has determined the transaction price to be $<ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="f-611">20.1</ix:nonFraction> million, for the initial performance obligations, comprised of the upfront payment. Recursion will fully constrain the amounts of remaining variable consideration to be received from potential milestones considering the stage of development and the risks associated with the remaining development required to achieve each milestone. Recursion will re-evaluate the transaction price each reporting period. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction price was allocated to the performance obligations based on the estimated relative stand-alone selling price of each performance obligation as determined using an expected cost plus margin approach. The Company recognizes revenue over time based on costs incurred relative to total expected costs to perform the research and development services. Recursion determined that this method provides a faithful depiction of the transfer of control to the customer. This method of recognizing revenue requires the Company to make estimates of total costs to provide the services required under the performance obligations. Significant inputs used to determine the total costs included the number of projects to be performed, the number of substitutions related to those projects, length of time required, service hours performed by Company employees and materials costs. A significant change in these estimates could have a material effect on the timing and amount of revenue recognized in future periods. Recursion was unable to estimate the completion date of the performance obligations due to the current stage of work.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Roche and Genentech</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Description</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, Recursion entered into a collaboration and license agreement with Roche and Genentech (collectively referred to as Roche). Recursion is constructing, using the Company&#8217;s imaging technology and proprietary machine-learning algorithms, unique maps of the inferred relationships amongst perturbation </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_7">Table of Contents</a></span></div></div><ix:continuation id="f-598-3" continuedAt="f-598-4"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">phenotypes in a given cellular context with the goal to discover and develop therapeutic small molecule programs in a gastrointestinal cancer indication and in key areas of neuroscience. Roche and Recursion will collaborate to select certain novel inferences with respect to small molecules or targets generated from the Phenomaps for further validation and optimization as collaboration programs. Roche and Recursion may also combine sequencing datasets from Roche with Recursion&#8217;s Phenomaps and collaborate to generate new algorithms to produce multi-modal maps from which additional collaboration programs may be initiated. For every collaboration program that successfully identifies potential therapeutic small molecules or validates a target, Roche will have an option to obtain an exclusive license to develop and commercialize such potential therapeutic small molecules or to exploit such target in the applicable exclusive field.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Pricing</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, Recursion received a $<ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-5" name="us-gaap:ContractWithCustomerLiability" scale="6" id="f-612">150.0</ix:nonFraction> million non-refundable upfront payment from the Company&#8217;s collaboration with Roche. In September 2024, Recursion received a $<ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="f-613">30.0</ix:nonFraction> million milestone payment (the &#8220;acceptance fee&#8221;), which was an acceptance fee related to the first accepted neuroscience Phenomap. Recursion is eligible for additional milestone payments based on performance progress of the collaboration. Each of the Phenomaps requested by Roche and created by Recursion may be subject to either an initiation fee, acceptance fee or both. Such fees could exceed $<ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-5" name="rxrx:RevenueRemainingPerformanceObligationVariableConsiderationAmount" scale="6" id="f-614">250.0</ix:nonFraction> million for <ix:nonFraction unitRef="phenomap" contextRef="c-125" decimals="INF" name="rxrx:ContractWithCustomerMaximumAcceptedProduct" scale="0" id="f-615">16</ix:nonFraction> accepted Phenomaps. In addition, for a period of time after Roche&#8217;s acceptance of certain Phenomaps, Roche will have the option to obtain, subject to payment of an exercise fee, rights to use outside the collaboration the raw images generated in the course of creating those Phenomaps. If Roche exercises its external use option for all <ix:nonFraction unitRef="phenomap" contextRef="c-126" decimals="INF" name="rxrx:ContractWithCustomerMaximumAcceptedProduct" scale="0" id="f-616">12</ix:nonFraction> eligible Phenomaps, Roche&#8217;s associated exercise fee payments to Recursion could exceed $<ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-5" name="rxrx:RevenueRemainingPerformanceObligationVariableConsiderationAmount" scale="6" id="f-617">250.0</ix:nonFraction> million. Under the collaboration, Roche may initiate up to <ix:nonFraction unitRef="program" contextRef="c-127" decimals="INF" name="rxrx:RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated" scale="0" id="f-618">40</ix:nonFraction> programs, each of which, if successfully developed and commercialized, could yield more than $<ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-5" name="rxrx:RevenueRemainingPerformanceObligationVariableConsiderationAmount" format="ixt:num-dot-decimal" scale="6" id="f-619">300.0</ix:nonFraction>&#160;million in development, commercialization and net revenue milestones for Recursion, as well as tiered royalties on net revenue.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Accounting</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This agreement represents a transaction with a customer and therefore is accounted for in accordance with ASC 606. Recursion has determined that it has <ix:nonFraction unitRef="performance_obligation" contextRef="c-128" decimals="INF" name="rxrx:RevenuePerformanceObligationNumberOfObligations" format="ixt-sec:numwordsen" scale="0" id="f-620">three</ix:nonFraction> performance obligations, <ix:nonFraction unitRef="performance_obligation" contextRef="c-129" decimals="INF" name="rxrx:RevenuePerformanceObligationNumberOfObligations" format="ixt-sec:numwordsen" scale="0" id="f-621">one</ix:nonFraction> related to gastrointestinal cancer and <ix:nonFraction unitRef="performance_obligation" contextRef="c-130" decimals="INF" name="rxrx:RevenuePerformanceObligationNumberOfObligations" format="ixt-sec:numwordsen" scale="0" id="f-622">two</ix:nonFraction> in neuroscience. These performance obligations are for performing research and development services for Roche to identify targets and medicines. The performance obligations also include potential licenses related to the intellectual property. The Company concluded that licenses within the contract are not distinct from the research and development services as they are interrelated due to the fact that the research and development services significantly impact the potential licenses. Any additional services are considered customer options and will be considered as separate contracts for accounting purposes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has determined the transaction price to be $<ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="f-623">180.0</ix:nonFraction> million, comprised of the upfront payment and the acceptance fee. Prior to the three months ended September 30, 2024, Recursion had fully constrained the $<ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="f-624">30.0</ix:nonFraction> million variable consideration acceptance fee. As a result of Roche&#8217;s acceptance of the neuroscience Phenomap, Recursion is now recognizing the acceptance fee as part of the transaction price over the completion period of one of the neuroscience performance obligations. Recursion has fully constrained the remaining amounts of variable consideration to be received from potential milestones considering the stage of development and the risks associated with the remaining development required to achieve each milestone. Recursion will re-evaluate the transaction price each reporting period. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction price was generally allocated to the performance obligations based on the estimated relative stand-alone selling price of each performance obligation as determined using an expected cost plus margin approach. The acceptance fee was allocated to one of the neuroscience performance obligations as the terms of the variable consideration related specifically to Recursion&#8217;s efforts to satisfy this performance obligation. The Company recognizes revenue over time based on costs incurred relative to total expected costs to perform the research and development services. Recursion determined that this method provides a faithful depiction of the transfer of control to the customer. This method of recognizing revenue requires the Company to make estimates of total costs to provide the services required under the performance obligations. Significant inputs used to determine the total costs included the length of time required, service hours performed by Company employees and materials costs. A significant change in these estimates could have a material effect on the timing and amount of revenue recognized in future periods. Recursion has estimated the completion of the performance obligations by 2026.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_7">Table of Contents</a></span></div></div><div><span><br/></span></div><ix:continuation id="f-598-4" continuedAt="f-598-5"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Additional Revenue Disclosures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Of the revenue recognized during the three and nine months ended September 30, 2025, $<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="f-625">4.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="f-626">36.6</ix:nonFraction> million was included in the unearned revenue balance as of December&#160;31, 2024, respectively. Of the revenue recognized during the three and nine months ended September 30, 2024, $<ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="f-627">4.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="f-628">29.0</ix:nonFraction> million was included in the unearned revenue balance as of December&#160;31, 2023, respectively. Revenue recognized was from the upfront and variable consideration payments received from the related contracts, which decreased the aggregate unearned revenue recognized. As of September&#160;30, 2025, the Company had $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="6" id="f-629">5.6</ix:nonFraction> million of costs incurred to fulfill a contract on its Condensed Consolidated Balance Sheet within &#8220;Other Current Assets.&#8221;</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-598-5">Unearned revenue was classified as short-term and long-term on the Condensed Consolidated Balance Sheets based on the Company&#8217;s estimate of revenue that will be recognized during the next twelve months.</ix:continuation> </span></div><div><span><br/></span></div><div><span><br/></span></div><div id="i5bc8ea8f307049f2861df48b957318f8_64"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 10. <ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="f-630" continuedAt="f-630-1" escape="true">Stock-Based Compensation </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-630-1" continuedAt="f-630-2"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, the Board of Directors and the stockholders of the Company adopted the 2021 Equity Incentive Plan (the 2021 Plan). The Company may grant stock options, restricted stock units (RSUs), stock appreciation rights, restricted stock awards and other forms of stock-based compensation. As of September&#160;30, 2025, <ix:nonFraction unitRef="shares" contextRef="c-131" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="6" id="f-631">13.3</ix:nonFraction>&#160;million shares of Class A common stock were available for grant in the 2021 plan. In November 2024, the Board of Directors and the stockholders of the Company adopted the 2024 Inducement Equity Incentive Plan (the 2024 Plan) as part of the Exscientia acquisition. See Note 4, &#8220;Acquisitions&#8221; for additional information. As of September&#160;30, 2025, <ix:nonFraction unitRef="shares" contextRef="c-132" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="6" id="f-632">11.3</ix:nonFraction>&#160;million shares of Class A common stock were available for grant in the 2024 plan.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="f-633" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the classification of stock-based compensation expense for employees and non-employees within the Condensed Consolidated Statements of Operations: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:51.259%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.109%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.109%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.177%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.782%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.964%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-634">964</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-635">1,153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-636">4,727</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-637">2,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-638">14,906</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-639">9,194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-640">46,795</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-641">25,141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-642">9,174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-643">7,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-644">34,911</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-645">21,470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-646">25,044</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-647">17,743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-648">86,433</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-649">49,211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options are primarily granted to executive leaders at the Company, generally vest over <ix:nonNumeric contextRef="c-145" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-650">four years</ix:nonNumeric> and expire no later than <ix:nonNumeric contextRef="c-145" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:duryear" id="f-651">10</ix:nonNumeric> years from the date of grant.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="f-652" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option activity during the nine months ended September 30, 2025 was as follows: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.642%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.499%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;(in thousands except share data and per share amounts)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares&#160;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Exercise</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Price </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Remaining&#160;Contractual Life (in years) </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-653">21,941,495</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-654">5.40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-94" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-655">7.9</ix:nonNumeric></span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="f-656">62,685</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="f-657">3,340,822</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-658">7.08</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-659">2,305,626</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="f-660">8.81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-661">4,519,592</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-662">1.08</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="f-663">24,350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of September 30, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-664">18,457,099</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-665">6.52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-666">7.2</ix:nonNumeric></span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="f-667">20,246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable as of September 30, 2025</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="f-668">10,189,094</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="f-669">6.64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="f-670">5.9</ix:nonNumeric></span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="3" id="f-671">14,363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_7">Table of Contents</a></span></div></div><ix:continuation id="f-630-2"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of options granted to employees is calculated on the grant date using the Black-Scholes option valuation model. The weighted-average grant-date fair values of stock options granted during the nine months ended September 30, 2025 and 2024 were $<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-672">4.47</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="c-22" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-673">5.88</ix:nonFraction>, respectively. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="f-674" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following weighted-average assumptions were used to calculate the grant-date fair value of stock options: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.052%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-145" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-675">5.5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-146" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-676">6.2</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-145" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-677">66</ix:nonFraction></span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-146" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-678">65</ix:nonFraction></span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-145" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="f-679">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-146" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="f-680">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-145" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-681">4.0</ix:nonFraction></span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-146" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-682">4.2</ix:nonFraction></span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2025, $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" scale="6" id="f-683">36.7</ix:nonFraction> million of unrecognized compensation cost related to stock options is expected to be recognized as expense over approximately the next <ix:nonNumeric contextRef="c-1" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:durwordsen" id="f-684">three years</ix:nonNumeric>. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RSUs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity awards granted to employees primarily consist of RSUs and generally vest over <ix:nonNumeric contextRef="c-147" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-685">four years</ix:nonNumeric>. The weighted-average grant-date fair value of RSUs generally is determined based on the number of units granted and the quoted price of Recursion&#8217;s common stock on the date of grant.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock" id="f-686" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes Recursion&#8217;s RSU activity during the nine months ended September 30, 2025: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.133%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock units</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average grant date fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-148" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-687">27,304,229</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-148" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-688">7.47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-147" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-689">14,980,106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-147" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-690">5.86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-147" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-691">6,742,946</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-147" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-692">7.62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-147" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-693">4,898,723</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-147" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-694">7.72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of September 30, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-149" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-695">30,642,666</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-149" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-696">6.61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair market value of RSUs vested was $<ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="f-697">50.8</ix:nonFraction> million during the nine months ended September 30, 2025. As of September&#160;30, 2025, $<ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" scale="6" id="f-698">188.1</ix:nonFraction> million of unrecognized compensation cost related to RSUs is expected to be recognized as expense over approximately the next <ix:nonNumeric contextRef="c-147" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:durwordsen" id="f-699">three years</ix:nonNumeric>.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="i5bc8ea8f307049f2861df48b957318f8_67"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 11. <ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-700" continuedAt="f-700-1" escape="true">Income Taxes </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-700-1" continuedAt="f-700-2"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did <ix:nonFraction unitRef="usd" contextRef="c-21" decimals="INF" name="us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations" format="ixt:fixed-zero" scale="0" id="f-701"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="INF" name="us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations" format="ixt:fixed-zero" scale="0" id="f-702"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="INF" name="us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations" format="ixt:fixed-zero" scale="0" id="f-703"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="INF" name="us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations" format="ixt:fixed-zero" scale="0" id="f-704">not</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> record any U.S. income tax expense during the three and nine months ended September 30, 2025 and 2024. The Company has historically incurred operating losses and maintains a full valuation allowance against its U.S. net deferred tax assets. Foreign taxes were insignificant during the three and nine months ended September 30, 2025 and 2024. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. net operating losses (NOLs) and tax credit carry-forwards are subject to review and possible adjustment by the Internal Revenue Service (&#8220;IRS&#8221;) and may become subject to annual limitation due to ownership changes that occur under Section 382 of the Internal Revenue Code, as amended and similar state provisions. These ownership changes may limit the amount of carryforwards that can be utilized annually to offset future taxable income. In general, an ownership change, as defined by Section 382, results from transactions increasing the ownership of certain shareholders or public groups in the stock of a corporation by more than 50% over a three-year period. As of December&#160;31, 2024, the Company completed a Section 382 study and did not identify ownership changes that would subject its NOLs or tax credit carry-forwards to Section 382 limitations. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files income tax returns in the United States, Canada and United Kingdom. The Company files state income tax returns in multiple states in the United States among others Utah, California and Massachusetts. The </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_7">Table of Contents</a></span></div></div><ix:continuation id="f-700-2" continuedAt="f-700-3"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company is not currently under examination in any of these jurisdictions. The Company is subject to income tax examinations for all US federal and state returns filed since the 2016 tax year, Canadian income tax returns since the 2021 tax year, and UK income tax returns since the 2021 tax year.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-700-3">In July 2025, congress approved the One Big Beautiful Bill Act (OBBBA), which extends, with modifications, many of the expiring provisions of the Tax Cuts and Jobs Act (TCJA) and makes additional changes to tax laws and regulations. OBBBA includes a broad array of changes including new and modified incentives for business investment and Inflation Reduction Act (IRA) tax credits and various limits on business tax deductions. It also impacts the deduction of research and development costs and property, plant and equipment costs. This act did not have a material impact on Recursion&#8217;s consolidated balance sheet and statement of operations. The Company will continue to monitor the impact of this Act in future periods.</ix:continuation>  </span></div><div><span><br/></span></div><div id="i5bc8ea8f307049f2861df48b957318f8_70"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 12. <ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerShareTextBlock" id="f-705" continuedAt="f-705-1" escape="true">Net Loss Per Share</ix:nonNumeric></span><ix:continuation id="f-705-1" continuedAt="f-705-2"><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></ix:continuation></div><div><span><br/></span></div><ix:continuation id="f-705-2"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September 30, 2025 and 2024, Recursion calculated net loss per share of Class A, Class B and the Exchangeable common stock. Basic net loss per share is computed using the weighted-average number of shares outstanding during the period. Diluted net loss per share is computed using the weighted-average number of shares and the effect of potentially dilutive securities outstanding during the period. Potentially dilutive securities consist of stock options and other contingently issuable shares. For periods presented in which the Company reports a net loss, all potentially dilutive shares are anti-dilutive and as such are excluded from the calculation. </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended September 30, 2025 and 2024</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company reported a net loss and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">therefore basic and diluted loss per share were the same.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rights, including the liquidation and dividend rights, of the holders of the Company&#8217;s Class A, Class B and the Exchangeable common stock are identical, except with respect to voting. As a result, the undistributed earnings for each period are allocated based on the contractual participation rights of the Class A, Class B and the Exchangeable common stock as if the earnings for the period had been distributed. As the liquidation and dividend rights are identical, the undistributed earnings are allocated on a proportionate basis and the resulting amount per share for Class A, Class B and the Exchangeable common stock was the same during the three and nine months ended September 30, 2025 and 2024.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="f-706" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth the computation of basic and diluted net loss per share of Class A, Class B and Exchangeable common stock:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.057%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.057%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.377%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-707">162,253</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-708">95,842</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-709">536,637</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-710">284,755</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-20" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-711"><ix:nonFraction unitRef="shares" contextRef="c-20" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-712">446,988,046</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-21" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-713"><ix:nonFraction unitRef="shares" contextRef="c-21" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-714">282,583,048</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-715"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-716">422,642,653</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-22" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-717"><ix:nonFraction unitRef="shares" contextRef="c-22" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-718">253,447,099</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share, basic and diluted</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-20" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-719"><ix:nonFraction unitRef="usdPerShare" contextRef="c-20" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-720">0.36</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-21" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-721"><ix:nonFraction unitRef="usdPerShare" contextRef="c-21" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-722">0.34</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-723"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-724">1.27</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-22" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-725"><ix:nonFraction unitRef="usdPerShare" contextRef="c-22" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-726">1.12</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="f-727" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company excluded the following potential common shares from the computation of diluted net loss per share for the periods indicated because including them would have had an anti-dilutive effect: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.736%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.375%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Stock based compensation</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-150" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-728">6,675,698</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-151" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-729">5,869,795</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-152" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-730">8,696,773</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-153" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-731">8,098,979</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Tempus agreement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-154" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-732">6,582,331</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-155" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-733">6,694,934</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-156" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-734">6,582,331</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-157" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-735">6,694,934</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Contingent stock relating to RE Ventures I transaction</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-158" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-736">1,250,621</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-159" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="0" id="f-737">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-160" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-738">421,455</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-161" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="0" id="f-739">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-20" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-740">14,508,650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-21" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-741">12,564,729</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-742">15,700,559</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-22" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-743">14,793,913</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div id="i5bc8ea8f307049f2861df48b957318f8_73"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Note 13. <ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueDisclosuresTextBlock" id="f-744" continuedAt="f-744-1" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-744-1" continuedAt="f-744-2"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value hierarchy consists of the following three levels:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8212; Valuations based on unadjusted quoted prices in active markets for identical assets that the company has the ability to access;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8212; Valuations based on quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-based valuations in which all significant inputs are observable in the market; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8212; Valuations using significant inputs that are unobservable in the market and include the use of judgment by the company's management about the assumptions market participants would use in pricing the asset or liability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to maintain a cash balance in a collateralized account to secure the Company&#8217;s credit cards. Additionally, the Company holds restricted cash related to an outstanding letter of credit issued by J.P. Morgan, which was obtained to secure certain Company obligations relating to tenant improvements. Recursion also holds restricted cash as required by a lease agreement.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="f-745" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the Company&#8217;s assets and liabilities that are measured at fair value on a recurring basis:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:1.0%"/><td style="width:43.727%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.741%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.744%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.745%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2025</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of fair value measurement</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-746">436,675</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-747">436,675</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-748">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-749">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-750">223,161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-751">223,161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-752">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-753">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-3" name="rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-754">7,309</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-3" name="rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-755">7,309</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-3" name="rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-756">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-173" decimals="-3" name="rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-757">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-758">667,145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-759">667,145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-760">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-173" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-761">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.452%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of fair value measurement</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-762">198,050</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-763">198,050</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-764">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-765">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-766">235,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-767">235,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-768">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-769">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank deposits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-182" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-770">160,487</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-771">160,487</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-772">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-773">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-3" name="rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-774">8,675</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-187" decimals="-3" name="rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-775">8,675</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-3" name="rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-776">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-3" name="rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-777">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-778">603,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-187" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-779">603,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-780">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-781">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the financial instruments that are recognized at fair value on the Condensed Consolidated Balance Sheet, the Company has certain financial instruments that are recognized at amortized cost or some basis other than fair value. The carrying amount of these instruments are considered to be representative of their approximate fair values. </span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_7">Table of Contents</a></span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock" id="f-782" escape="true"><ix:continuation id="f-744-2"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the Company&#8217;s financial instruments that are not measured at fair value: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.531%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.448%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Book values</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair values</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable and financing lease liabilities, current</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-783">8,919</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-784">8,425</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-192" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-785">8,919</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-786">8,425</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable and financing lease liabilities, non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="3" id="f-787">11,902</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="3" id="f-788">19,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-192" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="3" id="f-789">11,902</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="3" id="f-790">19,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-194" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-791">20,821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-195" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-792">27,447</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-196" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-793">20,821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-197" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-794">27,447</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div><span><br/></span></div><div><span><br/></span></div><div id="i5bc8ea8f307049f2861df48b957318f8_76"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 14. <ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingDisclosureTextBlock" id="f-795" continuedAt="f-795-1" escape="true">Segment Information</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-795-1" continuedAt="f-795-2"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment loss</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recursion operates as a single operating segment that is managed on a consolidated basis. The Company&#8217;s chief operating decision maker is its Chief Executive Officer. The Company&#8217;s chief operating decision maker uses segment net loss to evaluate the performance of its segment, analyze financial trends, compare the budget to the actual operating results and make resource allocation decisions. Segment net loss represents the Company&#8217;s consolidated net loss. All corporate costs, global function support costs, overhead costs and other shared costs are included within this segment. Other segment items primarily include general and administrative expenses including facilities, information technology, professional fees (including auditing, tax and legal) and insurance.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="f-796" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents Recursion&#8217;s segment net loss: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.508%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-797">5,175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-199" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-798">26,082</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-799">39,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-201" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-800">54,293</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Significant segment expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Salaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-3" name="us-gaap:LaborAndRelatedExpense" format="ixt:num-dot-decimal" scale="3" id="f-801">68,600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-199" decimals="-3" name="us-gaap:LaborAndRelatedExpense" format="ixt:num-dot-decimal" scale="3" id="f-802">55,515</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-3" name="us-gaap:LaborAndRelatedExpense" format="ixt:num-dot-decimal" scale="3" id="f-803">235,190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-201" decimals="-3" name="us-gaap:LaborAndRelatedExpense" format="ixt:num-dot-decimal" scale="3" id="f-804">156,171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Consumables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-3" name="rxrx:ConsumableExpense" format="ixt:num-dot-decimal" scale="3" id="f-805">8,928</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-199" decimals="-3" name="rxrx:ConsumableExpense" format="ixt:num-dot-decimal" scale="3" id="f-806">19,419</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-3" name="rxrx:ConsumableExpense" format="ixt:num-dot-decimal" scale="3" id="f-807">92,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-201" decimals="-3" name="rxrx:ConsumableExpense" format="ixt:num-dot-decimal" scale="3" id="f-808">54,176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Platform</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-3" name="rxrx:PlatformFeeExpense" format="ixt:num-dot-decimal" scale="3" id="f-809">14,377</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-199" decimals="-3" name="rxrx:PlatformFeeExpense" format="ixt:num-dot-decimal" scale="3" id="f-810">8,330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-3" name="rxrx:PlatformFeeExpense" format="ixt:num-dot-decimal" scale="3" id="f-811">36,934</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-201" decimals="-3" name="rxrx:PlatformFeeExpense" format="ixt:num-dot-decimal" scale="3" id="f-812">13,102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Discovery</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-3" name="rxrx:DiscoveryExpense" format="ixt:num-dot-decimal" scale="3" id="f-813">37,049</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-199" decimals="-3" name="rxrx:DiscoveryExpense" format="ixt:num-dot-decimal" scale="3" id="f-814">3,375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-3" name="rxrx:DiscoveryExpense" format="ixt:num-dot-decimal" scale="3" id="f-815">58,716</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-201" decimals="-3" name="rxrx:DiscoveryExpense" format="ixt:num-dot-decimal" scale="3" id="f-816">19,115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Clinical development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-3" name="rxrx:ClinicalDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-817">10,814</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-199" decimals="-3" name="rxrx:ClinicalDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-818">9,050</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-3" name="rxrx:ClinicalDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-819">33,338</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-201" decimals="-3" name="rxrx:ClinicalDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-820">31,966</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-821">18,708</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-199" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-822">6,637</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-823">64,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-201" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-824">22,982</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other segment items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-3" name="us-gaap:SegmentReportingOtherItemAmount" format="ixt:num-dot-decimal" scale="3" id="f-825">18,901</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-199" decimals="-3" name="us-gaap:SegmentReportingOtherItemAmount" format="ixt:num-dot-decimal" scale="3" id="f-826">22,110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-3" name="us-gaap:SegmentReportingOtherItemAmount" format="ixt:num-dot-decimal" scale="3" id="f-827">57,815</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-201" decimals="-3" name="us-gaap:SegmentReportingOtherItemAmount" format="ixt:num-dot-decimal" scale="3" id="f-828">52,017</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Loss from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-829">172,202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-199" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-830">98,354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-831">539,798</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-201" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-832">295,236</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other non-operating income (loss), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-833">9,952</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-199" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-834">2,679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-835">3,005</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-201" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-836">9,347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="f-837">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(<ix:nonFraction unitRef="usd" contextRef="c-199" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="f-838">167</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="f-839">156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-201" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-840">1,134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Total segment loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-841">162,253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-199" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-842">95,842</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-843">536,637</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-201" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-844">284,755</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Supplemental asset information</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Total expenditures for additions to long-lived assets</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-3" name="us-gaap:SegmentExpenditureAdditionToLongLivedAssets" scale="3" id="f-845">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-199" decimals="-3" name="us-gaap:SegmentExpenditureAdditionToLongLivedAssets" format="ixt:num-dot-decimal" scale="3" id="f-846">4,248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-3" name="us-gaap:SegmentExpenditureAdditionToLongLivedAssets" format="ixt:num-dot-decimal" scale="3" id="f-847">5,283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-201" decimals="-3" name="us-gaap:SegmentExpenditureAdditionToLongLivedAssets" format="ixt:num-dot-decimal" scale="3" id="f-848">12,633</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_7">Table of Contents</a></span></div></div><ix:continuation id="f-795-2"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Additional Segment Disclosures</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" id="f-849" continuedAt="f-849-1" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recursion&#8217;s revenues are attributed to the following geographic areas based on the location the services are performed: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.885%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-202" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-850">1,110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-203" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-851">26,082</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-204" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-852">22,393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-205" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-853">54,293</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-206" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-854">4,065</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-207" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-855">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-208" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-856">16,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-209" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-857">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-858">5,175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-859">26,082</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-860">39,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-861">54,293</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recursion generates revenue primarily from a single service, research and development services, therefore, the Company does not report additional information on revenue from external customers.</span></div><div><span><br/></span></div><ix:continuation id="f-849-1"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recursion&#8217;s long-lived assets are attributed to the following geographic areas based on their location: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.935%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.936%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-210" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-862">66,571</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-211" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-863">78,471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">United Kingdom</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-864">42,655</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-213" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-865">56,332</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Canada</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-866">2,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-215" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-867">2,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-216" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:fixed-zero" scale="3" id="f-868">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-217" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-869">3,629</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="i5bc8ea8f307049f2861df48b957318f8_79"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 15. <ix:nonNumeric contextRef="c-1" name="us-gaap:SubsequentEventsTextBlock" id="f-870" continuedAt="f-870-1" escape="true">Subsequent Events</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-870-1"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Roche and Genentech</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October&#160;27, 2025, Recursion received notice that Roche accepted the second neuroscience Phenomap under the December 2021 collaboration and license agreement which resulted in a $<ix:nonFraction unitRef="usd" contextRef="c-218" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="f-871">30</ix:nonFraction> million milestone which is an acceptance fee accounted for as variable consideration under ASC 606. See Note 9, &#8220;Collaborative Development Contracts&#8221; for additional information on the collaboration with Roche. This milestone payment was fully constrained variable consideration at September&#160;30, 2025 due to the uncertainty of the development. The variable consideration is no longer constrained and will be recognized as &#8220;Operating Revenue&#8221; in the Condensed Consolidated Statements of Operations as part of the transaction price over the completion period of the neuroscience performance obligation. The amount to be earned over the remaining estimated completion period will be recorded in &#8220;Unearned Revenue&#8221; and &#8220;Unearned Revenue, Non-Current&#8221; on the Consolidated Balance Sheet, classified as short-term and long-term based on the Company&#8217;s estimate of revenue that will be recognized during the next twelve months.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">At-The-Market Offering (Citi)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2025, Recursion</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sold <ix:nonFraction unitRef="shares" contextRef="c-219" decimals="-5" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="6" id="f-872">25.3</ix:nonFraction> million shares and received net proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-219" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="f-873">133.5</ix:nonFraction> million under the Sales Agreement. Pursuant to its terms, the Sales Agreement has completed and no amount remained available for future sales. In total, the Company sold <ix:nonFraction unitRef="shares" contextRef="c-220" decimals="-5" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="6" id="f-874">99.9</ix:nonFraction> million shares and received net proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-220" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="f-875">491.7</ix:nonFraction> million under the agreement.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><div id="i5bc8ea8f307049f2861df48b957318f8_82"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following is a discussion and analysis of the financial condition of Recursion Pharmaceuticals, Inc. (Recursion, the Company, we, us or our) and the results of operations. This commentary should be read in conjunction with the unaudited Condensed Consolidated Financial Statements and accompanying notes appearing in Item 1, &#8220;Financial Statements&#8221; and the Company&#8217;s audited consolidated financial statements and accompanying notes and "Management's Discussion and Analysis of Financial Condition and Results of Operations" included in the Annual Report on Form 10-K for the year ended December 31, 2024 (the 2024 Annual Report). This discussion, particularly information with respect to our future results of operations or financial condition, business strategy and plans and objectives of management for future operations, includes forward-looking statements that involve risks and uncertainties as described under the heading "Note About Forward-Looking Statements" in this Quarterly Report on Form 10-Q. You should review the disclosure under the heading "Risk Factors" in the 2024 Annual Report and in our subsequent Quarterly Reports on Form 10-Q, including this Quarterly Report on Form 10-Q, for a discussion of important factors that could cause our actual results to differ materially from those anticipated in these forward-looking statements. We assume no obligation to revise or publicly release any revision to any forward-looking statements contained in this Quarterly Report on Form 10-Q, unless required by law.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investors and others should note that we announce material financial and other information to our investors using our investor relations website (https://ir.recursion.com/), SEC filings, press releases, public conference calls and webcasts. We use these channels as well as social media and blogs to communicate with our stakeholders and the public about our company, our services and other issues. It is possible that the information we post on social media and blogs could be deemed to be material information. Therefore, we encourage investors, the media and others interested in our company to review the information we post on the social media channels and blogs listed on our investor relations website. Information contained in, or that can be accessed through, our website is not a part of, and is not incorporated into, this report.</span></div><div><span><br/></span></div><div id="i5bc8ea8f307049f2861df48b957318f8_85"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Recursion is a leading clinical stage TechBio company decoding biology to radically improve lives. We aim to achieve our mission by industrializing drug discovery using the Recursion Operating System (OS), a vertical platform of diverse technologies that enables us to map and navigate trillions of biological, chemical and patient-centric relationships utilizing approximately 65 petabytes of proprietary data. The Recursion OS integrates &#8216;Real World&#8217; data generated in our own wet-laboratories or by select partners and a &#8216;World Model&#8217; which is a collection of AI computational models we also build in-house. Today, our scaled &#8216;wet-lab&#8217; biology, chemistry and patient-centric experimental data feed our &#8216;dry-lab&#8217; computational tools to identify, validate and translate therapeutic insights, which we can then validate in our wet-lab to both advance drug discovery programs and to generate data to further refine our world model.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are a few key factors that differentiate Recursion from other technology-enabled drug discovery companies. </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Recursion has built a full-stack platform utilizing many biology, chemistry and patient-centric proprietary datasets and modular tools to industrialize drug discovery, while most other competitor companies rely on a point solution to solve one important step in drug discovery. We recognize that drug discovery is made up of many steps and a point solution is insufficient to generate efficiencies across the entire process. To decode biology, we must construct a full-stack technology platform capable of integrating and industrializing many complex workflows.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Recursion integrates wet-lab and dry-lab capabilities in-house to create a virtuous cycle of iteration. Fit-for-purpose wet-lab experimental data are translated by dry-lab digital tools into in silico hypotheses and testable predictions, which in turn generates more wet-lab data from which improved predictions can be made. Recursion is well positioned compared to companies of a similar stage either focused more specifically on the wet-lab only (traditional biotech or pharma companies) or dry-lab only (companies facing rapidly commoditized algorithms and a challenge differentiating on non-proprietary data).</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.15pt">Recursion has achieved a significant scale with respect to its scientific, technological and business endeavors. With 6 high potential clinical and pre-clinical programs across oncology and rare disease indications, four of the largest discovery partnerships in the biopharma industry with Roche and Genentech, Sanofi, Bayer and Merck KGaA </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and over four technology and data-focused partnerships, Recursion is on the precipice of demonstrating the potential of technology-driven approaches to in</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">crease speed, quality and scalability of drug discovery.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We leverage the Recursion OS to deliver value in three ways: 1) our own pipeline of clinical and preclinical potential medicines focused in precision oncology, rare disease and other areas of high unmet need; 2) by discovering new medicines with large biopharmaceutical companies in some of the biggest areas of unmet need in medicine like neuroscience and inflammation; and 3) by leveraging our tools, technology and data for the benefit of other partners in targeted and limited ways.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are actively advancing key catalysts in our pipeline while demonstrating significant progress in addressing high unmet medical needs. At the same time, we continue to validate various components of the Recursion OS, which has played a role in advancing every program in our portfolio, reinforcing its potential to accelerate drug discovery and development. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary of Business Highlights</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Portfolio - Internal and Partnered Programs </span></div><div><span><br/></span></div><div><img src="rxrx-20250930_g1.jpg" alt="3Q 2025 Earnings Deck_pipeline 02.jpg" style="height:351px;margin-bottom:5pt;vertical-align:text-bottom;width:684px" id="i-1"/></div><div><span><br/></span></div><div id="i5bc8ea8f307049f2861df48b957318f8_88"></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Internal Pipeline Updates:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">REC-617 (CDK7): </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Recursion announced progress in its ELUCIDATE Phase 1/2 trial evaluating REC-617, a precision-designed oral CDK7 inhibitor. The monotherapy dose-escalation study established the maximum tolerated dose (MTD) at 10 mg once-daily, demonstrating a manageable safety profile and preliminary anti-tumor activity consistent with the December 2024 update.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">As of September 29, 2025, 29 heavily pre-treated patients with advanced solid tumors had received REC-617 across six dose levels. Treatment was generally well tolerated, with the most common dose-limiting toxicities (DLTs) being nausea and thrombocytopenia. Grade &#8805;3 treatment-related adverse events (TRAEs) occurred in 27.6% of patients (n=8), with no Grade 4/5 TRAEs reported. Only 6.9% (n=2) discontinued due to a TRAE. Importantly, REC-617 demonstrated rates of GI-related toxicities consistent with best-in-class potential. Specifically, common GI toxicities with REC-617 treatment were diarrhea (69%), nausea (41%), and vomiting (28%). Toxicities reported for samuraciclib treatment also included diarrhea (82%), nausea (77%), and vomiting (80%) (Coombes et al, 2023).</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">REC-617 has shown early anti-tumor activity, including one confirmed partial response and five cases of stable disease. Pharmacokinetic data support dose-proportional exposure, rapid absorption, and a short half-life (~5 hours), in line with its design as a selective, reversible CDK7 inhibitor.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_7">Table of Contents</a></span></div></div><div style="padding-left:72pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">The ELUCIDATE study has now expanded into 2L+ platinum-resistant ovarian cancer (PROC), with a Phase 2 monotherapy cohort ongoing and a Phase 1 combination arm initiated. Combination regimens include bevacizumab plus paclitaxel or pegylated liposomal doxorubicin (PLD). Recursion is also leveraging Recursion OS insights to explore additional indications and dosing regimens for expansion cohorts.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">REC-7735 (PI3K&#945; H1047R)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Recursion announced progress on REC-7735, with nomination as a Development Candidate and IND-enabling studies now underway. REC-7735 is a precision-designed PI3K&#9082; H1047R inhibitor generated using the Recursion OS. In preclinical studies, REC-7735 demonstrated significant tumor regressions at low doses, outperforming approved agents, while maintaining high selectivity (&gt;100-fold) over wild-type PI3K&#9082; to reduce the risk of dose-limiting hyperglycemia.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">With a differentiated preclinical efficacy and tolerability profile, REC-7735 has the potential to be a best-in-class PI3K&#9082; H1047R inhibitor for breast and other solid tumors harboring this mutation. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Upcoming Milestones: </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">REC-4881 (MEK1/2): Additional data in FAP from the Phase 2 TUPELO study expected in December 2025</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">REC-1245 (RBM39): Early Phase 1 safety and PK monotherapy data expected in 1H26 </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">REC-3565 (MALT1): Early Phase 1 safety and PK monotherapy data expected in 1H27 </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">REC-102 (ENPP1): Potential Phase 1 initiation expected in 2H26 </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">REC-7735 (PI3K&#945; H1047R): Potential Phase 1 initiation expected in 2H26</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Recursion is well on track for over $100 million in milestone payments by end of 2026</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Programs are advancing towards potential development candidate designation over the next 12 months </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Multiple neuroscience target validation programs advancing by leveraging the Recursion OS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Partnered Discovery Updates:</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With the acceptance of the second neuro map and the $30 million milestone from Roche and Genentech, Recursion has now achieved more than $500 million in upfront and milestone payments from its partners. This milestone places Recursion among a small group of pre-commercial biotechnology companies to achieve such scale, underscoring the strength of its partnership strategy. These collaborations not only support the maintenance and expansion of the Recursion OS, but also provide access to insights from leading biopharma companies and the potential for future milestone payments exceeding $10 billion, as well as royalties across indications Recursion may not pursue independently.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Roche and Genentech: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recursion announced that it has achieved a second $30 million milestone from its partner, Roche and Genentech. The payment follows the acceptance of a novel whole-genome phenotypic map ("phenomap") of microglial cells, which are critical for brain health and implicated in a wide range of neurodegenerative and neuroinflammatory diseases.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">The milestone is part of a larger ongoing 10+ year collaboration to discover novel targets and develop potential therapeutic treatments for up to 40 programs in neuroscience and gastrointestinal oncology. </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Together, Recursion, Roche and Genentech have identified a number of biological insights from the first neuroscience-focused phenomap, that could become novel targets of interest.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Roche and Genentech have already optioned an initial program in gastrointestinal oncology with additional potential targets/programs under exploration based off of 4 whole-genome GI oncology phenomaps accepted by the partner to date. </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">To date, Recursion has achieved $213 million in upfront and milestone payments through the collaboration. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Sanofi:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Recursion and Sanofi continue to advance multi-target collaboration for up to 15 best-in-class or first-in-class programs across oncology and immunology, with $130 million in upfront and milestone payments achieved to date. Each program has the potential for over $300 million in milestone payments.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Sanofi continues to leverage combined Recursion OS 2.0, including phenomics, to identify new program opportunities.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Recursion and Sanofi are further advancing and expanding their joint pipeline across oncology and immunology.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Several programs are continuing to advance towards potential lead series and development candidate designation over the next 12 months.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Platform </span></div><div><img src="rxrx-20250930_g2.jpg" alt="3Q 2025 Earnings_FINAL_programs.jpg" style="height:316px;margin-bottom:5pt;vertical-align:text-bottom;width:684px" id="i-2"/></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Recursion OS 2.0:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> The platform is continuing to drive program development by integrating AI across multimodal biology, precision design, and clinical development&#8212;enabling faster, more efficient, and more innovative drug discovery and development.</span></div><div><span><br/></span></div><div id="i5bc8ea8f307049f2861df48b957318f8_91"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financing and Operations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, our financing and operations activities include the following:</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">July 2023</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we issued an aggregate of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.7&#160;million</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shares of our Class A common stock at a purchase price of $6.49 per share in the 2023 Private Placement with NVIDIA Corporation for net proceeds of approximately $49.9 million. In </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">August 2023</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we entered into an O</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">pen Market Sales Agreement with Jefferies LLC to provide for the offering, issuance and sale of up to an aggregate amount of </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$300.0 million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of its Class A common stock. The Company sold 26.8&#160;million shares and received net proceeds of $199.1 million under the agreement. In June 2024, we issued an aggregate of 35.4&#160;million shares of our Class A common stock at a purchase price of </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$6.50</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> per share and received net proceeds of $216.4 million</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, after deducting </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">transaction costs of $13.6 million. </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 8, &#8220;Common Stock&#8221; to the Condensed Consolidated Financial Statements for additional information on the public offering. In September 2024</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we received a Phenomap acceptance fee of $30.0 million from our collaboration with Roche. In </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 2025</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company terminated the Sales Agreement with Jefferies LLC and entered into a Sales Agreement with Citigroup Capital Markets Inc., to provide for the offering, issuance and sale of up to an aggregate amount of 500.0&#160;million of its Class A common stock. As of&#160;September&#160;30, 2025, an amount of $136.4 million remained available for future sales under the Sales Agreement all of which was sold in October 2025. For the nine months ended September 30, 2025, the Company has sold 74.6&#160;million shares and received net proceeds of $358.2 million under the agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the capital we have raised to fund operating and investing activities across platform research operations, drug discovery, clinical development, digital and other infrastructure, creation of our portfolio of intellectual property and administrative support. We do not have any products approved for commercial sale and have not generated any revenues from product sales. We had cash and cash equivalents of $659.8 million as of September&#160;30, 2025. Based on our current operating plan, we believe that our cash and cash equivalents will be sufficient to fund our operations for at least the next twelve months. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since inception, we have incurred significant operating losses. Our net losses were $162.3 million and $536.6 million during the three and nine months ended September 30, 2025, respectively. Our net losses were $95.8 million and $284.8 million during the three and nine months ended September 30, 2024, respectively. As of September&#160;30, 2025, our accumulated deficit was $2.0 billion. </span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2025, we did not have any unconditional outstanding commitments for additional funding. We anticipate that we will need to raise additional financing in the future to fund our operations, including the potential commercialization of any approved product candidates. Until such time, if ever, as we can generate significant product revenue, we expect to finance our operations with our existing cash and cash equivalents, any future equity or debt financings and upfront, milestone and royalty payments, if any, received under current or future license or collaboration agreements. We may not be able to raise additional capital on terms acceptable to us or at all. If we are unable to raise additional capital when desired, our business, results of operations and financial condition may be adversely affected.</span></div><div><span><br/></span></div><div id="i5bc8ea8f307049f2861df48b957318f8_94"></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our results of operations: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.532%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except percentages)</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Three months ended September 30,</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Change</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Nine months ended September 30,</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Change</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$ </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">% </span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revenue</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,983&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26,082&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(21,099)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38,905&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">53,977&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(15,072)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Grant revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">n/m</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">238&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,175&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26,082&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(20,907)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39,143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">54,293&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(15,150)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating costs and expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,079&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,608&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">56,678&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32,444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">121,062&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">74,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">46,462&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">379,331&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">216,087&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">163,244&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41,628&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37,757&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,871&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">142,932&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100,998&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41,934&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total operating costs and expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">177,377&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">124,436&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52,941&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">578,941&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">349,529&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">229,412&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(172,202)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(98,354)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(73,848)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(539,798)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(295,236)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(244,562)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other income, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,952&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&gt;100%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,005&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,342)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Loss before income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(162,250)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(95,675)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(66,575)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(536,793)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(285,889)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(250,904)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(167)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(98)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(978)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(86)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(162,253)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(95,842)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(66,411)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(536,637)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(284,755)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(251,882)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">n/m = Not meaningful </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our components of revenue: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.063%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.946%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Three months ended September 30,</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Change</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Nine months ended<br/>September 30,</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except percentages)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$ </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">% </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$ </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">% </span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,983&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,082&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21,099)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,905&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,977&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15,072)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Grant revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">n/m</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">238&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,175&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,082&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,907)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,143&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54,293&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15,150)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">n/m = Not meaningful </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating revenue is generated through research and development agreements derived from strategic alliances. We are entitled to receive variable consideration as certain milestones are achieved. The timing of revenue recognition is not directly correlated to the timing of cash receipts.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September 30, 2025, the decrease in revenue compared to prior period was due to the timing of projects from the Company&#8217;s Sanofi, Roche and Merck KGaA, Darmstadt, Germany collaborations. For the three months ended September 30, 2024, we recognized revenue related to the acceptance </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">fee for the completion of a Phenomap for one of our neuroscience performance obligations for the Roche agreement. Prior to the three months ended September 30, 2024, we had fully constrained the $30.0 million acceptance fee.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our cost of revenue: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:29.341%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.458%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.458%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.135%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.123%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.341%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.988%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.694%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.227%"/><td style="width:0.1%"/></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except percentages)</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Three months ended September 30,</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Change</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Nine months ended September 30,</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Change</span></td></tr><tr style="height:24pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$ </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">% </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$ </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">% </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total cost of revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,687&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,079&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,608&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56,678&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,444&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,234&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue consists of the Company&#8217;s costs to provide services for drug discovery required under performance obligations with partnership customers. These primarily include materials costs, service hours performed by our employees and depreciation of property and equipment. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September 30, 2025, the change in cost of revenue compared to prior period was due to our Exscientia acquisition for which our results now also include additional customers. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our components of research and development expense: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.163%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.379%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.651%"/><td style="width:0.1%"/></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except percentages)</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Three months ended September 30,</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Change</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Nine months ended September 30,</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Change</span></td></tr><tr style="height:24pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$ </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">% </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$ </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">% </span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Platform</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,227&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,094&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">191,096&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95,961&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95,135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discovery</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,799&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,584&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,767&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,468&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clinical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,752&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,004&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,748&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,877&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquired IPR&amp;D</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,840&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,840&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">n/m</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,840&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,840&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">n/m</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,457&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,966&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,031&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,281&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">UK R&amp;D tax credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,099)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,099)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">n/m</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,445)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,445)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">n/m</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,672)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,698&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,018&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total research and development expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121,062&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74,600&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,462&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">379,331&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">216,087&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">163,244&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">n/m = Not meaningful </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses account for a significant portion of our operating expenses. We recognize research and development expenses as they are incurred. Research and development expenses consist of costs incurred in performing activities including: </span></div><div><span><br/></span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">costs to develop and operate our platform; </span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">costs of discovery efforts which may lead to development candidates, including research materials and external research; </span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">costs for clinical development of our investigational products; </span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">costs for materials and supplies associated with the manufacture of active pharmaceutical ingredients, investigational products for preclinical testing and clinical trials; </span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">personnel-related expenses, including salaries, benefits, bonuses and stock-based compensation for employees engaged in research and development functions; </span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">costs associated with operating our digital infrastructure; and </span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">other direct and allocated expenses incurred as a result of research and development activities, including those for facilities, depreciation, amortization and insurance</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_7">Table of Contents</a></span></div></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">certain cash refundable research and development tax credits including the research and development expenditure credit (RDEC) in the United Kingdom. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize expenses associated with third-party contracted services as they are incurred. Upon termination of contracts with third parties, our financial obligations are generally limited to costs incurred or committed to date. Any advance payments for goods or services to be used or rendered in future research and product development activities pursuant to a contractual arrangement are classified as prepaid expenses until such goods or services are rendered. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant components of research and development expense include the following allocated by development phase: Platform, which refers primarily to expenses related to screening of product candidates through hit identification, this also includes expenses related to Tempus records purchased; Discovery, which refers primarily to expenses related to hit identification through development of candidates; and Clinical, which refers primarily to expenses related to development of candidates and beyond.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September 30, 2025, the increase in research and development expenses compared to the prior period was primarily driven by acquired IPR&amp;D purchases of $22.8 million and the inclusion of Exscientia&#8217;s results of $29.6 million. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September 30, 2025, the increase in research and development expenses compared to the prior period was primarily driven by Tempus record purchases of $46.9 million, the inclusion of Exscientia&#8217;s results of $85.1 million and acquired IPR&amp;D purchases of $22.8 million. </span></div><div><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General and Administrative Expense</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our general and administrative expense: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:29.251%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.111%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.111%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.826%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.551%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.671%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.675%"/><td style="width:0.1%"/></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except percentages)</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Three months ended September 30,</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Change</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Nine months ended September 30,</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Change</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$ </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">% </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$ </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">% </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total general and administrative expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,628&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,757&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,871&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">142,932&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100,998&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,934&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expense general and administrative costs as incurred. General and administrative expenses consist primarily of salaries; including employee benefits and stock-based compensation. General and administrative expenses also include facilities, depreciation, information technology, professional fees for auditing and tax, legal fees for corporate and patent matters and insurance costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September 30, 2025, the increase in general and administrative expense compared to prior period was primarily driven by the inclusion of Exscientia&#8217;s results. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September 30, 2025, the increase in general and administrative expense compared to prior period was primarily driven by the inclusion of Exscientia&#8217;s results of $23.9 million and an increase in salaries and wages of $15.0 million.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income (Loss), Net </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our components of other income (loss), net: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.116%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.116%"/><td style="width:0.1%"/></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except percentages)</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Three months ended September 30,</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Change</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Nine months ended September 30,</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Change</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$ </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">% </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$ </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">% </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,540&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,826&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,714&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,541&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,403&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(833)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(553)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(280)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,821)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(967)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(854)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(594)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,839&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">n/m</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,716)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(824)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10,892)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&gt;100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income (loss), net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,952&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,679&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,273&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&gt;100%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,004&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,347&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,343)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(67.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">n/m = Not meaningful</span></div><div><span><br/></span></div><div><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended September 30, 2025, the</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">increase in other income (loss), net compared to prior period related to an increase in other income driven primarily by foreign currency gains and investing activities. </span></div><div><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:130%">For the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:130%">nine months ended September 30, 2025</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:130%">, the</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:130%"> increase in other income (loss), net compared to prior period related to our loss on disposal of Exscientia GmbH of $4.5 million and our Vienna lease termination fee of $5.2 million. This decrease is partially offset by an increase in interest income driven by our increase in earnings on cash and cash equivalents.</span></div><div><span><br/></span></div><div id="i5bc8ea8f307049f2861df48b957318f8_97"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div id="i5bc8ea8f307049f2861df48b957318f8_100"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sources of Liquidity </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have not yet commercialized any products and do not expect to generate revenue from the sales of any product candidates for at least several years. Cash and cash equivalents totaled $659.8 million and $594.3 million as of September&#160;30, 2025 and December&#160;31, 2024, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have incurred operating losses and experienced negative operating cash flows and we anticipate that the Company will continue to incur losses for at least the foreseeable future. Our net loss was $162.3 million and $536.6 million during the three and nine months ended September 30, 2025, respectively. </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our net loss was </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$95.8 million</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$284.8 million</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> during the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three and nine months ended September 30, 2024</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As of September&#160;30, 2025, we had an accumulated deficit of $2.0 billion. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we have financed our operations primarily through Class A common stock issuances. As of September&#160;30, 2025, we have received net proceeds of $823.6 million from Class A common stock issuances. See Note 8, &#8220;Common Stock&#8221; to the Condensed Consolidated Financial Statements for additional details on Class A common stock issuances. Additionally, as of September&#160;30, 2025, we have received proceeds of $44.0 million from our strategic partnerships. See Note 9, &#8220;Collaborative Development Contracts&#8221; to the Condensed Consolidated Financial Statements for additional details on the strategic partnerships.</span></div><div><span><br/></span></div><div id="i5bc8ea8f307049f2861df48b957318f8_103"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Flows</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the Condensed Consolidated Statements of Cash Flows for each of the periods presented below: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.274%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.275%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash used in operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(325,735)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(243,744)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,627)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,397)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389,526&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293,481&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Operating Activities</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash used by operating activities increased during the nine months ended September 30, 2025 as a result of higher costs incurred for research and development and general and administrative primarily due to the Company&#8217;s </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">acquisition of Exscientia. This included Exscientia GmbH disposal related payments of $9.7 million and severance payments of $14.3 million. See Note 4</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Acquisitions&#8221; to the Consolidated Financial Statements for additional details related to the Exscientia acquisition and Exscientia GmbH disposal. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash used by operating activities increased during the nine months ended September 30, 2024 as a result of higher costs incurred for research and development and general and administrative due to the Company&#8217;s expansion and upgraded capabilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Investing Activities</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash used by investing activities during the nine months ended September 30, 2025 primarily consisted of the disposal of Exscientia GmbH of $4.4&#160;million and property and equipment purchases of $5.2&#160;million. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash used by investing activities during the nine months ended September 30, 2024 consisted primarily of purchases of property and equipment of $12.4&#160;million, which included $2.9&#160;million for a project to upgrade the BioHive -2 supercomputer and $2.7&#160;million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for lab equipment purchases. </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, investing activities included the purchase of an intangible asset of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$3.0&#160;million</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> from Helix.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Financing Activities </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash provided by financing activities during the nine months ended September 30, 2025 primarily included proceeds of $395.5 million from common stock issuances. Financing outflows included a $3.0 million payment for the purchase of an intangible asset that was not soon after the purchase. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash provided by financing activities during the nine months ended September 30, 2024 primarily included proceeds of $289.4 million from common stock issuances. Financing cash inflows also included proceeds from equity incentive plans of $6.4 million</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div id="i5bc8ea8f307049f2861df48b957318f8_106"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Estimates and Policies </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company&#8217;s significant accounting estimates and policies is included in Note 2, &#8220;Summary of Significant Accounting Policies&#8221; in our 2024 Annual Report. There were no significant changes in the Company&#8217;s application of its critical accounting policies during the nine months ended September 30, 2025.</span></div><div><span><br/></span></div><div id="i5bc8ea8f307049f2861df48b957318f8_109"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued and Adopted Accounting Pronouncements</span></div><div><span><br/></span></div><div><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 2, &#8220;Basis of Presentation</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in Item 1 of this Quarterly Report on Form 10-Q</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for information regarding recently issued and adopted accounting pronouncements. </span></div><div><span><br/></span></div><div id="i5bc8ea8f307049f2861df48b957318f8_112"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Quantitative and Qualitative Disclosures About Market Risk.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to market risk related to changes in interest rates on our investment portfolio of cash and cash equivalents. As of September&#160;30, 2025, our cash and cash equivalents consisted of money market funds. Our primary exposure to market risk is interest income sensitivity, which is affected by changes in interest rates. A hypothetical 100 basis point decrease in interest rates as of</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;30, 2025</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">would have an insignificant effect on net loss in the ensuing year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Exchange Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our employees and our operations are primarily located in the United States, United Kingdom and Canada and our expenses are primarily denominated in U.S. dollars, Great British pounds and Canadian dollars. We also have entered into a limited number of contracts with vendors for research and development services that have underlying payment obligations denominated in foreign currencies. We are subject to foreign currency transaction gains or losses on our contracts denominated in foreign currencies. To date, foreign currency transaction gains and losses have not been material to our financial statements and we do not have a formal hedging program with respect to foreign currency. A 10% increase or decrease in current exchange rates would have an insignificant effect on our financial results during the three and nine months ended September 30, 2025 and 2024.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><div id="i5bc8ea8f307049f2861df48b957318f8_115"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Controls and Procedures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has established disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the Exchange Act)) designed to provide reasonable assurance that information required to be disclosed in the reports that the Company files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms and is accumulated and communicated to management, including the principal executive officer (our Chief Executive Officer) and principal financial officer (our Chief Financial Officer), to allow timely decisions regarding required disclosure. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management has evaluated, with the participation of our Chief Executive Officer and Chief Financial Officer, the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this report. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives as management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Our disclosure controls and procedures have been designed to provide reasonable assurance of achieving their objectives. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as of September&#160;30, 2025, our disclosure controls and procedures were ineffective due to the material weaknesses in internal control over financial reporting disclosed in Part II, Item 9A of our Annual Report on Form 10-K for the year ended December 31, 2024.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Remediation of Material Weaknesses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following remediation actions have been taken as of September&#160;30, 2025 related to the material weakness for estimated costs and time to completion and controls to validate the completeness and accuracy of data used to calculate revenue and unearned revenue related to our license agreement:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Improvement of documentation procedures regarding specific inquiries related to the cost model used for revenue recognition and the resulting responses</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Improvement of documentation for the review of changes in cost model due to responses from inquiries</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Provision of additional documentation for internal reports to validate and support completeness and accuracy of reports</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Improvements in the documentation of these processes were executed with the input of our third-party consultants who continue to be involved in the design and enhancement of the revenue recognition policies and procedures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following remediation actions have been taken as of September&#160;30, 2025 related to the material weaknesses for the acquired Exscientia business:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Improvement of documentation of key processes and controls in the financial statement close process, including considerations around segregation of duties</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Improvement of documentation of key processes and controls related to information technology general controls that are significant to the financial statement close processes</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">On-going integration of Exscientia&#8217;s operations into our overall system of internal control over financial reporting</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While significant progress has been made to enhance our internal control over financial reporting, Recursion is still designing, implementing and testing the processes, procedures and controls related to the above material weaknesses. We believe the above actions will be effective in remediating the material weaknesses described above. However, the material weaknesses cannot be considered remediated until controls operate for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively. As such, we were unable to conclude that the material weaknesses have been remediated as of September&#160;30, 2025.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in Internal Control Over Financial Reporting</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September&#160;30, 2025, management was in the process of integrating the internal controls of the acquired business (Exscientia) into Recursion's existing operations as part of planned integration activities. There were no other changes in internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the quarter ended September&#160;30, 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="i5bc8ea8f307049f2861df48b957318f8_118"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II - OTHER INFORMATION</span></div><div><span><br/></span></div><div id="i5bc8ea8f307049f2861df48b957318f8_121"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Legal Proceedings.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may, from time to time, be involved in various legal proceedings arising in the normal course of business. An unfavorable resolution of any such matter could materially affect the Company&#8217;s future financial position, results of operations or cash flows. For more information pertaining to legal proceedings, see Part I, Item 1, Note 7, &#8220;Commitments and Contingencies,&#8221; which is incorporated herein by reference.</span></div><div><span><br/></span></div><div id="i5bc8ea8f307049f2861df48b957318f8_124"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. Risk Factors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investing in our common stock involves a high degree of risk. For a detailed discussion of the risks that affect our business. Please refer to the sections titled Part I, Item 1A. &#8220;Risk Factors&#8221; of our 2024 Annual Report and Part II, Item 1A. &#8220;Risk Factors&#8221; of our Quarterly Reports on Form 10-Q for the quarters ended March 31, 2025 and June 30, 2025.</span></div><div><span><br/></span></div><div id="i5bc8ea8f307049f2861df48b957318f8_127"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(a) Sales of Unregistered Securities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">RallyBio Private Placement</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July&#160;08, 2025, the Company, Exscientia Ventures I, Inc., an indirect wholly-owned subsidiary of the Company (&#8220;Buyer Sub&#8221;), Rallybio Corporation (&#8220;Rallybio&#8221;), and Rallybio IPB, LLC, a wholly-owned subsidiary of Rallybio (the &#8220;Seller&#8221;), entered into a Membership Interest Purchase Agreement (the &#8220;Purchase Agreement&#8221;). Pursuant to the Purchase Agreement, on July&#160;08, 2025, Buyer Sub acquired 50% of the issued and outstanding membership interests of RE Ventures I, LLC from the Seller in exchange for cash and shares of Class A common stock of the Company (the &#8220;Rallybio Shares&#8221;). Under the terms of the Purchase Agreement, as partial consideration, on July&#160;08, 2025, the Company paid the Seller 1,457,952 Shares and additional cash consideration in the amounts set forth in the Purchase Agreement. The sale was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act. Pursuant to the terms of the Purchase Agreement, the Company subsequently filed a prospectus supplement to a registration statement (File No. 333-284878) pursuant to Rule 424(b) on July&#160;08, 2025, to register the resale of the Rallybio Shares by Rallybio.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August&#160;27, 2025, following the achievement of certain milestones under the Purchase Agreement, the Company issued to the Seller an aggregate of 2,397,023 Shares (the &#8220;Contingent Shares&#8221;) pursuant to the terms of the Purchase Agreement. The sale was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act. Pursuant to the terms of the Purchase Agreement, on August 29, 2025, the Company filed a prospectus supplement to a registration statement (File No. 333-284878) pursuant to Rule 424(b) to register the resale of the Contingent Shares by Rallybio.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Stock Option Exercises</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September 30, 2025, we issued 60,800 shares of our Class A common stock to our employees, directors, advisors and consultants upon the exercise of stock options under our Key Personnel Incentive Stock Plan for aggregate consideration of approximately $21 thousand, in reliance on the exemption provided by Rule 701(b)(2) promulgated under the Securities Act, or pursuant to Section 4(a)(2) under the Securities Act, relative to transactions by an issuer not involving any public offering, to the extent an exemption from such registration was required. All recipients either received adequate information about our company or had access, through employment or other relationships, to such information.</span></div><div><span><br/></span></div><div id="i5bc8ea8f307049f2861df48b957318f8_130"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5. <ix:nonNumeric contextRef="c-1" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-876"><ix:nonNumeric contextRef="c-20" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-877"><ix:nonNumeric contextRef="c-20" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-878">Other Information</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric>.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-221" name="ecd:MtrlTermsOfTrdArrTextBlock" id="f-879" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On <ix:nonNumeric contextRef="c-221" name="ecd:TrdArrAdoptionDate" id="f-880">August 31, 2025</ix:nonNumeric>, <ix:nonNumeric contextRef="c-221" name="ecd:TrdArrIndName" id="f-881">Blake Borgeson</ix:nonNumeric>, <ix:nonNumeric contextRef="c-221" name="ecd:TrdArrIndTitle" id="f-882">a member of our Board of Directors</ix:nonNumeric>, <ix:nonNumeric contextRef="c-221" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-true" id="f-883">adopted</ix:nonNumeric> a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the potential sale of up to <ix:nonFraction unitRef="shares" contextRef="c-222" decimals="INF" name="ecd:TrdArrSecuritiesAggAvailAmt" format="ixt:num-dot-decimal" scale="0" id="f-884">3,868,000</ix:nonFraction> shares of the Company&#8217;s Class A common stock, a majority of which will not execute absent a significant increase in the market price of the Company&#8217;s Class A common stock. The plan is effective until no later than December&#160;01, 2026</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></ix:nonNumeric><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_7">Table of Contents</a></span></div></div><ix:nonNumeric contextRef="c-223" name="ecd:MtrlTermsOfTrdArrTextBlock" id="f-885" escape="true"><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On <ix:nonNumeric contextRef="c-223" name="ecd:TrdArrAdoptionDate" id="f-886">September 22, 2025</ix:nonNumeric>, <ix:nonNumeric contextRef="c-223" name="ecd:TrdArrIndName" id="f-887">Najat Khan</ix:nonNumeric>, <ix:nonNumeric contextRef="c-223" name="ecd:TrdArrIndTitle" id="f-888" continuedAt="f-888-1">Chief R&amp;D Officer, Chief </ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-888-1" continuedAt="f-888-2">Commercial</ix:continuation></span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-888-2"> Officer, and a member of our Board of Directors</ix:continuation>, <ix:nonNumeric contextRef="c-223" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-true" id="f-889">adopted</ix:nonNumeric> a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-224" decimals="INF" name="ecd:TrdArrSecuritiesAggAvailAmt" format="ixt:num-dot-decimal" scale="0" id="f-890">299,317</ix:nonFraction></span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shares of the Company&#8217;s Class A common stock until <ix:nonNumeric contextRef="c-223" name="ecd:TrdArrExpirationDate" id="f-891">December 22, 2026</ix:nonNumeric>.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="c-225" name="ecd:MtrlTermsOfTrdArrTextBlock" id="f-892" escape="true"><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On <ix:nonNumeric contextRef="c-225" name="ecd:TrdArrAdoptionDate" id="f-893">September 30, 2025</ix:nonNumeric>, <ix:nonNumeric contextRef="c-225" name="ecd:TrdArrIndName" id="f-894">Ben Taylor</ix:nonNumeric>, <ix:nonNumeric contextRef="c-225" name="ecd:TrdArrIndTitle" id="f-895">Chief Financial Officer and President of Recursion UK</ix:nonNumeric>, <ix:nonNumeric contextRef="c-225" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-true" id="f-896">adopted</ix:nonNumeric> a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">defense</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of Rule 10b5-1(c) for the sale of up to </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-226" decimals="INF" name="ecd:TrdArrSecuritiesAggAvailAmt" format="ixt:num-dot-decimal" scale="0" id="f-897">293,321</ix:nonFraction></span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shares of the Company&#8217;s Class A common stock until <ix:nonNumeric contextRef="c-225" name="ecd:TrdArrExpirationDate" id="f-898">December 29, 2026</ix:nonNumeric>.</span></div></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><div id="i5bc8ea8f307049f2861df48b957318f8_136"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_7">Table of Contents</a></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6. Exhibits.</span></div><div><span><br/></span></div><div><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit Index:</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.332%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.259%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporated by Reference</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit number</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">File No.</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit No. </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filing Date</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filed / Furnished Herewith</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601830/000119312524196505/d856792dex21.htm">Transaction Agreement by and between Recursion Pharmaceuticals, Inc. and Exscientia plc dated as of August 8, 2024.</a></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-40323</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">August 8, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001601830/000119312521123764/d149444dex31.htm">Amended and Restated Certificate of Incorporation of Recursion Pharmaceuticals, Inc.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-40323</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 21, 2021</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601830/000160183024000009/a1-25x24amendedbylaws.htm">Amended and Restated Bylaws of Recursion Pharmaceuticals, Inc.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-40323</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 31, 2024</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001601830/000119312521089610/d89478dex42.htm">Specimen Class A common stock certificate of the Registrant.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">S-1/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">333-254576</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 15, 2021</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601830/000160183023000036/exhibit42-valencexexchange.htm">Exchangeable Share Support Agreement, dated May 8, 2023.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">S-3ASR</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">333-272281</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 30, 2023</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601830/000119312522268003/d365090dex102.htm">Registration Rights Agreement, dated October 24, 2022, by and among the Company and the Purchasers.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-40323</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 25, 2022</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601830/000160183023000036/exhibit43-valencexregistra.htm">Registration Agreement, dated May 16, 2023, by and among the Registrant, Valence Discovery, Inc., and certain shareholders of Valence Discovery, Inc.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">S-3ASR</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">333-272281</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 30, 2023</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.5</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601830/000160183023000044/exhibit41registrationagree.htm">Registration Agreement, dated May 25, 2023, by and among the Registrant, Recursion Canada Inc., and certain shareholders of Cyclica Inc.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-40323</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 9, 2023</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.6</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601830/000160183023000050/ex102-rxrxxnvidiaregrights.htm">Registration Rights Agreement, dated July 11, 2023, by and among the Registrant and NVIDIA.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-40323</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 12. 2023</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit311-q0325.htm">Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit312-q0325.htm">Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.1**</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit321-q0325.htm">Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XBRL Instance Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;101.PRE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">X</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibits and/or schedules have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The registrant hereby undertakes to furnish supplementally copies of any of the omitted exhibits and schedules upon request by the SEC; provided, however, that the registrant may request confidential treatment pursuant to Rule 24b-2 under the Exchange Act for any exhibits or schedules so furnished.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The certifications furnished in Exhibit 32.1 hereto are deemed to accompany this Quarterly Report on Form 10-Q and will not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended. Such certifications will not be deemed to be incorporated by reference into any filings under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except to the extent that the Registrant specifically incorporates it by reference. </span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="18" style="padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><div id="i5bc8ea8f307049f2861df48b957318f8_139"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i5bc8ea8f307049f2861df48b957318f8_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized on November&#160;5, 2025. </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.444%"><tr><td style="width:1.0%"/><td style="width:7.781%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:88.704%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">RECURSION PHARMACEUTICALS, INC.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">By:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">/s/ Christopher Gibson</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Christopher Gibson</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Chief Executive Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(Principal Executive Officer)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">/s/ Ben Taylor</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Ben Taylor</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(Principal Financial and Accounting Officer)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-top:12pt;text-indent:30.6pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>exhibit311-q0325.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i314bac39386247658fe53fd34b4e63d2_1"></div><div style="min-height:63pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Principal Executive Officer</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Christopher Gibson, certify that&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.  I have reviewed this Quarterly Report on Form 10-Q of Recursion Pharmaceuticals, Inc.&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:68.589%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Christopher Gibson</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christopher Gibson, Chief Executive Officer (principal executive officer)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; November&#160;5, 2025</font></div></td></tr></table></div><div><font><br></font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>exhibit312-q0325.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i654e1271507c42a0ab99ed52ede0a5ac_1"></div><div style="min-height:63pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Principal Financial Officer</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Ben Taylor, certify that&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this Quarterly Report on Form 10-Q of Recursion Pharmaceuticals, Inc.&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:58.173%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Ben Taylor</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ben Taylor, Chief Financial Officer (principal financial officer)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; November&#160;5, 2025</font></div></td></tr></table></div><div><font><br></font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>exhibit321-q0325.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="ibc050af7c4cc408cb13dc3e4bec6c098_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certifications of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of Recursion Pharmaceuticals, Inc. (the &#8220;Company&#8221;) on Form 10-Q for the period ended September&#160;30, 2025 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), The undersigned certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.711%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Christopher Gibson</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christopher Gibson, Chief Executive Officer (principal executive officer)</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Ben Taylor</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ben Taylor, Chief Financial Officer (principal financial officer)</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; November&#160;5, 2025</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>rxrx-20250930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:84e2dd81-95f3-479b-879b-c1ea33e5483d,g:a06efc1c-9b19-4722-bcb5-747c44bbab78-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:rxrx="http://www.recursion.com/20250930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.recursion.com/20250930">
  <xs:import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2025" schemaLocation="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rxrx-20250930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rxrx-20250930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rxrx-20250930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rxrx-20250930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.recursion.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsunaudited" roleURI="http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited">
        <link:definition>9952151 - Statement - Condensed Consolidated Balance Sheets (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsunauditedParenthetical" roleURI="http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical">
        <link:definition>9952152 - Statement - Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperationsunaudited" roleURI="http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited">
        <link:definition>9952153 - Statement - Condensed Consolidated Statements of Operations (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveLossunaudited" roleURI="http://www.recursion.com/role/CondensedConsolidatedStatementsofComprehensiveLossunaudited">
        <link:definition>9952154 - Statement - Condensed Consolidated Statements of Comprehensive Loss (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofStockholdersEquityunaudited" roleURI="http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited">
        <link:definition>9952155 - Statement - Condensed Consolidated Statements of Stockholders&#8217; Equity (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlowsunaudited" roleURI="http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited">
        <link:definition>9952156 - Statement - Condensed Consolidated Statements of Cash Flows (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionoftheBusiness" roleURI="http://www.recursion.com/role/DescriptionoftheBusiness">
        <link:definition>9952157 - Disclosure - Description of the Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentation" roleURI="http://www.recursion.com/role/BasisofPresentation">
        <link:definition>9952158 - Disclosure - Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalFinancialInformation" roleURI="http://www.recursion.com/role/SupplementalFinancialInformation">
        <link:definition>9952159 - Disclosure - Supplemental Financial Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Acquisitions" roleURI="http://www.recursion.com/role/Acquisitions">
        <link:definition>9952160 - Disclosure - Acquisitions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.recursion.com/role/Leases">
        <link:definition>9952161 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssets" roleURI="http://www.recursion.com/role/GoodwillandIntangibleAssets">
        <link:definition>9952162 - Disclosure - Goodwill and Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.recursion.com/role/CommitmentsandContingencies">
        <link:definition>9952163 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStock" roleURI="http://www.recursion.com/role/CommonStock">
        <link:definition>9952164 - Disclosure - Common Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborativeDevelopmentContracts" roleURI="http://www.recursion.com/role/CollaborativeDevelopmentContracts">
        <link:definition>9952165 - Disclosure - Collaborative Development Contracts</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensation" roleURI="http://www.recursion.com/role/StockBasedCompensation">
        <link:definition>9952166 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.recursion.com/role/IncomeTaxes">
        <link:definition>9952167 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShare" roleURI="http://www.recursion.com/role/NetLossPerShare">
        <link:definition>9952168 - Disclosure - Net Loss Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.recursion.com/role/FairValueMeasurements">
        <link:definition>9952169 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformation" roleURI="http://www.recursion.com/role/SegmentInformation">
        <link:definition>9952170 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://www.recursion.com/role/SubsequentEvents">
        <link:definition>9952171 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationPolicies" roleURI="http://www.recursion.com/role/BasisofPresentationPolicies">
        <link:definition>9955511 - Disclosure - Basis of Presentation (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalFinancialInformationTables" roleURI="http://www.recursion.com/role/SupplementalFinancialInformationTables">
        <link:definition>9955512 - Disclosure - Supplemental Financial Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsTables" roleURI="http://www.recursion.com/role/AcquisitionsTables">
        <link:definition>9955513 - Disclosure - Acquisitions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.recursion.com/role/LeasesTables">
        <link:definition>9955514 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsTables" roleURI="http://www.recursion.com/role/GoodwillandIntangibleAssetsTables">
        <link:definition>9955515 - Disclosure - Goodwill and Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationTables" roleURI="http://www.recursion.com/role/StockBasedCompensationTables">
        <link:definition>9955516 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareTables" roleURI="http://www.recursion.com/role/NetLossPerShareTables">
        <link:definition>9955517 - Disclosure - Net Loss Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.recursion.com/role/FairValueMeasurementsTables">
        <link:definition>9955518 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationTables" roleURI="http://www.recursion.com/role/SegmentInformationTables">
        <link:definition>9955519 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionoftheBusinessDetails" roleURI="http://www.recursion.com/role/DescriptionoftheBusinessDetails">
        <link:definition>9955520 - Disclosure - Description of the Business (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalFinancialInformationNarrativeDetails" roleURI="http://www.recursion.com/role/SupplementalFinancialInformationNarrativeDetails">
        <link:definition>9955521 - Disclosure - Supplemental Financial Information - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails" roleURI="http://www.recursion.com/role/SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails">
        <link:definition>9955522 - Disclosure - Supplemental Financial Information - Schedule of Accrued Expenses and Other Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalFinancialInformationScheduleofRestructuringActionsandtheRelatedAccrualDetails" roleURI="http://www.recursion.com/role/SupplementalFinancialInformationScheduleofRestructuringActionsandtheRelatedAccrualDetails">
        <link:definition>9955523 - Disclosure - Supplemental Financial Information - Schedule of Restructuring Actions and the Related Accrual (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalFinancialInformationScheduleofInterestIncomeNetDetails" roleURI="http://www.recursion.com/role/SupplementalFinancialInformationScheduleofInterestIncomeNetDetails">
        <link:definition>9955524 - Disclosure - Supplemental Financial Information - Schedule of Interest Income, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsNarrativeDetails" roleURI="http://www.recursion.com/role/AcquisitionsNarrativeDetails">
        <link:definition>9955525 - Disclosure - Acquisitions - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsScheduleofAssetAcquisitionDetails" roleURI="http://www.recursion.com/role/AcquisitionsScheduleofAssetAcquisitionDetails">
        <link:definition>9955526 - Disclosure - Acquisitions - Schedule of Asset Acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsScheduleofContingentConsiderationTransferredDetails" roleURI="http://www.recursion.com/role/AcquisitionsScheduleofContingentConsiderationTransferredDetails">
        <link:definition>9955527 - Disclosure - Acquisitions - Schedule of Contingent Consideration Transferred (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails" roleURI="http://www.recursion.com/role/AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails">
        <link:definition>9955528 - Disclosure - Acquisitions - Schedule of Fair Value of Assets Acquired and Liabilities Assumed (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsScheduleofProFormaFinancialInformationDetails" roleURI="http://www.recursion.com/role/AcquisitionsScheduleofProFormaFinancialInformationDetails">
        <link:definition>9955529 - Disclosure - Acquisitions - Schedule of Pro Forma Financial Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://www.recursion.com/role/LeasesNarrativeDetails">
        <link:definition>9955530 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofSupplementalCashFlowInformationRelatedtoLeasesDetails" roleURI="http://www.recursion.com/role/LeasesScheduleofSupplementalCashFlowInformationRelatedtoLeasesDetails">
        <link:definition>9955531 - Disclosure - Leases - Schedule of Supplemental Cash Flow Information Related to Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsScheduleofChangesintheCarryingAmountofGoodwillDetails" roleURI="http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofChangesintheCarryingAmountofGoodwillDetails">
        <link:definition>9955532 - Disclosure - Goodwill and Intangible Assets - Schedule of Changes in the Carrying Amount of Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNarrativeDetails" roleURI="http://www.recursion.com/role/GoodwillandIntangibleAssetsNarrativeDetails">
        <link:definition>9955533 - Disclosure - Goodwill and Intangible Assets - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails" roleURI="http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails">
        <link:definition>9955534 - Disclosure - Goodwill and Intangible Assets - Schedule of Intangible assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails_1" roleURI="http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails_1">
        <link:definition>9955534 - Disclosure - Goodwill and Intangible Assets - Schedule of Intangible assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://www.recursion.com/role/CommitmentsandContingenciesDetails">
        <link:definition>9955535 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStockNarrativeDetails" roleURI="http://www.recursion.com/role/CommonStockNarrativeDetails">
        <link:definition>9955536 - Disclosure - Common Stock - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStockAtTheMarketOfferingNarrativeDetails" roleURI="http://www.recursion.com/role/CommonStockAtTheMarketOfferingNarrativeDetails">
        <link:definition>9955537 - Disclosure - Common Stock - At-The-Market Offering (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStockPublicOfferingofCommonStockNarrativeDetails" roleURI="http://www.recursion.com/role/CommonStockPublicOfferingofCommonStockNarrativeDetails">
        <link:definition>9955538 - Disclosure - Common Stock - Public Offering of Common Stock (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStockValenceAcquisitionExchangeableSharesNarrativeDetails" roleURI="http://www.recursion.com/role/CommonStockValenceAcquisitionExchangeableSharesNarrativeDetails">
        <link:definition>9955539 - Disclosure - Common Stock - Valence Acquisition Exchangeable Shares (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStockRegistrationRightsAgreementsNarrativeDetails" roleURI="http://www.recursion.com/role/CommonStockRegistrationRightsAgreementsNarrativeDetails">
        <link:definition>9955540 - Disclosure - Common Stock - Registration Rights Agreements (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStockClassAandBCommonSharesAuthorizationNarrativeDetails" roleURI="http://www.recursion.com/role/CommonStockClassAandBCommonSharesAuthorizationNarrativeDetails">
        <link:definition>9955541 - Disclosure - Common Stock - Class A and B Common Shares Authorization (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborativeDevelopmentContractsDetails" roleURI="http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails">
        <link:definition>9955542 - Disclosure - Collaborative Development Contracts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationNarrativeDetails" roleURI="http://www.recursion.com/role/StockBasedCompensationNarrativeDetails">
        <link:definition>9955543 - Disclosure - Stock-Based Compensation - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails" roleURI="http://www.recursion.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails">
        <link:definition>9955544 - Disclosure - Stock-Based Compensation - Schedule of Stock-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationScheduleofStockOptionActivityDetails" roleURI="http://www.recursion.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails">
        <link:definition>9955545 - Disclosure - Stock-Based Compensation - Schedule of Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoCalculateGrantDateFairValueofStockOptionsDetails" roleURI="http://www.recursion.com/role/StockBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoCalculateGrantDateFairValueofStockOptionsDetails">
        <link:definition>9955546 - Disclosure - Stock-Based Compensation - Schedule of Weighted-Average Assumptions Used to Calculate Grant-Date Fair Value of Stock Options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationScheduleofRSUActivityDetails" roleURI="http://www.recursion.com/role/StockBasedCompensationScheduleofRSUActivityDetails">
        <link:definition>9955547 - Disclosure - Stock-Based Compensation - Schedule of RSU Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://www.recursion.com/role/IncomeTaxesDetails">
        <link:definition>9955548 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareScheduleofComputationofBasicandDilutedNetLossPerShareDetails" roleURI="http://www.recursion.com/role/NetLossPerShareScheduleofComputationofBasicandDilutedNetLossPerShareDetails">
        <link:definition>9955549 - Disclosure - Net Loss Per Share - Schedule of Computation of Basic and Diluted Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossPerShareDetails" roleURI="http://www.recursion.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossPerShareDetails">
        <link:definition>9955550 - Disclosure - Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Computation of Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" roleURI="http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails">
        <link:definition>9955551 - Disclosure - Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails" roleURI="http://www.recursion.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails">
        <link:definition>9955552 - Disclosure - Fair Value Measurements - Schedule of Financial Instruments Not Measured at Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails" roleURI="http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails">
        <link:definition>9955553 - Disclosure - Segment Information - Schedule of Segment Net Loss and Reconciliations of Segment Operating Loss to Loss Before Income Tax Benefit (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationScheduleofRevenueandLongLivedAssetsBasedonGeographicAreasDetails" roleURI="http://www.recursion.com/role/SegmentInformationScheduleofRevenueandLongLivedAssetsBasedonGeographicAreasDetails">
        <link:definition>9955554 - Disclosure - Segment Information - Schedule of Revenue and Long-Lived Assets Based on Geographic Areas (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsDetails" roleURI="http://www.recursion.com/role/SubsequentEventsDetails">
        <link:definition>9955555 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="rxrx_AccruedDataCurrent" abstract="false" name="AccruedDataCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_ExchangeableStockMember" abstract="true" name="ExchangeableStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_IncreaseDecreaseInPrepaidDataAssets" abstract="false" name="IncreaseDecreaseInPrepaidDataAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_IncreaseDecreaseInAccruedDataLiability" abstract="false" name="IncreaseDecreaseInAccruedDataLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_IncreaseDecreaseInAccruedDevelopmentExpense" abstract="false" name="IncreaseDecreaseInAccruedDevelopmentExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_IncreaseDecreaseInLeaseLiability" abstract="false" name="IncreaseDecreaseInLeaseLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_PaymentsToAcquireIntangibleAssetsFinancialActivities" abstract="false" name="PaymentsToAcquireIntangibleAssetsFinancialActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_PurchaseOfAnEquityInvestmentNonCash" abstract="false" name="PurchaseOfAnEquityInvestmentNonCash" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_SupplementalFinancialInformationAbstract" abstract="true" name="SupplementalFinancialInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rxrx_SupplementalBalanceSheetAndIncomeStatementInformationTextBlock" abstract="false" name="SupplementalBalanceSheetAndIncomeStatementInformationTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="rxrx_TempusLabsIncMember" abstract="true" name="TempusLabsIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_LicenseAgreementTerm" abstract="false" name="LicenseAgreementTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="rxrx_LicenseAgreementAnnualPayments" abstract="false" name="LicenseAgreementAnnualPayments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_LicenseAgreementAggregatePayments" abstract="false" name="LicenseAgreementAggregatePayments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_LicenseAgreementTradingPeriodUsedForEquityValueDetermination" abstract="false" name="LicenseAgreementTradingPeriodUsedForEquityValueDetermination" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="rxrx_LicenseAgreementAmountOfTimePriorToThePaymentDate" abstract="false" name="LicenseAgreementAmountOfTimePriorToThePaymentDate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="rxrx_LicenseAgreementIncreaseDecreaseAccruedLiabilities" abstract="false" name="LicenseAgreementIncreaseDecreaseAccruedLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_AccruedDevelopmentCostsCurrent" abstract="false" name="AccruedDevelopmentCostsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_AccruedEarlyDiscoveryExpensesCurrent" abstract="false" name="AccruedEarlyDiscoveryExpensesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_MaterialsReceivedNotInvoiced" abstract="false" name="MaterialsReceivedNotInvoiced" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_AccruedLicenseFeeCurrent" abstract="false" name="AccruedLicenseFeeCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_REVenturesIMember" abstract="true" name="REVenturesIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_AlphaBiotechnologyGmbHAlphaMember" abstract="true" name="AlphaBiotechnologyGmbHAlphaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_ExscientiaGmbHMember" abstract="true" name="ExscientiaGmbHMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_ExscientiaPlcMember" abstract="true" name="ExscientiaPlcMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_AssetAcquisitionEquityOwnershipPercentage" abstract="false" name="AssetAcquisitionEquityOwnershipPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="rxrx_BusinessCombinationConsiderationTransferredEquityInterestsIssuable" abstract="false" name="BusinessCombinationConsiderationTransferredEquityInterestsIssuable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_BusinessCombinationEquityInterestIssuedOrIssuableSharesOfAcquirerStockPerShareOfAcquireeStockOutstanding" abstract="false" name="BusinessCombinationEquityInterestIssuedOrIssuableSharesOfAcquirerStockPerShareOfAcquireeStockOutstanding" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="rxrx_NumberOfAcquiredCustomerContractsWithContractLiabilities" abstract="false" name="NumberOfAcquiredCustomerContractsWithContractLiabilities" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rxrx_NumberOfInProcessResearchAndDevelopmentAssets" abstract="false" name="NumberOfInProcessResearchAndDevelopmentAssets" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rxrx_FiniteLivedIntangibleAssetDiscountRate" abstract="false" name="FiniteLivedIntangibleAssetDiscountRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="rxrx_AssetAcquisitionContingentConsiderationEquityInterestIssuedAndIssuable" abstract="false" name="AssetAcquisitionContingentConsiderationEquityInterestIssuedAndIssuable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_AssetAcquisitionContingentConsiderationCashPaid" abstract="false" name="AssetAcquisitionContingentConsiderationCashPaid" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_LeaseDescriptionAxis" abstract="true" name="LeaseDescriptionAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="rxrx_LeaseDescriptionDomain" abstract="true" name="LeaseDescriptionDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_ViennaFacilitiesOfExscientiaGmbHMember" abstract="true" name="ViennaFacilitiesOfExscientiaGmbHMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_SchrodingerLeasesMember" abstract="true" name="SchrodingerLeasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" abstract="false" name="IncreaseDecreaseInOperatingLeaseRightOfUseAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications" abstract="false" name="LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_TerminationOfLeaseFee" abstract="false" name="TerminationOfLeaseFee" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_IncreaseDecreaseInRightOfUseAssetsForFinanceLeases" abstract="false" name="IncreaseDecreaseInRightOfUseAssetsForFinanceLeases" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_LesseeFinanceLeaseIncreaseDecreaseInFinanceLeaseLiabilityDueToLeaseModifications" abstract="false" name="LesseeFinanceLeaseIncreaseDecreaseInFinanceLeaseLiabilityDueToLeaseModifications" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_CashPaidForAmountIncludedInTheMeasurementOfLeaseLiabilitiesAbstract" abstract="true" name="CashPaidForAmountIncludedInTheMeasurementOfLeaseLiabilitiesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rxrx_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract" abstract="true" name="RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rxrx_DurationOfTimeForPlaintiffToRefileClaim" abstract="false" name="DurationOfTimeForPlaintiffToRefileClaim" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="rxrx_FinanceLeasesAssetsPledgedAsCollateral" abstract="false" name="FinanceLeasesAssetsPledgedAsCollateral" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_CommonStockVotePerShare" abstract="false" name="CommonStockVotePerShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rxrx_AtTheMarketOfferingProgramCitiMember" abstract="true" name="AtTheMarketOfferingProgramCitiMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_AtTheMarketOfferingProgramJefferiesMember" abstract="true" name="AtTheMarketOfferingProgramJefferiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_SaleOfStockValueAuthorized" abstract="false" name="SaleOfStockValueAuthorized" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_SaleOfStockValueRemainingAuthorized" abstract="false" name="SaleOfStockValueRemainingAuthorized" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_SaleOfStockPercentageOfCommission" abstract="false" name="SaleOfStockPercentageOfCommission" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="rxrx_PublicOfferingOfCommonStockMember" abstract="true" name="PublicOfferingOfCommonStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_PublicOfferingOfCommonStockUnderwritingAgreementMember" abstract="true" name="PublicOfferingOfCommonStockUnderwritingAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_SaleOfStockUnderwritersOptionPeriodFromTheDateOfTheAgreement" abstract="false" name="SaleOfStockUnderwritersOptionPeriodFromTheDateOfTheAgreement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="rxrx_ValenceDiscoveryIncMember" abstract="true" name="ValenceDiscoveryIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares" abstract="false" name="BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="rxrx_CommonStockConversionRatio" abstract="false" name="CommonStockConversionRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="rxrx_RegistrationRightsAgreementTerm" abstract="false" name="RegistrationRightsAgreementTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="rxrx_CEOAndAffiliatesMember" abstract="true" name="CEOAndAffiliatesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_NumberOfClassesOfCommonStockAuthorized" abstract="false" name="NumberOfClassesOfCommonStockAuthorized" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rxrx_AffiliatedHoldersOwnershipPercentage" abstract="false" name="AffiliatedHoldersOwnershipPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="rxrx_AffiliatedHoldersPotentialOwnershipPercentageWhenOutstandingEquityAwardsVest" abstract="false" name="AffiliatedHoldersPotentialOwnershipPercentageWhenOutstandingEquityAwardsVest" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="rxrx_SanofiMember" abstract="true" name="SanofiMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_MerckKGaAMerckMember" abstract="true" name="MerckKGaAMerckMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_RocheAndGenentechMember" abstract="true" name="RocheAndGenentechMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_MilestoneTypeAxis" abstract="true" name="MilestoneTypeAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="rxrx_MilestoneTypeDomain" abstract="true" name="MilestoneTypeDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_ResearchMilestonesMember" abstract="true" name="ResearchMilestonesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_DevelopmentAndRegulatoryMilestonesMember" abstract="true" name="DevelopmentAndRegulatoryMilestonesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_DiscoveryDevelopmentAndSalesMilestonesMember" abstract="true" name="DiscoveryDevelopmentAndSalesMilestonesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_RevenueRemainingPerformanceObligationAxis" abstract="true" name="RevenueRemainingPerformanceObligationAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="rxrx_RevenueRemainingPerformanceObligationDomain" abstract="true" name="RevenueRemainingPerformanceObligationDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_PhenomapsCreationMember" abstract="true" name="PhenomapsCreationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_PhenomapsRawImagesMember" abstract="true" name="PhenomapsRawImagesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_DevelopedAndCommercializedProgramsMember" abstract="true" name="DevelopedAndCommercializedProgramsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_GastrointestinalCancerMember" abstract="true" name="GastrointestinalCancerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_NeuroscienceMember" abstract="true" name="NeuroscienceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_ContractWithCustomerNumberOfNovelSmallMoleculeCandidates" abstract="false" name="ContractWithCustomerNumberOfNovelSmallMoleculeCandidates" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rxrx_CollaborativeArrangementMilestonePaymentReceived" abstract="false" name="CollaborativeArrangementMilestonePaymentReceived" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_RevenuePerformanceObligationNumberOfObligations" abstract="false" name="RevenuePerformanceObligationNumberOfObligations" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rxrx_RevenueRemainingPerformanceObligationVariableConsiderationAmount" abstract="false" name="RevenueRemainingPerformanceObligationVariableConsiderationAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_ContractWithCustomerMaximumAcceptedProduct" abstract="false" name="ContractWithCustomerMaximumAcceptedProduct" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rxrx_RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated" abstract="false" name="RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rxrx_A2021EquityIncentivePlanMember" abstract="true" name="A2021EquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_A2024InducementEquityIncentivePlanMember" abstract="true" name="A2024InducementEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_TempusAgreementMember" abstract="true" name="TempusAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_ContingentStockRelatingToREVentures1AgreementMember" abstract="true" name="ContingentStockRelatingToREVentures1AgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure" abstract="false" name="RestrictedCashAndCashEquivalentsFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_ReportableSegmentMember" abstract="true" name="ReportableSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_SignificantSegmentExpensesAbstract" abstract="true" name="SignificantSegmentExpensesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rxrx_ConsumableExpense" abstract="false" name="ConsumableExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_PlatformFeeExpense" abstract="false" name="PlatformFeeExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_DiscoveryExpense" abstract="false" name="DiscoveryExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_ClinicalDevelopmentExpense" abstract="false" name="ClinicalDevelopmentExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_SupplementalAssetInformationAbstract" abstract="true" name="SupplementalAssetInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rxrx_OtherCountriesMember" abstract="true" name="OtherCountriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_BlakeBorgesonMember" abstract="true" name="BlakeBorgesonMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_NajatKhanMember" abstract="true" name="NajatKhanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_BenTaylorMember" abstract="true" name="BenTaylorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>rxrx-20250930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:84e2dd81-95f3-479b-879b-c1ea33e5483d,g:a06efc1c-9b19-4722-bcb5-747c44bbab78-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited" xlink:type="simple" xlink:href="rxrx-20250930.xsd#CondensedConsolidatedBalanceSheetsunaudited"/>
  <link:calculationLink xlink:role="http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_3963bb58-9f82-442c-a960-727df270a2f7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_4a0d9481-4656-404f-98ff-f6ab2c911417" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_3963bb58-9f82-442c-a960-727df270a2f7" xlink:to="loc_us-gaap_LiabilitiesCurrent_4a0d9481-4656-404f-98ff-f6ab2c911417" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_acc009f9-f4b9-4442-8314-121916705401" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_3963bb58-9f82-442c-a960-727df270a2f7" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_acc009f9-f4b9-4442-8314-121916705401" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c0c16e3b-a5af-443c-85cf-786a13838807" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_3963bb58-9f82-442c-a960-727df270a2f7" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c0c16e3b-a5af-443c-85cf-786a13838807" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_e9fa8c11-abba-48aa-9c65-f443f8a84b52" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_3963bb58-9f82-442c-a960-727df270a2f7" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_e9fa8c11-abba-48aa-9c65-f443f8a84b52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_aff6d89d-415a-40e5-abfd-1e31d60c0a07" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_3963bb58-9f82-442c-a960-727df270a2f7" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_aff6d89d-415a-40e5-abfd-1e31d60c0a07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_1d7b61a9-6d13-42b6-9b77-c8c311b40f8d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_3963bb58-9f82-442c-a960-727df270a2f7" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_1d7b61a9-6d13-42b6-9b77-c8c311b40f8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_df9f8a82-260b-4f30-868d-fe00397a62f6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_24d41ae0-6e57-4a27-93de-b11b5128ed7a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_df9f8a82-260b-4f30-868d-fe00397a62f6" xlink:to="loc_us-gaap_AccountsPayableCurrent_24d41ae0-6e57-4a27-93de-b11b5128ed7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_c6013083-b652-4a6b-958f-351ae8c77a7b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_df9f8a82-260b-4f30-868d-fe00397a62f6" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_c6013083-b652-4a6b-958f-351ae8c77a7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AccruedDataCurrent_3a4fcd50-a067-43bc-9d3c-be8c852e318a" xlink:href="rxrx-20250930.xsd#rxrx_AccruedDataCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_df9f8a82-260b-4f30-868d-fe00397a62f6" xlink:to="loc_rxrx_AccruedDataCurrent_3a4fcd50-a067-43bc-9d3c-be8c852e318a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_82a8e984-3fbf-41ca-8d56-281f5c0aef46" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_df9f8a82-260b-4f30-868d-fe00397a62f6" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_82a8e984-3fbf-41ca-8d56-281f5c0aef46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_9ea4ce0a-116e-45b4-86d8-a8f1f5525ce3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_df9f8a82-260b-4f30-868d-fe00397a62f6" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_9ea4ce0a-116e-45b4-86d8-a8f1f5525ce3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_0d6383fc-9a9b-42ef-b2a4-a00c7c33ea98" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_df9f8a82-260b-4f30-868d-fe00397a62f6" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_0d6383fc-9a9b-42ef-b2a4-a00c7c33ea98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_5e3191e2-3e70-4ddf-a861-a06ea949721b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_0f7a1e8a-ab18-4aed-b83c-01b00d6fd1ea" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_5e3191e2-3e70-4ddf-a861-a06ea949721b" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_0f7a1e8a-ab18-4aed-b83c-01b00d6fd1ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_555d71de-ae4f-48e5-9137-e21ac19b9569" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_5e3191e2-3e70-4ddf-a861-a06ea949721b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_555d71de-ae4f-48e5-9137-e21ac19b9569" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_8f5220ea-873c-4a12-a3aa-10ff0850f221" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_5e3191e2-3e70-4ddf-a861-a06ea949721b" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_8f5220ea-873c-4a12-a3aa-10ff0850f221" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_13021f04-ecd9-44b5-83af-ae1ee1e20641" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_5e3191e2-3e70-4ddf-a861-a06ea949721b" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_13021f04-ecd9-44b5-83af-ae1ee1e20641" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e2ef69ae-1c66-4128-a673-180e6c4675f1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_5e3191e2-3e70-4ddf-a861-a06ea949721b" xlink:to="loc_us-gaap_Goodwill_e2ef69ae-1c66-4128-a673-180e6c4675f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_b630b3f9-8aed-4439-8e38-0a82cbd68e18" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_5e3191e2-3e70-4ddf-a861-a06ea949721b" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_b630b3f9-8aed-4439-8e38-0a82cbd68e18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_7b03fe6b-1dd2-4f4b-9443-a5ecc9e63909" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_5e3191e2-3e70-4ddf-a861-a06ea949721b" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_7b03fe6b-1dd2-4f4b-9443-a5ecc9e63909" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_7ca912ec-aa3c-48e0-8a8b-da247d8e254b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_5e3191e2-3e70-4ddf-a861-a06ea949721b" xlink:to="loc_us-gaap_AssetsCurrent_7ca912ec-aa3c-48e0-8a8b-da247d8e254b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_e9a23061-0b05-41b9-b7f8-ae64ebf4a2d5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_5e3191e2-3e70-4ddf-a861-a06ea949721b" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_e9a23061-0b05-41b9-b7f8-ae64ebf4a2d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f466fe29-3898-4653-87f3-27782b3adde1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_5a5680bc-f308-4004-995c-5920ead9f700" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_f466fe29-3898-4653-87f3-27782b3adde1" xlink:to="loc_us-gaap_AdditionalPaidInCapital_5a5680bc-f308-4004-995c-5920ead9f700" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_51c8198b-0c79-48ec-9d2f-4e2e17618c77" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_f466fe29-3898-4653-87f3-27782b3adde1" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_51c8198b-0c79-48ec-9d2f-4e2e17618c77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_8959b29b-fd49-408c-8df0-31ef9f23837d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_f466fe29-3898-4653-87f3-27782b3adde1" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_8959b29b-fd49-408c-8df0-31ef9f23837d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_b3404516-fd73-48d6-a9e4-c89b6af50bb4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_f466fe29-3898-4653-87f3-27782b3adde1" xlink:to="loc_us-gaap_CommonStockValue_b3404516-fd73-48d6-a9e4-c89b6af50bb4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_62c3fa94-cd11-4fe1-be8b-831b7cb5c0fd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_3536d4f5-ea12-4058-a562-39d4fed0d08b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_62c3fa94-cd11-4fe1-be8b-831b7cb5c0fd" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_3536d4f5-ea12-4058-a562-39d4fed0d08b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_e3efac82-818b-406f-83ba-0c112b8de289" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_62c3fa94-cd11-4fe1-be8b-831b7cb5c0fd" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_e3efac82-818b-406f-83ba-0c112b8de289" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5a2e56b9-3e0c-43b1-a1b6-10ea3504b8b7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_62c3fa94-cd11-4fe1-be8b-831b7cb5c0fd" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5a2e56b9-3e0c-43b1-a1b6-10ea3504b8b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_ad6a1838-59fa-413b-8ec1-84498be84f2b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_62c3fa94-cd11-4fe1-be8b-831b7cb5c0fd" xlink:to="loc_us-gaap_RestrictedCashCurrent_ad6a1838-59fa-413b-8ec1-84498be84f2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_c25f923f-930d-413c-82ac-8630ac25abd6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_62c3fa94-cd11-4fe1-be8b-831b7cb5c0fd" xlink:to="loc_us-gaap_OtherAssetsCurrent_c25f923f-930d-413c-82ac-8630ac25abd6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_99d044b5-c70d-4cd3-ba79-194de9756d99" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_fbabf7c6-2c29-4fb4-9f9f-6b3d95339b88" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_99d044b5-c70d-4cd3-ba79-194de9756d99" xlink:to="loc_us-gaap_Liabilities_fbabf7c6-2c29-4fb4-9f9f-6b3d95339b88" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_8a94b652-fc7b-40eb-8e65-d2a15ac8f3ff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_99d044b5-c70d-4cd3-ba79-194de9756d99" xlink:to="loc_us-gaap_CommitmentsAndContingencies_8a94b652-fc7b-40eb-8e65-d2a15ac8f3ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a3f56a5c-e61b-4eff-badb-ce3396fd8d10" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_99d044b5-c70d-4cd3-ba79-194de9756d99" xlink:to="loc_us-gaap_StockholdersEquity_a3f56a5c-e61b-4eff-badb-ce3396fd8d10" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited" xlink:type="simple" xlink:href="rxrx-20250930.xsd#CondensedConsolidatedStatementsofOperationsunaudited"/>
  <link:calculationLink xlink:role="http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9d6ece42-dfba-45ff-802b-8876e10398d7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_df27a11b-4e11-4195-b9b5-d601dad14732" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9d6ece42-dfba-45ff-802b-8876e10398d7" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_df27a11b-4e11-4195-b9b5-d601dad14732" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_0ccd012a-f1bb-467f-ba4f-5b25fb471aed" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9d6ece42-dfba-45ff-802b-8876e10398d7" xlink:to="loc_us-gaap_OperatingIncomeLoss_0ccd012a-f1bb-467f-ba4f-5b25fb471aed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a99b6b80-741c-444e-85b0-577bab90dba6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6d22aa1d-9dc5-4f45-9de1-ebe6892c3eac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_a99b6b80-741c-444e-85b0-577bab90dba6" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6d22aa1d-9dc5-4f45-9de1-ebe6892c3eac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_27f9520a-ebc9-4005-a187-fd5ccd7570ad" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_a99b6b80-741c-444e-85b0-577bab90dba6" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_27f9520a-ebc9-4005-a187-fd5ccd7570ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_289ddced-ec91-4a54-934c-5d61b341e43b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b2176939-5c32-46f8-9326-cc9bdad179b1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_289ddced-ec91-4a54-934c-5d61b341e43b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b2176939-5c32-46f8-9326-cc9bdad179b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_ef20fa7c-6ae7-44dc-8e56-51ce3f497249" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_289ddced-ec91-4a54-934c-5d61b341e43b" xlink:to="loc_us-gaap_CostsAndExpenses_ef20fa7c-6ae7-44dc-8e56-51ce3f497249" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_780da2b7-1560-4c9c-9ad1-11daec10d419" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_bb040eea-d02d-4d59-9478-a162f29280cf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_780da2b7-1560-4c9c-9ad1-11daec10d419" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_bb040eea-d02d-4d59-9478-a162f29280cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_b106dc59-66b9-473e-a842-74a5b215ebe3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_780da2b7-1560-4c9c-9ad1-11daec10d419" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_b106dc59-66b9-473e-a842-74a5b215ebe3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_e0987774-7c5b-43e7-b09d-8b1a20464bb2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_780da2b7-1560-4c9c-9ad1-11daec10d419" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_e0987774-7c5b-43e7-b09d-8b1a20464bb2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CondensedConsolidatedStatementsofComprehensiveLossunaudited" xlink:type="simple" xlink:href="rxrx-20250930.xsd#CondensedConsolidatedStatementsofComprehensiveLossunaudited"/>
  <link:calculationLink xlink:role="http://www.recursion.com/role/CondensedConsolidatedStatementsofComprehensiveLossunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_47946f28-5968-4650-a8d0-3dc460da1e15" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_df2e1da7-6ec0-4b68-9d1e-ca90913ec32f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_47946f28-5968-4650-a8d0-3dc460da1e15" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_df2e1da7-6ec0-4b68-9d1e-ca90913ec32f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_a55f3daf-befe-4a79-9f35-32a24cb6ebd8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a851a439-26a7-4095-9ccf-3e5227d524f6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_a55f3daf-befe-4a79-9f35-32a24cb6ebd8" xlink:to="loc_us-gaap_NetIncomeLoss_a851a439-26a7-4095-9ccf-3e5227d524f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_4fd2a6e9-34fb-4363-80ea-ba7421aee72a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_a55f3daf-befe-4a79-9f35-32a24cb6ebd8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_4fd2a6e9-34fb-4363-80ea-ba7421aee72a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" xlink:type="simple" xlink:href="rxrx-20250930.xsd#CondensedConsolidatedStatementsofCashFlowsunaudited"/>
  <link:calculationLink xlink:role="http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9455e1a9-2e9e-4759-8906-d5d900b591a3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_699a95f2-4c84-4739-a07e-94784f83ebc1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9455e1a9-2e9e-4759-8906-d5d900b591a3" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_699a95f2-4c84-4739-a07e-94784f83ebc1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_50133307-9b0d-4712-a1a5-9daa291fab21" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9455e1a9-2e9e-4759-8906-d5d900b591a3" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_50133307-9b0d-4712-a1a5-9daa291fab21" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_930299f1-c7f4-405c-9631-000ee3f87f2b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9455e1a9-2e9e-4759-8906-d5d900b591a3" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_930299f1-c7f4-405c-9631-000ee3f87f2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_PaymentsToAcquireIntangibleAssetsFinancialActivities_16b466d9-564f-4201-8377-212df07447ce" xlink:href="rxrx-20250930.xsd#rxrx_PaymentsToAcquireIntangibleAssetsFinancialActivities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9455e1a9-2e9e-4759-8906-d5d900b591a3" xlink:to="loc_rxrx_PaymentsToAcquireIntangibleAssetsFinancialActivities_16b466d9-564f-4201-8377-212df07447ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cce4c7d7-a534-4b10-a605-551ce32bd9b4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_24bafe83-d98b-4645-8ce8-7572cff48e8b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cce4c7d7-a534-4b10-a605-551ce32bd9b4" xlink:to="loc_us-gaap_NetIncomeLoss_24bafe83-d98b-4645-8ce8-7572cff48e8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_97aeea75-59d9-4233-9358-232ff2fce9be" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cce4c7d7-a534-4b10-a605-551ce32bd9b4" xlink:to="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_97aeea75-59d9-4233-9358-232ff2fce9be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_9dd658bb-cdd4-4c0e-a056-a7dfe56820f3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cce4c7d7-a534-4b10-a605-551ce32bd9b4" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_9dd658bb-cdd4-4c0e-a056-a7dfe56820f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_7675017f-917e-4605-b4a5-3344f054980e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cce4c7d7-a534-4b10-a605-551ce32bd9b4" xlink:to="loc_us-gaap_ShareBasedCompensation_7675017f-917e-4605-b4a5-3344f054980e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges_7af080d5-9d3b-4119-8f8d-5c012299745d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cce4c7d7-a534-4b10-a605-551ce32bd9b4" xlink:to="loc_us-gaap_TangibleAssetImpairmentCharges_7af080d5-9d3b-4119-8f8d-5c012299745d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_8de1e21f-3c59-41b5-896c-9bc02017b33b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cce4c7d7-a534-4b10-a605-551ce32bd9b4" xlink:to="loc_us-gaap_OperatingLeaseExpense_8de1e21f-3c59-41b5-896c-9bc02017b33b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_dbfbb7f4-169e-4eef-b5b4-631fb2fb32f6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cce4c7d7-a534-4b10-a605-551ce32bd9b4" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_dbfbb7f4-169e-4eef-b5b4-631fb2fb32f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_acd10ebd-d1d7-4038-8ab6-570869116b06" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cce4c7d7-a534-4b10-a605-551ce32bd9b4" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_acd10ebd-d1d7-4038-8ab6-570869116b06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_74ddb1f7-73db-468a-8965-5bb6c1ca6a75" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cce4c7d7-a534-4b10-a605-551ce32bd9b4" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_74ddb1f7-73db-468a-8965-5bb6c1ca6a75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_IncreaseDecreaseInPrepaidDataAssets_d1569fa0-01f4-418f-9938-37eb35e0c870" xlink:href="rxrx-20250930.xsd#rxrx_IncreaseDecreaseInPrepaidDataAssets"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cce4c7d7-a534-4b10-a605-551ce32bd9b4" xlink:to="loc_rxrx_IncreaseDecreaseInPrepaidDataAssets_d1569fa0-01f4-418f-9938-37eb35e0c870" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_IncreaseDecreaseInAccruedDataLiability_53c2717b-4737-4409-9933-9646abe5a38d" xlink:href="rxrx-20250930.xsd#rxrx_IncreaseDecreaseInAccruedDataLiability"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cce4c7d7-a534-4b10-a605-551ce32bd9b4" xlink:to="loc_rxrx_IncreaseDecreaseInAccruedDataLiability_53c2717b-4737-4409-9933-9646abe5a38d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_031efedd-9df6-4ec9-97a8-609ad0ac9191" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cce4c7d7-a534-4b10-a605-551ce32bd9b4" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_031efedd-9df6-4ec9-97a8-609ad0ac9191" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_e4841315-a819-4f7e-8533-fcf8acdeaa5a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cce4c7d7-a534-4b10-a605-551ce32bd9b4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_e4841315-a819-4f7e-8533-fcf8acdeaa5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_IncreaseDecreaseInAccruedDevelopmentExpense_e48688a6-f3f1-4031-af08-1ef81e2eb8f0" xlink:href="rxrx-20250930.xsd#rxrx_IncreaseDecreaseInAccruedDevelopmentExpense"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cce4c7d7-a534-4b10-a605-551ce32bd9b4" xlink:to="loc_rxrx_IncreaseDecreaseInAccruedDevelopmentExpense_e48688a6-f3f1-4031-af08-1ef81e2eb8f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_d07ef01f-b7bd-4d59-8a7b-af079efab516" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cce4c7d7-a534-4b10-a605-551ce32bd9b4" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_d07ef01f-b7bd-4d59-8a7b-af079efab516" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_IncreaseDecreaseInLeaseLiability_6956fec8-2ce8-4161-975d-b06f64fc3c44" xlink:href="rxrx-20250930.xsd#rxrx_IncreaseDecreaseInLeaseLiability"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cce4c7d7-a534-4b10-a605-551ce32bd9b4" xlink:to="loc_rxrx_IncreaseDecreaseInLeaseLiability_6956fec8-2ce8-4161-975d-b06f64fc3c44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0749c139-0a7d-49fc-9cab-0dc64be5d449" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4d0a502a-8cbd-45ae-8000-d0d52b6a1861" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0749c139-0a7d-49fc-9cab-0dc64be5d449" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4d0a502a-8cbd-45ae-8000-d0d52b6a1861" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8cec2103-b185-4e45-9665-0a88e791964b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0749c139-0a7d-49fc-9cab-0dc64be5d449" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8cec2103-b185-4e45-9665-0a88e791964b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4fdbcf6b-baf9-4376-af84-f7413fa9522c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0749c139-0a7d-49fc-9cab-0dc64be5d449" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4fdbcf6b-baf9-4376-af84-f7413fa9522c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_758bca67-33f5-4ece-997b-c79a12d71694" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0749c139-0a7d-49fc-9cab-0dc64be5d449" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_758bca67-33f5-4ece-997b-c79a12d71694" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7fea3379-0228-45be-b86f-890f936c1fe1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_6cca81b4-88c0-457d-909b-9368a749fceb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7fea3379-0228-45be-b86f-890f936c1fe1" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_6cca81b4-88c0-457d-909b-9368a749fceb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_408ce6a7-f7f5-4e32-9515-0b6766f2606a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7fea3379-0228-45be-b86f-890f936c1fe1" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_408ce6a7-f7f5-4e32-9515-0b6766f2606a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_def76893-7a89-49dc-b846-53a5a41d0c33" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7fea3379-0228-45be-b86f-890f936c1fe1" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_def76893-7a89-49dc-b846-53a5a41d0c33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_73c86d5c-dbd0-4651-b804-e9a3090b8cc6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7fea3379-0228-45be-b86f-890f936c1fe1" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_73c86d5c-dbd0-4651-b804-e9a3090b8cc6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.recursion.com/role/SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_1af3b108-d9bf-4df8-8e55-2f7effdf9acf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b26172ac-47e1-497d-a95f-fc672939c913" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_1af3b108-d9bf-4df8-8e55-2f7effdf9acf" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b26172ac-47e1-497d-a95f-fc672939c913" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AccruedDevelopmentCostsCurrent_8ee29bfd-828f-4de3-b064-4438961f90ce" xlink:href="rxrx-20250930.xsd#rxrx_AccruedDevelopmentCostsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_1af3b108-d9bf-4df8-8e55-2f7effdf9acf" xlink:to="loc_rxrx_AccruedDevelopmentCostsCurrent_8ee29bfd-828f-4de3-b064-4438961f90ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AccruedEarlyDiscoveryExpensesCurrent_c1a488d2-579a-4c5b-a243-dd3e9899abd3" xlink:href="rxrx-20250930.xsd#rxrx_AccruedEarlyDiscoveryExpensesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_1af3b108-d9bf-4df8-8e55-2f7effdf9acf" xlink:to="loc_rxrx_AccruedEarlyDiscoveryExpensesCurrent_c1a488d2-579a-4c5b-a243-dd3e9899abd3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_e9979a54-89ea-4e52-841f-43c6b038e924" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_1af3b108-d9bf-4df8-8e55-2f7effdf9acf" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_e9979a54-89ea-4e52-841f-43c6b038e924" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_MaterialsReceivedNotInvoiced_4b23091a-7bd2-4a53-b8c9-b7232cdd9d19" xlink:href="rxrx-20250930.xsd#rxrx_MaterialsReceivedNotInvoiced"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_1af3b108-d9bf-4df8-8e55-2f7effdf9acf" xlink:to="loc_rxrx_MaterialsReceivedNotInvoiced_4b23091a-7bd2-4a53-b8c9-b7232cdd9d19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AccruedLicenseFeeCurrent_2eaab73d-ec0a-4c32-8927-2fed17031be7" xlink:href="rxrx-20250930.xsd#rxrx_AccruedLicenseFeeCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_1af3b108-d9bf-4df8-8e55-2f7effdf9acf" xlink:to="loc_rxrx_AccruedLicenseFeeCurrent_2eaab73d-ec0a-4c32-8927-2fed17031be7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_735b58db-b120-4ebd-a3f0-178e9807cd5a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_1af3b108-d9bf-4df8-8e55-2f7effdf9acf" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_735b58db-b120-4ebd-a3f0-178e9807cd5a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/SupplementalFinancialInformationScheduleofInterestIncomeNetDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#SupplementalFinancialInformationScheduleofInterestIncomeNetDetails"/>
  <link:calculationLink xlink:role="http://www.recursion.com/role/SupplementalFinancialInformationScheduleofInterestIncomeNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_2cb03b86-aa54-4ad5-bd67-5b9c0fcb1aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_6df69e6b-1aa7-4fe2-8aa5-adba644d793c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_2cb03b86-aa54-4ad5-bd67-5b9c0fcb1aa2" xlink:to="loc_us-gaap_InterestExpenseNonoperating_6df69e6b-1aa7-4fe2-8aa5-adba644d793c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNonoperating_1df2b177-6bc5-4120-8bf6-bec706bc71b3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeNonoperating"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_2cb03b86-aa54-4ad5-bd67-5b9c0fcb1aa2" xlink:to="loc_us-gaap_InvestmentIncomeNonoperating_1df2b177-6bc5-4120-8bf6-bec706bc71b3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/AcquisitionsScheduleofAssetAcquisitionDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#AcquisitionsScheduleofAssetAcquisitionDetails"/>
  <link:calculationLink xlink:role="http://www.recursion.com/role/AcquisitionsScheduleofAssetAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferred_d3d74aef-25da-4cdc-b77d-2a60ab3458bb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionConsiderationTransferred"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable_142c7a7e-4d95-43d4-a29b-94c539fcfdda" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetAcquisitionConsiderationTransferred_d3d74aef-25da-4cdc-b77d-2a60ab3458bb" xlink:to="loc_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable_142c7a7e-4d95-43d4-a29b-94c539fcfdda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration_0a1a466c-f285-4ff0-90b8-2ba324ccbb33" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetAcquisitionConsiderationTransferred_d3d74aef-25da-4cdc-b77d-2a60ab3458bb" xlink:to="loc_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration_0a1a466c-f285-4ff0-90b8-2ba324ccbb33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost_d47b9370-8966-437e-ad26-a308434b9adb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetAcquisitionConsiderationTransferred_d3d74aef-25da-4cdc-b77d-2a60ab3458bb" xlink:to="loc_us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost_d47b9370-8966-437e-ad26-a308434b9adb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_a1955ac0-5ecf-4752-a929-a8adcc4faff9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetAcquisitionConsiderationTransferred_d3d74aef-25da-4cdc-b77d-2a60ab3458bb" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_a1955ac0-5ecf-4752-a929-a8adcc4faff9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/AcquisitionsScheduleofContingentConsiderationTransferredDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#AcquisitionsScheduleofContingentConsiderationTransferredDetails"/>
  <link:calculationLink xlink:role="http://www.recursion.com/role/AcquisitionsScheduleofContingentConsiderationTransferredDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration_8db27358-0b5c-48e1-b4d3-72ba16176887" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AssetAcquisitionContingentConsiderationEquityInterestIssuedAndIssuable_2738dc3a-1ed6-4253-af82-3d2112c3869c" xlink:href="rxrx-20250930.xsd#rxrx_AssetAcquisitionContingentConsiderationEquityInterestIssuedAndIssuable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration_8db27358-0b5c-48e1-b4d3-72ba16176887" xlink:to="loc_rxrx_AssetAcquisitionContingentConsiderationEquityInterestIssuedAndIssuable_2738dc3a-1ed6-4253-af82-3d2112c3869c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AssetAcquisitionContingentConsiderationCashPaid_2562a005-bf4a-406c-b9f7-77e37e2fb5dd" xlink:href="rxrx-20250930.xsd#rxrx_AssetAcquisitionContingentConsiderationCashPaid"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration_8db27358-0b5c-48e1-b4d3-72ba16176887" xlink:to="loc_rxrx_AssetAcquisitionContingentConsiderationCashPaid_2562a005-bf4a-406c-b9f7-77e37e2fb5dd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:calculationLink xlink:role="http://www.recursion.com/role/AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_89f06a3c-d94d-4075-9c10-3cbb06eaf4a8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_a83c43cd-d6d1-4119-a649-8d2423469941" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_89f06a3c-d94d-4075-9c10-3cbb06eaf4a8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_a83c43cd-d6d1-4119-a649-8d2423469941" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_ed8cceb5-6aa9-44a2-9aec-7b3943a81c33" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_89f06a3c-d94d-4075-9c10-3cbb06eaf4a8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_ed8cceb5-6aa9-44a2-9aec-7b3943a81c33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_638cad7d-3f21-429c-9664-0be8d5de803a" xlink:href="rxrx-20250930.xsd#rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_89f06a3c-d94d-4075-9c10-3cbb06eaf4a8" xlink:to="loc_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_638cad7d-3f21-429c-9664-0be8d5de803a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_b3d6aed3-14e2-41e9-925a-b46d98c0e3e8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_89f06a3c-d94d-4075-9c10-3cbb06eaf4a8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_b3d6aed3-14e2-41e9-925a-b46d98c0e3e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_bd0c7fa8-363a-4b10-8761-374a55d6ab0b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_89f06a3c-d94d-4075-9c10-3cbb06eaf4a8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_bd0c7fa8-363a-4b10-8761-374a55d6ab0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_ba527915-4857-4047-8cf1-0d87fcc112fe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_89f06a3c-d94d-4075-9c10-3cbb06eaf4a8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_ba527915-4857-4047-8cf1-0d87fcc112fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables_1795e833-a9ac-4643-bad1-f929a0393f8d" xlink:href="rxrx-20250930.xsd#rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_89f06a3c-d94d-4075-9c10-3cbb06eaf4a8" xlink:to="loc_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables_1795e833-a9ac-4643-bad1-f929a0393f8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_977d6ba2-3525-4103-acc3-f4facf32b943" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_89f06a3c-d94d-4075-9c10-3cbb06eaf4a8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_977d6ba2-3525-4103-acc3-f4facf32b943" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_c6d8c0aa-0100-4db6-8d5f-5d8998c126c1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_89f06a3c-d94d-4075-9c10-3cbb06eaf4a8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_c6d8c0aa-0100-4db6-8d5f-5d8998c126c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_ac6e8008-c6eb-478b-ab5f-d967a1ec221c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_89f06a3c-d94d-4075-9c10-3cbb06eaf4a8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_ac6e8008-c6eb-478b-ab5f-d967a1ec221c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_453a32f0-79c2-479b-9aa5-e71c074569c8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_89f06a3c-d94d-4075-9c10-3cbb06eaf4a8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_453a32f0-79c2-479b-9aa5-e71c074569c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities_11353268-f10e-4301-acc4-df272ed56835" xlink:href="rxrx-20250930.xsd#rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_89f06a3c-d94d-4075-9c10-3cbb06eaf4a8" xlink:to="loc_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities_11353268-f10e-4301-acc4-df272ed56835" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_4668d1b1-e2f2-494c-a07b-82e25969b0dd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_89f06a3c-d94d-4075-9c10-3cbb06eaf4a8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_4668d1b1-e2f2-494c-a07b-82e25969b0dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_5da43eb8-95e2-4ac1-a8b4-ce851d193c7c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_89f06a3c-d94d-4075-9c10-3cbb06eaf4a8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_5da43eb8-95e2-4ac1-a8b4-ce851d193c7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_f835cbde-9cda-42db-9219-8fe647ce31e1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_c59cadf4-9839-4c4b-b525-dbd9fdd6696b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_f835cbde-9cda-42db-9219-8fe647ce31e1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_c59cadf4-9839-4c4b-b525-dbd9fdd6696b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_78ec45c9-44d3-448a-acdb-bd07579fde15" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_f835cbde-9cda-42db-9219-8fe647ce31e1" xlink:to="loc_us-gaap_Goodwill_78ec45c9-44d3-448a-acdb-bd07579fde15" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails"/>
  <link:calculationLink xlink:role="http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_db3b98f0-eaa7-4f71-99a5-798f0f5a4c8f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8323e5a6-2dae-435f-89eb-3e0a49dc2417" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_db3b98f0-eaa7-4f71-99a5-798f0f5a4c8f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8323e5a6-2dae-435f-89eb-3e0a49dc2417" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_427e697d-2f97-49ab-9818-fbff4b709f6b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_db3b98f0-eaa7-4f71-99a5-798f0f5a4c8f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_427e697d-2f97-49ab-9818-fbff4b709f6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_e7219f36-7d52-4d46-ad95-78162790cd6f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_f1444ff8-266c-4233-955e-4bbef6292d79" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_e7219f36-7d52-4d46-ad95-78162790cd6f" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_f1444ff8-266c-4233-955e-4bbef6292d79" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_5e375360-580c-407e-bf37-e57b9c81923f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_e7219f36-7d52-4d46-ad95-78162790cd6f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_5e375360-580c-407e-bf37-e57b9c81923f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_29454d16-6181-4ad6-a4d8-b23c1b15c61a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_a29a0112-cd59-4a3e-9e23-54095793e9d3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_29454d16-6181-4ad6-a4d8-b23c1b15c61a" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_a29a0112-cd59-4a3e-9e23-54095793e9d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9d22fd00-7bef-4c21-9bed-ff9d279861c5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_29454d16-6181-4ad6-a4d8-b23c1b15c61a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9d22fd00-7bef-4c21-9bed-ff9d279861c5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails_1" xlink:type="simple" xlink:href="rxrx-20250930.xsd#GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails_1"/>
  <link:calculationLink xlink:role="http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_603c193b-defb-4062-ade1-9f1edff20ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_02b45b56-bb85-4a42-a6ad-0bc04596f963" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_603c193b-defb-4062-ade1-9f1edff20ab2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_02b45b56-bb85-4a42-a6ad-0bc04596f963" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_34df1399-4137-42d9-a6d6-6f98e11627bd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_603c193b-defb-4062-ade1-9f1edff20ab2" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_34df1399-4137-42d9-a6d6-6f98e11627bd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_d0b04287-b292-40a4-90db-ab00f94b15de" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_1c9447dd-74a6-4dd1-b8c0-914c3b8eb067" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_d0b04287-b292-40a4-90db-ab00f94b15de" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_1c9447dd-74a6-4dd1-b8c0-914c3b8eb067" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure_c489f4e1-0181-475d-a470-d2bc3fec08db" xlink:href="rxrx-20250930.xsd#rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_d0b04287-b292-40a4-90db-ab00f94b15de" xlink:to="loc_rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure_c489f4e1-0181-475d-a470-d2bc3fec08db" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails"/>
  <link:calculationLink xlink:role="http://www.recursion.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_51949a25-97b1-4a54-85dc-c9b68236ae7b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_29bc66fe-a6c4-4b7a-a7d9-c9ab62855ac2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_51949a25-97b1-4a54-85dc-c9b68236ae7b" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_29bc66fe-a6c4-4b7a-a7d9-c9ab62855ac2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_b2d6c8fe-6e9d-4b0d-b368-b874a2caa83c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_51949a25-97b1-4a54-85dc-c9b68236ae7b" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_b2d6c8fe-6e9d-4b0d-b368-b874a2caa83c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails"/>
  <link:calculationLink xlink:role="http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_d0965b3a-d62e-435b-8bf0-3fb91c4bbabe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_PlatformFeeExpense_0c86a946-b528-4a73-a89f-a5145b178656" xlink:href="rxrx-20250930.xsd#rxrx_PlatformFeeExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_d0965b3a-d62e-435b-8bf0-3fb91c4bbabe" xlink:to="loc_rxrx_PlatformFeeExpense_0c86a946-b528-4a73-a89f-a5145b178656" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount_a13cfc1b-5648-4bf4-82bd-bc116593af24" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_d0965b3a-d62e-435b-8bf0-3fb91c4bbabe" xlink:to="loc_us-gaap_SegmentReportingOtherItemAmount_a13cfc1b-5648-4bf4-82bd-bc116593af24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LaborAndRelatedExpense_64708b83-1a6d-4659-8f65-72cfcc962042" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LaborAndRelatedExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_d0965b3a-d62e-435b-8bf0-3fb91c4bbabe" xlink:to="loc_us-gaap_LaborAndRelatedExpense_64708b83-1a6d-4659-8f65-72cfcc962042" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ClinicalDevelopmentExpense_615a9ba6-6733-4806-966c-fd5680c1c0ca" xlink:href="rxrx-20250930.xsd#rxrx_ClinicalDevelopmentExpense"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_d0965b3a-d62e-435b-8bf0-3fb91c4bbabe" xlink:to="loc_rxrx_ClinicalDevelopmentExpense_615a9ba6-6733-4806-966c-fd5680c1c0ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_DiscoveryExpense_ab673ff5-84d1-4167-ad13-850815c5647d" xlink:href="rxrx-20250930.xsd#rxrx_DiscoveryExpense"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_d0965b3a-d62e-435b-8bf0-3fb91c4bbabe" xlink:to="loc_rxrx_DiscoveryExpense_ab673ff5-84d1-4167-ad13-850815c5647d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_867717b7-3a81-46c4-87f3-02a26ddb79f5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_d0965b3a-d62e-435b-8bf0-3fb91c4bbabe" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_867717b7-3a81-46c4-87f3-02a26ddb79f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ConsumableExpense_fc5e7425-1d38-4f3f-a821-ddc821a9e89a" xlink:href="rxrx-20250930.xsd#rxrx_ConsumableExpense"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_d0965b3a-d62e-435b-8bf0-3fb91c4bbabe" xlink:to="loc_rxrx_ConsumableExpense_fc5e7425-1d38-4f3f-a821-ddc821a9e89a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_f1293168-15d5-4189-b74b-9fc554230a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_d0965b3a-d62e-435b-8bf0-3fb91c4bbabe" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_f1293168-15d5-4189-b74b-9fc554230a7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_bac929eb-6bf6-4d73-8d15-6b50c6f57099" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_616def9a-f02d-4fa9-8008-1ad1ef2f9f99" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_bac929eb-6bf6-4d73-8d15-6b50c6f57099" xlink:to="loc_us-gaap_OperatingIncomeLoss_616def9a-f02d-4fa9-8008-1ad1ef2f9f99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_4d828bb6-d74a-4ae7-9a22-62dd7ec7fc31" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_bac929eb-6bf6-4d73-8d15-6b50c6f57099" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_4d828bb6-d74a-4ae7-9a22-62dd7ec7fc31" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_2b88637a-e574-467f-8fca-e5c8579c6f7d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_bac929eb-6bf6-4d73-8d15-6b50c6f57099" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_2b88637a-e574-467f-8fca-e5c8579c6f7d" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>rxrx-20250930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:84e2dd81-95f3-479b-879b-c1ea33e5483d,g:a06efc1c-9b19-4722-bcb5-747c44bbab78-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.recursion.com/role/Cover" xlink:type="simple" xlink:href="rxrx-20250930.xsd#Cover"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_783f9067-e56b-4fb0-92d0-cecca561417e" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_DocumentInformationTable_783f9067-e56b-4fb0-92d0-cecca561417e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_126f30c1-f879-4b03-a001-4a1c3d500925" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_783f9067-e56b-4fb0-92d0-cecca561417e" xlink:to="loc_us-gaap_StatementClassOfStockAxis_126f30c1-f879-4b03-a001-4a1c3d500925" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_126f30c1-f879-4b03-a001-4a1c3d500925_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_126f30c1-f879-4b03-a001-4a1c3d500925" xlink:to="loc_us-gaap_ClassOfStockDomain_126f30c1-f879-4b03-a001-4a1c3d500925_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_122522a1-b5bb-4791-bfef-a88d01c54a46" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_126f30c1-f879-4b03-a001-4a1c3d500925" xlink:to="loc_us-gaap_ClassOfStockDomain_122522a1-b5bb-4791-bfef-a88d01c54a46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_f1496e99-fd88-49ee-bec9-f3b53e0aeace" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_122522a1-b5bb-4791-bfef-a88d01c54a46" xlink:to="loc_us-gaap_CommonClassAMember_f1496e99-fd88-49ee-bec9-f3b53e0aeace" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_ae72923d-8d78-40e4-85d8-976d51857744" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_122522a1-b5bb-4791-bfef-a88d01c54a46" xlink:to="loc_us-gaap_CommonClassBMember_ae72923d-8d78-40e4-85d8-976d51857744" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_ecce1684-8f59-4133-9df5-62cdbbc26e75" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_DocumentType_ecce1684-8f59-4133-9df5-62cdbbc26e75" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_ede760ec-ed59-4dac-bebf-103c59d87be7" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_DocumentQuarterlyReport_ede760ec-ed59-4dac-bebf-103c59d87be7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_8788cd3f-bd8d-4216-89d8-fe804dc214b6" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_DocumentPeriodEndDate_8788cd3f-bd8d-4216-89d8-fe804dc214b6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_5a6edb01-6297-42e3-9164-d0aa32a0d056" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_DocumentTransitionReport_5a6edb01-6297-42e3-9164-d0aa32a0d056" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_ff2d0ef7-a436-45fb-8a35-99295da2436b" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_EntityFileNumber_ff2d0ef7-a436-45fb-8a35-99295da2436b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_22b654a4-5b8d-4095-afcf-465f0456b36a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_EntityRegistrantName_22b654a4-5b8d-4095-afcf-465f0456b36a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_0c0a9d18-5989-44c9-a8fc-75940edb21fe" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_EntityIncorporationStateCountryCode_0c0a9d18-5989-44c9-a8fc-75940edb21fe" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_6997f959-f0be-4afd-8fb3-47a4d09f547c" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_EntityTaxIdentificationNumber_6997f959-f0be-4afd-8fb3-47a4d09f547c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_a7f05b67-af1c-4f81-9e48-69a12ab65bbc" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_EntityAddressAddressLine1_a7f05b67-af1c-4f81-9e48-69a12ab65bbc" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_c7a2722d-0c37-410d-a9ae-a3c516421381" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_EntityAddressCityOrTown_c7a2722d-0c37-410d-a9ae-a3c516421381" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_a8c39b20-528c-4b5b-be91-82e0b068674e" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_EntityAddressStateOrProvince_a8c39b20-528c-4b5b-be91-82e0b068674e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_05983976-512c-419a-b61a-3d083c642d58" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_EntityAddressPostalZipCode_05983976-512c-419a-b61a-3d083c642d58" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_abb8edd9-3ed7-4536-82e7-df70c0189257" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_CityAreaCode_abb8edd9-3ed7-4536-82e7-df70c0189257" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_4e59b4a2-dd97-4ff6-ad48-40f4cefcce34" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_LocalPhoneNumber_4e59b4a2-dd97-4ff6-ad48-40f4cefcce34" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_8986bbf7-5f7a-4343-aa9b-4577e57d3c46" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_Security12bTitle_8986bbf7-5f7a-4343-aa9b-4577e57d3c46" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_32cf7ce5-7340-4d81-8e76-bb152ea0dacd" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_TradingSymbol_32cf7ce5-7340-4d81-8e76-bb152ea0dacd" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_944e5419-1ffc-48b7-b4ba-b596245d9d10" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_SecurityExchangeName_944e5419-1ffc-48b7-b4ba-b596245d9d10" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_ab464586-1b7e-4d91-8570-84af0b4dbcad" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_EntityCurrentReportingStatus_ab464586-1b7e-4d91-8570-84af0b4dbcad" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_ba2113da-05ac-4cc0-9935-67dcc4891e17" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_EntityInteractiveDataCurrent_ba2113da-05ac-4cc0-9935-67dcc4891e17" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_9ebbf21e-1244-4045-bc68-90abeaaab385" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_EntityFilerCategory_9ebbf21e-1244-4045-bc68-90abeaaab385" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_219dfd6d-078d-47ce-9bb8-b5198e21a9b2" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_EntitySmallBusiness_219dfd6d-078d-47ce-9bb8-b5198e21a9b2" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_8259f3a3-8d49-4862-be75-ece43a061288" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_EntityEmergingGrowthCompany_8259f3a3-8d49-4862-be75-ece43a061288" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_d8e38fd8-30ac-4134-bbcd-1c0585aaffb0" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_EntityShellCompany_d8e38fd8-30ac-4134-bbcd-1c0585aaffb0" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_e6f541d7-e3b9-4405-96a2-4bcedf22fb87" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_e6f541d7-e3b9-4405-96a2-4bcedf22fb87" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_4b2b33bf-2c7c-4fc5-a433-3fde42a23a06" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_EntityCentralIndexKey_4b2b33bf-2c7c-4fc5-a433-3fde42a23a06" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_cacfc0ad-febd-4c58-8268-b7bb770ed649" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_AmendmentFlag_cacfc0ad-febd-4c58-8268-b7bb770ed649" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_bca06d96-31fb-4a90-a256-98025396e8dd" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_DocumentFiscalYearFocus_bca06d96-31fb-4a90-a256-98025396e8dd" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_344ad8d4-40c4-4adb-9311-36a74c7b361a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_DocumentFiscalPeriodFocus_344ad8d4-40c4-4adb-9311-36a74c7b361a" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_7c92e74c-a7e8-4358-9e8c-90afe71ced00" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_CurrentFiscalYearEndDate_7c92e74c-a7e8-4358-9e8c-90afe71ced00" xlink:type="arc" order="28"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical" xlink:type="simple" xlink:href="rxrx-20250930.xsd#CondensedConsolidatedBalanceSheetsunauditedParenthetical"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_953e6326-aac8-4f73-9c07-94aeeea7c311" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_672d58cc-bb32-4e6d-a6ec-0f0b88b1aab5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_953e6326-aac8-4f73-9c07-94aeeea7c311" xlink:to="loc_us-gaap_StatementTable_672d58cc-bb32-4e6d-a6ec-0f0b88b1aab5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_18411a15-4fef-44ad-b170-ddadeb602058" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_672d58cc-bb32-4e6d-a6ec-0f0b88b1aab5" xlink:to="loc_us-gaap_StatementClassOfStockAxis_18411a15-4fef-44ad-b170-ddadeb602058" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_18411a15-4fef-44ad-b170-ddadeb602058_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_18411a15-4fef-44ad-b170-ddadeb602058" xlink:to="loc_us-gaap_ClassOfStockDomain_18411a15-4fef-44ad-b170-ddadeb602058_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_0b2a7cee-7ff9-4b0e-9ef5-6c68131a5a3d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_18411a15-4fef-44ad-b170-ddadeb602058" xlink:to="loc_us-gaap_ClassOfStockDomain_0b2a7cee-7ff9-4b0e-9ef5-6c68131a5a3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_44fa8389-09b0-4e6f-b8c8-edf9c2837c1f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_0b2a7cee-7ff9-4b0e-9ef5-6c68131a5a3d" xlink:to="loc_us-gaap_CommonClassAMember_44fa8389-09b0-4e6f-b8c8-edf9c2837c1f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_8f5aadff-67cd-49ac-aaf8-dfe5931977f9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_0b2a7cee-7ff9-4b0e-9ef5-6c68131a5a3d" xlink:to="loc_us-gaap_CommonClassBMember_8f5aadff-67cd-49ac-aaf8-dfe5931977f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ExchangeableStockMember_807900ce-f1a2-4827-a242-f4bf8cf0ff9f" xlink:href="rxrx-20250930.xsd#rxrx_ExchangeableStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_0b2a7cee-7ff9-4b0e-9ef5-6c68131a5a3d" xlink:to="loc_rxrx_ExchangeableStockMember_807900ce-f1a2-4827-a242-f4bf8cf0ff9f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_d91351a0-d054-4720-a069-5c60dd36421d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_953e6326-aac8-4f73-9c07-94aeeea7c311" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_d91351a0-d054-4720-a069-5c60dd36421d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_636aefae-6a0a-467b-a7c3-918b1a1b723f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_953e6326-aac8-4f73-9c07-94aeeea7c311" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_636aefae-6a0a-467b-a7c3-918b1a1b723f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_db51e830-449c-4369-8461-79c7e5b922c1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_953e6326-aac8-4f73-9c07-94aeeea7c311" xlink:to="loc_us-gaap_CommonStockSharesIssued_db51e830-449c-4369-8461-79c7e5b922c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_114d0e59-0541-41f6-8e15-9272730e6b8a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_953e6326-aac8-4f73-9c07-94aeeea7c311" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_114d0e59-0541-41f6-8e15-9272730e6b8a" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited" xlink:type="simple" xlink:href="rxrx-20250930.xsd#CondensedConsolidatedStatementsofOperationsunaudited"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f107c9e7-a56f-43e2-82cd-17470980184d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_3b2ef99b-1f0d-406d-8495-70b7c89fa11c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_f107c9e7-a56f-43e2-82cd-17470980184d" xlink:to="loc_us-gaap_StatementTable_3b2ef99b-1f0d-406d-8495-70b7c89fa11c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4754e0c3-4bbc-4913-98b1-8c8a5502e829" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_3b2ef99b-1f0d-406d-8495-70b7c89fa11c" xlink:to="loc_srt_ProductOrServiceAxis_4754e0c3-4bbc-4913-98b1-8c8a5502e829" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4754e0c3-4bbc-4913-98b1-8c8a5502e829_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_4754e0c3-4bbc-4913-98b1-8c8a5502e829" xlink:to="loc_srt_ProductsAndServicesDomain_4754e0c3-4bbc-4913-98b1-8c8a5502e829_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_47541fca-97f7-43be-a5e6-a3685bf501e3" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_4754e0c3-4bbc-4913-98b1-8c8a5502e829" xlink:to="loc_srt_ProductsAndServicesDomain_47541fca-97f7-43be-a5e6-a3685bf501e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseAndServiceMember_19101cf5-d44d-4775-8e23-0321a3ebe669" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LicenseAndServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_47541fca-97f7-43be-a5e6-a3685bf501e3" xlink:to="loc_us-gaap_LicenseAndServiceMember_19101cf5-d44d-4775-8e23-0321a3ebe669" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrantMember_3c45fa0c-1d20-4d5f-b682-cc5ef99294d8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_47541fca-97f7-43be-a5e6-a3685bf501e3" xlink:to="loc_us-gaap_GrantMember_3c45fa0c-1d20-4d5f-b682-cc5ef99294d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_816ccc65-ae6b-4c10-8e92-7950a9b61b37" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f107c9e7-a56f-43e2-82cd-17470980184d" xlink:to="loc_us-gaap_RevenuesAbstract_816ccc65-ae6b-4c10-8e92-7950a9b61b37" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7c02ee3e-9dc8-43c0-899d-67f1d33db53b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_816ccc65-ae6b-4c10-8e92-7950a9b61b37" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7c02ee3e-9dc8-43c0-899d-67f1d33db53b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_156e020f-aed8-4936-86f1-12b8226e3c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f107c9e7-a56f-43e2-82cd-17470980184d" xlink:to="loc_us-gaap_OperatingExpensesAbstract_156e020f-aed8-4936-86f1-12b8226e3c6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_9d6c0f1f-afe1-421a-9415-289d6f460cc8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_156e020f-aed8-4936-86f1-12b8226e3c6e" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_9d6c0f1f-afe1-421a-9415-289d6f460cc8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_c7f36291-885a-4817-9375-814f8756da1a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_156e020f-aed8-4936-86f1-12b8226e3c6e" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_c7f36291-885a-4817-9375-814f8756da1a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_a1235d59-46f2-4435-a6ea-90a260ae9bae" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_156e020f-aed8-4936-86f1-12b8226e3c6e" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_a1235d59-46f2-4435-a6ea-90a260ae9bae" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_eafc3683-a884-42c4-96a9-0c173c299cc0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_156e020f-aed8-4936-86f1-12b8226e3c6e" xlink:to="loc_us-gaap_CostsAndExpenses_eafc3683-a884-42c4-96a9-0c173c299cc0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_35199800-ea2b-419c-9ba1-9fbf3e529a80" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f107c9e7-a56f-43e2-82cd-17470980184d" xlink:to="loc_us-gaap_OperatingIncomeLoss_35199800-ea2b-419c-9ba1-9fbf3e529a80" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_1f804134-7833-4272-a572-96f8c895ab78" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f107c9e7-a56f-43e2-82cd-17470980184d" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_1f804134-7833-4272-a572-96f8c895ab78" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1da5fbbf-22c0-44ce-a739-70ae83bcc820" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f107c9e7-a56f-43e2-82cd-17470980184d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1da5fbbf-22c0-44ce-a739-70ae83bcc820" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_9aab3e70-e86f-4795-877f-b90359886d02" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f107c9e7-a56f-43e2-82cd-17470980184d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_9aab3e70-e86f-4795-877f-b90359886d02" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0e9d0903-a130-41d4-9340-d3d757d45f38" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f107c9e7-a56f-43e2-82cd-17470980184d" xlink:to="loc_us-gaap_NetIncomeLoss_0e9d0903-a130-41d4-9340-d3d757d45f38" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_b9cf39cf-6602-4f9d-9b76-99387533c1a1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f107c9e7-a56f-43e2-82cd-17470980184d" xlink:to="loc_us-gaap_EarningsPerShareAbstract_b9cf39cf-6602-4f9d-9b76-99387533c1a1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_32e8b86c-79ec-4efa-9a99-986315904c49" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b9cf39cf-6602-4f9d-9b76-99387533c1a1" xlink:to="loc_us-gaap_EarningsPerShareBasic_32e8b86c-79ec-4efa-9a99-986315904c49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_8208dad4-da2c-4dc0-85df-b325ebffc7b7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b9cf39cf-6602-4f9d-9b76-99387533c1a1" xlink:to="loc_us-gaap_EarningsPerShareDiluted_8208dad4-da2c-4dc0-85df-b325ebffc7b7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0db6e2b0-b772-4550-9a92-7734da7b6696" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b9cf39cf-6602-4f9d-9b76-99387533c1a1" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0db6e2b0-b772-4550-9a92-7734da7b6696" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_73fa8caa-208a-450a-b72c-2fb4f15a7387" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b9cf39cf-6602-4f9d-9b76-99387533c1a1" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_73fa8caa-208a-450a-b72c-2fb4f15a7387" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited" xlink:type="simple" xlink:href="rxrx-20250930.xsd#CondensedConsolidatedStatementsofStockholdersEquityunaudited"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_fdaf0b6b-ae29-4e13-ae4d-4a0475166f82" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_37c03070-1bb3-41fd-90dd-f05d6077d882" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_fdaf0b6b-ae29-4e13-ae4d-4a0475166f82" xlink:to="loc_us-gaap_StatementTable_37c03070-1bb3-41fd-90dd-f05d6077d882" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3e2cf14f-7440-472d-96eb-83bee5421c7e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_37c03070-1bb3-41fd-90dd-f05d6077d882" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3e2cf14f-7440-472d-96eb-83bee5421c7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3e2cf14f-7440-472d-96eb-83bee5421c7e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3e2cf14f-7440-472d-96eb-83bee5421c7e" xlink:to="loc_us-gaap_EquityComponentDomain_3e2cf14f-7440-472d-96eb-83bee5421c7e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d7d4a2c4-8eb2-415e-8306-128835c38e34" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3e2cf14f-7440-472d-96eb-83bee5421c7e" xlink:to="loc_us-gaap_EquityComponentDomain_d7d4a2c4-8eb2-415e-8306-128835c38e34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_849716ad-f882-42d7-9bdd-7bd128cd078b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d7d4a2c4-8eb2-415e-8306-128835c38e34" xlink:to="loc_us-gaap_CommonStockMember_849716ad-f882-42d7-9bdd-7bd128cd078b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_85590d55-2eb3-4a9d-a7a2-c7e62a38ffe5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d7d4a2c4-8eb2-415e-8306-128835c38e34" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_85590d55-2eb3-4a9d-a7a2-c7e62a38ffe5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_b51918a8-14b3-4216-9eb2-7d6487e7956f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d7d4a2c4-8eb2-415e-8306-128835c38e34" xlink:to="loc_us-gaap_RetainedEarningsMember_b51918a8-14b3-4216-9eb2-7d6487e7956f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f3f15154-56ab-495e-8071-60873b88800b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d7d4a2c4-8eb2-415e-8306-128835c38e34" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f3f15154-56ab-495e-8071-60873b88800b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cd2c1644-a2c8-442f-a374-b08c21c4eaa5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_fdaf0b6b-ae29-4e13-ae4d-4a0475166f82" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cd2c1644-a2c8-442f-a374-b08c21c4eaa5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_5c30a6d5-413d-4636-93cd-1eedbf6f387d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cd2c1644-a2c8-442f-a374-b08c21c4eaa5" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_5c30a6d5-413d-4636-93cd-1eedbf6f387d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ff86c411-3f84-4c90-adbd-3d291080d11b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cd2c1644-a2c8-442f-a374-b08c21c4eaa5" xlink:to="loc_us-gaap_StockholdersEquity_ff86c411-3f84-4c90-adbd-3d291080d11b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b729fd4b-9bf8-4400-befa-b281bd9cef8c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cd2c1644-a2c8-442f-a374-b08c21c4eaa5" xlink:to="loc_us-gaap_NetIncomeLoss_b729fd4b-9bf8-4400-befa-b281bd9cef8c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a90130d4-4ee2-452f-ab38-dd725c09ee17" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cd2c1644-a2c8-442f-a374-b08c21c4eaa5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a90130d4-4ee2-452f-ab38-dd725c09ee17" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_e5f9c18a-50ec-4548-b93a-2e00ccd593ab" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cd2c1644-a2c8-442f-a374-b08c21c4eaa5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_e5f9c18a-50ec-4548-b93a-2e00ccd593ab" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_71f31973-8051-40b0-afdf-1a12dea2a5ef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cd2c1644-a2c8-442f-a374-b08c21c4eaa5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_71f31973-8051-40b0-afdf-1a12dea2a5ef" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_d3911a3d-0e81-438a-bd6e-fb251836b656" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cd2c1644-a2c8-442f-a374-b08c21c4eaa5" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_d3911a3d-0e81-438a-bd6e-fb251836b656" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_36ef2996-f1e9-4d8a-903d-34b964a34242" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cd2c1644-a2c8-442f-a374-b08c21c4eaa5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_36ef2996-f1e9-4d8a-903d-34b964a34242" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_3bce3dd0-1394-4aa8-a3bb-a133ae1f5957" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cd2c1644-a2c8-442f-a374-b08c21c4eaa5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_3bce3dd0-1394-4aa8-a3bb-a133ae1f5957" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_317f5a24-1b0d-4550-aa97-bd87f18b7542" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cd2c1644-a2c8-442f-a374-b08c21c4eaa5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_317f5a24-1b0d-4550-aa97-bd87f18b7542" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_b6c0ad4e-ee23-4f86-8cef-003af83e6367" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cd2c1644-a2c8-442f-a374-b08c21c4eaa5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_b6c0ad4e-ee23-4f86-8cef-003af83e6367" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_0b584924-4cbd-4bae-8fa4-d26c7989c4aa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e815a405-21c7-4f55-9776-eb1e5c9962d3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.recursion.com/role/SupplementalFinancialInformationNarrativeDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#SupplementalFinancialInformationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/SupplementalFinancialInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8cb90be2-0663-495f-862e-29602d749b48" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_90797213-f3e6-4a17-b10d-49ba6fb95e39" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8cb90be2-0663-495f-862e-29602d749b48" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_90797213-f3e6-4a17-b10d-49ba6fb95e39" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_769c8adf-d7ad-412a-9409-564c5cb35269" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_90797213-f3e6-4a17-b10d-49ba6fb95e39" xlink:to="loc_srt_CounterpartyNameAxis_769c8adf-d7ad-412a-9409-564c5cb35269" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_769c8adf-d7ad-412a-9409-564c5cb35269_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_769c8adf-d7ad-412a-9409-564c5cb35269" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_769c8adf-d7ad-412a-9409-564c5cb35269_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cc78f54f-c118-4919-bf7e-f41a39feff9b" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_769c8adf-d7ad-412a-9409-564c5cb35269" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cc78f54f-c118-4919-bf7e-f41a39feff9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_TempusLabsIncMember_083b9853-252b-4ebc-b689-5d2178163c73" xlink:href="rxrx-20250930.xsd#rxrx_TempusLabsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cc78f54f-c118-4919-bf7e-f41a39feff9b" xlink:to="loc_rxrx_TempusLabsIncMember_083b9853-252b-4ebc-b689-5d2178163c73" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c3f44802-7978-425c-9cfe-ddba1100b14f" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_90797213-f3e6-4a17-b10d-49ba6fb95e39" xlink:to="loc_srt_RangeAxis_c3f44802-7978-425c-9cfe-ddba1100b14f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c3f44802-7978-425c-9cfe-ddba1100b14f_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_c3f44802-7978-425c-9cfe-ddba1100b14f" xlink:to="loc_srt_RangeMember_c3f44802-7978-425c-9cfe-ddba1100b14f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2b85e4f5-4841-4fce-b03b-fed6b5930ba0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_c3f44802-7978-425c-9cfe-ddba1100b14f" xlink:to="loc_srt_RangeMember_2b85e4f5-4841-4fce-b03b-fed6b5930ba0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_52e1adb7-2585-4be4-886e-dd6d087651c8" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2b85e4f5-4841-4fce-b03b-fed6b5930ba0" xlink:to="loc_srt_MinimumMember_52e1adb7-2585-4be4-886e-dd6d087651c8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_206fae48-944a-40ed-8e12-28de41d1888b" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2b85e4f5-4841-4fce-b03b-fed6b5930ba0" xlink:to="loc_srt_MaximumMember_206fae48-944a-40ed-8e12-28de41d1888b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LicenseAgreementTerm_7716c3b2-c9ce-4cb1-8852-51f28007df1a" xlink:href="rxrx-20250930.xsd#rxrx_LicenseAgreementTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8cb90be2-0663-495f-862e-29602d749b48" xlink:to="loc_rxrx_LicenseAgreementTerm_7716c3b2-c9ce-4cb1-8852-51f28007df1a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LicenseAgreementAnnualPayments_ce1b2064-9a3e-4225-81e9-4848df6947b7" xlink:href="rxrx-20250930.xsd#rxrx_LicenseAgreementAnnualPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8cb90be2-0663-495f-862e-29602d749b48" xlink:to="loc_rxrx_LicenseAgreementAnnualPayments_ce1b2064-9a3e-4225-81e9-4848df6947b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LicenseAgreementAggregatePayments_71eca9d5-6352-4d08-93b3-fc170521d573" xlink:href="rxrx-20250930.xsd#rxrx_LicenseAgreementAggregatePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8cb90be2-0663-495f-862e-29602d749b48" xlink:to="loc_rxrx_LicenseAgreementAggregatePayments_71eca9d5-6352-4d08-93b3-fc170521d573" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LicenseAgreementTradingPeriodUsedForEquityValueDetermination_e8b2585c-b376-49ab-86d3-eb9426d0d08b" xlink:href="rxrx-20250930.xsd#rxrx_LicenseAgreementTradingPeriodUsedForEquityValueDetermination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8cb90be2-0663-495f-862e-29602d749b48" xlink:to="loc_rxrx_LicenseAgreementTradingPeriodUsedForEquityValueDetermination_e8b2585c-b376-49ab-86d3-eb9426d0d08b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LicenseAgreementAmountOfTimePriorToThePaymentDate_b7ff9362-783f-43b2-aefc-006fd62357f1" xlink:href="rxrx-20250930.xsd#rxrx_LicenseAgreementAmountOfTimePriorToThePaymentDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8cb90be2-0663-495f-862e-29602d749b48" xlink:to="loc_rxrx_LicenseAgreementAmountOfTimePriorToThePaymentDate_b7ff9362-783f-43b2-aefc-006fd62357f1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LicenseAgreementIncreaseDecreaseAccruedLiabilities_f7372b7e-e801-43ea-b8f8-f839cd5de044" xlink:href="rxrx-20250930.xsd#rxrx_LicenseAgreementIncreaseDecreaseAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8cb90be2-0663-495f-862e-29602d749b48" xlink:to="loc_rxrx_LicenseAgreementIncreaseDecreaseAccruedLiabilities_f7372b7e-e801-43ea-b8f8-f839cd5de044" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent_db7f3d70-1f10-4eef-8304-667484d13e90" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8cb90be2-0663-495f-862e-29602d749b48" xlink:to="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent_db7f3d70-1f10-4eef-8304-667484d13e90" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_c6297f24-1a76-449d-927e-03757d796322" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8cb90be2-0663-495f-862e-29602d749b48" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_c6297f24-1a76-449d-927e-03757d796322" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.recursion.com/role/AcquisitionsNarrativeDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#AcquisitionsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/AcquisitionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_4bb61542-3852-402d-ac19-1f0727841dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d07e4889-3648-442d-8a0d-c05ac6011149" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4bb61542-3852-402d-ac19-1f0727841dd8" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d07e4889-3648-442d-8a0d-c05ac6011149" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_f2ace846-d18f-41f3-8f8c-b5b95807fe2f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d07e4889-3648-442d-8a0d-c05ac6011149" xlink:to="loc_us-gaap_AssetAcquisitionAxis_f2ace846-d18f-41f3-8f8c-b5b95807fe2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_f2ace846-d18f-41f3-8f8c-b5b95807fe2f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AssetAcquisitionAxis_f2ace846-d18f-41f3-8f8c-b5b95807fe2f" xlink:to="loc_us-gaap_AssetAcquisitionDomain_f2ace846-d18f-41f3-8f8c-b5b95807fe2f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_10ee2e9e-7132-467d-98df-66769248844f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AssetAcquisitionAxis_f2ace846-d18f-41f3-8f8c-b5b95807fe2f" xlink:to="loc_us-gaap_AssetAcquisitionDomain_10ee2e9e-7132-467d-98df-66769248844f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_REVenturesIMember_4eefadfa-fb39-460e-882b-a9a72a656452" xlink:href="rxrx-20250930.xsd#rxrx_REVenturesIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_10ee2e9e-7132-467d-98df-66769248844f" xlink:to="loc_rxrx_REVenturesIMember_4eefadfa-fb39-460e-882b-a9a72a656452" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_41f6f70d-f760-4e7c-924a-9969964a2013" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d07e4889-3648-442d-8a0d-c05ac6011149" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_41f6f70d-f760-4e7c-924a-9969964a2013" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_41f6f70d-f760-4e7c-924a-9969964a2013_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_41f6f70d-f760-4e7c-924a-9969964a2013" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_41f6f70d-f760-4e7c-924a-9969964a2013_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_93648942-f115-4d11-9f49-c6bd095ee32d" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_41f6f70d-f760-4e7c-924a-9969964a2013" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_93648942-f115-4d11-9f49-c6bd095ee32d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AlphaBiotechnologyGmbHAlphaMember_d193c838-e892-4472-8c1b-359cf146478e" xlink:href="rxrx-20250930.xsd#rxrx_AlphaBiotechnologyGmbHAlphaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_93648942-f115-4d11-9f49-c6bd095ee32d" xlink:to="loc_rxrx_AlphaBiotechnologyGmbHAlphaMember_d193c838-e892-4472-8c1b-359cf146478e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_9a96439c-5a8b-486f-906a-254e84e8c0cc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d07e4889-3648-442d-8a0d-c05ac6011149" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_9a96439c-5a8b-486f-906a-254e84e8c0cc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_9a96439c-5a8b-486f-906a-254e84e8c0cc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_9a96439c-5a8b-486f-906a-254e84e8c0cc" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_9a96439c-5a8b-486f-906a-254e84e8c0cc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_85d42f94-5aaa-496e-8df3-220cc594bea6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_9a96439c-5a8b-486f-906a-254e84e8c0cc" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_85d42f94-5aaa-496e-8df3-220cc594bea6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_6fc4cc13-377e-4109-9a1d-d344f7e4570e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_85d42f94-5aaa-496e-8df3-220cc594bea6" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_6fc4cc13-377e-4109-9a1d-d344f7e4570e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a1eb9703-bce0-4fb2-8e1a-776c0e914d9e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d07e4889-3648-442d-8a0d-c05ac6011149" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a1eb9703-bce0-4fb2-8e1a-776c0e914d9e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a1eb9703-bce0-4fb2-8e1a-776c0e914d9e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a1eb9703-bce0-4fb2-8e1a-776c0e914d9e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a1eb9703-bce0-4fb2-8e1a-776c0e914d9e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4eddef23-603f-45a3-a889-afa4cf5b50f2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a1eb9703-bce0-4fb2-8e1a-776c0e914d9e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4eddef23-603f-45a3-a889-afa4cf5b50f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ExscientiaGmbHMember_8348c576-8d68-4259-9027-fbff6fc6d0fd" xlink:href="rxrx-20250930.xsd#rxrx_ExscientiaGmbHMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4eddef23-603f-45a3-a889-afa4cf5b50f2" xlink:to="loc_rxrx_ExscientiaGmbHMember_8348c576-8d68-4259-9027-fbff6fc6d0fd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e16fe651-2357-4ab0-b215-ab6460690433" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d07e4889-3648-442d-8a0d-c05ac6011149" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e16fe651-2357-4ab0-b215-ab6460690433" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e16fe651-2357-4ab0-b215-ab6460690433_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e16fe651-2357-4ab0-b215-ab6460690433" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e16fe651-2357-4ab0-b215-ab6460690433_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fa491605-b649-4be1-8a28-4ef6a6bb0de9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e16fe651-2357-4ab0-b215-ab6460690433" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fa491605-b649-4be1-8a28-4ef6a6bb0de9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ExscientiaPlcMember_06ac4a1e-771a-4c31-8048-61ee076cef23" xlink:href="rxrx-20250930.xsd#rxrx_ExscientiaPlcMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fa491605-b649-4be1-8a28-4ef6a6bb0de9" xlink:to="loc_rxrx_ExscientiaPlcMember_06ac4a1e-771a-4c31-8048-61ee076cef23" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_37c72370-7cdb-4301-8b31-6b8b1e73ea1b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d07e4889-3648-442d-8a0d-c05ac6011149" xlink:to="loc_us-gaap_StatementClassOfStockAxis_37c72370-7cdb-4301-8b31-6b8b1e73ea1b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_37c72370-7cdb-4301-8b31-6b8b1e73ea1b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_37c72370-7cdb-4301-8b31-6b8b1e73ea1b" xlink:to="loc_us-gaap_ClassOfStockDomain_37c72370-7cdb-4301-8b31-6b8b1e73ea1b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_f06db931-c889-45ed-be62-dcc3427cda1e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_37c72370-7cdb-4301-8b31-6b8b1e73ea1b" xlink:to="loc_us-gaap_ClassOfStockDomain_f06db931-c889-45ed-be62-dcc3427cda1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_db6310e8-5f18-4380-b68f-70c8d26cf94b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_f06db931-c889-45ed-be62-dcc3427cda1e" xlink:to="loc_us-gaap_CommonClassAMember_db6310e8-5f18-4380-b68f-70c8d26cf94b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c1241c7b-e15a-4e25-af2f-d2329ae99e96" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d07e4889-3648-442d-8a0d-c05ac6011149" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c1241c7b-e15a-4e25-af2f-d2329ae99e96" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c1241c7b-e15a-4e25-af2f-d2329ae99e96_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c1241c7b-e15a-4e25-af2f-d2329ae99e96" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c1241c7b-e15a-4e25-af2f-d2329ae99e96_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1b427187-e5c5-493a-a639-8735a25be02f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c1241c7b-e15a-4e25-af2f-d2329ae99e96" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1b427187-e5c5-493a-a639-8735a25be02f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_4c6a1841-014f-47bb-b942-6fc8cae1c707" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1b427187-e5c5-493a-a639-8735a25be02f" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_4c6a1841-014f-47bb-b942-6fc8cae1c707" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AssetAcquisitionEquityOwnershipPercentage_a7253a5f-ef60-4d4c-8efc-11b4611653e4" xlink:href="rxrx-20250930.xsd#rxrx_AssetAcquisitionEquityOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4bb61542-3852-402d-ac19-1f0727841dd8" xlink:to="loc_rxrx_AssetAcquisitionEquityOwnershipPercentage_a7253a5f-ef60-4d4c-8efc-11b4611653e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferred_15b7cffa-c61b-4993-bb3f-b1ac24c84127" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionConsiderationTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4bb61542-3852-402d-ac19-1f0727841dd8" xlink:to="loc_us-gaap_AssetAcquisitionConsiderationTransferred_15b7cffa-c61b-4993-bb3f-b1ac24c84127" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_ab799bf1-1896-4513-a8eb-3842999c4a71" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4bb61542-3852-402d-ac19-1f0727841dd8" xlink:to="loc_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_ab799bf1-1896-4513-a8eb-3842999c4a71" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_e49b42cc-c369-4ea6-9640-6638931774d0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4bb61542-3852-402d-ac19-1f0727841dd8" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_e49b42cc-c369-4ea6-9640-6638931774d0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_1066b381-1ddc-442e-9530-378b6cf9d2de" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4bb61542-3852-402d-ac19-1f0727841dd8" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_1066b381-1ddc-442e-9530-378b6cf9d2de" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_1c58dd82-e099-4350-b3a4-096805ec8440" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4bb61542-3852-402d-ac19-1f0727841dd8" xlink:to="loc_us-gaap_EquityMethodInvestments_1c58dd82-e099-4350-b3a4-096805ec8440" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_cb7eb77b-efa1-4dbe-bdd9-fa07433ad134" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4bb61542-3852-402d-ac19-1f0727841dd8" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_cb7eb77b-efa1-4dbe-bdd9-fa07433ad134" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_8895b4bb-b048-4db6-a6be-a6e16089e1ad" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4bb61542-3852-402d-ac19-1f0727841dd8" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_8895b4bb-b048-4db6-a6be-a6e16089e1ad" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_BusinessCombinationConsiderationTransferredEquityInterestsIssuable_b806b1bb-f6b0-4bd2-8387-846abf56f4bd" xlink:href="rxrx-20250930.xsd#rxrx_BusinessCombinationConsiderationTransferredEquityInterestsIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4bb61542-3852-402d-ac19-1f0727841dd8" xlink:to="loc_rxrx_BusinessCombinationConsiderationTransferredEquityInterestsIssuable_b806b1bb-f6b0-4bd2-8387-846abf56f4bd" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_7975a78d-c836-4b51-9150-f9c4fec7079e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4bb61542-3852-402d-ac19-1f0727841dd8" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_7975a78d-c836-4b51-9150-f9c4fec7079e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_BusinessCombinationEquityInterestIssuedOrIssuableSharesOfAcquirerStockPerShareOfAcquireeStockOutstanding_4533b2d0-b866-4557-97b1-d82ef74408a0" xlink:href="rxrx-20250930.xsd#rxrx_BusinessCombinationEquityInterestIssuedOrIssuableSharesOfAcquirerStockPerShareOfAcquireeStockOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4bb61542-3852-402d-ac19-1f0727841dd8" xlink:to="loc_rxrx_BusinessCombinationEquityInterestIssuedOrIssuableSharesOfAcquirerStockPerShareOfAcquireeStockOutstanding_4533b2d0-b866-4557-97b1-d82ef74408a0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_368b2a31-9501-42ac-b875-a7e50d6fc463" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4bb61542-3852-402d-ac19-1f0727841dd8" xlink:to="loc_us-gaap_SharePrice_368b2a31-9501-42ac-b875-a7e50d6fc463" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_dad3f1d5-23cc-412d-b6a6-df0a0b381f99" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4bb61542-3852-402d-ac19-1f0727841dd8" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_dad3f1d5-23cc-412d-b6a6-df0a0b381f99" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_02a2e7bd-ea63-4781-ab86-dc672e74b474" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4bb61542-3852-402d-ac19-1f0727841dd8" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_02a2e7bd-ea63-4781-ab86-dc672e74b474" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_NumberOfAcquiredCustomerContractsWithContractLiabilities_0df33ede-89ec-4450-8200-b63a3da28338" xlink:href="rxrx-20250930.xsd#rxrx_NumberOfAcquiredCustomerContractsWithContractLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4bb61542-3852-402d-ac19-1f0727841dd8" xlink:to="loc_rxrx_NumberOfAcquiredCustomerContractsWithContractLiabilities_0df33ede-89ec-4450-8200-b63a3da28338" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_NumberOfInProcessResearchAndDevelopmentAssets_6325d837-655e-48ba-8a29-59f867198fb4" xlink:href="rxrx-20250930.xsd#rxrx_NumberOfInProcessResearchAndDevelopmentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4bb61542-3852-402d-ac19-1f0727841dd8" xlink:to="loc_rxrx_NumberOfInProcessResearchAndDevelopmentAssets_6325d837-655e-48ba-8a29-59f867198fb4" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_FiniteLivedIntangibleAssetDiscountRate_c5363bd3-0517-4779-92d1-635e6322b213" xlink:href="rxrx-20250930.xsd#rxrx_FiniteLivedIntangibleAssetDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4bb61542-3852-402d-ac19-1f0727841dd8" xlink:to="loc_rxrx_FiniteLivedIntangibleAssetDiscountRate_c5363bd3-0517-4779-92d1-635e6322b213" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_39b291ea-3748-405a-980d-181fb46bf5ef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4bb61542-3852-402d-ac19-1f0727841dd8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_39b291ea-3748-405a-980d-181fb46bf5ef" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_6d456b42-559c-4923-a0aa-4e5c71789012" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4bb61542-3852-402d-ac19-1f0727841dd8" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_6d456b42-559c-4923-a0aa-4e5c71789012" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_76420f94-f260-417a-a26d-c608aabe00da" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4bb61542-3852-402d-ac19-1f0727841dd8" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_76420f94-f260-417a-a26d-c608aabe00da" xlink:type="arc" order="19"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.recursion.com/role/AcquisitionsScheduleofAssetAcquisitionDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#AcquisitionsScheduleofAssetAcquisitionDetails"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/AcquisitionsScheduleofAssetAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionLineItems_63557ee7-62d2-4232-88f3-00a09abe0235" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionTable_552881d1-0519-467f-91f8-0606082f157f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_63557ee7-62d2-4232-88f3-00a09abe0235" xlink:to="loc_us-gaap_AssetAcquisitionTable_552881d1-0519-467f-91f8-0606082f157f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_42c50789-92c6-4c5b-8208-bf3b73c787ca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AssetAcquisitionTable_552881d1-0519-467f-91f8-0606082f157f" xlink:to="loc_us-gaap_AssetAcquisitionAxis_42c50789-92c6-4c5b-8208-bf3b73c787ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_42c50789-92c6-4c5b-8208-bf3b73c787ca_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AssetAcquisitionAxis_42c50789-92c6-4c5b-8208-bf3b73c787ca" xlink:to="loc_us-gaap_AssetAcquisitionDomain_42c50789-92c6-4c5b-8208-bf3b73c787ca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_f292eac9-fbf0-4cc8-9e0e-2b2be8d6fec7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AssetAcquisitionAxis_42c50789-92c6-4c5b-8208-bf3b73c787ca" xlink:to="loc_us-gaap_AssetAcquisitionDomain_f292eac9-fbf0-4cc8-9e0e-2b2be8d6fec7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_REVenturesIMember_2cdce1cf-071a-46ca-8aee-9a9192c001ef" xlink:href="rxrx-20250930.xsd#rxrx_REVenturesIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_f292eac9-fbf0-4cc8-9e0e-2b2be8d6fec7" xlink:to="loc_rxrx_REVenturesIMember_2cdce1cf-071a-46ca-8aee-9a9192c001ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable_df53ddab-d552-4f55-951b-ad55eff0e3ff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_63557ee7-62d2-4232-88f3-00a09abe0235" xlink:to="loc_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable_df53ddab-d552-4f55-951b-ad55eff0e3ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration_37c36925-a70e-439d-b6bd-aa382ebdea0f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_63557ee7-62d2-4232-88f3-00a09abe0235" xlink:to="loc_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration_37c36925-a70e-439d-b6bd-aa382ebdea0f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost_a8285323-9b02-4e11-8ad2-be011c1b86d2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_63557ee7-62d2-4232-88f3-00a09abe0235" xlink:to="loc_us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost_a8285323-9b02-4e11-8ad2-be011c1b86d2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_01440d9d-1c1a-4c08-87f1-011bece014aa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_63557ee7-62d2-4232-88f3-00a09abe0235" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_01440d9d-1c1a-4c08-87f1-011bece014aa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferred_51b68d33-21de-4778-b2cc-6a3eaf9865fd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionConsiderationTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_63557ee7-62d2-4232-88f3-00a09abe0235" xlink:to="loc_us-gaap_AssetAcquisitionConsiderationTransferred_51b68d33-21de-4778-b2cc-6a3eaf9865fd" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.recursion.com/role/AcquisitionsScheduleofContingentConsiderationTransferredDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#AcquisitionsScheduleofContingentConsiderationTransferredDetails"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/AcquisitionsScheduleofContingentConsiderationTransferredDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionLineItems_8b77d76e-3f8b-4401-ab0e-8d6c7e45635b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionTable_1167f7f4-b8e0-4607-9c9e-19be9ccc295c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_8b77d76e-3f8b-4401-ab0e-8d6c7e45635b" xlink:to="loc_us-gaap_AssetAcquisitionTable_1167f7f4-b8e0-4607-9c9e-19be9ccc295c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_5faa9642-6161-4f99-b30c-e1ae4cd59ffb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AssetAcquisitionTable_1167f7f4-b8e0-4607-9c9e-19be9ccc295c" xlink:to="loc_us-gaap_AssetAcquisitionAxis_5faa9642-6161-4f99-b30c-e1ae4cd59ffb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_5faa9642-6161-4f99-b30c-e1ae4cd59ffb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AssetAcquisitionAxis_5faa9642-6161-4f99-b30c-e1ae4cd59ffb" xlink:to="loc_us-gaap_AssetAcquisitionDomain_5faa9642-6161-4f99-b30c-e1ae4cd59ffb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_520f7005-a118-445d-8798-cae8094a3dfa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AssetAcquisitionAxis_5faa9642-6161-4f99-b30c-e1ae4cd59ffb" xlink:to="loc_us-gaap_AssetAcquisitionDomain_520f7005-a118-445d-8798-cae8094a3dfa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_REVenturesIMember_47233d35-2b1d-4dfa-b8cd-f1cef0abc67c" xlink:href="rxrx-20250930.xsd#rxrx_REVenturesIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_520f7005-a118-445d-8798-cae8094a3dfa" xlink:to="loc_rxrx_REVenturesIMember_47233d35-2b1d-4dfa-b8cd-f1cef0abc67c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AssetAcquisitionContingentConsiderationEquityInterestIssuedAndIssuable_02974ca4-ad2a-4f03-9c1c-ba31c6dc6b99" xlink:href="rxrx-20250930.xsd#rxrx_AssetAcquisitionContingentConsiderationEquityInterestIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_8b77d76e-3f8b-4401-ab0e-8d6c7e45635b" xlink:to="loc_rxrx_AssetAcquisitionContingentConsiderationEquityInterestIssuedAndIssuable_02974ca4-ad2a-4f03-9c1c-ba31c6dc6b99" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AssetAcquisitionContingentConsiderationCashPaid_f5e83f22-18fb-4f86-9c29-ff77edfe4047" xlink:href="rxrx-20250930.xsd#rxrx_AssetAcquisitionContingentConsiderationCashPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_8b77d76e-3f8b-4401-ab0e-8d6c7e45635b" xlink:to="loc_rxrx_AssetAcquisitionContingentConsiderationCashPaid_f5e83f22-18fb-4f86-9c29-ff77edfe4047" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration_4de09014-bd2b-410d-b592-4f04a3f06b69" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_8b77d76e-3f8b-4401-ab0e-8d6c7e45635b" xlink:to="loc_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration_4de09014-bd2b-410d-b592-4f04a3f06b69" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.recursion.com/role/AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_967a6d1e-9508-4bef-bdad-d70bd3a7f42f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_aeec8782-4719-4e76-8de3-a47b5f1a04df" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_967a6d1e-9508-4bef-bdad-d70bd3a7f42f" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_aeec8782-4719-4e76-8de3-a47b5f1a04df" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_57c3739e-5a59-4165-af58-62a5db3197f5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_aeec8782-4719-4e76-8de3-a47b5f1a04df" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_57c3739e-5a59-4165-af58-62a5db3197f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_57c3739e-5a59-4165-af58-62a5db3197f5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_57c3739e-5a59-4165-af58-62a5db3197f5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_57c3739e-5a59-4165-af58-62a5db3197f5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_783a9075-d715-4605-9780-20b8c93470a3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_57c3739e-5a59-4165-af58-62a5db3197f5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_783a9075-d715-4605-9780-20b8c93470a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ExscientiaPlcMember_5d26f23a-29a4-454a-b916-c61a3f58c35f" xlink:href="rxrx-20250930.xsd#rxrx_ExscientiaPlcMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_783a9075-d715-4605-9780-20b8c93470a3" xlink:to="loc_rxrx_ExscientiaPlcMember_5d26f23a-29a4-454a-b916-c61a3f58c35f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_3cba97ea-8625-436a-912b-e35331fe92b4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_967a6d1e-9508-4bef-bdad-d70bd3a7f42f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_3cba97ea-8625-436a-912b-e35331fe92b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables_8fa25861-1d97-42b3-a681-5077f4d499c5" xlink:href="rxrx-20250930.xsd#rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_967a6d1e-9508-4bef-bdad-d70bd3a7f42f" xlink:to="loc_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables_8fa25861-1d97-42b3-a681-5077f4d499c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_31973424-bcd8-4f8a-8a68-71ba910be1f2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_967a6d1e-9508-4bef-bdad-d70bd3a7f42f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_31973424-bcd8-4f8a-8a68-71ba910be1f2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_aad149a0-e0af-408a-a5b8-daa47b113f44" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_967a6d1e-9508-4bef-bdad-d70bd3a7f42f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_aad149a0-e0af-408a-a5b8-daa47b113f44" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_d50fd7fe-ac7e-4cd5-86c6-3521b62a573c" xlink:href="rxrx-20250930.xsd#rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_967a6d1e-9508-4bef-bdad-d70bd3a7f42f" xlink:to="loc_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_d50fd7fe-ac7e-4cd5-86c6-3521b62a573c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_1b66272b-ed99-4c4c-b1c4-cc6cbe8a5c08" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_967a6d1e-9508-4bef-bdad-d70bd3a7f42f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_1b66272b-ed99-4c4c-b1c4-cc6cbe8a5c08" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_f2f87ee5-f05d-4bc1-b6f8-9ccc6fa35596" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_967a6d1e-9508-4bef-bdad-d70bd3a7f42f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_f2f87ee5-f05d-4bc1-b6f8-9ccc6fa35596" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_bf381e65-4ed0-4867-ad53-b6068362e04c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_967a6d1e-9508-4bef-bdad-d70bd3a7f42f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_bf381e65-4ed0-4867-ad53-b6068362e04c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_cb9af6fd-f656-4490-b9a1-31333f89c061" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_967a6d1e-9508-4bef-bdad-d70bd3a7f42f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_cb9af6fd-f656-4490-b9a1-31333f89c061" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_87c62c10-5ac5-42f4-945e-8db824e36615" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_967a6d1e-9508-4bef-bdad-d70bd3a7f42f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_87c62c10-5ac5-42f4-945e-8db824e36615" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities_60e06aaf-d2d2-4fab-a164-cbcef5a69a8d" xlink:href="rxrx-20250930.xsd#rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_967a6d1e-9508-4bef-bdad-d70bd3a7f42f" xlink:to="loc_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities_60e06aaf-d2d2-4fab-a164-cbcef5a69a8d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_962d4ce4-b5c3-4f8c-a862-5cbfa4e4c7a0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_967a6d1e-9508-4bef-bdad-d70bd3a7f42f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_962d4ce4-b5c3-4f8c-a862-5cbfa4e4c7a0" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_a6c97f79-b7ac-4d4a-912e-92a6d5a76d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_967a6d1e-9508-4bef-bdad-d70bd3a7f42f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_a6c97f79-b7ac-4d4a-912e-92a6d5a76d7d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_72379d8d-50fb-4684-8458-42748f682164" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_967a6d1e-9508-4bef-bdad-d70bd3a7f42f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_72379d8d-50fb-4684-8458-42748f682164" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_bcd8daab-874b-44ae-a425-e9a474ac6152" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_967a6d1e-9508-4bef-bdad-d70bd3a7f42f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_bcd8daab-874b-44ae-a425-e9a474ac6152" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_4acc641b-16b9-4964-bd41-674ce700e61d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_967a6d1e-9508-4bef-bdad-d70bd3a7f42f" xlink:to="loc_us-gaap_Goodwill_4acc641b-16b9-4964-bd41-674ce700e61d" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_4c81e625-192f-480e-b8af-5b7bddfaef96" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_967a6d1e-9508-4bef-bdad-d70bd3a7f42f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_4c81e625-192f-480e-b8af-5b7bddfaef96" xlink:type="arc" order="16"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.recursion.com/role/AcquisitionsScheduleofProFormaFinancialInformationDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#AcquisitionsScheduleofProFormaFinancialInformationDetails"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/AcquisitionsScheduleofProFormaFinancialInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_9eff7a1c-ae82-4b70-b995-ec3c81ed5fd9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0e03ae62-1123-4f10-beb1-2cdf708c9da3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9eff7a1c-ae82-4b70-b995-ec3c81ed5fd9" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0e03ae62-1123-4f10-beb1-2cdf708c9da3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9cc5c14f-ea05-4dc3-88ee-a3665a8892b2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0e03ae62-1123-4f10-beb1-2cdf708c9da3" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9cc5c14f-ea05-4dc3-88ee-a3665a8892b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9cc5c14f-ea05-4dc3-88ee-a3665a8892b2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9cc5c14f-ea05-4dc3-88ee-a3665a8892b2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9cc5c14f-ea05-4dc3-88ee-a3665a8892b2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_11d450d8-4079-4bc9-83ad-3f27e6c22888" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9cc5c14f-ea05-4dc3-88ee-a3665a8892b2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_11d450d8-4079-4bc9-83ad-3f27e6c22888" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ExscientiaPlcMember_21b4da53-f4e3-45a6-9c61-fc627b4d26d2" xlink:href="rxrx-20250930.xsd#rxrx_ExscientiaPlcMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_11d450d8-4079-4bc9-83ad-3f27e6c22888" xlink:to="loc_rxrx_ExscientiaPlcMember_21b4da53-f4e3-45a6-9c61-fc627b4d26d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_9b355238-060f-4e96-b9bc-a715f1b2cea8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9eff7a1c-ae82-4b70-b995-ec3c81ed5fd9" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_9b355238-060f-4e96-b9bc-a715f1b2cea8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_b42ddd2c-fb5c-48c6-bca6-a4fb0ea7b1b1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9eff7a1c-ae82-4b70-b995-ec3c81ed5fd9" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_b42ddd2c-fb5c-48c6-bca6-a4fb0ea7b1b1" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.recursion.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#LeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_2f2b6b17-1258-4b04-acde-c5cde18e2e01" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_d42b809e-2cdd-499e-9812-c8bd6de08b02" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2f2b6b17-1258-4b04-acde-c5cde18e2e01" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_d42b809e-2cdd-499e-9812-c8bd6de08b02" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d21c43cb-6db6-4487-9ec5-4e81e08cf496" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_d42b809e-2cdd-499e-9812-c8bd6de08b02" xlink:to="loc_srt_RangeAxis_d21c43cb-6db6-4487-9ec5-4e81e08cf496" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d21c43cb-6db6-4487-9ec5-4e81e08cf496_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_d21c43cb-6db6-4487-9ec5-4e81e08cf496" xlink:to="loc_srt_RangeMember_d21c43cb-6db6-4487-9ec5-4e81e08cf496_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_664466da-57d5-4e15-a8d9-cadbb9d5e9fc" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_d21c43cb-6db6-4487-9ec5-4e81e08cf496" xlink:to="loc_srt_RangeMember_664466da-57d5-4e15-a8d9-cadbb9d5e9fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c9f56b9c-9e0b-49a5-904c-3feb315a7769" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_664466da-57d5-4e15-a8d9-cadbb9d5e9fc" xlink:to="loc_srt_MinimumMember_c9f56b9c-9e0b-49a5-904c-3feb315a7769" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_090c8027-6dac-45d8-93ba-cef353fe90ab" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_664466da-57d5-4e15-a8d9-cadbb9d5e9fc" xlink:to="loc_srt_MaximumMember_090c8027-6dac-45d8-93ba-cef353fe90ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LeaseDescriptionAxis_a21b28c3-3375-47f6-941a-126c0800bf46" xlink:href="rxrx-20250930.xsd#rxrx_LeaseDescriptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_d42b809e-2cdd-499e-9812-c8bd6de08b02" xlink:to="loc_rxrx_LeaseDescriptionAxis_a21b28c3-3375-47f6-941a-126c0800bf46" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LeaseDescriptionDomain_a21b28c3-3375-47f6-941a-126c0800bf46_default" xlink:href="rxrx-20250930.xsd#rxrx_LeaseDescriptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rxrx_LeaseDescriptionAxis_a21b28c3-3375-47f6-941a-126c0800bf46" xlink:to="loc_rxrx_LeaseDescriptionDomain_a21b28c3-3375-47f6-941a-126c0800bf46_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LeaseDescriptionDomain_34a50b2b-39e0-4892-affd-8d3f57cd738e" xlink:href="rxrx-20250930.xsd#rxrx_LeaseDescriptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rxrx_LeaseDescriptionAxis_a21b28c3-3375-47f6-941a-126c0800bf46" xlink:to="loc_rxrx_LeaseDescriptionDomain_34a50b2b-39e0-4892-affd-8d3f57cd738e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ViennaFacilitiesOfExscientiaGmbHMember_e81e035d-02d5-4dd7-a420-351e49f0fcd8" xlink:href="rxrx-20250930.xsd#rxrx_ViennaFacilitiesOfExscientiaGmbHMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rxrx_LeaseDescriptionDomain_34a50b2b-39e0-4892-affd-8d3f57cd738e" xlink:to="loc_rxrx_ViennaFacilitiesOfExscientiaGmbHMember_e81e035d-02d5-4dd7-a420-351e49f0fcd8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SchrodingerLeasesMember_35b69a3f-bf94-4b71-9ad5-5464e8bea468" xlink:href="rxrx-20250930.xsd#rxrx_SchrodingerLeasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rxrx_LeaseDescriptionDomain_34a50b2b-39e0-4892-affd-8d3f57cd738e" xlink:to="loc_rxrx_SchrodingerLeasesMember_35b69a3f-bf94-4b71-9ad5-5464e8bea468" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_e3162a37-7759-47ee-9c0e-c1e3e4f66057" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2f2b6b17-1258-4b04-acde-c5cde18e2e01" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_e3162a37-7759-47ee-9c0e-c1e3e4f66057" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_7be0edee-cc7b-4a89-bf5e-a20883b12ce2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2f2b6b17-1258-4b04-acde-c5cde18e2e01" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_7be0edee-cc7b-4a89-bf5e-a20883b12ce2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets_f9d77544-9d10-45c2-baa6-b97629ab9b00" xlink:href="rxrx-20250930.xsd#rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2f2b6b17-1258-4b04-acde-c5cde18e2e01" xlink:to="loc_rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets_f9d77544-9d10-45c2-baa6-b97629ab9b00" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications_659df068-a569-4bf5-bd1c-ae58f5179edc" xlink:href="rxrx-20250930.xsd#rxrx_LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2f2b6b17-1258-4b04-acde-c5cde18e2e01" xlink:to="loc_rxrx_LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications_659df068-a569-4bf5-bd1c-ae58f5179edc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_TerminationOfLeaseFee_2e319164-7a37-4d6b-bc57-cecac32e8d68" xlink:href="rxrx-20250930.xsd#rxrx_TerminationOfLeaseFee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2f2b6b17-1258-4b04-acde-c5cde18e2e01" xlink:to="loc_rxrx_TerminationOfLeaseFee_2e319164-7a37-4d6b-bc57-cecac32e8d68" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLeasehold_c2014b90-77e6-4085-b64b-b5e9316f64f2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOfLeasehold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2f2b6b17-1258-4b04-acde-c5cde18e2e01" xlink:to="loc_us-gaap_ImpairmentOfLeasehold_c2014b90-77e6-4085-b64b-b5e9316f64f2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_IncreaseDecreaseInRightOfUseAssetsForFinanceLeases_a23d9a41-dfc9-40c5-9789-28ee9f5e2126" xlink:href="rxrx-20250930.xsd#rxrx_IncreaseDecreaseInRightOfUseAssetsForFinanceLeases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2f2b6b17-1258-4b04-acde-c5cde18e2e01" xlink:to="loc_rxrx_IncreaseDecreaseInRightOfUseAssetsForFinanceLeases_a23d9a41-dfc9-40c5-9789-28ee9f5e2126" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LesseeFinanceLeaseIncreaseDecreaseInFinanceLeaseLiabilityDueToLeaseModifications_abedcf6d-17c4-4471-aaac-582cb4265b31" xlink:href="rxrx-20250930.xsd#rxrx_LesseeFinanceLeaseIncreaseDecreaseInFinanceLeaseLiabilityDueToLeaseModifications"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2f2b6b17-1258-4b04-acde-c5cde18e2e01" xlink:to="loc_rxrx_LesseeFinanceLeaseIncreaseDecreaseInFinanceLeaseLiabilityDueToLeaseModifications_abedcf6d-17c4-4471-aaac-582cb4265b31" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_2dec6963-108e-4c02-9def-2027002a2df9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_4998b468-3202-4799-8724-2deeea793b66" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_2dec6963-108e-4c02-9def-2027002a2df9" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_4998b468-3202-4799-8724-2deeea793b66" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_44aeb9ea-f9b8-4d53-bb72-e73dbde25f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_4998b468-3202-4799-8724-2deeea793b66" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_44aeb9ea-f9b8-4d53-bb72-e73dbde25f6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_44aeb9ea-f9b8-4d53-bb72-e73dbde25f6c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_44aeb9ea-f9b8-4d53-bb72-e73dbde25f6c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_44aeb9ea-f9b8-4d53-bb72-e73dbde25f6c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0f55f01d-3bbd-4b91-b2a7-f6c9a43c16e0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_44aeb9ea-f9b8-4d53-bb72-e73dbde25f6c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0f55f01d-3bbd-4b91-b2a7-f6c9a43c16e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_0d542a63-da02-48a5-862d-782def40f532" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0f55f01d-3bbd-4b91-b2a7-f6c9a43c16e0" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_0d542a63-da02-48a5-862d-782def40f532" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_311ac23e-7729-4f4f-9984-4b1a5735c98c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0f55f01d-3bbd-4b91-b2a7-f6c9a43c16e0" xlink:to="loc_us-gaap_LicensingAgreementsMember_311ac23e-7729-4f4f-9984-4b1a5735c98c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_eebea2b0-4e79-41c8-9d9d-e2c6c7295ee9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_2dec6963-108e-4c02-9def-2027002a2df9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_eebea2b0-4e79-41c8-9d9d-e2c6c7295ee9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ce5e1535-4d1a-4488-a31f-4cb0dd69dedf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_2dec6963-108e-4c02-9def-2027002a2df9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ce5e1535-4d1a-4488-a31f-4cb0dd69dedf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c04ebc48-aba9-4d15-8b80-6278bc9cff2c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_2dec6963-108e-4c02-9def-2027002a2df9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c04ebc48-aba9-4d15-8b80-6278bc9cff2c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_0677202f-986a-480a-bbfa-16bf32af1457" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_2dec6963-108e-4c02-9def-2027002a2df9" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_0677202f-986a-480a-bbfa-16bf32af1457" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_9fd0ce2d-7e2f-4bc8-93d5-c52348de334b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_2dec6963-108e-4c02-9def-2027002a2df9" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_9fd0ce2d-7e2f-4bc8-93d5-c52348de334b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f4615d4c-c65a-4060-bf01-d28bed133787" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_2dec6963-108e-4c02-9def-2027002a2df9" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f4615d4c-c65a-4060-bf01-d28bed133787" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#CommitmentsandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_384d8590-e864-448b-83f3-bdd25035308a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_8f87a5c0-b9b9-4bfa-8477-c0587af9955d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_384d8590-e864-448b-83f3-bdd25035308a" xlink:to="loc_us-gaap_LossContingenciesTable_8f87a5c0-b9b9-4bfa-8477-c0587af9955d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_ad0a77e1-9f99-4be8-b7a2-63eca8c6b780" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_8f87a5c0-b9b9-4bfa-8477-c0587af9955d" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_ad0a77e1-9f99-4be8-b7a2-63eca8c6b780" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_ad0a77e1-9f99-4be8-b7a2-63eca8c6b780_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_ad0a77e1-9f99-4be8-b7a2-63eca8c6b780" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_ad0a77e1-9f99-4be8-b7a2-63eca8c6b780_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_e500e2a1-d2aa-40e0-8974-d1e4cd7035c4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_ad0a77e1-9f99-4be8-b7a2-63eca8c6b780" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_e500e2a1-d2aa-40e0-8974-d1e4cd7035c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_7d3c6849-a92b-4484-8e41-5570390e9ec2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_e500e2a1-d2aa-40e0-8974-d1e4cd7035c4" xlink:to="loc_us-gaap_SubsequentEventMember_7d3c6849-a92b-4484-8e41-5570390e9ec2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_bd90115f-4973-4eb8-a89f-76e6ff2c4840" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_384d8590-e864-448b-83f3-bdd25035308a" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_bd90115f-4973-4eb8-a89f-76e6ff2c4840" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_DurationOfTimeForPlaintiffToRefileClaim_404c6673-fd85-4362-9ac8-3afb572619a8" xlink:href="rxrx-20250930.xsd#rxrx_DurationOfTimeForPlaintiffToRefileClaim"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_384d8590-e864-448b-83f3-bdd25035308a" xlink:to="loc_rxrx_DurationOfTimeForPlaintiffToRefileClaim_404c6673-fd85-4362-9ac8-3afb572619a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_FinanceLeasesAssetsPledgedAsCollateral_91528a2e-7050-48fa-8ae9-56a79fd6fdab" xlink:href="rxrx-20250930.xsd#rxrx_FinanceLeasesAssetsPledgedAsCollateral"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_384d8590-e864-448b-83f3-bdd25035308a" xlink:to="loc_rxrx_FinanceLeasesAssetsPledgedAsCollateral_91528a2e-7050-48fa-8ae9-56a79fd6fdab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_dd2c534b-3ca5-426b-8dc2-1ab5fa025f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_384d8590-e864-448b-83f3-bdd25035308a" xlink:to="loc_us-gaap_FinanceLeaseLiability_dd2c534b-3ca5-426b-8dc2-1ab5fa025f5a" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CommonStockNarrativeDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#CommonStockNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/CommonStockNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_6a001e76-8e5e-4769-b977-56d6d3a7e8bb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_cf6a67cd-0949-4ffb-b88f-8cfa253979ce" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_6a001e76-8e5e-4769-b977-56d6d3a7e8bb" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_cf6a67cd-0949-4ffb-b88f-8cfa253979ce" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_efa6e186-37d0-4ff8-af0e-d2437e953604" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_cf6a67cd-0949-4ffb-b88f-8cfa253979ce" xlink:to="loc_us-gaap_StatementClassOfStockAxis_efa6e186-37d0-4ff8-af0e-d2437e953604" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_efa6e186-37d0-4ff8-af0e-d2437e953604_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_efa6e186-37d0-4ff8-af0e-d2437e953604" xlink:to="loc_us-gaap_ClassOfStockDomain_efa6e186-37d0-4ff8-af0e-d2437e953604_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_fb2bce99-601c-44db-abe1-a60bd9f094cc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_efa6e186-37d0-4ff8-af0e-d2437e953604" xlink:to="loc_us-gaap_ClassOfStockDomain_fb2bce99-601c-44db-abe1-a60bd9f094cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_87ada789-7af4-4345-ad60-41550e83cea3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_fb2bce99-601c-44db-abe1-a60bd9f094cc" xlink:to="loc_us-gaap_CommonClassAMember_87ada789-7af4-4345-ad60-41550e83cea3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_ca1638d6-bbda-4b04-b479-dfd098a1a097" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_fb2bce99-601c-44db-abe1-a60bd9f094cc" xlink:to="loc_us-gaap_CommonClassBMember_ca1638d6-bbda-4b04-b479-dfd098a1a097" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_CommonStockVotePerShare_4bbec2fb-872e-4007-b9a3-17fe77ba5ad4" xlink:href="rxrx-20250930.xsd#rxrx_CommonStockVotePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_6a001e76-8e5e-4769-b977-56d6d3a7e8bb" xlink:to="loc_rxrx_CommonStockVotePerShare_4bbec2fb-872e-4007-b9a3-17fe77ba5ad4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsStock_99a15483-0d76-40d0-837e-f25e8e989f50" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DividendsStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_6a001e76-8e5e-4769-b977-56d6d3a7e8bb" xlink:to="loc_us-gaap_DividendsStock_99a15483-0d76-40d0-837e-f25e8e989f50" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CommonStockAtTheMarketOfferingNarrativeDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#CommonStockAtTheMarketOfferingNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/CommonStockAtTheMarketOfferingNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_4134cb9a-bfeb-475d-97b3-1f298e231998" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_0145cb9d-df92-4410-8ff8-e24294e66247" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_4134cb9a-bfeb-475d-97b3-1f298e231998" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_0145cb9d-df92-4410-8ff8-e24294e66247" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_6d3c28d5-9bda-4ba5-917e-e477c2d07341" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_0145cb9d-df92-4410-8ff8-e24294e66247" xlink:to="loc_us-gaap_StatementClassOfStockAxis_6d3c28d5-9bda-4ba5-917e-e477c2d07341" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_6d3c28d5-9bda-4ba5-917e-e477c2d07341_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_6d3c28d5-9bda-4ba5-917e-e477c2d07341" xlink:to="loc_us-gaap_ClassOfStockDomain_6d3c28d5-9bda-4ba5-917e-e477c2d07341_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_f0a13d04-9316-4bcc-bfef-b800de2c0b24" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_6d3c28d5-9bda-4ba5-917e-e477c2d07341" xlink:to="loc_us-gaap_ClassOfStockDomain_f0a13d04-9316-4bcc-bfef-b800de2c0b24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_fdd21f56-874c-4b18-888a-4a4c7c724cc8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_f0a13d04-9316-4bcc-bfef-b800de2c0b24" xlink:to="loc_us-gaap_CommonClassAMember_fdd21f56-874c-4b18-888a-4a4c7c724cc8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_93703283-db28-424a-a013-976e2d234069" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_0145cb9d-df92-4410-8ff8-e24294e66247" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_93703283-db28-424a-a013-976e2d234069" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_93703283-db28-424a-a013-976e2d234069_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_93703283-db28-424a-a013-976e2d234069" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_93703283-db28-424a-a013-976e2d234069_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_02db2176-3df4-4bfb-bc60-748586436d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_93703283-db28-424a-a013-976e2d234069" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_02db2176-3df4-4bfb-bc60-748586436d0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AtTheMarketOfferingProgramCitiMember_fa9be1c0-7ced-4dc5-97d9-97e0147a0153" xlink:href="rxrx-20250930.xsd#rxrx_AtTheMarketOfferingProgramCitiMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_02db2176-3df4-4bfb-bc60-748586436d0c" xlink:to="loc_rxrx_AtTheMarketOfferingProgramCitiMember_fa9be1c0-7ced-4dc5-97d9-97e0147a0153" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AtTheMarketOfferingProgramJefferiesMember_8d0c29cd-28ed-4182-814d-94759891f532" xlink:href="rxrx-20250930.xsd#rxrx_AtTheMarketOfferingProgramJefferiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_02db2176-3df4-4bfb-bc60-748586436d0c" xlink:to="loc_rxrx_AtTheMarketOfferingProgramJefferiesMember_8d0c29cd-28ed-4182-814d-94759891f532" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SaleOfStockValueAuthorized_0b83abe8-aae0-45f6-9d9b-a504e0c36d11" xlink:href="rxrx-20250930.xsd#rxrx_SaleOfStockValueAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_4134cb9a-bfeb-475d-97b3-1f298e231998" xlink:to="loc_rxrx_SaleOfStockValueAuthorized_0b83abe8-aae0-45f6-9d9b-a504e0c36d11" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_9798ca2f-635e-48a1-94ab-4f2152e07d85" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_4134cb9a-bfeb-475d-97b3-1f298e231998" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_9798ca2f-635e-48a1-94ab-4f2152e07d85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_f46d618f-b501-401e-9e97-59dbdf148471" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_4134cb9a-bfeb-475d-97b3-1f298e231998" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_f46d618f-b501-401e-9e97-59dbdf148471" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SaleOfStockValueRemainingAuthorized_48b35073-2093-43f2-8fe5-6b1bc5dc01e4" xlink:href="rxrx-20250930.xsd#rxrx_SaleOfStockValueRemainingAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_4134cb9a-bfeb-475d-97b3-1f298e231998" xlink:to="loc_rxrx_SaleOfStockValueRemainingAuthorized_48b35073-2093-43f2-8fe5-6b1bc5dc01e4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SaleOfStockPercentageOfCommission_81469ace-ade4-447c-8adf-36e87331a4eb" xlink:href="rxrx-20250930.xsd#rxrx_SaleOfStockPercentageOfCommission"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_4134cb9a-bfeb-475d-97b3-1f298e231998" xlink:to="loc_rxrx_SaleOfStockPercentageOfCommission_81469ace-ade4-447c-8adf-36e87331a4eb" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CommonStockPublicOfferingofCommonStockNarrativeDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#CommonStockPublicOfferingofCommonStockNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/CommonStockPublicOfferingofCommonStockNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_8c98a64e-144d-4fb2-9ae0-739133fda6d2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_717f1c5b-de44-4635-9c84-9086cd205b72" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_8c98a64e-144d-4fb2-9ae0-739133fda6d2" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_717f1c5b-de44-4635-9c84-9086cd205b72" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_5ca43d25-9891-4ab5-b2d6-b698f93c874f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_717f1c5b-de44-4635-9c84-9086cd205b72" xlink:to="loc_us-gaap_StatementClassOfStockAxis_5ca43d25-9891-4ab5-b2d6-b698f93c874f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_5ca43d25-9891-4ab5-b2d6-b698f93c874f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_5ca43d25-9891-4ab5-b2d6-b698f93c874f" xlink:to="loc_us-gaap_ClassOfStockDomain_5ca43d25-9891-4ab5-b2d6-b698f93c874f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_b9e05786-ef84-4b84-8f82-9dc4555629e3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_5ca43d25-9891-4ab5-b2d6-b698f93c874f" xlink:to="loc_us-gaap_ClassOfStockDomain_b9e05786-ef84-4b84-8f82-9dc4555629e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_81a4fcb0-1011-46c9-8242-e6269a0ee465" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_b9e05786-ef84-4b84-8f82-9dc4555629e3" xlink:to="loc_us-gaap_CommonClassAMember_81a4fcb0-1011-46c9-8242-e6269a0ee465" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_18c8aa33-11bb-4c5c-9ada-d65c8f263f58" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_717f1c5b-de44-4635-9c84-9086cd205b72" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_18c8aa33-11bb-4c5c-9ada-d65c8f263f58" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_18c8aa33-11bb-4c5c-9ada-d65c8f263f58_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_18c8aa33-11bb-4c5c-9ada-d65c8f263f58" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_18c8aa33-11bb-4c5c-9ada-d65c8f263f58_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8c430dd6-867b-4a33-96d3-12f916e17dd4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_18c8aa33-11bb-4c5c-9ada-d65c8f263f58" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8c430dd6-867b-4a33-96d3-12f916e17dd4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_PublicOfferingOfCommonStockMember_3658bb79-1737-4f1b-aca8-705ad21a397f" xlink:href="rxrx-20250930.xsd#rxrx_PublicOfferingOfCommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8c430dd6-867b-4a33-96d3-12f916e17dd4" xlink:to="loc_rxrx_PublicOfferingOfCommonStockMember_3658bb79-1737-4f1b-aca8-705ad21a397f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_PublicOfferingOfCommonStockUnderwritingAgreementMember_f95d8051-38d8-4e72-b53b-de36a20643cd" xlink:href="rxrx-20250930.xsd#rxrx_PublicOfferingOfCommonStockUnderwritingAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8c430dd6-867b-4a33-96d3-12f916e17dd4" xlink:to="loc_rxrx_PublicOfferingOfCommonStockUnderwritingAgreementMember_f95d8051-38d8-4e72-b53b-de36a20643cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember_d185cf1a-a92a-43f8-8116-debebaaeaec0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8c430dd6-867b-4a33-96d3-12f916e17dd4" xlink:to="loc_us-gaap_OverAllotmentOptionMember_d185cf1a-a92a-43f8-8116-debebaaeaec0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_bebf73ca-1912-4cff-9a4a-d7e1c8489a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_8c98a64e-144d-4fb2-9ae0-739133fda6d2" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_bebf73ca-1912-4cff-9a4a-d7e1c8489a8c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_5b0c5f50-fb6f-4f96-897d-a8cc3cbd18fc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_8c98a64e-144d-4fb2-9ae0-739133fda6d2" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_5b0c5f50-fb6f-4f96-897d-a8cc3cbd18fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_cfb9e442-0f11-49fe-a5f4-49b9f81778c0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_8c98a64e-144d-4fb2-9ae0-739133fda6d2" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_cfb9e442-0f11-49fe-a5f4-49b9f81778c0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_2d990ab5-7787-429e-957a-2f9d504eb688" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_8c98a64e-144d-4fb2-9ae0-739133fda6d2" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_2d990ab5-7787-429e-957a-2f9d504eb688" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SaleOfStockUnderwritersOptionPeriodFromTheDateOfTheAgreement_481ae044-bfd4-447a-a52e-6846ad3081c9" xlink:href="rxrx-20250930.xsd#rxrx_SaleOfStockUnderwritersOptionPeriodFromTheDateOfTheAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_8c98a64e-144d-4fb2-9ae0-739133fda6d2" xlink:to="loc_rxrx_SaleOfStockUnderwritersOptionPeriodFromTheDateOfTheAgreement_481ae044-bfd4-447a-a52e-6846ad3081c9" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CommonStockValenceAcquisitionExchangeableSharesNarrativeDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#CommonStockValenceAcquisitionExchangeableSharesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/CommonStockValenceAcquisitionExchangeableSharesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_11dd39cf-d166-435d-af29-9082adcfe237" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_a2719367-4624-40c0-9486-65ae6d8aa0cc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_11dd39cf-d166-435d-af29-9082adcfe237" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_a2719367-4624-40c0-9486-65ae6d8aa0cc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3904acd6-5e7b-451b-bef4-3e00b1374903" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_a2719367-4624-40c0-9486-65ae6d8aa0cc" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3904acd6-5e7b-451b-bef4-3e00b1374903" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3904acd6-5e7b-451b-bef4-3e00b1374903_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3904acd6-5e7b-451b-bef4-3e00b1374903" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3904acd6-5e7b-451b-bef4-3e00b1374903_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ce29856a-99e2-4b3c-8622-d6d890c6dcb2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3904acd6-5e7b-451b-bef4-3e00b1374903" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ce29856a-99e2-4b3c-8622-d6d890c6dcb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ValenceDiscoveryIncMember_1e577c7c-6ddb-4afe-b43e-e4431337930d" xlink:href="rxrx-20250930.xsd#rxrx_ValenceDiscoveryIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ce29856a-99e2-4b3c-8622-d6d890c6dcb2" xlink:to="loc_rxrx_ValenceDiscoveryIncMember_1e577c7c-6ddb-4afe-b43e-e4431337930d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_4a0c9ece-9aab-4495-8574-dfb8a587b410" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_a2719367-4624-40c0-9486-65ae6d8aa0cc" xlink:to="loc_us-gaap_StatementClassOfStockAxis_4a0c9ece-9aab-4495-8574-dfb8a587b410" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_4a0c9ece-9aab-4495-8574-dfb8a587b410_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_4a0c9ece-9aab-4495-8574-dfb8a587b410" xlink:to="loc_us-gaap_ClassOfStockDomain_4a0c9ece-9aab-4495-8574-dfb8a587b410_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_cbc9076a-39be-4b33-9bd1-845d30cef62a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_4a0c9ece-9aab-4495-8574-dfb8a587b410" xlink:to="loc_us-gaap_ClassOfStockDomain_cbc9076a-39be-4b33-9bd1-845d30cef62a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ExchangeableStockMember_1e4441b4-4b54-43ff-b5d0-8b65d338aeb8" xlink:href="rxrx-20250930.xsd#rxrx_ExchangeableStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_cbc9076a-39be-4b33-9bd1-845d30cef62a" xlink:to="loc_rxrx_ExchangeableStockMember_1e4441b4-4b54-43ff-b5d0-8b65d338aeb8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_78ab6ded-3e97-423a-8795-20a3fe0c69a9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_cbc9076a-39be-4b33-9bd1-845d30cef62a" xlink:to="loc_us-gaap_CommonClassAMember_78ab6ded-3e97-423a-8795-20a3fe0c69a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares_e36526eb-305d-4411-8f4e-6529ee6ec333" xlink:href="rxrx-20250930.xsd#rxrx_BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_11dd39cf-d166-435d-af29-9082adcfe237" xlink:to="loc_rxrx_BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares_e36526eb-305d-4411-8f4e-6529ee6ec333" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_CommonStockConversionRatio_4d4dd29d-de75-4c23-84f0-682fae175253" xlink:href="rxrx-20250930.xsd#rxrx_CommonStockConversionRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_11dd39cf-d166-435d-af29-9082adcfe237" xlink:to="loc_rxrx_CommonStockConversionRatio_4d4dd29d-de75-4c23-84f0-682fae175253" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_1b8993e2-acb9-4125-9c61-be6388fec89b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_11dd39cf-d166-435d-af29-9082adcfe237" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_1b8993e2-acb9-4125-9c61-be6388fec89b" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CommonStockRegistrationRightsAgreementsNarrativeDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#CommonStockRegistrationRightsAgreementsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/CommonStockRegistrationRightsAgreementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_a732fc32-28f7-449e-abee-ac5aad3ff5be" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_1b8f50c5-e93b-4550-816f-f548f0689a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_a732fc32-28f7-449e-abee-ac5aad3ff5be" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_1b8f50c5-e93b-4550-816f-f548f0689a8f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_21d153e3-3e85-440b-88d3-9edbc02732e5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1b8f50c5-e93b-4550-816f-f548f0689a8f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_21d153e3-3e85-440b-88d3-9edbc02732e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_21d153e3-3e85-440b-88d3-9edbc02732e5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_21d153e3-3e85-440b-88d3-9edbc02732e5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_21d153e3-3e85-440b-88d3-9edbc02732e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0256d4ee-f7cf-46c8-98f5-280f04d108e5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_21d153e3-3e85-440b-88d3-9edbc02732e5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0256d4ee-f7cf-46c8-98f5-280f04d108e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ValenceDiscoveryIncMember_4809a5b7-6709-46a6-8686-fa87ec265b03" xlink:href="rxrx-20250930.xsd#rxrx_ValenceDiscoveryIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0256d4ee-f7cf-46c8-98f5-280f04d108e5" xlink:to="loc_rxrx_ValenceDiscoveryIncMember_4809a5b7-6709-46a6-8686-fa87ec265b03" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RegistrationRightsAgreementTerm_2f0ce740-da01-4800-8cab-c6afd959ffbb" xlink:href="rxrx-20250930.xsd#rxrx_RegistrationRightsAgreementTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a732fc32-28f7-449e-abee-ac5aad3ff5be" xlink:to="loc_rxrx_RegistrationRightsAgreementTerm_2f0ce740-da01-4800-8cab-c6afd959ffbb" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CommonStockClassAandBCommonSharesAuthorizationNarrativeDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#CommonStockClassAandBCommonSharesAuthorizationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/CommonStockClassAandBCommonSharesAuthorizationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_c1ef4886-3b4b-4d63-9058-4dc48b4f37c5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_d954e4ff-1023-403e-95a2-35cf4e24ae9b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_c1ef4886-3b4b-4d63-9058-4dc48b4f37c5" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_d954e4ff-1023-403e-95a2-35cf4e24ae9b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_36cc0ec9-8054-4814-a3aa-f1b5e732f315" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_d954e4ff-1023-403e-95a2-35cf4e24ae9b" xlink:to="loc_us-gaap_StatementClassOfStockAxis_36cc0ec9-8054-4814-a3aa-f1b5e732f315" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_36cc0ec9-8054-4814-a3aa-f1b5e732f315_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_36cc0ec9-8054-4814-a3aa-f1b5e732f315" xlink:to="loc_us-gaap_ClassOfStockDomain_36cc0ec9-8054-4814-a3aa-f1b5e732f315_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a40efc49-19ea-48eb-83e2-f66ce991de89" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_36cc0ec9-8054-4814-a3aa-f1b5e732f315" xlink:to="loc_us-gaap_ClassOfStockDomain_a40efc49-19ea-48eb-83e2-f66ce991de89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_c897a333-b80d-44c2-a83b-c3dd24481d6d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_a40efc49-19ea-48eb-83e2-f66ce991de89" xlink:to="loc_us-gaap_CommonClassAMember_c897a333-b80d-44c2-a83b-c3dd24481d6d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_8f0a8377-c8c1-4375-ae96-22ff53cef658" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_a40efc49-19ea-48eb-83e2-f66ce991de89" xlink:to="loc_us-gaap_CommonClassBMember_8f0a8377-c8c1-4375-ae96-22ff53cef658" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7afca1e9-885d-44b7-98d3-989615eb97a8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_d954e4ff-1023-403e-95a2-35cf4e24ae9b" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7afca1e9-885d-44b7-98d3-989615eb97a8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_7afca1e9-885d-44b7-98d3-989615eb97a8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7afca1e9-885d-44b7-98d3-989615eb97a8" xlink:to="loc_us-gaap_RelatedPartyDomain_7afca1e9-885d-44b7-98d3-989615eb97a8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_aa0509c7-414b-4dde-a566-4902150e91a1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7afca1e9-885d-44b7-98d3-989615eb97a8" xlink:to="loc_us-gaap_RelatedPartyDomain_aa0509c7-414b-4dde-a566-4902150e91a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_CEOAndAffiliatesMember_14dec137-6715-486c-a63a-c426a0eb819a" xlink:href="rxrx-20250930.xsd#rxrx_CEOAndAffiliatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_aa0509c7-414b-4dde-a566-4902150e91a1" xlink:to="loc_rxrx_CEOAndAffiliatesMember_14dec137-6715-486c-a63a-c426a0eb819a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_NumberOfClassesOfCommonStockAuthorized_8dd5768b-72ce-4fb2-aba8-9f266871783d" xlink:href="rxrx-20250930.xsd#rxrx_NumberOfClassesOfCommonStockAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_c1ef4886-3b4b-4d63-9058-4dc48b4f37c5" xlink:to="loc_rxrx_NumberOfClassesOfCommonStockAuthorized_8dd5768b-72ce-4fb2-aba8-9f266871783d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_CommonStockVotePerShare_958b33f9-7b6c-4631-8e54-5df5d578b7d0" xlink:href="rxrx-20250930.xsd#rxrx_CommonStockVotePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_c1ef4886-3b4b-4d63-9058-4dc48b4f37c5" xlink:to="loc_rxrx_CommonStockVotePerShare_958b33f9-7b6c-4631-8e54-5df5d578b7d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_CommonStockConversionRatio_b650af55-870a-44c1-b81a-f0fbddfcb1bd" xlink:href="rxrx-20250930.xsd#rxrx_CommonStockConversionRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_c1ef4886-3b4b-4d63-9058-4dc48b4f37c5" xlink:to="loc_rxrx_CommonStockConversionRatio_b650af55-870a-44c1-b81a-f0fbddfcb1bd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AffiliatedHoldersOwnershipPercentage_f76ae9c2-d682-4008-89b1-363e4d922ca5" xlink:href="rxrx-20250930.xsd#rxrx_AffiliatedHoldersOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_c1ef4886-3b4b-4d63-9058-4dc48b4f37c5" xlink:to="loc_rxrx_AffiliatedHoldersOwnershipPercentage_f76ae9c2-d682-4008-89b1-363e4d922ca5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AffiliatedHoldersPotentialOwnershipPercentageWhenOutstandingEquityAwardsVest_ac9d6469-d15e-47b7-827f-8a268dda8b3c" xlink:href="rxrx-20250930.xsd#rxrx_AffiliatedHoldersPotentialOwnershipPercentageWhenOutstandingEquityAwardsVest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_c1ef4886-3b4b-4d63-9058-4dc48b4f37c5" xlink:to="loc_rxrx_AffiliatedHoldersPotentialOwnershipPercentageWhenOutstandingEquityAwardsVest_ac9d6469-d15e-47b7-827f-8a268dda8b3c" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#CollaborativeDevelopmentContractsDetails"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_601288c0-6868-4410-a6fd-166d640f6363" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_758ee5ed-9413-427f-b4bd-c48d8534a08c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_601288c0-6868-4410-a6fd-166d640f6363" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_758ee5ed-9413-427f-b4bd-c48d8534a08c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_795553e4-7ff7-4cd7-9077-c3cf4ee0320f" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_758ee5ed-9413-427f-b4bd-c48d8534a08c" xlink:to="loc_srt_CounterpartyNameAxis_795553e4-7ff7-4cd7-9077-c3cf4ee0320f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_795553e4-7ff7-4cd7-9077-c3cf4ee0320f_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_795553e4-7ff7-4cd7-9077-c3cf4ee0320f" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_795553e4-7ff7-4cd7-9077-c3cf4ee0320f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5cac79af-4ee6-4636-8e2f-8a12e4ec50a6" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_795553e4-7ff7-4cd7-9077-c3cf4ee0320f" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5cac79af-4ee6-4636-8e2f-8a12e4ec50a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SanofiMember_f755e7d6-e153-4e1e-b80c-cfc35f7a8c2d" xlink:href="rxrx-20250930.xsd#rxrx_SanofiMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5cac79af-4ee6-4636-8e2f-8a12e4ec50a6" xlink:to="loc_rxrx_SanofiMember_f755e7d6-e153-4e1e-b80c-cfc35f7a8c2d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_MerckKGaAMerckMember_a32dda0d-3a8f-43dc-84e1-15134868020b" xlink:href="rxrx-20250930.xsd#rxrx_MerckKGaAMerckMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5cac79af-4ee6-4636-8e2f-8a12e4ec50a6" xlink:to="loc_rxrx_MerckKGaAMerckMember_a32dda0d-3a8f-43dc-84e1-15134868020b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RocheAndGenentechMember_56ebc793-e68f-4952-b577-44715e05b6de" xlink:href="rxrx-20250930.xsd#rxrx_RocheAndGenentechMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5cac79af-4ee6-4636-8e2f-8a12e4ec50a6" xlink:to="loc_rxrx_RocheAndGenentechMember_56ebc793-e68f-4952-b577-44715e05b6de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_5116a201-0802-45ea-93f4-77c25e4cd9e8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_758ee5ed-9413-427f-b4bd-c48d8534a08c" xlink:to="loc_us-gaap_TypeOfArrangementAxis_5116a201-0802-45ea-93f4-77c25e4cd9e8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_5116a201-0802-45ea-93f4-77c25e4cd9e8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_5116a201-0802-45ea-93f4-77c25e4cd9e8" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_5116a201-0802-45ea-93f4-77c25e4cd9e8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_862102f3-0459-4180-b061-95096b12e649" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_5116a201-0802-45ea-93f4-77c25e4cd9e8" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_862102f3-0459-4180-b061-95096b12e649" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_f28a4971-c0f5-4062-bcdd-5008ebff3be1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_862102f3-0459-4180-b061-95096b12e649" xlink:to="loc_us-gaap_CollaborativeArrangementMember_f28a4971-c0f5-4062-bcdd-5008ebff3be1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_MilestoneTypeAxis_44a21875-46ae-4808-bf74-3af33fa6f9af" xlink:href="rxrx-20250930.xsd#rxrx_MilestoneTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_758ee5ed-9413-427f-b4bd-c48d8534a08c" xlink:to="loc_rxrx_MilestoneTypeAxis_44a21875-46ae-4808-bf74-3af33fa6f9af" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_MilestoneTypeDomain_44a21875-46ae-4808-bf74-3af33fa6f9af_default" xlink:href="rxrx-20250930.xsd#rxrx_MilestoneTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rxrx_MilestoneTypeAxis_44a21875-46ae-4808-bf74-3af33fa6f9af" xlink:to="loc_rxrx_MilestoneTypeDomain_44a21875-46ae-4808-bf74-3af33fa6f9af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_MilestoneTypeDomain_a7654ac8-13b3-4b25-a263-97c127002338" xlink:href="rxrx-20250930.xsd#rxrx_MilestoneTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rxrx_MilestoneTypeAxis_44a21875-46ae-4808-bf74-3af33fa6f9af" xlink:to="loc_rxrx_MilestoneTypeDomain_a7654ac8-13b3-4b25-a263-97c127002338" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ResearchMilestonesMember_3e87210c-de06-4c62-93ab-4aa8a14b74f0" xlink:href="rxrx-20250930.xsd#rxrx_ResearchMilestonesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rxrx_MilestoneTypeDomain_a7654ac8-13b3-4b25-a263-97c127002338" xlink:to="loc_rxrx_ResearchMilestonesMember_3e87210c-de06-4c62-93ab-4aa8a14b74f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_DevelopmentAndRegulatoryMilestonesMember_71725e6b-0203-43ec-8a95-b4502d75b42d" xlink:href="rxrx-20250930.xsd#rxrx_DevelopmentAndRegulatoryMilestonesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rxrx_MilestoneTypeDomain_a7654ac8-13b3-4b25-a263-97c127002338" xlink:to="loc_rxrx_DevelopmentAndRegulatoryMilestonesMember_71725e6b-0203-43ec-8a95-b4502d75b42d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_DiscoveryDevelopmentAndSalesMilestonesMember_117aa0b4-f2b1-4886-9191-d4171938a4c3" xlink:href="rxrx-20250930.xsd#rxrx_DiscoveryDevelopmentAndSalesMilestonesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rxrx_MilestoneTypeDomain_a7654ac8-13b3-4b25-a263-97c127002338" xlink:to="loc_rxrx_DiscoveryDevelopmentAndSalesMilestonesMember_117aa0b4-f2b1-4886-9191-d4171938a4c3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RevenueRemainingPerformanceObligationAxis_c60dffea-f5a9-4fa0-8bb3-7dbf2e099d4a" xlink:href="rxrx-20250930.xsd#rxrx_RevenueRemainingPerformanceObligationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_758ee5ed-9413-427f-b4bd-c48d8534a08c" xlink:to="loc_rxrx_RevenueRemainingPerformanceObligationAxis_c60dffea-f5a9-4fa0-8bb3-7dbf2e099d4a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RevenueRemainingPerformanceObligationDomain_c60dffea-f5a9-4fa0-8bb3-7dbf2e099d4a_default" xlink:href="rxrx-20250930.xsd#rxrx_RevenueRemainingPerformanceObligationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rxrx_RevenueRemainingPerformanceObligationAxis_c60dffea-f5a9-4fa0-8bb3-7dbf2e099d4a" xlink:to="loc_rxrx_RevenueRemainingPerformanceObligationDomain_c60dffea-f5a9-4fa0-8bb3-7dbf2e099d4a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RevenueRemainingPerformanceObligationDomain_cc134f32-b2f6-4000-94fb-4c40dbe7aacc" xlink:href="rxrx-20250930.xsd#rxrx_RevenueRemainingPerformanceObligationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rxrx_RevenueRemainingPerformanceObligationAxis_c60dffea-f5a9-4fa0-8bb3-7dbf2e099d4a" xlink:to="loc_rxrx_RevenueRemainingPerformanceObligationDomain_cc134f32-b2f6-4000-94fb-4c40dbe7aacc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_PhenomapsCreationMember_adb75356-3590-4a6f-a2f9-083b2c7d33b6" xlink:href="rxrx-20250930.xsd#rxrx_PhenomapsCreationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rxrx_RevenueRemainingPerformanceObligationDomain_cc134f32-b2f6-4000-94fb-4c40dbe7aacc" xlink:to="loc_rxrx_PhenomapsCreationMember_adb75356-3590-4a6f-a2f9-083b2c7d33b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_PhenomapsRawImagesMember_e7319607-9b27-4246-a26f-3830197c3c40" xlink:href="rxrx-20250930.xsd#rxrx_PhenomapsRawImagesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rxrx_RevenueRemainingPerformanceObligationDomain_cc134f32-b2f6-4000-94fb-4c40dbe7aacc" xlink:to="loc_rxrx_PhenomapsRawImagesMember_e7319607-9b27-4246-a26f-3830197c3c40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_DevelopedAndCommercializedProgramsMember_f96f82aa-8a1c-4776-8f6e-389daf6c6a3c" xlink:href="rxrx-20250930.xsd#rxrx_DevelopedAndCommercializedProgramsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rxrx_RevenueRemainingPerformanceObligationDomain_cc134f32-b2f6-4000-94fb-4c40dbe7aacc" xlink:to="loc_rxrx_DevelopedAndCommercializedProgramsMember_f96f82aa-8a1c-4776-8f6e-389daf6c6a3c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_GastrointestinalCancerMember_d92ed997-4e54-4ff5-bfc6-b2328172ae95" xlink:href="rxrx-20250930.xsd#rxrx_GastrointestinalCancerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rxrx_RevenueRemainingPerformanceObligationDomain_cc134f32-b2f6-4000-94fb-4c40dbe7aacc" xlink:to="loc_rxrx_GastrointestinalCancerMember_d92ed997-4e54-4ff5-bfc6-b2328172ae95" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_NeuroscienceMember_c9fe0133-b520-4cd9-9380-30a5898a8462" xlink:href="rxrx-20250930.xsd#rxrx_NeuroscienceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rxrx_RevenueRemainingPerformanceObligationDomain_cc134f32-b2f6-4000-94fb-4c40dbe7aacc" xlink:to="loc_rxrx_NeuroscienceMember_c9fe0133-b520-4cd9-9380-30a5898a8462" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ContractWithCustomerNumberOfNovelSmallMoleculeCandidates_1fbde10b-0370-469c-9409-37f263ccd702" xlink:href="rxrx-20250930.xsd#rxrx_ContractWithCustomerNumberOfNovelSmallMoleculeCandidates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_601288c0-6868-4410-a6fd-166d640f6363" xlink:to="loc_rxrx_ContractWithCustomerNumberOfNovelSmallMoleculeCandidates_1fbde10b-0370-469c-9409-37f263ccd702" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_515512a7-c89b-493f-82ab-486a6df80be7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_601288c0-6868-4410-a6fd-166d640f6363" xlink:to="loc_us-gaap_ContractWithCustomerLiability_515512a7-c89b-493f-82ab-486a6df80be7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_559d699e-61fb-47ce-875b-83bd226ea042" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_601288c0-6868-4410-a6fd-166d640f6363" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_559d699e-61fb-47ce-875b-83bd226ea042" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_CollaborativeArrangementMilestonePaymentReceived_9df113c7-f7d4-4261-9cb6-8b1486aafb92" xlink:href="rxrx-20250930.xsd#rxrx_CollaborativeArrangementMilestonePaymentReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_601288c0-6868-4410-a6fd-166d640f6363" xlink:to="loc_rxrx_CollaborativeArrangementMilestonePaymentReceived_9df113c7-f7d4-4261-9cb6-8b1486aafb92" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RevenuePerformanceObligationNumberOfObligations_08f8803a-351d-42fb-bc4f-183d3a1441ad" xlink:href="rxrx-20250930.xsd#rxrx_RevenuePerformanceObligationNumberOfObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_601288c0-6868-4410-a6fd-166d640f6363" xlink:to="loc_rxrx_RevenuePerformanceObligationNumberOfObligations_08f8803a-351d-42fb-bc4f-183d3a1441ad" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_da21478e-8a53-47cb-8cd6-b90591003274" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_601288c0-6868-4410-a6fd-166d640f6363" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_da21478e-8a53-47cb-8cd6-b90591003274" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RevenueRemainingPerformanceObligationVariableConsiderationAmount_3791ce81-1b49-4355-a0ff-3de6c19898a3" xlink:href="rxrx-20250930.xsd#rxrx_RevenueRemainingPerformanceObligationVariableConsiderationAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_601288c0-6868-4410-a6fd-166d640f6363" xlink:to="loc_rxrx_RevenueRemainingPerformanceObligationVariableConsiderationAmount_3791ce81-1b49-4355-a0ff-3de6c19898a3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ContractWithCustomerMaximumAcceptedProduct_48e1e728-8d41-4063-8c76-aa2f334a53cc" xlink:href="rxrx-20250930.xsd#rxrx_ContractWithCustomerMaximumAcceptedProduct"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_601288c0-6868-4410-a6fd-166d640f6363" xlink:to="loc_rxrx_ContractWithCustomerMaximumAcceptedProduct_48e1e728-8d41-4063-8c76-aa2f334a53cc" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated_1f1531ab-d63c-489c-af69-eb9c30e51607" xlink:href="rxrx-20250930.xsd#rxrx_RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_601288c0-6868-4410-a6fd-166d640f6363" xlink:to="loc_rxrx_RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated_1f1531ab-d63c-489c-af69-eb9c30e51607" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_390eb85e-ef68-4650-a3a6-1111858b77d9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_f0f8bc14-379a-4500-802f-ba94b1825e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_601288c0-6868-4410-a6fd-166d640f6363" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_f0f8bc14-379a-4500-802f-ba94b1825e5a" xlink:type="arc" order="10"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.recursion.com/role/StockBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#StockBasedCompensationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/StockBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3a9e30fc-ef4f-4d70-9d36-e31317a82ec6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc5f8ba7-cc8d-4390-9d70-8e838e2da4ac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3a9e30fc-ef4f-4d70-9d36-e31317a82ec6" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc5f8ba7-cc8d-4390-9d70-8e838e2da4ac" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_4dbe2aea-1590-42d7-92d4-5a009eb096b1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc5f8ba7-cc8d-4390-9d70-8e838e2da4ac" xlink:to="loc_us-gaap_PlanNameAxis_4dbe2aea-1590-42d7-92d4-5a009eb096b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_4dbe2aea-1590-42d7-92d4-5a009eb096b1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_4dbe2aea-1590-42d7-92d4-5a009eb096b1" xlink:to="loc_us-gaap_PlanNameDomain_4dbe2aea-1590-42d7-92d4-5a009eb096b1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_30eb105e-3db4-407d-8222-e87e11c02e9f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_4dbe2aea-1590-42d7-92d4-5a009eb096b1" xlink:to="loc_us-gaap_PlanNameDomain_30eb105e-3db4-407d-8222-e87e11c02e9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_A2021EquityIncentivePlanMember_2f982c7f-3581-4c5c-bea7-b6478270aab0" xlink:href="rxrx-20250930.xsd#rxrx_A2021EquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_30eb105e-3db4-407d-8222-e87e11c02e9f" xlink:to="loc_rxrx_A2021EquityIncentivePlanMember_2f982c7f-3581-4c5c-bea7-b6478270aab0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_A2024InducementEquityIncentivePlanMember_9ac574e6-9225-4e27-a5b6-62fa77ee2c2d" xlink:href="rxrx-20250930.xsd#rxrx_A2024InducementEquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_30eb105e-3db4-407d-8222-e87e11c02e9f" xlink:to="loc_rxrx_A2024InducementEquityIncentivePlanMember_9ac574e6-9225-4e27-a5b6-62fa77ee2c2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_53f27a7f-6f78-4dba-8869-bc428854d8bb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc5f8ba7-cc8d-4390-9d70-8e838e2da4ac" xlink:to="loc_us-gaap_AwardTypeAxis_53f27a7f-6f78-4dba-8869-bc428854d8bb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_53f27a7f-6f78-4dba-8869-bc428854d8bb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_53f27a7f-6f78-4dba-8869-bc428854d8bb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_53f27a7f-6f78-4dba-8869-bc428854d8bb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6e147151-f0f3-46c1-a076-cb2be386ed7a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_53f27a7f-6f78-4dba-8869-bc428854d8bb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6e147151-f0f3-46c1-a076-cb2be386ed7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_e4a66c2b-c001-4e70-ac5f-fed78c6e2937" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6e147151-f0f3-46c1-a076-cb2be386ed7a" xlink:to="loc_us-gaap_EmployeeStockOptionMember_e4a66c2b-c001-4e70-ac5f-fed78c6e2937" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_5f2f27c2-e699-456f-a023-b08c1ced2b34" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6e147151-f0f3-46c1-a076-cb2be386ed7a" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_5f2f27c2-e699-456f-a023-b08c1ced2b34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_1d3c9d3e-2a5d-4e1e-84ba-702b63097a06" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3a9e30fc-ef4f-4d70-9d36-e31317a82ec6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_1d3c9d3e-2a5d-4e1e-84ba-702b63097a06" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_eecae285-62a4-4420-be7a-50d9588bcd77" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3a9e30fc-ef4f-4d70-9d36-e31317a82ec6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_eecae285-62a4-4420-be7a-50d9588bcd77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_4c90b6ae-5919-4b0e-8263-3cb0820e1282" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3a9e30fc-ef4f-4d70-9d36-e31317a82ec6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_4c90b6ae-5919-4b0e-8263-3cb0820e1282" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_8243990b-46ae-4dad-91c9-347d47690d99" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3a9e30fc-ef4f-4d70-9d36-e31317a82ec6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_8243990b-46ae-4dad-91c9-347d47690d99" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_afeeba54-42bc-4534-bd79-9645b3772464" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3a9e30fc-ef4f-4d70-9d36-e31317a82ec6" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_afeeba54-42bc-4534-bd79-9645b3772464" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dbe61d85-132c-4dfc-9b48-7be8f7c6d2d0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3a9e30fc-ef4f-4d70-9d36-e31317a82ec6" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dbe61d85-132c-4dfc-9b48-7be8f7c6d2d0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_362dd835-6f78-444e-8c59-2d5d9bfc3e3d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3a9e30fc-ef4f-4d70-9d36-e31317a82ec6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_362dd835-6f78-444e-8c59-2d5d9bfc3e3d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_a83cdb37-5ac1-4f69-8a8a-bb82607430a7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3a9e30fc-ef4f-4d70-9d36-e31317a82ec6" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_a83cdb37-5ac1-4f69-8a8a-bb82607430a7" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.recursion.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_8f12f4b1-cd32-4290-844d-b806e0a6f77e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_5ecf7dab-3fde-439f-960b-60b9aeef23f0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_8f12f4b1-cd32-4290-844d-b806e0a6f77e" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_5ecf7dab-3fde-439f-960b-60b9aeef23f0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_b82088b5-1451-4e09-84e2-3212aeea0b83" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_5ecf7dab-3fde-439f-960b-60b9aeef23f0" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_b82088b5-1451-4e09-84e2-3212aeea0b83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b82088b5-1451-4e09-84e2-3212aeea0b83_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b82088b5-1451-4e09-84e2-3212aeea0b83" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b82088b5-1451-4e09-84e2-3212aeea0b83_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_bbf32d7a-fa62-4627-b718-c43c56cf9b7d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b82088b5-1451-4e09-84e2-3212aeea0b83" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_bbf32d7a-fa62-4627-b718-c43c56cf9b7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_aa8a91f5-6f45-4be1-9397-127271cc79f8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bbf32d7a-fa62-4627-b718-c43c56cf9b7d" xlink:to="loc_us-gaap_CostOfSalesMember_aa8a91f5-6f45-4be1-9397-127271cc79f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_5b1c4a66-bce4-49ad-a885-a22b1239b107" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bbf32d7a-fa62-4627-b718-c43c56cf9b7d" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_5b1c4a66-bce4-49ad-a885-a22b1239b107" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_28aa269e-b9df-468c-af7d-6de6361cb01c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bbf32d7a-fa62-4627-b718-c43c56cf9b7d" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_28aa269e-b9df-468c-af7d-6de6361cb01c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_336e319e-b0b6-4bec-923d-687e679e43ec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_8f12f4b1-cd32-4290-844d-b806e0a6f77e" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_336e319e-b0b6-4bec-923d-687e679e43ec" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.recursion.com/role/StockBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoCalculateGrantDateFairValueofStockOptionsDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#StockBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoCalculateGrantDateFairValueofStockOptionsDetails"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/StockBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoCalculateGrantDateFairValueofStockOptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_54ffab9e-0c8f-41ba-9273-dc300b31513c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_39ad3a13-2fa4-427e-9da3-366f19cbc3cd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_54ffab9e-0c8f-41ba-9273-dc300b31513c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_39ad3a13-2fa4-427e-9da3-366f19cbc3cd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_be586a33-7d45-4199-babe-710f711876cf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_39ad3a13-2fa4-427e-9da3-366f19cbc3cd" xlink:to="loc_us-gaap_AwardTypeAxis_be586a33-7d45-4199-babe-710f711876cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_be586a33-7d45-4199-babe-710f711876cf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_be586a33-7d45-4199-babe-710f711876cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_be586a33-7d45-4199-babe-710f711876cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a67b1ab6-30c3-4cb8-855a-91f741b99327" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_be586a33-7d45-4199-babe-710f711876cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a67b1ab6-30c3-4cb8-855a-91f741b99327" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_1e71993f-c5ac-448b-b89a-1549dc28a1cb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a67b1ab6-30c3-4cb8-855a-91f741b99327" xlink:to="loc_us-gaap_EmployeeStockOptionMember_1e71993f-c5ac-448b-b89a-1549dc28a1cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_b950070b-e05e-4c0f-b2ad-7bb4ad812880" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_54ffab9e-0c8f-41ba-9273-dc300b31513c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_b950070b-e05e-4c0f-b2ad-7bb4ad812880" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2009fe16-672e-425d-b787-f48830f02d81" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_54ffab9e-0c8f-41ba-9273-dc300b31513c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2009fe16-672e-425d-b787-f48830f02d81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_801188a2-353a-4e64-a66a-98ce871fcf79" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_54ffab9e-0c8f-41ba-9273-dc300b31513c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_801188a2-353a-4e64-a66a-98ce871fcf79" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_a27096cc-4349-47fd-b0e0-52db9f9107db" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_54ffab9e-0c8f-41ba-9273-dc300b31513c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_a27096cc-4349-47fd-b0e0-52db9f9107db" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.recursion.com/role/StockBasedCompensationScheduleofRSUActivityDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#StockBasedCompensationScheduleofRSUActivityDetails"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/StockBasedCompensationScheduleofRSUActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_82b0d79a-a395-48a9-a945-cee86332fb2a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6083a7ca-85f0-4200-8dc4-30835fc94076" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_82b0d79a-a395-48a9-a945-cee86332fb2a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6083a7ca-85f0-4200-8dc4-30835fc94076" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e0d701ea-4dec-4ab7-9227-bc9be6fc8ad9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6083a7ca-85f0-4200-8dc4-30835fc94076" xlink:to="loc_us-gaap_AwardTypeAxis_e0d701ea-4dec-4ab7-9227-bc9be6fc8ad9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e0d701ea-4dec-4ab7-9227-bc9be6fc8ad9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_e0d701ea-4dec-4ab7-9227-bc9be6fc8ad9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e0d701ea-4dec-4ab7-9227-bc9be6fc8ad9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9883e7ef-0fec-4d70-8ba6-b6cc387b8a6b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_e0d701ea-4dec-4ab7-9227-bc9be6fc8ad9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9883e7ef-0fec-4d70-8ba6-b6cc387b8a6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_852143d2-9ec4-4203-85f1-b3d918d4c41e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9883e7ef-0fec-4d70-8ba6-b6cc387b8a6b" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_852143d2-9ec4-4203-85f1-b3d918d4c41e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_7f8d3631-60e6-429d-9490-c270c8ea10c5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_82b0d79a-a395-48a9-a945-cee86332fb2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_7f8d3631-60e6-429d-9490-c270c8ea10c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e6439d4c-ff67-484b-9ed9-72439c28e2ad" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_7f8d3631-60e6-429d-9490-c270c8ea10c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e6439d4c-ff67-484b-9ed9-72439c28e2ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_b6025f20-bc27-4148-b71d-791dc9c60aae" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_7f8d3631-60e6-429d-9490-c270c8ea10c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_b6025f20-bc27-4148-b71d-791dc9c60aae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_33faf5ee-84c7-468d-beb6-a7329699a951" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_7f8d3631-60e6-429d-9490-c270c8ea10c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_33faf5ee-84c7-468d-beb6-a7329699a951" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_f599dacd-a0fb-42f4-a988-41bc30dc745b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_7f8d3631-60e6-429d-9490-c270c8ea10c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_f599dacd-a0fb-42f4-a988-41bc30dc745b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_43399c82-9301-43c4-a9e9-371ea4e99792" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_cacc238c-6b84-4791-8144-514442fb9f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_82b0d79a-a395-48a9-a945-cee86332fb2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_cacc238c-6b84-4791-8144-514442fb9f8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_782058ca-43dd-41c7-8188-1836325bd405" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_cacc238c-6b84-4791-8144-514442fb9f8c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_782058ca-43dd-41c7-8188-1836325bd405" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e31b643b-5e41-44c1-affb-db6e9d28737b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_cacc238c-6b84-4791-8144-514442fb9f8c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e31b643b-5e41-44c1-affb-db6e9d28737b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_09597f4e-2129-4e64-8622-564ed46c78f6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_cacc238c-6b84-4791-8144-514442fb9f8c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_09597f4e-2129-4e64-8622-564ed46c78f6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_d5446cd1-bdb8-414e-9b8c-c8eb3b4bf473" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_cacc238c-6b84-4791-8144-514442fb9f8c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_d5446cd1-bdb8-414e-9b8c-c8eb3b4bf473" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3648fc2c-427c-44f6-bb3f-991d47791975" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.recursion.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossPerShareDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossPerShareDetails"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_110a8ea5-e373-44dd-aa70-efb10301bfcb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_67cfc461-cccf-48da-a162-52e573f52c4b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_110a8ea5-e373-44dd-aa70-efb10301bfcb" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_67cfc461-cccf-48da-a162-52e573f52c4b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f07363ab-4a2d-4c1c-ab99-9bf2d460a3c1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_67cfc461-cccf-48da-a162-52e573f52c4b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f07363ab-4a2d-4c1c-ab99-9bf2d460a3c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f07363ab-4a2d-4c1c-ab99-9bf2d460a3c1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f07363ab-4a2d-4c1c-ab99-9bf2d460a3c1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f07363ab-4a2d-4c1c-ab99-9bf2d460a3c1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_da5565f3-cfc5-4729-b722-4a9b8dbf33f2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f07363ab-4a2d-4c1c-ab99-9bf2d460a3c1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_da5565f3-cfc5-4729-b722-4a9b8dbf33f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_9ef78e90-f1b4-4056-a434-15c9ca8c36e2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_da5565f3-cfc5-4729-b722-4a9b8dbf33f2" xlink:to="loc_us-gaap_StockCompensationPlanMember_9ef78e90-f1b4-4056-a434-15c9ca8c36e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_TempusAgreementMember_61a06009-5ac8-4937-92bc-12e49c5fd387" xlink:href="rxrx-20250930.xsd#rxrx_TempusAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_da5565f3-cfc5-4729-b722-4a9b8dbf33f2" xlink:to="loc_rxrx_TempusAgreementMember_61a06009-5ac8-4937-92bc-12e49c5fd387" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ContingentStockRelatingToREVentures1AgreementMember_0ccb4d83-8efd-4c29-b5af-8e1d26b0302b" xlink:href="rxrx-20250930.xsd#rxrx_ContingentStockRelatingToREVentures1AgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_da5565f3-cfc5-4729-b722-4a9b8dbf33f2" xlink:to="loc_rxrx_ContingentStockRelatingToREVentures1AgreementMember_0ccb4d83-8efd-4c29-b5af-8e1d26b0302b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_77f0a209-ef85-4625-89a9-c263ea71167e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_110a8ea5-e373-44dd-aa70-efb10301bfcb" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_77f0a209-ef85-4625-89a9-c263ea71167e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_54bbba80-860b-4303-aa26-f86611482bfd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_8e2944ea-9d44-41ef-bc1e-b5f873c14eed" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_54bbba80-860b-4303-aa26-f86611482bfd" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_8e2944ea-9d44-41ef-bc1e-b5f873c14eed" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d4abe2e6-ee2e-44d7-859e-5c2af148ef79" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_8e2944ea-9d44-41ef-bc1e-b5f873c14eed" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d4abe2e6-ee2e-44d7-859e-5c2af148ef79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_d4abe2e6-ee2e-44d7-859e-5c2af148ef79_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d4abe2e6-ee2e-44d7-859e-5c2af148ef79" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_d4abe2e6-ee2e-44d7-859e-5c2af148ef79_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_ac9cafdc-c379-45be-aa00-c57aab77c572" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d4abe2e6-ee2e-44d7-859e-5c2af148ef79" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_ac9cafdc-c379-45be-aa00-c57aab77c572" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_4de91eca-6251-4435-a68b-5e0bcb5db277" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_ac9cafdc-c379-45be-aa00-c57aab77c572" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_4de91eca-6251-4435-a68b-5e0bcb5db277" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_43f847d7-67a0-45c0-8382-e50f0c257e3e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_8e2944ea-9d44-41ef-bc1e-b5f873c14eed" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_43f847d7-67a0-45c0-8382-e50f0c257e3e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_43f847d7-67a0-45c0-8382-e50f0c257e3e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_43f847d7-67a0-45c0-8382-e50f0c257e3e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_43f847d7-67a0-45c0-8382-e50f0c257e3e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c0fae41-4136-434a-ac6f-d3743f235175" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_43f847d7-67a0-45c0-8382-e50f0c257e3e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c0fae41-4136-434a-ac6f-d3743f235175" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_c1f0baf7-f7b4-4af4-adad-a877205e37bb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c0fae41-4136-434a-ac6f-d3743f235175" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_c1f0baf7-f7b4-4af4-adad-a877205e37bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_bee08c31-88f4-4bd1-8f38-116603adc841" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c0fae41-4136-434a-ac6f-d3743f235175" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_bee08c31-88f4-4bd1-8f38-116603adc841" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_9f6db1c9-7ac1-45f7-940d-7e5cfb9524fa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c0fae41-4136-434a-ac6f-d3743f235175" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_9f6db1c9-7ac1-45f7-940d-7e5cfb9524fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_61b9bab5-eae6-4663-8261-c7aa8893564c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_8e2944ea-9d44-41ef-bc1e-b5f873c14eed" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_61b9bab5-eae6-4663-8261-c7aa8893564c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_61b9bab5-eae6-4663-8261-c7aa8893564c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_61b9bab5-eae6-4663-8261-c7aa8893564c" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_61b9bab5-eae6-4663-8261-c7aa8893564c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_d8958e9b-d5e9-497b-ae1c-9661952cd560" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_61b9bab5-eae6-4663-8261-c7aa8893564c" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_d8958e9b-d5e9-497b-ae1c-9661952cd560" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember_87a83e0b-8b79-4add-8c4c-099dd93309fa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_d8958e9b-d5e9-497b-ae1c-9661952cd560" xlink:to="loc_us-gaap_CashMember_87a83e0b-8b79-4add-8c4c-099dd93309fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_a19c7a32-56fe-4b65-8b0f-3c96deca4a11" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_d8958e9b-d5e9-497b-ae1c-9661952cd560" xlink:to="loc_us-gaap_MoneyMarketFundsMember_a19c7a32-56fe-4b65-8b0f-3c96deca4a11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BankTimeDepositsMember_9d335dc3-6a6a-416a-b817-1deff3f77943" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BankTimeDepositsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_d8958e9b-d5e9-497b-ae1c-9661952cd560" xlink:to="loc_us-gaap_BankTimeDepositsMember_9d335dc3-6a6a-416a-b817-1deff3f77943" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_b4884ae7-3688-4cd9-8158-31580ff4a4b4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_54bbba80-860b-4303-aa26-f86611482bfd" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_b4884ae7-3688-4cd9-8158-31580ff4a4b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure_d74ef0d0-b5ee-45a4-9275-b712625449ec" xlink:href="rxrx-20250930.xsd#rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_54bbba80-860b-4303-aa26-f86611482bfd" xlink:to="loc_rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure_d74ef0d0-b5ee-45a4-9275-b712625449ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_504573fe-278d-4170-ae96-304a42ef1cfe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_54bbba80-860b-4303-aa26-f86611482bfd" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_504573fe-278d-4170-ae96-304a42ef1cfe" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.recursion.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_6338562f-7e87-4924-aa21-75cbd5d8f1d9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_2426cb59-6465-4649-8bbc-bdd06a32e06d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_6338562f-7e87-4924-aa21-75cbd5d8f1d9" xlink:to="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_2426cb59-6465-4649-8bbc-bdd06a32e06d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_151b7625-1815-4f45-8cfc-addec794eccf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_2426cb59-6465-4649-8bbc-bdd06a32e06d" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_151b7625-1815-4f45-8cfc-addec794eccf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_151b7625-1815-4f45-8cfc-addec794eccf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_151b7625-1815-4f45-8cfc-addec794eccf" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_151b7625-1815-4f45-8cfc-addec794eccf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_f7f765bf-1c64-4c04-ae68-efa231d742bc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_151b7625-1815-4f45-8cfc-addec794eccf" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_f7f765bf-1c64-4c04-ae68-efa231d742bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_9e5008c7-c5e1-4d6a-98e2-f43d15222269" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_f7f765bf-1c64-4c04-ae68-efa231d742bc" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_9e5008c7-c5e1-4d6a-98e2-f43d15222269" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember_d9e2be1b-7d6e-48f2-9ed7-9fe12ac2a515" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_9e5008c7-c5e1-4d6a-98e2-f43d15222269" xlink:to="loc_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember_d9e2be1b-7d6e-48f2-9ed7-9fe12ac2a515" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_682a3bbc-d779-4062-aaf3-8557bed41527" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_9e5008c7-c5e1-4d6a-98e2-f43d15222269" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_682a3bbc-d779-4062-aaf3-8557bed41527" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_bad3e18d-9591-4708-ad7e-15dbd04743c5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_2426cb59-6465-4649-8bbc-bdd06a32e06d" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_bad3e18d-9591-4708-ad7e-15dbd04743c5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_bad3e18d-9591-4708-ad7e-15dbd04743c5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_bad3e18d-9591-4708-ad7e-15dbd04743c5" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_bad3e18d-9591-4708-ad7e-15dbd04743c5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1079e6e3-5148-4b9e-985d-beeccdddb680" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_bad3e18d-9591-4708-ad7e-15dbd04743c5" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1079e6e3-5148-4b9e-985d-beeccdddb680" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_964fa74a-ecad-4619-9407-cb2f1c77a050" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1079e6e3-5148-4b9e-985d-beeccdddb680" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_964fa74a-ecad-4619-9407-cb2f1c77a050" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_187d8fe9-3589-412b-8e1c-59534b70e686" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_6338562f-7e87-4924-aa21-75cbd5d8f1d9" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_187d8fe9-3589-412b-8e1c-59534b70e686" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_44d6c131-9516-4023-a889-8d695bd9b8ac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_6338562f-7e87-4924-aa21-75cbd5d8f1d9" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_44d6c131-9516-4023-a889-8d695bd9b8ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_407c52dc-1888-4541-9b11-20d6743516d5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_6338562f-7e87-4924-aa21-75cbd5d8f1d9" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_407c52dc-1888-4541-9b11-20d6743516d5" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_8d7cd238-7319-4707-be17-3ed3db17b4c6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_dca97abd-195a-4052-a694-a371d7e930dd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8d7cd238-7319-4707-be17-3ed3db17b4c6" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_dca97abd-195a-4052-a694-a371d7e930dd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_70c46fef-f27a-42e1-9a91-b80fc2cc3ff2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_dca97abd-195a-4052-a694-a371d7e930dd" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_70c46fef-f27a-42e1-9a91-b80fc2cc3ff2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_70c46fef-f27a-42e1-9a91-b80fc2cc3ff2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_70c46fef-f27a-42e1-9a91-b80fc2cc3ff2" xlink:to="loc_us-gaap_SegmentDomain_70c46fef-f27a-42e1-9a91-b80fc2cc3ff2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_096872f4-e547-4c24-9d24-a2af0964940d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_70c46fef-f27a-42e1-9a91-b80fc2cc3ff2" xlink:to="loc_us-gaap_SegmentDomain_096872f4-e547-4c24-9d24-a2af0964940d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ReportableSegmentMember_7f3ab37c-378e-470d-87cc-d2b0599505d9" xlink:href="rxrx-20250930.xsd#rxrx_ReportableSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_096872f4-e547-4c24-9d24-a2af0964940d" xlink:to="loc_rxrx_ReportableSegmentMember_7f3ab37c-378e-470d-87cc-d2b0599505d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_74bfd8c4-2a70-4192-baab-12e0a15bb092" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8d7cd238-7319-4707-be17-3ed3db17b4c6" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_74bfd8c4-2a70-4192-baab-12e0a15bb092" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SignificantSegmentExpensesAbstract_309a5d67-b190-493f-9b05-cf2a59f872c3" xlink:href="rxrx-20250930.xsd#rxrx_SignificantSegmentExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8d7cd238-7319-4707-be17-3ed3db17b4c6" xlink:to="loc_rxrx_SignificantSegmentExpensesAbstract_309a5d67-b190-493f-9b05-cf2a59f872c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LaborAndRelatedExpense_2922f66b-b7b1-4fb8-8f49-22a94304fca0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LaborAndRelatedExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rxrx_SignificantSegmentExpensesAbstract_309a5d67-b190-493f-9b05-cf2a59f872c3" xlink:to="loc_us-gaap_LaborAndRelatedExpense_2922f66b-b7b1-4fb8-8f49-22a94304fca0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ConsumableExpense_1cbb5727-5190-4557-b297-7c3c9850cd28" xlink:href="rxrx-20250930.xsd#rxrx_ConsumableExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rxrx_SignificantSegmentExpensesAbstract_309a5d67-b190-493f-9b05-cf2a59f872c3" xlink:to="loc_rxrx_ConsumableExpense_1cbb5727-5190-4557-b297-7c3c9850cd28" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_PlatformFeeExpense_cb4dbf09-8818-4bac-b387-b9474929fb09" xlink:href="rxrx-20250930.xsd#rxrx_PlatformFeeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rxrx_SignificantSegmentExpensesAbstract_309a5d67-b190-493f-9b05-cf2a59f872c3" xlink:to="loc_rxrx_PlatformFeeExpense_cb4dbf09-8818-4bac-b387-b9474929fb09" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_DiscoveryExpense_847feb62-132c-4b32-acd4-b4aec38286c7" xlink:href="rxrx-20250930.xsd#rxrx_DiscoveryExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rxrx_SignificantSegmentExpensesAbstract_309a5d67-b190-493f-9b05-cf2a59f872c3" xlink:to="loc_rxrx_DiscoveryExpense_847feb62-132c-4b32-acd4-b4aec38286c7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ClinicalDevelopmentExpense_556a2dc9-1e62-4e5e-ad0e-df50426913f7" xlink:href="rxrx-20250930.xsd#rxrx_ClinicalDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rxrx_SignificantSegmentExpensesAbstract_309a5d67-b190-493f-9b05-cf2a59f872c3" xlink:to="loc_rxrx_ClinicalDevelopmentExpense_556a2dc9-1e62-4e5e-ad0e-df50426913f7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_5252dfb9-c51d-4696-9106-09450069effd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rxrx_SignificantSegmentExpensesAbstract_309a5d67-b190-493f-9b05-cf2a59f872c3" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_5252dfb9-c51d-4696-9106-09450069effd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount_6a95cece-aaa8-4dbd-85b2-01226bd64eeb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rxrx_SignificantSegmentExpensesAbstract_309a5d67-b190-493f-9b05-cf2a59f872c3" xlink:to="loc_us-gaap_SegmentReportingOtherItemAmount_6a95cece-aaa8-4dbd-85b2-01226bd64eeb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_1e3cc89d-c276-4022-b47b-8464216d278b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rxrx_SignificantSegmentExpensesAbstract_309a5d67-b190-493f-9b05-cf2a59f872c3" xlink:to="loc_us-gaap_OperatingIncomeLoss_1e3cc89d-c276-4022-b47b-8464216d278b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_ba469668-8214-4bc7-87dd-582aeac30bac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rxrx_SignificantSegmentExpensesAbstract_309a5d67-b190-493f-9b05-cf2a59f872c3" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_ba469668-8214-4bc7-87dd-582aeac30bac" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_31db4d9e-88a2-4119-b787-83c3a2b9d80d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rxrx_SignificantSegmentExpensesAbstract_309a5d67-b190-493f-9b05-cf2a59f872c3" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_31db4d9e-88a2-4119-b787-83c3a2b9d80d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9fd83ac6-8f0c-459b-90fa-d0846600f1e6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rxrx_SignificantSegmentExpensesAbstract_309a5d67-b190-493f-9b05-cf2a59f872c3" xlink:to="loc_us-gaap_NetIncomeLoss_9fd83ac6-8f0c-459b-90fa-d0846600f1e6" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SupplementalAssetInformationAbstract_bee42cd0-bbdb-467a-b716-7611228a15f0" xlink:href="rxrx-20250930.xsd#rxrx_SupplementalAssetInformationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8d7cd238-7319-4707-be17-3ed3db17b4c6" xlink:to="loc_rxrx_SupplementalAssetInformationAbstract_bee42cd0-bbdb-467a-b716-7611228a15f0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentExpenditureAdditionToLongLivedAssets_0ce015e9-d891-4bce-8b04-99b0532e38b4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentExpenditureAdditionToLongLivedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rxrx_SupplementalAssetInformationAbstract_bee42cd0-bbdb-467a-b716-7611228a15f0" xlink:to="loc_us-gaap_SegmentExpenditureAdditionToLongLivedAssets_0ce015e9-d891-4bce-8b04-99b0532e38b4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.recursion.com/role/SegmentInformationScheduleofRevenueandLongLivedAssetsBasedonGeographicAreasDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#SegmentInformationScheduleofRevenueandLongLivedAssetsBasedonGeographicAreasDetails"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/SegmentInformationScheduleofRevenueandLongLivedAssetsBasedonGeographicAreasDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_3b41a441-e15e-44a8-9a46-57ccd890a0b9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_4406b6fe-2b8c-442e-9648-4ce61cc0b0b0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_3b41a441-e15e-44a8-9a46-57ccd890a0b9" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_4406b6fe-2b8c-442e-9648-4ce61cc0b0b0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_49806c9f-9fed-4a99-a0d2-0f1585b5acf8" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_4406b6fe-2b8c-442e-9648-4ce61cc0b0b0" xlink:to="loc_srt_StatementGeographicalAxis_49806c9f-9fed-4a99-a0d2-0f1585b5acf8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_49806c9f-9fed-4a99-a0d2-0f1585b5acf8_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_49806c9f-9fed-4a99-a0d2-0f1585b5acf8" xlink:to="loc_srt_SegmentGeographicalDomain_49806c9f-9fed-4a99-a0d2-0f1585b5acf8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_99da0c53-278f-4c4e-8d2a-d955b029ba5c" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_49806c9f-9fed-4a99-a0d2-0f1585b5acf8" xlink:to="loc_srt_SegmentGeographicalDomain_99da0c53-278f-4c4e-8d2a-d955b029ba5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_39300a2c-258b-4243-9e87-fbe16528b1f1" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_99da0c53-278f-4c4e-8d2a-d955b029ba5c" xlink:to="loc_country_US_39300a2c-258b-4243-9e87-fbe16528b1f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_ea3f4410-de19-4b76-8931-1c3271e4f808" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_99da0c53-278f-4c4e-8d2a-d955b029ba5c" xlink:to="loc_country_GB_ea3f4410-de19-4b76-8931-1c3271e4f808" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_7a93c810-f2d5-4504-8202-0456b11bf5e0" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_99da0c53-278f-4c4e-8d2a-d955b029ba5c" xlink:to="loc_country_CA_7a93c810-f2d5-4504-8202-0456b11bf5e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_OtherCountriesMember_12224126-c15c-4dc9-90a1-a2c01bfd8e88" xlink:href="rxrx-20250930.xsd#rxrx_OtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_99da0c53-278f-4c4e-8d2a-d955b029ba5c" xlink:to="loc_rxrx_OtherCountriesMember_12224126-c15c-4dc9-90a1-a2c01bfd8e88" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e443f588-18ba-4ad0-be94-79954bd48e46" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_3b41a441-e15e-44a8-9a46-57ccd890a0b9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e443f588-18ba-4ad0-be94-79954bd48e46" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_5af5cd1a-6b3b-48f8-8a9f-c7064b5982e3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_3b41a441-e15e-44a8-9a46-57ccd890a0b9" xlink:to="loc_us-gaap_NoncurrentAssets_5af5cd1a-6b3b-48f8-8a9f-c7064b5982e3" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.recursion.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#SubsequentEventsDetails"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_519fa831-5b5d-492e-a5e0-91133da7c90b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_981445b9-13ce-40b6-8559-5a6f8b93c397" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_519fa831-5b5d-492e-a5e0-91133da7c90b" xlink:to="loc_us-gaap_SubsequentEventTable_981445b9-13ce-40b6-8559-5a6f8b93c397" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_41456a91-4a0d-4529-8b9e-ebe9317543d4" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_981445b9-13ce-40b6-8559-5a6f8b93c397" xlink:to="loc_srt_CounterpartyNameAxis_41456a91-4a0d-4529-8b9e-ebe9317543d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_41456a91-4a0d-4529-8b9e-ebe9317543d4_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_41456a91-4a0d-4529-8b9e-ebe9317543d4" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_41456a91-4a0d-4529-8b9e-ebe9317543d4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_de9fd3b2-aaf6-429f-9169-c899a3eb92d3" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_41456a91-4a0d-4529-8b9e-ebe9317543d4" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_de9fd3b2-aaf6-429f-9169-c899a3eb92d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RocheAndGenentechMember_bdf5dfc2-ce5e-4a52-bac9-6cff788be7f2" xlink:href="rxrx-20250930.xsd#rxrx_RocheAndGenentechMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_de9fd3b2-aaf6-429f-9169-c899a3eb92d3" xlink:to="loc_rxrx_RocheAndGenentechMember_bdf5dfc2-ce5e-4a52-bac9-6cff788be7f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_40d7b5cb-c39c-4df4-9efc-6bf618a6baf7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_981445b9-13ce-40b6-8559-5a6f8b93c397" xlink:to="loc_us-gaap_TypeOfArrangementAxis_40d7b5cb-c39c-4df4-9efc-6bf618a6baf7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_40d7b5cb-c39c-4df4-9efc-6bf618a6baf7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_40d7b5cb-c39c-4df4-9efc-6bf618a6baf7" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_40d7b5cb-c39c-4df4-9efc-6bf618a6baf7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_55a41bdc-ed60-4b00-a87a-d07571cfd92a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_40d7b5cb-c39c-4df4-9efc-6bf618a6baf7" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_55a41bdc-ed60-4b00-a87a-d07571cfd92a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_68946221-637f-4e47-a5a3-b646bca7183b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_55a41bdc-ed60-4b00-a87a-d07571cfd92a" xlink:to="loc_us-gaap_CollaborativeArrangementMember_68946221-637f-4e47-a5a3-b646bca7183b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_55d2df91-c415-4c7c-b37f-1dfaae87dd64" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_981445b9-13ce-40b6-8559-5a6f8b93c397" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_55d2df91-c415-4c7c-b37f-1dfaae87dd64" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_55d2df91-c415-4c7c-b37f-1dfaae87dd64_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_55d2df91-c415-4c7c-b37f-1dfaae87dd64" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_55d2df91-c415-4c7c-b37f-1dfaae87dd64_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_f4ef7f92-c164-4742-8faa-131b4ae48d0e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_55d2df91-c415-4c7c-b37f-1dfaae87dd64" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_f4ef7f92-c164-4742-8faa-131b4ae48d0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AtTheMarketOfferingProgramJefferiesMember_26aa0718-72b9-4bd3-abef-00ba4d97a9d6" xlink:href="rxrx-20250930.xsd#rxrx_AtTheMarketOfferingProgramJefferiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_f4ef7f92-c164-4742-8faa-131b4ae48d0e" xlink:to="loc_rxrx_AtTheMarketOfferingProgramJefferiesMember_26aa0718-72b9-4bd3-abef-00ba4d97a9d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AtTheMarketOfferingProgramCitiMember_0748e8a4-89d0-4867-828f-13db373071f4" xlink:href="rxrx-20250930.xsd#rxrx_AtTheMarketOfferingProgramCitiMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_f4ef7f92-c164-4742-8faa-131b4ae48d0e" xlink:to="loc_rxrx_AtTheMarketOfferingProgramCitiMember_0748e8a4-89d0-4867-828f-13db373071f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_43b263ab-4496-4237-b0fb-cfbb17381801" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_981445b9-13ce-40b6-8559-5a6f8b93c397" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_43b263ab-4496-4237-b0fb-cfbb17381801" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_43b263ab-4496-4237-b0fb-cfbb17381801_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_43b263ab-4496-4237-b0fb-cfbb17381801" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_43b263ab-4496-4237-b0fb-cfbb17381801_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_a333d4e3-1a98-4693-a727-d4678494b36c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_43b263ab-4496-4237-b0fb-cfbb17381801" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_a333d4e3-1a98-4693-a727-d4678494b36c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_5c27b9e1-5e06-41fd-b85d-cf3f35068ff3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_a333d4e3-1a98-4693-a727-d4678494b36c" xlink:to="loc_us-gaap_SubsequentEventMember_5c27b9e1-5e06-41fd-b85d-cf3f35068ff3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_b64b6020-a052-4331-b614-f07c0aeb03a5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_519fa831-5b5d-492e-a5e0-91133da7c90b" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_b64b6020-a052-4331-b614-f07c0aeb03a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_226f07e2-6811-4e1a-9b7d-6e14b64a49ad" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_519fa831-5b5d-492e-a5e0-91133da7c90b" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_226f07e2-6811-4e1a-9b7d-6e14b64a49ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_7b4c1c36-737c-482b-afc9-43dad3d077aa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_519fa831-5b5d-492e-a5e0-91133da7c90b" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_7b4c1c36-737c-482b-afc9-43dad3d077aa" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#IndividualsOnly"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_BlakeBorgesonMember_b3b9911c-e913-4feb-8601-988889f5d392" xlink:href="rxrx-20250930.xsd#rxrx_BlakeBorgesonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_rxrx_BlakeBorgesonMember_b3b9911c-e913-4feb-8601-988889f5d392" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_NajatKhanMember_ac0f1368-b08a-41c6-a42b-10c7db016f2d" xlink:href="rxrx-20250930.xsd#rxrx_NajatKhanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_rxrx_NajatKhanMember_ac0f1368-b08a-41c6-a42b-10c7db016f2d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_BenTaylorMember_cb99c907-94f3-44c7-a68a-bf60e6f65b34" xlink:href="rxrx-20250930.xsd#rxrx_BenTaylorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_rxrx_BenTaylorMember_cb99c907-94f3-44c7-a68a-bf60e6f65b34" xlink:type="arc" order="4"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>rxrx-20250930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:84e2dd81-95f3-479b-879b-c1ea33e5483d,g:a06efc1c-9b19-4722-bcb5-747c44bbab78-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_rxrx_DiscoveryExpense_71ddbdea-3d3c-4b94-91c3-972d1860b5bc_terseLabel_en-US" xlink:label="lab_rxrx_DiscoveryExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discovery</link:label>
    <link:label id="lab_rxrx_DiscoveryExpense_label_en-US" xlink:label="lab_rxrx_DiscoveryExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discovery Expense</link:label>
    <link:label id="lab_rxrx_DiscoveryExpense_documentation_en-US" xlink:label="lab_rxrx_DiscoveryExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Discovery Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_DiscoveryExpense" xlink:href="rxrx-20250930.xsd#rxrx_DiscoveryExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_DiscoveryExpense" xlink:to="lab_rxrx_DiscoveryExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_515b6920-0743-49d3-b405-a6ee05998110_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_AffiliatedHoldersOwnershipPercentage_443ed6c4-b0cd-4cf2-9c27-3ef77f336298_terseLabel_en-US" xlink:label="lab_rxrx_AffiliatedHoldersOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Affiliated holders, ownership percentage</link:label>
    <link:label id="lab_rxrx_AffiliatedHoldersOwnershipPercentage_label_en-US" xlink:label="lab_rxrx_AffiliatedHoldersOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Affiliated Holders, Ownership Percentage</link:label>
    <link:label id="lab_rxrx_AffiliatedHoldersOwnershipPercentage_documentation_en-US" xlink:label="lab_rxrx_AffiliatedHoldersOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Affiliated Holders, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AffiliatedHoldersOwnershipPercentage" xlink:href="rxrx-20250930.xsd#rxrx_AffiliatedHoldersOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_AffiliatedHoldersOwnershipPercentage" xlink:to="lab_rxrx_AffiliatedHoldersOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_13df2760-c459-4034-b6df-ef929f508a0b_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_ecc2b3fb-4c0e-4185-84f2-4196c1c93f6c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Asset Acquired, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_LicenseAgreementIncreaseDecreaseAccruedLiabilities_3494343f-eb2d-41bd-91dc-8cc210c4a5d5_terseLabel_en-US" xlink:label="lab_rxrx_LicenseAgreementIncreaseDecreaseAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">License Agreement, increase (decrease) prepaid expenses</link:label>
    <link:label id="lab_rxrx_LicenseAgreementIncreaseDecreaseAccruedLiabilities_label_en-US" xlink:label="lab_rxrx_LicenseAgreementIncreaseDecreaseAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License Agreement, Increase (Decrease) Accrued Liabilities</link:label>
    <link:label id="lab_rxrx_LicenseAgreementIncreaseDecreaseAccruedLiabilities_documentation_en-US" xlink:label="lab_rxrx_LicenseAgreementIncreaseDecreaseAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">License Agreement, Increase (Decrease) Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LicenseAgreementIncreaseDecreaseAccruedLiabilities" xlink:href="rxrx-20250930.xsd#rxrx_LicenseAgreementIncreaseDecreaseAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_LicenseAgreementIncreaseDecreaseAccruedLiabilities" xlink:to="lab_rxrx_LicenseAgreementIncreaseDecreaseAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_481cac86-35a4-4461-8df7-3ffc8ca964b1_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent" xlink:to="lab_us-gaap_RestrictedCashCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined</link:label>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_label_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgPredtrmndFlag" xlink:to="lab_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares_683f5969-d96b-4354-9802-6b2cc16d1c4d_terseLabel_en-US" xlink:label="lab_rxrx_BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity interest issued or issuable (in shares)</link:label>
    <link:label id="lab_rxrx_BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares_label_en-US" xlink:label="lab_rxrx_BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition , Contingent Consideration, Equity Interests Issuable, Number Of Shares</link:label>
    <link:label id="lab_rxrx_BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares_documentation_en-US" xlink:label="lab_rxrx_BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Acquisition , Contingent Consideration, Equity Interests Issuable, Number Of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares" xlink:href="rxrx-20250930.xsd#rxrx_BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares" xlink:to="lab_rxrx_BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_e8a4d871-96cb-4f7e-8d90-a9907f4ff923_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Intangible assets, gross</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_aa123541-80fe-478f-a824-97befdf863a1_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_6000c664-6868-4915-933d-22fd302e50ff_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional Paid-in-Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_PhenomapsRawImagesMember_61412cbc-8a48-42b0-95c6-740df9e6a4ae_terseLabel_en-US" xlink:label="lab_rxrx_PhenomapsRawImagesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Phenomaps Raw Images</link:label>
    <link:label id="lab_rxrx_PhenomapsRawImagesMember_label_en-US" xlink:label="lab_rxrx_PhenomapsRawImagesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Phenomaps Raw Images [Member]</link:label>
    <link:label id="lab_rxrx_PhenomapsRawImagesMember_documentation_en-US" xlink:label="lab_rxrx_PhenomapsRawImagesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Phenomaps Raw Images</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_PhenomapsRawImagesMember" xlink:href="rxrx-20250930.xsd#rxrx_PhenomapsRawImagesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_PhenomapsRawImagesMember" xlink:to="lab_rxrx_PhenomapsRawImagesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TabularListTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tabular List, Table</link:label>
    <link:label id="lab_ecd_TabularListTableTextBlock_label_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tabular List [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TabularListTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TabularListTableTextBlock" xlink:to="lab_ecd_TabularListTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_623f4d3e-3259-4c0d-be54-9d31e3ae1ac8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity interest issued or issuable (in shares)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interest, Share Issued, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_39d47b1f-d130-45dd-bcbb-11fd976d7483_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_51cb630f-8d32-48da-bedc-5691d85f45a8_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Decrease in cash related to disposal of a business</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Divestiture of Businesses, Net of Cash Divested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_466bb419-9215-44a4-a58a-cd0cabb76d51_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_b51daffd-5862-4b89-a7c2-d3bdef2854ef_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost incurred</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:to="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsStock_7e41eb4b-86b1-4732-a19c-5c8c69cc2bf9_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends declared</link:label>
    <link:label id="lab_us-gaap_DividendsStock_label_en-US" xlink:label="lab_us-gaap_DividendsStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends, Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsStock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DividendsStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsStock" xlink:to="lab_us-gaap_DividendsStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_30ac0a29-f9d9-4dcc-b47c-8c3d0a190008_totalLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Interest income, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Income (Expense), Nonoperating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_110398ed-a960-48e7-a1dd-db4d0828f10e_terseLabel_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock based compensation</link:label>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_label_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockCompensationPlanMember" xlink:to="lab_us-gaap_StockCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_fa71bc60-ba65-42be-8256-8a2bbef32a44_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrByIndTable_terseLabel_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual</link:label>
    <link:label id="lab_ecd_TradingArrByIndTable_label_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrByIndTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="lab_ecd_TradingArrByIndTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_f63e3098-8bad-4ddc-83bc-d78606434438_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_7ceb5c2a-4544-495b-8e79-f2d511e6e50c_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net loss per share of class A, B and Exchangeable common stock, basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_a7abddce-70f7-4d0d-943e-19da46a272a1_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss per share, basic (in dollars per shares)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAxis_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation:</link:label>
    <link:label id="lab_ecd_AdjToCompAxis_label_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="lab_ecd_AdjToCompAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_CollaborativeArrangementMilestonePaymentReceived_1418ac8e-b7e3-4f5d-9af4-33da91a4dc7b_terseLabel_en-US" xlink:label="lab_rxrx_CollaborativeArrangementMilestonePaymentReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Milestone payment received</link:label>
    <link:label id="lab_rxrx_CollaborativeArrangementMilestonePaymentReceived_label_en-US" xlink:label="lab_rxrx_CollaborativeArrangementMilestonePaymentReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Milestone Payment Received</link:label>
    <link:label id="lab_rxrx_CollaborativeArrangementMilestonePaymentReceived_documentation_en-US" xlink:label="lab_rxrx_CollaborativeArrangementMilestonePaymentReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Milestone Payment Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_CollaborativeArrangementMilestonePaymentReceived" xlink:href="rxrx-20250930.xsd#rxrx_CollaborativeArrangementMilestonePaymentReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_CollaborativeArrangementMilestonePaymentReceived" xlink:to="lab_rxrx_CollaborativeArrangementMilestonePaymentReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_label_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_LicenseAgreementTerm_dd2162ad-231c-4aae-9dde-9b0abe374833_terseLabel_en-US" xlink:label="lab_rxrx_LicenseAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">License agreement, term</link:label>
    <link:label id="lab_rxrx_LicenseAgreementTerm_label_en-US" xlink:label="lab_rxrx_LicenseAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License Agreement, Term</link:label>
    <link:label id="lab_rxrx_LicenseAgreementTerm_documentation_en-US" xlink:label="lab_rxrx_LicenseAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">License Agreement, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LicenseAgreementTerm" xlink:href="rxrx-20250930.xsd#rxrx_LicenseAgreementTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_LicenseAgreementTerm" xlink:to="lab_rxrx_LicenseAgreementTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_PublicOfferingOfCommonStockUnderwritingAgreementMember_e6118017-51bf-4a65-ac57-89f5eac557d0_terseLabel_en-US" xlink:label="lab_rxrx_PublicOfferingOfCommonStockUnderwritingAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Public Offering of Common Stock, Underwriting Agreement</link:label>
    <link:label id="lab_rxrx_PublicOfferingOfCommonStockUnderwritingAgreementMember_label_en-US" xlink:label="lab_rxrx_PublicOfferingOfCommonStockUnderwritingAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Public Offering Of Common Stock, Underwriting Agreement [Member]</link:label>
    <link:label id="lab_rxrx_PublicOfferingOfCommonStockUnderwritingAgreementMember_documentation_en-US" xlink:label="lab_rxrx_PublicOfferingOfCommonStockUnderwritingAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Public Offering Of Common Stock, Underwriting Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_PublicOfferingOfCommonStockUnderwritingAgreementMember" xlink:href="rxrx-20250930.xsd#rxrx_PublicOfferingOfCommonStockUnderwritingAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_PublicOfferingOfCommonStockUnderwritingAgreementMember" xlink:to="lab_rxrx_PublicOfferingOfCommonStockUnderwritingAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_c938f9c9-e937-445a-a700-25bfe3307c35_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock, Class of Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_31321efa-fb41-4775-aa29-233721779427_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Net Loss and Reconciliations of Segment Operating Loss to Loss Before Income Tax Benefit</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_FiniteLivedIntangibleAssetDiscountRate_ac0a694e-4637-48e4-86d6-91b4353fbd9f_terseLabel_en-US" xlink:label="lab_rxrx_FiniteLivedIntangibleAssetDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discount rate (as a percent)</link:label>
    <link:label id="lab_rxrx_FiniteLivedIntangibleAssetDiscountRate_label_en-US" xlink:label="lab_rxrx_FiniteLivedIntangibleAssetDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Discount Rate</link:label>
    <link:label id="lab_rxrx_FiniteLivedIntangibleAssetDiscountRate_documentation_en-US" xlink:label="lab_rxrx_FiniteLivedIntangibleAssetDiscountRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_FiniteLivedIntangibleAssetDiscountRate" xlink:href="rxrx-20250930.xsd#rxrx_FiniteLivedIntangibleAssetDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_FiniteLivedIntangibleAssetDiscountRate" xlink:to="lab_rxrx_FiniteLivedIntangibleAssetDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_335442fa-609b-4b71-bc91-8f20bfede2e8_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remaining performance obligation revenue</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
    <link:label id="lab_ecd_AdjToCompAmt_label_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAmt" xlink:to="lab_ecd_AdjToCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_CashPaidForAmountIncludedInTheMeasurementOfLeaseLiabilitiesAbstract_0f4d690c-fe0b-4146-9a1c-7a785dec0ea6_terseLabel_en-US" xlink:label="lab_rxrx_CashPaidForAmountIncludedInTheMeasurementOfLeaseLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash paid for amount included in the measurement of lease liabilities:</link:label>
    <link:label id="lab_rxrx_CashPaidForAmountIncludedInTheMeasurementOfLeaseLiabilitiesAbstract_label_en-US" xlink:label="lab_rxrx_CashPaidForAmountIncludedInTheMeasurementOfLeaseLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Paid For Amount Included In The Measurement Of Lease Liabilities [Abstract]</link:label>
    <link:label id="lab_rxrx_CashPaidForAmountIncludedInTheMeasurementOfLeaseLiabilitiesAbstract_documentation_en-US" xlink:label="lab_rxrx_CashPaidForAmountIncludedInTheMeasurementOfLeaseLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash Paid For Amount Included In The Measurement Of Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_CashPaidForAmountIncludedInTheMeasurementOfLeaseLiabilitiesAbstract" xlink:href="rxrx-20250930.xsd#rxrx_CashPaidForAmountIncludedInTheMeasurementOfLeaseLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_CashPaidForAmountIncludedInTheMeasurementOfLeaseLiabilitiesAbstract" xlink:to="lab_rxrx_CashPaidForAmountIncludedInTheMeasurementOfLeaseLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_f7fdda5c-6f2d-4b31-a2a5-5debcd94586b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other receivables and assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_085b3ef8-83a4-4a42-a182-7ba8188876f8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_b81a4847-a960-4248-9a73-ab99f7dd9b15_verboseLabel_en-US" xlink:label="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">U.S. income tax expense</link:label>
    <link:label id="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_label_en-US" xlink:label="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Federal Income Tax Expense (Benefit), Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:to="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_6d6d157d-a250-46e4-93d8-a6046f1b2d5c_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_08a85bbf-bc86-487d-90e0-0c43ab0f9c0d_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock based compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:to="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_261fb2cb-02ba-41ab-a68a-80f86972716c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_addf6629-5fa3-4179-a9cf-3484764a1746_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_08ab868f-000e-4a25-85b7-ecc92a258b00_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_083f951d-cb6c-46d0-b657-a9ca5ad85aaf_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_911da0a5-6536-4812-86c4-51e4be334eac_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_9ae8558f-ba08-4377-a10c-d0804a3004f9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_4ad8b1e6-38cb-439d-aa7f-14fe316b54ab_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss):</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingPoliciesProcLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_b6847b02-aa63-4d93-aa94-2aa60c41c5bc_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based payment arrangement, expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_SaleOfStockValueAuthorized_82f957af-483e-4170-afaa-dce3cf774e18_terseLabel_en-US" xlink:label="lab_rxrx_SaleOfStockValueAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of stock, value authorized</link:label>
    <link:label id="lab_rxrx_SaleOfStockValueAuthorized_label_en-US" xlink:label="lab_rxrx_SaleOfStockValueAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale Of Stock, Value, Authorized</link:label>
    <link:label id="lab_rxrx_SaleOfStockValueAuthorized_documentation_en-US" xlink:label="lab_rxrx_SaleOfStockValueAuthorized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sale Of Stock, Value, Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SaleOfStockValueAuthorized" xlink:href="rxrx-20250930.xsd#rxrx_SaleOfStockValueAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_SaleOfStockValueAuthorized" xlink:to="lab_rxrx_SaleOfStockValueAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_BenTaylorMember_label_en-US" xlink:label="lab_rxrx_BenTaylorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ben Taylor [Member]</link:label>
    <link:label id="lab_rxrx_BenTaylorMember_documentation_en-US" xlink:label="lab_rxrx_BenTaylorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Ben Taylor</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_BenTaylorMember" xlink:href="rxrx-20250930.xsd#rxrx_BenTaylorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_BenTaylorMember" xlink:to="lab_rxrx_BenTaylorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_16929b80-7498-414b-8e1b-26911d1e906b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_dcbac039-a894-44a8-81e2-aca756c1031b_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock sales issuances, net of issuance costs (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_a264259a-6f55-4722-8c8e-2c4b0b97bbc8_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_478b9ee3-9d96-4e2e-91d9-3049f2a9c746_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Cancelled (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_DurationOfTimeForPlaintiffToRefileClaim_906a5254-6be8-4bdc-865f-f0cdd9cc7a01_terseLabel_en-US" xlink:label="lab_rxrx_DurationOfTimeForPlaintiffToRefileClaim" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Duration of time for plaintiff to refile claim</link:label>
    <link:label id="lab_rxrx_DurationOfTimeForPlaintiffToRefileClaim_label_en-US" xlink:label="lab_rxrx_DurationOfTimeForPlaintiffToRefileClaim" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Duration Of Time For Plaintiff To Refile Claim</link:label>
    <link:label id="lab_rxrx_DurationOfTimeForPlaintiffToRefileClaim_documentation_en-US" xlink:label="lab_rxrx_DurationOfTimeForPlaintiffToRefileClaim" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Duration Of Time For Plaintiff To Refile Claim</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_DurationOfTimeForPlaintiffToRefileClaim" xlink:href="rxrx-20250930.xsd#rxrx_DurationOfTimeForPlaintiffToRefileClaim"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_DurationOfTimeForPlaintiffToRefileClaim" xlink:to="lab_rxrx_DurationOfTimeForPlaintiffToRefileClaim" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_26306e97-733f-444e-958a-f90fd4098779_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_ConsumableExpense_5ea14fe0-f482-485c-b240-a584382aa6fb_terseLabel_en-US" xlink:label="lab_rxrx_ConsumableExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consumables</link:label>
    <link:label id="lab_rxrx_ConsumableExpense_label_en-US" xlink:label="lab_rxrx_ConsumableExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consumable Expense</link:label>
    <link:label id="lab_rxrx_ConsumableExpense_documentation_en-US" xlink:label="lab_rxrx_ConsumableExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Consumable Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ConsumableExpense" xlink:href="rxrx-20250930.xsd#rxrx_ConsumableExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_ConsumableExpense" xlink:to="lab_rxrx_ConsumableExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_b91ba514-1245-41c2-9f10-79f2d70c37f0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_227402c3-b079-406f-8e67-1c69df67b940_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_NumberOfInProcessResearchAndDevelopmentAssets_f4304514-0082-4482-819d-3f7532c6a546_terseLabel_en-US" xlink:label="lab_rxrx_NumberOfInProcessResearchAndDevelopmentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of in-process research and development assets</link:label>
    <link:label id="lab_rxrx_NumberOfInProcessResearchAndDevelopmentAssets_label_en-US" xlink:label="lab_rxrx_NumberOfInProcessResearchAndDevelopmentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of In Process Research And Development Assets</link:label>
    <link:label id="lab_rxrx_NumberOfInProcessResearchAndDevelopmentAssets_documentation_en-US" xlink:label="lab_rxrx_NumberOfInProcessResearchAndDevelopmentAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of In Process Research And Development Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_NumberOfInProcessResearchAndDevelopmentAssets" xlink:href="rxrx-20250930.xsd#rxrx_NumberOfInProcessResearchAndDevelopmentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_NumberOfInProcessResearchAndDevelopmentAssets" xlink:to="lab_rxrx_NumberOfInProcessResearchAndDevelopmentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_9ae2919d-ff23-4650-b9ca-299cae2c36ab_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class A shares issued for asset acquisition (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_397d1e1f-49e0-4ce4-ab37-aa9b22814b6d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares&#160;</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_59408ca9-3a5b-41b4-8eec-a4313e618953_terseLabel_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Definite-lived licensed intangible assets</link:label>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_label_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Licensing Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicensingAgreementsMember" xlink:to="lab_us-gaap_LicensingAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_MaterialsReceivedNotInvoiced_ded485d6-457c-4412-b4ce-f186cb68816b_terseLabel_en-US" xlink:label="lab_rxrx_MaterialsReceivedNotInvoiced" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Materials received not invoiced</link:label>
    <link:label id="lab_rxrx_MaterialsReceivedNotInvoiced_label_en-US" xlink:label="lab_rxrx_MaterialsReceivedNotInvoiced" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Materials Received Not Invoiced</link:label>
    <link:label id="lab_rxrx_MaterialsReceivedNotInvoiced_documentation_en-US" xlink:label="lab_rxrx_MaterialsReceivedNotInvoiced" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Materials Received Not Invoiced</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_MaterialsReceivedNotInvoiced" xlink:href="rxrx-20250930.xsd#rxrx_MaterialsReceivedNotInvoiced"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_MaterialsReceivedNotInvoiced" xlink:to="lab_rxrx_MaterialsReceivedNotInvoiced" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9915f62b-0318-4632-ba5d-b104e2fb1fc7_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_26621f4a-ab5f-4150-abe4-f82c6f71485b_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_3920066f-21b0-4507-b3d7-e0e4437761ff_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_5a5bb6f9-bf85-4168-bfdd-21c6e05965b1_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_6a557059-b9bf-492c-bd14-b2b0bdfa5481_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_5421050c-5ff0-4614-8627-46112367a55c_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_abbc66a2-9715-4bf9-97a7-96c77ec4b2f3_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Useful life (in years)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentExpenditureAdditionToLongLivedAssets_22066909-cbda-4c31-9e6a-fb053b061bdb_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentExpenditureAdditionToLongLivedAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total expenditures for additions to long-lived assets</link:label>
    <link:label id="lab_us-gaap_SegmentExpenditureAdditionToLongLivedAssets_label_en-US" xlink:label="lab_us-gaap_SegmentExpenditureAdditionToLongLivedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment, Expenditure, Addition to Long-Lived Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentExpenditureAdditionToLongLivedAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentExpenditureAdditionToLongLivedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentExpenditureAdditionToLongLivedAssets" xlink:to="lab_us-gaap_SegmentExpenditureAdditionToLongLivedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_15f7295b-d237-4bf5-a551-e029f1aa9ebb_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net carrying amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c41d9e9f-e128-4464-b1ed-c0a29c8b28a6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_ContingentStockRelatingToREVentures1AgreementMember_f6698dfc-3d80-418f-aac1-61ffc3386406_terseLabel_en-US" xlink:label="lab_rxrx_ContingentStockRelatingToREVentures1AgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent stock relating to RE Ventures I transaction</link:label>
    <link:label id="lab_rxrx_ContingentStockRelatingToREVentures1AgreementMember_label_en-US" xlink:label="lab_rxrx_ContingentStockRelatingToREVentures1AgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent Stock Relating To RE Ventures 1 Agreement [Member]</link:label>
    <link:label id="lab_rxrx_ContingentStockRelatingToREVentures1AgreementMember_documentation_en-US" xlink:label="lab_rxrx_ContingentStockRelatingToREVentures1AgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contingent Stock Relating To RE Ventures 1 Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ContingentStockRelatingToREVentures1AgreementMember" xlink:href="rxrx-20250930.xsd#rxrx_ContingentStockRelatingToREVentures1AgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_ContingentStockRelatingToREVentures1AgreementMember" xlink:to="lab_rxrx_ContingentStockRelatingToREVentures1AgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_4eaff769-13fa-4e27-a4bf-79bba0b82d68_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair market value of vested shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PayVsPerformanceDisclosureLineItems_label_en-US" xlink:label="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_AccruedDevelopmentCostsCurrent_d3056888-92a3-495c-b562-1caf363131bb_terseLabel_en-US" xlink:label="lab_rxrx_AccruedDevelopmentCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued development expenses</link:label>
    <link:label id="lab_rxrx_AccruedDevelopmentCostsCurrent_label_en-US" xlink:label="lab_rxrx_AccruedDevelopmentCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Development Costs, Current</link:label>
    <link:label id="lab_rxrx_AccruedDevelopmentCostsCurrent_documentation_en-US" xlink:label="lab_rxrx_AccruedDevelopmentCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Development Costs, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AccruedDevelopmentCostsCurrent" xlink:href="rxrx-20250930.xsd#rxrx_AccruedDevelopmentCostsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_AccruedDevelopmentCostsCurrent" xlink:to="lab_rxrx_AccruedDevelopmentCostsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_8eb10301-fca2-4903-a7d4-9f5931c75844_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_97826e70-a517-452b-8c42-49f602533ef8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:to="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_dd810fa8-6260-4b76-b16b-97a0959d4a4f_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Loss before income tax benefit</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_20eaa27b-78e6-456e-bf44-0583cd14c691_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_417223d8-68a7-42ab-be1d-ef8621e4c296_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Long-Lived Assets Based on Geographic Areas</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_1c21918b-cc81-4177-b7a3-55cd516f8f88_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other liabilities, non-current</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_ca21a76f-78d2-4347-ae5b-2e2350faac99_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_28bf6c15-a10f-4bdb-aca7-232a283a2d94_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remaining operating lease term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureAmt" xlink:to="lab_ecd_CoSelectedMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_ff4a4372-1ff9-499b-8bfc-d60720ffbf30_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeNonoperating_000660e6-a2fb-4e9e-b303-f920f8c8f684_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNonoperating" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeNonoperating_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNonoperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment Income, Nonoperating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNonoperating" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeNonoperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeNonoperating" xlink:to="lab_us-gaap_InvestmentIncomeNonoperating" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1d62ec9f-6a27-4c0a-a5f1-9fdb2e445ccc_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureName_terseLabel_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_MeasureName_label_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureName" xlink:to="lab_ecd_MeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_AssetAcquisitionContingentConsiderationEquityInterestIssuedAndIssuable_c9feb66b-c29a-49cf-98c9-5928dc4339dd_terseLabel_en-US" xlink:label="lab_rxrx_AssetAcquisitionContingentConsiderationEquityInterestIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recursion Class A common stock</link:label>
    <link:label id="lab_rxrx_AssetAcquisitionContingentConsiderationEquityInterestIssuedAndIssuable_label_en-US" xlink:label="lab_rxrx_AssetAcquisitionContingentConsiderationEquityInterestIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition, Contingent Consideration, Equity Interest Issued and Issuable</link:label>
    <link:label id="lab_rxrx_AssetAcquisitionContingentConsiderationEquityInterestIssuedAndIssuable_documentation_en-US" xlink:label="lab_rxrx_AssetAcquisitionContingentConsiderationEquityInterestIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Asset Acquisition, Contingent Consideration, Equity Interest Issued and Issuable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AssetAcquisitionContingentConsiderationEquityInterestIssuedAndIssuable" xlink:href="rxrx-20250930.xsd#rxrx_AssetAcquisitionContingentConsiderationEquityInterestIssuedAndIssuable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_AssetAcquisitionContingentConsiderationEquityInterestIssuedAndIssuable" xlink:to="lab_rxrx_AssetAcquisitionContingentConsiderationEquityInterestIssuedAndIssuable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_960a3cf2-90ca-431b-93e6-d6fed9bd0952_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance as of December 31, 2024</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_e6505c41-3cbb-4068-9515-2add6a2bab65_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance as of September 30, 2025</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_LicenseAgreementAnnualPayments_75830da8-4f72-45dc-bd57-483cfe94b588_terseLabel_en-US" xlink:label="lab_rxrx_LicenseAgreementAnnualPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Annual payments</link:label>
    <link:label id="lab_rxrx_LicenseAgreementAnnualPayments_label_en-US" xlink:label="lab_rxrx_LicenseAgreementAnnualPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License Agreement, Annual Payments</link:label>
    <link:label id="lab_rxrx_LicenseAgreementAnnualPayments_documentation_en-US" xlink:label="lab_rxrx_LicenseAgreementAnnualPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">License Agreement, Annual Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LicenseAgreementAnnualPayments" xlink:href="rxrx-20250930.xsd#rxrx_LicenseAgreementAnnualPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_LicenseAgreementAnnualPayments" xlink:to="lab_rxrx_LicenseAgreementAnnualPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_RevenueRemainingPerformanceObligationVariableConsiderationAmount_909f2b00-4866-43fe-a0db-4d3e83bfa7a0_terseLabel_en-US" xlink:label="lab_rxrx_RevenueRemainingPerformanceObligationVariableConsiderationAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research project, fees and milestones payments receivable for an option on a lead series</link:label>
    <link:label id="lab_rxrx_RevenueRemainingPerformanceObligationVariableConsiderationAmount_label_en-US" xlink:label="lab_rxrx_RevenueRemainingPerformanceObligationVariableConsiderationAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Variable Consideration Amount</link:label>
    <link:label id="lab_rxrx_RevenueRemainingPerformanceObligationVariableConsiderationAmount_documentation_en-US" xlink:label="lab_rxrx_RevenueRemainingPerformanceObligationVariableConsiderationAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Variable Consideration Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RevenueRemainingPerformanceObligationVariableConsiderationAmount" xlink:href="rxrx-20250930.xsd#rxrx_RevenueRemainingPerformanceObligationVariableConsiderationAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_RevenueRemainingPerformanceObligationVariableConsiderationAmount" xlink:to="lab_rxrx_RevenueRemainingPerformanceObligationVariableConsiderationAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_b1b0f1f9-ff6c-4123-adfa-54a1ebd86519_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock-Based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_cbc59605-89e4-47da-a9cc-39da9a5d2a33_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_da7c0010-0bdb-4395-84ec-55174ea1ff62_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_5d7ad128-c5ef-44fe-9c3e-40da730b7a1a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_043bd15d-069d-460e-880f-969095e20d69_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Method</link:label>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMethodTextBlock" xlink:to="lab_ecd_AwardTmgMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_ExscientiaGmbHMember_eadd36d3-5214-4a9a-a8ea-25a887749a1b_terseLabel_en-US" xlink:label="lab_rxrx_ExscientiaGmbHMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exscientia GmbH</link:label>
    <link:label id="lab_rxrx_ExscientiaGmbHMember_label_en-US" xlink:label="lab_rxrx_ExscientiaGmbHMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exscientia GmbH [Member]</link:label>
    <link:label id="lab_rxrx_ExscientiaGmbHMember_documentation_en-US" xlink:label="lab_rxrx_ExscientiaGmbHMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Exscientia GmbH</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ExscientiaGmbHMember" xlink:href="rxrx-20250930.xsd#rxrx_ExscientiaGmbHMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_ExscientiaGmbHMember" xlink:to="lab_rxrx_ExscientiaGmbHMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_32083deb-4fa3-4f98-8721-6f1aef9843a3_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_5d7e0e8f-1989-4387-b535-0d1b8f395df9_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unearned revenue, non-current</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_b44a0ab8-b360-4154-8c83-917683458c79_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Pro Forma Financial Information</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Pro Forma Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_b62cd012-8fc5-48e5-8810-f78ab8631214_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_4c0422b2-7ffb-4496-88bd-a82561b62a24_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_eaece846-b3ff-4abe-a101-1023f3f36e02_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember_83c5c465-0518-4983-9b76-c7d5f74892ef_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Book values</link:label>
    <link:label id="lab_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Portion at Other than Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_0848051f-963e-4ec1-ba1e-c0c285497945_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_0ca81528-7903-4873-8a04-045786b8a4dd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_c13a36f6-31b5-45f8-96a0-0fbc8e9489a7_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_A2024InducementEquityIncentivePlanMember_419b2dd5-7cfa-46a5-89eb-6dce41f91b5f_terseLabel_en-US" xlink:label="lab_rxrx_A2024InducementEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2024 Inducement Equity Incentive Plan</link:label>
    <link:label id="lab_rxrx_A2024InducementEquityIncentivePlanMember_label_en-US" xlink:label="lab_rxrx_A2024InducementEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2024 Inducement Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_rxrx_A2024InducementEquityIncentivePlanMember_documentation_en-US" xlink:label="lab_rxrx_A2024InducementEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2024 Inducement Equity Incentive Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_A2024InducementEquityIncentivePlanMember" xlink:href="rxrx-20250930.xsd#rxrx_A2024InducementEquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_A2024InducementEquityIncentivePlanMember" xlink:to="lab_rxrx_A2024InducementEquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_IncreaseDecreaseInRightOfUseAssetsForFinanceLeases_63106142-962c-48c0-8fb1-4376eee139ab_verboseLabel_en-US" xlink:label="lab_rxrx_IncreaseDecreaseInRightOfUseAssetsForFinanceLeases" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Increase (decrease) in finance lease right-of-use assets</link:label>
    <link:label id="lab_rxrx_IncreaseDecreaseInRightOfUseAssetsForFinanceLeases_ff30a069-8a8b-4b09-b5c4-34afbb9aee78_terseLabel_en-US" xlink:label="lab_rxrx_IncreaseDecreaseInRightOfUseAssetsForFinanceLeases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financing leases</link:label>
    <link:label id="lab_rxrx_IncreaseDecreaseInRightOfUseAssetsForFinanceLeases_label_en-US" xlink:label="lab_rxrx_IncreaseDecreaseInRightOfUseAssetsForFinanceLeases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Right Of Use Assets For Finance Leases</link:label>
    <link:label id="lab_rxrx_IncreaseDecreaseInRightOfUseAssetsForFinanceLeases_documentation_en-US" xlink:label="lab_rxrx_IncreaseDecreaseInRightOfUseAssetsForFinanceLeases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Right Of Use Assets For Finance Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_IncreaseDecreaseInRightOfUseAssetsForFinanceLeases" xlink:href="rxrx-20250930.xsd#rxrx_IncreaseDecreaseInRightOfUseAssetsForFinanceLeases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_IncreaseDecreaseInRightOfUseAssetsForFinanceLeases" xlink:to="lab_rxrx_IncreaseDecreaseInRightOfUseAssetsForFinanceLeases" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_LicenseAgreementAggregatePayments_86608d1b-9b72-4154-b6cd-b60707bf8255_terseLabel_en-US" xlink:label="lab_rxrx_LicenseAgreementAggregatePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate amount payable in cash or equity</link:label>
    <link:label id="lab_rxrx_LicenseAgreementAggregatePayments_label_en-US" xlink:label="lab_rxrx_LicenseAgreementAggregatePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License Agreement, Aggregate Payments</link:label>
    <link:label id="lab_rxrx_LicenseAgreementAggregatePayments_documentation_en-US" xlink:label="lab_rxrx_LicenseAgreementAggregatePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">License Agreement, Aggregate Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LicenseAgreementAggregatePayments" xlink:href="rxrx-20250930.xsd#rxrx_LicenseAgreementAggregatePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_LicenseAgreementAggregatePayments" xlink:to="lab_rxrx_LicenseAgreementAggregatePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_AccruedEarlyDiscoveryExpensesCurrent_d6a3560a-674b-4404-b387-a8cf76a2dbd7_terseLabel_en-US" xlink:label="lab_rxrx_AccruedEarlyDiscoveryExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued early discovery expenses</link:label>
    <link:label id="lab_rxrx_AccruedEarlyDiscoveryExpensesCurrent_label_en-US" xlink:label="lab_rxrx_AccruedEarlyDiscoveryExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Early Discovery Expenses, Current</link:label>
    <link:label id="lab_rxrx_AccruedEarlyDiscoveryExpensesCurrent_documentation_en-US" xlink:label="lab_rxrx_AccruedEarlyDiscoveryExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Early Discovery Expenses, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AccruedEarlyDiscoveryExpensesCurrent" xlink:href="rxrx-20250930.xsd#rxrx_AccruedEarlyDiscoveryExpensesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_AccruedEarlyDiscoveryExpensesCurrent" xlink:to="lab_rxrx_AccruedEarlyDiscoveryExpensesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_ef35f8f4-9681-42b4-bc10-73981e12b0a7_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock option exercises and other (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_565cbd8b-aea5-47fc-9582-eea5d4558d07_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_NumberOfAcquiredCustomerContractsWithContractLiabilities_6c69861c-ede1-4b0c-8a48-59e52a99fe8a_terseLabel_en-US" xlink:label="lab_rxrx_NumberOfAcquiredCustomerContractsWithContractLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of acquired customer contracts with contract liabilities</link:label>
    <link:label id="lab_rxrx_NumberOfAcquiredCustomerContractsWithContractLiabilities_label_en-US" xlink:label="lab_rxrx_NumberOfAcquiredCustomerContractsWithContractLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Acquired Customer Contracts With Contract Liabilities</link:label>
    <link:label id="lab_rxrx_NumberOfAcquiredCustomerContractsWithContractLiabilities_documentation_en-US" xlink:label="lab_rxrx_NumberOfAcquiredCustomerContractsWithContractLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Acquired Customer Contracts With Contract Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_NumberOfAcquiredCustomerContractsWithContractLiabilities" xlink:href="rxrx-20250930.xsd#rxrx_NumberOfAcquiredCustomerContractsWithContractLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_NumberOfAcquiredCustomerContractsWithContractLiabilities" xlink:to="lab_rxrx_NumberOfAcquiredCustomerContractsWithContractLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_818df774-5652-48dd-8245-624abc860702_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingOtherItemAmount_63995740-5800-4d88-bbdc-57c12698ed20_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingOtherItemAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other segment items</link:label>
    <link:label id="lab_us-gaap_SegmentReportingOtherItemAmount_label_en-US" xlink:label="lab_us-gaap_SegmentReportingOtherItemAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting, Other Segment Item, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingOtherItemAmount" xlink:to="lab_us-gaap_SegmentReportingOtherItemAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_RevenueRemainingPerformanceObligationAxis_f70f3656-09e6-4680-a03d-befc3c977227_terseLabel_en-US" xlink:label="lab_rxrx_RevenueRemainingPerformanceObligationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation [Axis]</link:label>
    <link:label id="lab_rxrx_RevenueRemainingPerformanceObligationAxis_label_en-US" xlink:label="lab_rxrx_RevenueRemainingPerformanceObligationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation [Axis]</link:label>
    <link:label id="lab_rxrx_RevenueRemainingPerformanceObligationAxis_documentation_en-US" xlink:label="lab_rxrx_RevenueRemainingPerformanceObligationAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RevenueRemainingPerformanceObligationAxis" xlink:href="rxrx-20250930.xsd#rxrx_RevenueRemainingPerformanceObligationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_RevenueRemainingPerformanceObligationAxis" xlink:to="lab_rxrx_RevenueRemainingPerformanceObligationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d2ba75ca-85c0-4d88-998e-8cceda2c0979_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of exchange rate changes on cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_2bfa0a4a-cead-4a65-8085-75bd92b65742_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_5d247ceb-7df7-4387-99bb-a55dc753db01_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">RSUs</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_8ba0acac-5369-48ba-bfb6-2a61b68457f0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business combination, consideration transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_fbbce415-00f9-42ab-85b0-baf5db5c7813_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_6207e7d8-09ce-42ba-b780-d766385025c8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchase of an intangible asset</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_1e569699-99ac-46e7-bd90-c1f04a6ec130_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c988fd8d-2c17-4b4e-be3b-a3a23c488e5f_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_bd5825ae-2360-4a48-971b-a47f4694710b_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</link:label>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:to="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_865ca78b-7916-4445-a838-fc577dc79b9a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_513f01d7-eec0-443b-ac8d-56e63b3713e2_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity method investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_cce38aac-865d-4d60-acf2-357e4f261189_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_6e021448-f298-46fa-b789-dc6c3a998e05_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indefinite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_e646ce8b-05df-4fc3-8f06-d7cd13f53942_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combination [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_RevenuePerformanceObligationNumberOfObligations_a9f12bac-497f-4fd5-9233-7105ca2e6307_terseLabel_en-US" xlink:label="lab_rxrx_RevenuePerformanceObligationNumberOfObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of performance obligations under the agreement (in performance obligations)</link:label>
    <link:label id="lab_rxrx_RevenuePerformanceObligationNumberOfObligations_label_en-US" xlink:label="lab_rxrx_RevenuePerformanceObligationNumberOfObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Performance Obligation, Number Of Obligations</link:label>
    <link:label id="lab_rxrx_RevenuePerformanceObligationNumberOfObligations_documentation_en-US" xlink:label="lab_rxrx_RevenuePerformanceObligationNumberOfObligations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revenue, Performance Obligation, Number Of Obligations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RevenuePerformanceObligationNumberOfObligations" xlink:href="rxrx-20250930.xsd#rxrx_RevenuePerformanceObligationNumberOfObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_RevenuePerformanceObligationNumberOfObligations" xlink:to="lab_rxrx_RevenuePerformanceObligationNumberOfObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_3a4f0e47-c734-4b0a-91d5-8279f68af2e0_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Common sock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_5d176c27-93db-48bf-9f82-e559fd0627c2_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_751139b6-1122-434f-8ad3-2f490a93293c_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_d1c57db9-e6ad-498f-bf5b-12668b817eb0_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure_534eedf2-7ad4-4361-bac3-9b4a5eb7ce2c_terseLabel_en-US" xlink:label="lab_rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash And Cash Equivalents, Fair Value Disclosure</link:label>
    <link:label id="lab_rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure_documentation_en-US" xlink:label="lab_rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Restricted Cash And Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure" xlink:href="rxrx-20250930.xsd#rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_a97eb37e-d043-41ce-bee4-e3676ec41081_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoMember_terseLabel_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO</link:label>
    <link:label id="lab_ecd_PeoMember_label_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoMember" xlink:to="lab_ecd_PeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_95889ffa-7f3b-4a93-8285-95d18bcf1a06_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental schedule of non-cash investing and financing activities</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_9ca81a11-ac3c-401d-8145-c86c87923007_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_aa0d7dd4-6497-479e-82d8-5586047841c6_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year</link:label>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_label_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:to="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_aaeb62d8-9d18-40d3-af37-664fa76aef36_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_MerckKGaAMerckMember_093c5e33-45b2-434b-a4da-d9b6e61c9e85_terseLabel_en-US" xlink:label="lab_rxrx_MerckKGaAMerckMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Merck KGaA (Merck)</link:label>
    <link:label id="lab_rxrx_MerckKGaAMerckMember_label_en-US" xlink:label="lab_rxrx_MerckKGaAMerckMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Merck KGaA (Merck) [Member]</link:label>
    <link:label id="lab_rxrx_MerckKGaAMerckMember_documentation_en-US" xlink:label="lab_rxrx_MerckKGaAMerckMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Merck KGaA (Merck)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_MerckKGaAMerckMember" xlink:href="rxrx-20250930.xsd#rxrx_MerckKGaAMerckMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_MerckKGaAMerckMember" xlink:to="lab_rxrx_MerckKGaAMerckMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_48caf0f4-78be-45c2-a38c-30f360258a10_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_1d6c2d2c-79a1-44df-af67-c5093249fc02_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDeterminationDate_terseLabel_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:label id="lab_ecd_RestatementDeterminationDate_label_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDeterminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDeterminationDate" xlink:to="lab_ecd_RestatementDeterminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_71f205ea-791b-477a-9ed0-b7de1f69dc22_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents and restricted cash, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d269e755-abdc-4a11-857a-c03f235fd216_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents and restricted cash, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_c12e33de-df53-4f82-abe0-dc6a67a724aa_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Income tax benefit (expense)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonClassBMember_f6feb53a-6f85-405d-9be7-b0670391a40c_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonClassBMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Class B Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonClassBMember_8c52864e-f9ef-4f48-97d7-b9355df87935_terseLabel_en-US" xlink:label="lab_us-gaap_CommonClassBMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class B</link:label>
    <link:label id="lab_us-gaap_CommonClassBMember_label_en-US" xlink:label="lab_us-gaap_CommonClassBMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Class B [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonClassBMember" xlink:to="lab_us-gaap_CommonClassBMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_551e2109-92d5-471d-aa66-b4b0c2ff8a92_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_6b6755fa-90cb-4aab-9ccb-97705332c070_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Repayment of long-term debt and finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayment of Long-Term Debt, Long-Term Lease Obligation, and Capital Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationLineItems_3bdc8908-ccb4-4e15-b296-1ad6c9bbf74a_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_0d720d51-ff2d-4780-96fa-633439001ebd_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_7e8fc9c8-c9fb-4441-a324-9542a78963c2_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsSvcCstMember" xlink:to="lab_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_33ae7ddc-1dc3-43fe-997d-d15909c66465_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_4f78501b-d595-4974-9822-f93be38458e1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_SanofiMember_81a7f34e-627e-4030-aef3-18bdc0e88d9d_terseLabel_en-US" xlink:label="lab_rxrx_SanofiMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sanofi</link:label>
    <link:label id="lab_rxrx_SanofiMember_label_en-US" xlink:label="lab_rxrx_SanofiMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sanofi [Member]</link:label>
    <link:label id="lab_rxrx_SanofiMember_documentation_en-US" xlink:label="lab_rxrx_SanofiMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sanofi</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SanofiMember" xlink:href="rxrx-20250930.xsd#rxrx_SanofiMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_SanofiMember" xlink:to="lab_rxrx_SanofiMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_terseLabel_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement does not require Recovery</link:label>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_label_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Does Not Require Recovery [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_054a3e8e-a4e0-4948-9a0f-65c4eabf7ddc_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5a06445f-be9b-4d9b-988a-7f43f5e1a768_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combination [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e56d3b33-b43f-4242-8fcf-398767eb2207_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_5f326470-81d5-4bc7-bae2-655d11df98a3_terseLabel_en-US" xlink:label="lab_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_label_en-US" xlink:label="lab_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Operating Lease Right-Of-Use Assets</link:label>
    <link:label id="lab_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_documentation_en-US" xlink:label="lab_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Operating Lease Right-Of-Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:href="rxrx-20250930.xsd#rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:to="lab_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_ExscientiaPlcMember_f77002b2-2fd4-4847-89ba-a1790da9f9f7_terseLabel_en-US" xlink:label="lab_rxrx_ExscientiaPlcMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exscientia Plc</link:label>
    <link:label id="lab_rxrx_ExscientiaPlcMember_label_en-US" xlink:label="lab_rxrx_ExscientiaPlcMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exscientia Plc [Member]</link:label>
    <link:label id="lab_rxrx_ExscientiaPlcMember_documentation_en-US" xlink:label="lab_rxrx_ExscientiaPlcMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Exscientia Plc</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ExscientiaPlcMember" xlink:href="rxrx-20250930.xsd#rxrx_ExscientiaPlcMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_ExscientiaPlcMember" xlink:to="lab_rxrx_ExscientiaPlcMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_SupplementalBalanceSheetAndIncomeStatementInformationTextBlock_baf972f8-74ef-4004-be25-7e5bee2a9cb2_terseLabel_en-US" xlink:label="lab_rxrx_SupplementalBalanceSheetAndIncomeStatementInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental Financial Information</link:label>
    <link:label id="lab_rxrx_SupplementalBalanceSheetAndIncomeStatementInformationTextBlock_label_en-US" xlink:label="lab_rxrx_SupplementalBalanceSheetAndIncomeStatementInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Balance Sheet And Income Statement Information [Text Block]</link:label>
    <link:label id="lab_rxrx_SupplementalBalanceSheetAndIncomeStatementInformationTextBlock_documentation_en-US" xlink:label="lab_rxrx_SupplementalBalanceSheetAndIncomeStatementInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Supplemental Balance Sheet And Income Statement Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SupplementalBalanceSheetAndIncomeStatementInformationTextBlock" xlink:href="rxrx-20250930.xsd#rxrx_SupplementalBalanceSheetAndIncomeStatementInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_SupplementalBalanceSheetAndIncomeStatementInformationTextBlock" xlink:to="lab_rxrx_SupplementalBalanceSheetAndIncomeStatementInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableOtherPayablesMember_404dd66b-d833-4cbb-96cb-3f968a73c8a0_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes Payable</link:label>
    <link:label id="lab_us-gaap_NotesPayableOtherPayablesMember_label_en-US" xlink:label="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes Payable, Other Payables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableOtherPayablesMember" xlink:to="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_6ad915f6-8f0b-4fa2-a4b6-b493c014fe75_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value of Assets Acquired and Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Asset Acquired and Liability Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_db803b8f-833c-4fd5-80fa-b8984059ce2c_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_6fb5790d-7bd1-44d8-bce3-6d3f981e6f6d_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllTradingArrangementsMember_terseLabel_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Trading Arrangements</link:label>
    <link:label id="lab_ecd_AllTradingArrangementsMember_label_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Trading Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllTradingArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllTradingArrangementsMember" xlink:to="lab_ecd_AllTradingArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:to="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_f9dd61ee-f216-4eec-9a8d-2bc15a968c76_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses and other liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_25752b09-ef05-4102-8be2-2d266ab682fc_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses and other liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_324cbbf8-bbe7-45b9-8bca-618f3d35f715_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance, (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_afaad311-b7fa-4ab6-995f-c7cd0df0821d_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance, (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_bfdbf3bd-4f35-451d-a5a1-2745ea4ded93_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_78b0bd7e-2b5a-4084-8d05-d1a3608f9351_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncurrentAssets_701a8c10-4554-40a3-990a-4816124db3bd_terseLabel_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-lived assets</link:label>
    <link:label id="lab_us-gaap_NoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncurrentAssets" xlink:to="lab_us-gaap_NoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_bdbf8bbd-6dd8-4b3d-9c5e-018dfac041d8_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unvested stock options, unamortized stock-based compensation cost</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTable_terseLabel_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure</link:label>
    <link:label id="lab_ecd_PvpTable_label_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTable" xlink:to="lab_ecd_PvpTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_1f646301-da0a-4bac-a090-c59a420c9197_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Operating Activity, Including Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_SchrodingerLeasesMember_8325d2d5-3d1b-497d-80ab-5fdd18a3d718_terseLabel_en-US" xlink:label="lab_rxrx_SchrodingerLeasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schrodinger Leases</link:label>
    <link:label id="lab_rxrx_SchrodingerLeasesMember_label_en-US" xlink:label="lab_rxrx_SchrodingerLeasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schrodinger Leases [Member]</link:label>
    <link:label id="lab_rxrx_SchrodingerLeasesMember_documentation_en-US" xlink:label="lab_rxrx_SchrodingerLeasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schrodinger Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SchrodingerLeasesMember" xlink:href="rxrx-20250930.xsd#rxrx_SchrodingerLeasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_SchrodingerLeasesMember" xlink:to="lab_rxrx_SchrodingerLeasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_cd874089-f8eb-4db1-a4c5-917fe1524e2b_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_c47c144a-6edd-4d4e-bed3-6f636fdc987a_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_637fc511-0141-4880-8f04-b5d30a1bc7f6_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_fdbb5d56-95c1-47af-9be3-14e0f5e76e84_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Weighted-Average Assumptions Used to Calculate Grant-Date Fair Value of Stock Options</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_173aa118-62e4-4096-ad99-977f28a63026_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Asset Acquired, Other Asset, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_9aeb8982-4f38-43ad-a0db-5e62f20a3435_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of revenue</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_ceca7d03-76a1-4636-a99f-2155371b41c7_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_63606b54-e913-4278-902a-079debfc90cc_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Goodwill, beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_ba4644e7-eafa-4722-a71b-6bb8b4754109_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Goodwill, ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_label_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_e3e6fa21-9c17-48cd-b5e5-6ed9a22ff5a9_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Components of Lease Cost and Supplemental Cash Flow Information Related to Leases and Lease Term and Discount Rates</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoTotalCompAmt_label_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoTotalCompAmt" xlink:to="lab_ecd_PeoTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_a8497299-b89c-4203-b1e4-ae12b32b4029_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_41e4b8cf-c505-4b5b-a1e5-905fe80cdd2c_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_SaleOfStockValueRemainingAuthorized_0cf3665d-5752-41d8-bd31-a784d9a96a23_terseLabel_en-US" xlink:label="lab_rxrx_SaleOfStockValueRemainingAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of stock, value remaining authorized</link:label>
    <link:label id="lab_rxrx_SaleOfStockValueRemainingAuthorized_label_en-US" xlink:label="lab_rxrx_SaleOfStockValueRemainingAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale Of Stock Value Remaining Authorized</link:label>
    <link:label id="lab_rxrx_SaleOfStockValueRemainingAuthorized_documentation_en-US" xlink:label="lab_rxrx_SaleOfStockValueRemainingAuthorized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sale Of Stock Value Remaining Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SaleOfStockValueRemainingAuthorized" xlink:href="rxrx-20250930.xsd#rxrx_SaleOfStockValueRemainingAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_SaleOfStockValueRemainingAuthorized" xlink:to="lab_rxrx_SaleOfStockValueRemainingAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TangibleAssetImpairmentCharges_b275d385-715b-480b-97b3-488dff614498_terseLabel_en-US" xlink:label="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset impairment</link:label>
    <link:label id="lab_us-gaap_TangibleAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tangible Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TangibleAssetImpairmentCharges" xlink:to="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_234db093-6d91-4aa9-9810-a045d90c0f63_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_8ed0eb7e-9dfb-48d1-a978-951f9d83becf_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_aa5516c1-77c5-4500-bfb5-5742f2c8c396_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfOperations_8a506be7-a146-426e-9467-98f990a862d6_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Description of the Business</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NatureOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:to="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_NeuroscienceMember_57f42b8b-11b2-49c6-8f0f-b6328dc3161e_terseLabel_en-US" xlink:label="lab_rxrx_NeuroscienceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Neuroscience</link:label>
    <link:label id="lab_rxrx_NeuroscienceMember_label_en-US" xlink:label="lab_rxrx_NeuroscienceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Neuroscience [Member]</link:label>
    <link:label id="lab_rxrx_NeuroscienceMember_documentation_en-US" xlink:label="lab_rxrx_NeuroscienceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Neuroscience</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_NeuroscienceMember" xlink:href="rxrx-20250930.xsd#rxrx_NeuroscienceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_NeuroscienceMember" xlink:to="lab_rxrx_NeuroscienceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_label_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OtherPerfMeasureAmt" xlink:to="lab_ecd_OtherPerfMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_82d06231-6432-44e4-bff4-e9fed2209883_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_8c6d614e-7aaa-4e10-b831-b35b7fd707f5_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_ecf49b61-3864-41fc-92c1-941ff40af291_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Financing cash flows from financing leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_f26c876e-6b7d-4f3b-9fe1-866ad6ed79f9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Security, Excluded EPS Calculation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_66203e2b-c7d6-419f-a367-d2af869dd34a_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related and Nonrelated Parties [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_67173ef2-ba11-4137-9b40-c37aea522e47_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OverAllotmentOptionMember_6a212e7c-7f78-47af-8bf2-cb0e0705e48f_terseLabel_en-US" xlink:label="lab_us-gaap_OverAllotmentOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Over-Allotment Option</link:label>
    <link:label id="lab_us-gaap_OverAllotmentOptionMember_label_en-US" xlink:label="lab_us-gaap_OverAllotmentOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Over-Allotment Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OverAllotmentOptionMember" xlink:to="lab_us-gaap_OverAllotmentOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_CEOAndAffiliatesMember_f2f8dc7c-62fe-48f1-9c8e-6b9c98089191_terseLabel_en-US" xlink:label="lab_rxrx_CEOAndAffiliatesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CEO and Affiliates</link:label>
    <link:label id="lab_rxrx_CEOAndAffiliatesMember_label_en-US" xlink:label="lab_rxrx_CEOAndAffiliatesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CEO And Affiliates [Member]</link:label>
    <link:label id="lab_rxrx_CEOAndAffiliatesMember_documentation_en-US" xlink:label="lab_rxrx_CEOAndAffiliatesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">CEO And Affiliates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_CEOAndAffiliatesMember" xlink:href="rxrx-20250930.xsd#rxrx_CEOAndAffiliatesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_CEOAndAffiliatesMember" xlink:to="lab_rxrx_CEOAndAffiliatesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent_688aa2fe-29e0-4c09-87d1-ecc0fdc082b0_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Workforce reduction percentage</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring and Related Cost, Number of Positions Eliminated, Period Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent" xlink:to="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_IndividualAxis_terseLabel_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Individual:</link:label>
    <link:label id="lab_ecd_IndividualAxis_label_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_IndividualAxis" xlink:to="lab_ecd_IndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_MilestoneTypeDomain_57a1f53a-b7be-4f3e-8265-04c9cad735b3_terseLabel_en-US" xlink:label="lab_rxrx_MilestoneTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Milestone, Type [Domain]</link:label>
    <link:label id="lab_rxrx_MilestoneTypeDomain_label_en-US" xlink:label="lab_rxrx_MilestoneTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Milestone, Type [Domain]</link:label>
    <link:label id="lab_rxrx_MilestoneTypeDomain_documentation_en-US" xlink:label="lab_rxrx_MilestoneTypeDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Milestone, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_MilestoneTypeDomain" xlink:href="rxrx-20250930.xsd#rxrx_MilestoneTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_MilestoneTypeDomain" xlink:to="lab_rxrx_MilestoneTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_5dc359bd-1ba9-4f25-9bc7-2586dfbc8f48_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Finance Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:to="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_3e66ed43-4b5f-4d84-b776-cc06941d91fe_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_2c2a9f6e-af6f-4579-81b6-4ce5d6260a42_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_fcbc1549-a5be-4017-adc7-f84abdc41787_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Investing Activity, Including Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_LesseeFinanceLeaseIncreaseDecreaseInFinanceLeaseLiabilityDueToLeaseModifications_c4c13b4d-68d4-4611-871a-e81188153fad_terseLabel_en-US" xlink:label="lab_rxrx_LesseeFinanceLeaseIncreaseDecreaseInFinanceLeaseLiabilityDueToLeaseModifications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (decrease) in finance lease liabilities</link:label>
    <link:label id="lab_rxrx_LesseeFinanceLeaseIncreaseDecreaseInFinanceLeaseLiabilityDueToLeaseModifications_label_en-US" xlink:label="lab_rxrx_LesseeFinanceLeaseIncreaseDecreaseInFinanceLeaseLiabilityDueToLeaseModifications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Finance Lease, Increase (Decrease) In Finance Lease Liability Due To Lease Modifications</link:label>
    <link:label id="lab_rxrx_LesseeFinanceLeaseIncreaseDecreaseInFinanceLeaseLiabilityDueToLeaseModifications_documentation_en-US" xlink:label="lab_rxrx_LesseeFinanceLeaseIncreaseDecreaseInFinanceLeaseLiabilityDueToLeaseModifications" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee, Finance Lease, Increase (Decrease) In Finance Lease Liability Due To Lease Modifications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LesseeFinanceLeaseIncreaseDecreaseInFinanceLeaseLiabilityDueToLeaseModifications" xlink:href="rxrx-20250930.xsd#rxrx_LesseeFinanceLeaseIncreaseDecreaseInFinanceLeaseLiabilityDueToLeaseModifications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_LesseeFinanceLeaseIncreaseDecreaseInFinanceLeaseLiabilityDueToLeaseModifications" xlink:to="lab_rxrx_LesseeFinanceLeaseIncreaseDecreaseInFinanceLeaseLiabilityDueToLeaseModifications" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_d72e2d59-753f-49ec-8030-f02e9b2c271e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Loss on disposal of a business</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Disposition of Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:to="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_378d284d-9565-47c6-9ad3-99ea92dabc69_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_67964282-7780-4bba-bcd0-42f2db50f51c_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_ContractWithCustomerMaximumAcceptedProduct_fee70a06-f326-49cd-b4a8-4bff9b5080af_terseLabel_en-US" xlink:label="lab_rxrx_ContractWithCustomerMaximumAcceptedProduct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of eligible phenomaps</link:label>
    <link:label id="lab_rxrx_ContractWithCustomerMaximumAcceptedProduct_label_en-US" xlink:label="lab_rxrx_ContractWithCustomerMaximumAcceptedProduct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract With Customer, Maximum Accepted Product</link:label>
    <link:label id="lab_rxrx_ContractWithCustomerMaximumAcceptedProduct_documentation_en-US" xlink:label="lab_rxrx_ContractWithCustomerMaximumAcceptedProduct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contract With Customer, Maximum Accepted Product</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ContractWithCustomerMaximumAcceptedProduct" xlink:href="rxrx-20250930.xsd#rxrx_ContractWithCustomerMaximumAcceptedProduct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_ContractWithCustomerMaximumAcceptedProduct" xlink:to="lab_rxrx_ContractWithCustomerMaximumAcceptedProduct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_b4ba4d37-e291-4b5a-ae93-e6446f80ddfc_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_6e4a9264-2c9f-4d02-80de-11053a645afc_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_145346f8-ccc3-4e3d-9066-c941a1480016_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_23f05dc1-4843-4605-877d-6ad1f9f9b009_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unvested stock options, unamortized stock-based compensation cost, weighted average period recognition</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_ViennaFacilitiesOfExscientiaGmbHMember_afd44587-7df7-4c55-8048-0893a5b986ba_terseLabel_en-US" xlink:label="lab_rxrx_ViennaFacilitiesOfExscientiaGmbHMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vienna facilities of Exscientia GmbH</link:label>
    <link:label id="lab_rxrx_ViennaFacilitiesOfExscientiaGmbHMember_label_en-US" xlink:label="lab_rxrx_ViennaFacilitiesOfExscientiaGmbHMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vienna Facilities Of Exscientia GmbH [Member]</link:label>
    <link:label id="lab_rxrx_ViennaFacilitiesOfExscientiaGmbHMember_documentation_en-US" xlink:label="lab_rxrx_ViennaFacilitiesOfExscientiaGmbHMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vienna Facilities Of Exscientia GmbH</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ViennaFacilitiesOfExscientiaGmbHMember" xlink:href="rxrx-20250930.xsd#rxrx_ViennaFacilitiesOfExscientiaGmbHMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_ViennaFacilitiesOfExscientiaGmbHMember" xlink:to="lab_rxrx_ViennaFacilitiesOfExscientiaGmbHMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_679ca62c-36c2-470d-9493-ed5dffe69e77_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_GastrointestinalCancerMember_8555a652-05b5-4d75-95ed-a60b94c9a24e_terseLabel_en-US" xlink:label="lab_rxrx_GastrointestinalCancerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gastrointestinal Cancer</link:label>
    <link:label id="lab_rxrx_GastrointestinalCancerMember_label_en-US" xlink:label="lab_rxrx_GastrointestinalCancerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gastrointestinal Cancer [Member]</link:label>
    <link:label id="lab_rxrx_GastrointestinalCancerMember_documentation_en-US" xlink:label="lab_rxrx_GastrointestinalCancerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Gastrointestinal Cancer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_GastrointestinalCancerMember" xlink:href="rxrx-20250930.xsd#rxrx_GastrointestinalCancerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_GastrointestinalCancerMember" xlink:to="lab_rxrx_GastrointestinalCancerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0bfc8485-c843-4f2a-addf-7b0d7a6c357f_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise, intrinsic value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_RocheAndGenentechMember_7155d40f-f4ba-4dba-b1e9-55cb0855c700_terseLabel_en-US" xlink:label="lab_rxrx_RocheAndGenentechMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Roche and Genentech</link:label>
    <link:label id="lab_rxrx_RocheAndGenentechMember_label_en-US" xlink:label="lab_rxrx_RocheAndGenentechMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Roche and Genentech [Member]</link:label>
    <link:label id="lab_rxrx_RocheAndGenentechMember_documentation_en-US" xlink:label="lab_rxrx_RocheAndGenentechMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Roche and Genentech</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RocheAndGenentechMember" xlink:href="rxrx-20250930.xsd#rxrx_RocheAndGenentechMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_RocheAndGenentechMember" xlink:to="lab_rxrx_RocheAndGenentechMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_PublicOfferingOfCommonStockMember_ae11f435-2eaf-4e3b-bd3e-5a8356289267_terseLabel_en-US" xlink:label="lab_rxrx_PublicOfferingOfCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Public Offering of Common Stock</link:label>
    <link:label id="lab_rxrx_PublicOfferingOfCommonStockMember_label_en-US" xlink:label="lab_rxrx_PublicOfferingOfCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Public Offering Of Common Stock [Member]</link:label>
    <link:label id="lab_rxrx_PublicOfferingOfCommonStockMember_documentation_en-US" xlink:label="lab_rxrx_PublicOfferingOfCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Public Offering Of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_PublicOfferingOfCommonStockMember" xlink:href="rxrx-20250930.xsd#rxrx_PublicOfferingOfCommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_PublicOfferingOfCommonStockMember" xlink:to="lab_rxrx_PublicOfferingOfCommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_a83fe47b-9dbf-4c15-9048-cfc7212eb5d6_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_59eb59b4-b273-4b2e-9fab-ed3360048b2a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_b3c6fd5c-ac8c-4beb-a9c4-c93a99361d37_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Notes payable and financing lease liabilities</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_549fcae7-3020-48f3-a169-05fa17208374_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes payable and financing lease liabilities, current</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt and Lease Obligation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_LicenseAgreementAmountOfTimePriorToThePaymentDate_8ceb60ae-9c2e-4ffa-af8d-b6f9cbab9494_terseLabel_en-US" xlink:label="lab_rxrx_LicenseAgreementAmountOfTimePriorToThePaymentDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business days prior to the payment date</link:label>
    <link:label id="lab_rxrx_LicenseAgreementAmountOfTimePriorToThePaymentDate_label_en-US" xlink:label="lab_rxrx_LicenseAgreementAmountOfTimePriorToThePaymentDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License Agreement, Amount Of Time Prior To The Payment Date</link:label>
    <link:label id="lab_rxrx_LicenseAgreementAmountOfTimePriorToThePaymentDate_documentation_en-US" xlink:label="lab_rxrx_LicenseAgreementAmountOfTimePriorToThePaymentDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">License Agreement, Amount Of Time Prior To The Payment Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LicenseAgreementAmountOfTimePriorToThePaymentDate" xlink:href="rxrx-20250930.xsd#rxrx_LicenseAgreementAmountOfTimePriorToThePaymentDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_LicenseAgreementAmountOfTimePriorToThePaymentDate" xlink:to="lab_rxrx_LicenseAgreementAmountOfTimePriorToThePaymentDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4eb690c6-dba0-406f-8e11-2d3c4a78a49c_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_284bf83a-5084-4aad-b413-2c8c7518633b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Liability Assumed, Other Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_56f08968-c9a5-4d75-a6ca-bfe5b11871c0_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_3d2f5332-d9b7-41cd-9ea7-9a11a24132c7_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_8086624e-2f19-4907-9689-4908e76d7b81_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash paid</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_595ddc42-b95d-46c7-ad85-5e3bca6e490b_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_93a8fd03-ede5-4508-9e8d-8dc6340bfc97_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other assets, non-current</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_SignificantSegmentExpensesAbstract_db47a865-ea42-41c9-a68a-482cc874861e_terseLabel_en-US" xlink:label="lab_rxrx_SignificantSegmentExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Significant segment expenses</link:label>
    <link:label id="lab_rxrx_SignificantSegmentExpensesAbstract_label_en-US" xlink:label="lab_rxrx_SignificantSegmentExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant Segment Expenses [Abstract]</link:label>
    <link:label id="lab_rxrx_SignificantSegmentExpensesAbstract_documentation_en-US" xlink:label="lab_rxrx_SignificantSegmentExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Significant Segment Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SignificantSegmentExpensesAbstract" xlink:href="rxrx-20250930.xsd#rxrx_SignificantSegmentExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_SignificantSegmentExpensesAbstract" xlink:to="lab_rxrx_SignificantSegmentExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_a9c5a8c4-026c-4504-a78b-6357c844d769_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoName_terseLabel_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:label id="lab_ecd_PeoName_label_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoName" xlink:to="lab_ecd_PeoName" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_BusinessCombinationEquityInterestIssuedOrIssuableSharesOfAcquirerStockPerShareOfAcquireeStockOutstanding_5d445499-e131-4a52-bcfc-5d676b974ca6_terseLabel_en-US" xlink:label="lab_rxrx_BusinessCombinationEquityInterestIssuedOrIssuableSharesOfAcquirerStockPerShareOfAcquireeStockOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares of acquirer stock per share of acquiree stock outstanding (in shares)</link:label>
    <link:label id="lab_rxrx_BusinessCombinationEquityInterestIssuedOrIssuableSharesOfAcquirerStockPerShareOfAcquireeStockOutstanding_label_en-US" xlink:label="lab_rxrx_BusinessCombinationEquityInterestIssuedOrIssuableSharesOfAcquirerStockPerShareOfAcquireeStockOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Equity Interest Issued Or Issuable, Shares of Acquirer Stock Per Share of Acquiree Stock Outstanding</link:label>
    <link:label id="lab_rxrx_BusinessCombinationEquityInterestIssuedOrIssuableSharesOfAcquirerStockPerShareOfAcquireeStockOutstanding_documentation_en-US" xlink:label="lab_rxrx_BusinessCombinationEquityInterestIssuedOrIssuableSharesOfAcquirerStockPerShareOfAcquireeStockOutstanding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Equity Interest Issued Or Issuable, Shares of Acquirer Stock Per Share of Acquiree Stock Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_BusinessCombinationEquityInterestIssuedOrIssuableSharesOfAcquirerStockPerShareOfAcquireeStockOutstanding" xlink:href="rxrx-20250930.xsd#rxrx_BusinessCombinationEquityInterestIssuedOrIssuableSharesOfAcquirerStockPerShareOfAcquireeStockOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_BusinessCombinationEquityInterestIssuedOrIssuableSharesOfAcquirerStockPerShareOfAcquireeStockOutstanding" xlink:to="lab_rxrx_BusinessCombinationEquityInterestIssuedOrIssuableSharesOfAcquirerStockPerShareOfAcquireeStockOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_67eb3c47-c27a-4040-ae73-370889736e35_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_212b79ea-af13-4f09-808f-81c3c36fba08_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net proceeds received</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year</link:label>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_label_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:to="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_6f3a2fa2-7d95-4948-9915-bb5fecccffbd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingAggtErrCompAmt" xlink:to="lab_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_6e0a4211-07d4-40a3-bdf9-073ac15a44d0_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Finance lease liability</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrDuration_terseLabel_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Arrangement Duration</link:label>
    <link:label id="lab_ecd_TrdArrDuration_label_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrDuration" xlink:to="lab_ecd_TrdArrDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bd35b4f7-78e6-4dad-b667-6012af71dcdc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_96c2052b-67c0-441f-b849-0b48e7e0f10e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Operating loss</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Acquiree's Earnings (Loss) since Acquisition Date, Actual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:to="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_REVenturesIMember_f613cb27-7349-47b3-9a67-212ce1e89683_terseLabel_en-US" xlink:label="lab_rxrx_REVenturesIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">RE Ventures I</link:label>
    <link:label id="lab_rxrx_REVenturesIMember_label_en-US" xlink:label="lab_rxrx_REVenturesIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">RE Ventures I [Member]</link:label>
    <link:label id="lab_rxrx_REVenturesIMember_documentation_en-US" xlink:label="lab_rxrx_REVenturesIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">RE Ventures I</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_REVenturesIMember" xlink:href="rxrx-20250930.xsd#rxrx_REVenturesIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_REVenturesIMember" xlink:to="lab_rxrx_REVenturesIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_a51f56e2-8b21-4bdf-acc4-3990fc29ac34_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unearned revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_e1e866e5-447b-4e4d-8b4b-f0f700e74a06_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrantMember_64622517-05da-4019-8a9a-ae0f9081f94a_terseLabel_en-US" xlink:label="lab_us-gaap_GrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Grant revenue</link:label>
    <link:label id="lab_us-gaap_GrantMember_label_en-US" xlink:label="lab_us-gaap_GrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Grant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrantMember" xlink:to="lab_us-gaap_GrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications_3707ba0b-3449-4dac-b3bf-fea6432da413_terseLabel_en-US" xlink:label="lab_rxrx_LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (decrease) in operating lease liabilities</link:label>
    <link:label id="lab_rxrx_LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications_label_en-US" xlink:label="lab_rxrx_LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Increase (Decrease) In Operating Lease Liability Due To Lease Modifications</link:label>
    <link:label id="lab_rxrx_LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications_documentation_en-US" xlink:label="lab_rxrx_LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Increase (Decrease) In Operating Lease Liability Due To Lease Modifications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications" xlink:href="rxrx-20250930.xsd#rxrx_LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications" xlink:to="lab_rxrx_LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardExrcPrice_terseLabel_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise Price</link:label>
    <link:label id="lab_ecd_AwardExrcPrice_label_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardExrcPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardExrcPrice" xlink:to="lab_ecd_AwardExrcPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_03e4bc7d-3049-4b4f-9e64-d8c9ca2d1f51_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_IncreaseDecreaseInAccruedDevelopmentExpense_be517f47-4072-49bb-bc3d-eab4804404f1_terseLabel_en-US" xlink:label="lab_rxrx_IncreaseDecreaseInAccruedDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued development expense</link:label>
    <link:label id="lab_rxrx_IncreaseDecreaseInAccruedDevelopmentExpense_label_en-US" xlink:label="lab_rxrx_IncreaseDecreaseInAccruedDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Accrued Development Expense</link:label>
    <link:label id="lab_rxrx_IncreaseDecreaseInAccruedDevelopmentExpense_documentation_en-US" xlink:label="lab_rxrx_IncreaseDecreaseInAccruedDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Accrued Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_IncreaseDecreaseInAccruedDevelopmentExpense" xlink:href="rxrx-20250930.xsd#rxrx_IncreaseDecreaseInAccruedDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_IncreaseDecreaseInAccruedDevelopmentExpense" xlink:to="lab_rxrx_IncreaseDecreaseInAccruedDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_710b6ba6-6e8e-426d-afd2-fd7691c185dc_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_b3f874ee-e834-4b8b-9050-e548d3b8aa9d_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_label_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Additional402vDisclosureTextBlock" xlink:to="lab_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_90ad53c2-f1d7-479a-b100-64fb5094bf6e_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized compensation cost</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_9d2b295c-d8eb-4777-98fe-caa2e6156930_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_AffiliatedHoldersPotentialOwnershipPercentageWhenOutstandingEquityAwardsVest_bc3591c6-de66-4c78-9a17-cc5993ba7ed5_terseLabel_en-US" xlink:label="lab_rxrx_AffiliatedHoldersPotentialOwnershipPercentageWhenOutstandingEquityAwardsVest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Affiliated holders, potential ownership percentage when outstanding equity awards vest</link:label>
    <link:label id="lab_rxrx_AffiliatedHoldersPotentialOwnershipPercentageWhenOutstandingEquityAwardsVest_label_en-US" xlink:label="lab_rxrx_AffiliatedHoldersPotentialOwnershipPercentageWhenOutstandingEquityAwardsVest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Affiliated Holders, Potential Ownership Percentage When Outstanding Equity Awards Vest</link:label>
    <link:label id="lab_rxrx_AffiliatedHoldersPotentialOwnershipPercentageWhenOutstandingEquityAwardsVest_documentation_en-US" xlink:label="lab_rxrx_AffiliatedHoldersPotentialOwnershipPercentageWhenOutstandingEquityAwardsVest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Affiliated Holders, Potential Ownership Percentage When Outstanding Equity Awards Vest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AffiliatedHoldersPotentialOwnershipPercentageWhenOutstandingEquityAwardsVest" xlink:href="rxrx-20250930.xsd#rxrx_AffiliatedHoldersPotentialOwnershipPercentageWhenOutstandingEquityAwardsVest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_AffiliatedHoldersPotentialOwnershipPercentageWhenOutstandingEquityAwardsVest" xlink:to="lab_rxrx_AffiliatedHoldersPotentialOwnershipPercentageWhenOutstandingEquityAwardsVest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharePrice_5be00a45-6bda-4f23-b3ac-7fb186ca838d_terseLabel_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharePrice_label_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice" xlink:to="lab_us-gaap_SharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_eea45c7f-8660-4ac9-9033-1c9bf2aa7bcd_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_99ad102c-8fc5-4827-abe7-75258a8876eb_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_073c8d03-57e6-4e95-b914-95e19b04df29_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Asset Acquired, Cash and Cash Equivalent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_2b8bc21e-b9f0-41fc-92ce-8c1d1a9f7d94_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected cost</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring and Related Cost, Expected Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_7b568ef0-e0fd-44d1-8d31-b4ac23c64c3d_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_terseLabel_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change</link:label>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_label_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:to="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_82128063-e0bd-4aa6-a12c-dee6956d2f67_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_d34f9691-2453-4ad2-8d7e-173173fc69c6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BankTimeDepositsMember_4dc2dcad-267a-4e82-bd2f-55760e2eb298_terseLabel_en-US" xlink:label="lab_us-gaap_BankTimeDepositsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Bank deposits</link:label>
    <link:label id="lab_us-gaap_BankTimeDepositsMember_label_en-US" xlink:label="lab_us-gaap_BankTimeDepositsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Bank Time Deposits [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BankTimeDepositsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BankTimeDepositsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BankTimeDepositsMember" xlink:to="lab_us-gaap_BankTimeDepositsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_2a2d1e18-00d2-4514-88e5-35421c641cee_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combination [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_e1749f30-a8c2-4f56-94cd-12e6760cc205_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross carrying amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_8f4fe998-6533-4189-8d33-de375980a2b8_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year</link:label>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:to="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_31657a7f-ec12-4db4-b627-9f5ecce96a18_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_2f4309ec-4d75-4692-9470-55a3ed3f18a3_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7abcdcc3-abfa-47e2-bc3a-d34fdbb98085_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9473d62f-ba7b-4597-9e20-fd13591838d3_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_dec13e5a-265a-4578-b704-22550037feb8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities, non-current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_031aa1a8-6921-455a-b47f-faa21477bee5_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares issued in the period, upon conversion (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssued1_459c789a-1ea5-40d4-9b1c-ed7307bbaaa6_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssued1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of shares for the acquisition of an asset</link:label>
    <link:label id="lab_us-gaap_StockIssued1_label_en-US" xlink:label="lab_us-gaap_StockIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssued1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssued1" xlink:to="lab_us-gaap_StockIssued1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardGrantDateFairValue_terseLabel_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value as of Grant Date</link:label>
    <link:label id="lab_ecd_AwardGrantDateFairValue_label_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardGrantDateFairValue" xlink:to="lab_ecd_AwardGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_1f6798e2-2fe5-4749-a625-50b7c5885f07_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementMember_96f31804-6a42-4a46-b781-5934de2f2c6c_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementMember_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementMember" xlink:to="lab_us-gaap_CollaborativeArrangementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_label_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LaborAndRelatedExpense_34b05ab4-0dd2-4f56-94b8-27a4bc8e2a87_terseLabel_en-US" xlink:label="lab_us-gaap_LaborAndRelatedExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Salaries</link:label>
    <link:label id="lab_us-gaap_LaborAndRelatedExpense_label_en-US" xlink:label="lab_us-gaap_LaborAndRelatedExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Labor and Related Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LaborAndRelatedExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LaborAndRelatedExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LaborAndRelatedExpense" xlink:to="lab_us-gaap_LaborAndRelatedExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_ValenceDiscoveryIncMember_405f2e6f-3aef-4325-8e0f-eb6a7e2cfb92_terseLabel_en-US" xlink:label="lab_rxrx_ValenceDiscoveryIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Valence Discovery Inc</link:label>
    <link:label id="lab_rxrx_ValenceDiscoveryIncMember_label_en-US" xlink:label="lab_rxrx_ValenceDiscoveryIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Valence Discovery Inc [Member]</link:label>
    <link:label id="lab_rxrx_ValenceDiscoveryIncMember_documentation_en-US" xlink:label="lab_rxrx_ValenceDiscoveryIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Valence Discovery Inc</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ValenceDiscoveryIncMember" xlink:href="rxrx-20250930.xsd#rxrx_ValenceDiscoveryIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_ValenceDiscoveryIncMember" xlink:to="lab_rxrx_ValenceDiscoveryIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d60485bd-4523-47e8-8c01-a169eca22e38_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_a2f5f52f-48f1-4025-92a1-f52b6e6174ef_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchases of investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_dafaef98-de30-47aa-b633-7c6079c69146_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total operating costs and expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_0b3b8761-ca6e-4f75-afe7-8e06365cf62c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_LeaseDescriptionAxis_cc6c3aae-085c-44c5-bd84-bc728e85af4f_terseLabel_en-US" xlink:label="lab_rxrx_LeaseDescriptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease Description [Axis]</link:label>
    <link:label id="lab_rxrx_LeaseDescriptionAxis_label_en-US" xlink:label="lab_rxrx_LeaseDescriptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease Description [Axis]</link:label>
    <link:label id="lab_rxrx_LeaseDescriptionAxis_documentation_en-US" xlink:label="lab_rxrx_LeaseDescriptionAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lease Description</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LeaseDescriptionAxis" xlink:href="rxrx-20250930.xsd#rxrx_LeaseDescriptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_LeaseDescriptionAxis" xlink:to="lab_rxrx_LeaseDescriptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_0960642e-de2b-41de-8288-101231087eef_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_4620e9b1-8c91-49a6-87e2-9b626d4b54f4_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_label_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:to="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_PlatformFeeExpense_e593bbbf-0b93-4136-807b-0e0b0e082267_terseLabel_en-US" xlink:label="lab_rxrx_PlatformFeeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Platform</link:label>
    <link:label id="lab_rxrx_PlatformFeeExpense_label_en-US" xlink:label="lab_rxrx_PlatformFeeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Platform Fee Expense</link:label>
    <link:label id="lab_rxrx_PlatformFeeExpense_documentation_en-US" xlink:label="lab_rxrx_PlatformFeeExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Platform Fee Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_PlatformFeeExpense" xlink:href="rxrx-20250930.xsd#rxrx_PlatformFeeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_PlatformFeeExpense" xlink:to="lab_rxrx_PlatformFeeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_9b913f3a-a627-41fd-a1e9-851590dd5311_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_CommonStockConversionRatio_b49a1790-22d5-40f9-bf86-234952bf597f_terseLabel_en-US" xlink:label="lab_rxrx_CommonStockConversionRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, conversion ratio</link:label>
    <link:label id="lab_rxrx_CommonStockConversionRatio_label_en-US" xlink:label="lab_rxrx_CommonStockConversionRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Conversion Ratio</link:label>
    <link:label id="lab_rxrx_CommonStockConversionRatio_documentation_en-US" xlink:label="lab_rxrx_CommonStockConversionRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Common Stock, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_CommonStockConversionRatio" xlink:href="rxrx-20250930.xsd#rxrx_CommonStockConversionRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_CommonStockConversionRatio" xlink:to="lab_rxrx_CommonStockConversionRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToPeoCompFnTextBlock" xlink:to="lab_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_3b0b2dad-a5ae-4ad2-ac40-aea491a7e53e_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options, outstanding, weighted average remaining contractual life</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_5edffc16-076e-4033-a1ff-d06795e9ac09_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Accrued Expenses and Other Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_79493e6e-6290-4419-9011-2a1d416095d4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b034eb91-4cba-4afe-9186-f1a4c2ae5b33_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related and Nonrelated Parties [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndTitle_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title</link:label>
    <link:label id="lab_ecd_TrdArrIndTitle_label_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Title</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndTitle" xlink:to="lab_ecd_TrdArrIndTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_SupplementalAssetInformationAbstract_29805e15-c579-4e8b-97fe-3a07ad828731_terseLabel_en-US" xlink:label="lab_rxrx_SupplementalAssetInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental asset information</link:label>
    <link:label id="lab_rxrx_SupplementalAssetInformationAbstract_label_en-US" xlink:label="lab_rxrx_SupplementalAssetInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Asset Information [Abstract]</link:label>
    <link:label id="lab_rxrx_SupplementalAssetInformationAbstract_documentation_en-US" xlink:label="lab_rxrx_SupplementalAssetInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Supplemental Asset Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SupplementalAssetInformationAbstract" xlink:href="rxrx-20250930.xsd#rxrx_SupplementalAssetInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_SupplementalAssetInformationAbstract" xlink:to="lab_rxrx_SupplementalAssetInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_1f5348cd-62e2-4e50-8a03-4e4f0db39306_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_05ed9de6-fbb0-4746-899e-45e84d5f4072_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_IncreaseDecreaseInLeaseLiability_9eead2ce-3342-40d5-97ce-4ff6637a599a_terseLabel_en-US" xlink:label="lab_rxrx_IncreaseDecreaseInLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_rxrx_IncreaseDecreaseInLeaseLiability_label_en-US" xlink:label="lab_rxrx_IncreaseDecreaseInLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Lease Liability</link:label>
    <link:label id="lab_rxrx_IncreaseDecreaseInLeaseLiability_documentation_en-US" xlink:label="lab_rxrx_IncreaseDecreaseInLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_IncreaseDecreaseInLeaseLiability" xlink:href="rxrx-20250930.xsd#rxrx_IncreaseDecreaseInLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_IncreaseDecreaseInLeaseLiability" xlink:to="lab_rxrx_IncreaseDecreaseInLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDateAxis_terseLabel_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date:</link:label>
    <link:label id="lab_ecd_RestatementDateAxis_label_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDateAxis" xlink:to="lab_ecd_RestatementDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_272fbff0-6469-4219-9d98-f7f2a3c02db7_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock option exercises and other</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoMember_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO</link:label>
    <link:label id="lab_ecd_NonPeoNeoMember_label_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoMember" xlink:to="lab_ecd_NonPeoNeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_42b3654f-98ca-4459-81cb-bde0761c9510_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options, outstanding, intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_d46f436d-f2f6-4c94-ba10-5b6361ab97f7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Liability Assumed, Deferred Revenue, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_8434aeb6-d1ba-4387-a25a-95a8f6b1fa98_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Restructuring Actions and the Related Accrual</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_NajatKhanMember_label_en-US" xlink:label="lab_rxrx_NajatKhanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Najat Khan [Member]</link:label>
    <link:label id="lab_rxrx_NajatKhanMember_documentation_en-US" xlink:label="lab_rxrx_NajatKhanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Najat Khan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_NajatKhanMember" xlink:href="rxrx-20250930.xsd#rxrx_NajatKhanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_NajatKhanMember" xlink:to="lab_rxrx_NajatKhanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_0221b472-9c6f-4f9c-8146-5f2b89ec9fdc_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndName_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_TrdArrIndName_label_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndName" xlink:to="lab_ecd_TrdArrIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7ac7d40b-3973-4c74-8277-320d7a2972d9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="lab_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_1a6fb86a-9347-4c5d-ae51-de489aed79c0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:to="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CA_6cecf93e-d4f9-4d87-b88f-94af38cafa50_terseLabel_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Canada</link:label>
    <link:label id="lab_country_CA_label_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CANADA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_CA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CA" xlink:to="lab_country_CA" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryCompAmt" xlink:to="lab_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_7ac774ec-747b-4da6-9a30-98d19a32875e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RecoveryOfErrCompDisclosureLineItems_label_en-US" xlink:label="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recovery of Erroneously Awarded Compensation Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_20888f8e-6e1c-4a85-af5c-b9f6a515f56f_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair values</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_de5823de-22f1-44c7-acaa-5c3dce73426d_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue recognized</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_1869585e-c2d2-4d68-8f06-d4925496de9f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recursion Class A common stock</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_terseLabel_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_label_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:to="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:to="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost_65dabec5-a649-4afc-a328-7d2033323f64_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Transactions costs</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition, Consideration Transferred, Transaction Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost" xlink:to="lab_us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_54174c8e-5203-4377-8006-6344bf3da591_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance, (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3acac28e-aac8-42f2-bb40-6d506d94a080_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance, (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_48d6cd13-cc25-45bf-8b12-d568ee8fcdf3_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_9719285f-699f-4e22-84b0-354bda3de60d_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted cash, non-current</link:label>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent" xlink:to="lab_us-gaap_RestrictedCashNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_c04d8a9e-fcaa-4499-8e77-df27062a2680_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Asset Acquired, Deferred Tax Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_label_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionLineItems_e399d50f-69c6-4553-aaa7-39ec131fd520_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionLineItems" xlink:to="lab_us-gaap_AssetAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_IncreaseDecreaseInAccruedDataLiability_c024e6eb-2237-449c-b573-a69d5ac5436c_terseLabel_en-US" xlink:label="lab_rxrx_IncreaseDecreaseInAccruedDataLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued data liability</link:label>
    <link:label id="lab_rxrx_IncreaseDecreaseInAccruedDataLiability_label_en-US" xlink:label="lab_rxrx_IncreaseDecreaseInAccruedDataLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Accrued Data liability</link:label>
    <link:label id="lab_rxrx_IncreaseDecreaseInAccruedDataLiability_documentation_en-US" xlink:label="lab_rxrx_IncreaseDecreaseInAccruedDataLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Accrued Data liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_IncreaseDecreaseInAccruedDataLiability" xlink:href="rxrx-20250930.xsd#rxrx_IncreaseDecreaseInAccruedDataLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_IncreaseDecreaseInAccruedDataLiability" xlink:to="lab_rxrx_IncreaseDecreaseInAccruedDataLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_aff1b2fd-0a6a-4f0f-afc6-f4e17d18d029_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_ExchangeableStockMember_995e986f-10bc-40c8-bd68-4148c546eff5_terseLabel_en-US" xlink:label="lab_rxrx_ExchangeableStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exchangeable Stock</link:label>
    <link:label id="lab_rxrx_ExchangeableStockMember_label_en-US" xlink:label="lab_rxrx_ExchangeableStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exchangeable Stock [Member]</link:label>
    <link:label id="lab_rxrx_ExchangeableStockMember_documentation_en-US" xlink:label="lab_rxrx_ExchangeableStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Exchangeable Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ExchangeableStockMember" xlink:href="rxrx-20250930.xsd#rxrx_ExchangeableStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_ExchangeableStockMember" xlink:to="lab_rxrx_ExchangeableStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_b6bcc284-ddf7-403e-a530-f5ecaced1643_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_AccruedLicenseFeeCurrent_c4835300-6098-4bf1-b06a-70bb07c1952f_terseLabel_en-US" xlink:label="lab_rxrx_AccruedLicenseFeeCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued license fees</link:label>
    <link:label id="lab_rxrx_AccruedLicenseFeeCurrent_label_en-US" xlink:label="lab_rxrx_AccruedLicenseFeeCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued License Fee, Current</link:label>
    <link:label id="lab_rxrx_AccruedLicenseFeeCurrent_documentation_en-US" xlink:label="lab_rxrx_AccruedLicenseFeeCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued License Fee, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AccruedLicenseFeeCurrent" xlink:href="rxrx-20250930.xsd#rxrx_AccruedLicenseFeeCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_AccruedLicenseFeeCurrent" xlink:to="lab_rxrx_AccruedLicenseFeeCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_10e39060-e57c-435d-8a42-a51b60884eb7_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_a3160e79-eefa-44b6-8405-797f9ebb8dc3_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Notes payable and financing lease liabilities, non-current</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_ff10a134-b0da-4750-8495-e1f653f65543_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes payable and financing lease liabilities, non-current</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_TempusAgreementMember_093eef57-01d6-42ea-aadb-827975015bb9_terseLabel_en-US" xlink:label="lab_rxrx_TempusAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tempus agreement</link:label>
    <link:label id="lab_rxrx_TempusAgreementMember_label_en-US" xlink:label="lab_rxrx_TempusAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tempus Agreement [Member]</link:label>
    <link:label id="lab_rxrx_TempusAgreementMember_documentation_en-US" xlink:label="lab_rxrx_TempusAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tempus Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_TempusAgreementMember" xlink:href="rxrx-20250930.xsd#rxrx_TempusAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_TempusAgreementMember" xlink:to="lab_rxrx_TempusAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_ec8de952-a837-466b-844b-0bae67e07615_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_5987962b-9e77-4262-9759-9c97bfd917a0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_3879e8c9-4d45-499f-8925-d7f7192f7153_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8aded05e-8d91-48b5-a25a-acd572284f56_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_LeaseDescriptionDomain_23a46714-0eef-41b6-b28e-46d4d5edb1f3_terseLabel_en-US" xlink:label="lab_rxrx_LeaseDescriptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease Description [Domain]</link:label>
    <link:label id="lab_rxrx_LeaseDescriptionDomain_label_en-US" xlink:label="lab_rxrx_LeaseDescriptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease Description [Domain]</link:label>
    <link:label id="lab_rxrx_LeaseDescriptionDomain_documentation_en-US" xlink:label="lab_rxrx_LeaseDescriptionDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lease Description [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LeaseDescriptionDomain" xlink:href="rxrx-20250930.xsd#rxrx_LeaseDescriptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_LeaseDescriptionDomain" xlink:to="lab_rxrx_LeaseDescriptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2de6f78f-1d4d-4902-8c44-15706fc7a136_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_72ddab0b-d9bc-4e20-9092-42d19774056c_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureName_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureName_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureName" xlink:to="lab_ecd_CoSelectedMeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_50472580-e965-4445-8e9a-76b46999ecf7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_e13ccc70-1df6-415c-b4a4-b0d08c0283eb_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating loss</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Pro Forma Information, Pro Forma Income (Loss), after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_terseLabel_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Available</link:label>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_label_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Securities Aggregate Available Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_1ef6e93b-bf2b-432c-82d3-d6b0c20b0d99_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_BlakeBorgesonMember_label_en-US" xlink:label="lab_rxrx_BlakeBorgesonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Blake Borgeson [Member]</link:label>
    <link:label id="lab_rxrx_BlakeBorgesonMember_documentation_en-US" xlink:label="lab_rxrx_BlakeBorgesonMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Blake Borgeson</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_BlakeBorgesonMember" xlink:href="rxrx-20250930.xsd#rxrx_BlakeBorgesonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_BlakeBorgesonMember" xlink:to="lab_rxrx_BlakeBorgesonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_42ff5e6f-225f-42df-88c3-f2da3f4fe330_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating cash flows from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_DiscoveryDevelopmentAndSalesMilestonesMember_879b5f73-a494-4387-9069-86eb15a26053_terseLabel_en-US" xlink:label="lab_rxrx_DiscoveryDevelopmentAndSalesMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discovery, Development And Sales Milestones</link:label>
    <link:label id="lab_rxrx_DiscoveryDevelopmentAndSalesMilestonesMember_label_en-US" xlink:label="lab_rxrx_DiscoveryDevelopmentAndSalesMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discovery, Development And Sales Milestones [Member]</link:label>
    <link:label id="lab_rxrx_DiscoveryDevelopmentAndSalesMilestonesMember_documentation_en-US" xlink:label="lab_rxrx_DiscoveryDevelopmentAndSalesMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Discovery, Development And Sales Milestones</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_DiscoveryDevelopmentAndSalesMilestonesMember" xlink:href="rxrx-20250930.xsd#rxrx_DiscoveryDevelopmentAndSalesMilestonesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_DiscoveryDevelopmentAndSalesMilestonesMember" xlink:to="lab_rxrx_DiscoveryDevelopmentAndSalesMilestonesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_terseLabel_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Executive Categories</link:label>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_label_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Executive Categories [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="lab_ecd_AllExecutiveCategoriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_MilestoneTypeAxis_65840ef4-96ef-480e-966a-96d67125ca35_terseLabel_en-US" xlink:label="lab_rxrx_MilestoneTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Milestone, Type [Axis]</link:label>
    <link:label id="lab_rxrx_MilestoneTypeAxis_label_en-US" xlink:label="lab_rxrx_MilestoneTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Milestone, Type [Axis]</link:label>
    <link:label id="lab_rxrx_MilestoneTypeAxis_documentation_en-US" xlink:label="lab_rxrx_MilestoneTypeAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Milestone, Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_MilestoneTypeAxis" xlink:href="rxrx-20250930.xsd#rxrx_MilestoneTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_MilestoneTypeAxis" xlink:to="lab_rxrx_MilestoneTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_0e6346fe-16e6-4c81-a278-29e8926e19f8_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, $0.00001 par value; 2,000,000,000 shares (Class A 1,989,032,117 and Class B 10,967,883) authorized as of September&#160;30, 2025 and December&#160;31, 2024; 491,800,501 shares (Class A 485,213,547, Class B 5,967,334 and Exchangeable 619,620) and 396,802,394 shares (Class A 389,547,223, Class B 6,958,575 and Exchangeable 296,596) issued and outstanding as of September&#160;30, 2025 and December&#160;31, 2024, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_7fcb3e2e-0499-4fd0-a0da-fb332ec4d8b2_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financing lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_b6bdb12c-1fb1-48a7-a093-3c3c23692b2b_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_ca5789bc-2628-436d-83b6-0e5e400ecf75_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_de0597fc-03f2-45c0-9fb0-47ff9a5dff3e_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average shares (Class A, B and Exchangeable) outstanding, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_aea404db-d39e-496e-a8f8-c92fdacb0a02_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average common shares outstanding, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_a9dd34b3-d167-411b-8a24-263d1763a9f3_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and contingencies (Note&#160;7)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description</link:label>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_label_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_4050fee2-9094-4d65-ab0e-da8f5e4ca612_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets, technology</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Asset Acquired, Identifiable Intangible Asset, Finite-Lived</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_2b139df6-a2ff-4d9d-9e16-29c18aea9c1d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combination [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_1c59178c-61bd-4d8f-9fb2-69679c9e31c0_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_b00fcf17-090a-41c8-9937-8159f79d40dc_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underwriting discounts and commissions</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_AssetAcquisitionEquityOwnershipPercentage_f9c157aa-2142-42a0-bdac-657d5d8cce96_terseLabel_en-US" xlink:label="lab_rxrx_AssetAcquisitionEquityOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest acquired</link:label>
    <link:label id="lab_rxrx_AssetAcquisitionEquityOwnershipPercentage_label_en-US" xlink:label="lab_rxrx_AssetAcquisitionEquityOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition, Equity Ownership, Percentage</link:label>
    <link:label id="lab_rxrx_AssetAcquisitionEquityOwnershipPercentage_documentation_en-US" xlink:label="lab_rxrx_AssetAcquisitionEquityOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Asset Acquisition, Equity Ownership, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AssetAcquisitionEquityOwnershipPercentage" xlink:href="rxrx-20250930.xsd#rxrx_AssetAcquisitionEquityOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_AssetAcquisitionEquityOwnershipPercentage" xlink:to="lab_rxrx_AssetAcquisitionEquityOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable_90de6af0-77e2-4bf2-9625-29c779b2d690_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recursion Class A common stock</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition, Consideration Transferred, Equity Interest Issued and Issuable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:to="lab_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_5351ac71-67f5-41b4-b697-ce83ab77a605_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_182fa52a-8e78-415b-8186-e53cb087a204_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other assets, non-current</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Asset Acquired, Other Asset, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_AtTheMarketOfferingProgramCitiMember_33553c7e-1417-4538-86f7-d35c731627ec_terseLabel_en-US" xlink:label="lab_rxrx_AtTheMarketOfferingProgramCitiMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">At-The-Market Offering Program Citi</link:label>
    <link:label id="lab_rxrx_AtTheMarketOfferingProgramCitiMember_label_en-US" xlink:label="lab_rxrx_AtTheMarketOfferingProgramCitiMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">At-The-Market Offering Program Citi [Member]</link:label>
    <link:label id="lab_rxrx_AtTheMarketOfferingProgramCitiMember_documentation_en-US" xlink:label="lab_rxrx_AtTheMarketOfferingProgramCitiMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">At-The-Market Offering Program Citi</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AtTheMarketOfferingProgramCitiMember" xlink:href="rxrx-20250930.xsd#rxrx_AtTheMarketOfferingProgramCitiMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_AtTheMarketOfferingProgramCitiMember" xlink:to="lab_rxrx_AtTheMarketOfferingProgramCitiMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_7cb19a73-18b5-45d0-8c75-0b02f2b74bad_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity method investment ownership percentage</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock_a67ae899-797f-4909-aeee-f7fecd13e89b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Financial Instruments Not Measured at Fair Value</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock" xlink:to="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock_553bdca6-af9c-4fd8-b5d3-25a6f829c53b_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Contingent Consideration Transferred</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition, Contingent Consideration [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock" xlink:to="lab_us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_terseLabel_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Securities</link:label>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_label_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Underlying Securities Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:to="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_CommonStockVotePerShare_f122b835-302e-4e20-824a-8949f0a53542_terseLabel_en-US" xlink:label="lab_rxrx_CommonStockVotePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vote per share of common stock (in votes)</link:label>
    <link:label id="lab_rxrx_CommonStockVotePerShare_label_en-US" xlink:label="lab_rxrx_CommonStockVotePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Vote Per Share</link:label>
    <link:label id="lab_rxrx_CommonStockVotePerShare_documentation_en-US" xlink:label="lab_rxrx_CommonStockVotePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Common Stock, Vote Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_CommonStockVotePerShare" xlink:href="rxrx-20250930.xsd#rxrx_CommonStockVotePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_CommonStockVotePerShare" xlink:to="lab_rxrx_CommonStockVotePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables_30909461-0fa2-45a3-81e1-f03b890e7f68_terseLabel_en-US" xlink:label="lab_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables_label_en-US" xlink:label="lab_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Receivables</link:label>
    <link:label id="lab_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables_documentation_en-US" xlink:label="lab_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables" xlink:href="rxrx-20250930.xsd#rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables" xlink:to="lab_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_a7b9fb4c-c240-4d3e-b6cb-a083200937cb_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_f3daea15-e5e9-42f7-8dbb-83d27226d2e1_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_label_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoActuallyPaidCompAmt" xlink:to="lab_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_a97e1d79-1ab9-4230-abe2-d4a4dabadb20_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_1d2bf4eb-6c77-4c21-a435-b105210d03cb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonClassAMember_bb9d2e78-a7d2-4c43-84f2-5781110d4ff9_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonClassAMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Class A Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonClassAMember_b0460e87-078e-4de6-8992-7db32b73c6de_terseLabel_en-US" xlink:label="lab_us-gaap_CommonClassAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class A Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonClassAMember_label_en-US" xlink:label="lab_us-gaap_CommonClassAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Class A [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonClassAMember" xlink:to="lab_us-gaap_CommonClassAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_country_GB_87a09aec-0345-46ef-bab0-7cd3017d16d5_terseLabel_en-US" xlink:label="lab_country_GB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">United Kingdom</link:label>
    <link:label id="lab_country_GB_label_en-US" xlink:label="lab_country_GB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">UNITED KINGDOM</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_GB"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_GB" xlink:to="lab_country_GB" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_91cb28ef-eb91-458a-9267-7a1f306dc359_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options, exercisable, weighted average remaining contractual life</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_fff67ded-c527-471b-bf63-68ef74e02bd3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Liability Assumed, Deferred Tax Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_AlphaBiotechnologyGmbHAlphaMember_503377fe-5778-4db4-b7be-ffef96d05f77_terseLabel_en-US" xlink:label="lab_rxrx_AlphaBiotechnologyGmbHAlphaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Alpha Biotechnology GmbH (Alpha)</link:label>
    <link:label id="lab_rxrx_AlphaBiotechnologyGmbHAlphaMember_label_en-US" xlink:label="lab_rxrx_AlphaBiotechnologyGmbHAlphaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alpha Biotechnology GmbH (Alpha) [Member]</link:label>
    <link:label id="lab_rxrx_AlphaBiotechnologyGmbHAlphaMember_documentation_en-US" xlink:label="lab_rxrx_AlphaBiotechnologyGmbHAlphaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Alpha Biotechnology GmbH (Alpha)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AlphaBiotechnologyGmbHAlphaMember" xlink:href="rxrx-20250930.xsd#rxrx_AlphaBiotechnologyGmbHAlphaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_AlphaBiotechnologyGmbHAlphaMember" xlink:to="lab_rxrx_AlphaBiotechnologyGmbHAlphaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionTableTextBlock_a4fe91d1-5f2b-4d74-a9ed-cb92612c7c21_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Asset Acquisition</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionTableTextBlock_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionTableTextBlock" xlink:to="lab_us-gaap_AssetAcquisitionTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_ResearchMilestonesMember_4cc44da4-9b14-49e2-bb8b-ab7d66e28080_terseLabel_en-US" xlink:label="lab_rxrx_ResearchMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research Milestones</link:label>
    <link:label id="lab_rxrx_ResearchMilestonesMember_label_en-US" xlink:label="lab_rxrx_ResearchMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research Milestones [Member]</link:label>
    <link:label id="lab_rxrx_ResearchMilestonesMember_documentation_en-US" xlink:label="lab_rxrx_ResearchMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Research Milestones</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ResearchMilestonesMember" xlink:href="rxrx-20250930.xsd#rxrx_ResearchMilestonesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_ResearchMilestonesMember" xlink:to="lab_rxrx_ResearchMilestonesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_096df622-2c89-4bc6-ae4f-5c156727c3f2_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_a3fabe20-9fee-46cf-bbca-715e2e895518_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_0bdcd824-fb97-401f-a7c5-e1ca155164f7_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryIndName" xlink:to="lab_ecd_OutstandingRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_6a57928e-4876-409f-9fe5-8920d04b45dd_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_0027e815-2153-4ab7-9e61-7452306f964f_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_864a7991-95b5-4f87-987f-4dc66c1e5f96_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionDomain_476fd928-8527-4b02-bb2a-79e9c7621893_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionDomain_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionDomain" xlink:to="lab_us-gaap_AssetAcquisitionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_46a3fb30-a304-4f02-ac8d-542e04829c8e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of common shares, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5f3bf063-6982-4b39-b848-3c4c211dd7f9_netLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Total revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_80bb338d-7ae3-4bc1-8073-f5966bfdc5d8_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7a7051e9-fe2e-4b6d-b47b-1cf581d80496_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllIndividualsMember_terseLabel_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Individuals</link:label>
    <link:label id="lab_ecd_AllIndividualsMember_label_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Individuals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="lab_ecd_AllIndividualsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_0077fad2-1131-40e1-83ee-8224133eb347_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_TempusLabsIncMember_66fd9d7a-3b7e-49e1-a779-8a59ac197ad9_terseLabel_en-US" xlink:label="lab_rxrx_TempusLabsIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tempus Labs, Inc</link:label>
    <link:label id="lab_rxrx_TempusLabsIncMember_label_en-US" xlink:label="lab_rxrx_TempusLabsIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tempus Labs, Inc [Member]</link:label>
    <link:label id="lab_rxrx_TempusLabsIncMember_documentation_en-US" xlink:label="lab_rxrx_TempusLabsIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tempus Labs, Inc</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_TempusLabsIncMember" xlink:href="rxrx-20250930.xsd#rxrx_TempusLabsIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_TempusLabsIncMember" xlink:to="lab_rxrx_TempusLabsIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_PurchaseOfAnEquityInvestmentNonCash_c7a8d691-2d91-4001-8d10-4c0793d4e215_terseLabel_en-US" xlink:label="lab_rxrx_PurchaseOfAnEquityInvestmentNonCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase of an equity investment</link:label>
    <link:label id="lab_rxrx_PurchaseOfAnEquityInvestmentNonCash_label_en-US" xlink:label="lab_rxrx_PurchaseOfAnEquityInvestmentNonCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase Of An Equity Investment, Non-Cash</link:label>
    <link:label id="lab_rxrx_PurchaseOfAnEquityInvestmentNonCash_documentation_en-US" xlink:label="lab_rxrx_PurchaseOfAnEquityInvestmentNonCash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Purchase Of An Equity Investment, Non-Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_PurchaseOfAnEquityInvestmentNonCash" xlink:href="rxrx-20250930.xsd#rxrx_PurchaseOfAnEquityInvestmentNonCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_PurchaseOfAnEquityInvestmentNonCash" xlink:to="lab_rxrx_PurchaseOfAnEquityInvestmentNonCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2b8a6d2f-03b6-4db4-b991-acc473a40f89_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionConsiderationTransferred_e1d18ead-acf9-4789-866c-3e664b89e47c_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset acquisition, consideration transferred</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionConsiderationTransferred_c0fa3297-018f-4910-9d57-4adf38e4b927_totalLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionConsiderationTransferred_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionConsiderationTransferred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:to="lab_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryIndName" xlink:to="lab_ecd_ForgoneRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_d8c4110e-f9e3-423a-b88f-e4872e6d1ef7_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock options, expiration period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_5c271d4a-29a5-4f8b-968c-01ecc9d8b1e3_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_f3364d59-e911-4537-aa85-96a1acb05fc7_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_label_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:to="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_e8cb4a52-bdee-4a87-b7ce-beabfaeb2f2f_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_f4c4bce6-4e07-4d7d-856f-a7f8ca495b95_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss contingency accrual</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_20141f4f-dc7d-4742-81fd-83f0fd7543ed_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from equity incentive plans</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_AccruedDataCurrent_89067c94-d25d-4232-a5b9-089b8facc695_terseLabel_en-US" xlink:label="lab_rxrx_AccruedDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued data liability</link:label>
    <link:label id="lab_rxrx_AccruedDataCurrent_label_en-US" xlink:label="lab_rxrx_AccruedDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Data, Current</link:label>
    <link:label id="lab_rxrx_AccruedDataCurrent_documentation_en-US" xlink:label="lab_rxrx_AccruedDataCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Data, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AccruedDataCurrent" xlink:href="rxrx-20250930.xsd#rxrx_AccruedDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_AccruedDataCurrent" xlink:to="lab_rxrx_AccruedDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_7bd55b7e-5055-43bc-8dad-9377a3147b07_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivablesNetCurrent" xlink:to="lab_us-gaap_OtherReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_AggtErrCompAmt_label_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompAmt" xlink:to="lab_ecd_AggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_1ee802fe-27ab-46bc-afe2-03e017a52f8a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Foreign Currency Translation, Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5206f423-7dc1-41dd-8711-fa61f3d5c212_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_ef127b6e-43c1-481c-b5a9-f871c452a584_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise, intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_SaleOfStockUnderwritersOptionPeriodFromTheDateOfTheAgreement_db9b4019-9b0b-4db6-a249-b9a41ff6fc02_terseLabel_en-US" xlink:label="lab_rxrx_SaleOfStockUnderwritersOptionPeriodFromTheDateOfTheAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of stock, underwriters option period from the date of the agreement</link:label>
    <link:label id="lab_rxrx_SaleOfStockUnderwritersOptionPeriodFromTheDateOfTheAgreement_label_en-US" xlink:label="lab_rxrx_SaleOfStockUnderwritersOptionPeriodFromTheDateOfTheAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale Of Stock, Underwriters Option Period From The Date Of The Agreement</link:label>
    <link:label id="lab_rxrx_SaleOfStockUnderwritersOptionPeriodFromTheDateOfTheAgreement_documentation_en-US" xlink:label="lab_rxrx_SaleOfStockUnderwritersOptionPeriodFromTheDateOfTheAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sale Of Stock, Underwriters Option Period From The Date Of The Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SaleOfStockUnderwritersOptionPeriodFromTheDateOfTheAgreement" xlink:href="rxrx-20250930.xsd#rxrx_SaleOfStockUnderwritersOptionPeriodFromTheDateOfTheAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_SaleOfStockUnderwritersOptionPeriodFromTheDateOfTheAgreement" xlink:to="lab_rxrx_SaleOfStockUnderwritersOptionPeriodFromTheDateOfTheAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_SaleOfStockPercentageOfCommission_0b147aee-64c3-4300-95a5-1e758fe6000e_terseLabel_en-US" xlink:label="lab_rxrx_SaleOfStockPercentageOfCommission" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of stock, percentage of commission</link:label>
    <link:label id="lab_rxrx_SaleOfStockPercentageOfCommission_label_en-US" xlink:label="lab_rxrx_SaleOfStockPercentageOfCommission" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale Of Stock, Percentage Of Commission</link:label>
    <link:label id="lab_rxrx_SaleOfStockPercentageOfCommission_documentation_en-US" xlink:label="lab_rxrx_SaleOfStockPercentageOfCommission" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sale Of Stock, Percentage Of Commission</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SaleOfStockPercentageOfCommission" xlink:href="rxrx-20250930.xsd#rxrx_SaleOfStockPercentageOfCommission"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_SaleOfStockPercentageOfCommission" xlink:to="lab_rxrx_SaleOfStockPercentageOfCommission" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_TerminationOfLeaseFee_512bb0ce-87f4-4cc4-8c4c-8cfb6bcc10af_terseLabel_en-US" xlink:label="lab_rxrx_TerminationOfLeaseFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Termination of lease fee</link:label>
    <link:label id="lab_rxrx_TerminationOfLeaseFee_label_en-US" xlink:label="lab_rxrx_TerminationOfLeaseFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Termination Of Lease Fee</link:label>
    <link:label id="lab_rxrx_TerminationOfLeaseFee_documentation_en-US" xlink:label="lab_rxrx_TerminationOfLeaseFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Termination Of Lease Fee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_TerminationOfLeaseFee" xlink:href="rxrx-20250930.xsd#rxrx_TerminationOfLeaseFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_TerminationOfLeaseFee" xlink:to="lab_rxrx_TerminationOfLeaseFee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_68c61054-d381-41f6-a1e8-01bcccca7996_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments to acquire IPR&amp;D</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire in Process Research and Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" xlink:to="lab_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_label_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:to="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration_a94d75d5-293d-440e-9ba0-627901cb1857_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration liability</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration_5a3b5dd5-7b81-47ac-a87b-78dbd60b828e_totalLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration liability</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition, Consideration Transferred, Contingent Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration" xlink:to="lab_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_label_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompAnalysisTextBlock" xlink:to="lab_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_IncreaseDecreaseInPrepaidDataAssets_f25e71d7-79af-4fa3-bbd3-5722e5540a14_negatedLabel_en-US" xlink:label="lab_rxrx_IncreaseDecreaseInPrepaidDataAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Prepaid data assets</link:label>
    <link:label id="lab_rxrx_IncreaseDecreaseInPrepaidDataAssets_label_en-US" xlink:label="lab_rxrx_IncreaseDecreaseInPrepaidDataAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Prepaid Data Assets</link:label>
    <link:label id="lab_rxrx_IncreaseDecreaseInPrepaidDataAssets_documentation_en-US" xlink:label="lab_rxrx_IncreaseDecreaseInPrepaidDataAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Prepaid Data Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_IncreaseDecreaseInPrepaidDataAssets" xlink:href="rxrx-20250930.xsd#rxrx_IncreaseDecreaseInPrepaidDataAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_IncreaseDecreaseInPrepaidDataAssets" xlink:to="lab_rxrx_IncreaseDecreaseInPrepaidDataAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_c6ea3c9f-ab70-4ad5-8f6b-d39e439d05ee_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3599a253-64f7-4c08-a07f-3ff2d887ca04_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_8ed4ced9-ec5f-4f64-a8ab-98257a5d0637_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_e68a91bf-61e1-4425-aed6-1a409d85adcb_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_719e0e52-845c-4b67-a931-e922514db792_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:to="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_1981fbbf-f8af-4569-823b-d0b878eb3c9f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicenseAndServiceMember_08510b0e-a4d0-4949-a137-253445eba90f_terseLabel_en-US" xlink:label="lab_us-gaap_LicenseAndServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating revenue</link:label>
    <link:label id="lab_us-gaap_LicenseAndServiceMember_label_en-US" xlink:label="lab_us-gaap_LicenseAndServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License and Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseAndServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LicenseAndServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicenseAndServiceMember" xlink:to="lab_us-gaap_LicenseAndServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_375a4897-7d82-468b-9054-418753280637_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_45fa4b54-edc8-4ffe-9a9a-59ccd09b63da_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Pro Forma Information, Pro Forma Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_70ba8840-504e-404d-b455-fff0c18cd812_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems" xlink:to="lab_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_43047a52-d601-4344-b40a-3eaf853e56bb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Liability Assumed, Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_ec0eaf6c-52e0-4258-9319-27be43cce2a4_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net loss per share of class A, B and Exchangeable common stock, diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_bd378844-366c-47c5-af59-91084e5968b0_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss per share, diluted (in dollars per shares)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_d276a84d-01be-4be8-96d9-f2e70cd6cdcb_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Other Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_e8dfede5-14d4-4262-a3bf-dd2f69e60fb0_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost, Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets_9c4a4626-e2f6-4875-9708-5d6c8e40ebbc_verboseLabel_en-US" xlink:label="lab_rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Increase (decrease) in operating lease right-of-use assets</link:label>
    <link:label id="lab_rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets_4c848565-01cf-4b7d-8ccb-f46d12cc193e_terseLabel_en-US" xlink:label="lab_rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets_label_en-US" xlink:label="lab_rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Lease Right-Of-Use Assets</link:label>
    <link:label id="lab_rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets_documentation_en-US" xlink:label="lab_rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Lease Right-Of-Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" xlink:href="rxrx-20250930.xsd#rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" xlink:to="lab_rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompRecoveryTable_terseLabel_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery</link:label>
    <link:label id="lab_ecd_ErrCompRecoveryTable_label_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompRecoveryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="lab_ecd_ErrCompRecoveryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_e659aee5-bda1-4841-a291-64182663375a_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_23f9f550-7774-42ad-b0b4-f6cf3acab4d0_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_BusinessCombinationConsiderationTransferredEquityInterestsIssuable_600d5d70-8c25-4370-a549-7fff2dd5562a_terseLabel_en-US" xlink:label="lab_rxrx_BusinessCombinationConsiderationTransferredEquityInterestsIssuable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of stock and equity awards</link:label>
    <link:label id="lab_rxrx_BusinessCombinationConsiderationTransferredEquityInterestsIssuable_label_en-US" xlink:label="lab_rxrx_BusinessCombinationConsiderationTransferredEquityInterestsIssuable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interests Issuable</link:label>
    <link:label id="lab_rxrx_BusinessCombinationConsiderationTransferredEquityInterestsIssuable_documentation_en-US" xlink:label="lab_rxrx_BusinessCombinationConsiderationTransferredEquityInterestsIssuable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interests Issuable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_BusinessCombinationConsiderationTransferredEquityInterestsIssuable" xlink:href="rxrx-20250930.xsd#rxrx_BusinessCombinationConsiderationTransferredEquityInterestsIssuable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_BusinessCombinationConsiderationTransferredEquityInterestsIssuable" xlink:to="lab_rxrx_BusinessCombinationConsiderationTransferredEquityInterestsIssuable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_1ae13b40-638a-4f40-9a0f-16ebe2323673_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_29a57cc7-7ab3-4fba-9ea5-5de6edc1cbf4_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Per share data</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_d5901d0c-d925-4bbc-a458-db828eb760dc_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_5d8c23cc-d7e4-47dc-ad55-9fd57636507f_verboseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other non-operating income (loss), net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_DevelopedAndCommercializedProgramsMember_e9558f70-a35d-41b1-9852-6ffc010d9fba_terseLabel_en-US" xlink:label="lab_rxrx_DevelopedAndCommercializedProgramsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Developed and Commercialized Programs</link:label>
    <link:label id="lab_rxrx_DevelopedAndCommercializedProgramsMember_label_en-US" xlink:label="lab_rxrx_DevelopedAndCommercializedProgramsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Developed And Commercialized Programs [Member]</link:label>
    <link:label id="lab_rxrx_DevelopedAndCommercializedProgramsMember_documentation_en-US" xlink:label="lab_rxrx_DevelopedAndCommercializedProgramsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Developed And Commercialized Programs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_DevelopedAndCommercializedProgramsMember" xlink:href="rxrx-20250930.xsd#rxrx_DevelopedAndCommercializedProgramsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_DevelopedAndCommercializedProgramsMember" xlink:to="lab_rxrx_DevelopedAndCommercializedProgramsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionTable_704121fa-5b91-4503-9aab-22b47be8a490_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionTable" xlink:to="lab_us-gaap_AssetAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_347a8c00-8833-46fe-8990-f71057d24ba9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_eb3526bc-df5c-4a64-acb6-65b81bfbfc2e_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Interest Income, Net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Income and Interest Expense Disclosure [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:to="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_513f3a25-bba2-4b4e-9320-bfd60cb59562_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unearned revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_ReportableSegmentMember_89700742-4403-45fe-a952-44591bf4f6b8_terseLabel_en-US" xlink:label="lab_rxrx_ReportableSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reportable Segment</link:label>
    <link:label id="lab_rxrx_ReportableSegmentMember_label_en-US" xlink:label="lab_rxrx_ReportableSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reportable Segment [Member]</link:label>
    <link:label id="lab_rxrx_ReportableSegmentMember_documentation_en-US" xlink:label="lab_rxrx_ReportableSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Reportable Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ReportableSegmentMember" xlink:href="rxrx-20250930.xsd#rxrx_ReportableSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_ReportableSegmentMember" xlink:to="lab_rxrx_ReportableSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_PhenomapsCreationMember_57ba2b5a-0084-4b73-bf38-eed45883d1b9_terseLabel_en-US" xlink:label="lab_rxrx_PhenomapsCreationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Phenomaps Creation</link:label>
    <link:label id="lab_rxrx_PhenomapsCreationMember_label_en-US" xlink:label="lab_rxrx_PhenomapsCreationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Phenomaps Creation [Member]</link:label>
    <link:label id="lab_rxrx_PhenomapsCreationMember_documentation_en-US" xlink:label="lab_rxrx_PhenomapsCreationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Phenomaps Creation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_PhenomapsCreationMember" xlink:href="rxrx-20250930.xsd#rxrx_PhenomapsCreationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_PhenomapsCreationMember" xlink:to="lab_rxrx_PhenomapsCreationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_RegistrationRightsAgreementTerm_c1cd861f-e596-4f55-82dd-c1da57a372da_terseLabel_en-US" xlink:label="lab_rxrx_RegistrationRightsAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Registration rights agreement term</link:label>
    <link:label id="lab_rxrx_RegistrationRightsAgreementTerm_label_en-US" xlink:label="lab_rxrx_RegistrationRightsAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Registration Rights Agreement, Term</link:label>
    <link:label id="lab_rxrx_RegistrationRightsAgreementTerm_documentation_en-US" xlink:label="lab_rxrx_RegistrationRightsAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Registration Rights Agreement, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RegistrationRightsAgreementTerm" xlink:href="rxrx-20250930.xsd#rxrx_RegistrationRightsAgreementTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_RegistrationRightsAgreementTerm" xlink:to="lab_rxrx_RegistrationRightsAgreementTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities_6f846fd0-92d4-43ba-bb1f-1050af649f84_negatedTerseLabel_en-US" xlink:label="lab_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities_label_en-US" xlink:label="lab_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Lease Liabilities</link:label>
    <link:label id="lab_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities_documentation_en-US" xlink:label="lab_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities" xlink:href="rxrx-20250930.xsd#rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities" xlink:to="lab_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2f5f4bee-ffc0-4f6e-addd-c1590cba447c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_889894b9-9014-4426-b7b0-e9eb793910a3_terseLabel_en-US" xlink:label="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of RSU Activity</link:label>
    <link:label id="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonvested Restricted Stock Shares Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:to="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_0dd45ec2-e026-4dcd-a224-8fea6e95c4e8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgDiscLineItems_label_en-US" xlink:label="lab_ecd_AwardTmgDiscLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="lab_ecd_AwardTmgDiscLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_ebb2a63b-32e7-4d81-971d-7f08e4ad71fb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_ff3c86eb-54fe-4eca-987a-5755cfe69b57_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_1a012c3b-94bf-4434-a01e-34dbf84bdaa1_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_729317ee-b772-4cc5-a0ec-df8eab7aa904_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease, renewal term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_8b8aaee9-cfe8-4dd2-81f4-4576fcdce865_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquired IPR&amp;D</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Asset Acquired in Transaction Other than Business Combination or Joint Venture Formation, Writeoff</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" xlink:to="lab_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_67bbdfd5-3d5c-4288-9871-3faf0b89e394_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_a79a834a-2974-4aa2-a3f2-754849c6d16f_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_eeee3800-2bdc-414e-b36c-771cb5391a04_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_b0131857-e1b2-436b-abec-c3ca355a504d_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_a379e94b-bacc-4ba2-b99d-c8f84319ba20_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Total segment loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_08b53813-04b5-45a9-b176-60f8c496e05a_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_PaymentsToAcquireIntangibleAssetsFinancialActivities_022870a8-cdb6-49eb-b89a-b8488b783b23_negatedTerseLabel_en-US" xlink:label="lab_rxrx_PaymentsToAcquireIntangibleAssetsFinancialActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchase of an intangible asset</link:label>
    <link:label id="lab_rxrx_PaymentsToAcquireIntangibleAssetsFinancialActivities_label_en-US" xlink:label="lab_rxrx_PaymentsToAcquireIntangibleAssetsFinancialActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Intangible Assets, Financial Activities</link:label>
    <link:label id="lab_rxrx_PaymentsToAcquireIntangibleAssetsFinancialActivities_documentation_en-US" xlink:label="lab_rxrx_PaymentsToAcquireIntangibleAssetsFinancialActivities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payments to Acquire Intangible Assets, Financial Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_PaymentsToAcquireIntangibleAssetsFinancialActivities" xlink:href="rxrx-20250930.xsd#rxrx_PaymentsToAcquireIntangibleAssetsFinancialActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_PaymentsToAcquireIntangibleAssetsFinancialActivities" xlink:to="lab_rxrx_PaymentsToAcquireIntangibleAssetsFinancialActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrExpirationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expiration Date</link:label>
    <link:label id="lab_ecd_TrdArrExpirationDate_label_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Expiration Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrExpirationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrExpirationDate" xlink:to="lab_ecd_TrdArrExpirationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_db59ffdd-9b14-414d-93cc-d4b2abf24262_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued other expenses</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_b17b12a8-4306-48fb-be3c-029515d6d725_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock options, vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_37d97502-a610-4db9-8a15-018a5ca384ac_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_fb22f308-f164-452a-86ae-925f8a714fc9_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_46132e3a-38ee-456b-92d2-af173eba8cb3_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expense</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrAdoptionDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adoption Date</link:label>
    <link:label id="lab_ecd_TrdArrAdoptionDate_label_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Adoption Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrAdoptionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrAdoptionDate" xlink:to="lab_ecd_TrdArrAdoptionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_ClinicalDevelopmentExpense_570462ed-cafa-4027-8226-4e5d3b0af350_terseLabel_en-US" xlink:label="lab_rxrx_ClinicalDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Clinical development</link:label>
    <link:label id="lab_rxrx_ClinicalDevelopmentExpense_label_en-US" xlink:label="lab_rxrx_ClinicalDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Clinical Development Expense</link:label>
    <link:label id="lab_rxrx_ClinicalDevelopmentExpense_documentation_en-US" xlink:label="lab_rxrx_ClinicalDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Clinical Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ClinicalDevelopmentExpense" xlink:href="rxrx-20250930.xsd#rxrx_ClinicalDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_ClinicalDevelopmentExpense" xlink:to="lab_rxrx_ClinicalDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_953d58fc-0194-41d1-bb63-aa56949a77ee_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_97646714-3220-4d8f-b0d0-9b7a36479bf6_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_fade1069-ec7c-472d-ad87-0b2e64f94a2a_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_e8245f67-7b32-49c2-ab7d-5b4c6e7bae96_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_122d265f-2a49-49f6-88a3-ceebc5a6c0f7_negatedLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_DevelopmentAndRegulatoryMilestonesMember_f96d9d6c-9194-417c-81fd-1d7dc508284c_terseLabel_en-US" xlink:label="lab_rxrx_DevelopmentAndRegulatoryMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Development And Regulatory Milestones</link:label>
    <link:label id="lab_rxrx_DevelopmentAndRegulatoryMilestonesMember_label_en-US" xlink:label="lab_rxrx_DevelopmentAndRegulatoryMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Development And Regulatory Milestones [Member]</link:label>
    <link:label id="lab_rxrx_DevelopmentAndRegulatoryMilestonesMember_documentation_en-US" xlink:label="lab_rxrx_DevelopmentAndRegulatoryMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Development And Regulatory Milestones</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_DevelopmentAndRegulatoryMilestonesMember" xlink:href="rxrx-20250930.xsd#rxrx_DevelopmentAndRegulatoryMilestonesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_DevelopmentAndRegulatoryMilestonesMember" xlink:to="lab_rxrx_DevelopmentAndRegulatoryMilestonesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_terseLabel_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_label_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:to="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_terseLabel_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Executive Category:</link:label>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_label_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Executive Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="lab_ecd_ExecutiveCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_5bfaa4c7-2adc-49f3-b1b9-cf37d981c2e1_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment of indefinite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_AtTheMarketOfferingProgramJefferiesMember_7c967938-806e-404c-ab18-2c75a2079c6b_terseLabel_en-US" xlink:label="lab_rxrx_AtTheMarketOfferingProgramJefferiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">At-The-Market Offering Program Jefferies</link:label>
    <link:label id="lab_rxrx_AtTheMarketOfferingProgramJefferiesMember_label_en-US" xlink:label="lab_rxrx_AtTheMarketOfferingProgramJefferiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">At-The-Market Offering Program Jefferies [Member]</link:label>
    <link:label id="lab_rxrx_AtTheMarketOfferingProgramJefferiesMember_documentation_en-US" xlink:label="lab_rxrx_AtTheMarketOfferingProgramJefferiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">At-The-Market Offering Program Jefferies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AtTheMarketOfferingProgramJefferiesMember" xlink:href="rxrx-20250930.xsd#rxrx_AtTheMarketOfferingProgramJefferiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_AtTheMarketOfferingProgramJefferiesMember" xlink:to="lab_rxrx_AtTheMarketOfferingProgramJefferiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_AssetAcquisitionContingentConsiderationCashPaid_764b4790-0779-499e-9486-646a8f4d1453_terseLabel_en-US" xlink:label="lab_rxrx_AssetAcquisitionContingentConsiderationCashPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash paid</link:label>
    <link:label id="lab_rxrx_AssetAcquisitionContingentConsiderationCashPaid_label_en-US" xlink:label="lab_rxrx_AssetAcquisitionContingentConsiderationCashPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition, Contingent Consideration, Cash Paid</link:label>
    <link:label id="lab_rxrx_AssetAcquisitionContingentConsiderationCashPaid_documentation_en-US" xlink:label="lab_rxrx_AssetAcquisitionContingentConsiderationCashPaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Asset Acquisition, Contingent Consideration, Cash Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AssetAcquisitionContingentConsiderationCashPaid" xlink:href="rxrx-20250930.xsd#rxrx_AssetAcquisitionContingentConsiderationCashPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_AssetAcquisitionContingentConsiderationCashPaid" xlink:to="lab_rxrx_AssetAcquisitionContingentConsiderationCashPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_e2f296fc-e490-422f-84b1-309f81d6df88_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_3146bfb7-4c18-4623-9747-c8a648cc566b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_0cfcd550-2a51-4b69-a284-4164b9dd0f58_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Definite-lived technology intangible assets</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_6f2bb60a-bce6-4160-b512-7c329245c1b1_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected term (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_fe08a887-5f7b-428e-b474-158a5ebb1a59_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_19bbb5e1-f80c-46c0-b604-0fc26bc4548b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_LicenseAgreementTradingPeriodUsedForEquityValueDetermination_969aa02b-0104-417e-9a26-2d010c5f63fa_terseLabel_en-US" xlink:label="lab_rxrx_LicenseAgreementTradingPeriodUsedForEquityValueDetermination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading period used for equity value determination</link:label>
    <link:label id="lab_rxrx_LicenseAgreementTradingPeriodUsedForEquityValueDetermination_label_en-US" xlink:label="lab_rxrx_LicenseAgreementTradingPeriodUsedForEquityValueDetermination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License Agreement, Trading Period Used For Equity Value Determination</link:label>
    <link:label id="lab_rxrx_LicenseAgreementTradingPeriodUsedForEquityValueDetermination_documentation_en-US" xlink:label="lab_rxrx_LicenseAgreementTradingPeriodUsedForEquityValueDetermination" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">License Agreement, Trading Period Used For Equity Value Determination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LicenseAgreementTradingPeriodUsedForEquityValueDetermination" xlink:href="rxrx-20250930.xsd#rxrx_LicenseAgreementTradingPeriodUsedForEquityValueDetermination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_LicenseAgreementTradingPeriodUsedForEquityValueDetermination" xlink:to="lab_rxrx_LicenseAgreementTradingPeriodUsedForEquityValueDetermination" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_02254d75-d309-4b4a-85d9-1b85f2b0b73f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average grant date fair value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_840a1cf0-5c8a-4af8-a9f8-fa87fd337196_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares available for grant (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_29c3391b-bd32-42fd-9d0f-3dc6f41dad36_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfLeasehold_5d2163a7-8dee-4be6-aa1a-a6c9bf2bc906_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLeasehold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment of leasehold improvements</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLeasehold_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfLeasehold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment of Leasehold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLeasehold" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOfLeasehold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLeasehold" xlink:to="lab_us-gaap_ImpairmentOfLeasehold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1_7ce8efa2-2c58-41b2-8f0e-d1bccf61b294_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase of an intangible asset</link:label>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1_label_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncash or Part Noncash Acquisition, Intangible Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1" xlink:to="lab_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_60259e8a-fce0-4c84-a1c0-a1673ddcec0c_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_aaa2cab6-632d-46d7-8a92-d56241db5a9f_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Development Contracts</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6500dc0c-b77b-41e5-8dd6-ff3fb0c1d445_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashMember_2aa42c32-747f-43c8-accd-71c7b2b4f275_terseLabel_en-US" xlink:label="lab_us-gaap_CashMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_CashMember_label_en-US" xlink:label="lab_us-gaap_CashMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashMember" xlink:to="lab_us-gaap_CashMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_45ea8e52-3d8d-4aa2-abdc-60877795f397_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options granted in period, weighted average grant date fair value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_0883380c-6f13-47ed-86a1-b908d25de458_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets acquired and liabilities assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less), and Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_OtherCountriesMember_266e530c-9f12-47bb-8d51-4eedebe2002d_terseLabel_en-US" xlink:label="lab_rxrx_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_rxrx_OtherCountriesMember_label_en-US" xlink:label="lab_rxrx_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Countries [Member]</link:label>
    <link:label id="lab_rxrx_OtherCountriesMember_documentation_en-US" xlink:label="lab_rxrx_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Countries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_OtherCountriesMember" xlink:href="rxrx-20250930.xsd#rxrx_OtherCountriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_OtherCountriesMember" xlink:to="lab_rxrx_OtherCountriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_f872e9ff-2af2-4dc2-951d-89e38cdd2423_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remaining unearned revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_67eba7aa-ca42-47ca-a84a-52cbcd450391_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_33121949-4b2f-4c9e-93ad-aea0eb5c5b41_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class A shares issued for asset acquisition</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_a7a6204c-782b-4532-b79c-ab85047463cb_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total identifiable net assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2e94523e-d7c6-4798-bd74-e8f796d8d229_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive securities excluded from computation of loss per share, amount (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_a529b82b-f753-4d4b-ac36-2f7bcd97eedb_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllAdjToCompMember_terseLabel_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation</link:label>
    <link:label id="lab_ecd_AllAdjToCompMember_label_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllAdjToCompMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="lab_ecd_AllAdjToCompMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_db7cbc97-e774-4792-a42b-69cd39a8cb51_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_eacf752a-278e-47c8-8f5d-a76f20cf38dc_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_64f98fe7-e265-4b23-b99c-3c3d97112a34_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Price per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated_d2a3e14d-3427-4840-b8a4-51075f3b91a4_terseLabel_en-US" xlink:label="lab_rxrx_RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of projects that may be initiated</link:label>
    <link:label id="lab_rxrx_RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated_label_en-US" xlink:label="lab_rxrx_RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Number Of Projects That May Be Initiated</link:label>
    <link:label id="lab_rxrx_RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated_documentation_en-US" xlink:label="lab_rxrx_RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Number Of Projects That May Be Initiated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated" xlink:href="rxrx-20250930.xsd#rxrx_RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated" xlink:to="lab_rxrx_RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_0b93c075-44e8-4315-98a0-9fb11e3af449_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrTerminationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Termination Date</link:label>
    <link:label id="lab_ecd_TrdArrTerminationDate_label_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Termination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrTerminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrTerminationDate" xlink:to="lab_ecd_TrdArrTerminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_5ae054d5-dc6d-47fe-9a5d-b914c949f2b7_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Financing Activity, Including Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureAxis_terseLabel_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measure:</link:label>
    <link:label id="lab_ecd_MeasureAxis_label_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureAxis" xlink:to="lab_ecd_MeasureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_bf956a53-2709-4948-98bc-e39851b383c4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets, indefinite-lived</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Asset Acquired, Identifiable Intangible Asset, Indefinite-Lived</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_0b484cca-621a-4208-b9a8-29000259b60c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock Option Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_0365c9b5-449a-4f99-a196-8471de1166c0_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_89fb656b-e3b0-4608-bde3-32ddad0c2a7f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net revenues</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Acquiree's Revenue since Acquisition Date, Actual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:to="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8b5f26fd-a42a-469d-8f74-7cbf88e894a1_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average shares (Class A, B and Exchangeable) outstanding, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_08f4df3a-0ebe-42d2-ba89-9db2b767a150_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average common shares outstanding, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_500b74d3-452d-43d1-b5e4-c306d363435d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_f921f694-6cde-4a46-9206-c62067a48ddb_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of revenue</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Product and Service Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_e3ec27cd-c5ce-4f07-b7b7-b73d971ba1cf_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_5fec253d-e01b-4b3a-9ff4-c2ee7472387e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Computation of Basic and Diluted Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_94265d84-1e34-4404-93f0-dce56d711f18_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_NumberOfClassesOfCommonStockAuthorized_90c84d86-d531-4e40-b022-929996c13d13_terseLabel_en-US" xlink:label="lab_rxrx_NumberOfClassesOfCommonStockAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of classes of common stock authorized</link:label>
    <link:label id="lab_rxrx_NumberOfClassesOfCommonStockAuthorized_label_en-US" xlink:label="lab_rxrx_NumberOfClassesOfCommonStockAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Classes Of Common Stock Authorized</link:label>
    <link:label id="lab_rxrx_NumberOfClassesOfCommonStockAuthorized_documentation_en-US" xlink:label="lab_rxrx_NumberOfClassesOfCommonStockAuthorized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Classes Of Common Stock Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_NumberOfClassesOfCommonStockAuthorized" xlink:href="rxrx-20250930.xsd#rxrx_NumberOfClassesOfCommonStockAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_NumberOfClassesOfCommonStockAuthorized" xlink:to="lab_rxrx_NumberOfClassesOfCommonStockAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
    <link:label id="lab_ecd_PvpTableTextBlock_label_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTableTextBlock" xlink:to="lab_ecd_PvpTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_d524c4ae-f875-40a0-95dc-1cbb5d86d086_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_375eacc4-1fb0-47c4-8242-8e161ef79cb4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_fd2ba09d-5868-493e-91dd-445d3160c7f9_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionAxis_c7467eeb-1196-4e14-92c6-dab1bb19d44f_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionAxis" xlink:to="lab_us-gaap_AssetAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_RevenueRemainingPerformanceObligationDomain_4cb9b338-5806-468e-80f8-ec6f9e0bd19f_terseLabel_en-US" xlink:label="lab_rxrx_RevenueRemainingPerformanceObligationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation [Domain]</link:label>
    <link:label id="lab_rxrx_RevenueRemainingPerformanceObligationDomain_label_en-US" xlink:label="lab_rxrx_RevenueRemainingPerformanceObligationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation [Domain]</link:label>
    <link:label id="lab_rxrx_RevenueRemainingPerformanceObligationDomain_documentation_en-US" xlink:label="lab_rxrx_RevenueRemainingPerformanceObligationDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RevenueRemainingPerformanceObligationDomain" xlink:href="rxrx-20250930.xsd#rxrx_RevenueRemainingPerformanceObligationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_RevenueRemainingPerformanceObligationDomain" xlink:to="lab_rxrx_RevenueRemainingPerformanceObligationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_babc7e42-37dd-47d5-94e1-b3c6643f36cc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable" xlink:to="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_deead063-e968-444b-9783-baca4954563c_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_70da5cd0-5945-4973-af97-ac98f4920ebb_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_19eb8442-3625-46bb-9de5-3c870a702255_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_dde0c540-975c-4716-924d-f85e1bab9d1a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_b354bb3b-3511-4864-84aa-75fc6e3ec5a6_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_521df0ff-1374-4ced-90e7-3f87bdb9aa5d_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_99fde285-e0ce-4a94-81aa-e4b831f55122_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract_d7db123d-f831-4cc9-8c71-709882e473d1_terseLabel_en-US" xlink:label="lab_rxrx_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Right-of-use assets additions, modifications and termination:</link:label>
    <link:label id="lab_rxrx_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract_label_en-US" xlink:label="lab_rxrx_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Right-Of-Use Assets Obtained In Exchange For Lease Liabilities [Abstract]</link:label>
    <link:label id="lab_rxrx_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract_documentation_en-US" xlink:label="lab_rxrx_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Right-Of-Use Assets Obtained In Exchange For Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract" xlink:href="rxrx-20250930.xsd#rxrx_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract" xlink:to="lab_rxrx_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_4e59cf81-ec24-4ddb-a824-dbd2e05cb435_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating cash flows from financing leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseNonoperating_beef2b99-f045-44b3-9572-989090dae51a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseNonoperating" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseNonoperating_label_en-US" xlink:label="lab_us-gaap_InterestExpenseNonoperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense, Nonoperating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseNonoperating" xlink:to="lab_us-gaap_InterestExpenseNonoperating" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_22704489-64cc-4351-8001-8d8a316251fc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrAxis_terseLabel_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangement:</link:label>
    <link:label id="lab_ecd_TradingArrAxis_label_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrAxis" xlink:to="lab_ecd_TradingArrAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnAmt" xlink:to="lab_ecd_TotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_ContractWithCustomerNumberOfNovelSmallMoleculeCandidates_81e22231-5cc4-44e9-aee8-f8652bf34b88_terseLabel_en-US" xlink:label="lab_rxrx_ContractWithCustomerNumberOfNovelSmallMoleculeCandidates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum number of novel small molecule candidates</link:label>
    <link:label id="lab_rxrx_ContractWithCustomerNumberOfNovelSmallMoleculeCandidates_label_en-US" xlink:label="lab_rxrx_ContractWithCustomerNumberOfNovelSmallMoleculeCandidates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract With Customer, Number Of Novel Small Molecule Candidates</link:label>
    <link:label id="lab_rxrx_ContractWithCustomerNumberOfNovelSmallMoleculeCandidates_documentation_en-US" xlink:label="lab_rxrx_ContractWithCustomerNumberOfNovelSmallMoleculeCandidates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contract With Customer, Number Of Novel Small Molecule Candidates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ContractWithCustomerNumberOfNovelSmallMoleculeCandidates" xlink:href="rxrx-20250930.xsd#rxrx_ContractWithCustomerNumberOfNovelSmallMoleculeCandidates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_ContractWithCustomerNumberOfNovelSmallMoleculeCandidates" xlink:to="lab_rxrx_ContractWithCustomerNumberOfNovelSmallMoleculeCandidates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_2fc60435-0952-45e7-8790-f512867ff0ff_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_2555e412-cf19-40e1-8658-f63186c2abeb_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingArrLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingArrLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="lab_ecd_InsiderTradingArrLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_ee4cbf74-96a8-4ac2-a06a-c419d17c1d2e_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_88d2ff61-2cf8-41e4-98ac-b1ba1b13bf34_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cancelled (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_d2500911-9855-45b2-bcda-d8322e147268_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock units</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_cd84072a-f372-408c-a982-4d5cde8cfbfe_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_b8bca915-3294-44e5-a000-5a9f281f87bb_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:to="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_edb30e7e-761b-47d5-bc24-e808894c3075_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_84af7146-5396-4fcd-9e7f-14481f6915a0_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued property and equipment</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_A2021EquityIncentivePlanMember_03ed4bef-157d-4de1-b63d-4ca519d094ec_terseLabel_en-US" xlink:label="lab_rxrx_A2021EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2021 Equity Incentive Plan</link:label>
    <link:label id="lab_rxrx_A2021EquityIncentivePlanMember_label_en-US" xlink:label="lab_rxrx_A2021EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2021 Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_rxrx_A2021EquityIncentivePlanMember_documentation_en-US" xlink:label="lab_rxrx_A2021EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2021 Equity Incentive Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_A2021EquityIncentivePlanMember" xlink:href="rxrx-20250930.xsd#rxrx_A2021EquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_A2021EquityIncentivePlanMember" xlink:to="lab_rxrx_A2021EquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:to="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_396481b7-c86b-4da2-bf0e-284f9555de5f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating costs and expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_27f20bbb-7a4e-472d-ba06-61dc975a887d_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid data assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="lab_us-gaap_PrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_terseLabel_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_label_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_FinanceLeasesAssetsPledgedAsCollateral_86f81234-5415-458f-aa6b-67f8eeac5d38_terseLabel_en-US" xlink:label="lab_rxrx_FinanceLeasesAssetsPledgedAsCollateral" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance leases, assets pledged as collateral</link:label>
    <link:label id="lab_rxrx_FinanceLeasesAssetsPledgedAsCollateral_label_en-US" xlink:label="lab_rxrx_FinanceLeasesAssetsPledgedAsCollateral" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Leases, Assets Pledged As Collateral</link:label>
    <link:label id="lab_rxrx_FinanceLeasesAssetsPledgedAsCollateral_documentation_en-US" xlink:label="lab_rxrx_FinanceLeasesAssetsPledgedAsCollateral" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Finance Leases, Assets Pledged As Collateral</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_FinanceLeasesAssetsPledgedAsCollateral" xlink:href="rxrx-20250930.xsd#rxrx_FinanceLeasesAssetsPledgedAsCollateral"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_FinanceLeasesAssetsPledgedAsCollateral" xlink:to="lab_rxrx_FinanceLeasesAssetsPledgedAsCollateral" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_eead7db1-de3f-49c0-bb40-1e12ae70f7e4_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock sales issuances, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_9879d95b-80e6-4cc4-9f3f-f72cfcc4ed20_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_SupplementalFinancialInformationAbstract_label_en-US" xlink:label="lab_rxrx_SupplementalFinancialInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Financial Information [Abstract]</link:label>
    <link:label id="lab_rxrx_SupplementalFinancialInformationAbstract_documentation_en-US" xlink:label="lab_rxrx_SupplementalFinancialInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Supplemental Financial Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SupplementalFinancialInformationAbstract" xlink:href="rxrx-20250930.xsd#rxrx_SupplementalFinancialInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_SupplementalFinancialInformationAbstract" xlink:to="lab_rxrx_SupplementalFinancialInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:to="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_67377afe-53b0-40dd-8862-3b6baceba458_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_787caae7-47d9-4c1d-8001-80e23a3c2c50_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_c03338a2-17f0-43aa-9b72-af4dafb3731a_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_b61f675d-1a49-4ab2-8a2e-f0d075d1a276_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Deferred Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_50dfeed5-26b7-49fb-aa9e-caa747778f05_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock (Class A, B and Exchangeable)</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_818f9c03-4db9-47b0-8a35-4988c8ba03e3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_00cfc612-ba74-4d36-a472-62ce2e16549f_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonNeosMember_terseLabel_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-NEOs</link:label>
    <link:label id="lab_ecd_NonNeosMember_label_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-NEOs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonNeosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonNeosMember" xlink:to="lab_ecd_NonNeosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d64e5d32-4a64-4add-bacb-bdcfea61fe76_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net change in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_19ecf2c0-a4f4-440a-b47d-0fd42bfb2a5f_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued professional fees</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>rxrx-20250930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:84e2dd81-95f3-479b-879b-c1ea33e5483d,g:a06efc1c-9b19-4722-bcb5-747c44bbab78-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.recursion.com/role/Cover" xlink:type="simple" xlink:href="rxrx-20250930.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_154e3693-1bcc-45b9-b45e-9faf379d71fe" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_783f9067-e56b-4fb0-92d0-cecca561417e" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_154e3693-1bcc-45b9-b45e-9faf379d71fe" xlink:to="loc_dei_DocumentInformationTable_783f9067-e56b-4fb0-92d0-cecca561417e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_126f30c1-f879-4b03-a001-4a1c3d500925" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_783f9067-e56b-4fb0-92d0-cecca561417e" xlink:to="loc_us-gaap_StatementClassOfStockAxis_126f30c1-f879-4b03-a001-4a1c3d500925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_122522a1-b5bb-4791-bfef-a88d01c54a46" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_126f30c1-f879-4b03-a001-4a1c3d500925" xlink:to="loc_us-gaap_ClassOfStockDomain_122522a1-b5bb-4791-bfef-a88d01c54a46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_f1496e99-fd88-49ee-bec9-f3b53e0aeace" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_122522a1-b5bb-4791-bfef-a88d01c54a46" xlink:to="loc_us-gaap_CommonClassAMember_f1496e99-fd88-49ee-bec9-f3b53e0aeace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_ae72923d-8d78-40e4-85d8-976d51857744" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_122522a1-b5bb-4791-bfef-a88d01c54a46" xlink:to="loc_us-gaap_CommonClassBMember_ae72923d-8d78-40e4-85d8-976d51857744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_783f9067-e56b-4fb0-92d0-cecca561417e" xlink:to="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_ecce1684-8f59-4133-9df5-62cdbbc26e75" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_DocumentType_ecce1684-8f59-4133-9df5-62cdbbc26e75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_ede760ec-ed59-4dac-bebf-103c59d87be7" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_DocumentQuarterlyReport_ede760ec-ed59-4dac-bebf-103c59d87be7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_8788cd3f-bd8d-4216-89d8-fe804dc214b6" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_DocumentPeriodEndDate_8788cd3f-bd8d-4216-89d8-fe804dc214b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_5a6edb01-6297-42e3-9164-d0aa32a0d056" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_DocumentTransitionReport_5a6edb01-6297-42e3-9164-d0aa32a0d056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_ff2d0ef7-a436-45fb-8a35-99295da2436b" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_EntityFileNumber_ff2d0ef7-a436-45fb-8a35-99295da2436b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_22b654a4-5b8d-4095-afcf-465f0456b36a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_EntityRegistrantName_22b654a4-5b8d-4095-afcf-465f0456b36a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_0c0a9d18-5989-44c9-a8fc-75940edb21fe" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_EntityIncorporationStateCountryCode_0c0a9d18-5989-44c9-a8fc-75940edb21fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_6997f959-f0be-4afd-8fb3-47a4d09f547c" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_EntityTaxIdentificationNumber_6997f959-f0be-4afd-8fb3-47a4d09f547c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_a7f05b67-af1c-4f81-9e48-69a12ab65bbc" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_EntityAddressAddressLine1_a7f05b67-af1c-4f81-9e48-69a12ab65bbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_c7a2722d-0c37-410d-a9ae-a3c516421381" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_EntityAddressCityOrTown_c7a2722d-0c37-410d-a9ae-a3c516421381" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_a8c39b20-528c-4b5b-be91-82e0b068674e" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_EntityAddressStateOrProvince_a8c39b20-528c-4b5b-be91-82e0b068674e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_05983976-512c-419a-b61a-3d083c642d58" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_EntityAddressPostalZipCode_05983976-512c-419a-b61a-3d083c642d58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_abb8edd9-3ed7-4536-82e7-df70c0189257" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_CityAreaCode_abb8edd9-3ed7-4536-82e7-df70c0189257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_4e59b4a2-dd97-4ff6-ad48-40f4cefcce34" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_LocalPhoneNumber_4e59b4a2-dd97-4ff6-ad48-40f4cefcce34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_8986bbf7-5f7a-4343-aa9b-4577e57d3c46" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_Security12bTitle_8986bbf7-5f7a-4343-aa9b-4577e57d3c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_32cf7ce5-7340-4d81-8e76-bb152ea0dacd" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_TradingSymbol_32cf7ce5-7340-4d81-8e76-bb152ea0dacd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_944e5419-1ffc-48b7-b4ba-b596245d9d10" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_SecurityExchangeName_944e5419-1ffc-48b7-b4ba-b596245d9d10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_ab464586-1b7e-4d91-8570-84af0b4dbcad" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_EntityCurrentReportingStatus_ab464586-1b7e-4d91-8570-84af0b4dbcad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_ba2113da-05ac-4cc0-9935-67dcc4891e17" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_EntityInteractiveDataCurrent_ba2113da-05ac-4cc0-9935-67dcc4891e17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_9ebbf21e-1244-4045-bc68-90abeaaab385" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_EntityFilerCategory_9ebbf21e-1244-4045-bc68-90abeaaab385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_219dfd6d-078d-47ce-9bb8-b5198e21a9b2" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_EntitySmallBusiness_219dfd6d-078d-47ce-9bb8-b5198e21a9b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_8259f3a3-8d49-4862-be75-ece43a061288" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_EntityEmergingGrowthCompany_8259f3a3-8d49-4862-be75-ece43a061288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_d8e38fd8-30ac-4134-bbcd-1c0585aaffb0" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_EntityShellCompany_d8e38fd8-30ac-4134-bbcd-1c0585aaffb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_e6f541d7-e3b9-4405-96a2-4bcedf22fb87" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_e6f541d7-e3b9-4405-96a2-4bcedf22fb87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_4b2b33bf-2c7c-4fc5-a433-3fde42a23a06" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_EntityCentralIndexKey_4b2b33bf-2c7c-4fc5-a433-3fde42a23a06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_cacfc0ad-febd-4c58-8268-b7bb770ed649" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_AmendmentFlag_cacfc0ad-febd-4c58-8268-b7bb770ed649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_bca06d96-31fb-4a90-a256-98025396e8dd" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_DocumentFiscalYearFocus_bca06d96-31fb-4a90-a256-98025396e8dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_344ad8d4-40c4-4adb-9311-36a74c7b361a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_DocumentFiscalPeriodFocus_344ad8d4-40c4-4adb-9311-36a74c7b361a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_7c92e74c-a7e8-4358-9e8c-90afe71ced00" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b5720db9-61fa-4ca4-b310-92184f432fd7" xlink:to="loc_dei_CurrentFiscalYearEndDate_7c92e74c-a7e8-4358-9e8c-90afe71ced00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited" xlink:type="simple" xlink:href="rxrx-20250930.xsd#CondensedConsolidatedBalanceSheetsunaudited"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_6721f5b1-093c-482e-953f-1cf9292b5135" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_1ee4e3ec-d29f-4a5f-9e26-245ab48d16b6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6721f5b1-093c-482e-953f-1cf9292b5135" xlink:to="loc_us-gaap_AssetsAbstract_1ee4e3ec-d29f-4a5f-9e26-245ab48d16b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_e35a28be-2817-4d43-ac79-708321f8eee6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1ee4e3ec-d29f-4a5f-9e26-245ab48d16b6" xlink:to="loc_us-gaap_AssetsCurrentAbstract_e35a28be-2817-4d43-ac79-708321f8eee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f54df8f9-86ef-47d9-a376-db5b72b66557" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e35a28be-2817-4d43-ac79-708321f8eee6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f54df8f9-86ef-47d9-a376-db5b72b66557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_ac675842-21e6-4382-be76-6349c6ea09f4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e35a28be-2817-4d43-ac79-708321f8eee6" xlink:to="loc_us-gaap_RestrictedCashCurrent_ac675842-21e6-4382-be76-6349c6ea09f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_9115aefd-a0af-4d90-84e1-8bbee99b858a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e35a28be-2817-4d43-ac79-708321f8eee6" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_9115aefd-a0af-4d90-84e1-8bbee99b858a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_ac721974-a41e-4d93-8c9b-9d5e2751c0ad" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e35a28be-2817-4d43-ac79-708321f8eee6" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_ac721974-a41e-4d93-8c9b-9d5e2751c0ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_43a11c69-653b-4f92-a281-dee3924892c9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e35a28be-2817-4d43-ac79-708321f8eee6" xlink:to="loc_us-gaap_OtherAssetsCurrent_43a11c69-653b-4f92-a281-dee3924892c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_7651ac7d-b30a-49f3-ba9d-60e1208ae785" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e35a28be-2817-4d43-ac79-708321f8eee6" xlink:to="loc_us-gaap_AssetsCurrent_7651ac7d-b30a-49f3-ba9d-60e1208ae785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_58d94178-2579-4142-9979-76b684aac362" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1ee4e3ec-d29f-4a5f-9e26-245ab48d16b6" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_58d94178-2579-4142-9979-76b684aac362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_eb779e90-4847-4340-9443-b964e554bc6c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1ee4e3ec-d29f-4a5f-9e26-245ab48d16b6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_eb779e90-4847-4340-9443-b964e554bc6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_bb2c01ef-12a7-4f2e-b7d6-eca5cc21c711" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1ee4e3ec-d29f-4a5f-9e26-245ab48d16b6" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_bb2c01ef-12a7-4f2e-b7d6-eca5cc21c711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_3fac493c-5f4f-4e1c-bee8-7c78c1e3f054" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1ee4e3ec-d29f-4a5f-9e26-245ab48d16b6" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_3fac493c-5f4f-4e1c-bee8-7c78c1e3f054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b241d5cf-58b4-44b8-bb75-3856969497da" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1ee4e3ec-d29f-4a5f-9e26-245ab48d16b6" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b241d5cf-58b4-44b8-bb75-3856969497da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d5b8cde5-e70d-4cae-ad55-57fc34b11f55" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1ee4e3ec-d29f-4a5f-9e26-245ab48d16b6" xlink:to="loc_us-gaap_Goodwill_d5b8cde5-e70d-4cae-ad55-57fc34b11f55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_f8772188-4223-4345-ac25-33f331427c77" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1ee4e3ec-d29f-4a5f-9e26-245ab48d16b6" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_f8772188-4223-4345-ac25-33f331427c77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_56593105-54e6-4780-9944-4ee24b47bca4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1ee4e3ec-d29f-4a5f-9e26-245ab48d16b6" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_56593105-54e6-4780-9944-4ee24b47bca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_8cc9344f-b860-49c0-bde6-3fda2fe88da3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1ee4e3ec-d29f-4a5f-9e26-245ab48d16b6" xlink:to="loc_us-gaap_Assets_8cc9344f-b860-49c0-bde6-3fda2fe88da3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_34a26518-b387-43c9-99e9-07c96ec80445" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6721f5b1-093c-482e-953f-1cf9292b5135" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_34a26518-b387-43c9-99e9-07c96ec80445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_ef88d88b-ace1-4a07-ba97-9341fdf34590" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_34a26518-b387-43c9-99e9-07c96ec80445" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_ef88d88b-ace1-4a07-ba97-9341fdf34590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_248834ac-7eb0-42a5-9042-ac5d213ef993" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ef88d88b-ace1-4a07-ba97-9341fdf34590" xlink:to="loc_us-gaap_AccountsPayableCurrent_248834ac-7eb0-42a5-9042-ac5d213ef993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_bde48ace-b4b0-4ee3-a3ec-aff556fc2184" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ef88d88b-ace1-4a07-ba97-9341fdf34590" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_bde48ace-b4b0-4ee3-a3ec-aff556fc2184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AccruedDataCurrent_fa1bc69f-7563-4725-962f-94138d49086e" xlink:href="rxrx-20250930.xsd#rxrx_AccruedDataCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ef88d88b-ace1-4a07-ba97-9341fdf34590" xlink:to="loc_rxrx_AccruedDataCurrent_fa1bc69f-7563-4725-962f-94138d49086e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_b4a765f7-76dc-4610-beb4-e8c63ff9d873" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ef88d88b-ace1-4a07-ba97-9341fdf34590" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_b4a765f7-76dc-4610-beb4-e8c63ff9d873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_185d0dde-c610-4365-b381-ecc8b70b461b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ef88d88b-ace1-4a07-ba97-9341fdf34590" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_185d0dde-c610-4365-b381-ecc8b70b461b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_0cd32744-5a21-4093-9bb1-bbf7682fd08d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ef88d88b-ace1-4a07-ba97-9341fdf34590" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_0cd32744-5a21-4093-9bb1-bbf7682fd08d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_37674d86-5a9d-45de-9aba-f24a752a2787" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ef88d88b-ace1-4a07-ba97-9341fdf34590" xlink:to="loc_us-gaap_LiabilitiesCurrent_37674d86-5a9d-45de-9aba-f24a752a2787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_c6198f7b-2e3d-4d97-ada7-fd360acf8053" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_34a26518-b387-43c9-99e9-07c96ec80445" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_c6198f7b-2e3d-4d97-ada7-fd360acf8053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d9e22fde-dd3e-44b4-98aa-8986cfea1b0b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_34a26518-b387-43c9-99e9-07c96ec80445" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d9e22fde-dd3e-44b4-98aa-8986cfea1b0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_d4ab63ec-7b88-4eba-86e3-ad388031f92e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_34a26518-b387-43c9-99e9-07c96ec80445" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_d4ab63ec-7b88-4eba-86e3-ad388031f92e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_606359ff-11f8-4d6e-9e98-502ce698db4c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_34a26518-b387-43c9-99e9-07c96ec80445" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_606359ff-11f8-4d6e-9e98-502ce698db4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_11831316-ff1d-4e76-9ddb-1f6ecde39c57" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_34a26518-b387-43c9-99e9-07c96ec80445" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_11831316-ff1d-4e76-9ddb-1f6ecde39c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_9012ed7f-14e0-4039-b53e-06bfab566353" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_34a26518-b387-43c9-99e9-07c96ec80445" xlink:to="loc_us-gaap_Liabilities_9012ed7f-14e0-4039-b53e-06bfab566353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_6a26dcbe-cbd9-4532-a43b-d322d8eabdda" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_34a26518-b387-43c9-99e9-07c96ec80445" xlink:to="loc_us-gaap_CommitmentsAndContingencies_6a26dcbe-cbd9-4532-a43b-d322d8eabdda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_c82ebd09-3d64-49a2-afd7-ea885fb776a3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_34a26518-b387-43c9-99e9-07c96ec80445" xlink:to="loc_us-gaap_StockholdersEquityAbstract_c82ebd09-3d64-49a2-afd7-ea885fb776a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_43019705-bc8b-427d-8eb4-dfc3de47d980" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c82ebd09-3d64-49a2-afd7-ea885fb776a3" xlink:to="loc_us-gaap_CommonStockValue_43019705-bc8b-427d-8eb4-dfc3de47d980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_106798bc-4dd0-47ce-80e7-e412f5f59f86" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c82ebd09-3d64-49a2-afd7-ea885fb776a3" xlink:to="loc_us-gaap_AdditionalPaidInCapital_106798bc-4dd0-47ce-80e7-e412f5f59f86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_85c72183-9ec2-42a5-9f09-90b0147a388a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c82ebd09-3d64-49a2-afd7-ea885fb776a3" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_85c72183-9ec2-42a5-9f09-90b0147a388a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7a88773b-64f0-4029-9e01-5ddcafff2f82" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c82ebd09-3d64-49a2-afd7-ea885fb776a3" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7a88773b-64f0-4029-9e01-5ddcafff2f82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2c461e60-7eb9-45bb-8602-7f55fe029116" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c82ebd09-3d64-49a2-afd7-ea885fb776a3" xlink:to="loc_us-gaap_StockholdersEquity_2c461e60-7eb9-45bb-8602-7f55fe029116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_93c52879-b4c0-4828-8992-b8518dbf75a6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_34a26518-b387-43c9-99e9-07c96ec80445" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_93c52879-b4c0-4828-8992-b8518dbf75a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical" xlink:type="simple" xlink:href="rxrx-20250930.xsd#CondensedConsolidatedBalanceSheetsunauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_abbad6aa-33c0-4c63-ab46-0a7646b90e90" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_672d58cc-bb32-4e6d-a6ec-0f0b88b1aab5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_abbad6aa-33c0-4c63-ab46-0a7646b90e90" xlink:to="loc_us-gaap_StatementTable_672d58cc-bb32-4e6d-a6ec-0f0b88b1aab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_18411a15-4fef-44ad-b170-ddadeb602058" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_672d58cc-bb32-4e6d-a6ec-0f0b88b1aab5" xlink:to="loc_us-gaap_StatementClassOfStockAxis_18411a15-4fef-44ad-b170-ddadeb602058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_0b2a7cee-7ff9-4b0e-9ef5-6c68131a5a3d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_18411a15-4fef-44ad-b170-ddadeb602058" xlink:to="loc_us-gaap_ClassOfStockDomain_0b2a7cee-7ff9-4b0e-9ef5-6c68131a5a3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_44fa8389-09b0-4e6f-b8c8-edf9c2837c1f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_0b2a7cee-7ff9-4b0e-9ef5-6c68131a5a3d" xlink:to="loc_us-gaap_CommonClassAMember_44fa8389-09b0-4e6f-b8c8-edf9c2837c1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_8f5aadff-67cd-49ac-aaf8-dfe5931977f9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_0b2a7cee-7ff9-4b0e-9ef5-6c68131a5a3d" xlink:to="loc_us-gaap_CommonClassBMember_8f5aadff-67cd-49ac-aaf8-dfe5931977f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ExchangeableStockMember_807900ce-f1a2-4827-a242-f4bf8cf0ff9f" xlink:href="rxrx-20250930.xsd#rxrx_ExchangeableStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_0b2a7cee-7ff9-4b0e-9ef5-6c68131a5a3d" xlink:to="loc_rxrx_ExchangeableStockMember_807900ce-f1a2-4827-a242-f4bf8cf0ff9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_953e6326-aac8-4f73-9c07-94aeeea7c311" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_672d58cc-bb32-4e6d-a6ec-0f0b88b1aab5" xlink:to="loc_us-gaap_StatementLineItems_953e6326-aac8-4f73-9c07-94aeeea7c311" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_d91351a0-d054-4720-a069-5c60dd36421d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_953e6326-aac8-4f73-9c07-94aeeea7c311" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_d91351a0-d054-4720-a069-5c60dd36421d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_636aefae-6a0a-467b-a7c3-918b1a1b723f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_953e6326-aac8-4f73-9c07-94aeeea7c311" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_636aefae-6a0a-467b-a7c3-918b1a1b723f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_db51e830-449c-4369-8461-79c7e5b922c1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_953e6326-aac8-4f73-9c07-94aeeea7c311" xlink:to="loc_us-gaap_CommonStockSharesIssued_db51e830-449c-4369-8461-79c7e5b922c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_114d0e59-0541-41f6-8e15-9272730e6b8a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_953e6326-aac8-4f73-9c07-94aeeea7c311" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_114d0e59-0541-41f6-8e15-9272730e6b8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited" xlink:type="simple" xlink:href="rxrx-20250930.xsd#CondensedConsolidatedStatementsofOperationsunaudited"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_511d11b9-0ba9-4c07-8614-a85041ba0a70" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_3b2ef99b-1f0d-406d-8495-70b7c89fa11c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_511d11b9-0ba9-4c07-8614-a85041ba0a70" xlink:to="loc_us-gaap_StatementTable_3b2ef99b-1f0d-406d-8495-70b7c89fa11c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4754e0c3-4bbc-4913-98b1-8c8a5502e829" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_3b2ef99b-1f0d-406d-8495-70b7c89fa11c" xlink:to="loc_srt_ProductOrServiceAxis_4754e0c3-4bbc-4913-98b1-8c8a5502e829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_47541fca-97f7-43be-a5e6-a3685bf501e3" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_4754e0c3-4bbc-4913-98b1-8c8a5502e829" xlink:to="loc_srt_ProductsAndServicesDomain_47541fca-97f7-43be-a5e6-a3685bf501e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseAndServiceMember_19101cf5-d44d-4775-8e23-0321a3ebe669" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LicenseAndServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_47541fca-97f7-43be-a5e6-a3685bf501e3" xlink:to="loc_us-gaap_LicenseAndServiceMember_19101cf5-d44d-4775-8e23-0321a3ebe669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrantMember_3c45fa0c-1d20-4d5f-b682-cc5ef99294d8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_47541fca-97f7-43be-a5e6-a3685bf501e3" xlink:to="loc_us-gaap_GrantMember_3c45fa0c-1d20-4d5f-b682-cc5ef99294d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f107c9e7-a56f-43e2-82cd-17470980184d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_3b2ef99b-1f0d-406d-8495-70b7c89fa11c" xlink:to="loc_us-gaap_StatementLineItems_f107c9e7-a56f-43e2-82cd-17470980184d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_816ccc65-ae6b-4c10-8e92-7950a9b61b37" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f107c9e7-a56f-43e2-82cd-17470980184d" xlink:to="loc_us-gaap_RevenuesAbstract_816ccc65-ae6b-4c10-8e92-7950a9b61b37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7c02ee3e-9dc8-43c0-899d-67f1d33db53b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_816ccc65-ae6b-4c10-8e92-7950a9b61b37" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7c02ee3e-9dc8-43c0-899d-67f1d33db53b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_156e020f-aed8-4936-86f1-12b8226e3c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f107c9e7-a56f-43e2-82cd-17470980184d" xlink:to="loc_us-gaap_OperatingExpensesAbstract_156e020f-aed8-4936-86f1-12b8226e3c6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_9d6c0f1f-afe1-421a-9415-289d6f460cc8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_156e020f-aed8-4936-86f1-12b8226e3c6e" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_9d6c0f1f-afe1-421a-9415-289d6f460cc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_c7f36291-885a-4817-9375-814f8756da1a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_156e020f-aed8-4936-86f1-12b8226e3c6e" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_c7f36291-885a-4817-9375-814f8756da1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_a1235d59-46f2-4435-a6ea-90a260ae9bae" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_156e020f-aed8-4936-86f1-12b8226e3c6e" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_a1235d59-46f2-4435-a6ea-90a260ae9bae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_eafc3683-a884-42c4-96a9-0c173c299cc0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_156e020f-aed8-4936-86f1-12b8226e3c6e" xlink:to="loc_us-gaap_CostsAndExpenses_eafc3683-a884-42c4-96a9-0c173c299cc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_35199800-ea2b-419c-9ba1-9fbf3e529a80" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f107c9e7-a56f-43e2-82cd-17470980184d" xlink:to="loc_us-gaap_OperatingIncomeLoss_35199800-ea2b-419c-9ba1-9fbf3e529a80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_1f804134-7833-4272-a572-96f8c895ab78" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f107c9e7-a56f-43e2-82cd-17470980184d" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_1f804134-7833-4272-a572-96f8c895ab78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1da5fbbf-22c0-44ce-a739-70ae83bcc820" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f107c9e7-a56f-43e2-82cd-17470980184d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1da5fbbf-22c0-44ce-a739-70ae83bcc820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_9aab3e70-e86f-4795-877f-b90359886d02" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f107c9e7-a56f-43e2-82cd-17470980184d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_9aab3e70-e86f-4795-877f-b90359886d02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0e9d0903-a130-41d4-9340-d3d757d45f38" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f107c9e7-a56f-43e2-82cd-17470980184d" xlink:to="loc_us-gaap_NetIncomeLoss_0e9d0903-a130-41d4-9340-d3d757d45f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_b9cf39cf-6602-4f9d-9b76-99387533c1a1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f107c9e7-a56f-43e2-82cd-17470980184d" xlink:to="loc_us-gaap_EarningsPerShareAbstract_b9cf39cf-6602-4f9d-9b76-99387533c1a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_32e8b86c-79ec-4efa-9a99-986315904c49" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b9cf39cf-6602-4f9d-9b76-99387533c1a1" xlink:to="loc_us-gaap_EarningsPerShareBasic_32e8b86c-79ec-4efa-9a99-986315904c49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_8208dad4-da2c-4dc0-85df-b325ebffc7b7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b9cf39cf-6602-4f9d-9b76-99387533c1a1" xlink:to="loc_us-gaap_EarningsPerShareDiluted_8208dad4-da2c-4dc0-85df-b325ebffc7b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0db6e2b0-b772-4550-9a92-7734da7b6696" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b9cf39cf-6602-4f9d-9b76-99387533c1a1" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0db6e2b0-b772-4550-9a92-7734da7b6696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_73fa8caa-208a-450a-b72c-2fb4f15a7387" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b9cf39cf-6602-4f9d-9b76-99387533c1a1" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_73fa8caa-208a-450a-b72c-2fb4f15a7387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CondensedConsolidatedStatementsofComprehensiveLossunaudited" xlink:type="simple" xlink:href="rxrx-20250930.xsd#CondensedConsolidatedStatementsofComprehensiveLossunaudited"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/CondensedConsolidatedStatementsofComprehensiveLossunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7215a543-9aee-47d1-a378-5d0148277a5c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c4309801-930a-4253-bfb0-d046904c4457" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7215a543-9aee-47d1-a378-5d0148277a5c" xlink:to="loc_us-gaap_NetIncomeLoss_c4309801-930a-4253-bfb0-d046904c4457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c7a29fa5-bb66-46a3-a024-c5cf3279ecee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7215a543-9aee-47d1-a378-5d0148277a5c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c7a29fa5-bb66-46a3-a024-c5cf3279ecee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_71d8b37c-e642-41ed-8bf1-47178692c204" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c7a29fa5-bb66-46a3-a024-c5cf3279ecee" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_71d8b37c-e642-41ed-8bf1-47178692c204" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_7f2f22d1-6194-4bf7-837a-8b7754e155da" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c7a29fa5-bb66-46a3-a024-c5cf3279ecee" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_7f2f22d1-6194-4bf7-837a-8b7754e155da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_eaa463c1-10aa-4207-8c71-5dff1baf52b7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7215a543-9aee-47d1-a378-5d0148277a5c" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_eaa463c1-10aa-4207-8c71-5dff1baf52b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited" xlink:type="simple" xlink:href="rxrx-20250930.xsd#CondensedConsolidatedStatementsofStockholdersEquityunaudited"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_58a7f07e-3dec-48c6-93e7-301385d8bc72" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_37c03070-1bb3-41fd-90dd-f05d6077d882" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_58a7f07e-3dec-48c6-93e7-301385d8bc72" xlink:to="loc_us-gaap_StatementTable_37c03070-1bb3-41fd-90dd-f05d6077d882" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3e2cf14f-7440-472d-96eb-83bee5421c7e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_37c03070-1bb3-41fd-90dd-f05d6077d882" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3e2cf14f-7440-472d-96eb-83bee5421c7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d7d4a2c4-8eb2-415e-8306-128835c38e34" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3e2cf14f-7440-472d-96eb-83bee5421c7e" xlink:to="loc_us-gaap_EquityComponentDomain_d7d4a2c4-8eb2-415e-8306-128835c38e34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_849716ad-f882-42d7-9bdd-7bd128cd078b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d7d4a2c4-8eb2-415e-8306-128835c38e34" xlink:to="loc_us-gaap_CommonStockMember_849716ad-f882-42d7-9bdd-7bd128cd078b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_85590d55-2eb3-4a9d-a7a2-c7e62a38ffe5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d7d4a2c4-8eb2-415e-8306-128835c38e34" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_85590d55-2eb3-4a9d-a7a2-c7e62a38ffe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_b51918a8-14b3-4216-9eb2-7d6487e7956f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d7d4a2c4-8eb2-415e-8306-128835c38e34" xlink:to="loc_us-gaap_RetainedEarningsMember_b51918a8-14b3-4216-9eb2-7d6487e7956f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f3f15154-56ab-495e-8071-60873b88800b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d7d4a2c4-8eb2-415e-8306-128835c38e34" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f3f15154-56ab-495e-8071-60873b88800b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_fdaf0b6b-ae29-4e13-ae4d-4a0475166f82" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_37c03070-1bb3-41fd-90dd-f05d6077d882" xlink:to="loc_us-gaap_StatementLineItems_fdaf0b6b-ae29-4e13-ae4d-4a0475166f82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cd2c1644-a2c8-442f-a374-b08c21c4eaa5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fdaf0b6b-ae29-4e13-ae4d-4a0475166f82" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cd2c1644-a2c8-442f-a374-b08c21c4eaa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_5c30a6d5-413d-4636-93cd-1eedbf6f387d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cd2c1644-a2c8-442f-a374-b08c21c4eaa5" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_5c30a6d5-413d-4636-93cd-1eedbf6f387d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ff86c411-3f84-4c90-adbd-3d291080d11b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cd2c1644-a2c8-442f-a374-b08c21c4eaa5" xlink:to="loc_us-gaap_StockholdersEquity_ff86c411-3f84-4c90-adbd-3d291080d11b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b729fd4b-9bf8-4400-befa-b281bd9cef8c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cd2c1644-a2c8-442f-a374-b08c21c4eaa5" xlink:to="loc_us-gaap_NetIncomeLoss_b729fd4b-9bf8-4400-befa-b281bd9cef8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a90130d4-4ee2-452f-ab38-dd725c09ee17" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cd2c1644-a2c8-442f-a374-b08c21c4eaa5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a90130d4-4ee2-452f-ab38-dd725c09ee17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_e5f9c18a-50ec-4548-b93a-2e00ccd593ab" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cd2c1644-a2c8-442f-a374-b08c21c4eaa5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_e5f9c18a-50ec-4548-b93a-2e00ccd593ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_71f31973-8051-40b0-afdf-1a12dea2a5ef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cd2c1644-a2c8-442f-a374-b08c21c4eaa5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_71f31973-8051-40b0-afdf-1a12dea2a5ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_d3911a3d-0e81-438a-bd6e-fb251836b656" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cd2c1644-a2c8-442f-a374-b08c21c4eaa5" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_d3911a3d-0e81-438a-bd6e-fb251836b656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_36ef2996-f1e9-4d8a-903d-34b964a34242" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cd2c1644-a2c8-442f-a374-b08c21c4eaa5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_36ef2996-f1e9-4d8a-903d-34b964a34242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_3bce3dd0-1394-4aa8-a3bb-a133ae1f5957" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cd2c1644-a2c8-442f-a374-b08c21c4eaa5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_3bce3dd0-1394-4aa8-a3bb-a133ae1f5957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_317f5a24-1b0d-4550-aa97-bd87f18b7542" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cd2c1644-a2c8-442f-a374-b08c21c4eaa5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_317f5a24-1b0d-4550-aa97-bd87f18b7542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_b6c0ad4e-ee23-4f86-8cef-003af83e6367" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cd2c1644-a2c8-442f-a374-b08c21c4eaa5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_b6c0ad4e-ee23-4f86-8cef-003af83e6367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_0b584924-4cbd-4bae-8fa4-d26c7989c4aa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cd2c1644-a2c8-442f-a374-b08c21c4eaa5" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_0b584924-4cbd-4bae-8fa4-d26c7989c4aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e815a405-21c7-4f55-9776-eb1e5c9962d3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cd2c1644-a2c8-442f-a374-b08c21c4eaa5" xlink:to="loc_us-gaap_StockholdersEquity_e815a405-21c7-4f55-9776-eb1e5c9962d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" xlink:type="simple" xlink:href="rxrx-20250930.xsd#CondensedConsolidatedStatementsofCashFlowsunaudited"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_d8b54c72-7b06-4e16-9045-2ab19f589aec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9803c013-5f95-460c-a7ac-24fa99b9f9fe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d8b54c72-7b06-4e16-9045-2ab19f589aec" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9803c013-5f95-460c-a7ac-24fa99b9f9fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_32e8296e-8fd2-47d3-acce-1a476187b9a2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9803c013-5f95-460c-a7ac-24fa99b9f9fe" xlink:to="loc_us-gaap_NetIncomeLoss_32e8296e-8fd2-47d3-acce-1a476187b9a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_75a8d875-c2a5-46e3-840f-b5271f3c36e2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9803c013-5f95-460c-a7ac-24fa99b9f9fe" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_75a8d875-c2a5-46e3-840f-b5271f3c36e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_8950af83-9179-4fe4-8224-f8284be145a6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_75a8d875-c2a5-46e3-840f-b5271f3c36e2" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_8950af83-9179-4fe4-8224-f8284be145a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_0f41d79b-11cb-40b7-8673-ac34e249b039" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_75a8d875-c2a5-46e3-840f-b5271f3c36e2" xlink:to="loc_us-gaap_ShareBasedCompensation_0f41d79b-11cb-40b7-8673-ac34e249b039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges_28cf684e-9e32-4276-b217-b7907e4367ee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_75a8d875-c2a5-46e3-840f-b5271f3c36e2" xlink:to="loc_us-gaap_TangibleAssetImpairmentCharges_28cf684e-9e32-4276-b217-b7907e4367ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_26c275da-29b4-4558-84cf-f704dc6f69af" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_75a8d875-c2a5-46e3-840f-b5271f3c36e2" xlink:to="loc_us-gaap_OperatingLeaseExpense_26c275da-29b4-4558-84cf-f704dc6f69af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_0f2f024a-7777-4de6-b2b5-02382ffa7300" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_75a8d875-c2a5-46e3-840f-b5271f3c36e2" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_0f2f024a-7777-4de6-b2b5-02382ffa7300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_aa371cce-5493-42e5-9eca-4ff1df6e2ee8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_75a8d875-c2a5-46e3-840f-b5271f3c36e2" xlink:to="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_aa371cce-5493-42e5-9eca-4ff1df6e2ee8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_b7ab058d-52f6-4a2d-9c37-ef23a79478b1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_75a8d875-c2a5-46e3-840f-b5271f3c36e2" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_b7ab058d-52f6-4a2d-9c37-ef23a79478b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_05414eda-b729-4635-919a-da50c0f50551" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_75a8d875-c2a5-46e3-840f-b5271f3c36e2" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_05414eda-b729-4635-919a-da50c0f50551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_2c84b359-f164-4c4c-9d49-c495929ba0d3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_05414eda-b729-4635-919a-da50c0f50551" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_2c84b359-f164-4c4c-9d49-c495929ba0d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_IncreaseDecreaseInPrepaidDataAssets_9a036bfe-78ba-49b7-a4e0-dd40615ff32a" xlink:href="rxrx-20250930.xsd#rxrx_IncreaseDecreaseInPrepaidDataAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_05414eda-b729-4635-919a-da50c0f50551" xlink:to="loc_rxrx_IncreaseDecreaseInPrepaidDataAssets_9a036bfe-78ba-49b7-a4e0-dd40615ff32a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_IncreaseDecreaseInAccruedDataLiability_5cee6c15-4349-49e2-99cd-44da7a42dcd2" xlink:href="rxrx-20250930.xsd#rxrx_IncreaseDecreaseInAccruedDataLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_05414eda-b729-4635-919a-da50c0f50551" xlink:to="loc_rxrx_IncreaseDecreaseInAccruedDataLiability_5cee6c15-4349-49e2-99cd-44da7a42dcd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_190f1ec7-2a95-4443-b123-1b82e7c955d7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_05414eda-b729-4635-919a-da50c0f50551" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_190f1ec7-2a95-4443-b123-1b82e7c955d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_01deba9d-e097-4b24-aa0a-1594a1557962" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_05414eda-b729-4635-919a-da50c0f50551" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_01deba9d-e097-4b24-aa0a-1594a1557962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_IncreaseDecreaseInAccruedDevelopmentExpense_df324b2c-d97f-46ab-851c-ee32088841c2" xlink:href="rxrx-20250930.xsd#rxrx_IncreaseDecreaseInAccruedDevelopmentExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_05414eda-b729-4635-919a-da50c0f50551" xlink:to="loc_rxrx_IncreaseDecreaseInAccruedDevelopmentExpense_df324b2c-d97f-46ab-851c-ee32088841c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_9f17d704-84f9-4ea8-a41b-c253a5fa155a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_05414eda-b729-4635-919a-da50c0f50551" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_9f17d704-84f9-4ea8-a41b-c253a5fa155a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_IncreaseDecreaseInLeaseLiability_21da4d6b-0751-4a8a-82fa-03c7966bbb28" xlink:href="rxrx-20250930.xsd#rxrx_IncreaseDecreaseInLeaseLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_05414eda-b729-4635-919a-da50c0f50551" xlink:to="loc_rxrx_IncreaseDecreaseInLeaseLiability_21da4d6b-0751-4a8a-82fa-03c7966bbb28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e10835a2-46f3-470f-82ea-652b0f85898b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9803c013-5f95-460c-a7ac-24fa99b9f9fe" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e10835a2-46f3-470f-82ea-652b0f85898b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_54ca145c-7b8a-46e8-a3d7-96ba933dd8e9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d8b54c72-7b06-4e16-9045-2ab19f589aec" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_54ca145c-7b8a-46e8-a3d7-96ba933dd8e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_02c00ee3-2ad8-4832-9461-f7d874839f2e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_54ca145c-7b8a-46e8-a3d7-96ba933dd8e9" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_02c00ee3-2ad8-4832-9461-f7d874839f2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_b05bf039-a180-4699-ab7d-910d37191594" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_54ca145c-7b8a-46e8-a3d7-96ba933dd8e9" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_b05bf039-a180-4699-ab7d-910d37191594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_cb9e0ccb-abe3-4553-bddd-468780ca0378" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_54ca145c-7b8a-46e8-a3d7-96ba933dd8e9" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_cb9e0ccb-abe3-4553-bddd-468780ca0378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_03efefcd-a36d-4ad2-80e5-a343097abb47" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_54ca145c-7b8a-46e8-a3d7-96ba933dd8e9" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_03efefcd-a36d-4ad2-80e5-a343097abb47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_cf13121a-db22-426d-be8d-23ca09134232" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_54ca145c-7b8a-46e8-a3d7-96ba933dd8e9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_cf13121a-db22-426d-be8d-23ca09134232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_38199044-5806-4279-a1f4-da632277cd8d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d8b54c72-7b06-4e16-9045-2ab19f589aec" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_38199044-5806-4279-a1f4-da632277cd8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_bc422a6b-5c33-4d64-af30-d99a1d4e90f5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_38199044-5806-4279-a1f4-da632277cd8d" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_bc422a6b-5c33-4d64-af30-d99a1d4e90f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_a1f9192f-f6b7-4a22-ad31-c8fb4719b430" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_38199044-5806-4279-a1f4-da632277cd8d" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_a1f9192f-f6b7-4a22-ad31-c8fb4719b430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_020ca077-3b29-4bda-86f2-895cb6d5af32" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_38199044-5806-4279-a1f4-da632277cd8d" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_020ca077-3b29-4bda-86f2-895cb6d5af32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_PaymentsToAcquireIntangibleAssetsFinancialActivities_4def905c-b963-4d67-a4b4-010a4517eea8" xlink:href="rxrx-20250930.xsd#rxrx_PaymentsToAcquireIntangibleAssetsFinancialActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_38199044-5806-4279-a1f4-da632277cd8d" xlink:to="loc_rxrx_PaymentsToAcquireIntangibleAssetsFinancialActivities_4def905c-b963-4d67-a4b4-010a4517eea8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a1b53785-4c18-4186-8c81-142eb0a3ce27" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_38199044-5806-4279-a1f4-da632277cd8d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a1b53785-4c18-4186-8c81-142eb0a3ce27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1f7dcca6-468e-4f82-b607-2cb1e158eed5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d8b54c72-7b06-4e16-9045-2ab19f589aec" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1f7dcca6-468e-4f82-b607-2cb1e158eed5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0c755d21-29ec-4372-8f20-81a901562bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d8b54c72-7b06-4e16-9045-2ab19f589aec" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0c755d21-29ec-4372-8f20-81a901562bf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f6ded6dc-346c-4160-a762-557e04da28b1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d8b54c72-7b06-4e16-9045-2ab19f589aec" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f6ded6dc-346c-4160-a762-557e04da28b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4b9708ee-c8ff-4efa-be9c-05204944c2b2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d8b54c72-7b06-4e16-9045-2ab19f589aec" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4b9708ee-c8ff-4efa-be9c-05204944c2b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_1471c7b5-d77a-45cb-a4b3-4b50d4d752b1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d8b54c72-7b06-4e16-9045-2ab19f589aec" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_1471c7b5-d77a-45cb-a4b3-4b50d4d752b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssued1_0dc02651-66a9-4274-bf98-1c365d159ccc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssued1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_1471c7b5-d77a-45cb-a4b3-4b50d4d752b1" xlink:to="loc_us-gaap_StockIssued1_0dc02651-66a9-4274-bf98-1c365d159ccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_2c231cb2-57b1-4518-a332-9c9fe33c1271" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_1471c7b5-d77a-45cb-a4b3-4b50d4d752b1" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_2c231cb2-57b1-4518-a332-9c9fe33c1271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_PurchaseOfAnEquityInvestmentNonCash_aea7f727-6dee-40b7-a8cd-28baf1bc1440" xlink:href="rxrx-20250930.xsd#rxrx_PurchaseOfAnEquityInvestmentNonCash"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_1471c7b5-d77a-45cb-a4b3-4b50d4d752b1" xlink:to="loc_rxrx_PurchaseOfAnEquityInvestmentNonCash_aea7f727-6dee-40b7-a8cd-28baf1bc1440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1_77c8ddbc-111a-4683-ab78-58491992fd12" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_1471c7b5-d77a-45cb-a4b3-4b50d4d752b1" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1_77c8ddbc-111a-4683-ab78-58491992fd12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/DescriptionoftheBusiness" xlink:type="simple" xlink:href="rxrx-20250930.xsd#DescriptionoftheBusiness"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/DescriptionoftheBusiness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_5a9ed700-7bad-4f35-9244-2eb60e39e122" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_ae9a56cd-70d5-45a7-88fe-8ffaa2dc7bf7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_5a9ed700-7bad-4f35-9244-2eb60e39e122" xlink:to="loc_us-gaap_NatureOfOperations_ae9a56cd-70d5-45a7-88fe-8ffaa2dc7bf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/BasisofPresentation" xlink:type="simple" xlink:href="rxrx-20250930.xsd#BasisofPresentation"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/BasisofPresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d3c102ef-36f3-4d07-bbd4-c84e9e8b2016" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_3537b8f0-207f-4e34-85aa-8afa34a863d9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d3c102ef-36f3-4d07-bbd4-c84e9e8b2016" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_3537b8f0-207f-4e34-85aa-8afa34a863d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/SupplementalFinancialInformation" xlink:type="simple" xlink:href="rxrx-20250930.xsd#SupplementalFinancialInformation"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/SupplementalFinancialInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SupplementalFinancialInformationAbstract_a4a49541-c4c7-4901-8d07-c2d28b59d044" xlink:href="rxrx-20250930.xsd#rxrx_SupplementalFinancialInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SupplementalBalanceSheetAndIncomeStatementInformationTextBlock_dd285475-6783-468d-a71a-137a97527401" xlink:href="rxrx-20250930.xsd#rxrx_SupplementalBalanceSheetAndIncomeStatementInformationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SupplementalFinancialInformationAbstract_a4a49541-c4c7-4901-8d07-c2d28b59d044" xlink:to="loc_rxrx_SupplementalBalanceSheetAndIncomeStatementInformationTextBlock_dd285475-6783-468d-a71a-137a97527401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/Acquisitions" xlink:type="simple" xlink:href="rxrx-20250930.xsd#Acquisitions"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/Acquisitions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_349f67a8-8283-4e43-9641-ee4ca179ec58" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_34882983-7c07-4da3-95fa-de046ce1d20e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_349f67a8-8283-4e43-9641-ee4ca179ec58" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_34882983-7c07-4da3-95fa-de046ce1d20e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/Leases" xlink:type="simple" xlink:href="rxrx-20250930.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_156a3a99-292a-40af-ab21-3284d4be9dea" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_549b2b4a-8e0d-41cb-af06-fe116239b5ee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_156a3a99-292a-40af-ab21-3284d4be9dea" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_549b2b4a-8e0d-41cb-af06-fe116239b5ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock_45145aaa-ee25-49e5-b362-cba39f9f777d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_156a3a99-292a-40af-ab21-3284d4be9dea" xlink:to="loc_us-gaap_LesseeFinanceLeasesTextBlock_45145aaa-ee25-49e5-b362-cba39f9f777d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/GoodwillandIntangibleAssets" xlink:type="simple" xlink:href="rxrx-20250930.xsd#GoodwillandIntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/GoodwillandIntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7dd7c16f-89b3-49dd-aaa3-1606302d13a8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_4e148dc5-ca6e-41b6-8d93-eed1e8f8938b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7dd7c16f-89b3-49dd-aaa3-1606302d13a8" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_4e148dc5-ca6e-41b6-8d93-eed1e8f8938b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="rxrx-20250930.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6e18b676-f5a0-4761-b857-887c09c2ff16" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_cae4589c-5ed9-4f7e-a293-a39be95b975f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6e18b676-f5a0-4761-b857-887c09c2ff16" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_cae4589c-5ed9-4f7e-a293-a39be95b975f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CommonStock" xlink:type="simple" xlink:href="rxrx-20250930.xsd#CommonStock"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/CommonStock" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_19599c1f-5d8c-4031-a8df-12f14e7ffbba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_f43204f1-a5c1-477f-bb7e-e12549237c0b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_19599c1f-5d8c-4031-a8df-12f14e7ffbba" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_f43204f1-a5c1-477f-bb7e-e12549237c0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CollaborativeDevelopmentContracts" xlink:type="simple" xlink:href="rxrx-20250930.xsd#CollaborativeDevelopmentContracts"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/CollaborativeDevelopmentContracts" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cc77bb13-40e0-4c52-ad11-6f729a51e717" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_3966711c-f898-4f1c-8d09-0fb516b903ad" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cc77bb13-40e0-4c52-ad11-6f729a51e717" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_3966711c-f898-4f1c-8d09-0fb516b903ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="rxrx-20250930.xsd#StockBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/StockBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_801f1083-eb2f-4232-91f5-f6bf1a0e1f78" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_4a104782-3c8f-4504-a3ad-1e280e69caad" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_801f1083-eb2f-4232-91f5-f6bf1a0e1f78" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_4a104782-3c8f-4504-a3ad-1e280e69caad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/IncomeTaxes" xlink:type="simple" xlink:href="rxrx-20250930.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_ff053f79-ab34-4682-8ffc-613b6e3b8db4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_3afca56a-5b08-4570-95ef-9a08c1556f9b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ff053f79-ab34-4682-8ffc-613b6e3b8db4" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_3afca56a-5b08-4570-95ef-9a08c1556f9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/NetLossPerShare" xlink:type="simple" xlink:href="rxrx-20250930.xsd#NetLossPerShare"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/NetLossPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_20425467-8041-41fe-9942-7b589a6b62ea" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_a2df2517-ca72-4610-b554-7e35a076023b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_20425467-8041-41fe-9942-7b589a6b62ea" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_a2df2517-ca72-4610-b554-7e35a076023b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="rxrx-20250930.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_3d8efd12-a159-42c9-b1c0-6a4d2d3b2246" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_a6c736cb-6afb-499a-b601-11ba9cb54097" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3d8efd12-a159-42c9-b1c0-6a4d2d3b2246" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_a6c736cb-6afb-499a-b601-11ba9cb54097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/SegmentInformation" xlink:type="simple" xlink:href="rxrx-20250930.xsd#SegmentInformation"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/SegmentInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_b98a35cc-7603-44a5-81b8-75bcad389386" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_1d266263-0c7e-4de1-9c2e-f08c641da785" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_b98a35cc-7603-44a5-81b8-75bcad389386" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_1d266263-0c7e-4de1-9c2e-f08c641da785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/SubsequentEvents" xlink:type="simple" xlink:href="rxrx-20250930.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_a98ae18b-b41b-4540-bd53-c8d369e4f661" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_b06d0a08-c2fc-4dc5-83dd-6d3d2a28fecb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_a98ae18b-b41b-4540-bd53-c8d369e4f661" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_b06d0a08-c2fc-4dc5-83dd-6d3d2a28fecb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/BasisofPresentationPolicies" xlink:type="simple" xlink:href="rxrx-20250930.xsd#BasisofPresentationPolicies"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/BasisofPresentationPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_193f4f02-03ae-4a5c-8117-58312b306517" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_5cfa6bda-7bdc-44ab-8040-4e7b1cfa2943" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_193f4f02-03ae-4a5c-8117-58312b306517" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_5cfa6bda-7bdc-44ab-8040-4e7b1cfa2943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_f5a46697-d1ce-467b-ab32-5d002e2a5493" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_193f4f02-03ae-4a5c-8117-58312b306517" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_f5a46697-d1ce-467b-ab32-5d002e2a5493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/SupplementalFinancialInformationTables" xlink:type="simple" xlink:href="rxrx-20250930.xsd#SupplementalFinancialInformationTables"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/SupplementalFinancialInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SupplementalFinancialInformationAbstract_fb6e1782-87da-488a-91ff-0b8e7653ecb8" xlink:href="rxrx-20250930.xsd#rxrx_SupplementalFinancialInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_3e321e5d-6f22-4e38-8136-4c51186bb1fd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SupplementalFinancialInformationAbstract_fb6e1782-87da-488a-91ff-0b8e7653ecb8" xlink:to="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_3e321e5d-6f22-4e38-8136-4c51186bb1fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_dc81790c-5858-4828-9f3e-5c3e3924d47c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SupplementalFinancialInformationAbstract_fb6e1782-87da-488a-91ff-0b8e7653ecb8" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_dc81790c-5858-4828-9f3e-5c3e3924d47c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_7c43a3d5-fcb6-47c5-bdeb-bb60d24dda42" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SupplementalFinancialInformationAbstract_fb6e1782-87da-488a-91ff-0b8e7653ecb8" xlink:to="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_7c43a3d5-fcb6-47c5-bdeb-bb60d24dda42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/AcquisitionsTables" xlink:type="simple" xlink:href="rxrx-20250930.xsd#AcquisitionsTables"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/AcquisitionsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_5f44148f-603a-4229-aa6c-1c80882c8d2e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionTableTextBlock_4e52a0be-3991-4d3c-b513-ef0620b02262" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_5f44148f-603a-4229-aa6c-1c80882c8d2e" xlink:to="loc_us-gaap_AssetAcquisitionTableTextBlock_4e52a0be-3991-4d3c-b513-ef0620b02262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock_665e75e0-5dc3-4ed2-824e-30d079e8eb15" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_5f44148f-603a-4229-aa6c-1c80882c8d2e" xlink:to="loc_us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock_665e75e0-5dc3-4ed2-824e-30d079e8eb15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_e6eabf71-5517-4af2-bfb3-5ae8cb14bc5f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_5f44148f-603a-4229-aa6c-1c80882c8d2e" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_e6eabf71-5517-4af2-bfb3-5ae8cb14bc5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_e32a2c9b-8293-4cb7-8711-5c1e50a274ac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_5f44148f-603a-4229-aa6c-1c80882c8d2e" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_e32a2c9b-8293-4cb7-8711-5c1e50a274ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/LeasesTables" xlink:type="simple" xlink:href="rxrx-20250930.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_9bc3f010-4704-494a-981b-9f5dca8cc1e5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_1d2a697b-a1ab-4b19-ad75-35594f3a896c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9bc3f010-4704-494a-981b-9f5dca8cc1e5" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_1d2a697b-a1ab-4b19-ad75-35594f3a896c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/GoodwillandIntangibleAssetsTables" xlink:type="simple" xlink:href="rxrx-20250930.xsd#GoodwillandIntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/GoodwillandIntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a0f8d58e-3b2b-476c-a78d-bcf5a967367f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_ebdd66ac-842c-4913-8825-c728e23e5241" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a0f8d58e-3b2b-476c-a78d-bcf5a967367f" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_ebdd66ac-842c-4913-8825-c728e23e5241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_cf20e217-c242-4308-83dc-86c925c97f14" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a0f8d58e-3b2b-476c-a78d-bcf5a967367f" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_cf20e217-c242-4308-83dc-86c925c97f14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_e8e93fce-ceeb-404f-a0f7-aa9a45b466ad" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a0f8d58e-3b2b-476c-a78d-bcf5a967367f" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_e8e93fce-ceeb-404f-a0f7-aa9a45b466ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/StockBasedCompensationTables" xlink:type="simple" xlink:href="rxrx-20250930.xsd#StockBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/StockBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d1f36621-42f0-4596-9f1b-bbe1abe78266" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_09dcbf71-7c2e-40bd-849f-31f018a4d305" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d1f36621-42f0-4596-9f1b-bbe1abe78266" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_09dcbf71-7c2e-40bd-849f-31f018a4d305" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_5ae0b969-590b-4a72-9350-43bf5d63b505" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d1f36621-42f0-4596-9f1b-bbe1abe78266" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_5ae0b969-590b-4a72-9350-43bf5d63b505" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_740376e0-3053-4297-abf5-5b37c28f9862" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d1f36621-42f0-4596-9f1b-bbe1abe78266" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_740376e0-3053-4297-abf5-5b37c28f9862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_ff7063dc-1e63-4dda-be96-e87a6ed8d771" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d1f36621-42f0-4596-9f1b-bbe1abe78266" xlink:to="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_ff7063dc-1e63-4dda-be96-e87a6ed8d771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/NetLossPerShareTables" xlink:type="simple" xlink:href="rxrx-20250930.xsd#NetLossPerShareTables"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/NetLossPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_a8d94254-9e5b-4f25-8d2a-006b7891f05e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_47d6d055-590f-4d1a-a2b7-e06f1c4e1b4c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a8d94254-9e5b-4f25-8d2a-006b7891f05e" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_47d6d055-590f-4d1a-a2b7-e06f1c4e1b4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_beeb4eb8-92cb-4db1-a58d-c6c54295e49f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a8d94254-9e5b-4f25-8d2a-006b7891f05e" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_beeb4eb8-92cb-4db1-a58d-c6c54295e49f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="rxrx-20250930.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_baa42a15-a29a-4df3-9772-aa8d42787419" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_5c2ed0c8-39a7-4c6a-94f2-37c45caa9f1c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_baa42a15-a29a-4df3-9772-aa8d42787419" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_5c2ed0c8-39a7-4c6a-94f2-37c45caa9f1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock_d72fc015-45ef-4b59-b898-5e98713b5e8f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_baa42a15-a29a-4df3-9772-aa8d42787419" xlink:to="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock_d72fc015-45ef-4b59-b898-5e98713b5e8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/SegmentInformationTables" xlink:type="simple" xlink:href="rxrx-20250930.xsd#SegmentInformationTables"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/SegmentInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_de5b24c5-f734-417f-b0d7-519bc51fb244" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_5e342f39-104f-45ed-8d2d-39cba239ddd8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_de5b24c5-f734-417f-b0d7-519bc51fb244" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_5e342f39-104f-45ed-8d2d-39cba239ddd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_93a6cadb-870b-42f2-975d-0b50abbb37ab" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_de5b24c5-f734-417f-b0d7-519bc51fb244" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_93a6cadb-870b-42f2-975d-0b50abbb37ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/DescriptionoftheBusinessDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#DescriptionoftheBusinessDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/DescriptionoftheBusinessDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_28430e69-b0fd-4cd3-8306-2e9bdd56e2cb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_c97f5ad9-833d-49af-9787-f7d4c5e7da56" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_28430e69-b0fd-4cd3-8306-2e9bdd56e2cb" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_c97f5ad9-833d-49af-9787-f7d4c5e7da56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/SupplementalFinancialInformationNarrativeDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#SupplementalFinancialInformationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/SupplementalFinancialInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SupplementalFinancialInformationAbstract_200a6cfb-3cfc-48d2-a813-f277555dcd22" xlink:href="rxrx-20250930.xsd#rxrx_SupplementalFinancialInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_90797213-f3e6-4a17-b10d-49ba6fb95e39" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SupplementalFinancialInformationAbstract_200a6cfb-3cfc-48d2-a813-f277555dcd22" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_90797213-f3e6-4a17-b10d-49ba6fb95e39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_769c8adf-d7ad-412a-9409-564c5cb35269" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_90797213-f3e6-4a17-b10d-49ba6fb95e39" xlink:to="loc_srt_CounterpartyNameAxis_769c8adf-d7ad-412a-9409-564c5cb35269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cc78f54f-c118-4919-bf7e-f41a39feff9b" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_769c8adf-d7ad-412a-9409-564c5cb35269" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cc78f54f-c118-4919-bf7e-f41a39feff9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_TempusLabsIncMember_083b9853-252b-4ebc-b689-5d2178163c73" xlink:href="rxrx-20250930.xsd#rxrx_TempusLabsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cc78f54f-c118-4919-bf7e-f41a39feff9b" xlink:to="loc_rxrx_TempusLabsIncMember_083b9853-252b-4ebc-b689-5d2178163c73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c3f44802-7978-425c-9cfe-ddba1100b14f" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_90797213-f3e6-4a17-b10d-49ba6fb95e39" xlink:to="loc_srt_RangeAxis_c3f44802-7978-425c-9cfe-ddba1100b14f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2b85e4f5-4841-4fce-b03b-fed6b5930ba0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_c3f44802-7978-425c-9cfe-ddba1100b14f" xlink:to="loc_srt_RangeMember_2b85e4f5-4841-4fce-b03b-fed6b5930ba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_52e1adb7-2585-4be4-886e-dd6d087651c8" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2b85e4f5-4841-4fce-b03b-fed6b5930ba0" xlink:to="loc_srt_MinimumMember_52e1adb7-2585-4be4-886e-dd6d087651c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_206fae48-944a-40ed-8e12-28de41d1888b" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2b85e4f5-4841-4fce-b03b-fed6b5930ba0" xlink:to="loc_srt_MaximumMember_206fae48-944a-40ed-8e12-28de41d1888b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8cb90be2-0663-495f-862e-29602d749b48" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_90797213-f3e6-4a17-b10d-49ba6fb95e39" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8cb90be2-0663-495f-862e-29602d749b48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LicenseAgreementTerm_7716c3b2-c9ce-4cb1-8852-51f28007df1a" xlink:href="rxrx-20250930.xsd#rxrx_LicenseAgreementTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8cb90be2-0663-495f-862e-29602d749b48" xlink:to="loc_rxrx_LicenseAgreementTerm_7716c3b2-c9ce-4cb1-8852-51f28007df1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LicenseAgreementAnnualPayments_ce1b2064-9a3e-4225-81e9-4848df6947b7" xlink:href="rxrx-20250930.xsd#rxrx_LicenseAgreementAnnualPayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8cb90be2-0663-495f-862e-29602d749b48" xlink:to="loc_rxrx_LicenseAgreementAnnualPayments_ce1b2064-9a3e-4225-81e9-4848df6947b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LicenseAgreementAggregatePayments_71eca9d5-6352-4d08-93b3-fc170521d573" xlink:href="rxrx-20250930.xsd#rxrx_LicenseAgreementAggregatePayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8cb90be2-0663-495f-862e-29602d749b48" xlink:to="loc_rxrx_LicenseAgreementAggregatePayments_71eca9d5-6352-4d08-93b3-fc170521d573" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LicenseAgreementTradingPeriodUsedForEquityValueDetermination_e8b2585c-b376-49ab-86d3-eb9426d0d08b" xlink:href="rxrx-20250930.xsd#rxrx_LicenseAgreementTradingPeriodUsedForEquityValueDetermination"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8cb90be2-0663-495f-862e-29602d749b48" xlink:to="loc_rxrx_LicenseAgreementTradingPeriodUsedForEquityValueDetermination_e8b2585c-b376-49ab-86d3-eb9426d0d08b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LicenseAgreementAmountOfTimePriorToThePaymentDate_b7ff9362-783f-43b2-aefc-006fd62357f1" xlink:href="rxrx-20250930.xsd#rxrx_LicenseAgreementAmountOfTimePriorToThePaymentDate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8cb90be2-0663-495f-862e-29602d749b48" xlink:to="loc_rxrx_LicenseAgreementAmountOfTimePriorToThePaymentDate_b7ff9362-783f-43b2-aefc-006fd62357f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LicenseAgreementIncreaseDecreaseAccruedLiabilities_f7372b7e-e801-43ea-b8f8-f839cd5de044" xlink:href="rxrx-20250930.xsd#rxrx_LicenseAgreementIncreaseDecreaseAccruedLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8cb90be2-0663-495f-862e-29602d749b48" xlink:to="loc_rxrx_LicenseAgreementIncreaseDecreaseAccruedLiabilities_f7372b7e-e801-43ea-b8f8-f839cd5de044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent_db7f3d70-1f10-4eef-8304-667484d13e90" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8cb90be2-0663-495f-862e-29602d749b48" xlink:to="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent_db7f3d70-1f10-4eef-8304-667484d13e90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_c6297f24-1a76-449d-927e-03757d796322" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8cb90be2-0663-495f-862e-29602d749b48" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_c6297f24-1a76-449d-927e-03757d796322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SupplementalFinancialInformationAbstract_318faead-8507-42d2-96ed-f00c212b1a7c" xlink:href="rxrx-20250930.xsd#rxrx_SupplementalFinancialInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_64208060-10c9-4f3b-af06-f41ec69ce71f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SupplementalFinancialInformationAbstract_318faead-8507-42d2-96ed-f00c212b1a7c" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_64208060-10c9-4f3b-af06-f41ec69ce71f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AccruedDevelopmentCostsCurrent_2af0cca4-21b4-4eb3-bee8-f87bf6114cdf" xlink:href="rxrx-20250930.xsd#rxrx_AccruedDevelopmentCostsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SupplementalFinancialInformationAbstract_318faead-8507-42d2-96ed-f00c212b1a7c" xlink:to="loc_rxrx_AccruedDevelopmentCostsCurrent_2af0cca4-21b4-4eb3-bee8-f87bf6114cdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AccruedEarlyDiscoveryExpensesCurrent_fc4ce693-9a21-4d11-a007-54fb9d669b64" xlink:href="rxrx-20250930.xsd#rxrx_AccruedEarlyDiscoveryExpensesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SupplementalFinancialInformationAbstract_318faead-8507-42d2-96ed-f00c212b1a7c" xlink:to="loc_rxrx_AccruedEarlyDiscoveryExpensesCurrent_fc4ce693-9a21-4d11-a007-54fb9d669b64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_bf952085-5c13-46f1-90a1-95ee2736734a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SupplementalFinancialInformationAbstract_318faead-8507-42d2-96ed-f00c212b1a7c" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_bf952085-5c13-46f1-90a1-95ee2736734a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_MaterialsReceivedNotInvoiced_62011e78-8885-4464-ba90-59ffcb95c6bc" xlink:href="rxrx-20250930.xsd#rxrx_MaterialsReceivedNotInvoiced"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SupplementalFinancialInformationAbstract_318faead-8507-42d2-96ed-f00c212b1a7c" xlink:to="loc_rxrx_MaterialsReceivedNotInvoiced_62011e78-8885-4464-ba90-59ffcb95c6bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AccruedLicenseFeeCurrent_cfcaf226-8cc7-47b3-955f-502feeabcdb2" xlink:href="rxrx-20250930.xsd#rxrx_AccruedLicenseFeeCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SupplementalFinancialInformationAbstract_318faead-8507-42d2-96ed-f00c212b1a7c" xlink:to="loc_rxrx_AccruedLicenseFeeCurrent_cfcaf226-8cc7-47b3-955f-502feeabcdb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_4c70fe36-b46c-49ee-b4c8-fc6cacf71147" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SupplementalFinancialInformationAbstract_318faead-8507-42d2-96ed-f00c212b1a7c" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_4c70fe36-b46c-49ee-b4c8-fc6cacf71147" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_330421a4-1f29-4fcd-9ce3-284c2d00c57a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SupplementalFinancialInformationAbstract_318faead-8507-42d2-96ed-f00c212b1a7c" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_330421a4-1f29-4fcd-9ce3-284c2d00c57a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/SupplementalFinancialInformationScheduleofRestructuringActionsandtheRelatedAccrualDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#SupplementalFinancialInformationScheduleofRestructuringActionsandtheRelatedAccrualDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/SupplementalFinancialInformationScheduleofRestructuringActionsandtheRelatedAccrualDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_af807cbb-bf81-482e-a92a-451bbe8652b8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_daf02002-8a0f-4770-b26a-3cac02ad2540" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_af807cbb-bf81-482e-a92a-451bbe8652b8" xlink:to="loc_us-gaap_RestructuringReserveRollForward_daf02002-8a0f-4770-b26a-3cac02ad2540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_6e52c77f-88a3-4cca-a9bd-b2752d5440e2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_daf02002-8a0f-4770-b26a-3cac02ad2540" xlink:to="loc_us-gaap_RestructuringReserve_6e52c77f-88a3-4cca-a9bd-b2752d5440e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_ac37a9f4-9ca1-4d58-a7c1-3b7e5ad03cff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_daf02002-8a0f-4770-b26a-3cac02ad2540" xlink:to="loc_us-gaap_RestructuringCharges_ac37a9f4-9ca1-4d58-a7c1-3b7e5ad03cff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_dc437034-03c1-4263-b79c-9501012c0c0a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_daf02002-8a0f-4770-b26a-3cac02ad2540" xlink:to="loc_us-gaap_PaymentsForRestructuring_dc437034-03c1-4263-b79c-9501012c0c0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_a8912c0f-f330-4187-bfde-c158f2de570d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_daf02002-8a0f-4770-b26a-3cac02ad2540" xlink:to="loc_us-gaap_RestructuringReserve_a8912c0f-f330-4187-bfde-c158f2de570d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/SupplementalFinancialInformationScheduleofInterestIncomeNetDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#SupplementalFinancialInformationScheduleofInterestIncomeNetDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/SupplementalFinancialInformationScheduleofInterestIncomeNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SupplementalFinancialInformationAbstract_6d6e2a56-3bb7-47e3-b8e6-7bb91dfbb099" xlink:href="rxrx-20250930.xsd#rxrx_SupplementalFinancialInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNonoperating_c346b6d2-1996-4dcc-8578-56162269937b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeNonoperating"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SupplementalFinancialInformationAbstract_6d6e2a56-3bb7-47e3-b8e6-7bb91dfbb099" xlink:to="loc_us-gaap_InvestmentIncomeNonoperating_c346b6d2-1996-4dcc-8578-56162269937b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_b00c682b-08a5-4f2d-a9bf-f564737a4d31" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SupplementalFinancialInformationAbstract_6d6e2a56-3bb7-47e3-b8e6-7bb91dfbb099" xlink:to="loc_us-gaap_InterestExpenseNonoperating_b00c682b-08a5-4f2d-a9bf-f564737a4d31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_dede73fb-22c1-4e84-89d2-450398bd2aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SupplementalFinancialInformationAbstract_6d6e2a56-3bb7-47e3-b8e6-7bb91dfbb099" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_dede73fb-22c1-4e84-89d2-450398bd2aa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/AcquisitionsNarrativeDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#AcquisitionsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/AcquisitionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_21f75793-68c0-48cd-95e0-05ca5cccdfb9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d07e4889-3648-442d-8a0d-c05ac6011149" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_21f75793-68c0-48cd-95e0-05ca5cccdfb9" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d07e4889-3648-442d-8a0d-c05ac6011149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_f2ace846-d18f-41f3-8f8c-b5b95807fe2f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d07e4889-3648-442d-8a0d-c05ac6011149" xlink:to="loc_us-gaap_AssetAcquisitionAxis_f2ace846-d18f-41f3-8f8c-b5b95807fe2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_10ee2e9e-7132-467d-98df-66769248844f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionAxis_f2ace846-d18f-41f3-8f8c-b5b95807fe2f" xlink:to="loc_us-gaap_AssetAcquisitionDomain_10ee2e9e-7132-467d-98df-66769248844f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_REVenturesIMember_4eefadfa-fb39-460e-882b-a9a72a656452" xlink:href="rxrx-20250930.xsd#rxrx_REVenturesIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_10ee2e9e-7132-467d-98df-66769248844f" xlink:to="loc_rxrx_REVenturesIMember_4eefadfa-fb39-460e-882b-a9a72a656452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_41f6f70d-f760-4e7c-924a-9969964a2013" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d07e4889-3648-442d-8a0d-c05ac6011149" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_41f6f70d-f760-4e7c-924a-9969964a2013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_93648942-f115-4d11-9f49-c6bd095ee32d" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_41f6f70d-f760-4e7c-924a-9969964a2013" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_93648942-f115-4d11-9f49-c6bd095ee32d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AlphaBiotechnologyGmbHAlphaMember_d193c838-e892-4472-8c1b-359cf146478e" xlink:href="rxrx-20250930.xsd#rxrx_AlphaBiotechnologyGmbHAlphaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_93648942-f115-4d11-9f49-c6bd095ee32d" xlink:to="loc_rxrx_AlphaBiotechnologyGmbHAlphaMember_d193c838-e892-4472-8c1b-359cf146478e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_9a96439c-5a8b-486f-906a-254e84e8c0cc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d07e4889-3648-442d-8a0d-c05ac6011149" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_9a96439c-5a8b-486f-906a-254e84e8c0cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_85d42f94-5aaa-496e-8df3-220cc594bea6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_9a96439c-5a8b-486f-906a-254e84e8c0cc" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_85d42f94-5aaa-496e-8df3-220cc594bea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_6fc4cc13-377e-4109-9a1d-d344f7e4570e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_85d42f94-5aaa-496e-8df3-220cc594bea6" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_6fc4cc13-377e-4109-9a1d-d344f7e4570e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a1eb9703-bce0-4fb2-8e1a-776c0e914d9e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d07e4889-3648-442d-8a0d-c05ac6011149" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a1eb9703-bce0-4fb2-8e1a-776c0e914d9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4eddef23-603f-45a3-a889-afa4cf5b50f2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a1eb9703-bce0-4fb2-8e1a-776c0e914d9e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4eddef23-603f-45a3-a889-afa4cf5b50f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ExscientiaGmbHMember_8348c576-8d68-4259-9027-fbff6fc6d0fd" xlink:href="rxrx-20250930.xsd#rxrx_ExscientiaGmbHMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4eddef23-603f-45a3-a889-afa4cf5b50f2" xlink:to="loc_rxrx_ExscientiaGmbHMember_8348c576-8d68-4259-9027-fbff6fc6d0fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e16fe651-2357-4ab0-b215-ab6460690433" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d07e4889-3648-442d-8a0d-c05ac6011149" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e16fe651-2357-4ab0-b215-ab6460690433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fa491605-b649-4be1-8a28-4ef6a6bb0de9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e16fe651-2357-4ab0-b215-ab6460690433" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fa491605-b649-4be1-8a28-4ef6a6bb0de9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ExscientiaPlcMember_06ac4a1e-771a-4c31-8048-61ee076cef23" xlink:href="rxrx-20250930.xsd#rxrx_ExscientiaPlcMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fa491605-b649-4be1-8a28-4ef6a6bb0de9" xlink:to="loc_rxrx_ExscientiaPlcMember_06ac4a1e-771a-4c31-8048-61ee076cef23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_37c72370-7cdb-4301-8b31-6b8b1e73ea1b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d07e4889-3648-442d-8a0d-c05ac6011149" xlink:to="loc_us-gaap_StatementClassOfStockAxis_37c72370-7cdb-4301-8b31-6b8b1e73ea1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_f06db931-c889-45ed-be62-dcc3427cda1e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_37c72370-7cdb-4301-8b31-6b8b1e73ea1b" xlink:to="loc_us-gaap_ClassOfStockDomain_f06db931-c889-45ed-be62-dcc3427cda1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_db6310e8-5f18-4380-b68f-70c8d26cf94b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_f06db931-c889-45ed-be62-dcc3427cda1e" xlink:to="loc_us-gaap_CommonClassAMember_db6310e8-5f18-4380-b68f-70c8d26cf94b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c1241c7b-e15a-4e25-af2f-d2329ae99e96" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d07e4889-3648-442d-8a0d-c05ac6011149" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c1241c7b-e15a-4e25-af2f-d2329ae99e96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1b427187-e5c5-493a-a639-8735a25be02f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c1241c7b-e15a-4e25-af2f-d2329ae99e96" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1b427187-e5c5-493a-a639-8735a25be02f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_4c6a1841-014f-47bb-b942-6fc8cae1c707" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1b427187-e5c5-493a-a639-8735a25be02f" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_4c6a1841-014f-47bb-b942-6fc8cae1c707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_4bb61542-3852-402d-ac19-1f0727841dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d07e4889-3648-442d-8a0d-c05ac6011149" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_4bb61542-3852-402d-ac19-1f0727841dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AssetAcquisitionEquityOwnershipPercentage_a7253a5f-ef60-4d4c-8efc-11b4611653e4" xlink:href="rxrx-20250930.xsd#rxrx_AssetAcquisitionEquityOwnershipPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4bb61542-3852-402d-ac19-1f0727841dd8" xlink:to="loc_rxrx_AssetAcquisitionEquityOwnershipPercentage_a7253a5f-ef60-4d4c-8efc-11b4611653e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferred_15b7cffa-c61b-4993-bb3f-b1ac24c84127" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionConsiderationTransferred"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4bb61542-3852-402d-ac19-1f0727841dd8" xlink:to="loc_us-gaap_AssetAcquisitionConsiderationTransferred_15b7cffa-c61b-4993-bb3f-b1ac24c84127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_ab799bf1-1896-4513-a8eb-3842999c4a71" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4bb61542-3852-402d-ac19-1f0727841dd8" xlink:to="loc_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_ab799bf1-1896-4513-a8eb-3842999c4a71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_e49b42cc-c369-4ea6-9640-6638931774d0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4bb61542-3852-402d-ac19-1f0727841dd8" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_e49b42cc-c369-4ea6-9640-6638931774d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_1066b381-1ddc-442e-9530-378b6cf9d2de" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4bb61542-3852-402d-ac19-1f0727841dd8" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_1066b381-1ddc-442e-9530-378b6cf9d2de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_1c58dd82-e099-4350-b3a4-096805ec8440" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4bb61542-3852-402d-ac19-1f0727841dd8" xlink:to="loc_us-gaap_EquityMethodInvestments_1c58dd82-e099-4350-b3a4-096805ec8440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_cb7eb77b-efa1-4dbe-bdd9-fa07433ad134" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4bb61542-3852-402d-ac19-1f0727841dd8" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_cb7eb77b-efa1-4dbe-bdd9-fa07433ad134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_8895b4bb-b048-4db6-a6be-a6e16089e1ad" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4bb61542-3852-402d-ac19-1f0727841dd8" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_8895b4bb-b048-4db6-a6be-a6e16089e1ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_BusinessCombinationConsiderationTransferredEquityInterestsIssuable_b806b1bb-f6b0-4bd2-8387-846abf56f4bd" xlink:href="rxrx-20250930.xsd#rxrx_BusinessCombinationConsiderationTransferredEquityInterestsIssuable"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4bb61542-3852-402d-ac19-1f0727841dd8" xlink:to="loc_rxrx_BusinessCombinationConsiderationTransferredEquityInterestsIssuable_b806b1bb-f6b0-4bd2-8387-846abf56f4bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_7975a78d-c836-4b51-9150-f9c4fec7079e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4bb61542-3852-402d-ac19-1f0727841dd8" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_7975a78d-c836-4b51-9150-f9c4fec7079e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_BusinessCombinationEquityInterestIssuedOrIssuableSharesOfAcquirerStockPerShareOfAcquireeStockOutstanding_4533b2d0-b866-4557-97b1-d82ef74408a0" xlink:href="rxrx-20250930.xsd#rxrx_BusinessCombinationEquityInterestIssuedOrIssuableSharesOfAcquirerStockPerShareOfAcquireeStockOutstanding"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4bb61542-3852-402d-ac19-1f0727841dd8" xlink:to="loc_rxrx_BusinessCombinationEquityInterestIssuedOrIssuableSharesOfAcquirerStockPerShareOfAcquireeStockOutstanding_4533b2d0-b866-4557-97b1-d82ef74408a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_368b2a31-9501-42ac-b875-a7e50d6fc463" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4bb61542-3852-402d-ac19-1f0727841dd8" xlink:to="loc_us-gaap_SharePrice_368b2a31-9501-42ac-b875-a7e50d6fc463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_dad3f1d5-23cc-412d-b6a6-df0a0b381f99" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4bb61542-3852-402d-ac19-1f0727841dd8" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_dad3f1d5-23cc-412d-b6a6-df0a0b381f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_02a2e7bd-ea63-4781-ab86-dc672e74b474" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4bb61542-3852-402d-ac19-1f0727841dd8" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_02a2e7bd-ea63-4781-ab86-dc672e74b474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_NumberOfAcquiredCustomerContractsWithContractLiabilities_0df33ede-89ec-4450-8200-b63a3da28338" xlink:href="rxrx-20250930.xsd#rxrx_NumberOfAcquiredCustomerContractsWithContractLiabilities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4bb61542-3852-402d-ac19-1f0727841dd8" xlink:to="loc_rxrx_NumberOfAcquiredCustomerContractsWithContractLiabilities_0df33ede-89ec-4450-8200-b63a3da28338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_NumberOfInProcessResearchAndDevelopmentAssets_6325d837-655e-48ba-8a29-59f867198fb4" xlink:href="rxrx-20250930.xsd#rxrx_NumberOfInProcessResearchAndDevelopmentAssets"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4bb61542-3852-402d-ac19-1f0727841dd8" xlink:to="loc_rxrx_NumberOfInProcessResearchAndDevelopmentAssets_6325d837-655e-48ba-8a29-59f867198fb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_FiniteLivedIntangibleAssetDiscountRate_c5363bd3-0517-4779-92d1-635e6322b213" xlink:href="rxrx-20250930.xsd#rxrx_FiniteLivedIntangibleAssetDiscountRate"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4bb61542-3852-402d-ac19-1f0727841dd8" xlink:to="loc_rxrx_FiniteLivedIntangibleAssetDiscountRate_c5363bd3-0517-4779-92d1-635e6322b213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_39b291ea-3748-405a-980d-181fb46bf5ef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4bb61542-3852-402d-ac19-1f0727841dd8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_39b291ea-3748-405a-980d-181fb46bf5ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_6d456b42-559c-4923-a0aa-4e5c71789012" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4bb61542-3852-402d-ac19-1f0727841dd8" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_6d456b42-559c-4923-a0aa-4e5c71789012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_76420f94-f260-417a-a26d-c608aabe00da" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4bb61542-3852-402d-ac19-1f0727841dd8" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_76420f94-f260-417a-a26d-c608aabe00da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/AcquisitionsScheduleofAssetAcquisitionDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#AcquisitionsScheduleofAssetAcquisitionDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/AcquisitionsScheduleofAssetAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_5de4562e-5b05-482d-b023-1f58b9c2edd7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionTable_552881d1-0519-467f-91f8-0606082f157f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_5de4562e-5b05-482d-b023-1f58b9c2edd7" xlink:to="loc_us-gaap_AssetAcquisitionTable_552881d1-0519-467f-91f8-0606082f157f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_42c50789-92c6-4c5b-8208-bf3b73c787ca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionTable_552881d1-0519-467f-91f8-0606082f157f" xlink:to="loc_us-gaap_AssetAcquisitionAxis_42c50789-92c6-4c5b-8208-bf3b73c787ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_f292eac9-fbf0-4cc8-9e0e-2b2be8d6fec7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionAxis_42c50789-92c6-4c5b-8208-bf3b73c787ca" xlink:to="loc_us-gaap_AssetAcquisitionDomain_f292eac9-fbf0-4cc8-9e0e-2b2be8d6fec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_REVenturesIMember_2cdce1cf-071a-46ca-8aee-9a9192c001ef" xlink:href="rxrx-20250930.xsd#rxrx_REVenturesIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_f292eac9-fbf0-4cc8-9e0e-2b2be8d6fec7" xlink:to="loc_rxrx_REVenturesIMember_2cdce1cf-071a-46ca-8aee-9a9192c001ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionLineItems_63557ee7-62d2-4232-88f3-00a09abe0235" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionTable_552881d1-0519-467f-91f8-0606082f157f" xlink:to="loc_us-gaap_AssetAcquisitionLineItems_63557ee7-62d2-4232-88f3-00a09abe0235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable_df53ddab-d552-4f55-951b-ad55eff0e3ff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_63557ee7-62d2-4232-88f3-00a09abe0235" xlink:to="loc_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable_df53ddab-d552-4f55-951b-ad55eff0e3ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration_37c36925-a70e-439d-b6bd-aa382ebdea0f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_63557ee7-62d2-4232-88f3-00a09abe0235" xlink:to="loc_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration_37c36925-a70e-439d-b6bd-aa382ebdea0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost_a8285323-9b02-4e11-8ad2-be011c1b86d2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_63557ee7-62d2-4232-88f3-00a09abe0235" xlink:to="loc_us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost_a8285323-9b02-4e11-8ad2-be011c1b86d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_01440d9d-1c1a-4c08-87f1-011bece014aa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_63557ee7-62d2-4232-88f3-00a09abe0235" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_01440d9d-1c1a-4c08-87f1-011bece014aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferred_51b68d33-21de-4778-b2cc-6a3eaf9865fd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionConsiderationTransferred"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_63557ee7-62d2-4232-88f3-00a09abe0235" xlink:to="loc_us-gaap_AssetAcquisitionConsiderationTransferred_51b68d33-21de-4778-b2cc-6a3eaf9865fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/AcquisitionsScheduleofContingentConsiderationTransferredDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#AcquisitionsScheduleofContingentConsiderationTransferredDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/AcquisitionsScheduleofContingentConsiderationTransferredDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_798d4da7-3b22-4ded-972e-915dfd03c15d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionTable_1167f7f4-b8e0-4607-9c9e-19be9ccc295c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_798d4da7-3b22-4ded-972e-915dfd03c15d" xlink:to="loc_us-gaap_AssetAcquisitionTable_1167f7f4-b8e0-4607-9c9e-19be9ccc295c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_5faa9642-6161-4f99-b30c-e1ae4cd59ffb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionTable_1167f7f4-b8e0-4607-9c9e-19be9ccc295c" xlink:to="loc_us-gaap_AssetAcquisitionAxis_5faa9642-6161-4f99-b30c-e1ae4cd59ffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_520f7005-a118-445d-8798-cae8094a3dfa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionAxis_5faa9642-6161-4f99-b30c-e1ae4cd59ffb" xlink:to="loc_us-gaap_AssetAcquisitionDomain_520f7005-a118-445d-8798-cae8094a3dfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_REVenturesIMember_47233d35-2b1d-4dfa-b8cd-f1cef0abc67c" xlink:href="rxrx-20250930.xsd#rxrx_REVenturesIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_520f7005-a118-445d-8798-cae8094a3dfa" xlink:to="loc_rxrx_REVenturesIMember_47233d35-2b1d-4dfa-b8cd-f1cef0abc67c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionLineItems_8b77d76e-3f8b-4401-ab0e-8d6c7e45635b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionTable_1167f7f4-b8e0-4607-9c9e-19be9ccc295c" xlink:to="loc_us-gaap_AssetAcquisitionLineItems_8b77d76e-3f8b-4401-ab0e-8d6c7e45635b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AssetAcquisitionContingentConsiderationEquityInterestIssuedAndIssuable_02974ca4-ad2a-4f03-9c1c-ba31c6dc6b99" xlink:href="rxrx-20250930.xsd#rxrx_AssetAcquisitionContingentConsiderationEquityInterestIssuedAndIssuable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_8b77d76e-3f8b-4401-ab0e-8d6c7e45635b" xlink:to="loc_rxrx_AssetAcquisitionContingentConsiderationEquityInterestIssuedAndIssuable_02974ca4-ad2a-4f03-9c1c-ba31c6dc6b99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AssetAcquisitionContingentConsiderationCashPaid_f5e83f22-18fb-4f86-9c29-ff77edfe4047" xlink:href="rxrx-20250930.xsd#rxrx_AssetAcquisitionContingentConsiderationCashPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_8b77d76e-3f8b-4401-ab0e-8d6c7e45635b" xlink:to="loc_rxrx_AssetAcquisitionContingentConsiderationCashPaid_f5e83f22-18fb-4f86-9c29-ff77edfe4047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration_4de09014-bd2b-410d-b592-4f04a3f06b69" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_8b77d76e-3f8b-4401-ab0e-8d6c7e45635b" xlink:to="loc_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration_4de09014-bd2b-410d-b592-4f04a3f06b69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_691d3947-88a7-4783-84fe-8c27fd0c1a50" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_aeec8782-4719-4e76-8de3-a47b5f1a04df" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_691d3947-88a7-4783-84fe-8c27fd0c1a50" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_aeec8782-4719-4e76-8de3-a47b5f1a04df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_57c3739e-5a59-4165-af58-62a5db3197f5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_aeec8782-4719-4e76-8de3-a47b5f1a04df" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_57c3739e-5a59-4165-af58-62a5db3197f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_783a9075-d715-4605-9780-20b8c93470a3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_57c3739e-5a59-4165-af58-62a5db3197f5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_783a9075-d715-4605-9780-20b8c93470a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ExscientiaPlcMember_5d26f23a-29a4-454a-b916-c61a3f58c35f" xlink:href="rxrx-20250930.xsd#rxrx_ExscientiaPlcMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_783a9075-d715-4605-9780-20b8c93470a3" xlink:to="loc_rxrx_ExscientiaPlcMember_5d26f23a-29a4-454a-b916-c61a3f58c35f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_967a6d1e-9508-4bef-bdad-d70bd3a7f42f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_aeec8782-4719-4e76-8de3-a47b5f1a04df" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_967a6d1e-9508-4bef-bdad-d70bd3a7f42f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_3cba97ea-8625-436a-912b-e35331fe92b4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_967a6d1e-9508-4bef-bdad-d70bd3a7f42f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_3cba97ea-8625-436a-912b-e35331fe92b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables_8fa25861-1d97-42b3-a681-5077f4d499c5" xlink:href="rxrx-20250930.xsd#rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_967a6d1e-9508-4bef-bdad-d70bd3a7f42f" xlink:to="loc_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables_8fa25861-1d97-42b3-a681-5077f4d499c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_31973424-bcd8-4f8a-8a68-71ba910be1f2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_967a6d1e-9508-4bef-bdad-d70bd3a7f42f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_31973424-bcd8-4f8a-8a68-71ba910be1f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_aad149a0-e0af-408a-a5b8-daa47b113f44" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_967a6d1e-9508-4bef-bdad-d70bd3a7f42f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_aad149a0-e0af-408a-a5b8-daa47b113f44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_d50fd7fe-ac7e-4cd5-86c6-3521b62a573c" xlink:href="rxrx-20250930.xsd#rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_967a6d1e-9508-4bef-bdad-d70bd3a7f42f" xlink:to="loc_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_d50fd7fe-ac7e-4cd5-86c6-3521b62a573c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_1b66272b-ed99-4c4c-b1c4-cc6cbe8a5c08" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_967a6d1e-9508-4bef-bdad-d70bd3a7f42f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_1b66272b-ed99-4c4c-b1c4-cc6cbe8a5c08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_f2f87ee5-f05d-4bc1-b6f8-9ccc6fa35596" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_967a6d1e-9508-4bef-bdad-d70bd3a7f42f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_f2f87ee5-f05d-4bc1-b6f8-9ccc6fa35596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_bf381e65-4ed0-4867-ad53-b6068362e04c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_967a6d1e-9508-4bef-bdad-d70bd3a7f42f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_bf381e65-4ed0-4867-ad53-b6068362e04c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_cb9af6fd-f656-4490-b9a1-31333f89c061" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_967a6d1e-9508-4bef-bdad-d70bd3a7f42f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_cb9af6fd-f656-4490-b9a1-31333f89c061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_87c62c10-5ac5-42f4-945e-8db824e36615" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_967a6d1e-9508-4bef-bdad-d70bd3a7f42f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_87c62c10-5ac5-42f4-945e-8db824e36615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities_60e06aaf-d2d2-4fab-a164-cbcef5a69a8d" xlink:href="rxrx-20250930.xsd#rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_967a6d1e-9508-4bef-bdad-d70bd3a7f42f" xlink:to="loc_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities_60e06aaf-d2d2-4fab-a164-cbcef5a69a8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_962d4ce4-b5c3-4f8c-a862-5cbfa4e4c7a0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_967a6d1e-9508-4bef-bdad-d70bd3a7f42f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_962d4ce4-b5c3-4f8c-a862-5cbfa4e4c7a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_a6c97f79-b7ac-4d4a-912e-92a6d5a76d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_967a6d1e-9508-4bef-bdad-d70bd3a7f42f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_a6c97f79-b7ac-4d4a-912e-92a6d5a76d7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_72379d8d-50fb-4684-8458-42748f682164" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_967a6d1e-9508-4bef-bdad-d70bd3a7f42f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_72379d8d-50fb-4684-8458-42748f682164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_bcd8daab-874b-44ae-a425-e9a474ac6152" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_967a6d1e-9508-4bef-bdad-d70bd3a7f42f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_bcd8daab-874b-44ae-a425-e9a474ac6152" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_4acc641b-16b9-4964-bd41-674ce700e61d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_967a6d1e-9508-4bef-bdad-d70bd3a7f42f" xlink:to="loc_us-gaap_Goodwill_4acc641b-16b9-4964-bd41-674ce700e61d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_4c81e625-192f-480e-b8af-5b7bddfaef96" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_967a6d1e-9508-4bef-bdad-d70bd3a7f42f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_4c81e625-192f-480e-b8af-5b7bddfaef96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/AcquisitionsScheduleofProFormaFinancialInformationDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#AcquisitionsScheduleofProFormaFinancialInformationDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/AcquisitionsScheduleofProFormaFinancialInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_50222fd8-d10e-4fed-bc53-a67d3ebf18bc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0e03ae62-1123-4f10-beb1-2cdf708c9da3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_50222fd8-d10e-4fed-bc53-a67d3ebf18bc" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0e03ae62-1123-4f10-beb1-2cdf708c9da3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9cc5c14f-ea05-4dc3-88ee-a3665a8892b2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0e03ae62-1123-4f10-beb1-2cdf708c9da3" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9cc5c14f-ea05-4dc3-88ee-a3665a8892b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_11d450d8-4079-4bc9-83ad-3f27e6c22888" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9cc5c14f-ea05-4dc3-88ee-a3665a8892b2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_11d450d8-4079-4bc9-83ad-3f27e6c22888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ExscientiaPlcMember_21b4da53-f4e3-45a6-9c61-fc627b4d26d2" xlink:href="rxrx-20250930.xsd#rxrx_ExscientiaPlcMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_11d450d8-4079-4bc9-83ad-3f27e6c22888" xlink:to="loc_rxrx_ExscientiaPlcMember_21b4da53-f4e3-45a6-9c61-fc627b4d26d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_9eff7a1c-ae82-4b70-b995-ec3c81ed5fd9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0e03ae62-1123-4f10-beb1-2cdf708c9da3" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_9eff7a1c-ae82-4b70-b995-ec3c81ed5fd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_9b355238-060f-4e96-b9bc-a715f1b2cea8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9eff7a1c-ae82-4b70-b995-ec3c81ed5fd9" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_9b355238-060f-4e96-b9bc-a715f1b2cea8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_b42ddd2c-fb5c-48c6-bca6-a4fb0ea7b1b1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9eff7a1c-ae82-4b70-b995-ec3c81ed5fd9" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_b42ddd2c-fb5c-48c6-bca6-a4fb0ea7b1b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_9c8b67eb-19a9-4e0d-b259-953c5dd6a6fb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_d42b809e-2cdd-499e-9812-c8bd6de08b02" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9c8b67eb-19a9-4e0d-b259-953c5dd6a6fb" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_d42b809e-2cdd-499e-9812-c8bd6de08b02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d21c43cb-6db6-4487-9ec5-4e81e08cf496" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_d42b809e-2cdd-499e-9812-c8bd6de08b02" xlink:to="loc_srt_RangeAxis_d21c43cb-6db6-4487-9ec5-4e81e08cf496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_664466da-57d5-4e15-a8d9-cadbb9d5e9fc" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_d21c43cb-6db6-4487-9ec5-4e81e08cf496" xlink:to="loc_srt_RangeMember_664466da-57d5-4e15-a8d9-cadbb9d5e9fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c9f56b9c-9e0b-49a5-904c-3feb315a7769" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_664466da-57d5-4e15-a8d9-cadbb9d5e9fc" xlink:to="loc_srt_MinimumMember_c9f56b9c-9e0b-49a5-904c-3feb315a7769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_090c8027-6dac-45d8-93ba-cef353fe90ab" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_664466da-57d5-4e15-a8d9-cadbb9d5e9fc" xlink:to="loc_srt_MaximumMember_090c8027-6dac-45d8-93ba-cef353fe90ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LeaseDescriptionAxis_a21b28c3-3375-47f6-941a-126c0800bf46" xlink:href="rxrx-20250930.xsd#rxrx_LeaseDescriptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_d42b809e-2cdd-499e-9812-c8bd6de08b02" xlink:to="loc_rxrx_LeaseDescriptionAxis_a21b28c3-3375-47f6-941a-126c0800bf46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LeaseDescriptionDomain_34a50b2b-39e0-4892-affd-8d3f57cd738e" xlink:href="rxrx-20250930.xsd#rxrx_LeaseDescriptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_LeaseDescriptionAxis_a21b28c3-3375-47f6-941a-126c0800bf46" xlink:to="loc_rxrx_LeaseDescriptionDomain_34a50b2b-39e0-4892-affd-8d3f57cd738e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ViennaFacilitiesOfExscientiaGmbHMember_e81e035d-02d5-4dd7-a420-351e49f0fcd8" xlink:href="rxrx-20250930.xsd#rxrx_ViennaFacilitiesOfExscientiaGmbHMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_LeaseDescriptionDomain_34a50b2b-39e0-4892-affd-8d3f57cd738e" xlink:to="loc_rxrx_ViennaFacilitiesOfExscientiaGmbHMember_e81e035d-02d5-4dd7-a420-351e49f0fcd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SchrodingerLeasesMember_35b69a3f-bf94-4b71-9ad5-5464e8bea468" xlink:href="rxrx-20250930.xsd#rxrx_SchrodingerLeasesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_LeaseDescriptionDomain_34a50b2b-39e0-4892-affd-8d3f57cd738e" xlink:to="loc_rxrx_SchrodingerLeasesMember_35b69a3f-bf94-4b71-9ad5-5464e8bea468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_2f2b6b17-1258-4b04-acde-c5cde18e2e01" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_d42b809e-2cdd-499e-9812-c8bd6de08b02" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_2f2b6b17-1258-4b04-acde-c5cde18e2e01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_e3162a37-7759-47ee-9c0e-c1e3e4f66057" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2f2b6b17-1258-4b04-acde-c5cde18e2e01" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_e3162a37-7759-47ee-9c0e-c1e3e4f66057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_7be0edee-cc7b-4a89-bf5e-a20883b12ce2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2f2b6b17-1258-4b04-acde-c5cde18e2e01" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_7be0edee-cc7b-4a89-bf5e-a20883b12ce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets_f9d77544-9d10-45c2-baa6-b97629ab9b00" xlink:href="rxrx-20250930.xsd#rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2f2b6b17-1258-4b04-acde-c5cde18e2e01" xlink:to="loc_rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets_f9d77544-9d10-45c2-baa6-b97629ab9b00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications_659df068-a569-4bf5-bd1c-ae58f5179edc" xlink:href="rxrx-20250930.xsd#rxrx_LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2f2b6b17-1258-4b04-acde-c5cde18e2e01" xlink:to="loc_rxrx_LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications_659df068-a569-4bf5-bd1c-ae58f5179edc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_TerminationOfLeaseFee_2e319164-7a37-4d6b-bc57-cecac32e8d68" xlink:href="rxrx-20250930.xsd#rxrx_TerminationOfLeaseFee"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2f2b6b17-1258-4b04-acde-c5cde18e2e01" xlink:to="loc_rxrx_TerminationOfLeaseFee_2e319164-7a37-4d6b-bc57-cecac32e8d68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLeasehold_c2014b90-77e6-4085-b64b-b5e9316f64f2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOfLeasehold"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2f2b6b17-1258-4b04-acde-c5cde18e2e01" xlink:to="loc_us-gaap_ImpairmentOfLeasehold_c2014b90-77e6-4085-b64b-b5e9316f64f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_IncreaseDecreaseInRightOfUseAssetsForFinanceLeases_a23d9a41-dfc9-40c5-9789-28ee9f5e2126" xlink:href="rxrx-20250930.xsd#rxrx_IncreaseDecreaseInRightOfUseAssetsForFinanceLeases"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2f2b6b17-1258-4b04-acde-c5cde18e2e01" xlink:to="loc_rxrx_IncreaseDecreaseInRightOfUseAssetsForFinanceLeases_a23d9a41-dfc9-40c5-9789-28ee9f5e2126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LesseeFinanceLeaseIncreaseDecreaseInFinanceLeaseLiabilityDueToLeaseModifications_abedcf6d-17c4-4471-aaac-582cb4265b31" xlink:href="rxrx-20250930.xsd#rxrx_LesseeFinanceLeaseIncreaseDecreaseInFinanceLeaseLiabilityDueToLeaseModifications"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2f2b6b17-1258-4b04-acde-c5cde18e2e01" xlink:to="loc_rxrx_LesseeFinanceLeaseIncreaseDecreaseInFinanceLeaseLiabilityDueToLeaseModifications_abedcf6d-17c4-4471-aaac-582cb4265b31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/LeasesScheduleofSupplementalCashFlowInformationRelatedtoLeasesDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#LeasesScheduleofSupplementalCashFlowInformationRelatedtoLeasesDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/LeasesScheduleofSupplementalCashFlowInformationRelatedtoLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_67db6faa-7e6c-4dba-bfdd-37a24d1957ef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_CashPaidForAmountIncludedInTheMeasurementOfLeaseLiabilitiesAbstract_037b7f11-837e-43c3-a570-bf13cc71d74e" xlink:href="rxrx-20250930.xsd#rxrx_CashPaidForAmountIncludedInTheMeasurementOfLeaseLiabilitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_67db6faa-7e6c-4dba-bfdd-37a24d1957ef" xlink:to="loc_rxrx_CashPaidForAmountIncludedInTheMeasurementOfLeaseLiabilitiesAbstract_037b7f11-837e-43c3-a570-bf13cc71d74e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_033aac99-2aaa-4a4b-a206-36adc9e177d9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_CashPaidForAmountIncludedInTheMeasurementOfLeaseLiabilitiesAbstract_037b7f11-837e-43c3-a570-bf13cc71d74e" xlink:to="loc_us-gaap_OperatingLeasePayments_033aac99-2aaa-4a4b-a206-36adc9e177d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_4a144de5-23e2-4582-bfca-663997f16d88" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_CashPaidForAmountIncludedInTheMeasurementOfLeaseLiabilitiesAbstract_037b7f11-837e-43c3-a570-bf13cc71d74e" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_4a144de5-23e2-4582-bfca-663997f16d88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_d460a257-54a2-4933-9b17-b2842713db85" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_CashPaidForAmountIncludedInTheMeasurementOfLeaseLiabilitiesAbstract_037b7f11-837e-43c3-a570-bf13cc71d74e" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_d460a257-54a2-4933-9b17-b2842713db85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract_1c4e83e2-d467-4315-81d8-d207688fe1f9" xlink:href="rxrx-20250930.xsd#rxrx_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_67db6faa-7e6c-4dba-bfdd-37a24d1957ef" xlink:to="loc_rxrx_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract_1c4e83e2-d467-4315-81d8-d207688fe1f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets_fc64837c-48ad-4825-9049-c555547538cc" xlink:href="rxrx-20250930.xsd#rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract_1c4e83e2-d467-4315-81d8-d207688fe1f9" xlink:to="loc_rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets_fc64837c-48ad-4825-9049-c555547538cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_IncreaseDecreaseInRightOfUseAssetsForFinanceLeases_d3a3a974-2fae-4739-a0dd-9d77687d84db" xlink:href="rxrx-20250930.xsd#rxrx_IncreaseDecreaseInRightOfUseAssetsForFinanceLeases"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract_1c4e83e2-d467-4315-81d8-d207688fe1f9" xlink:to="loc_rxrx_IncreaseDecreaseInRightOfUseAssetsForFinanceLeases_d3a3a974-2fae-4739-a0dd-9d77687d84db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofChangesintheCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#GoodwillandIntangibleAssetsScheduleofChangesintheCarryingAmountofGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofChangesintheCarryingAmountofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b050888f-4830-4c39-91db-89e3d84f8da1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_5f1621f1-a836-48c2-914b-3f2f08510a05" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b050888f-4830-4c39-91db-89e3d84f8da1" xlink:to="loc_us-gaap_GoodwillRollForward_5f1621f1-a836-48c2-914b-3f2f08510a05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d3aafdd7-0a7b-471e-9c3e-395499f346db" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_5f1621f1-a836-48c2-914b-3f2f08510a05" xlink:to="loc_us-gaap_Goodwill_d3aafdd7-0a7b-471e-9c3e-395499f346db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_92afa1d0-caa3-4363-a267-442d8825f46b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_5f1621f1-a836-48c2-914b-3f2f08510a05" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_92afa1d0-caa3-4363-a267-442d8825f46b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_2cfb15f7-8c04-4c85-91d5-b4f247359a99" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_5f1621f1-a836-48c2-914b-3f2f08510a05" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_2cfb15f7-8c04-4c85-91d5-b4f247359a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_68f51de8-2df4-469b-965e-e84e1abcdfbf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_5f1621f1-a836-48c2-914b-3f2f08510a05" xlink:to="loc_us-gaap_Goodwill_68f51de8-2df4-469b-965e-e84e1abcdfbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/GoodwillandIntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#GoodwillandIntangibleAssetsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/GoodwillandIntangibleAssetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_37062d40-73bf-4a58-99f3-f1c140aeef42" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_3e2e28ad-557a-48dc-9d41-0f5554940e76" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_37062d40-73bf-4a58-99f3-f1c140aeef42" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_3e2e28ad-557a-48dc-9d41-0f5554940e76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_9e4510ac-9c00-4cc0-9221-437fbe2c6c9f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_37062d40-73bf-4a58-99f3-f1c140aeef42" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_9e4510ac-9c00-4cc0-9221-437fbe2c6c9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_0d48409a-e88b-490e-87e6-a937e9628e8b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_37062d40-73bf-4a58-99f3-f1c140aeef42" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_0d48409a-e88b-490e-87e6-a937e9628e8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f684aafd-493a-47ed-a70e-3e0ddf9809e3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_4998b468-3202-4799-8724-2deeea793b66" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f684aafd-493a-47ed-a70e-3e0ddf9809e3" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_4998b468-3202-4799-8724-2deeea793b66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_44aeb9ea-f9b8-4d53-bb72-e73dbde25f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_4998b468-3202-4799-8724-2deeea793b66" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_44aeb9ea-f9b8-4d53-bb72-e73dbde25f6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0f55f01d-3bbd-4b91-b2a7-f6c9a43c16e0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_44aeb9ea-f9b8-4d53-bb72-e73dbde25f6c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0f55f01d-3bbd-4b91-b2a7-f6c9a43c16e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_0d542a63-da02-48a5-862d-782def40f532" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0f55f01d-3bbd-4b91-b2a7-f6c9a43c16e0" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_0d542a63-da02-48a5-862d-782def40f532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_311ac23e-7729-4f4f-9984-4b1a5735c98c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0f55f01d-3bbd-4b91-b2a7-f6c9a43c16e0" xlink:to="loc_us-gaap_LicensingAgreementsMember_311ac23e-7729-4f4f-9984-4b1a5735c98c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_2dec6963-108e-4c02-9def-2027002a2df9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_4998b468-3202-4799-8724-2deeea793b66" xlink:to="loc_us-gaap_GoodwillLineItems_2dec6963-108e-4c02-9def-2027002a2df9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_eebea2b0-4e79-41c8-9d9d-e2c6c7295ee9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_2dec6963-108e-4c02-9def-2027002a2df9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_eebea2b0-4e79-41c8-9d9d-e2c6c7295ee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ce5e1535-4d1a-4488-a31f-4cb0dd69dedf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_2dec6963-108e-4c02-9def-2027002a2df9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ce5e1535-4d1a-4488-a31f-4cb0dd69dedf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c04ebc48-aba9-4d15-8b80-6278bc9cff2c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_2dec6963-108e-4c02-9def-2027002a2df9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c04ebc48-aba9-4d15-8b80-6278bc9cff2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_0677202f-986a-480a-bbfa-16bf32af1457" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_2dec6963-108e-4c02-9def-2027002a2df9" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_0677202f-986a-480a-bbfa-16bf32af1457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_9fd0ce2d-7e2f-4bc8-93d5-c52348de334b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_2dec6963-108e-4c02-9def-2027002a2df9" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_9fd0ce2d-7e2f-4bc8-93d5-c52348de334b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f4615d4c-c65a-4060-bf01-d28bed133787" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_2dec6963-108e-4c02-9def-2027002a2df9" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f4615d4c-c65a-4060-bf01-d28bed133787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ec9f6b3a-94dc-4142-b83d-eb471929ccd5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_8f87a5c0-b9b9-4bfa-8477-c0587af9955d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ec9f6b3a-94dc-4142-b83d-eb471929ccd5" xlink:to="loc_us-gaap_LossContingenciesTable_8f87a5c0-b9b9-4bfa-8477-c0587af9955d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_ad0a77e1-9f99-4be8-b7a2-63eca8c6b780" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_8f87a5c0-b9b9-4bfa-8477-c0587af9955d" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_ad0a77e1-9f99-4be8-b7a2-63eca8c6b780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_e500e2a1-d2aa-40e0-8974-d1e4cd7035c4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_ad0a77e1-9f99-4be8-b7a2-63eca8c6b780" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_e500e2a1-d2aa-40e0-8974-d1e4cd7035c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_7d3c6849-a92b-4484-8e41-5570390e9ec2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_e500e2a1-d2aa-40e0-8974-d1e4cd7035c4" xlink:to="loc_us-gaap_SubsequentEventMember_7d3c6849-a92b-4484-8e41-5570390e9ec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_384d8590-e864-448b-83f3-bdd25035308a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_8f87a5c0-b9b9-4bfa-8477-c0587af9955d" xlink:to="loc_us-gaap_LossContingenciesLineItems_384d8590-e864-448b-83f3-bdd25035308a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_bd90115f-4973-4eb8-a89f-76e6ff2c4840" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_384d8590-e864-448b-83f3-bdd25035308a" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_bd90115f-4973-4eb8-a89f-76e6ff2c4840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_DurationOfTimeForPlaintiffToRefileClaim_404c6673-fd85-4362-9ac8-3afb572619a8" xlink:href="rxrx-20250930.xsd#rxrx_DurationOfTimeForPlaintiffToRefileClaim"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_384d8590-e864-448b-83f3-bdd25035308a" xlink:to="loc_rxrx_DurationOfTimeForPlaintiffToRefileClaim_404c6673-fd85-4362-9ac8-3afb572619a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_FinanceLeasesAssetsPledgedAsCollateral_91528a2e-7050-48fa-8ae9-56a79fd6fdab" xlink:href="rxrx-20250930.xsd#rxrx_FinanceLeasesAssetsPledgedAsCollateral"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_384d8590-e864-448b-83f3-bdd25035308a" xlink:to="loc_rxrx_FinanceLeasesAssetsPledgedAsCollateral_91528a2e-7050-48fa-8ae9-56a79fd6fdab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_dd2c534b-3ca5-426b-8dc2-1ab5fa025f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_384d8590-e864-448b-83f3-bdd25035308a" xlink:to="loc_us-gaap_FinanceLeaseLiability_dd2c534b-3ca5-426b-8dc2-1ab5fa025f5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CommonStockNarrativeDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#CommonStockNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/CommonStockNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_2118e3a0-cee8-4332-b512-f8e9c3bcdfc4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_cf6a67cd-0949-4ffb-b88f-8cfa253979ce" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2118e3a0-cee8-4332-b512-f8e9c3bcdfc4" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_cf6a67cd-0949-4ffb-b88f-8cfa253979ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_efa6e186-37d0-4ff8-af0e-d2437e953604" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_cf6a67cd-0949-4ffb-b88f-8cfa253979ce" xlink:to="loc_us-gaap_StatementClassOfStockAxis_efa6e186-37d0-4ff8-af0e-d2437e953604" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_fb2bce99-601c-44db-abe1-a60bd9f094cc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_efa6e186-37d0-4ff8-af0e-d2437e953604" xlink:to="loc_us-gaap_ClassOfStockDomain_fb2bce99-601c-44db-abe1-a60bd9f094cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_87ada789-7af4-4345-ad60-41550e83cea3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_fb2bce99-601c-44db-abe1-a60bd9f094cc" xlink:to="loc_us-gaap_CommonClassAMember_87ada789-7af4-4345-ad60-41550e83cea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_ca1638d6-bbda-4b04-b479-dfd098a1a097" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_fb2bce99-601c-44db-abe1-a60bd9f094cc" xlink:to="loc_us-gaap_CommonClassBMember_ca1638d6-bbda-4b04-b479-dfd098a1a097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_6a001e76-8e5e-4769-b977-56d6d3a7e8bb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_cf6a67cd-0949-4ffb-b88f-8cfa253979ce" xlink:to="loc_us-gaap_ClassOfStockLineItems_6a001e76-8e5e-4769-b977-56d6d3a7e8bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_CommonStockVotePerShare_4bbec2fb-872e-4007-b9a3-17fe77ba5ad4" xlink:href="rxrx-20250930.xsd#rxrx_CommonStockVotePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_6a001e76-8e5e-4769-b977-56d6d3a7e8bb" xlink:to="loc_rxrx_CommonStockVotePerShare_4bbec2fb-872e-4007-b9a3-17fe77ba5ad4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsStock_99a15483-0d76-40d0-837e-f25e8e989f50" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DividendsStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_6a001e76-8e5e-4769-b977-56d6d3a7e8bb" xlink:to="loc_us-gaap_DividendsStock_99a15483-0d76-40d0-837e-f25e8e989f50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CommonStockAtTheMarketOfferingNarrativeDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#CommonStockAtTheMarketOfferingNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/CommonStockAtTheMarketOfferingNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_e7408c8c-4fa4-4d10-9d59-475481b0b897" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_0145cb9d-df92-4410-8ff8-e24294e66247" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e7408c8c-4fa4-4d10-9d59-475481b0b897" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_0145cb9d-df92-4410-8ff8-e24294e66247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_6d3c28d5-9bda-4ba5-917e-e477c2d07341" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_0145cb9d-df92-4410-8ff8-e24294e66247" xlink:to="loc_us-gaap_StatementClassOfStockAxis_6d3c28d5-9bda-4ba5-917e-e477c2d07341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_f0a13d04-9316-4bcc-bfef-b800de2c0b24" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_6d3c28d5-9bda-4ba5-917e-e477c2d07341" xlink:to="loc_us-gaap_ClassOfStockDomain_f0a13d04-9316-4bcc-bfef-b800de2c0b24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_fdd21f56-874c-4b18-888a-4a4c7c724cc8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_f0a13d04-9316-4bcc-bfef-b800de2c0b24" xlink:to="loc_us-gaap_CommonClassAMember_fdd21f56-874c-4b18-888a-4a4c7c724cc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_93703283-db28-424a-a013-976e2d234069" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_0145cb9d-df92-4410-8ff8-e24294e66247" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_93703283-db28-424a-a013-976e2d234069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_02db2176-3df4-4bfb-bc60-748586436d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_93703283-db28-424a-a013-976e2d234069" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_02db2176-3df4-4bfb-bc60-748586436d0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AtTheMarketOfferingProgramCitiMember_fa9be1c0-7ced-4dc5-97d9-97e0147a0153" xlink:href="rxrx-20250930.xsd#rxrx_AtTheMarketOfferingProgramCitiMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_02db2176-3df4-4bfb-bc60-748586436d0c" xlink:to="loc_rxrx_AtTheMarketOfferingProgramCitiMember_fa9be1c0-7ced-4dc5-97d9-97e0147a0153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AtTheMarketOfferingProgramJefferiesMember_8d0c29cd-28ed-4182-814d-94759891f532" xlink:href="rxrx-20250930.xsd#rxrx_AtTheMarketOfferingProgramJefferiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_02db2176-3df4-4bfb-bc60-748586436d0c" xlink:to="loc_rxrx_AtTheMarketOfferingProgramJefferiesMember_8d0c29cd-28ed-4182-814d-94759891f532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_4134cb9a-bfeb-475d-97b3-1f298e231998" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_0145cb9d-df92-4410-8ff8-e24294e66247" xlink:to="loc_us-gaap_ClassOfStockLineItems_4134cb9a-bfeb-475d-97b3-1f298e231998" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SaleOfStockValueAuthorized_0b83abe8-aae0-45f6-9d9b-a504e0c36d11" xlink:href="rxrx-20250930.xsd#rxrx_SaleOfStockValueAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_4134cb9a-bfeb-475d-97b3-1f298e231998" xlink:to="loc_rxrx_SaleOfStockValueAuthorized_0b83abe8-aae0-45f6-9d9b-a504e0c36d11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_9798ca2f-635e-48a1-94ab-4f2152e07d85" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_4134cb9a-bfeb-475d-97b3-1f298e231998" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_9798ca2f-635e-48a1-94ab-4f2152e07d85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_f46d618f-b501-401e-9e97-59dbdf148471" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_4134cb9a-bfeb-475d-97b3-1f298e231998" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_f46d618f-b501-401e-9e97-59dbdf148471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SaleOfStockValueRemainingAuthorized_48b35073-2093-43f2-8fe5-6b1bc5dc01e4" xlink:href="rxrx-20250930.xsd#rxrx_SaleOfStockValueRemainingAuthorized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_4134cb9a-bfeb-475d-97b3-1f298e231998" xlink:to="loc_rxrx_SaleOfStockValueRemainingAuthorized_48b35073-2093-43f2-8fe5-6b1bc5dc01e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SaleOfStockPercentageOfCommission_81469ace-ade4-447c-8adf-36e87331a4eb" xlink:href="rxrx-20250930.xsd#rxrx_SaleOfStockPercentageOfCommission"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_4134cb9a-bfeb-475d-97b3-1f298e231998" xlink:to="loc_rxrx_SaleOfStockPercentageOfCommission_81469ace-ade4-447c-8adf-36e87331a4eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CommonStockPublicOfferingofCommonStockNarrativeDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#CommonStockPublicOfferingofCommonStockNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/CommonStockPublicOfferingofCommonStockNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_0c2628db-1047-4507-a679-7020637f5b81" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_717f1c5b-de44-4635-9c84-9086cd205b72" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0c2628db-1047-4507-a679-7020637f5b81" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_717f1c5b-de44-4635-9c84-9086cd205b72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_5ca43d25-9891-4ab5-b2d6-b698f93c874f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_717f1c5b-de44-4635-9c84-9086cd205b72" xlink:to="loc_us-gaap_StatementClassOfStockAxis_5ca43d25-9891-4ab5-b2d6-b698f93c874f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_b9e05786-ef84-4b84-8f82-9dc4555629e3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_5ca43d25-9891-4ab5-b2d6-b698f93c874f" xlink:to="loc_us-gaap_ClassOfStockDomain_b9e05786-ef84-4b84-8f82-9dc4555629e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_81a4fcb0-1011-46c9-8242-e6269a0ee465" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_b9e05786-ef84-4b84-8f82-9dc4555629e3" xlink:to="loc_us-gaap_CommonClassAMember_81a4fcb0-1011-46c9-8242-e6269a0ee465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_18c8aa33-11bb-4c5c-9ada-d65c8f263f58" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_717f1c5b-de44-4635-9c84-9086cd205b72" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_18c8aa33-11bb-4c5c-9ada-d65c8f263f58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8c430dd6-867b-4a33-96d3-12f916e17dd4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_18c8aa33-11bb-4c5c-9ada-d65c8f263f58" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8c430dd6-867b-4a33-96d3-12f916e17dd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_PublicOfferingOfCommonStockMember_3658bb79-1737-4f1b-aca8-705ad21a397f" xlink:href="rxrx-20250930.xsd#rxrx_PublicOfferingOfCommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8c430dd6-867b-4a33-96d3-12f916e17dd4" xlink:to="loc_rxrx_PublicOfferingOfCommonStockMember_3658bb79-1737-4f1b-aca8-705ad21a397f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_PublicOfferingOfCommonStockUnderwritingAgreementMember_f95d8051-38d8-4e72-b53b-de36a20643cd" xlink:href="rxrx-20250930.xsd#rxrx_PublicOfferingOfCommonStockUnderwritingAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8c430dd6-867b-4a33-96d3-12f916e17dd4" xlink:to="loc_rxrx_PublicOfferingOfCommonStockUnderwritingAgreementMember_f95d8051-38d8-4e72-b53b-de36a20643cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember_d185cf1a-a92a-43f8-8116-debebaaeaec0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8c430dd6-867b-4a33-96d3-12f916e17dd4" xlink:to="loc_us-gaap_OverAllotmentOptionMember_d185cf1a-a92a-43f8-8116-debebaaeaec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_8c98a64e-144d-4fb2-9ae0-739133fda6d2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_717f1c5b-de44-4635-9c84-9086cd205b72" xlink:to="loc_us-gaap_ClassOfStockLineItems_8c98a64e-144d-4fb2-9ae0-739133fda6d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_bebf73ca-1912-4cff-9a4a-d7e1c8489a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_8c98a64e-144d-4fb2-9ae0-739133fda6d2" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_bebf73ca-1912-4cff-9a4a-d7e1c8489a8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_5b0c5f50-fb6f-4f96-897d-a8cc3cbd18fc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_8c98a64e-144d-4fb2-9ae0-739133fda6d2" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_5b0c5f50-fb6f-4f96-897d-a8cc3cbd18fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_cfb9e442-0f11-49fe-a5f4-49b9f81778c0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_8c98a64e-144d-4fb2-9ae0-739133fda6d2" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_cfb9e442-0f11-49fe-a5f4-49b9f81778c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_2d990ab5-7787-429e-957a-2f9d504eb688" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_8c98a64e-144d-4fb2-9ae0-739133fda6d2" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_2d990ab5-7787-429e-957a-2f9d504eb688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SaleOfStockUnderwritersOptionPeriodFromTheDateOfTheAgreement_481ae044-bfd4-447a-a52e-6846ad3081c9" xlink:href="rxrx-20250930.xsd#rxrx_SaleOfStockUnderwritersOptionPeriodFromTheDateOfTheAgreement"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_8c98a64e-144d-4fb2-9ae0-739133fda6d2" xlink:to="loc_rxrx_SaleOfStockUnderwritersOptionPeriodFromTheDateOfTheAgreement_481ae044-bfd4-447a-a52e-6846ad3081c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CommonStockValenceAcquisitionExchangeableSharesNarrativeDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#CommonStockValenceAcquisitionExchangeableSharesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/CommonStockValenceAcquisitionExchangeableSharesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_62a2fee4-fa0e-4c61-9852-547fa8a0620c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_a2719367-4624-40c0-9486-65ae6d8aa0cc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_62a2fee4-fa0e-4c61-9852-547fa8a0620c" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_a2719367-4624-40c0-9486-65ae6d8aa0cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3904acd6-5e7b-451b-bef4-3e00b1374903" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_a2719367-4624-40c0-9486-65ae6d8aa0cc" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3904acd6-5e7b-451b-bef4-3e00b1374903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ce29856a-99e2-4b3c-8622-d6d890c6dcb2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3904acd6-5e7b-451b-bef4-3e00b1374903" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ce29856a-99e2-4b3c-8622-d6d890c6dcb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ValenceDiscoveryIncMember_1e577c7c-6ddb-4afe-b43e-e4431337930d" xlink:href="rxrx-20250930.xsd#rxrx_ValenceDiscoveryIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ce29856a-99e2-4b3c-8622-d6d890c6dcb2" xlink:to="loc_rxrx_ValenceDiscoveryIncMember_1e577c7c-6ddb-4afe-b43e-e4431337930d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_4a0c9ece-9aab-4495-8574-dfb8a587b410" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_a2719367-4624-40c0-9486-65ae6d8aa0cc" xlink:to="loc_us-gaap_StatementClassOfStockAxis_4a0c9ece-9aab-4495-8574-dfb8a587b410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_cbc9076a-39be-4b33-9bd1-845d30cef62a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_4a0c9ece-9aab-4495-8574-dfb8a587b410" xlink:to="loc_us-gaap_ClassOfStockDomain_cbc9076a-39be-4b33-9bd1-845d30cef62a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ExchangeableStockMember_1e4441b4-4b54-43ff-b5d0-8b65d338aeb8" xlink:href="rxrx-20250930.xsd#rxrx_ExchangeableStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_cbc9076a-39be-4b33-9bd1-845d30cef62a" xlink:to="loc_rxrx_ExchangeableStockMember_1e4441b4-4b54-43ff-b5d0-8b65d338aeb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_78ab6ded-3e97-423a-8795-20a3fe0c69a9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_cbc9076a-39be-4b33-9bd1-845d30cef62a" xlink:to="loc_us-gaap_CommonClassAMember_78ab6ded-3e97-423a-8795-20a3fe0c69a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_11dd39cf-d166-435d-af29-9082adcfe237" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_a2719367-4624-40c0-9486-65ae6d8aa0cc" xlink:to="loc_us-gaap_ClassOfStockLineItems_11dd39cf-d166-435d-af29-9082adcfe237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares_e36526eb-305d-4411-8f4e-6529ee6ec333" xlink:href="rxrx-20250930.xsd#rxrx_BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_11dd39cf-d166-435d-af29-9082adcfe237" xlink:to="loc_rxrx_BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares_e36526eb-305d-4411-8f4e-6529ee6ec333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_CommonStockConversionRatio_4d4dd29d-de75-4c23-84f0-682fae175253" xlink:href="rxrx-20250930.xsd#rxrx_CommonStockConversionRatio"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_11dd39cf-d166-435d-af29-9082adcfe237" xlink:to="loc_rxrx_CommonStockConversionRatio_4d4dd29d-de75-4c23-84f0-682fae175253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_1b8993e2-acb9-4125-9c61-be6388fec89b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_11dd39cf-d166-435d-af29-9082adcfe237" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_1b8993e2-acb9-4125-9c61-be6388fec89b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CommonStockRegistrationRightsAgreementsNarrativeDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#CommonStockRegistrationRightsAgreementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/CommonStockRegistrationRightsAgreementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_0632aef0-5b01-4f94-918f-094c867f5728" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_1b8f50c5-e93b-4550-816f-f548f0689a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0632aef0-5b01-4f94-918f-094c867f5728" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_1b8f50c5-e93b-4550-816f-f548f0689a8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_21d153e3-3e85-440b-88d3-9edbc02732e5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1b8f50c5-e93b-4550-816f-f548f0689a8f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_21d153e3-3e85-440b-88d3-9edbc02732e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0256d4ee-f7cf-46c8-98f5-280f04d108e5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_21d153e3-3e85-440b-88d3-9edbc02732e5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0256d4ee-f7cf-46c8-98f5-280f04d108e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ValenceDiscoveryIncMember_4809a5b7-6709-46a6-8686-fa87ec265b03" xlink:href="rxrx-20250930.xsd#rxrx_ValenceDiscoveryIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0256d4ee-f7cf-46c8-98f5-280f04d108e5" xlink:to="loc_rxrx_ValenceDiscoveryIncMember_4809a5b7-6709-46a6-8686-fa87ec265b03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_a732fc32-28f7-449e-abee-ac5aad3ff5be" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1b8f50c5-e93b-4550-816f-f548f0689a8f" xlink:to="loc_us-gaap_ClassOfStockLineItems_a732fc32-28f7-449e-abee-ac5aad3ff5be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RegistrationRightsAgreementTerm_2f0ce740-da01-4800-8cab-c6afd959ffbb" xlink:href="rxrx-20250930.xsd#rxrx_RegistrationRightsAgreementTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a732fc32-28f7-449e-abee-ac5aad3ff5be" xlink:to="loc_rxrx_RegistrationRightsAgreementTerm_2f0ce740-da01-4800-8cab-c6afd959ffbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CommonStockClassAandBCommonSharesAuthorizationNarrativeDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#CommonStockClassAandBCommonSharesAuthorizationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/CommonStockClassAandBCommonSharesAuthorizationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_5158bba6-e7c5-41f7-ad15-c9e98e01d32f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_d954e4ff-1023-403e-95a2-35cf4e24ae9b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5158bba6-e7c5-41f7-ad15-c9e98e01d32f" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_d954e4ff-1023-403e-95a2-35cf4e24ae9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_36cc0ec9-8054-4814-a3aa-f1b5e732f315" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_d954e4ff-1023-403e-95a2-35cf4e24ae9b" xlink:to="loc_us-gaap_StatementClassOfStockAxis_36cc0ec9-8054-4814-a3aa-f1b5e732f315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a40efc49-19ea-48eb-83e2-f66ce991de89" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_36cc0ec9-8054-4814-a3aa-f1b5e732f315" xlink:to="loc_us-gaap_ClassOfStockDomain_a40efc49-19ea-48eb-83e2-f66ce991de89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_c897a333-b80d-44c2-a83b-c3dd24481d6d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_a40efc49-19ea-48eb-83e2-f66ce991de89" xlink:to="loc_us-gaap_CommonClassAMember_c897a333-b80d-44c2-a83b-c3dd24481d6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_8f0a8377-c8c1-4375-ae96-22ff53cef658" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_a40efc49-19ea-48eb-83e2-f66ce991de89" xlink:to="loc_us-gaap_CommonClassBMember_8f0a8377-c8c1-4375-ae96-22ff53cef658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7afca1e9-885d-44b7-98d3-989615eb97a8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_d954e4ff-1023-403e-95a2-35cf4e24ae9b" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7afca1e9-885d-44b7-98d3-989615eb97a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_aa0509c7-414b-4dde-a566-4902150e91a1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7afca1e9-885d-44b7-98d3-989615eb97a8" xlink:to="loc_us-gaap_RelatedPartyDomain_aa0509c7-414b-4dde-a566-4902150e91a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_CEOAndAffiliatesMember_14dec137-6715-486c-a63a-c426a0eb819a" xlink:href="rxrx-20250930.xsd#rxrx_CEOAndAffiliatesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_aa0509c7-414b-4dde-a566-4902150e91a1" xlink:to="loc_rxrx_CEOAndAffiliatesMember_14dec137-6715-486c-a63a-c426a0eb819a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_c1ef4886-3b4b-4d63-9058-4dc48b4f37c5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_d954e4ff-1023-403e-95a2-35cf4e24ae9b" xlink:to="loc_us-gaap_ClassOfStockLineItems_c1ef4886-3b4b-4d63-9058-4dc48b4f37c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_NumberOfClassesOfCommonStockAuthorized_8dd5768b-72ce-4fb2-aba8-9f266871783d" xlink:href="rxrx-20250930.xsd#rxrx_NumberOfClassesOfCommonStockAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c1ef4886-3b4b-4d63-9058-4dc48b4f37c5" xlink:to="loc_rxrx_NumberOfClassesOfCommonStockAuthorized_8dd5768b-72ce-4fb2-aba8-9f266871783d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_CommonStockVotePerShare_958b33f9-7b6c-4631-8e54-5df5d578b7d0" xlink:href="rxrx-20250930.xsd#rxrx_CommonStockVotePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c1ef4886-3b4b-4d63-9058-4dc48b4f37c5" xlink:to="loc_rxrx_CommonStockVotePerShare_958b33f9-7b6c-4631-8e54-5df5d578b7d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_CommonStockConversionRatio_b650af55-870a-44c1-b81a-f0fbddfcb1bd" xlink:href="rxrx-20250930.xsd#rxrx_CommonStockConversionRatio"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c1ef4886-3b4b-4d63-9058-4dc48b4f37c5" xlink:to="loc_rxrx_CommonStockConversionRatio_b650af55-870a-44c1-b81a-f0fbddfcb1bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AffiliatedHoldersOwnershipPercentage_f76ae9c2-d682-4008-89b1-363e4d922ca5" xlink:href="rxrx-20250930.xsd#rxrx_AffiliatedHoldersOwnershipPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c1ef4886-3b4b-4d63-9058-4dc48b4f37c5" xlink:to="loc_rxrx_AffiliatedHoldersOwnershipPercentage_f76ae9c2-d682-4008-89b1-363e4d922ca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AffiliatedHoldersPotentialOwnershipPercentageWhenOutstandingEquityAwardsVest_ac9d6469-d15e-47b7-827f-8a268dda8b3c" xlink:href="rxrx-20250930.xsd#rxrx_AffiliatedHoldersPotentialOwnershipPercentageWhenOutstandingEquityAwardsVest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c1ef4886-3b4b-4d63-9058-4dc48b4f37c5" xlink:to="loc_rxrx_AffiliatedHoldersPotentialOwnershipPercentageWhenOutstandingEquityAwardsVest_ac9d6469-d15e-47b7-827f-8a268dda8b3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#CollaborativeDevelopmentContractsDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3174836a-4ac1-4f06-9680-4237b1d4bbcc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_758ee5ed-9413-427f-b4bd-c48d8534a08c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3174836a-4ac1-4f06-9680-4237b1d4bbcc" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_758ee5ed-9413-427f-b4bd-c48d8534a08c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_795553e4-7ff7-4cd7-9077-c3cf4ee0320f" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_758ee5ed-9413-427f-b4bd-c48d8534a08c" xlink:to="loc_srt_CounterpartyNameAxis_795553e4-7ff7-4cd7-9077-c3cf4ee0320f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5cac79af-4ee6-4636-8e2f-8a12e4ec50a6" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_795553e4-7ff7-4cd7-9077-c3cf4ee0320f" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5cac79af-4ee6-4636-8e2f-8a12e4ec50a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SanofiMember_f755e7d6-e153-4e1e-b80c-cfc35f7a8c2d" xlink:href="rxrx-20250930.xsd#rxrx_SanofiMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5cac79af-4ee6-4636-8e2f-8a12e4ec50a6" xlink:to="loc_rxrx_SanofiMember_f755e7d6-e153-4e1e-b80c-cfc35f7a8c2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_MerckKGaAMerckMember_a32dda0d-3a8f-43dc-84e1-15134868020b" xlink:href="rxrx-20250930.xsd#rxrx_MerckKGaAMerckMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5cac79af-4ee6-4636-8e2f-8a12e4ec50a6" xlink:to="loc_rxrx_MerckKGaAMerckMember_a32dda0d-3a8f-43dc-84e1-15134868020b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RocheAndGenentechMember_56ebc793-e68f-4952-b577-44715e05b6de" xlink:href="rxrx-20250930.xsd#rxrx_RocheAndGenentechMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5cac79af-4ee6-4636-8e2f-8a12e4ec50a6" xlink:to="loc_rxrx_RocheAndGenentechMember_56ebc793-e68f-4952-b577-44715e05b6de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_5116a201-0802-45ea-93f4-77c25e4cd9e8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_758ee5ed-9413-427f-b4bd-c48d8534a08c" xlink:to="loc_us-gaap_TypeOfArrangementAxis_5116a201-0802-45ea-93f4-77c25e4cd9e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_862102f3-0459-4180-b061-95096b12e649" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_5116a201-0802-45ea-93f4-77c25e4cd9e8" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_862102f3-0459-4180-b061-95096b12e649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_f28a4971-c0f5-4062-bcdd-5008ebff3be1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_862102f3-0459-4180-b061-95096b12e649" xlink:to="loc_us-gaap_CollaborativeArrangementMember_f28a4971-c0f5-4062-bcdd-5008ebff3be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_MilestoneTypeAxis_44a21875-46ae-4808-bf74-3af33fa6f9af" xlink:href="rxrx-20250930.xsd#rxrx_MilestoneTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_758ee5ed-9413-427f-b4bd-c48d8534a08c" xlink:to="loc_rxrx_MilestoneTypeAxis_44a21875-46ae-4808-bf74-3af33fa6f9af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_MilestoneTypeDomain_a7654ac8-13b3-4b25-a263-97c127002338" xlink:href="rxrx-20250930.xsd#rxrx_MilestoneTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_MilestoneTypeAxis_44a21875-46ae-4808-bf74-3af33fa6f9af" xlink:to="loc_rxrx_MilestoneTypeDomain_a7654ac8-13b3-4b25-a263-97c127002338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ResearchMilestonesMember_3e87210c-de06-4c62-93ab-4aa8a14b74f0" xlink:href="rxrx-20250930.xsd#rxrx_ResearchMilestonesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_MilestoneTypeDomain_a7654ac8-13b3-4b25-a263-97c127002338" xlink:to="loc_rxrx_ResearchMilestonesMember_3e87210c-de06-4c62-93ab-4aa8a14b74f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_DevelopmentAndRegulatoryMilestonesMember_71725e6b-0203-43ec-8a95-b4502d75b42d" xlink:href="rxrx-20250930.xsd#rxrx_DevelopmentAndRegulatoryMilestonesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_MilestoneTypeDomain_a7654ac8-13b3-4b25-a263-97c127002338" xlink:to="loc_rxrx_DevelopmentAndRegulatoryMilestonesMember_71725e6b-0203-43ec-8a95-b4502d75b42d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_DiscoveryDevelopmentAndSalesMilestonesMember_117aa0b4-f2b1-4886-9191-d4171938a4c3" xlink:href="rxrx-20250930.xsd#rxrx_DiscoveryDevelopmentAndSalesMilestonesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_MilestoneTypeDomain_a7654ac8-13b3-4b25-a263-97c127002338" xlink:to="loc_rxrx_DiscoveryDevelopmentAndSalesMilestonesMember_117aa0b4-f2b1-4886-9191-d4171938a4c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RevenueRemainingPerformanceObligationAxis_c60dffea-f5a9-4fa0-8bb3-7dbf2e099d4a" xlink:href="rxrx-20250930.xsd#rxrx_RevenueRemainingPerformanceObligationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_758ee5ed-9413-427f-b4bd-c48d8534a08c" xlink:to="loc_rxrx_RevenueRemainingPerformanceObligationAxis_c60dffea-f5a9-4fa0-8bb3-7dbf2e099d4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RevenueRemainingPerformanceObligationDomain_cc134f32-b2f6-4000-94fb-4c40dbe7aacc" xlink:href="rxrx-20250930.xsd#rxrx_RevenueRemainingPerformanceObligationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_RevenueRemainingPerformanceObligationAxis_c60dffea-f5a9-4fa0-8bb3-7dbf2e099d4a" xlink:to="loc_rxrx_RevenueRemainingPerformanceObligationDomain_cc134f32-b2f6-4000-94fb-4c40dbe7aacc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_PhenomapsCreationMember_adb75356-3590-4a6f-a2f9-083b2c7d33b6" xlink:href="rxrx-20250930.xsd#rxrx_PhenomapsCreationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_RevenueRemainingPerformanceObligationDomain_cc134f32-b2f6-4000-94fb-4c40dbe7aacc" xlink:to="loc_rxrx_PhenomapsCreationMember_adb75356-3590-4a6f-a2f9-083b2c7d33b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_PhenomapsRawImagesMember_e7319607-9b27-4246-a26f-3830197c3c40" xlink:href="rxrx-20250930.xsd#rxrx_PhenomapsRawImagesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_RevenueRemainingPerformanceObligationDomain_cc134f32-b2f6-4000-94fb-4c40dbe7aacc" xlink:to="loc_rxrx_PhenomapsRawImagesMember_e7319607-9b27-4246-a26f-3830197c3c40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_DevelopedAndCommercializedProgramsMember_f96f82aa-8a1c-4776-8f6e-389daf6c6a3c" xlink:href="rxrx-20250930.xsd#rxrx_DevelopedAndCommercializedProgramsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_RevenueRemainingPerformanceObligationDomain_cc134f32-b2f6-4000-94fb-4c40dbe7aacc" xlink:to="loc_rxrx_DevelopedAndCommercializedProgramsMember_f96f82aa-8a1c-4776-8f6e-389daf6c6a3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_GastrointestinalCancerMember_d92ed997-4e54-4ff5-bfc6-b2328172ae95" xlink:href="rxrx-20250930.xsd#rxrx_GastrointestinalCancerMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_RevenueRemainingPerformanceObligationDomain_cc134f32-b2f6-4000-94fb-4c40dbe7aacc" xlink:to="loc_rxrx_GastrointestinalCancerMember_d92ed997-4e54-4ff5-bfc6-b2328172ae95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_NeuroscienceMember_c9fe0133-b520-4cd9-9380-30a5898a8462" xlink:href="rxrx-20250930.xsd#rxrx_NeuroscienceMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_RevenueRemainingPerformanceObligationDomain_cc134f32-b2f6-4000-94fb-4c40dbe7aacc" xlink:to="loc_rxrx_NeuroscienceMember_c9fe0133-b520-4cd9-9380-30a5898a8462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_601288c0-6868-4410-a6fd-166d640f6363" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_758ee5ed-9413-427f-b4bd-c48d8534a08c" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_601288c0-6868-4410-a6fd-166d640f6363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ContractWithCustomerNumberOfNovelSmallMoleculeCandidates_1fbde10b-0370-469c-9409-37f263ccd702" xlink:href="rxrx-20250930.xsd#rxrx_ContractWithCustomerNumberOfNovelSmallMoleculeCandidates"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_601288c0-6868-4410-a6fd-166d640f6363" xlink:to="loc_rxrx_ContractWithCustomerNumberOfNovelSmallMoleculeCandidates_1fbde10b-0370-469c-9409-37f263ccd702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_515512a7-c89b-493f-82ab-486a6df80be7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_601288c0-6868-4410-a6fd-166d640f6363" xlink:to="loc_us-gaap_ContractWithCustomerLiability_515512a7-c89b-493f-82ab-486a6df80be7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_559d699e-61fb-47ce-875b-83bd226ea042" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_601288c0-6868-4410-a6fd-166d640f6363" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_559d699e-61fb-47ce-875b-83bd226ea042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_CollaborativeArrangementMilestonePaymentReceived_9df113c7-f7d4-4261-9cb6-8b1486aafb92" xlink:href="rxrx-20250930.xsd#rxrx_CollaborativeArrangementMilestonePaymentReceived"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_601288c0-6868-4410-a6fd-166d640f6363" xlink:to="loc_rxrx_CollaborativeArrangementMilestonePaymentReceived_9df113c7-f7d4-4261-9cb6-8b1486aafb92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RevenuePerformanceObligationNumberOfObligations_08f8803a-351d-42fb-bc4f-183d3a1441ad" xlink:href="rxrx-20250930.xsd#rxrx_RevenuePerformanceObligationNumberOfObligations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_601288c0-6868-4410-a6fd-166d640f6363" xlink:to="loc_rxrx_RevenuePerformanceObligationNumberOfObligations_08f8803a-351d-42fb-bc4f-183d3a1441ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_da21478e-8a53-47cb-8cd6-b90591003274" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_601288c0-6868-4410-a6fd-166d640f6363" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_da21478e-8a53-47cb-8cd6-b90591003274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RevenueRemainingPerformanceObligationVariableConsiderationAmount_3791ce81-1b49-4355-a0ff-3de6c19898a3" xlink:href="rxrx-20250930.xsd#rxrx_RevenueRemainingPerformanceObligationVariableConsiderationAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_601288c0-6868-4410-a6fd-166d640f6363" xlink:to="loc_rxrx_RevenueRemainingPerformanceObligationVariableConsiderationAmount_3791ce81-1b49-4355-a0ff-3de6c19898a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ContractWithCustomerMaximumAcceptedProduct_48e1e728-8d41-4063-8c76-aa2f334a53cc" xlink:href="rxrx-20250930.xsd#rxrx_ContractWithCustomerMaximumAcceptedProduct"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_601288c0-6868-4410-a6fd-166d640f6363" xlink:to="loc_rxrx_ContractWithCustomerMaximumAcceptedProduct_48e1e728-8d41-4063-8c76-aa2f334a53cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated_1f1531ab-d63c-489c-af69-eb9c30e51607" xlink:href="rxrx-20250930.xsd#rxrx_RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_601288c0-6868-4410-a6fd-166d640f6363" xlink:to="loc_rxrx_RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated_1f1531ab-d63c-489c-af69-eb9c30e51607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_390eb85e-ef68-4650-a3a6-1111858b77d9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_f0f8bc14-379a-4500-802f-ba94b1825e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_601288c0-6868-4410-a6fd-166d640f6363" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_f0f8bc14-379a-4500-802f-ba94b1825e5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/StockBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#StockBasedCompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/StockBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d8063358-e647-45b7-807c-f8ea7edc74a9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc5f8ba7-cc8d-4390-9d70-8e838e2da4ac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d8063358-e647-45b7-807c-f8ea7edc74a9" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc5f8ba7-cc8d-4390-9d70-8e838e2da4ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_4dbe2aea-1590-42d7-92d4-5a009eb096b1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc5f8ba7-cc8d-4390-9d70-8e838e2da4ac" xlink:to="loc_us-gaap_PlanNameAxis_4dbe2aea-1590-42d7-92d4-5a009eb096b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_30eb105e-3db4-407d-8222-e87e11c02e9f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_4dbe2aea-1590-42d7-92d4-5a009eb096b1" xlink:to="loc_us-gaap_PlanNameDomain_30eb105e-3db4-407d-8222-e87e11c02e9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_A2021EquityIncentivePlanMember_2f982c7f-3581-4c5c-bea7-b6478270aab0" xlink:href="rxrx-20250930.xsd#rxrx_A2021EquityIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_30eb105e-3db4-407d-8222-e87e11c02e9f" xlink:to="loc_rxrx_A2021EquityIncentivePlanMember_2f982c7f-3581-4c5c-bea7-b6478270aab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_A2024InducementEquityIncentivePlanMember_9ac574e6-9225-4e27-a5b6-62fa77ee2c2d" xlink:href="rxrx-20250930.xsd#rxrx_A2024InducementEquityIncentivePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_30eb105e-3db4-407d-8222-e87e11c02e9f" xlink:to="loc_rxrx_A2024InducementEquityIncentivePlanMember_9ac574e6-9225-4e27-a5b6-62fa77ee2c2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_53f27a7f-6f78-4dba-8869-bc428854d8bb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc5f8ba7-cc8d-4390-9d70-8e838e2da4ac" xlink:to="loc_us-gaap_AwardTypeAxis_53f27a7f-6f78-4dba-8869-bc428854d8bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6e147151-f0f3-46c1-a076-cb2be386ed7a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_53f27a7f-6f78-4dba-8869-bc428854d8bb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6e147151-f0f3-46c1-a076-cb2be386ed7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_e4a66c2b-c001-4e70-ac5f-fed78c6e2937" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6e147151-f0f3-46c1-a076-cb2be386ed7a" xlink:to="loc_us-gaap_EmployeeStockOptionMember_e4a66c2b-c001-4e70-ac5f-fed78c6e2937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_5f2f27c2-e699-456f-a023-b08c1ced2b34" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6e147151-f0f3-46c1-a076-cb2be386ed7a" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_5f2f27c2-e699-456f-a023-b08c1ced2b34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3a9e30fc-ef4f-4d70-9d36-e31317a82ec6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc5f8ba7-cc8d-4390-9d70-8e838e2da4ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3a9e30fc-ef4f-4d70-9d36-e31317a82ec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_1d3c9d3e-2a5d-4e1e-84ba-702b63097a06" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3a9e30fc-ef4f-4d70-9d36-e31317a82ec6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_1d3c9d3e-2a5d-4e1e-84ba-702b63097a06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_eecae285-62a4-4420-be7a-50d9588bcd77" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3a9e30fc-ef4f-4d70-9d36-e31317a82ec6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_eecae285-62a4-4420-be7a-50d9588bcd77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_4c90b6ae-5919-4b0e-8263-3cb0820e1282" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3a9e30fc-ef4f-4d70-9d36-e31317a82ec6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_4c90b6ae-5919-4b0e-8263-3cb0820e1282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_8243990b-46ae-4dad-91c9-347d47690d99" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3a9e30fc-ef4f-4d70-9d36-e31317a82ec6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_8243990b-46ae-4dad-91c9-347d47690d99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_afeeba54-42bc-4534-bd79-9645b3772464" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3a9e30fc-ef4f-4d70-9d36-e31317a82ec6" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_afeeba54-42bc-4534-bd79-9645b3772464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dbe61d85-132c-4dfc-9b48-7be8f7c6d2d0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3a9e30fc-ef4f-4d70-9d36-e31317a82ec6" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dbe61d85-132c-4dfc-9b48-7be8f7c6d2d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_362dd835-6f78-444e-8c59-2d5d9bfc3e3d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3a9e30fc-ef4f-4d70-9d36-e31317a82ec6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_362dd835-6f78-444e-8c59-2d5d9bfc3e3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_a83cdb37-5ac1-4f69-8a8a-bb82607430a7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3a9e30fc-ef4f-4d70-9d36-e31317a82ec6" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_a83cdb37-5ac1-4f69-8a8a-bb82607430a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0ee8e3bb-8ea2-4fb5-9b25-5dc6c965d321" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_5ecf7dab-3fde-439f-960b-60b9aeef23f0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0ee8e3bb-8ea2-4fb5-9b25-5dc6c965d321" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_5ecf7dab-3fde-439f-960b-60b9aeef23f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_b82088b5-1451-4e09-84e2-3212aeea0b83" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_5ecf7dab-3fde-439f-960b-60b9aeef23f0" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_b82088b5-1451-4e09-84e2-3212aeea0b83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_bbf32d7a-fa62-4627-b718-c43c56cf9b7d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b82088b5-1451-4e09-84e2-3212aeea0b83" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_bbf32d7a-fa62-4627-b718-c43c56cf9b7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_aa8a91f5-6f45-4be1-9397-127271cc79f8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bbf32d7a-fa62-4627-b718-c43c56cf9b7d" xlink:to="loc_us-gaap_CostOfSalesMember_aa8a91f5-6f45-4be1-9397-127271cc79f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_5b1c4a66-bce4-49ad-a885-a22b1239b107" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bbf32d7a-fa62-4627-b718-c43c56cf9b7d" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_5b1c4a66-bce4-49ad-a885-a22b1239b107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_28aa269e-b9df-468c-af7d-6de6361cb01c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bbf32d7a-fa62-4627-b718-c43c56cf9b7d" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_28aa269e-b9df-468c-af7d-6de6361cb01c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_8f12f4b1-cd32-4290-844d-b806e0a6f77e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_5ecf7dab-3fde-439f-960b-60b9aeef23f0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_8f12f4b1-cd32-4290-844d-b806e0a6f77e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_336e319e-b0b6-4bec-923d-687e679e43ec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_8f12f4b1-cd32-4290-844d-b806e0a6f77e" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_336e319e-b0b6-4bec-923d-687e679e43ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#StockBasedCompensationScheduleofStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_75e3beab-4274-46a1-b0d2-c737158e6a98" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_62f352b5-4276-434f-a9ab-11990bc2c036" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_75e3beab-4274-46a1-b0d2-c737158e6a98" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_62f352b5-4276-434f-a9ab-11990bc2c036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6c314d87-edb7-4a9e-8c6d-8213731c8b49" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_62f352b5-4276-434f-a9ab-11990bc2c036" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6c314d87-edb7-4a9e-8c6d-8213731c8b49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d84915e9-951d-45dd-b0c8-5303db78c8dc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_62f352b5-4276-434f-a9ab-11990bc2c036" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d84915e9-951d-45dd-b0c8-5303db78c8dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_6588fadc-f87f-4c19-8130-61a6bc843133" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_62f352b5-4276-434f-a9ab-11990bc2c036" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_6588fadc-f87f-4c19-8130-61a6bc843133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3177e4cb-6071-46d8-8243-6d14e721f075" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_62f352b5-4276-434f-a9ab-11990bc2c036" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3177e4cb-6071-46d8-8243-6d14e721f075" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_52ec3f53-1c8d-4783-ab41-a97c430e0bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_62f352b5-4276-434f-a9ab-11990bc2c036" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_52ec3f53-1c8d-4783-ab41-a97c430e0bf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_d9427526-f70c-4630-b770-07ecf131718e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_75e3beab-4274-46a1-b0d2-c737158e6a98" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_d9427526-f70c-4630-b770-07ecf131718e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2371ca2e-e31b-47da-b299-7b7a1bcc6d89" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_75e3beab-4274-46a1-b0d2-c737158e6a98" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2371ca2e-e31b-47da-b299-7b7a1bcc6d89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_af7f7d89-ced7-4d3e-b7dd-5bd3031b4e01" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2371ca2e-e31b-47da-b299-7b7a1bcc6d89" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_af7f7d89-ced7-4d3e-b7dd-5bd3031b4e01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_eed0a3b2-3c6d-4e01-9bce-78f947f62817" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2371ca2e-e31b-47da-b299-7b7a1bcc6d89" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_eed0a3b2-3c6d-4e01-9bce-78f947f62817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1ada2eb0-1ddb-4ae8-ab9a-21887fdb38bb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2371ca2e-e31b-47da-b299-7b7a1bcc6d89" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1ada2eb0-1ddb-4ae8-ab9a-21887fdb38bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_4abb4fbf-0991-4b5c-b866-84ec5ff104c4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2371ca2e-e31b-47da-b299-7b7a1bcc6d89" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_4abb4fbf-0991-4b5c-b866-84ec5ff104c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_5143f51f-e550-4b08-97f0-8108351dc585" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2371ca2e-e31b-47da-b299-7b7a1bcc6d89" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_5143f51f-e550-4b08-97f0-8108351dc585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_a5ab7618-bf0d-47a1-baca-c5323455ad60" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_75e3beab-4274-46a1-b0d2-c737158e6a98" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_a5ab7618-bf0d-47a1-baca-c5323455ad60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_93396af0-431c-404d-ae56-f4aa96d158ca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_75e3beab-4274-46a1-b0d2-c737158e6a98" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_93396af0-431c-404d-ae56-f4aa96d158ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_c7144d04-81d1-41a0-950d-f8765fb2b8e6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_75e3beab-4274-46a1-b0d2-c737158e6a98" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_c7144d04-81d1-41a0-950d-f8765fb2b8e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_c8a6b10f-3023-4b0f-8266-f4d6b1271f17" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_75e3beab-4274-46a1-b0d2-c737158e6a98" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_c8a6b10f-3023-4b0f-8266-f4d6b1271f17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_d9d8888f-3c7c-4b15-9661-e5a56a0c7e28" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_75e3beab-4274-46a1-b0d2-c737158e6a98" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_d9d8888f-3c7c-4b15-9661-e5a56a0c7e28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_5e53c0cb-4f3a-4784-a2b7-e658f4f75c99" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_75e3beab-4274-46a1-b0d2-c737158e6a98" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_5e53c0cb-4f3a-4784-a2b7-e658f4f75c99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/StockBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoCalculateGrantDateFairValueofStockOptionsDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#StockBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoCalculateGrantDateFairValueofStockOptionsDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/StockBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoCalculateGrantDateFairValueofStockOptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_dcaa93dd-15d6-473f-9eea-cf2723d8452d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_39ad3a13-2fa4-427e-9da3-366f19cbc3cd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_dcaa93dd-15d6-473f-9eea-cf2723d8452d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_39ad3a13-2fa4-427e-9da3-366f19cbc3cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_be586a33-7d45-4199-babe-710f711876cf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_39ad3a13-2fa4-427e-9da3-366f19cbc3cd" xlink:to="loc_us-gaap_AwardTypeAxis_be586a33-7d45-4199-babe-710f711876cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a67b1ab6-30c3-4cb8-855a-91f741b99327" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_be586a33-7d45-4199-babe-710f711876cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a67b1ab6-30c3-4cb8-855a-91f741b99327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_1e71993f-c5ac-448b-b89a-1549dc28a1cb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a67b1ab6-30c3-4cb8-855a-91f741b99327" xlink:to="loc_us-gaap_EmployeeStockOptionMember_1e71993f-c5ac-448b-b89a-1549dc28a1cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_54ffab9e-0c8f-41ba-9273-dc300b31513c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_39ad3a13-2fa4-427e-9da3-366f19cbc3cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_54ffab9e-0c8f-41ba-9273-dc300b31513c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_b950070b-e05e-4c0f-b2ad-7bb4ad812880" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_54ffab9e-0c8f-41ba-9273-dc300b31513c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_b950070b-e05e-4c0f-b2ad-7bb4ad812880" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2009fe16-672e-425d-b787-f48830f02d81" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_54ffab9e-0c8f-41ba-9273-dc300b31513c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2009fe16-672e-425d-b787-f48830f02d81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_801188a2-353a-4e64-a66a-98ce871fcf79" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_54ffab9e-0c8f-41ba-9273-dc300b31513c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_801188a2-353a-4e64-a66a-98ce871fcf79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_a27096cc-4349-47fd-b0e0-52db9f9107db" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_54ffab9e-0c8f-41ba-9273-dc300b31513c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_a27096cc-4349-47fd-b0e0-52db9f9107db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/StockBasedCompensationScheduleofRSUActivityDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#StockBasedCompensationScheduleofRSUActivityDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/StockBasedCompensationScheduleofRSUActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_261182e3-4484-473f-b8f1-370c7fd09281" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6083a7ca-85f0-4200-8dc4-30835fc94076" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_261182e3-4484-473f-b8f1-370c7fd09281" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6083a7ca-85f0-4200-8dc4-30835fc94076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e0d701ea-4dec-4ab7-9227-bc9be6fc8ad9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6083a7ca-85f0-4200-8dc4-30835fc94076" xlink:to="loc_us-gaap_AwardTypeAxis_e0d701ea-4dec-4ab7-9227-bc9be6fc8ad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9883e7ef-0fec-4d70-8ba6-b6cc387b8a6b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_e0d701ea-4dec-4ab7-9227-bc9be6fc8ad9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9883e7ef-0fec-4d70-8ba6-b6cc387b8a6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_852143d2-9ec4-4203-85f1-b3d918d4c41e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9883e7ef-0fec-4d70-8ba6-b6cc387b8a6b" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_852143d2-9ec4-4203-85f1-b3d918d4c41e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_82b0d79a-a395-48a9-a945-cee86332fb2a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6083a7ca-85f0-4200-8dc4-30835fc94076" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_82b0d79a-a395-48a9-a945-cee86332fb2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_7f8d3631-60e6-429d-9490-c270c8ea10c5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_82b0d79a-a395-48a9-a945-cee86332fb2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_7f8d3631-60e6-429d-9490-c270c8ea10c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e6439d4c-ff67-484b-9ed9-72439c28e2ad" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_7f8d3631-60e6-429d-9490-c270c8ea10c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e6439d4c-ff67-484b-9ed9-72439c28e2ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_b6025f20-bc27-4148-b71d-791dc9c60aae" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_7f8d3631-60e6-429d-9490-c270c8ea10c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_b6025f20-bc27-4148-b71d-791dc9c60aae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_33faf5ee-84c7-468d-beb6-a7329699a951" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_7f8d3631-60e6-429d-9490-c270c8ea10c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_33faf5ee-84c7-468d-beb6-a7329699a951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_f599dacd-a0fb-42f4-a988-41bc30dc745b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_7f8d3631-60e6-429d-9490-c270c8ea10c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_f599dacd-a0fb-42f4-a988-41bc30dc745b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_43399c82-9301-43c4-a9e9-371ea4e99792" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_7f8d3631-60e6-429d-9490-c270c8ea10c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_43399c82-9301-43c4-a9e9-371ea4e99792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_cacc238c-6b84-4791-8144-514442fb9f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_82b0d79a-a395-48a9-a945-cee86332fb2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_cacc238c-6b84-4791-8144-514442fb9f8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_782058ca-43dd-41c7-8188-1836325bd405" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_cacc238c-6b84-4791-8144-514442fb9f8c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_782058ca-43dd-41c7-8188-1836325bd405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e31b643b-5e41-44c1-affb-db6e9d28737b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_cacc238c-6b84-4791-8144-514442fb9f8c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e31b643b-5e41-44c1-affb-db6e9d28737b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_09597f4e-2129-4e64-8622-564ed46c78f6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_cacc238c-6b84-4791-8144-514442fb9f8c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_09597f4e-2129-4e64-8622-564ed46c78f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_d5446cd1-bdb8-414e-9b8c-c8eb3b4bf473" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_cacc238c-6b84-4791-8144-514442fb9f8c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_d5446cd1-bdb8-414e-9b8c-c8eb3b4bf473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3648fc2c-427c-44f6-bb3f-991d47791975" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_cacc238c-6b84-4791-8144-514442fb9f8c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3648fc2c-427c-44f6-bb3f-991d47791975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_db81d3fa-5dcb-41bb-8425-5a01ac8b0880" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_ae53e4ab-0431-484d-920b-dd05e6aed707" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_db81d3fa-5dcb-41bb-8425-5a01ac8b0880" xlink:to="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_ae53e4ab-0431-484d-920b-dd05e6aed707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/NetLossPerShareScheduleofComputationofBasicandDilutedNetLossPerShareDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#NetLossPerShareScheduleofComputationofBasicandDilutedNetLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/NetLossPerShareScheduleofComputationofBasicandDilutedNetLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_fd8fcfdf-676e-4c61-902c-72162244fcf9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_1deed7d2-5e08-478a-b5f1-c5f3b62629d0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_fd8fcfdf-676e-4c61-902c-72162244fcf9" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_1deed7d2-5e08-478a-b5f1-c5f3b62629d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7fc2ed9d-78a5-4d98-9d0f-33dc6afd0a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_1deed7d2-5e08-478a-b5f1-c5f3b62629d0" xlink:to="loc_us-gaap_NetIncomeLoss_7fc2ed9d-78a5-4d98-9d0f-33dc6afd0a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_5d307aab-60ab-4f53-a33b-6ce0e95b6833" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_fd8fcfdf-676e-4c61-902c-72162244fcf9" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_5d307aab-60ab-4f53-a33b-6ce0e95b6833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e542179c-3b0d-4851-b4cf-3fa4d513287c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_5d307aab-60ab-4f53-a33b-6ce0e95b6833" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e542179c-3b0d-4851-b4cf-3fa4d513287c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_23e9b7bb-5345-444e-9e04-88afd533b871" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_5d307aab-60ab-4f53-a33b-6ce0e95b6833" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_23e9b7bb-5345-444e-9e04-88afd533b871" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_a40263e3-710f-48de-b444-00b0991967e3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_fd8fcfdf-676e-4c61-902c-72162244fcf9" xlink:to="loc_us-gaap_EarningsPerShareBasic_a40263e3-710f-48de-b444-00b0991967e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_e2060598-f673-4fca-9e31-07552ed3eb0a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_fd8fcfdf-676e-4c61-902c-72162244fcf9" xlink:to="loc_us-gaap_EarningsPerShareDiluted_e2060598-f673-4fca-9e31-07552ed3eb0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossPerShareDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_59c46735-345b-4453-bd94-654a544fe0a2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_67cfc461-cccf-48da-a162-52e573f52c4b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_59c46735-345b-4453-bd94-654a544fe0a2" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_67cfc461-cccf-48da-a162-52e573f52c4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f07363ab-4a2d-4c1c-ab99-9bf2d460a3c1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_67cfc461-cccf-48da-a162-52e573f52c4b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f07363ab-4a2d-4c1c-ab99-9bf2d460a3c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_da5565f3-cfc5-4729-b722-4a9b8dbf33f2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f07363ab-4a2d-4c1c-ab99-9bf2d460a3c1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_da5565f3-cfc5-4729-b722-4a9b8dbf33f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_9ef78e90-f1b4-4056-a434-15c9ca8c36e2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_da5565f3-cfc5-4729-b722-4a9b8dbf33f2" xlink:to="loc_us-gaap_StockCompensationPlanMember_9ef78e90-f1b4-4056-a434-15c9ca8c36e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_TempusAgreementMember_61a06009-5ac8-4937-92bc-12e49c5fd387" xlink:href="rxrx-20250930.xsd#rxrx_TempusAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_da5565f3-cfc5-4729-b722-4a9b8dbf33f2" xlink:to="loc_rxrx_TempusAgreementMember_61a06009-5ac8-4937-92bc-12e49c5fd387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ContingentStockRelatingToREVentures1AgreementMember_0ccb4d83-8efd-4c29-b5af-8e1d26b0302b" xlink:href="rxrx-20250930.xsd#rxrx_ContingentStockRelatingToREVentures1AgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_da5565f3-cfc5-4729-b722-4a9b8dbf33f2" xlink:to="loc_rxrx_ContingentStockRelatingToREVentures1AgreementMember_0ccb4d83-8efd-4c29-b5af-8e1d26b0302b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_110a8ea5-e373-44dd-aa70-efb10301bfcb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_67cfc461-cccf-48da-a162-52e573f52c4b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_110a8ea5-e373-44dd-aa70-efb10301bfcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_77f0a209-ef85-4625-89a9-c263ea71167e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_110a8ea5-e373-44dd-aa70-efb10301bfcb" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_77f0a209-ef85-4625-89a9-c263ea71167e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_6838b42f-807a-4da9-b38c-decfdd9d93e7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_8e2944ea-9d44-41ef-bc1e-b5f873c14eed" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_6838b42f-807a-4da9-b38c-decfdd9d93e7" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_8e2944ea-9d44-41ef-bc1e-b5f873c14eed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d4abe2e6-ee2e-44d7-859e-5c2af148ef79" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_8e2944ea-9d44-41ef-bc1e-b5f873c14eed" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d4abe2e6-ee2e-44d7-859e-5c2af148ef79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_ac9cafdc-c379-45be-aa00-c57aab77c572" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d4abe2e6-ee2e-44d7-859e-5c2af148ef79" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_ac9cafdc-c379-45be-aa00-c57aab77c572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_4de91eca-6251-4435-a68b-5e0bcb5db277" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_ac9cafdc-c379-45be-aa00-c57aab77c572" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_4de91eca-6251-4435-a68b-5e0bcb5db277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_43f847d7-67a0-45c0-8382-e50f0c257e3e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_8e2944ea-9d44-41ef-bc1e-b5f873c14eed" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_43f847d7-67a0-45c0-8382-e50f0c257e3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c0fae41-4136-434a-ac6f-d3743f235175" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_43f847d7-67a0-45c0-8382-e50f0c257e3e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c0fae41-4136-434a-ac6f-d3743f235175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_c1f0baf7-f7b4-4af4-adad-a877205e37bb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c0fae41-4136-434a-ac6f-d3743f235175" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_c1f0baf7-f7b4-4af4-adad-a877205e37bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_bee08c31-88f4-4bd1-8f38-116603adc841" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c0fae41-4136-434a-ac6f-d3743f235175" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_bee08c31-88f4-4bd1-8f38-116603adc841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_9f6db1c9-7ac1-45f7-940d-7e5cfb9524fa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c0fae41-4136-434a-ac6f-d3743f235175" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_9f6db1c9-7ac1-45f7-940d-7e5cfb9524fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_61b9bab5-eae6-4663-8261-c7aa8893564c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_8e2944ea-9d44-41ef-bc1e-b5f873c14eed" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_61b9bab5-eae6-4663-8261-c7aa8893564c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_d8958e9b-d5e9-497b-ae1c-9661952cd560" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_61b9bab5-eae6-4663-8261-c7aa8893564c" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_d8958e9b-d5e9-497b-ae1c-9661952cd560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember_87a83e0b-8b79-4add-8c4c-099dd93309fa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_d8958e9b-d5e9-497b-ae1c-9661952cd560" xlink:to="loc_us-gaap_CashMember_87a83e0b-8b79-4add-8c4c-099dd93309fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_a19c7a32-56fe-4b65-8b0f-3c96deca4a11" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_d8958e9b-d5e9-497b-ae1c-9661952cd560" xlink:to="loc_us-gaap_MoneyMarketFundsMember_a19c7a32-56fe-4b65-8b0f-3c96deca4a11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BankTimeDepositsMember_9d335dc3-6a6a-416a-b817-1deff3f77943" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BankTimeDepositsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_d8958e9b-d5e9-497b-ae1c-9661952cd560" xlink:to="loc_us-gaap_BankTimeDepositsMember_9d335dc3-6a6a-416a-b817-1deff3f77943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_54bbba80-860b-4303-aa26-f86611482bfd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_8e2944ea-9d44-41ef-bc1e-b5f873c14eed" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_54bbba80-860b-4303-aa26-f86611482bfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_b4884ae7-3688-4cd9-8158-31580ff4a4b4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_54bbba80-860b-4303-aa26-f86611482bfd" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_b4884ae7-3688-4cd9-8158-31580ff4a4b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure_d74ef0d0-b5ee-45a4-9275-b712625449ec" xlink:href="rxrx-20250930.xsd#rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_54bbba80-860b-4303-aa26-f86611482bfd" xlink:to="loc_rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure_d74ef0d0-b5ee-45a4-9275-b712625449ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_504573fe-278d-4170-ae96-304a42ef1cfe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_54bbba80-860b-4303-aa26-f86611482bfd" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_504573fe-278d-4170-ae96-304a42ef1cfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_aa792c7e-2c8e-4909-8f24-ebdd96c7dcfc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_2426cb59-6465-4649-8bbc-bdd06a32e06d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_aa792c7e-2c8e-4909-8f24-ebdd96c7dcfc" xlink:to="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_2426cb59-6465-4649-8bbc-bdd06a32e06d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_151b7625-1815-4f45-8cfc-addec794eccf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_2426cb59-6465-4649-8bbc-bdd06a32e06d" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_151b7625-1815-4f45-8cfc-addec794eccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_f7f765bf-1c64-4c04-ae68-efa231d742bc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_151b7625-1815-4f45-8cfc-addec794eccf" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_f7f765bf-1c64-4c04-ae68-efa231d742bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_9e5008c7-c5e1-4d6a-98e2-f43d15222269" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_f7f765bf-1c64-4c04-ae68-efa231d742bc" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_9e5008c7-c5e1-4d6a-98e2-f43d15222269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember_d9e2be1b-7d6e-48f2-9ed7-9fe12ac2a515" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_9e5008c7-c5e1-4d6a-98e2-f43d15222269" xlink:to="loc_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember_d9e2be1b-7d6e-48f2-9ed7-9fe12ac2a515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_682a3bbc-d779-4062-aaf3-8557bed41527" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_9e5008c7-c5e1-4d6a-98e2-f43d15222269" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_682a3bbc-d779-4062-aaf3-8557bed41527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_bad3e18d-9591-4708-ad7e-15dbd04743c5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_2426cb59-6465-4649-8bbc-bdd06a32e06d" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_bad3e18d-9591-4708-ad7e-15dbd04743c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1079e6e3-5148-4b9e-985d-beeccdddb680" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_bad3e18d-9591-4708-ad7e-15dbd04743c5" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1079e6e3-5148-4b9e-985d-beeccdddb680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_964fa74a-ecad-4619-9407-cb2f1c77a050" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1079e6e3-5148-4b9e-985d-beeccdddb680" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_964fa74a-ecad-4619-9407-cb2f1c77a050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_6338562f-7e87-4924-aa21-75cbd5d8f1d9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_2426cb59-6465-4649-8bbc-bdd06a32e06d" xlink:to="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_6338562f-7e87-4924-aa21-75cbd5d8f1d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_187d8fe9-3589-412b-8e1c-59534b70e686" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_6338562f-7e87-4924-aa21-75cbd5d8f1d9" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_187d8fe9-3589-412b-8e1c-59534b70e686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_44d6c131-9516-4023-a889-8d695bd9b8ac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_6338562f-7e87-4924-aa21-75cbd5d8f1d9" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_44d6c131-9516-4023-a889-8d695bd9b8ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_407c52dc-1888-4541-9b11-20d6743516d5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_6338562f-7e87-4924-aa21-75cbd5d8f1d9" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_407c52dc-1888-4541-9b11-20d6743516d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_31c68040-c90a-4975-a75e-37bbafc551d1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_dca97abd-195a-4052-a694-a371d7e930dd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_31c68040-c90a-4975-a75e-37bbafc551d1" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_dca97abd-195a-4052-a694-a371d7e930dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_70c46fef-f27a-42e1-9a91-b80fc2cc3ff2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_dca97abd-195a-4052-a694-a371d7e930dd" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_70c46fef-f27a-42e1-9a91-b80fc2cc3ff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_096872f4-e547-4c24-9d24-a2af0964940d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_70c46fef-f27a-42e1-9a91-b80fc2cc3ff2" xlink:to="loc_us-gaap_SegmentDomain_096872f4-e547-4c24-9d24-a2af0964940d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ReportableSegmentMember_7f3ab37c-378e-470d-87cc-d2b0599505d9" xlink:href="rxrx-20250930.xsd#rxrx_ReportableSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_096872f4-e547-4c24-9d24-a2af0964940d" xlink:to="loc_rxrx_ReportableSegmentMember_7f3ab37c-378e-470d-87cc-d2b0599505d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_8d7cd238-7319-4707-be17-3ed3db17b4c6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_dca97abd-195a-4052-a694-a371d7e930dd" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_8d7cd238-7319-4707-be17-3ed3db17b4c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_74bfd8c4-2a70-4192-baab-12e0a15bb092" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8d7cd238-7319-4707-be17-3ed3db17b4c6" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_74bfd8c4-2a70-4192-baab-12e0a15bb092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SignificantSegmentExpensesAbstract_309a5d67-b190-493f-9b05-cf2a59f872c3" xlink:href="rxrx-20250930.xsd#rxrx_SignificantSegmentExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8d7cd238-7319-4707-be17-3ed3db17b4c6" xlink:to="loc_rxrx_SignificantSegmentExpensesAbstract_309a5d67-b190-493f-9b05-cf2a59f872c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LaborAndRelatedExpense_2922f66b-b7b1-4fb8-8f49-22a94304fca0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LaborAndRelatedExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SignificantSegmentExpensesAbstract_309a5d67-b190-493f-9b05-cf2a59f872c3" xlink:to="loc_us-gaap_LaborAndRelatedExpense_2922f66b-b7b1-4fb8-8f49-22a94304fca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ConsumableExpense_1cbb5727-5190-4557-b297-7c3c9850cd28" xlink:href="rxrx-20250930.xsd#rxrx_ConsumableExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SignificantSegmentExpensesAbstract_309a5d67-b190-493f-9b05-cf2a59f872c3" xlink:to="loc_rxrx_ConsumableExpense_1cbb5727-5190-4557-b297-7c3c9850cd28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_PlatformFeeExpense_cb4dbf09-8818-4bac-b387-b9474929fb09" xlink:href="rxrx-20250930.xsd#rxrx_PlatformFeeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SignificantSegmentExpensesAbstract_309a5d67-b190-493f-9b05-cf2a59f872c3" xlink:to="loc_rxrx_PlatformFeeExpense_cb4dbf09-8818-4bac-b387-b9474929fb09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_DiscoveryExpense_847feb62-132c-4b32-acd4-b4aec38286c7" xlink:href="rxrx-20250930.xsd#rxrx_DiscoveryExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SignificantSegmentExpensesAbstract_309a5d67-b190-493f-9b05-cf2a59f872c3" xlink:to="loc_rxrx_DiscoveryExpense_847feb62-132c-4b32-acd4-b4aec38286c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ClinicalDevelopmentExpense_556a2dc9-1e62-4e5e-ad0e-df50426913f7" xlink:href="rxrx-20250930.xsd#rxrx_ClinicalDevelopmentExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SignificantSegmentExpensesAbstract_309a5d67-b190-493f-9b05-cf2a59f872c3" xlink:to="loc_rxrx_ClinicalDevelopmentExpense_556a2dc9-1e62-4e5e-ad0e-df50426913f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_5252dfb9-c51d-4696-9106-09450069effd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SignificantSegmentExpensesAbstract_309a5d67-b190-493f-9b05-cf2a59f872c3" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_5252dfb9-c51d-4696-9106-09450069effd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount_6a95cece-aaa8-4dbd-85b2-01226bd64eeb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SignificantSegmentExpensesAbstract_309a5d67-b190-493f-9b05-cf2a59f872c3" xlink:to="loc_us-gaap_SegmentReportingOtherItemAmount_6a95cece-aaa8-4dbd-85b2-01226bd64eeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_1e3cc89d-c276-4022-b47b-8464216d278b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SignificantSegmentExpensesAbstract_309a5d67-b190-493f-9b05-cf2a59f872c3" xlink:to="loc_us-gaap_OperatingIncomeLoss_1e3cc89d-c276-4022-b47b-8464216d278b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_ba469668-8214-4bc7-87dd-582aeac30bac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SignificantSegmentExpensesAbstract_309a5d67-b190-493f-9b05-cf2a59f872c3" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_ba469668-8214-4bc7-87dd-582aeac30bac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_31db4d9e-88a2-4119-b787-83c3a2b9d80d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SignificantSegmentExpensesAbstract_309a5d67-b190-493f-9b05-cf2a59f872c3" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_31db4d9e-88a2-4119-b787-83c3a2b9d80d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9fd83ac6-8f0c-459b-90fa-d0846600f1e6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SignificantSegmentExpensesAbstract_309a5d67-b190-493f-9b05-cf2a59f872c3" xlink:to="loc_us-gaap_NetIncomeLoss_9fd83ac6-8f0c-459b-90fa-d0846600f1e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SupplementalAssetInformationAbstract_bee42cd0-bbdb-467a-b716-7611228a15f0" xlink:href="rxrx-20250930.xsd#rxrx_SupplementalAssetInformationAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8d7cd238-7319-4707-be17-3ed3db17b4c6" xlink:to="loc_rxrx_SupplementalAssetInformationAbstract_bee42cd0-bbdb-467a-b716-7611228a15f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentExpenditureAdditionToLongLivedAssets_0ce015e9-d891-4bce-8b04-99b0532e38b4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentExpenditureAdditionToLongLivedAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SupplementalAssetInformationAbstract_bee42cd0-bbdb-467a-b716-7611228a15f0" xlink:to="loc_us-gaap_SegmentExpenditureAdditionToLongLivedAssets_0ce015e9-d891-4bce-8b04-99b0532e38b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/SegmentInformationScheduleofRevenueandLongLivedAssetsBasedonGeographicAreasDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#SegmentInformationScheduleofRevenueandLongLivedAssetsBasedonGeographicAreasDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/SegmentInformationScheduleofRevenueandLongLivedAssetsBasedonGeographicAreasDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_c02692a1-10e3-4deb-9f58-fa60e2789674" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_4406b6fe-2b8c-442e-9648-4ce61cc0b0b0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c02692a1-10e3-4deb-9f58-fa60e2789674" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_4406b6fe-2b8c-442e-9648-4ce61cc0b0b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_49806c9f-9fed-4a99-a0d2-0f1585b5acf8" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_4406b6fe-2b8c-442e-9648-4ce61cc0b0b0" xlink:to="loc_srt_StatementGeographicalAxis_49806c9f-9fed-4a99-a0d2-0f1585b5acf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_99da0c53-278f-4c4e-8d2a-d955b029ba5c" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_49806c9f-9fed-4a99-a0d2-0f1585b5acf8" xlink:to="loc_srt_SegmentGeographicalDomain_99da0c53-278f-4c4e-8d2a-d955b029ba5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_39300a2c-258b-4243-9e87-fbe16528b1f1" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_99da0c53-278f-4c4e-8d2a-d955b029ba5c" xlink:to="loc_country_US_39300a2c-258b-4243-9e87-fbe16528b1f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_ea3f4410-de19-4b76-8931-1c3271e4f808" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_GB"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_99da0c53-278f-4c4e-8d2a-d955b029ba5c" xlink:to="loc_country_GB_ea3f4410-de19-4b76-8931-1c3271e4f808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_7a93c810-f2d5-4504-8202-0456b11bf5e0" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_CA"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_99da0c53-278f-4c4e-8d2a-d955b029ba5c" xlink:to="loc_country_CA_7a93c810-f2d5-4504-8202-0456b11bf5e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_OtherCountriesMember_12224126-c15c-4dc9-90a1-a2c01bfd8e88" xlink:href="rxrx-20250930.xsd#rxrx_OtherCountriesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_99da0c53-278f-4c4e-8d2a-d955b029ba5c" xlink:to="loc_rxrx_OtherCountriesMember_12224126-c15c-4dc9-90a1-a2c01bfd8e88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_3b41a441-e15e-44a8-9a46-57ccd890a0b9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_4406b6fe-2b8c-442e-9648-4ce61cc0b0b0" xlink:to="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_3b41a441-e15e-44a8-9a46-57ccd890a0b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e443f588-18ba-4ad0-be94-79954bd48e46" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_3b41a441-e15e-44a8-9a46-57ccd890a0b9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e443f588-18ba-4ad0-be94-79954bd48e46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_5af5cd1a-6b3b-48f8-8a9f-c7064b5982e3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncurrentAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_3b41a441-e15e-44a8-9a46-57ccd890a0b9" xlink:to="loc_us-gaap_NoncurrentAssets_5af5cd1a-6b3b-48f8-8a9f-c7064b5982e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="rxrx-20250930.xsd#SubsequentEventsDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_2d9b3bc7-7323-4821-a6da-bf1dd16859a6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_981445b9-13ce-40b6-8559-5a6f8b93c397" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_2d9b3bc7-7323-4821-a6da-bf1dd16859a6" xlink:to="loc_us-gaap_SubsequentEventTable_981445b9-13ce-40b6-8559-5a6f8b93c397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_41456a91-4a0d-4529-8b9e-ebe9317543d4" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_981445b9-13ce-40b6-8559-5a6f8b93c397" xlink:to="loc_srt_CounterpartyNameAxis_41456a91-4a0d-4529-8b9e-ebe9317543d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_de9fd3b2-aaf6-429f-9169-c899a3eb92d3" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_41456a91-4a0d-4529-8b9e-ebe9317543d4" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_de9fd3b2-aaf6-429f-9169-c899a3eb92d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RocheAndGenentechMember_bdf5dfc2-ce5e-4a52-bac9-6cff788be7f2" xlink:href="rxrx-20250930.xsd#rxrx_RocheAndGenentechMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_de9fd3b2-aaf6-429f-9169-c899a3eb92d3" xlink:to="loc_rxrx_RocheAndGenentechMember_bdf5dfc2-ce5e-4a52-bac9-6cff788be7f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_40d7b5cb-c39c-4df4-9efc-6bf618a6baf7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_981445b9-13ce-40b6-8559-5a6f8b93c397" xlink:to="loc_us-gaap_TypeOfArrangementAxis_40d7b5cb-c39c-4df4-9efc-6bf618a6baf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_55a41bdc-ed60-4b00-a87a-d07571cfd92a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_40d7b5cb-c39c-4df4-9efc-6bf618a6baf7" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_55a41bdc-ed60-4b00-a87a-d07571cfd92a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_68946221-637f-4e47-a5a3-b646bca7183b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_55a41bdc-ed60-4b00-a87a-d07571cfd92a" xlink:to="loc_us-gaap_CollaborativeArrangementMember_68946221-637f-4e47-a5a3-b646bca7183b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_55d2df91-c415-4c7c-b37f-1dfaae87dd64" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_981445b9-13ce-40b6-8559-5a6f8b93c397" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_55d2df91-c415-4c7c-b37f-1dfaae87dd64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_f4ef7f92-c164-4742-8faa-131b4ae48d0e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_55d2df91-c415-4c7c-b37f-1dfaae87dd64" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_f4ef7f92-c164-4742-8faa-131b4ae48d0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AtTheMarketOfferingProgramJefferiesMember_26aa0718-72b9-4bd3-abef-00ba4d97a9d6" xlink:href="rxrx-20250930.xsd#rxrx_AtTheMarketOfferingProgramJefferiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_f4ef7f92-c164-4742-8faa-131b4ae48d0e" xlink:to="loc_rxrx_AtTheMarketOfferingProgramJefferiesMember_26aa0718-72b9-4bd3-abef-00ba4d97a9d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AtTheMarketOfferingProgramCitiMember_0748e8a4-89d0-4867-828f-13db373071f4" xlink:href="rxrx-20250930.xsd#rxrx_AtTheMarketOfferingProgramCitiMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_f4ef7f92-c164-4742-8faa-131b4ae48d0e" xlink:to="loc_rxrx_AtTheMarketOfferingProgramCitiMember_0748e8a4-89d0-4867-828f-13db373071f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_43b263ab-4496-4237-b0fb-cfbb17381801" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_981445b9-13ce-40b6-8559-5a6f8b93c397" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_43b263ab-4496-4237-b0fb-cfbb17381801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_a333d4e3-1a98-4693-a727-d4678494b36c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_43b263ab-4496-4237-b0fb-cfbb17381801" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_a333d4e3-1a98-4693-a727-d4678494b36c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_5c27b9e1-5e06-41fd-b85d-cf3f35068ff3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_a333d4e3-1a98-4693-a727-d4678494b36c" xlink:to="loc_us-gaap_SubsequentEventMember_5c27b9e1-5e06-41fd-b85d-cf3f35068ff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_519fa831-5b5d-492e-a5e0-91133da7c90b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_981445b9-13ce-40b6-8559-5a6f8b93c397" xlink:to="loc_us-gaap_SubsequentEventLineItems_519fa831-5b5d-492e-a5e0-91133da7c90b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_b64b6020-a052-4331-b614-f07c0aeb03a5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_519fa831-5b5d-492e-a5e0-91133da7c90b" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_b64b6020-a052-4331-b614-f07c0aeb03a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_226f07e2-6811-4e1a-9b7d-6e14b64a49ad" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_519fa831-5b5d-492e-a5e0-91133da7c90b" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_226f07e2-6811-4e1a-9b7d-6e14b64a49ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_7b4c1c36-737c-482b-afc9-43dad3d077aa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_519fa831-5b5d-492e-a5e0-91133da7c90b" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_7b4c1c36-737c-482b-afc9-43dad3d077aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#AwardTimingDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaap_AwardTypeAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockOptionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardExrcPrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardExrcPrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ErrCompDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompRecoveryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompRecoveryTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_RestatementDateAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonNeosMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ecd_NonNeosMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDeterminationDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDeterminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompAmt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_ExecutiveCategoryAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="loc_ecd_AllExecutiveCategoriesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_PeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_NonPeoNeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_AdjToCompAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllAdjToCompMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="loc_ecd_AllAdjToCompMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_MeasureAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoTotalCompAmt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TabularListTableTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TabularListTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_OtherPerfMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAmt"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoName"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureName"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_MeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#InsiderTradingArrangements"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrByIndTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TradingArrByIndTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_TradingArrAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllTradingArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrAxis" xlink:to="loc_ecd_AllTradingArrangementsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_BlakeBorgesonMember" xlink:href="rxrx-20250930.xsd#rxrx_BlakeBorgesonMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_rxrx_BlakeBorgesonMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_NajatKhanMember" xlink:href="rxrx-20250930.xsd#rxrx_NajatKhanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_rxrx_NajatKhanMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_BenTaylorMember" xlink:href="rxrx-20250930.xsd#rxrx_BenTaylorMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_rxrx_BenTaylorMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndTitle"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndTitle" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrAdoptionDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrAdoptionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrTerminationDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrTerminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrExpirationDate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrExpirationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrDuration"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrDuration" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#InsiderTradingPoliciesProc"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>rxrx-20250930_g1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 rxrx-20250930_g1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" ,S!CL# 2(  A$! Q$!_\0
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M),K XVE"^0?;%=5JOB72-"T5]8U+5;+3])1%D:_NKA(H IQAC(Q"X.1@Y[T
M:5%<KX-^*W@GXB33Q>%?%^@^)98!NECTC4H;IHQG&6$;$@9[FJ?BCXW_  Z\
M$:D^G>(O'OAG0=00@/::EK%O;S+D9&4=P1P0>E ';45F>'?%&C>,-+34M!U:
MQUO3I"0EYIUREQ"Q'4!T)!_.N9UKX[?#;PWK#Z1JWQ!\+:7JL;;'L;S6K:*9
M6]"C."#[$4 =S16=<>(M*L]$;6;C4[.#1UB\]M0DN$6W$?\ ?,A.W;[YQ6%X
M1^+_ ($^(%]+8^&/&GA[Q%>P@M);:5JD%S(JC@DJC$@<CF@#KJ**^ OVBO\
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M2@#OJ*^:/VQOVTK/]D^+P]'%H-KXLU+5'D\W3_[66TFMHU VR%?+D)5CN )
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MN^+?AWPMI/C/Q#\$%C\$Z@R^3JL-Q-'%*"3C;*4903@XR.<4 ?HW17FO@/\
M:&\#^./A7X;\?-KEEH&B:[&3;G6KJ.U(D5F62(EV +*R.#@G[N1Q796GC'0-
M0UA=)M=<TVYU5H!=+8PW<;3F$@$2! =VSYE^;&/F'K0!L45Q&N?''X<^&=<;
M1M8\?>&-*U=6V-87NL6\,ZMZ%&<,#[$5V37,2VYN#*@@">892PV[<9W9Z8QW
MH EHKB-(^.7PX\0:TNCZ7\0/"^I:LS;%L;36;:6=F] BN6)]L5\Z^!?VLO&G
MB3]N[Q'\';NWTE?"FGK.898[=Q=G9 CC+[RIY8_PT ?8-%?-G[-WQ8^*_CKX
MI>,](\<KX.&@:<LG]G_\(_J-O<7883[5$R1W$C)\F<[E7GCKQ7L#_&KX>QZ;
M>:@WCOPRMA9LJ7-T=8M_*@9MVT.V_"D[&P#UVGTH [.BN)\2>/$U;X2^(_$W
M@/5=%UVXATN[N-,O%O8I+"2XCB<QAY0X0)O W$L !G)'6N$_9)^(GQ"^)7@+
M5=2^(P\,_P!JPZFUO;GPM>PW=OY(BC;YVBFE4/N9N"P.-O'() /<:*X:;X[?
M#6WUPZ-+\0O"L>L!_+.GOK5L)P^<;=F_=G/;&:N>+_BYX&^'\Z0>*/&?A_PY
M/(@D2+5M4@MG93T8*[ D<'D>E '6T5A>$_'GAKQ]9/>>&/$.E>([2-MKW&DW
ML5U&I]"T;$ U\M_L?_M9>-/CM\<?B;X1\1V^DQ:7X<:4636%N\<IVW+1#>6=
M@?E'8#F@#[!HHHH **** "BBB@ HHHH **** "BOA/XR?M]_$3P?^TIKGPE\
M%_#FQ\6W]G(B6B+-+]HN/]%6X?Y5X^52Y^BUM?L__P#!0J^\>_&:+X6_$;P!
M<> _%-PYA@S*Y'G!-XBDB=%9-R\JV2#E>QS0!]I45\8_!;]LWQ'XM_:T^*?P
M_P#%T_A_1_!7A5-1>"_=3;N@@O8H(S+*\FS&V0YX&3CITKZQ\(^//#7Q T][
M_P +^(=*\1V,;^6]SI-['=1JV,[2T;$ ^U &[17GE]^T5\*=,U!K&\^)G@^U
MO58HUO-KUJDBL.Q4R9!^M=U;ZE:7EBE]!=0SV3IYJW$<@:-DQG<&!P1CO0!9
MHK@K3X_?#"_U8:7;?$?PE<:D6V"SBURU:4MG&W8'SGVKI?%'C+0/ ^F_VCXC
MUS3= T_=L^U:I=QVT6[&<;W(&>#QGM0!L45SW@[XA^%OB)9RW?A7Q+I'B2VB
M(62;2;Z*Z5">@8QL<'V-=#0 45\ ?'C_ (*K:9X,\81>'O /APZ[-:7,UIJE
MQK(:WC21'"!80K$MR'R6 'W<9YK[_H **^=?VXOVFKS]F;X56FI:%#:WGBW5
M[Z.RTRUO(VD0X^:61D5E+ * O!^](GTK7^)GQ@\<_!O]FW3?%NH^&(_%GC]H
MK.&YT73%DC0W<[*K(BJ)&(0MC Y;;U&: /<Z*_.77?\ @I%\8?A#XBTC_A:O
MP9CT#0]2):(()[>X:,8WE&D+([+N4E"%/(!VYS7Z&:'K5IXDT33]6L)/.L;^
MWCNK>3&-\;J&4_B"* +U%%% !1110 445\Q?MQ?M:ZO^RCHGA2^TG0;+77UF
MXN(9%O9701B-4((V]<[OTH ^G:*_/"__ ."EOQ+^&MSH=[\2O@E-HOAS5@'@
MO()I8FE0@$M$74HY"D';D9R.1UKVGX]?'SXD:?JOPYO_ (5R>#KKPKXDLHKZ
M2;Q)J$%I<21R,A0PI+<1,V8W' 5N2![4 ?4U%8*>/O#$GB8^'$\1Z2WB$$@Z
M2M]$;O(3>1Y6[?\ =^;ITYZ4:EX^\,Z/KUMH=_XCTFQUJZV"#3;F^BCN9=YV
MILC+!FR00,#DT ;U%<EXO^+O@7X?WD5IXH\9^'_#EW* T<&K:I!;2."< A78
M$C@\^U,\9?%#0O"GPRU7QNFI:=>Z1:6,EY!<"]C6WN2JDHBS<K\[ *",\G@'
MI0!V%%?-/[)O[;6@_M*Z'?7&I6VE^"=7CU$6%KH]QK4<\]YE%8.BLD;')8K@
M*>1U[5ZQK'[0/PO\/:G)IVJ?$CPEINH1N8Y+6[URUBE1@<%65G!!SQ@T =]1
M7F/QR^*DO@G]G_Q;X]\*W6GZI-IVER7UC/N$]K*5'!RC#<OT-<A^Q'\=/$7[
M1'P-A\7>*(K&'57U"XM2NG0M%%L0KM^5F8YY/>@#WVBOF3]N/]J+6OV=_#?A
M6P\&V=GJGCGQ+J(M;&RO(FE4Q+@.VU64EB[Q(.?XSZ4[]K3]IKQ3^RK\&/"/
MB&?2=+\0^(;Z[@T[4$)DAM_--O))(\8!) WQG )/!ZT ?3-%?G3>?\%+OBGX
M'TC0?$GC7X(-9>$=96*2TU*&XFB2>.1-Z&.1D922GS!3C(!^H[?]L;]NK7_A
M7\._A3XP^&D>F7FE^,H+FZ)UFU=W5$6 HN%D7:P,KAAD\C\P#[?HKDK/XM>"
M;SQ,OAJ/QAH$GB;[IT:/4X#=[@.1Y.[?D8/&.U3>,/BCX-^'C1+XJ\6Z'X::
M5=\:ZOJ4-J77.,J)&&1GTH Z>BN=\'_$;PI\0K>6?PMXGT?Q+#$0))-(OXKI
M4)[,8V./QJIXN^+O@7X?WD=IXH\:>'O#EU( R0:MJD%J[ ]"%D<$CWH ZVBL
MS0?%&C>*M+74]$U:QUC36R%O+"Y2>$XZX="1^M<UI?QR^'&MZ\FAZ=X_\+W^
MM.WEII]MK-O)<,W]T1ARQ/L!F@#N***^5?VD/VG/BSX!^*4?@?X8?":3QM.N
MG17\^J.)G@C\QW4(P0*JXV9R9.<]!B@#ZJHKXH_9Q_;V\4^.OCLGPB^)W@!?
M"'BJ<2+$UJTBB.1(3/LDBDR0&C4LKAB#E>,-D?:] !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 V3_5M]*(_]6OTHD_U;?2B/_5K
M]* '5^8?_!67_DLGPC_Z]Y/_ $HCK]/*\)_:&_8Y\%_M+>)O#FN>)]3UZQN]
M"1DMDTFXACC<%P_SB2%R>5'0B@ _;:\:>#O!/[.7B6?QUIMWK6A7AAL_[+L;
MC[/+=RF172,2?P#*99ADA5; )XK\I_CO\/[N;X.^&_B-IOP8TKX9>$=0O$@L
M-1M=<GO+F\5TD9 T<LS'&(V._8I.!V(K]E/C5\&?#?Q[^'NH>#O%4,TFEWA5
MQ);2>7-!(IRDD;$$!@?4$$$@@@D5\QP_\$H_AA-X?32M2\6>-K](9=]K)_:,
M*BV7G<D<9A9 &)!8[<Y48QSD ^</^"B&K7>O?LW_ ++>IZA.]U?WOAXW-Q/(
MQ9I)'L[!F8D]222?QKU_XW?LJZ)^Q_\ LV_%+QMX#U[Q-=^)-7TNWTN]N]3O
M(I#Y,][ )Y%V1*P8J67.3@,3UYKWSXO?L,^ _C1X!^'OA'6]6\16NF^![ :=
MITNGW,"32QB*&+,Q>!@S;8$^Z%&2W'0#UCXP6<4_PA\90R^'O^$NC71;LC0=
MK,=1*PL5MQM!;+D!1M&<D8YQ0!^3>A_!'X1-_P $\=:^(4T]E??%#SP%9M3=
M9K-OMRQ"$6XD"DF$%_F0DAR1P!CLO%WC+7/"?_!)GX=VVCSS6D&M:[=:=J$T
M+8)MS=7TAC)'(#-$@/J 0>&Q7DGBKX1VGBC2[C2O _[.7Q&T?Q9?21HKZI<7
M%S;:>-X+;%^S1DY *[I6PH8GJ 1^G/P-_9?T[3?V0O#?PD^(FEP:I$;1WU*T
M\PD1S2SO<8612"&C:0 ,IZKP2* /SG7]E'XB_$SX'>#[_P (_!C1=*CCMXK\
M^,[7Q5;F:^C\LES*DEQMC^;#$8!C*%>.16]^WUX+@M[+X ^)M=@BD\7^)-"B
M3Q'J4=_]I2]>&*T0.'1VC(P[G?'PV[.3P:^I#_P2=^&BR-;Q>,O&\6B/)YCZ
M6M]!Y9.?7R>G;D$^]>P?&3]BOX>_&SX:^#_!>KG4[&T\)6J6>CWUC<*+F"%8
MHX]C%T97#+%'G*YRH((H [_X/_ OP/\  70KS1_ >B?V%IMY<_:YX?M<]QOE
MVJF[=,[D?*JC ..*[VO*/V=/V=='_9M\)ZAH6CZWK6O1WUW]LEN-;G2616$:
M1A5VHN%"H.#GOSVKU>@ HHHH **** "BBB@ HHHH **** "BBB@!DWW/QI],
MF^Y^-/H \F_:T_Y-A^*O_8M7_P#Z(>OF+_@E+XHT?PG^RUXMU#6]4L])L;?Q
M3=2RW%Y.L2(@LK/))8CBOM7XB>!['XE^ _$'A/5);B#3M;L9M/N);1E69(Y$
M*,4+*P#8/&01[5\AVW_!(OX-03!WU[QK<*/^6<FH6H4_]\VH/ZT >$?\$](T
M\6?MT?$CQ/X2MWA\&;-4F1T0I&MO/=J;:/&!@D ,%/:,^E8W[ .EZCKGPI_:
M=T[2-<A\.:K>:=8V]IJ5Q<"W2.5S>JBF4D!-Q(3=U&_(YK]-/@_\$_!OP'\)
MKX=\%:-'I&G&0S2G>TDL\A !>21B68X ZG '  '%>/\ P_\ ^"?OPX^'?@GX
M@^%;+4_$E]I?C>*WAU+[==P&2,0O(Z&%DA3:<R'.X-T'OD _-.U\%2?L[:'+
MI?QJ_9YN=3T^ZNS&OB07UU:3(2O"17$;O;N0%9E7'S8.<CIZ3^VMXS_X3#Q3
M^SWX1\.QW&I?#QO#&DW>E:3JMXEJ+PR2-#MN)@55'\N)(V<D!"7((!S7U5:_
M\$KOAVTUG;ZKXU\<:YH-FX>'1[S48O(&.,?+$,#!Q\FT^]>T?&K]D#X9_'7P
M9HOAO7-'?3[;0X1;Z3=:.XMY[&(!5\N,D,I7"K\K*PXSC/- 'PGX>_9I^+W@
M?]I'X>?$#3?A9H_PFT:UU2QM+JULO%%K)#.KS;)0OF7!9FDB<IY:Y+8X!8\W
M?BM/X0^/W[4'Q \-_#SX$P?$;Q=#/)_:VM:[XAGM(!Y!2WD:...6-40,J@-O
M+-G@5]&?#W_@F?\ #_P+XX\/^)Y_%?B[7[GP_>0WNFVNH7L1ABDB=7CR%B!(
M#*. 0#Z5<\>?\$W?ASXV^*>I^.+?7/$_AJ[U:9[C4+/1;U(8IW<[I2&,990Y
MR6 .,DXQ0!\F_P#!.>'6],_X:%\(IKJ>%Y4T&:,7DEUM@T^[0S1+<>9G"["Q
M._T4'/%>/VOPYU;]G#3=17XP_L_OXKT:YN%_XJ)K^Z@\L,  L5W [0$'[RY&
M22<DC 'Z6?"[_@G_ /#7X26/CJQT>]\0W-AXPTV32;ZVOKR)UBMWW9$)6)6!
M ; +%N@Z]:X&/_@E7\/6$%C=>.?'5[X=AD$B:--J,/DY!SCB' 'T /O0!\H_
MMF>/K76_A1^SUX8\%MJ$?PVNM)^TVUGJETD3S3)-Y)CN)!A-T>TKO^Z-Y-:^
ML?LP_%_P_P#$KP7X_P##OPBT3X3VNBW5LSRV/BVU>"<B5<,S37)Y93L('WP<
M$$GG]!?B3^R'\,/BC\+=%\ :IH1M-#T.,1Z3)I\IBN+#Y<$QR'.2W\0<,&."
M02 :\:\+_P#!+?X=>'_$&E:A=^+O&6M6VDW"7%EI]W>PB%"C!E!VQ XR/X=M
M 'V97YA_\%=/^2G?"7_KWN/_ $?%7Z>5\??$/_@E[\+/B7XZU_Q7JGB'QC#J
M.M7TVH7$5K>VJPI)*Y=@@:V8A02< DG'<T 8_P#P5P_Y-DT?_L:+7_TFNJ^2
M/VF/V7_!'PS_ &-?A#\2-"M[R+Q+KXT]=2FFNFD2;[18R3MA#PNUH\#;C@\Y
MZU]_:I^P7X U?]G_ $GX03ZSXF'AK3=4;5X;M;JW^VM,?-^5G,&PK^^;@(#P
M.?7>^*'['W@WXM?!'PA\+=7U/7;;P_X7-H;.YL;B%;N3[/;O;IYC-"RG*.2<
M(O(&,#B@#X+_ &ZO&FN>,O _[,_AG5=7EM=&UCPUI^I7]U,_R27,L<*--)GJ
M44LV3_ST;UJC^VQ\ ?A[\ OC!\&K#P!IG]GP:@8YKJ0WLMRUP5N(@DA+NP&0
M6^Z #Z<5]]_%S]BWP!\9?A3X1\#:V^I1P^%+.*RTG5[>9%O8HTB2+#$IL8.L
M:;AL )4$;:\KT?\ X)2_"329]$NUUSQ<^H:9,L_VC[=;_OV5E9593 0%!7 "
MX."<D\8 /)?V@?\ E*U\,_\ <T[_ -K5R7B;PW9?M+?\%.-6\(_$NZDE\.Z=
M+-:V>DR7+0B6*&#=%#&RD%=[$RG:02-W-?<_C#]D7P?XV_:"T+XP7VI:Y%XF
MT<0B"UMYX5LV\K=MWH8BY^^<X<=NE8W[0W["WPW_ &C/$47B35O[3T#Q/&B(
MVK:'.L4DP3[GF*Z,K%>S !L #=@   \B^-?P?^ '[)?PS^)UXEA>7%AX@L]/
MM+WP99:O^\=A.[P,K.6EB5V5]S$D8C;:,C%?"WQW^']W-\'?#?Q&TWX,:5\,
MO".H7B06&HVNN3WES>*Z2,@:.69CC$;'?L4G [$5^D/A7_@F]\,= \#^+O#=
M_J7B+Q#_ ,).(#>:AJ%W&;B)X69HGA*Q@*P+'[P;(.#D<5RT/_!*/X83>'TT
MK4O%GC:_2&7?:R?VC"HMEYW)'&860!B06.W.5&,<Y /F3_@H!X=L-2^ ?[.W
MQ NH9+CQ=K7ANSM]0U.2:1FG1;.&50REMN=\TC;@,G=R3@5[-^UY\!O /P1_
M89UQ_ NAKHZ:W=:1<WK+>3W G<,-K?O9'Q]]ONX'-?3?Q,_8_P# ?Q8^#'A;
MX;:XVIMI?AFUM[72]1AG1+V+R8!"K%MFQB4 W IM)YP,#'"Z)_P3M\":7\)?
M$7P^N?%/BW4-*URYL[B:XFNX//A^S%C$D1,)55^8Y!![8Q0!\A_M'>+];T/_
M ()R? C1M/GEM]*U@LNH&)L"41[VCB;U4L2V/6,>E1?MD_LY_#CX(_LV_"3Q
MMX$WZ?XINY[0-J4%](TE\KVK3-<C+$*5D1""@4#S,>F/T(O/V4? 6L? +3?A
M!J]O>:QX7TV)4M9[J91>1.I8K*LB*H#C<W(7!!((()!\4\+_ /!*[X6Z/KFG
MW>L:]XI\5:9IS[K71]4O(_LP7.2K!(U)4GDA2H/?- 'S+^WE?7OQ('[+]YX@
M,@U#7O#MK+J#+A7\R8VYD(P, Y8GIQ5;]J;X"^%_V5_VIO@U_P *\2\TJ&[N
M+.Y=9;IYF$R7BJ6#,<_,I (SC@\<U]__ !V_8_\ !?[07BCPEKNOW^M:=<^&
M>+*#2)H8H6&]7 =7B<D90#Y2O%.^.7[(G@[]H#QYX4\6^(=2URSU+PV5-I%I
MD\,<,FV42CS \3D_,.Q''YT >X4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 ,E_U;4Y?NCZ4V7_5M3E^Z/I0 M<9\:O\ DC?CS_L
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M_P I6OAG_N:=_P"UJ^KO@'^Q'\+/V==8;6O#6EW5[K^QHDU;6+CSYXD;A@@
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MF^"/PW\$7V@:!X?^&MI8Z=/IVIFYA4SVZ6P2WFE"S22D^4V[:$7EN0,8#O\
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M$/CGX>?&'QS\0/%7PRC^-_@S4+FZN4UQ+J>>V-OYA(G\VTD_=%47:1(,)@@
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M#Y@*KAEQ@* , 8KP<_\ !)WX:+(UO%XR\;Q:(\GF/I:WT'EDY]?)Z=N03[T
M?4WP1N=9O/@WX&F\13QW6O2:)9M?7$5REPDTWDIOD$L9*.&.6W*2#G()%<_\
M:7N/B1X9\0> ? _Q$LO"'Q!46T@FAN%:[LT\Q)"3$&#@/&&4'I\U=]X.\*V'
M@7PCH?AO2UD33-'L8-.M5E?>XABC6- S=SM4<U\[_M#?\$]_A]^T7XZG\8:O
MJVOZ/KL\4<,KZ;/%Y+A%"J2CQL00 .A% 'R!^SK?:A\#?^"ADWACQE<V/Q-\
M4:I*+!O%J7<TUQ;/);[MR[FQD+B-U8$J%(5@ 0WZOU\V?L[_ + OPS_9Q\2#
MQ)I/]I:]XC1&C@U#69D<VP88;RD1%521D;B"V"0" 2*^DZ "BBB@ HK(\6^'
M]+\5>';W2M:TVSUC2[E0L]C?P)/!* P(#(X*L,@'D=0*\L_X9K^$7_1*_!7_
M (3MG_\ &Z /:J*\5_X9K^$7_1*_!7_A.V?_ ,;H_P"&:_A%_P!$K\%?^$[9
M_P#QN@#VJBO%?^&:_A%_T2OP5_X3MG_\;H_X9K^$7_1*_!7_ (3MG_\ &Z /
M:J*\5_X9K^$7_1*_!7_A.V?_ ,;H_P"&:_A%_P!$K\%?^$[9_P#QN@#VJBO%
M?^&:_A%_T2OP5_X3MG_\;H_X9K^$7_1*_!7_ (3MG_\ &Z /:J*\5_X9K^$7
M_1*_!7_A.V?_ ,;H_P"&:_A%_P!$K\%?^$[9_P#QN@#VJBO%?^&:_A%_T2OP
M5_X3MG_\;H_X9K^$7_1*_!7_ (3MG_\ &Z /:J*\5_X9K^$7_1*_!7_A.V?_
M ,;H_P"&:_A%_P!$K\%?^$[9_P#QN@#VJBO%?^&:_A%_T2OP5_X3MG_\;H_X
M9K^$7_1*_!7_ (3MG_\ &Z /:)/]6WTHC_U:_2O%_P#AFOX1?]$K\%?^$[9_
M_&Z/^&:_A%_T2OP5_P"$[9__ !N@#VJBO%?^&:_A%_T2OP5_X3MG_P#&Z/\
MAFOX1?\ 1*_!7_A.V?\ \;H ]JHKQ7_AFOX1?]$K\%?^$[9__&Z/^&:_A%_T
M2OP5_P"$[9__ !N@#VJBO%?^&:_A%_T2OP5_X3MG_P#&Z/\ AFOX1?\ 1*_!
M7_A.V?\ \;H ]JHKQ7_AFOX1?]$K\%?^$[9__&Z/^&:_A%_T2OP5_P"$[9__
M !N@#VJBO%?^&:_A%_T2OP5_X3MG_P#&Z/\ AFOX1?\ 1*_!7_A.V?\ \;H
M]JHKQ7_AFOX1?]$K\%?^$[9__&Z/^&:_A%_T2OP5_P"$[9__ !N@#VJBO%?^
M&:_A%_T2OP5_X3MG_P#&Z/\ AFOX1?\ 1*_!7_A.V?\ \;H ]JHKQ7_AFOX1
M?]$K\%?^$[9__&Z/^&:_A%_T2OP5_P"$[9__ !N@#VJBO%?^&:_A%_T2OP5_
MX3MG_P#&Z/\ AFOX1?\ 1*_!7_A.V?\ \;H ]JHKQ7_AFOX1?]$K\%?^$[9_
M_&Z/^&:_A%_T2OP5_P"$[9__ !N@#VJBO%?^&:_A%_T2OP5_X3MG_P#&Z/\
MAFOX1?\ 1*_!7_A.V?\ \;H ]JHKQ7_AFOX1?]$K\%?^$[9__&Z/^&:_A%_T
M2OP5_P"$[9__ !N@#V>;[GXT^O%?^&:_A%_T2OP5_P"$[9__ !NC_AFOX1?]
M$K\%?^$[9_\ QN@#VJBO%?\ AFOX1?\ 1*_!7_A.V?\ \;H_X9K^$7_1*_!7
M_A.V?_QN@#VJBO%?^&:_A%_T2OP5_P"$[9__ !NC_AFOX1?]$K\%?^$[9_\
MQN@#VJBO%?\ AFOX1?\ 1*_!7_A.V?\ \;H_X9K^$7_1*_!7_A.V?_QN@#VJ
MBO%?^&:_A%_T2OP5_P"$[9__ !NC_AFOX1?]$K\%?^$[9_\ QN@#VJBO%?\
MAFOX1?\ 1*_!7_A.V?\ \;H_X9K^$7_1*_!7_A.V?_QN@#VJBO%?^&:_A%_T
M2OP5_P"$[9__ !NC_AFOX1?]$K\%?^$[9_\ QN@#VJBO%?\ AFOX1?\ 1*_!
M7_A.V?\ \;H_X9K^$7_1*_!7_A.V?_QN@#VJBO%?^&:_A%_T2OP5_P"$[9__
M !NC_AFOX1?]$K\%?^$[9_\ QN@#VJBO%?\ AFOX1?\ 1*_!7_A.V?\ \;H_
MX9K^$7_1*_!7_A.V?_QN@#VJBO%?^&:_A%_T2OP5_P"$[9__ !NC_AFOX1?]
M$K\%?^$[9_\ QN@#VJBO%?\ AFOX1?\ 1*_!7_A.V?\ \;H_X9K^$7_1*_!7
M_A.V?_QN@#VJBO%?^&:_A%_T2OP5_P"$[9__ !NC_AFOX1?]$K\%?^$[9_\
MQN@#VJBO%?\ AFOX1?\ 1*_!7_A.V?\ \;H_X9K^$7_1*_!7_A.V?_QN@#VJ
MBO%?^&:_A%_T2OP5_P"$[9__ !NC_AFOX1?]$K\%?^$[9_\ QN@#VJBO%?\
MAFOX1?\ 1*_!7_A.V?\ \;H_X9K^$7_1*_!7_A.V?_QN@#VJBO%?^&:_A%_T
M2OP5_P"$[9__ !NC_AFOX1?]$K\%?^$[9_\ QN@#VJBO%?\ AFOX1?\ 1*_!
M7_A.V?\ \;H_X9K^$7_1*_!7_A.V?_QN@#VJBO%?^&:_A%_T2OP5_P"$[9__
M !NC_AFOX1?]$K\%?^$[9_\ QN@#VJBO%?\ AFOX1?\ 1*_!7_A.V?\ \;H_
MX9K^$7_1*_!7_A.V?_QN@#VJBO%?^&:_A%_T2OP5_P"$[9__ !NC_AFOX1?]
M$K\%?^$[9_\ QN@#VJBO%?\ AFOX1?\ 1*_!7_A.V?\ \;H_X9K^$7_1*_!7
M_A.V?_QN@#VJBO%?^&:_A%_T2OP5_P"$[9__ !NC_AFOX1?]$K\%?^$[9_\
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MH5KY2R-=7:LX7R\!B%4$XR0H]*[[_AFOX1?]$K\%?^$[9_\ QN@#VJBO%?\
MAFOX1?\ 1*_!7_A.V?\ \;H_X9K^$7_1*_!7_A.V?_QN@#VJBO%?^&:_A%_T
M2OP5_P"$[9__ !NC_AFOX1?]$K\%?^$[9_\ QN@#VJBO%?\ AFOX1?\ 1*_!
M7_A.V?\ \;H_X9K^$7_1*_!7_A.V?_QN@#VJBO%?^&:_A%_T2OP5_P"$[9__
M !NC_AFOX1?]$K\%?^$[9_\ QN@#VJBO%?\ AFOX1?\ 1*_!7_A.V?\ \;H_
MX9K^$7_1*_!7_A.V?_QN@#VJBO%?^&:_A%_T2OP5_P"$[9__ !NC_AFOX1?]
M$K\%?^$[9_\ QN@#VJBO%?\ AFOX1?\ 1*_!7_A.V?\ \;H_X9K^$7_1*_!7
M_A.V?_QN@#VJBO%?^&:_A%_T2OP5_P"$[9__ !NC_AFOX1?]$K\%?^$[9_\
MQN@#VJBO%?\ AFOX1?\ 1*_!7_A.V?\ \;H_X9K^$7_1*_!7_A.V?_QN@#VJ
MBO%?^&:_A%_T2OP5_P"$[9__ !NC_AFOX1?]$K\%?^$[9_\ QN@#VJBO%?\
MAFOX1?\ 1*_!7_A.V?\ \;H_X9K^$7_1*_!7_A.V?_QN@#VJBO%?^&:_A%_T
M2OP5_P"$[9__ !NL#X@?LZ_"BS\!^)+BW^&/@V"XATRYDCECT"T5D81,0P(C
MR"#WH ^B:*^=OA_^SK\*+SP'X;N+CX8^#9[B;3+:22630+1F=C$I+$F/))/>
MM_\ X9K^$7_1*_!7_A.V?_QN@#VJBO%?^&:_A%_T2OP5_P"$[9__ !NC_AFO
MX1?]$K\%?^$[9_\ QN@#VJBO%?\ AFOX1?\ 1*_!7_A.V?\ \;H_X9K^$7_1
M*_!7_A.V?_QN@#VJBO%?^&:_A%_T2OP5_P"$[9__ !NC_AFOX1?]$K\%?^$[
M9_\ QN@#VJBO%?\ AFOX1?\ 1*_!7_A.V?\ \;H_X9K^$7_1*_!7_A.V?_QN
M@#VJBO%?^&:_A%_T2OP5_P"$[9__ !NC_AFOX1?]$K\%?^$[9_\ QN@#VJBO
M%?\ AFOX1?\ 1*_!7_A.V?\ \;H_X9K^$7_1*_!7_A.V?_QN@#VJBO%?^&:_
MA%_T2OP5_P"$[9__ !NC_AFOX1?]$K\%?^$[9_\ QN@#VJBO%?\ AFOX1?\
M1*_!7_A.V?\ \;H_X9K^$7_1*_!7_A.V?_QN@#VJBO%?^&:_A%_T2OP5_P"$
M[9__ !NC_AFOX1?]$K\%?^$[9_\ QN@#VJBO%?\ AFOX1?\ 1*_!7_A.V?\
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MEY7H]><6/_)Q>M_]BI8?^EEY7H] !1110 4444 %%%% !1110 4444 %%%%
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M(\(R7AD34-6B@)SY"RQG'L"4SCZY/O7T!_8__3;_ ,=_^O1_8_\ TV_\=_\
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MR.I?LJ^%;R^FEM;[5--MIFS):6\RF/'7 W*3C/KFO>?['_Z;?^.__7H_L?\
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M/_TV_P#'?_KT?V/_ --O_'?_ *] &=16C_8__3;_ ,=_^O1_8_\ TV_\=_\
MKT 9U%:/]C_]-O\ QW_Z]']C_P#3;_QW_P"O0!G45H_V/_TV_P#'?_KT?V/_
M --O_'?_ *] &=16C_8__3;_ ,=_^O1_8_\ TV_\=_\ KT 9U%:/]C_]-O\
MQW_Z]']C_P#3;_QW_P"O0!G45H_V/_TV_P#'?_KT?V/_ --O_'?_ *] &=16
MC_8__3;_ ,=_^O1_8_\ TV_\=_\ KT 9U%:/]C_]-O\ QW_Z]']C_P#3;_QW
M_P"O0!G45H_V/_TV_P#'?_KT?V/_ --O_'?_ *] &=6];?\ 'O%_N#^54O['
M_P"FW_CO_P!>M"-/+C1,YV@#- #J*** "BBB@ HKPW]L;]H34?V9_A"OC'2]
M)M=9NCJ,%E]FNY&1-KJY+97G(V?K7RO<?\%)?C'X?\&Z9XWUOX'QKX)O2ACU
M6*XF2&16) Q+M8+G! +#K0!^C5%?-/C[]LBVL/V/5^.7A/25OHY1 $TW4G*>
M6[72V\J.4[JV_!'7 />O"O!_[>O[0WC_ ,.VFO>'/@!_;6BW>_[/?68N9(I=
MKLC;6'7#*P^H- 'Z%T5\R?'#]M2T_9X^"OA#Q%XN\/2CQWXBL(YH_"L<GE-#
M/Y2M,)68$I'&S!2<%B2!CJ1X6W[?W[0&@^'X?&NN_ 39X#D43?:HEN8G6$\A
MVD.[:I'1VC"G(]: /T/HJEHFIKK6BV&H+&8EN[>.X$;')4.H;&?QKF_BY\5M
M ^"?P]U?QEXFG>'2=-C#.L*AI969@J1QJ2,LS$ #('.20 30!V-%? 6B_MT?
MM!?%;3)?$?PW^ JWWA-9'6*ZO)9)7G520=A#1AB",'8& (([5]7?'#]H+PU^
MSO\ #RT\7>,X[Z.SN+B.S6&P@\V4SO&[A,$@#B-N21VH ]/HKY)_8K_;8U7]
MJSQ=XQTZ\\.6>AV&CPQW%J\$KO*ZO(R@/GC("CIWS70?M+?'CXS?"_QW8Z5\
M._A'+X]T2;3H[F;4D64B.X,LJM%\G'"I&W_ Z /I:BOSNT/_ (*0?%*/XU>&
M_AWXG^%5CH&K:EJ=G93VLDL_VB%)Y$&_9Z[&W#/;':OT1H **** "BBB@ HH
MKY8_X:B^(GQ@\6>(=+^!G@;2M=T'0;I["[\6>)+]H+&>Z7&Z.!(_FD &#N!Z
M$' !4L ?4]%?-FF_M"?%/P[X-^)5Q\0?AA#X=UCPGX?N-<L[ZSO3<:9JGEQN
MPC5P,HP*C*EBV#G XSROA;]H[]HK7/ >C^.(/@MH7B'P[J-G'J,=OH^O[+UH
M'4,"J.IRVT_= )/04 ?7M%>2?#7]H_P]\8/@OJ?CWPP'+Z?:W#7>E7GR3V=U
M%&7:"8#H>!R.H((KF?!_[6VC+^RKHWQE\;I#H<5]!(_]GV;&1IIA+)&D$(;E
MW;9P.W)) !( /H&BO"/#WQ"^-WB;X+IXHA\ :'I_BZ_N5DL?#6H7\D9ALFZ-
M<2$#$N,'8 ,=\'*CR7XN?M0?M#?!/PU;ZUXF^&?@Z."ZO(=/M;>TUJ2:XN;B
M0D)''&!EF."?H#0!]HT5';L\EO&TJ>7(R@LN<X..14E !1110 4444 %%%%
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MEMHY. <#K0!?HKEM9^*O@KPY#<S:MXPT#2X;6?[+/)>:G!"L4V,^6Y9AM?\
MV3S1KGQ5\%>&=.L-0UCQAH.DV&H#=9W5]J<$,5R#C!C9F <<CIGK0!U-%00W
MUM<627D5Q%):/&)5N$<&-D(R&#=",<YZ5S_ACXH>#?&VH7%CX=\6Z%KU];@F
M:VTO4H;F2(# )948D=1U]: .GHK*NO%6B6.H3V%SK%A;WUO;?;)K66Z198X,
M[?-92<A,\;CQGO6???$SPAIGAV/7[SQ7HEIH4C%$U2?484M68$@@2EMI((/&
M>QH Z6BLCPSXPT'QI8&^\/:WIVO66=OVG3+N.XCSZ;D)&:UZ "BBB@ HHHH
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MG_#:7_4G?^53_P"TT?\ #:7_ %)W_E4_^TTO[!S'_GU^,?\ ,?\ K;DO_/\
M_P#)9_\ R)]-T5\R_P##:'_4G?\ E4_^TTH_;0S_ ,R?_P"5/_[31_8.8_\
M/K\8_P"8?ZVY+_S_ /\ R6?_ ,B?3-%?,_\ PV=_U)__ )4__M-+_P -G?\
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M.?.QMQQMSDYP.F_X;"_ZE+_RI?\ VFE_8V/_ .??XK_,/]:LG_Y__P#DLO\
MY$^CZ*^<?^&P/^I2_P#*E_\ :J/^&P/^I2_\J7_VJE_8^._Y]_BO\Q_ZTY/_
M ,_O_)9?_(GT=17SG_PU]_U*7_E2_P#M5'_#7W_4I_\ E2_^U4?V/CO^??XK
M_,/]:<G_ .?W_DLO_D3Z,HKYT'[7O_4I_P#E2_\ M5'_  UY_P!2G_Y4O_M5
M+^Q\=_S[_%?YC_UIRC_G]_Y++_Y$^BZ*^=/^&O/^I3_\J7_VJE_X:[_ZE/\
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M7_)^*_S'_K-E/_/[_P EE_\ (GT-17SS_P -;?\ 4J_^5'_[51_PUM_U*O\
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M_P 27$FN>'K;0K.WN;MU++>/!<LUTV3G<71XR>2?F'7-?I;K'Q8\#:1\/?\
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M#+";@[TD\YU4*F&!^YN[<])X(^&OQ-^"/BOXP_$F'P5H'P]\/77@J[GC\/\
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M..*C^$_[+_A;X7+XHN+B^U;QKK?BB(6^LZUXIN1=W5W"$*"$G: (PIQM Z
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M3!KDNF7VK:]KFO3K<ZMKVOW?VF^O70$)O? &%#-@ ?Q'K7J% !1110 4444
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M>,/^@EH?_?\ F_\ C5)YM@?^?J*_U=S7_H'D>)4JU[;_ ,,C^,/^@EH?_?\
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M_P :J'C</_.@_L+,_P#GPSQRBO8_^&6?%?\ T$-&_P"_TO\ \:H_X99\5_\
M00T;_O\ 2_\ QJE]=P_\Z*_L+,O^?#/'J*]B_P"&6_%?_00T?_O]+_\ &J/^
M&6_%?_00T?\ [_2__&JAXS#_ ,Z#^PLR_P"?#/':*]B_X9;\5_\ 00T?_O\
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M!/\ L4O$/_I9HM 'IE%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% '-_$GQK#\-_A[XF\67-M)>6^AZ
M;<:E);Q,%>588FD*@G@$A<<^M?-D/[>>K0^#+?QIJ/P+\;V_@N6V6^;6K4P7
M"+;,-WG;0P^7!SDD #KBO9OVIO\ DV?XK_\ 8JZG_P"DLE?)/@WX2_M(?$S]
MD3PYH6A>-?"%OX5U7PU!!#IOV.6&[ELWA ^SO.590S(=I8 =3R* /KOQ%\9W
M7X<>&/&7@OPSJ/CZPUZ6U,,.F?NY([:9"WVAPPR%4  @C()Q7IE?GEXV^+&G
M_$#]B?X3WOAO2;CPC!I?C/2M!DTM+DR>0;=FC*"7@NI4*V2,DDYR>3Z)XH\%
MV?[4W[8WCOP1XZN;ZZ\!^!-(L&MO#MO>2VL%[<W48E,\IC96;:&*\$=!_M!@
M#[)HKX\^!,-U\'_CQ\8/@WIVJ7^H>"K#0X=>T:WO[A[A],\Q<20+(Q)V%GW
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M^.?A_'XCNK_7?&D=W)K7BJ^MQ)-<7=PA5IC$&'RC.0F_U^;))JQ=?LO?:D^
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MGYN=H  ! KZ,HH X?XQ> ]<^(G@UM+\-^,K[P)K,=Q%<V^LV$0F9&0YV/&6
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M_E04445RGMA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>9Z_\
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MJ<9-6** (+NRM[^+RKF"*XCR&V3(&&1T.#4PXX' I:* "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH \D_:X_P"37_BI_P!BW??^B6KYXOO'GB+X
M(^ _V5?B%'K-XGP_ET/2O#_B;3#*?LJ+/9Q^1=E>@*,7);_90=Z^J?CGX&O_
M (F_!OQKX2TN:WM]1UK2;FPMY;QF6%9)(RJERJL0N3S@$^U>2?&OP/H_@O\
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M!0!Y%\"?B9XH^$&I?M&^$?%?B74O'EA\,;:#5].U'6)=]Y+;RV<MR8I)>2Q
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M_@MA_P#B:7_A5_@W_H4M#_\ !;#_ /$UTU%'UBM_._O8?4\-_P ^H_<CF?\
MA6'@W_H4M#_\%L/_ ,31_P *Q\'?]"GH?_@MA_\ B:Z:BCZQ6_G?WL/J>&_Y
M]1^Y',_\*Q\'?]"GH?\ X+8?_B:/^%8^#O\ H4]#_P#!;#_\37344OK%;^=_
M>Q_4\-_S[C]R.:_X5EX/_P"A3T/_ ,%T/_Q-'_"L_!__ $*FA_\ @NA_^)KI
M:*/K%;^=_>P^IX;_ )]Q^Y'-?\*S\'_]"IHG_@NA_P#B:/\ A6?A#_H5-$_\
M%T/_ ,372T4>WJ_SO[V'U/#?\^X_<CF_^%:>$/\ H5=$_P#!=#_\31_PK7PA
M_P!"KHG_ (+H?_B:Z2BCV]7^=_>P^IX;_GW'[D<W_P *U\(?]"KHG_@NA_\
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M?_B:Z*BCVU3^9_>'U3#_ //N/W(YW_A7/A/_ *%?1?\ P7P__$T?\*Y\)_\
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M -BEJW_I'+7IE>9_M.?\FU_%G_L4M6_](Y:],H **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \ST__ ).4UW_L4M/_
M /2R]KTRO,]/_P"3E-=_[%+3_P#TLO:],H **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ KF?B=_R37Q9_V"+O\ ]$O735S/
MQ._Y)KXL_P"P1=_^B7H /AC_ ,DU\)_]@BT_]$I735S/PQ_Y)KX3_P"P1:?^
MB4KIJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M7_R(_P#7W,_^?=/[I?\ R1]W_P##3'PV_P"AD_\ )&Y_^-TO_#2_PV_Z&/\
M\D;G_P"-U\(TZI_U7P7\\OO7_P B5_KYF?\ S[I_=+_Y(^[?^&EOAO\ ]#'_
M .2-S_\ &Z/^&E/AQ_T,?_DC<_\ QNOA5>U.J?\ 5?!_SR^]?_(E?Z]YG_S[
MI_=+_P"2/NG_ (:4^''_ $,?_DC<_P#QNC_AI/X<?]#%_P"2-S_\;KX87I3E
MJ?\ 5C!_SR^]?_(C_P!>\R_Y]P^Z7_R1]S?\-)?#G_H8O_)&Y_\ C='_  TC
M\.?^AB_\D;G_ .-U\-TZI_U9P?\ -+[U_D5_KUF7_/N'W2_^2/N/_AI#X=?]
M#%_Y(W/_ ,;H_P"&D/AU_P!#%_Y)7/\ \;KX>6EJ?]6L)_-+[U_D/_7K,O\
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M%*O6I_U>PO\ -+[U_D/_ %WS'_GW#[I?_)'VM_PT1\/O^A@_\DKC_P"-T?\
M#1'P^_Z&#_R2N/\ XW7Q72KUJ?\ 5_"_S2^]?Y%?Z[9C_)#[I?\ R1]-V?QB
M\(1?&[5O$#:OC2)_#MG8QW'V:;YIH[FZ=TV[-PPLJ'.,<\'@UW/_  T-\/\
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M/_H._P#DG<?_ !NC_A?W@/\ Z#O_ ))W'_QNOCNBE_9E'N_P_P A_P"N&/\
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MQ>9*!LA) R-V>^#@8^OZ* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH Y'XOW,5G\)?&UQ<2I!!%HE[))+(P5440.2Q)X
M[U\&CX4^-L?\B?K_ /X+)_\ XFOM3]IS_DVOXL_]BEJW_I'+7IE?197G-3*X
M2A""ES.^I\=GG#=+/*D*E2HX\JMHD?G"OPJ\:_\ 0GZ]_P""R?\ ^)I__"J_
M&O\ T*&O?^"R?_XFOT;HKV?];*__ #Z7WL^:_P"(?X7_ )_R^Y'YS#X5^-,?
M\BAKW_@LG_\ B:<OPL\:?]"AKW_@LG_^)K]%Z*7^M=?_ )]+[V/_ (A_A?\
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M[7WL?^H>&_Y_R^Y'Y^#X9>,./^*3US_P73?_ !-._P"%9^,/^A4US_P73?\
MQ-?H#12_UFK?\^U][*_U$PW_ #_E]R/S_7X9^,/^A4US_P %TW_Q-+_PK/QA
M_P!"IK?_ (+IO_B:^_Z*7^LE7_GVOO8?ZBX;_G_+[D? 7_"M/%__ $*NM_\
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MN_%?_0L:S_X+Y?\ XFON>BI_MFI_(A_ZEX?_ )_/[D?#'_"N_%?_ $+&L_\
M@OE_^)H_X5WXK_Z%C6?_  7R_P#Q-?<]%+^V*G\B#_4O#_\ /Y_<CX8_X5WX
MK_Z%C6?_  7R_P#Q-'_"N_%?_0L:S_X+Y?\ XFON>BE_:\_Y$'^IF'_Y_/[D
M?#'_  KOQ7_T+&L_^"^7_P")I1\._%>/^18UC_P E_\ B:^YJ*7]K3_D0_\
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M6:+7IE>9Z_\ \G*>!/\ L4O$/_I9HM 'IE%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?+7_!1W
MXE>*/A3^SNNM^$=:NM!U8ZS:V_VNT8!_+99"R\CH<#\J^0?$7B+]IKP!^SGX
M?^-__"[&N](O_(D&ES[6F7S'*J-KQE).1DCTR><&OIG_ (*O?\FKI_V'[/\
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MBU)+B?4)"P$EN(I5:+Y58\NT;=/X*\F^-/[&MY^TEXLM/'<'Q/U_P;'?Z;;
M:3IZEXH\)G.1(N2=W/':O2/AGX-T[]CWX#ZL/$GC"^\1:7HYN-4N=6U)<3;"
M ?+ +MDY "C/)8#O0!^>_P"T[XJ_:*_9AUG0-%U3XZW/B'6]81I8].TEG,L4
M88*KL&C'WVW*H')*-Z5]E_$#X/\ Q_\ 'WPH^%-OX<^)8\%>*=.TG;XFDN'9
MGO+IXX,9*(02C++GW?C-?,G[&/@W5_VQOVI_$?QU\96Q;0]$O!)8VLGS1"Z
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M3&#UH ^8?@#\:?C!\/?VQ]%^%=S\3H?B_H%]($O+B&Y^VQ+&86D:196RR/$
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MS40L"F]6&<?-@]< =#7WQ7YT?LC_ +-,WQI^&WC"XO?B9XV\.Z#-XIU.UN-
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M&W?[T9= VT^XSC\*X31?C#<:K^T5XC^&C:9'';:3H5KK"Z@)27D:61D*%,8
M&,YS5.^_LC]JOX2Z%JW@WQ]K_AK2;R5+Z+5/"]TMM=':CHUO*65L ,WS)C(:
M,<\<_+GAO]FW4KK]L/QEX;'QA^(L$]KX6LKMM;BU6,7\X>9AY,C^5@QKC(&.
M">M 'W_7S5_P42\2:KX3_95\2ZGHVJ7FCW\5W8A;RPN'@E4&ZC# .A!&02#Z
M@U[?\-_!<WP_\(6>AW'B+6/%<MNTA.JZ].L]Y+N=FP[A5!"YVCCH!7@'_!3
M@?L@^*2>GVS3\_\ @7%0!J:'^WQ\-M:\7:-H[Z?XJTG3=;N5M-*\3:KHKVVE
M7TK'"".5CN^;C!* <C.!FNC^*W[8GPX^"_CR;PAXJO+^TUA-,CU.)(+)IQ<J
M\OEI%$$RS2D@G;C&%))XKQ?]O/XG^"?BK\$-*\#^#/$>C^*?%WB36=/BT2ST
M6\BNI4<3 ^;B-CL4+N7<<?>QZUU>GV<%Q_P4QU*2>&.:6W^&:212.@)C;[>B
MEE]#M9AD=F([T =OJ/[8W@32_A]X=\4S6GB S^(KF:TTCPY'I3OJ][+$Y214
MM@<\$9R2!@KSD@5L?!_]IKPQ\8O$>J>&H-,\0>$_%FFP+=7'A[Q5IQL;T0$@
M"94RP9,D#(/<>HKYO_:\LY]$_;,^&/B'5?&UU\-O#UUX?N-,L?%,-O#+%:7P
MDE9T=IE9(P\<B+N('UQNQT7@'PWX1TO]H&V\8?\ "])/BY\0+#P]>0V^D6JV
MDC26J@N49K9<+\SY4.026XS0!V.K_M[>$=#DO;B[\!?$E/#]E,\-SXD'AICI
ML6UBK.9=^=N0>0OX5Z'\2/VFO GPR\$^'/$]Y?7.KVGB4QKH5GHMLUU=:H9%
M#J(8Q@GY64\X R!U(!^'$^*4?QH_9S\2^/?B/^TC<:'J^H6>H1IX!\/W5M9)
M"P\R.*T>#:\TRN N<C)5^6."U=S8^&/!'BW]F;]FR+7OB<OPJ\<66G27WAC7
MIMOEAD6-9T8R%4(^>'Y2ZDXP,C(H ^@=!_;#T#Q1IWBJ*/PAXZT#7]#TM]4?
M1-9\/O!?2PA@F^*/<P?#,O&?Y&N(_8F_:VU3XO> _!ND>+-(\5ZKXMU 7GVK
MQ/\ V (=(D\N6=D_?QA8QB-%CX4?.,=>:J_L\?&SQUXA^,GC#X4>)/%GA[XI
M6]AH#:E;^+O#L"1!'9UC^S3^6?*#G=NPO(QR3SMF_P"";_Q(\*C]F7P+X.?Q
M%I<7BVVFU&WDT*6[C2]$GVNXG*^23O/[H[^!T!]#0!]:7=W!I]K-=7,T=O;0
MHTDLTK!410,EB3P  "<U\T7'_!0KX;Q+-J,&A^-K_P (PS-#)XPM/#TKZ0"&
MVD^=G=@'_9KTG]JC0=7\4?LX?$C2M"CDGU6ZT.ZCAAA&7E^0EHU'<LH90.^:
M\R^ ?[3GP9T#]EWP9<7GC+0-'LM,T*VL[W3+BY07,4T<*I+&;<9D=BP8\*2^
M<C.: .T^*'[56D_#'QI<>&%\">/O&&I6T,<\[>%-!-]%$KC(W/O7G%:/A?\
M:B\"^,/@WK_Q+TRXO9=#T%+@ZI:R6QCO;22%=TD+Q,1AP".,X.1S7SQXP^+>
MI_$K]I#XD^#O$_QK_P"%)>%/"'V6*RL;6:VL;S5/,CWR3_:9\\#C"KGY73@$
M$MYQ\&[C3;C]F']L%]&UZ\\4:2UYJ+VVM:A)YD]\IMC^^D;:NYGZD[1G- 'T
M$W_!1[X6?9]/U)=+\8OX8N6B27Q.-"<:9:2/C]W+*6!W*25.Q6Y4XS7LOQ@^
M/7@[X(>%[+7/$M_(8M0F6WTZTT^(W-S?RL,JD,:_?)'?@<CGD9^?OBO;1/\
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MI_T-^O?^#.?_ .*KE%I]?:_5J'\B^Y'YBL;BO^?LOO9U?_"TO&G_ $-^O?\
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MK25#I4_Y5]P_K6(_Y^/[V='_ ,+%\5_]#/K/_@PE_P#BJ7_A8GBO_H9]9_\
M!A+_ /%5SM+67LJ?\J^XOZUB/^?C^]G0_P#"Q/%?_0SZS_X,)?\ XJC_ (6)
MXK_Z&?6?_!A+_P#%5SU%0Z</Y5]P?6L1_P _'][.B7XB>*_^AGUG_P #Y?\
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M>O\ _)RG@3_L4O$/_I9HM>F5YGK_ /R<IX$_[%+Q#_Z6:+0!Z91110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%8_B_Q=I/@/PW?:_KMW]ATFQ0/<7'EO)L4D*#M0%CR1T!KR3_AMSX*_
M]#I_Y2KW_P",T >M>+/!?A[QYI7]F>)M!TSQ%IOF++]CU:SCNH=XSAMDBD9&
M3@X[FB'P7X?M_"O_  C,6A:;'X;\@VO]CI9QBS\D@@Q^3MV;""?EQCFO)?\
MAMSX*_\ 0Z?^4J]_^,T?\-N?!7_H=/\ RE7O_P 9H [BS^ OPSTW1]1TFT^'
M7A.UTK4C&;VQAT.U2"Z,;;H_-0)M?:Q)7<#@G(K._P"&8_@[_P!$F\#_ /A-
MV?\ \;KF/^&W/@K_ -#I_P"4J]_^,T?\-N?!7_H=/_*5>_\ QF@#V"+PSH\/
MAU- CTFQCT*.W%HFEK;(+58 NT1"+&T(%XVXQCBN'TO]F?X2:)K"ZK8?#/PG
M9Z@C;TGAT:W4QMZK\F%/N,5R_P#PVY\%?^AT_P#*5>__ !FC_AMSX*_]#I_Y
M2KW_ .,T >Y5E^)O"NB>-='FTCQ#H^GZ]I,Q4RV.IVJ7,$A5@REHW!4X(!&1
MP0#7D/\ PVY\%?\ H=/_ "E7O_QFC_AMSX*_]#I_Y2KW_P",T >M^%?!N@>!
M-)&E^&M#TWP]I@=I!9:5:1VL(<]6V1@+DX&3BH?&'@'PQ\0K"&Q\5>'-)\36
M4,OG16VL6,5W&DF"-ZK(I ;!(R.<$UY5_P -N?!7_H=/_*5>_P#QFC_AMSX*
M_P#0Z?\ E*O?_C- 'LFA:#IGA?2+72M&TZTTC2[5=EO8V,"PP0KG.U$4!5&2
M> .]<[XZ^#G@3XG/%)XM\':'XCFB79'-J=A%/)&N<X5V4LHY/ ->>_\ #;GP
M5_Z'3_RE7O\ \9H_X;<^"O\ T.G_ )2KW_XS0!Z)X$^$/@?X7B;_ (1'PCHO
MAMYE"RR:981022@= [*H+#ZDU3\<? ?X<?$K4/M_BKP-X?U[4,!3>7VG123D
M 8 ,A7<0!VS7#_\ #;GP5_Z'3_RE7O\ \9H_X;<^"O\ T.G_ )2KW_XS0!ZG
MX-^'_ACX<Z:VG^%?#NE^'+%VWO;Z59QVR.V,;F" 9/N>:Z"O#/\ AMSX*_\
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MGH\;Q:;>O:1F:R1UV.L+XW1AE^4A2,C@UL5X9_PVY\%?^AT_\I5[_P#&:/\
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MF7X:_P#0M_\ D]<__'*YS_AMSX*_]#I_Y2KW_P",T?\ #;GP5_Z'3_RE7O\
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M_P",T?7\7_S^E_X$_P#,/['RW_H&A_X!'_(ZG_AG+X=_]"]_Y.W'_P <I?\
MAG/X>?\ 0O?^3MQ_\<KE?^&W/@K_ -#I_P"4J]_^,T?\-N?!7_H=/_*5>_\
MQFE]>Q?_ #]E_P"!/_,?]D9=_P! T/\ P"/^1U?_  SK\//^A?\ _)VX_P#C
ME'_#.OP]_P"A?_\ )VX_^.5RG_#;GP5_Z'3_ ,I5[_\ &:/^&W/@K_T.G_E*
MO?\ XS1]>Q?_ #]E_P"!/_,/[(R[_H&A_P" 1_R.L_X9V^'O_0O_ /D[<?\
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M?_'*/^% ^ _^@%_Y.7'_ ,<KCO\ AMSX*_\ 0Z?^4J]_^,T?\-N?!7_H=/\
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M'3_RE7O_ ,9H_P"&W/@K_P!#I_Y2KW_XS0![G17AG_#;GP5_Z'3_ ,I5[_\
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M'3_RE7O_ ,9H_P"&W/@K_P!#I_Y2KW_XS0![G17AG_#;GP5_Z'3_ ,I5[_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% 'G'[2G_)NGQ3_P"Q4U7_ -(Y:]'KSC]I3_DW3XI_]BIJ
MO_I'+7H] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% 'G%C_R<7K?_ &*EA_Z67E>CUYQ8_P#)Q>M_]BI8?^EEY7H]
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@#SC]I3_ )-T^*?_ &*FJ_\ I'+7H]><?M*?\FZ?%/\
M[%35?_2.6O1Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** /.+'_DXO6_^Q4L/_2R\KT>O.+'_ ).+UO\ [%2P_P#2
MR\KT>@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "N<^)7_ "3KQ5_V"KK_ -$M71USGQ*_Y)UXJ_[!5U_Z):@ ^&O_ "3K
MPK_V"K7_ -$K71USGPU_Y)UX5_[!5K_Z)6NCH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ KSC7O\ DXOP/_V*FO\ _I9H
MU>CUYQKW_)Q?@?\ [%37_P#TLT:@#T>BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "MZV_X]XO]P?RK!K>MO^/>+_<'
M\J ):*** (KBW6Y0*Q( .>*K_P!DP_WG_,?X5=HH I?V3#_>?\Q_A1_9,/\
M>?\ ,?X5=HH I?V3#_>?\Q_A1_9,/]Y_S'^%7:* *7]DP_WG_,?X4?V3#_>?
M\Q_A5VB@"E_9,/\ >?\ ,?X4?V3#_>?\Q_A5VB@"E_9,/]Y_S'^%']DP_P!Y
M_P Q_A5VB@"E_9,/]Y_S'^%']DP_WG_,?X5=HH I?V3#_>?\Q_A1_9,/]Y_S
M'^%7:* *7]DP_P!Y_P Q_A1_9,/]Y_S'^%7:* *7]DP_WG_,?X4?V3#_ 'G_
M #'^%7:* *7]DP_WG_,?X4?V3#_>?\Q_A5VB@"E_9,/]Y_S'^%']DP_WG_,?
MX5=HH I?V3#_ 'G_ #'^%']DP_WG_,?X5=HH I?V3#_>?\Q_A1_9,/\ >?\
M,?X5=HH I?V3#_>?\Q_A1_9,/]Y_S'^%7:* *7]DP_WG_,?X4?V3#_>?\Q_A
M5VB@"E_9,/\ >?\ ,?X4?V3#_>?\Q_A5VB@"E_9,/]Y_S'^%']DP_P!Y_P Q
M_A5VB@"E_9,/]Y_S'^%']DP_WG_,?X5=HH I?V3#_>?\Q_A1_9,/]Y_S'^%7
M:* *7]DP_P!Y_P Q_A1_9,/]Y_S'^%7:* *7]DP_WG_,?X4?V3#_ 'G_ #'^
M%7:* *7]DP_WG_,?X4?V3#_>?\Q_A5VB@"E_9,/]Y_S'^%']DP_WG_,?X5=H
MH I?V3#_ 'G_ #'^%']DP_WG_,?X5=HH I?V3#_>?\Q_A1_9,/\ >?\ ,?X5
M=HH I?V3#_>?\Q_A1_9,/]Y_S'^%7:* *7]DP_WG_,?X4?V3#_>?\Q_A5VB@
M"E_9,/\ >?\ ,?X4?V3#_>?\Q_A5VB@"E_9,/]Y_S'^%']DP_P!Y_P Q_A5V
MB@"E_9,/]Y_S'^%']DP_WG_,?X5=HH I?V3#_>?\Q_A1_9,/]Y_S'^%7:* *
M7]DP_P!Y_P Q_A1_9,/]Y_S'^%7:* *7]DP_WG_,?X4?V3#_ 'G_ #'^%7:*
M *7]DP_WG_,?X4?V3#_>?\Q_A5VB@"E_9,/]Y_S'^%']DP_WG_,?X5=HH I?
MV3#_ 'G_ #'^%']DP_WG_,?X5=HH I?V3#_>?\Q_A1_9,/\ >?\ ,?X5=HH
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MC_"KM% %+^R8?[S_ )C_  H_LF'^\_YC_"KM% %+^R8?[S_F/\*/[)A_O/\
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M#_>?\Q_A1_9,/]Y_S'^%7:* *7]DP_WG_,?X4?V3#_>?\Q_A5VB@"E_9,/\
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M_2:2OQKKZ7*L/2K0DZD;V9]ED6$H8FG-UH)V9]7_ /#R#XE_] /PI_X"7/\
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MZGA_Y$:+(\M_Y\(^H_\ AXC\1_\ H"^%O_ 2Y_\ DBE'_!1#XCG_ )@OA?\
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M_P /"OB+_P! 7PO_ . MS_\ )%?,%%3]4H?R(T7#V5?] \3Z@/\ P4)^(O\
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M8"KW_#P3XB?] ;PQ_P" MQ_\?KYDHH^JT/Y44N%<D_Z!8GTW_P /!/B)_P!
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M"?\ 8I>(?_2S1:],KS/7_P#DY3P)_P!BEXA_]+-%H ],HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@#C/BQ\'_"'QP\*CPWXVTC^VM%^T)=?9?M,T'[Q 0K;HG5N-QXSCFH3\$?
M!#?"<?#.30(IO XM/L0TF::611$#D 2,QDR#R&W;@0"""!7<T4 >(Z1^Q;\'
M-"\ Z]X)L?"<L/A;79H;C4-,.L7[QRR1,&C<%IR48$+DH1N"@'( %<M_P[=_
M9T_Z)W_Y6]1_^2*^EZ* .*U#X+^"-6^&ME\/]0\.6>H^#[.UBLK?2[P-,L4<
M:;(]KN2X95'#[MPZYS7CVE_\$Y/V?=)UA=1C\""=D;<EM=:E=S0*?=&E(8>S
M9'M7TM10!';V\5I;Q001K##$H1(XU 55 P  .@ J2BB@#S+XK_LV?#KXW:YH
MFK^-/#YUC4-%S]AF%[<0>5EE8\12*&Y4'Y@>E:_Q8^"W@GXX>'TT7QOX?MM>
ML(W\R(3%DDA?&"T<B$.AQUVD9[UVU% 'SOX _8!^!GPW\0VVN:9X+6ZU*UD$
MMO)J=Y-=I$P.0PC=RF00""5)&.#7>_&;]F_X<_M 6MK%XY\-6^L2V@*VUVLC
MP7$()R566-E;;GG:21GM7I=% 'AOPE_8G^#GP4U^+7?#/A&-=<A_U.H7]S+=
M20G!&8Q(Q5&P2-R@'!ZUJ_&#]D[X5?'KQ#::YX[\*_V[JEK:BRAN/[1N[?;"
M'9PNV&5%/S.QR1GGKTKUVB@#Q;X6_L;_  ?^"OBV+Q/X,\(?V-KD43P)=?VG
M>3X1QAAMEF9>1[5[3110 4444 %<M\._ACX:^$^ASZ/X5TW^RM.GNYKZ2'SY
M9MTTK;I'S(S$9/;.!V KJ:* .4\3_"WPOXR\8>%?%.L:9]LU[PN]Q)I%W]HE
M3[,TZJDIV*P5]RHH^<-C'&*\W^(W[$?P5^+7C/4?%GBOP9_:OB#43&;J\_M6
M]A\S9&L:_)',JC"(HX Z9ZU[G10!Y+\+_P!E/X6?!BT\06W@[PO_ &/!K]N+
M34E_M"ZG\^(!P%S+*VWB1^5P>?I7;>!/AUX=^&G@FP\(^'--6P\.V,;PV]B\
MKSJJ,S,REI&9F!+-]XGK7244 >9>%_V;/AUX+\&^)O">B:!)IOAOQ&TCZCID
M.HW7DN7!#^6#+^XR./W6S@+Z#'&Z#^P9\#?#&OV>MZ9X,GMM4M+B*ZBN/[=U
M%R)(V#(Q#7!#8('# CVKW^B@#QGX'_!W6_!_Q$^*/COQ9/977B'Q;JR_9?L4
MC2);:9 @2UB)95P^"Q< 8) .36W\9OV;_AU^T&-''C_P[_;XTCSOL7^FW-MY
M7F[/,_U,B;L^6GWLXQQC)KTNB@#P+P7^PA\#/AYXKTOQ+X?\#_V?K6F3K<VE
MU_:U]+Y<@Z-M><J?H017OM%% !1110 4444 %%%% !1110 4444 %%%% !11
M10!E^*O#.F>-?#.K>']:MOMFD:K:2V5Y;^8T?FPR(4==RD,N5)&001G@TSPC
MX3TKP)X7TKP[H=K]AT;2[:.SL[;S'D\J)%"JNYR6. !R23[UKT4 >-?&#]D/
MX5?'3Q);>(/%_AK[7K,,0@-Y:WDUK)+$,X20Q.N\8)&3R!QG%:W@7]F7X9_#
M/2_%&F^%_"L.C6'B>VCM-6M[>YGV7$21O&HP7.P[9'R4VDEB22>:]/HH XJ/
MX-^#XOA2?ALNCX\%?83IO]F?:9O^/<]4\W?YG?KNS[T>)O@WX/\ &'PM'PYU
M?1_M?@P6MO9#3?M,R?N8"AA7S%<2?*8DYW9.WDG)KM:* .1U+X4>%=8\9>%?
M%=WI7G:_X7BG@TB\^T2K]F2:/RY1L#!7W)Q\X;'48/-5])^"_@W0X_&D=EHW
MDIXRFEN-='VJ9OMDDB%'/+GR\J2,)M SQ7;44 >3>+/V5?A?XV^%^C?#[5O#
M$<_A?10!IEN+F82VF,\I-O\ ,[\Y8Y[YK/\ AQ^QO\(?A/XDT?Q%X9\)+8^(
M-*,YMM3>^N99B9HS'(7+2$294D ,"%R=N"37M-% '+>#OACX9\ :MXEU/0=,
M^P7OB.^.I:I+Y\LGVBX(P7P[$)QV4 >U:GBCPOI/C;P[J&@Z[80ZIH^H0M;W
M5G<+N25#U!_Q'((!'-:M% 'S;IO_  3K^ &FVUS ? QO$FV@&ZU2\=H5#[P(
MV\W*<CDJ02,@D@D5Z+\:/V;_ (>?M 0Z>OC?0%U.?3V+6EY#/);W$.>H$D;*
MQ4X^Z<C/.,\UZ;10!Y9\*?V7_AA\$=<DUCP3X5AT+4Y+'^SI+B*ZGD,D&\/A
M@\C!FW '>1NX SCBN:\=_L.?!7XC>)+[7M7\&K'J6H.7OGTZ^N;-+LDY)DCA
MD5223DMC)/))KWBB@#SD?L\?#Q?#O@S0H_#<4.D>#M1CU;0[6&XFC6SND9G6
M3Y7!<[G8D/N!).0:W?%WPQ\,^/-<\,ZOKNF?;M1\-WAO]*F\^6/[/.1@OA&
M?@='!'M74T4 >/\ Q8_9+^%WQJ\0IK_BCPV9=<6(0/J-C>3V<TT0XV2-"Z^8
M, #YLD#@$"NFTWX'^!M'^%MS\.+#P[;V/@NYM9+.;2[9WC$D<@(?=(&$A9LG
M+[MQZYKNJ* .*U[X-^#_ !-\*T^&^I:/]I\%I96^GKIGVF9,00;/*3S5<2?+
MY:<[LG').34OCKX2^$_B5X/M_"WB32O[2T&WD@ECM/M$L6UH2#$=Z.K'! ZG
MGOFNPHH \D^,_P"RK\,_C]JFGZIXS\/?;=5L8_)AO[6ZEMIQ'DGRV:-EW+DG
M .<;CC&36A\*?V;?AO\  _4[[4/ _A>'P_=WUM%:7+PW$SB6./[F5=V&[))+
M8W'N37I=% 'C?@_]D/X4> ?B6OCSP_X7_LKQ$DLUQ&\%]<"WCDE1XY'6#S/+
M!*.XQMP,\ 5BZG^PA\#]6\43:Y<>"(A+/<?:YK&*]N([&6;.=[6RR"/_ (#M
MVG)R#FO?J* ..^)'PA\(?%OP3)X1\5:';ZGX?;85L\M$(BG"-&R$%"HX!4C@
MD="17GG@7]B/X,?#G5]'U?1/!RPZUI-U]MM=2FO[F2X67;MRS-)\RX_@.5'7
M&>:]THH \"\7_L*?!7QQXIU3Q#J?A*7^T=5G>YU'[+JEW;QWDCL69I(TE"DE
MB2< 9)KVKPSX9TGP9X?L-#T+3[?2M(L8A!;6=J@2.)!T  _R2236G10!\R?M
M=? 6Z^.WQ#^#%M<>'FU_PAI^J7C:^HG$2Q0/$@4DAU?EE_@Y&*]&^#_[+OPR
M^!&H7NH^#/#,>GZI>)Y<^H7%Q-=7#)G.P22NQ5>!D+@':,YP*]5HH \6^)W[
M'/PE^+WBB;Q'XC\+E]:N$$5W=6%]<6;7: 8"S"%U#\ #)&[  S@"NPOO@?X&
MU#X5/\-7\.V\/@=X!;-H]J[VZ; X?&Z-E?)<;BV[)))).37<T4 >&_M8>%?%
M&J?LYZKX(^'?A\:MJ.L10Z%'$\B>79VC_+),YD;D+&I4$98,RGG%>E?"_P"'
M^G?"GX=^'?"&DKBPT:RCLXVQ@R%5^:0_[3-N8^[&NHHH ^&_V<?^"?7@O4_
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M #]_"/\ D?#_ /P[/_ZJ/_Y0O_NFE_X=H_\ 51__ "A__=-?;]%+^TL5_/\
M@O\ (K_6#,O^?OX1_P CXA_X=H\?\E'_ /*'_P#=- _X)H_]5'_\H?\ ]TU]
MO44?VCBOY_P7^0_]8<S_ .?O_DL?\CXA_P"':7_51_\ RA__ '32_P##M/\
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M@S_S4/\ \HG_ -T4?\.X?^JA_P#E$_\ NBOM.BCZ_B?YOP7^0_\ 6S.O^?\
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MX=S?]5"_\HO_ -T4?\.YO^JA?^47_P"Z*^SZ*/KV(_F_!?Y#_P!=,^_Z"/\
MR6'_ ,B?&'_#N;_JH7_E%_\ NBC_ (=S?]5"_P#*+_\ =%?9]%'U[$?S?@O\
MA_ZZY]_T$?\ DL/_ )$^,/\ AW-_U4+_ ,HO_P!T4?\ #N;_ *J%_P"47_[H
MK[/HH^O8C^;\%_D/_77/_P#H(_\ )8?_ ")\8?\ #N;_ *J%_P"47_[HK,\3
M_L ?\(WX:U;5O^$\^T?8+2:Z\G^Q]N_8A;;GSSC.,9P:^XJYGXG?\DU\6?\
M8(N__1+T?7L1_-^"_P @_P!=L_\ ^@C_ ,DA_P#(GR'X8_8 _P"$D\-:3JW_
M  GGV?[?:0W7D_V/NV;T#;<^>,XSC.!6G_P[F_ZJ%_Y1?_NBOJGX8_\ )-?"
M?_8(M/\ T2E=-1]>Q'\WX+_(?^N_$'_03_Y)#_Y$^,/^'<W_ %4+_P HO_W1
M1_P[F_ZJ%_Y1?_NBOL^BCZ]B/YOP7^0_]=^(/^@G_P DA_\ (GQA_P .YO\
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M_P HG_W12?\ #N/_ *J'_P"43_[HK[2HH^OXC^;\%_D/_7KB+_H)_P#)(?\
MR)\6G_@G#_U4/_RB?_=%?57PR^']A\+? ND>%M-DEFM-/C91+,<O(S.SNQ],
MLS'';.*ZBBL:N)JUE:H[H\;-.(\USFE&CCJW/&+NE:*UVO[J04445S'S8444
M4 %%%% !7F>O_P#)RG@3_L4O$/\ Z6:+7IE>9Z__ ,G*>!/^Q2\0_P#I9HM
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MW]@;5MS>2)\ ^7TSG!':NOM/'6@7_@I?%]MJUM/X9:R.HC4XWW0_9PA<R9]
MH)]>* -VBN'UKXW>!?#GP_L?'.I^)K&S\)7PC-MJTC'R91)DI@XSS@]JS?A_
M^TE\+OBEJXTKPIXZT76M48%EL8+H"=P!DE4;#-@<G .* /2J*\I\9?M4?"7X
M>>*;SPWXD\=Z3HVN6907%E=2,KQ;T5UW<8&593U[UWWA/QCH7CS0X-9\-ZQ8
MZ[I,^?+O-/N%FB8CJ-RDC([CJ.] &Q17/GQ]X>'CH>#/[6M_^$I-@=4_LL,3
M-]E#^7YI'9=QQ704 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_!&TDM? ^@7JW=S=6;L]M'%'#MN"C,2?+DD+1KR0=^5^7&/UQK\UOV:_A_\
MM7_L]V-AX>T'X-^%-.T>XNXFU74Y+RUEO+A-V&>1Q?98JI;"A<#G"\G/Z4T
M%%%% !1110 5^:/[*?CR\\.>#O%5I!^S]J/Q,3_A*=1?^V[6WMG0$NO[K,@+
M97&?3YJ_2ZOACX!Q_M#_ +.OAW7_  U9_ %?%-I=Z]>ZI%J!\8Z?:;DF8;1Y
M9+D<*#DGOT% #/VJ=5_X3+]E'26O_AQ/\.8Y?&NG02:!?11*9$+@&0K&-I#
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M.Y\2OAY\1OAW^UMXC^)VC?"BS^,.D:_IEK:6"OJ-O:SZ-)%&J,JF8' <J6+
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M((_"O&S3X8GXIXH./U7#+KS2];61U=%%%?.G\\A1110 4444 %%%% !1110
M5S/Q._Y)KXL_[!%W_P"B7KIJYGXG?\DU\6?]@B[_ /1+T 'PQ_Y)KX3_ .P1
M:?\ HE*Z:N9^&/\ R37PG_V"+3_T2E=-0 4444 %%%% !1110 4444 %%%%
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M_H.^!_\ P2WG_P ET?V?\8O^@[X'_P#!+>?_ "70!Z917F?]G_&+_H.^!_\
MP2WG_P ET?V?\8O^@[X'_P#!+>?_ "70!Z917F?]G_&+_H.^!_\ P2WG_P E
MT?V?\8O^@[X'_P#!+>?_ "70!Z917F?]G_&+_H.^!_\ P2WG_P ET?V?\8O^
M@[X'_P#!+>?_ "70!Z917F?]G_&+_H.^!_\ P2WG_P ET?V?\8O^@[X'_P#!
M+>?_ "70!Z917F?]G_&+_H.^!_\ P2WG_P ET?V?\8O^@[X'_P#!+>?_ "70
M!Z917F?]G_&+_H.^!_\ P2WG_P ET?V?\8O^@[X'_P#!+>?_ "70!Z917F?]
MG_&+_H.^!_\ P2WG_P ET?V?\8O^@[X'_P#!+>?_ "70!Z917F?]G_&+_H.^
M!_\ P2WG_P ET?V?\8O^@[X'_P#!+>?_ "70!Z917F?]G_&+_H.^!_\ P2WG
M_P ET?V?\8O^@[X'_P#!+>?_ "70!Z917F?]G_&+_H.^!_\ P2WG_P ET?V?
M\8O^@[X'_P#!+>?_ "70!Z917F?]G_&+_H.^!_\ P2WG_P ET?V?\8O^@[X'
M_P#!+>?_ "70!Z917F?]G_&+_H.^!_\ P2WG_P ET?V?\8O^@[X'_P#!+>?_
M "70!Z917F?]G_&+_H.^!_\ P2WG_P ET?V?\8O^@[X'_P#!+>?_ "70!Z91
M7F?]G_&+_H.^!_\ P2WG_P ET?V?\8O^@[X'_P#!+>?_ "70!Z/=6XNK:6%F
M=%D0H6C8HPR,9!'(/N*Y;X5_"KPS\%_!=IX5\):?_9VC6SR2I$TKRNSNY=V9
MW)9B2>I/0 = *P?[/^,7_0=\#_\ @EO/_DNC^S_C%_T'? __ ();S_Y+H WH
M?A7X<M_BI/\ $5+.0>*Y])&B/=^>^TVHE$H3R\[<[P#NQGMFNNKS/^S_ (Q?
M]!WP/_X);S_Y+H_L_P",7_0=\#_^"6\_^2Z /3*Y'Q]\*_#GQ,NO#-QX@LY+
MN7PYJT.MZ:R3O'Y5U%G8YVD;@,_=.0?2L'^S_C%_T'? _P#X);S_ .2Z/[/^
M,7_0=\#_ /@EO/\ Y+H ],HKS/\ L_XQ?]!WP/\ ^"6\_P#DNC^S_C%_T'?
M_P#X);S_ .2Z /3**\S_ +/^,7_0=\#_ /@EO/\ Y+H_L_XQ?]!WP/\ ^"6\
M_P#DN@#TRL7QIX/TOX@>$M7\-:W USI&K6LEG=PK(T9>)U*L RD$<'J#7&_V
M?\8O^@[X'_\ !+>?_)=']G_&+_H.^!__  2WG_R70!W'A7PW8>#/#&D>'])B
M:#2])LX;"TB9RY2&) B*6)R<*H&3R:U*\S_L_P",7_0=\#_^"6\_^2Z/[/\
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M,7_0=\#_ /@EO/\ Y+H_L_XQ?]!WP/\ ^"6\_P#DN@#TRBO,_P"S_C%_T'?
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MN@#TRBO,_P"S_C%_T'? _P#X);S_ .2Z/[/^,7_0=\#_ /@EO/\ Y+H -/\
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M8O\ H.^!_P#P2WG_ ,ET >F45YG_ &?\8O\ H.^!_P#P2WG_ ,ET?V?\8O\
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MWGP_^+-]X\T?Q4_B3P8MYIFFWVF1PKHMWY;1W4MI([-_I6=P-F@&#C#-G/&
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MU#3_ !S<^%="\*W7B34+>S2ZEDANHX(XF=CA'9^%^49SR3G&.]0:3\=--N/
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M)'-<)\*?BIXINO"^M^*=;T6:?P[/->ZE#J$E_'BVMXU;; D>-Q :,J#WW9H
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M3?,6N+A@  &;:#CG  '2NV\%^(-7\06=TVM>'IO#EY;S>5Y$EPDZR#:#O1U
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M"'X>^$_#7B;5/%:R:#XC:Y73+ZQM)KE+@P.$F^XA(VL0.<<Y]*_/3]FGX$>
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MME?&/]G?X.^"O#OBJVTVU^,7B"2[EO+ZY6WDM["U6=DA<+"3&692N"<@!&W
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MR'#YE65:O.7332VG;2Z\[-#E34W=G<T5PW_"]OAK_P!%"\*_^#NV_P#BZ/\
MA>WPU_Z*%X5_\'=M_P#%U]*;'<T5PW_"]OAK_P!%"\*_^#NV_P#BZ/\ A>WP
MU_Z*%X5_\'=M_P#%T =S17#?\+V^&O\ T4+PK_X.[;_XNC_A>WPU_P"BA>%?
M_!W;?_%T =S17#?\+V^&O_10O"O_ (.[;_XNC_A>WPU_Z*%X5_\ !W;?_%T
M=S17#?\ "]OAK_T4+PK_ .#NV_\ BZ/^%[?#7_HH7A7_ ,'=M_\ %T =S17#
M?\+V^&O_ $4+PK_X.[;_ .+H_P"%[?#7_HH7A7_P=VW_ ,70!W-%<-_PO;X:
M_P#10O"O_@[MO_BZ/^%[?#7_ **%X5_\'=M_\70!W-%<-_PO;X:_]%"\*_\
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M4^YZ]^R3X^\6?\$Z_#/PN:P@T[QWI,_VTZ;<7<11F%U.WE^:C,F3'+D'=C.
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M_P"BA>%?_!W;?_%T =S17#?\+V^&O_10O"O_ (.[;_XNC_A>WPU_Z*%X5_\
M!W;?_%T =S17#?\ "]OAK_T4+PK_ .#NV_\ BZ/^%[?#7_HH7A7_ ,'=M_\
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MVVN6="EVDC 12/M*B9"-V.3QT-?8O_"]OAK_ -%"\*_^#NV_^+H_X7M\-?\
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MGPSJITDRFRDB\3I;M#YNSS/]7, V?+3[P.-O&.: /SRU[Q7\0OBI^V]\&O\
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M_A+*RY'(SW!^T?\ A>WPU_Z*%X5_\'=M_P#%T?\ "]OAK_T4+PK_ .#NV_\
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M4+PK_P"#NV_^+H [FBN&_P"%[?#7_HH7A7_P=VW_ ,71_P +V^&O_10O"O\
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M .#NV_\ BZ .YHKAO^%[?#7_ **%X5_\'=M_\71_PO;X:_\ 10O"O_@[MO\
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M ,!D_P */^$7T;_H$V/_ (#)_A6G10!F?\(OHW_0)L?_  &3_"C_ (1?1O\
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M_P" R?X5IT4 9G_"+Z-_T";'_P !D_PH_P"$7T;_ *!-C_X#)_A6G10!F?\
M"+Z-_P! FQ_\!D_PH_X1?1O^@38_^ R?X5IT4 9G_"+Z-_T";'_P&3_"C_A%
M]&_Z!-C_ . R?X5IT4 9G_"+Z-_T";'_ ,!D_P */^$7T;_H$V/_ (#)_A6G
M10!F?\(OHW_0)L?_  &3_"C_ (1?1O\ H$V/_@,G^%:=% &9_P (OHW_ $";
M'_P&3_"C_A%]&_Z!-C_X#)_A6G10!F?\(OHW_0)L?_ 9/\*/^$7T;_H$V/\
MX#)_A6G10!F?\(OHW_0)L?\ P&3_  H_X1?1O^@38_\ @,G^%:=% &9_PB^C
M?] FQ_\  9/\*/\ A%]&_P"@38_^ R?X5IT4 9G_  B^C?\ 0)L?_ 9/\*/^
M$7T;_H$V/_@,G^%:=% &9_PB^C?] FQ_\!D_PH_X1?1O^@38_P#@,G^%:=%
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M0!F?\(OHW_0)L?\ P&3_  H_X1?1O^@38_\ @,G^%:=% &9_PB^C?] FQ_\
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MPH_X1?1O^@38_P#@,G^%:=% &9_PB^C?] FQ_P# 9/\ "C_A%]&_Z!-C_P"
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M ,!D_P */^$7T;_H$V/_ (#)_A6G10!F?\(OHW_0)L?_  &3_"C_ (1?1O\
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M_P" R?X5IT4 9G_"+Z-_T";'_P !D_PH_P"$7T;_ *!-C_X#)_A6G10!F?\
M"+Z-_P! FQ_\!D_PH_X1?1O^@38_^ R?X5IT4 9G_"+Z-_T";'_P&3_"C_A%
M]&_Z!-C_ . R?X5IT4 9G_"+Z-_T";'_ ,!D_P */^$7T;_H$V/_ (#)_A6G
M10!F?\(OHW_0)L?_  &3_"C_ (1?1O\ H$V/_@,G^%:=% &9_P (OHW_ $";
M'_P&3_"C_A%]&_Z!-C_X#)_A6G10!F?\(OHW_0)L?_ 9/\*/^$7T;_H$V/\
MX#)_A6G10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M3]4\0SM;:7;2AMUU(NTLJX!&1N7KCK0!TM%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 445YG\>?VA?"'[./AFPU[QE+
M>0Z?>W@L839VYF;S2COR >!A&YH ],HKY,TK_@J%\!=2OHK>76]5T])&V_:+
MK2I?+3W.S<<?A7U1I.K66O:7::EIMW#?Z?>1+/;W5NX>.6-@"KJPX(((((H
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M8#YB*T]LI*3?D.XWX!_MQ:UJ?[)OC?XA>-8(=4USPI<BT5K=%@%\THC$&]5
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M!T ' [5YI^QW^R39?!?QG\1O$6J>#X-%U)O$VH1^&KI;L3$:*Y7R54)(P4$
M\. X[UZ19[=^T-XVOOAO\"_'OB?2R5U/2]%NKFT<(&V3"-O+<@]0K88^P->&
M_LV^$/AE^SY^RCH?Q(\6QV7FZOIMMK>O>)KZT:\N99;PH0&95=R TRI@#U)Y
M+&OI[QAX5T_QUX3UKPYJT;2Z7J]E-872(VUC%*A1P#V.&//:ODSX:V_[07[+
MOAQ/ !^'-K\9/!^FDQZ-K6G:U#8W,=N6)2&>*8$L5R -HPHXW, , 'HO[/7C
M+]GWXD>./%.K?"4Z;-KT]G%'K/\ 9^FW%G'+#O;87C>-$9B2V6 W'OVKC_V,
M--LX/C/^TF\=I!&\/C)HXV6-047#_*O' ]A5WX#_  _^)VG_ !=^*WQ=\5>"
M;'PW=^(M,M8-.\)V^L17,YDMHMJJ\RJ(EW[5^;/!8Y&!6=^R7X;^+/@_XN_$
MN^\8?"V3PUHOC75Y-:&H-KUE="R8*VV$QQ.6<DM]X  8Z4 ?4/C+Q1:>"/".
MN>(]0#&PT>QGU"X\O&[RXHVD;&>^%-?'NB>+/VE_'7P;E^-FF^-?#^DVLEI+
MK-C\/VT-)H9K),LJ/=EA*)'121C@[ARN?E^O_''A2U\>>"]?\-7K-'9ZSI]Q
MIT[( 66.:-HV(SWPQKXZT"S_ &CO 7P1D^"5I\,++6+R&RET33_',>N01V L
MW!19WA;]X&1&QMQD[0=IZ$ Z'XO?M2^,]5^#?P+\7?#/^S].U;Q[K]CIKV>K
M1^;;[I5=7A=@-P02KM+IAL#(P:%\;?'#X%_'3X9Z1\0?&^C^._#/CJ[GTU[>
MST=+%M-N%0,GELOS.N2.7)R W .#5GQE^S#XA\/_  [_ &;?"/AFU&N1^!?%
MFF:CK%T)HX0D,99KB<!V4L-[,0JY;!'!KN_VC/AAXF\>?%+X':QH6F_;M.\-
M^(WO]5F\^*/[/ 8P ^'8%^1T0$^U '$M\0OB]^T3\6?'^A?#;Q9IGPW\(>";
M[^QYM6N-)CU*[U&_4?O4"2-L2-"",]>0><X4^(WQ6^,WPQ\+^ ?A_<WOAW5?
MBWXTUJXTVQUV&W9;*&RB"L]V\)Q^\5'7* ;>O7 #5[/PG\6?V9?BY\1=4\%^
M 8_B=X'\;:D=<%O:ZM#87>FWK_ZT,)>'1V/\.<  DCD%WQ/^'OQF^)_A_P"'
M?Q-_X1?2-'^*'@G6KB_M?"0U%7BN+"951[=KG.SSF5%^;(7D].* +5CX^^+/
M[/\ \:O ?A3XD>,-/^)'A7QQ-+86NKPZ/%IEUI]\JAD0QQL5>-]P4$Y/?C&&
MYSP'\0;7X4_'3]LWQA>PM<6VB1:+>M APTI2QG*H#V+'"Y]ZW(/"OQ2_:/\
MC?\ #WQ)XU\!CX9^#? L\NI1V=UJD-[=ZE?,H5,>5PB(5!R<9YQG/RV;']FW
M7_%7C[]J:VU^T_LKP]\0K?3;;1]2$T4OF&*TEC>3RU8LNR1DX<+GMGK0!Q]U
MXL_:9TOX)#XXS>-?#UQ:KIR^()?A_P#V&BVZ:>5\TJ+O=YOF"$[L'N,9)Z]M
M\5/VD_%'BR'X.^&?A-]CTWQ-\3;,ZK%J>K1B9-)L4@6:1S'T:3#$ '(RC#J0
M1P=W:?M(:K\!Q\#9/A?8V]Z^F#PY-XY;78#IQL0GDF?R1^]W-$,;<;LG=M_A
MKL/BA^SCXK\#M\$_$?PJET[5?%'PXL&T9=+UB86Z:O:-;K%)ANBR8#-UQ\Y/
M\(! *WASQ5\9OA?^U'\.?AUXT^(]CX]T+Q)8ZC>/<1Z!!ITX,,+,%/EDC 8*
M001GG-=/\!?V@-8AO_C!X5^*>I0?V]\/;V6[EU 0) +C2&C,D,^Q0!G8I)P/
MXT[UY+HVN?$KQA^WQ\+'^(&BZ#X>O=/T+5+F/1M&OFO)K2W>)H]]S)]W+N0%
MV\8%4?V\/A/=>,OVC/AMI'A+5Y-+USXA64WAWQ!;VH^>32X9HIWF;CHJA\YP
M6$849 - 'T=^R'X\\:?%?X3_ /"<>,WCB_X2"_N+S1]/C@6/['IV_; C$#+D
MA2VXDY5EKVVO*/CMX^M/V;/V<_$.OZ1:V\$7AS2DM]+M)03"LGRP6R$ @E0[
M1@@$' ZBNF^#NH^*M8^%_AG4/&\5I;^*[RRCN=0M[&%HHH9'&\1A69B"BE5/
M)R5)H U?%7@;P]XXCT^/Q%HECKD6GW(O;6+4+=9DBG"LHD"L"-P#M@XXS7R#
MXDT_1/B=_P % ? 2?#K3;2(_#^VNI?%NN:;"J1!I(S'%:.ZC#R [EV]0)''\
M# >N_MD)\9M0^'%KI/P9TPWFJ:C<&#4KJ&]@M;FVM=IR89)G55=C\NX!BO4
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M5'[!K_%:'P+K/PXUV+PGXL\%V-OINF/>%_)>WMV#6X,B@LCQMDA@K9W<CH0
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MM.G2:.634KF6=-PL_MD4L8D9FC.W"E0<?,>N 1C^%/&?QA_;J_:8\9Z3X?\
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M@C?%R^^&_BCP3J_P_P#B3\6/B#?S:O;VOB'1?&&EW;6-Q9R<2RPJ\"B!E.,
M$D9ZG!W?37PR\;:]JG[:7QF\-7>K7=QH&EZ5I$UEITDA,-N\D(,C(O0%CR?6
MJ6DZ;^UC?76E:9J^K?#/3--MYHC?ZWIL=W+>742L"XCBD3RU=E!!R !NRN,"
MJOQ(^"OQ=\+_ +0VK?%#X0WGA2Z/B/2X--U?3/%9G6-)(<".9#",D!0!C/\
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M'POH.G:-IENMIINGVT=I;0)]V.*-0J*/8  5H4 %%%% !1110 4444 %%%%
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M^-']FVO_ #S'_?1_QK"HH^L0_D7]?(+^1N_V;:_\\Q_WT?\ &C^S;7_GF/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1L5PTW5SRPXXX\B33I6<M;F?0^I*_*[]F-/CG^U/;_$#3;#XW:YX?32#;O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MH **** "BBB@ HHHH **** "BBB@ HHHH \O_:8_Y(CXD_[=O_2F*O4*\O\
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M-'^S_P#&/4/#/QRU'P]IWB;QQXX^&4^@3:E]N\;64XO-/O(<LZ">6)"R-&O
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MY^7L<9[^Y44 ?*D'[*?BR+X1_L_^%CJ.C?VA\/\ Q+9:SJD@FF\J:&&21G6
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ;%%%%
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MVKX;\-^#_$GP+?X-:U\:[R]\1?![3EBO](^PL)(?#5_)A[<7F(_,F1 0%;.
M<@# "L ?I97'_%;QMJOP^\&W.M:+X4U#QI?Q21HND:6P$\@9@"P)!X4')^E<
M7^R)\0O%7Q6^ ?AWQ;XQ,9UC5&N)AY4 A'DB9UB.T>JJ#GN"#7%_\%&+VXT_
M]D[Q1/:SR6TRW5AB2%RC#-W%W% 'TM&Q:-6*E21DJ>WM3J^-_P!H#X?P_%C]
MMKP/X3U+6=9TS0[CPA<3W<&CWSVK7*K</^Z=E_@;C..2!C(KB?#O[,GA^/\
M:L\4?!ZWUSQ+8_"\>'H/$C>&[76)EAEN/-6'8[DERGS,V P).W)^44 ??U%?
M'G[-.@K\)?C%^T)\+M%O+Q_!^AV^G7VE65W<--]C-Q:-)*J%CG!)4?\  !WR
M:\9^$7[,GAWX@?L-O\2=<UGQ'?\ BZTT;5;_ $JYDU>81:8]O+<[%AC! "EH
M]S9R27;!'& #]*:*_.7Q)\ ]-\0?L:CXW:KXC\3ZI\45T:'7(-?NM7E+VT@*
MGRXD4A53:,#C(ZYKUWXE>*=1UWXD_L?ZG<74BSZL;BYNQ&Q597>Q@<Y X(RQ
MXH ^O:*^9_C9>7$/[:W[.%O'/(D$T/B#S(E<A7Q8Y&X=#@^M>9^&_@7HG[0'
M[5W[0=CXPU+7+G0-*NM)VZ'::E+;VEPTEJ_SRJA!8KL.W! ^=LYH ^Y**_/?
MP[X_U_\ 9Y^ ?[3>B>']4O;BW\$:XMCX?DNY#-+8Q7,B1 *Q_P">>_>.VX$X
MY-;'Q7_9?T/X)_LZO\5/"NN:W9_%+1+.VU:;Q1)JL\KZC*60RI*C.49'WN H
M'< EN<@'T[XX^-4O@_X\?#3X=KI*747C"+497U SE6M?LL'F@!-IW[NG48]Z
M]3KY&\9>()/%G[6'[*.MRP_9Y=2T76;UX@"-ADTT.5Y]-V*YKX.?!G0?VQ-3
M^(_CKXG3:GK$]MXFO-$T;3XM1GMHM(M[?;L,:1N )#OR=V02,XR30!]O45^>
MW_"]/''@/]CGXIZ3#X@NKW7O"?C&?P3I_B2X<M.+;SHT$K29SO56<!NJY3TI
MW[5O[)?@CX#_  )7Q/X<DUD>+XM0L(+S6YM6N&DO]\RJ[2H7V<GD848.* /T
M'HKY6^+5[<_ O]K_ ,">.3<2IX2\>0_\(KK",Y\F&]&#:38/ +;53/98W/>I
MOV:[RY^-7QV^)GQ?EN)9?#MM-_PB?AF/>?*:W@(:>X4="'DP5;K\SB@#ZCHH
MHH **** "BBB@ HHHH **** "BBB@ HHHH \O_:8_P"2(^)/^W;_ -*8J]0K
MR_\ :8_Y(CXD_P"W;_TIBKU"@ HKS[X_:QXR\/\ P;\5:C\/K'^T?&-O:;M/
MM_+\QF;<H8JF#O8(795P<D =Z\[_ &(O&/Q8\;?".XOOBY87-GK2Z@\=G+?6
M0L[F>V"(0SPA5 ^8N V!D#IQD@'T+1110!\X>+_VO-2T?XM>+? ?AWX5^(O&
MMYX9%LU]<Z3-%M GA65#M;GHQ'U4UZ#\"OV@?#OQ\T?5+C2+;4=(U71[G['J
MNB:Q!Y%Y8S<_+(F3P<-@Y_A(.""!\QZ7\0_&'@']MGX_GPA\.;WXAW-XFBK+
M%:ZC#9K;;;)=I=I!C#;CTZ;33]5TGXC_ +/?P0_: ^-7B**TT+Q_XO>T>'2M
M.E$ZZ3&)!;Q$N/E:51<,Q(R/D4YY( !]ST5\'_%?]E_0_@G^SJ_Q4\*ZYK=G
M\4M$L[;5IO%$FJSROJ,I9#*DJ,Y1D?>X"@=P"6YS=^).DW_QY_:D^%%B_B36
M_"%EKGP_.HWPT*Y-O,ZLY=H0QSL!W $X)P".] 'U1X^^,6B_#GQAX'\-ZE;7
MTU]XOO9+&PDM8T:*.1$#$REG!"X(QM#'VK+_ &A/C='\"?!=EJL6BS^)-9U;
M4[?1=(T>WE$37=Y-N\M"Y!"#"MS@] .]?)GQ\_9-\!>#_BO\!M!@&LWMEK6M
M75G>/?:O.\K1!!(%5PP*G<['<N&YQG &-7]KK]F[P+X1TWX&:1IEE?Q6-QX]
ML=)D635+F5OL]R[M, S2$AB5&&!W+V(H ^LOA#XD\=^)M NKCX@>#K7P7JJ7
M&R&SM=32_66'8I#ET&%.XLN/]G/0UW=?%WQ:^&>FV'Q0^$'[/FA7FJZ#\/M:
M.HZSK$4.HSM/?"%"ZVYF=R^PLIW+GH01@@5;L? EA^RG^UA\,/#G@*>^LO!?
MCVUU&VO_  Y->2W4$$UM")4N(_,9F5B64$YZ!O7@ ]8^&_[1&H_$/P#\2O$%
MIX0FNK[PCX@U#0[?2+"X\V;43;+&0RDJ-K/YF-N#C'4UZQX2UFZ\1>%M(U6]
MTNXT2\O;2*XFTRZ(,MH[H&:)\?Q*25/N*^(_AO/);?LF?M92PR-%*GBOQ.RR
M(Q#*?(AY!'2I]7FU'XJ6?[*WPBO-7U#3O"_B+PG#JVN-9W#13:@L%A&Z0&0'
M.TLK%A_M ]0* /NNBOCFQ\"6'[*?[6'PP\.> I[ZR\%^/;74;:_\.37DMU!!
M-;0B5+B/S&9E8EE!.>@;UX^QJ "O.OC[\9K+X#?#6^\5W>GSZQ-'+%:V>FV[
M!7N[B5PD<88@[02<DX. #@$X!^6OV>_@/X?_ &P? .L?%'XE7>L:IXFUO4[Q
M-.>#4I[<:'#'(8XX[>-&"@K@GY@PZ<=2?*_B!<7/QA_8Z\%ZAXSN[K6]?\,^
M./\ A&$U5KB16NH&F56=\-AV*K&N\Y(VDYR22 ??/P;\6?$3Q78:A+\0? EK
MX&N(VC-I#;:M'?\ G*P);<4'RE2 /?/'2O1:XWX5_"/PU\&?#L^B>%K:YM=/
MFNFO'2ZO9KIC(RHA.^5F8#"+P#CCW-?/G[;&@2^,?BM\ ?#8UG5-$M=6UF]M
M[BYT>Z-O<>7Y,9(5QT)&1G'<T ?6M%?$^J?";2OV3OVG/@\WP]NM3L](\:7%
MYI>MZ/=7TMS%<[(U9)_G8G>K/DG/&T8P"P.1\+/@-;_'SXO?'A/$OB[Q/;Z!
MIWB^>*/0]*U%K:WDD()\R0C); P O '/7- 'W?17Q/X7^$NC?M*?'[XE>'/'
M5QJ>J^#/AS%IVAZ+X?.H301Y:$E[F4QLK/(3'PV>0>?NBMO]G_PNEQXP^.W[
M/^N:CJ7B#P1H$UA)IK7%Y+]HM[>ZB,QMO/5@X5"J!<$'A_6@#Z,^&OCC5O'%
MKK<NK>$M1\)/8:G-801ZBP)O(D"E;E, ?(VXX_W378U^;WA_XB:W\$?V-_CC
M)X5O+N"_M/B+?:#IMT\SRRV<+&VB!5V)(8)N 8GAB#UJKX@^%VN^%=)T76OA
M7\&_B=H'Q.TVZ@N)?$>J:@)5U,*?WR7*?:64JXSP%QVZ$T ?I77"?&[XQ:+\
M!?ASJ/C3Q!;7]YI5B\,<L.FQH\Y,DBQKM#NB]6&<L.,U\\>)O"L?[47[7'C3
MP/XRO=1'@/P1I-C)'X=M+N2UBOKFYC60S3&-@S!0Q7@C&!@CYMW#_MI?LQ>$
MOA#^RCXKET6ZUJ:TM=3L[S3K&_U.6>&P9Y8X9%C!/*LI)P^[!Y!Z8 /OJBOE
MCXP?LSW7PU_9]\>Z=\#(=4L/$^L+:^<HU:>:XGABD.](7FD/EL4>3[I!8<<G
M%>8_LYVOP/T_XQ>%;+3_  [\0/A)\2$WNNE>))KI(]8;RG$B.9&=9!C+#B/)
M5<#M0!]YR?ZMOH:H%@O).*N74@AM9I"K,%0MM49)P.@'K7Y0?LZ_#B[_ ."A
M7Q,\=>(/B7XHUA--TKRGM].TZY5!"9VD\N.-75U2-%B;HN22"3G.>'$0YGS-
MV2)9^JE(K!LX(.#@X[5^8W[8.G^*/V2?@SX7^%?A_P 9ZI?:3X@U34+U]0F=
MHKA+1$MU2T+AON9D=FV[0>. "0<?]ISX#M^PHWP^\9_#GQ?K,>LW,[PWQNIU
M*7$B*CEMJA<QME@R-N&"O/7/)&BI6][?8FQ^J5)D<U^9?[;-_J?CS]J7X'6U
MEJU_X;D\0Z3I $]E*R26CSWT@\Q0"/F3<"/=16'J7PWO/V1_V]/AOH?AWQ1J
MVIVVO3:>]U/?R@RSQ7-R]O+'+MP''R%AD<$CN,T*C=7OJ%C[GUC]J[PIHO[1
M%C\')M-UE_$MX$,=Y'#$;,;H3*,L9-_W01]SK^=1?'CXW>//A?XL\.:9X3^%
MNI>/-/U%<W>H61E"61\P+AMD3CH2W)'2O@KXI?L_:%JW_!1!? 4NK:U'I>O7
M1OKB\CN8Q=Q/- ]PRQOY>U5#?* 5.%XR3S76_ML>#(_@SXP^ /@_0]5U2?3=
M/#QI->W.Z>4&\C8F1E"ACEB.@XK14H7BEU0['Z;TF1S7YO?\% +?4=;_ &RO
MA+H-AK=]H3:G:Z;:K>6,K));M)J,R"5<$?,N01]!7(:E\-[S]D?]O3X;Z'X=
M\4:MJ=MKTVGO=3W\H,L\5S<O;RQR[<!Q\A89'!([C-9JC=)WU:N*Q^J-%?G>
M^J72_P#!7A;4W<PM,8\GS#L_Y .?NYQU_6GZ/J5V?^"MFHVOVJ;[+L;]SYAV
M?\@93]W..O-+V/GTN%CZ>^&OQN\>>,/C9XG\'ZU\+=2\-^&-,:[%EXHN#+Y%
M\(IUCB*[HE7]XA+C#'@<9ZU[=G')X%?GG^R3J5W<?\%%?C5;RW4TENB:SMB>
M0E5QJ4 &!G XKQ/]CW]GN?\ :BA^)NF:GXUUW1[+31;.MI9S;H;F9S<B-IE8
MD,J;&XQGYSR*N5%:N]DK?B%C]>:3(SC/-?EU^Q;\;?%/@S]E7X[36E_-</X9
MMK:XTE9B9!:27 FC9D!Z*IC5]O3()QR<\C\-?V=;?XA_LL^/OCCKWB[7Y_%U
MK]K:V^SWHP_EA=WVAF5G8L6;(#+QCKFE["S:;'8_72O-_CY\=M"_9W\!CQ9X
MBL]1OM/^UQV?E:9'&\N]PQ!P[H,?*>]>,?\ !,N\GO?V8;>2XGDN)/[7NQOE
M<L<93C)KCO\ @JQX#LM4^$.A^+I+J\2_TG4%LH;>.11;R).,NSKMR6'E+M((
MQEN#GB(TU[7D8NMCZ^^'?CBQ^)G@70?%>F0W%OI^L6<=[!%=JJRJCKD!PI(!
MY[$_6NAW#=MR-V,X[U^=GA+P!!^R_P#L6ZC\9?".M:[+XMUWPU96YCO+B.2T
MLFN9X5:2%!&"I7<=I9FP0.M>7:1^S#:>(/V-;WX]W/B[77\?YGU%+AKS*!8[
MMH2K,1YA<[6;=O'S$<<'-^QB[N^E[!8_66BOG[]A7XI:Y\7/V<=!UCQ'<27N
MKVTTUA+>RYWW(B?"2,?XFVE06[E2>IKQO_@J3\9/$W@'PAX0\+^'K^YTF'Q%
M)=/?W5H[1R21PB("$.#G:QF)8#KM4="0<HTVY^S"VMC[D#!L@$$@X/M2U^/%
MU\/?'GP[\5>&/$OP?^%WQ:\.ZO8'?J$NL6,TRWC J1Q'$ORM\X=&R""/?/O?
M[>_A"]^!OC;PK\=O!6M_V'K%Q?1I>:--,0)YMA/F+%GYE9 4E4>H/5B:T]BK
MI<VX6/T,HK\]_P!@?PG=_M!?$;Q/\<?&VO+JVKV]^8K/18YCLM92@*RM'GY4
M5"$B!S]UCU4&O)?V>_@@O[2GQT^,/AO6O%OB#1M,M9[J8Q:7=!5F;[6RH)%8
M,&1>NW'XBCV*3:;V"Q^L(.>1R*-PW;<C=C..]?F'^Q3XXF\"R_'CX=>)/%%U
M'X&T72KUSJ2[G%F8Y3;M+"H)P75PP4=2BX]_!?&WA?P==> [[Q=\-O"WQ->#
M2[A/,\9:U/"+,,9%4[A%%\K99<8ER"PSFJ6']YJX['[;TF1G'>OS*^.7Q U_
MQC_P3/\ A=K^JZI=7.L3:Z+:6]:5O-E6%K^%"S=6.V)<D\DC)YKS;X^? &Z^
M&?[/'PH^,$'CC7]3U_5X]/CVW4Y_T(26;31+ X.Y!&(MHY]",8Q2C0ON^MA6
M/U_KYM_:@_:[N/V=_'7@?P_;^&8=>C\2$AKA[TP&#$J1\ (V[[^>HZ5\Q?ML
M?&CQEXL\ _ KP?::M-I__"8:%9:GJLT;F(74TR1*JNPQ\@8NQ7IDJ3T%><_M
M2?LS:!^S-\3OA/I.@:OJ^JQZA,LTYU25&59%N(@3&J(NP'/0Y/ YJJ=%77.]
M[C2/V!A_U2U)4</^J6I*].G\"*6P44458PHHHH **** "BBB@ HHHH ****
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M^P-I$=K:;)[=H0L*QN!$07+,Q5B^U1\N,UZ1\./@I_PK_P"+7Q/\;?VS]O\
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M7C(!JGJ7[+^N^/O@[XU\%_$?XDW_ (PO_$SQ2C4UL([6+3VB97B$%NK%0H9
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M\ # KD/VE/V:?#7[37@VWT779I]/O;&5I]/U2U ,ELY&&!!X9&P-R\9VCD$
MU[;16:PK3YE+4.4^$Q^P3\3]2TJ+PYK/[16OW?A&)1%]@AMI5:2(# C.;@C
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MF1P_ZI:DHHKIBN5)%!1115 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ;
M%%%% !4%Y_Q[M^%3U!>?\>[?A0!G4444 %%%% !1110 4444 %%%% !1110
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MN<4 9=%6_P"SS_?_ $H_L\_W_P!* *E%6_[//]_]*/[//]_]* *E%6_[//\
M?_2C^SS_ '_TH J45;_L\_W_ -*/[//]_P#2@"I15O\ L\_W_P!*/[//]_\
M2@"I15O^SS_?_2C^SS_?_2@"I15O^SS_ '_TH_L\_P!_]* *E%6_[//]_P#2
MC^SS_?\ TH J45;_ +//]_\ 2C^SS_?_ $H J45;_L\_W_TH_L\_W_TH J45
M;_L\_P!_]*/[//\ ?_2@"I15O^SS_?\ TH_L\_W_ -* *E%6_P"SS_?_ $H_
ML\_W_P!* *E%6_[//]_]*/[//]_]* *E%6_[//\ ?_2C^SS_ '_TH J45;_L
M\_W_ -*/[//]_P#2@"I15O\ L\_W_P!*/[//]_\ 2@"I15O^SS_?_2C^SS_?
M_2@"I15O^SS_ '_TH_L\_P!_]* *E%6_[//]_P#2C^SS_?\ TH J45;_ +//
M]_\ 2C^SS_?_ $H J45;_L\_W_TI#I[8X<$_2@"K15G[!)ZK^9H^P2>J_F:
M*U%6?L$GJOYFC[!)ZK^9H K459^P2>J_F:/L$GJOYF@"M15G[!)ZK^9H^P2>
MJ_F: *U%6?L$GJOYFC[!)ZK^9H K459^P2>J_F:/L$GJOYF@"M15G[!)ZK^9
MH^P2>J_F: *U%6?L$GJOYFC[!)ZK^9H K459^P2>J_F:/L$GJOYF@"M15G[!
M)ZK^9H^P2>J_F: *U%6?L$GJOYFC[!)ZK^9H K459^P2>J_F:/L$GJOYF@"M
M15G[!)ZK^9H^P2>J_F: *U%6?L$GJOYFC[!)ZK^9H K459^P2>J_F:/L$GJO
MYF@"M15G[!)ZK^9H^P2>J_F: *U%6?L$GJOYFC[!)ZK^9H K459^P2>J_F:/
ML$GJOYF@"M15G[!)ZK^9H^P2>J_F: *U%6?L$GJOYFC[!)ZK^9H K459^P2>
MJ_F:/L$GJOYF@"M15G[!)ZK^9H^P2>J_F: *U%6?L$GJOYFC[!)ZK^9H K45
M9^P2>J_F:/L$GJOYF@#R;]IC_DB/B3_MV_\ 2F*O4*\V_:=M'B^!WB5B5P/L
MW3_KYBKU+[!)ZK^9H K459^P2>J_F:/L$GJOYF@"M15G[!)ZK^9H^P2>J_F:
M /FO]H;]B7X??M':O%K6N1ZCI'B".(0G4](E6-YD7.U9%=&5L9X. V,#. !6
M#\#_ /@GK\-?@EXLM?$\+:MXDUVT;S+6?6)4:.WDY'F)&B*-W/!;=@X(P1FO
MK+[!)ZK^9H^P2>J_F:Y/8.W+S.Q-C\S?VK_@;K/Q8_;N\+6L^B^(!X6O;6RM
MKK6=+MI L S)EA/L**P..O2OI/X"_L*_#_X ^+)/%&G2:OK_ (B*ND-_K4R2
M&W# AC&J(HW,"06.3@G&,G/T_P#8)/5?S-'V"3U7\S52HWBH\V@['RY\<?V#
M_A[\</%K>*[E]7\->)I-IFU#0YUC,[* %9U=&&X  ;EVDXY)J;X?_L+?#SP/
M\._%7@^Z&K>)]/\ $[Q2ZC-K%P&E,D6XQO&T:KL*EB<\G/4D<5]._8)/5?S-
M'V"3U7\S4^P=K<S%8^(=)_X);_#6SU*T.H:_XMUK1;20R0Z-=WD:P<G+*Q2-
M6P>^PJ?>O6/C[^Q_X+_:(TGPMIFN3ZOHMCX;26.P@T*2&%51UC7:0\3C"B)0
M ,8YZU]#?8)/5?S-'V"3U7\S3]@VT^9A8^?OCI^R5X3_ &@O$7A?6?$5]KEE
M=>'<_94TR:*-'RZ/^\#Q.3R@Z$=33OBU^R;X4^,OQ2\*>/=:OM<M=8\-F VD
M-A-$EO)Y4YF7S%:)F/S'!PPX].M>_P#V"3U7\S1]@D]5_,U*P]K6D%CP#Q=^
MR;X4\9?'G1/BU>WVN1>(])$(@M;>:(6;>7NV[E,1<_>.<..U'A_]DWPIX<_:
M U/XP6U]K;^)=0$@EM99HC9KOC5#M01!^BCJYYKW_P"P2>J_F:/L$GJOYFCZ
MOTY@L?/_ (5_9,\*>$/CWK/Q;L[[7)/$FJB836L\T1LU\P*&VJ(@X^Z,9<U\
M(?'3P7X9E^,'C*6X_9M\<SZBFK726SZ3<W,>FZKB5@EP4%L659,!R(GP=W!&
M:_6_[!)ZK^9H^P2>J_F:TC1Y7=L=CX8_X)G_ +/WBSX0^#?%FN>+-(N-#O/$
M,ULMOI]VA2=(8!)\[H>4W-,< \_+R!D5]5_$CX?67Q1\!ZYX3U5[JWT[6+5[
M2>6S*K,J-U*%E8 _4&N\^P2>J_F:/L$GJOYFHEAU*7/<5CYTT;]CGP?H?[/N
MK?!Z#4->?PSJ4QGFNI)X3>*QE23Y7$(0#,:]4/!-$G['/@^7]G6+X,'4->_X
M1>.;SQ=B>'[;N^T&X^_Y.S&\D?<Z>_-?1?V"3U7\S1]@D]5_,TOJ[_F\PL?-
M_BK]C'P;XN^ _AWX2WFH^((O#FA7*W5M=03PB[=AYN [&$H1^^?H@Z#WS6^*
MG[$/@GXO>!/ /A/6=3\16VG>"[+[!I\MC<0)-+'Y<4>9BT+!FQ"OW0HR3QTQ
M],_8)/5?S-'V"3U7\S3^KM?:"QXA\>OV7_!'[1FB65AXML;H7%CN^QZG82>5
M=6^[&X*Q!4@X&592.,XSS7DW@'_@F_X&\$>--!\23^)O%FNW.@W<-[IUM?W<
M?DQ/$ZO'D+&"0&4< @&OLC[!)ZK^9H^P2>J_F:%0<592=@L?&_B__@G'X-\2
M>+->URR\8>,_#[:[=RWFH6>GWL8AD>1BS@ QYP2QX8MUKT_P!^R7\/?AS\)=
M9^'>G:5/<:'K4;IJ<UW)NN;LLNW<TB@8('W=H 4\@9)S[S]@D]5_,T?8)/5?
MS-#H-JSDPL?*7P7_ &!_!?P/\=)XDT;7/$E]'$LZQZ3J,\4EIB6,QMO01#<=
MI(Z^F<URGB+_ ()??#75-9OKG2M;\4^&M,OWW7.D:;=QFW(!R%7?&QP#R Q;
M';%?;'V"3U7\S1]@D]5_,T_8RO?F86/!9OV3? R_ .^^$.GVU]HWA:]V-<36
M4J_:Y)%E24RM(ZL"[-&H)*XQP  !BL/V1_"8_9O/P3^WZY_PBI.?MGG1?;O^
M/O[7]_RMG^LX^Y]WCKS7T']@D]5_,T?8)/5?S-3]7_O/N%CP:Q_9-\"1? 6Q
M^$6HV=YKOA6R,CP2:A*/M22-,\OF"2-4VLK2, 0!QP<@G/B</_!+#X>(Z6\G
MBWQI/HJ/YBZ8UY"$SG)R1#C\@#[U]R_8)/5?S-'V"3U7\S5*@X[286/E/XJ?
ML%^$/B9XL@\30>(O%/A?68;*#3Q-H]XB*T42!$SN0MG:H!PPSZ5U?[._[(/@
MG]G/4M0U31/[2U;7]14QW.LZS*LMP4+;BBE54*"V">,D@9)P*^@?L$GJOYFC
M[!)ZK^9IQHM6][8=C%\1:#9^*O#^IZ+J,?G:?J5K+9W$?]Z.1"CC\037@'['
M5WXD\ Z/JOP<\7Z;J":AX.E>+2]::UD^R:IIK/NA=)L;-ZAPI3.0 HY*MCZ9
M^P2>J_F:/L$GJOYFND9\T:E^Q#X?M]9U:\\'>._'7PXLM6G:YO=(\+:Q]GLW
MD;[SHA1C&Q]C@#@ #BNB\6_LD^#O&/P(L?A->:CKL7AVTN!=+>1W:/?22>:\
MK,\DD;!BSR,3\O?C%>Z_8)/5?S-'V"3U7\S0!\__ +7'A[PE??".QMO%G@SQ
M+XTTRWOX!$OA.!IM1L'"/MNDVD8"XVD]/G'!KYP^!_P=LO&?[2G@/Q7X3\*?
M$"P\/^&([NYU7Q/\1'E%SJ$CP^7;V\"N<%48LQ*@?>;/1<_H?]@D]5_,T?8)
M/5?S- 'EMG\!?#]E\>K[XM)>:D?$=YI0T>2U:6/[&(0R'<%V;]_[L<[\=>*]
M)JS]@D]5_,T?8)/5?S- 'S+K'[#'A6\\6:YJ6E>,/&OA;1->NFO-6\,Z%K!M
MM/O)6^^2@7<%?G< >AP-H  Z_P *_LI> O#7P+F^$DUO>:[X0F>61H]4F5I]
MSR>;D/&J8*M@J0,C Y->U_8)/5?S-'V"3U7\S0!\RZ3^Q)IEG=:7'?\ Q1^)
M.NZ!I<T4]KH.HZZ'M,QL&1741@NJE1@<8Q7H'[0G[.GA7]I;P?:>'?%;WUM;
MVEXM[!=:9(D=Q&X5E(#.CC:0QR,=AZ"O6OL$GJOYFC[!)ZK^9H YJY\$Z'>>
M#'\)7&F03>''L?[-;3G7]T;;9Y?EX]-O%?/R_L&Z':Z>=#LOB=\2M/\ !N6
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M,[4&2<*0<GDGI7TI]@D]5_,T?8)/5?S- '@'Q$_9'T7QQ\2+_P <:7XS\8>
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ML$GJOYFC[!)ZK^9H K459^P2>J_F:/L$GJOYF@"M15G[!)ZK^9H^P2>J_F:
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MD8Z9Q7M_[2G[87A+]F_2=):[MKCQ#K>L1^=I^E6+*K/'Q^\=S]Q"3@'!).<
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M!#MB:-GEE4@>8)<J/]AJ /7J1F"J23@#DDUXC\$?VD[GXE>-O$'@;Q9X)O\
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MB37/!_B[X%G4[[7_ !WXF^*?VI7OVU"4S:9:1F5@&+MEB67: 2V=Q(P*]O\
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M@#\W/AMX\TWP?\7?AIH/[/?QA\6?$G1=2U*.#5O".MQ2W%MI^E]995EEB3R
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M2_W_ -!1]LE_O_H*AHH F^V2_P!_]!1]LE_O_H*AHH F^V2_W_T%'VR7^_\
MH*AHH F^V2_W_P!!1]LE_O\ Z"H:* )OMDO]_P#04?;)?[_Z"H:* )OMDO\
M?_04?;)?[_Z"H:* )OMDO]_]!1]LE_O_ *"H:* )OMDO]_\ 04?;)?[_ .@J
M&B@";[9+_?\ T%'VR7^_^@J&B@";[9+_ '_T%'VR7^_^@J&B@";[9+_?_04?
M;)?[_P"@J&B@";[9+_?_ $%'VR7^_P#H*AHH F^V2_W_ -!1]LE_O_H*AHH
M\T_:<N))/@?XD5FR#]F[#_GYBKU'[9+_ '_T%>4_M,?\D1\2?]NW_I3%7J%
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MR7^_^@H^V2_W_P!!4-% $WVR7^_^@H^V2_W_ -!4-% $WVR7^_\ H*/MDO\
M?_05#10!-]LE_O\ Z"C[9+_?_05#10!-]LE_O_H*/MDO]_\ 05#10!-]LE_O
M_H*/MDO]_P#05#10!-]LE_O_ *"C[9+_ '_T%0T4 3?;)?[_ .@H^V2_W_T%
M0T4 3?;)?[_Z"C[9+_?_ $%0T4 3?;)?[_Z"C[9+_?\ T%0T4 3?;)?[_P"@
MH^V2_P!_]!4-% $WVR7^_P#H*/MDO]_]!4-% $WVR7^_^@H^V2_W_P!!4-%
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MDA.[!)!8@'I@8QL_MZ_&?1O%_P"V#H.E:S%=:IX,\$2P07UG8JLCSN766Z5
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MK&MZ=X?L6O=4O[73;-2%:XO)EBC!)P 68@<F@"[12 Y&1R*6@ HHHH ****
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M"/XT>*/B;H^I:Y<Z]XA^U_:K>^GA>U3[1<+._EJL2L,,@ RQXSG)YKPW3/\
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M@, G&>E?,W[(O[8T_P"TY)XY%WX6C\.IX9%NP,-Z;@SB7S\\%%VX\GWSN]J
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M/B1XBUK]LKX-_$;P3H?@'Q/X5M9--BFL-4\56GV 7UW'.DRP1QL?NDQ &0G
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M9R5.:X[]M7P?XJTUO WQ:^'NC7.N>-/!FH,AT^RMWFEO+&X7RY8]B LV"5Z
M[0[MVI/ /P8\8?#O]B76- T)YXOB;K6E76J7<^_RKE]2N5+N-^1ME52(PV1A
MD!SWH XWQ]^U)\:O@CIY\0>.K'X5W>E6LL8OO#NAZS,-:C1G"DJLC%&*[AD*
M#T)Z9(]'^.O[1GC#P3\1/AGX6\ >%;#Q=<^-+2\GABO+HVQ7RHE='WYVA &+
ML""2%(&"17QQK7AC0M4_9GN?!_A3]F?QB_Q+2P@CU37]1T M)#<*Z&>:.=]T
MCL[!L(BJ=K'@ 8KZN\2>#=?G_:4_9FU2/0]2DTW2-$U2+4;Q;20PV3O8!$69
M\8C+-\H#$9/ H T_A7\=OB7:_'9?A=\6?#WAZPU+4M)?6-)U'PS-,\#HCE7B
M<2DG< &.1C[O0A@1CZ/^T%\9/C=>Z_JGP>\)^%#X*TF^ET^'4O%=W<)-JTD9
MP[6Z18"+DC!?CWSD+O\ CCPKK5Y^W%\-M>@TB_FT*U\-:A;W&IQVSM;0R,6V
MH\H&U6.> 3DUYA\#?'7B/]COPSJOPQ\4?#+QIXBM]/U*YFT/6/"FDF_M]0MY
M7+H&8,-DF2?E/(!YQCD ]$\=_M+>-=";P!X,T_PCI=G\6?%%I)>76GZQJ!&G
M:/%&2'EFE09=258*$.3CJ3@-<^$/[0'C&X^,]Q\+/B5I_AQ?$$VE?VQINK^$
MKB62QNX0^QXRLN7212">3T!XZ$^1_M ?#S5?''CSX<?&CQ'\']0\7:$VBMI6
MO^"8U^TZCIZF622&9(QM\QP93E0.,$'&<CLOV=8?AW>_%:"?P+^S[X@\#QV]
MI,9?%6N:4VG+&Q 'DQJS,9"V2#R,8[YH ^A/BYJWBG0_AQKM_P""M)M]<\40
M0A['3[N18XIFW+D,Q=0,+N/+#I7Y/_L#^ M7^)'Q0GU2;P%IOC73+?4K2;5=
M=U.\*3Z42TD@EB7SD+NS)DG:_P!P=,G/["ZHI?3;E5&6,;  =^*^#?\ @EK\
M.?%GP]TOXC+XI\+ZSX::ZFL#;KK&GRVAF"K<;BGF*-V-RYQTR*Y*TN52^1+*
M?['/Q T2X^,WQK.C^ ]%\.7^CVUW(U]93W<DEWLN6XD$LSJ 2H8[ O/M6!X'
M_P""C7QC^(?A[46\-?!T>)]5MYE#7&CVEW/:V\94G$BH68N3T^9> >#VN_L?
M_"_QEX9^,/Q\O=8\):YI-GJ5G?+8W%]ILT,=T6N'*B)F4!R001MSD&NO_P""
M7?P]\4_#_P $^.8/%'AK6/#<]QJ%N\,>KV$MJTJB-@2HD4$@'N*YY\BYI-7V
M$0?&#]O#QE8_&E_AE\//#OA]=7M0L5W?>++O[-"T_EAW1 TL04#.!EB6/0=,
MGQ*^*_QZ\4_LQ_%2#Q9\.-)TR_MK-8I;FRN ;2;39H)_M%Q"YF97:,(G"NQ^
M?[M>9?M3^'=,\8?%[Q8_C+X">-I[Y;DP6'BOP8957485 6%I$>*2(L% !9>2
M  0,"M_]C_X _%:T_9M^,>AZY8WVD67B329K70=#U8M'*+@PS OY;X\I7+QJ
M20"Q7)& ,G+",5*W8.A2_P"";OC/XGZ'X.@L[/PKI<OPG75;NXU;Q+/=(MQ:
MNMNK,!'YH8@;8^1&?O'TX^N+/]L;X+:A>06MO\1='EN)W6*.-7?+,QP /E[D
MU\M_L'>)/&GPXT]O@QXK^$?B6&TU34[J6ZUNYM9H;6VA>W 82$QX()BVA@X!
M\P8Z<_3%C^Q'\#]-O+>[MOA[I\5Q!(LL<@GGRK*<@_ZSL145>3G?-^ GN>$7
MWC#01_P4ZM_#S>!='?6'VO\ \),;BZ^V C2"X^3SO)^Z!'_J^G/7FK'CG]M[
MXH:?^T?XH^%O@[X?:9XLN;%WBL8TDDBF8B)7\R1B^S:NXY'RYX&1UK,OOAOX
MM?\ X*F6GBQ?"VM-X651G7!I\WV$?\2=H_\ 7[=GW_EZ_>XZTOPV^&_BVQ_X
M*6>+/%%SX6UJW\-3+<^5K,NGS+9R9MD VS%=AR01P>HJO=W>ONC.O_9-_;.\
M8?%OXN^(/AM\1/"^G^'_ !%I\,TJ'3EDC"/$ZK)#(CN^3\V0P;'RGCD&O6/^
M&TO@A_T4G1?^^W_^)KYV^#GPU\6Z7_P4>\=>);SPMK5IX;N1?>3K$^GS)9R[
MECV[9BNQLX.,'G!KWW_AA?X$_P#1.M/_ ._]Q_\ '*SFJ:>OX"T//_VE?VUM
M;^'OQ6T[X6?#3PM;^+/'-T(M_P!M=A!$\JAXX@H92Q*$.6+JJ@CKSCD/'GQ2
M^-OB+X,_%_PS\7/A]8^&!#X4GOK75-)+-;3,'1/*W"65"V&)QO!&W[O>N=_:
M+^%7Q#^"_P"V'8?'7PAX-N_'>B2^6\]CI\;2RPM]E^RR(RJ&=<H-ZR!2H)P>
MF#UWB3XX?$G]I+X6_%71U^$&O>%M"'AB869O+2>2[OKTN@$<0V*"-A?Y55CD
M Y'2K48I1<4O4"M^P[KWB?PQ^POJ.I^#-$C\1>)X-4N?L.F2DA9W,D2D$Y'
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M'7Q-\-^&0=9NH;*&^\+W@F$3S-LB8LL\R."^ 5RK*#G'8L_X*:>!?'WBK5O
MEUI>B:QXF\"698ZCIFC"1V\[>"6D5 V,Q_*KE2%.[UP?#K/X2ZOJ?[37PAU_
MP9\!_%?P^\'6NJ:5+,+FVNKH$)?!I+F>1@?*^7LY^Z@;HPJJ<(.'O CZ3^,?
M[;'Q$\#_ +4%_P#"GPEX%T[Q:RQQBS@622.ZFD>S6?);=L"JS$G@?*IY'W@_
M]F_]M7QYXV_: N_A/\3O"&G>'=<*3>0-/61&AECC,ICD#R.&#1@L&4CH."#D
M<Y??#?Q:_P#P5,M/%B^%M:;PLJC.N#3YOL(_XD[1_P"OV[/O_+U^]QUIMO\
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M>))_[4\-SVMU:W\-L59DN(MJ^8C!U3#;2""0>#FO&/!WP)\4Z]\:_"UY\'/
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M1_9OD_9OM%S'/_KO-;?M\O;]Q<YSQC%'[.W['O\ PH/XN>.?&_\ PEO]N_\
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M+E252I96'WHUSD'C/3K7=T4U1IIW2"R/C+1/^"6OPWM]:L[[7O$WBKQ1;VK
MQV-_=QB)E'\#%4W;?92M?85MI<%G;Q6]NBP00H(XXHU"JB@8"@#H .U6Z*J5
M.,OB06(/LJ^IH^RKZFIZ*CV%/L%D0?95]31]E7U-3T4>PI]@LB#[*OJ:/LJ^
MIJ>BCV%/L%D0K;A&!R>*FHHK2,(P5HH844458!1110 4444 %%%% &Q1110
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MS_C!_>\$?^3E']G_ !@_O>"/_)R@#OJ*X'^S_C!_>\$?^3E']G_&#^]X(_\
M)R@#OJ*X'^S_ (P?WO!'_DY1_9_Q@_O>"/\ R<H [ZBN!_L_XP?WO!'_ ).4
M?V?\8/[W@C_R<H ]6HID0=8T$C*\F!N95V@GN0,G _$T^@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
@B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>rxrx-20250930_g2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 rxrx-20250930_g2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" -8!SP# 2(  A$! Q$!_\0
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MWWB^^\-0RN^JV-NES.GEG8BMC;\W3)R#B@# _P"%L?\ 4G>+/_!7_P#9T?\
M"V/^I.\6?^"O_P"SKO** .#_ .%L?]2=XL_\%?\ ]G1_PMC_ *D[Q9_X*_\
M[.NNUW6K3PWHM]JM_)Y5E90O<3.!DA5!)P.YXZ517Q=9S>#1XEMX;JZL&LOM
MT44,),\L>S> J=V(Q@>] '/_ /"V/^I.\6?^"O\ ^SH_X6Q_U)WBS_P5_P#V
M==7X>UE?$6B66I):75BMU$)1;WL8CFC![.H)P?;-:- '!_\ "V/^I.\6?^"O
M_P"SH_X6Q_U)WBS_ ,%?_P!G7>44 <'_ ,+8_P"I.\6?^"O_ .SH_P"%L?\
M4G>+/_!7_P#9UWE% '-^$?'-IXOFU"WBLK_3KJQ,8GM]1@$4B[P2IQD]0#72
M5P?A#_DJ7Q _[A__ *(:N\H **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BO%O'GQ4\;6?Q8_P"$,\):5I%_)]@6]W:@SJ>I#<AP/3M4_@OXS>(!X^M_
M!?CKP[%H>KWD32V5S9R^9!. "<=3CA6YW'D8(% 'L5%>8?!_Q[JWC#Q%\0+3
M5)HY+?1M9EL[0)&$VQ*[@ D=>%')KM1XV\.FZ6U&O:8;ECM$/VR/>3Z;=V:
M-JBN.^+7Q!7X8^!=0U\017D]N8Q%:R2^7YI:1$(!P3P&)X':KVE>/-(O_#L&
MJ2:A9QYLUNYHEN$8Q J"0>>Q./KB@#HZ*^??ACX^^(7Q2U2RUR+6_#^DZ!->
MX&BL UU) CX<="=VT'!R,GG %>WZAXHT;2;I+6]U:QL[E_NPW%RB.WT4G)H
MTZ*BFNH;6!IYI4BA4;FD=@J@>I)J%M6L4^SAKRW4W&/)S*O[W/3;SSGVH MT
M5G77B32;&&::YU2RMX87\N626X15C;^ZQ)X/!X/I3I/$&EQ::-1?4K1-/;I=
MM.HB/_ \X_6@"_15;3]3L]7M5N;&[@O;9ONS6\BR(?H0<57\1W&H6OA_49])
MBBGU.*WD>VAF!*/(%)53@@X)P.O>@#1HK@O@G\2F^*G@.WUF>**WOUEDM[N"
M#.Q)%.1C))Y4H>?6J/B/XG:C;_&3P_X(T>UM;A+BW:[U*>8,6@B&2 N" "=O
M<'[ZT >ET5XGJOQ8\:^+O&VMZ!\/-(TNXMM$817NHZL[;&ER040*P[AAWZ'I
MQ71_![XJ7?CYM:TG7-.32/$VBS"&]M8VS&P).'3))Q\I[GL<\T >DT45XO\
M&[]H=?AG'>Z?IFE7-YK4+1CSKJV;[$H8*W+A@6.TX '?Z8H ]HHJMIMTU[IM
MK<. KS1)(0O0$@&K- !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M'804*CIP5''IQ0!\X:QIOB6Z\,I?V^F_$E_B I2;^T)4V6@DW N@C63 CQD
M!?3(QQ7U?8-,]C;M<J%N#&IE4= V!D?G7F&B_#'QY;2V%OJ?Q,GO-)M)8W,-
MOIJ0SSJI!V/*&+ $#!ZDY.:]6H **** .#\(?\E2^('_ '#_ /T0U=Y7!^$/
M^2I?$#_N'_\ HAJ[R@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^:/'
MGB+5?"_[4?VW1_#\WB6\_L-4^PP3")MI)RVXJ>!@=N]=!X:\(>-/B-\6-+\:
M^+=(A\,:=HT3)9::)UFED9@>6([9;/./N@ =377?\*VU/_A?'_";>?:?V5_9
M?V'R=[>?OSG.-NW;_P "S[5Z30!X!\%+VRTW5?C7=ZE+Y&GPZW=27$AS\L8:
M8L>.>F>E>:W6C>%_$GA'4&\(?![4[O31#)Y6O75^T# J#^]7<6W8(SM!P<8K
MVGP[\$[V"Q^)]CJEY;K;>++V>XMY+1F9X4<N5+AE'S#<. 2.#S7+Z-\,_C)8
M>%?^$.37= LM$BA>W2^1'><Q'/R@%>,@XSC('>@#F->AC\5?L7:?JVJ*;S4=
M- 6UN)'8M'B]$/KS^[^7FO2=&^"/@BV^&KWD6@0K<WNBJ;B3S9,R?(DO][CY
MT5N/2K&B_!.\7]GL_#W4[RV6^:.4?:;8L\0<W#31GY@I(SMSP.]/^'_AGXF6
M&FR:)XFN]!FT>#3'LK>2S,AG=]H6-G)4# 4'/ /L: .!^ ?@_P /Z)\%X_'Z
M:3')XFT^VO[B.\+.3E/-4#;NV_=&.E7/@G\$_#/Q ^&L7B+Q1:OK>MZXTTT]
M[-,_F)B1D&T@\'Y<Y]3CH,5Z9\'_ (<W/@?X6VOA;6VM;R51.D_V5F:)TD=C
M@%E4_=;!XK@M%^&?Q6^&MC=>'O!^LZ'=^'I)':TFU17%Q9ACDX !7J<_Q G)
MP,XH Y'P[JM\W[.7Q+T"\NGO4T"YFL;:>3DF(,N%S[$''H"!T%=G\'OV?_"T
MWACPEXHU#[=J>MFVM+^*XN+I\0,JJ\:*H(&Q<  '/ K8T_X$S:%\$];\(65_
M%=:UJP>6XO[DLL<D[%<DX#$* H'0D]>]>B>!-"G\+^"= T>Z>.2YT^P@M97A
M)*%DC"DJ2 <9'<"@#YZ^%/PD\-?$3XA?$N]\0VDFHBSU^XCAMVF9(ANED)8A
M2"3QCDX]JK?"?X,>'/$7Q&\?:'JL=U?:'X>OE^P::]U(($\TR98@$$L!&HSG
MG'.:]E^%'PYU+P+KGC>]OY[6:+7-6DO[9;=V9DC9G(#Y48;YATR/>CX<_#G4
MO"'C[Q]KEY/:RVFOW,,UJD#L9$5/,R'!4 'YQT)Z&@#A_@7I$'@GXS?$CPMI
MF^+1H!;W$-NSEA&64'C//1\>N%&>E>_5YSX3^'.I:#\8/&/BN>>U?3M8B@CM
MXHW8RJ410=X*@#E3C!->C4 ?/WPVD3X7?'[QCX3F86^E:U'_ &Q8;CA5(RS@
M>@ ,@^D0JS^SK"_C3Q9XV^(]PIQJ=V;&P+#E;>/']!&/JAK5^/\ \%]6^)LV
MC:AX=OK73=8LEFMY)KF1XP\$BX*Y56.1DCIT=J[[X;^#H_ '@;1M C*LUG;A
M973[KRGYI&'L6+'\: /+OV5?^/7QX9<?:SX@F\WUZ#^NZCP)Q^U?\1?*QY/]
MG6^_;TW^7;__ &53ZE\+?'/@CQQKNN_#V_TEK+7'$UWINK!PJ39)+IM'/+,>
MHZXP<"ND^#OPLO\ P--K>M>(-0AU7Q/K<PENYX%(B0 G")D XY]!V&.* /2Z
M\<_:T_Y(GJG_ %\6_P#Z-6NC\$^%?%^C^/O%&I:UK:7^@WKDZ;9+/(YMUWDX
M*LH5>,#@FN7^-OP]^(OQ+AU#1-.N_#<'AB9HGB^U-.MV"H4G<51E^^#T[8H
M]9T'_D!Z=_U[1_\ H(J_7&?#6Q\;:?97%OXPFT281K$EF='\W[H!#>9O Y^[
MC'O79T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5II"2TBH[!23W.W SWQ7=6_PW^,6E^%V\%V>NZ ^@^6;6/5)%E%W';GC8!C
M.W@=<=F'!K;\:? 6:\^"%CX#\.W5NDUM+'*;F^9D61@S-(QVJQ!+,2!VZ9H
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH *YKXF?\ )-_%?_8)N_\ T2]=
M+61XOTB;Q!X3UO2[=D2>^L9[:-I"0H9XV4$X!.,GTH ^;_A%X_\ B%;?"/2-
M&\+> I+W;',EOK4]VBPDF5R6V,!G!)'WOX:@^)/PTF^%7[+9T>[FCGOY=3BN
MKEHB2@D8XVJ3U 55&?4&O?/@_P"#;WX?_#C1O#^H2P37EFL@DDM69HSNE=Q@
ML >C#M6=\=OAWJ/Q0\ 2Z'I<]K;W;7$4P>\9ECPI.1E58Y_"@#EOCUJ7@L2^
M&;#Q#H-[XKUI@[:=H]B7#/N"AF;:1Q\H]>AXZUY?HUM<>%?CEX$NK+P/<?#^
M'49)+:2!K_SUO$P V4Q\F-R\'@G:>HKUOXK_  K\2ZMXQ\/>,_!]]9P:]I-N
M;4P7^?*DC.[I@'G]XX(..HY&*QHOA1\2?$GQ \)^*/%6M:+*FDW#2'3[-718
M4.W[AV?,S8YW$8VC!.> # F^%_A?Q!^U-KFEZAI,=S83:2=1DA:1P&N'D0M)
MD-G)W-QTYZ4GQJ^%OA;3_B%\*M-MM(CBL;RZDL[B%9'Q)"K1%4)W9X+OTYYK
MN?B%\,_%Z_$RV\<>"+W38[\V7V&ZM-4#^7(N<@@J.?X>,C[HY.<5-X@^&OBO
MQ=JWPUU?5+O2_P"T- NI;G4O):14DW,A A&WG 3'S8H XSXL>#]-L_$OP^^&
M>D1-H_AC5+R6[OK>WD8>=MVG;N))[-QZE3V%5_CE\/\ 1?@O:>'?&?@^U_L7
M4+/48K>2."1REQ$P8E6!)S]W'N&.>U>G_&3X6W?Q AT?4=%U%=)\3:)/]HL+
MJ0$QY."4? /!*J<X/3&"":Y&X^%OQ!^)FN:,WQ!O]&@T'2K@7/\ 9^CB0FZD
M7H7W= 1GG/0D #.0 8?Q6\&6_C[]IS0]&O+NZM+.;P_NG^QR>6\B"2<F,G^Z
M>_M5#]H#X4>'?A_\.]%T[0;::Q@O_$=KYQ\]Y&SY,R[@6)P<&O6M1^'.I7GQ
MVTOQJD]J-+M=):P>%F;SS(6D.0-NW;AQ_%G@\4?&[X<ZE\2M#T2RTR>UMY;'
M5H;^1KMF53&BN"!M5OF^8=<#KS0!X[^T)\&?#/PQ^'=EK?AFWN-,UBSOHE%^
MEU(9GW!LDG=P<@'( QCBK7QT^!?A3X>_"B?6]$MKB#6]/G@E&I/<NTTC-(JD
MMSC.6SP!@CBO6?CQ\.=2^*/@)M$TJ>UM[LW,<V^\9E3:N<C*JQSSZ5;^-7@6
M_P#B/\-]2\/Z;-;P7MRT)22Z9EC&R57.2JL>BGM0!UFA7;W^AZ?<RG,DUO'(
MWU*@G^=>?_M&^"SXU^$^K11)OO; #4+;'7=&"6 ]RA<?4BO0=%LWTW1["TD*
MM);V\<3%>A*J <>W%7&4.I5@&4C!!Z&@#YI^(GQ2G\:_L^^%[.P?S=>\52Q:
M6R _,71@LQ^A8*/I)7T%X5\/V_A+PSIFC6O%O86R0*V,;MJ@%C[DY)^M>'?#
MO]FC4_"'Q0BU>\U"SN?#&G7%S<Z98I([21O)@+N4H%&% )(8\HM>D_&OPAXC
M\=>!Y=&\,ZE#I=W<3*)Y)Y'C5X,-N3<JL>3M[<@$>Q /,OB=X@N/V@/$4?P_
M\)MYFA6LZ3:UK2C,2A3Q&AZ,<]/5@,< FOH.RLXM/LX+6!=D$$:Q1KZ*HP!^
M0KP/P;\-OC#X!T&#2-$O?!5I9Q<GY)R\C=W=O*^9CZ_TXKN_'7A?Q[XF^&^G
MV&FZW9Z5XL62-[N\MII886P&#A2JEL$D<$=J .1_;"S_ ,*YT4-C[.=<M_.S
M_=\N7]*[3]H$1_\ "F/%?F8V?8^,^NY=OZXJYX_^'"?$;X<2>&]2N=EV\,9%
MXHW[)TP=_.,@D$'ID,>E>8:I\+/BSXXT*U\)>)==T2'P[&T8N;RR$C75S&A!
M .5 )R ?X>1GF@#U'X+^9_PJ3P?YOWO[+M\?[NP;?TQ7:56TW3[?2--M;"TC
M$5K:Q+!%&.BHH"J/R JS0 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 <;K/PQM-6UZ\U:'6M:TFYO!&)UTV\
M$*2;%VJ2-IZ#W_G57_A4_P#U./BS_P &G_V%=Y10!P?_  J?_J<?%G_@T_\
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MLC; 0HS@= 372444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445AVGBJ*[\6
M7NA"!UEM81,9B1M8$(< ?\#'Y4 ;E%%% !1110 4444 %%%% !1110 4444
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M>7G=CCKC%:E !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MW2M0M=3LV)5;BSF66,D'! 921P: +U%)N!8KD;AR1GFEH **** "O/\ 1O\
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M_LM^&?$OBGPO+=>(]0:]2;4X-2NHG^2ZFC0A%D\L$*JC[G;G/-7/V*O&^J?
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M7:!9^+_V,?VQO 'P^L/'FM>,O 7C1-ATW7)C/+:EF9 PYVJRLJMO4+E=P*\
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MAWX /\ _@?86^JQM_P )=KS?VMK<TO,OGR#*Q,3S^[7"GG[Q<_Q4 ?0E%%%
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M[%O[&FA_M&_ \>,=;\<^-M*UO^T;BT3^S-318%6,+M.UXV8GYCGYA^%>W_\
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MUO(I ^4AE; /3TC]N.^^/=MX)\8OX'E\+Z;\/K?0II]1OIFE&K[%C<W"1]4
M*# ( ;DX(.")OV=OV1_%OASXP7WQA^,/BRU\7?$.:%K:SBTU&6SL(V782A*I
MD["R!0B@!F/S%LCUG]JW_DV3XK?]BOJ/_I,] ''?\$_+F:\_8_\ AU-/*\\K
M076Z21BS'_3)QR37T-7SK_P3S_Y,Y^''_7O=?^ED]?15 !1110 4444 %%%%
M !1110 5B>-?!>C?$3PGJGAKQ#9_VAHFIP&WN[7S7B\R,]1N0AA]00:VZ* ,
M'P)X%T/X9^$=,\,>&['^S=#TV+R;2U\UY?+3);&]V9CR3U)J7QAX1TGQ]X5U
M7PYKUI]OT;5+=[6[MO,>/S8F&&7<A##([@@ULT4 ?/7AO_@G_P# 3PCXBTK7
M=)\!_9-5TN[BO;2X_MB_?RIHW#HVUIRIPR@X((..0:Z7XR?LD_"GX]ZI'JGC
M3PK'J.KQQ"%=0@N9K:;8,X4F-UW 9.-P.,U[!2;AD#/)Z4 >&_"/]B?X._!+
M7H]<\->$HQK<7^JU#4+B6[EA]XQ(Q5&[;E .#C-=[\7/@OX-^.OAB+P]XXT?
M^V]'BNDO$MOM4UOB9595;=$Z-P'88SCGI7;44 ,AA2WACBC7;'&H55] !@5Y
MIX-_9K^&_P ._B)JGCGPUX<_L7Q+JGF?;;BSO;E(9]Y#-NM_,\GEAN^YP>1S
MS7IU% 'BNF_L9?!K2?B.?'-IX'LXO$'VG[:K>=,;=+C)(E6W+^4&!.00O!Y&
M#S6KX7_9=^&/@SXH:A\0]'\+0VGBR]FEN)+W[1,RK+*")72(N8T9@S9*J#\S
M>ISZK10 4444 %%%% !7G_PW_P"1J\:?]?O_ +4EKT"O/_AO_P C5XT_Z_?_
M &I+0!Z!1110 4444 %%%% 'R?\ '?\ 8C\0?%;XZ#XG^&/BU>_#W5ET^.P0
M6&EF6554,&(E%Q&<,&Z8K'L_V+/C5;7D$TG[5WBB>..17:)M,DPX!R5/^F=Z
M^R** /CGQU^PIXJL?B]XD\>?"'XK7?PYG\32--JUA]E,\;RLQ9W4[AP69F"D
M94LV& .!/\+_ -@"[\ _'OPK\5M5^*FK^,-=TR*;^T!J]GYCWLLD,T(*2&4F
M)%65<(0_W#R <#Z_HH ^<OVG?V19?CIXN\+^./#/C.[\ ^//#J-#:ZM;0><K
MQ$LP1EWJ1@N_()!$C JP(QJ>$_V:=3UCX,^)? ?QA\:W/Q1&NW)G>^FM_LK6
MBA(PB0_,VTH\?F!@!RQXZY]YHH ^*=+_ &&_B_X'TL>'/!7[2>M:1X04E;>R
MN--\V:TCS\J)()1T_P!CRQ["OHG]GOX*GX$> I/#\WB74O%]_<WLNH7FL:J<
MS3S2!0QZDX^0=68^]>FT4 %%%% !1110 4444 %%%% !1110 4444 <3\:OA
MM_PN'X4>*/!7]H_V1_;=D]G]N\CSO)W8^;9N7=TZ;A]:^4_#/_!/_P"*_@W0
M;/1="_:B\0Z3I-FGEV]E::1(D42Y)PJB]P!DG\Z^XJ* /"/@/^SSXR^&H\2P
M>//BWJGQ7T[6+5;5;/5;1X4MU^<28S/)G>K8.,=*\2T+_@GW\1OAK=:GHWPV
M^/>K>$/ M_=-<G3ELR]Q!NP#M<2*"V !O783@9'%?<E% 'S-^S#^Q3;_ +,_
MQ&\5^*+;QI?>)X]=M4@,.I6H%PCA@[R/.'/F%FW'[BXSU.,GK/V>OV:_^%#>
M+OB?KG_"1_VY_P )MK+:O]G^P_9_L69)G\O=YC^9_KL;L+]WISQ[;10!XE^U
M=^S7_P -/>#- T#_ (2/_A&O[*UF+5_M'V'[5YNR.1/+V^8FW/F9W9/3IS7L
M6K:K::%I5[J6H3I:V%G"]Q<7$APL<:*69C[  G\*MUE>*?"^E^-O#NHZ#K=H
MM_I&H0M;W5J[,JRQMPRDJ0<$<'F@#X-_X)C_  GTO5_%WQ)^,UGI7]F:1J6I
M7.F^'+.0<V]J9?-DQ] 88P1_<D%?H/6%X)\#Z%\-_"]CX<\,Z9!H^B6*LMO9
M6X.R,,Q=L9)/+,Q)/<FMV@ HHHH **** "BBB@ KG/B3X/\ ^%A?#OQ3X5^U
M_8/[<TJZTS[7Y?F>3YT+1[]F1NV[LXR,XQD5T=% 'E_[-/P3_P"&=_@SH7@+
M^V?^$@_LQKAO[0^R_9O,\V>27_5[WQCS,?>.<9XSBMWXQ?"K1OC=\-->\$^(
M!*-+U:$1O) V)(G5@\<BD\;E=589X.,'(KLZ* /A[PW^P-\4;'1;;P;J7[0^
MN?\ "N;9?(72]+M3;SR6_P#SQ\PR'8N.,'>N.-N*]J_9/_9<3]EWX9ZYX03Q
M*WB1-2U.;41=M8_93$'ABBV;?,?=CRL[LC.[H,5[O10!XO\ LF_LX_\ #+OP
MNF\'?\)#_P )-YFHS:A]M^Q?9,;TC79L\R3IY?7=WZ54_:L_9;LOVFO#VA1I
MK]UX4\2>'[PWNDZU:Q^8T#G;N!7<IP2B$$,""BD'J#[G10!\V>#OV9_B*WPV
M^(_A?X@_&*Z\:R^+-).E6L\VF[(]+!CE1I53S?WA;S5)'RD^6.?3U#]G[X2_
M\**^#WAOP)_:O]M_V-%)%_:'V?[/YVZ5Y,^7O?;C?C[QZ5Z'10!XC\!?V:_^
M%(_$GXM^+/\ A(_[:_X3[5EU3[']A\C[#B6XD\O?YC>9_P ?&,X7[G3GCRSQ
M'^P3JWA?QYK/BOX*_%/4_A;)K#M-?:/':BYLI)"Q;*KO4*H).%*OMR0I XK[
M!HH ^<O@'^RSXJ^&OQ$F\=>.OBUK7Q(UYK"73X(;N(PVMM'(\;OL0R/@YC7[
MNT>H-=!\'?V:_P#A4WQH^*/C_P#X2/\ M7_A-[B.X_L_[#Y/V+:SMCS/,;S,
M[^NU>E>VT4 <+\:?@SX9^/GP^O\ P?XKMI)M,NBLBRP,$FMY5.4EC8@[6'/8
M@@D$$$BOF2P_8C^-7AO28O#?A_\ :;UNP\*PKY<$3:83<V\8^[&D@GW8 X&&
M4#' %?:M% '@]K^R)X<N?V:YO@[X@U?4O$5A.TL\NM73+]L-R\[3^>"<X8.W
M?.1D$G)SXGI/_!/GXCS:"G@WQ!^T/X@O/A[!%]G32+"V:%Y8<86)F:9@$''R
MG>,#  [?<E% 'CW[*O[/?_#,OPIC\%_V_P#\))MO9KS[=]C^RY\S;\NSS'Z;
M>N[G->PT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110!\\?\,\>(_^&V?^%P_;=+_X1G_A'_[)^R>;)]L\W'WMGE[-
MOOOS[5]#T44 ?.'@G]F_Q+X;_;@^('QDN;[2I/#'B#1(M-M;2&64WJ2+'9*2
MZ&,(%S:R<AR>5XY./-/BA^RO\=X_VK/%OQ=^%7BKPAH?]M64%@@UAIGF$2P6
MZ.&3[-(@R]N"""3C'3)%?;5% 'QM:_#_ /;=6ZA-Q\2_AR\ =3(JVSY*YY _
MT'KBNZ^/G[-_B7XI_M%?!WQ]I5]I5OH_@ZY::_@O)95N)5,B/^Z58V4G"G[S
M+7T?10!Y3^TE^SKX;_:6^'%UX8UY!!=)F;3=4C0&6QN,8#KZJ>C+G##T(!&1
M^R?X$^*WPO\ AVOA3XGZOH?B$Z9MATK5-+NIY9VMP"!'.)84Y3 "L"20<'[N
M6]MHH ^!/C-^R[^U/\<-4\,7GB#Q1\,\^&M1_M+31;->1XD#*1O_ -&.X?(O
M'UKZ&\*^+?B;\'_A+XV\5_'#5/"^I2:/!)?6I\,"5$,21D^6WF(OSL^%& ?O
M"O=:RO%'A31O&^@W6B>(=*L]:T>ZVB>QOX5FAEVL&7<C @X95(SW H ^9/\
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M_<XQC^-/6OO_ .*GQ(TCX0_#O7_&.NR>7IFCVK7,@! :1APD:Y_B=BJCW84
M?F?\9OV6]&\$_M'?#?X5_#7QAXQUKQ5J5PE]J\FKZFDT&GV:G=N(CB0[MJ2.
M03T"C'SBO7/V^O#/_"POVJ/@3X-N=6U32]*UP2VMT^EW/DRA6E7)4D%=WN5-
M=?\ \$]?AWJ_BAO%G[0'C6/?XL\=W#_80X/^C:>'X"9Y"L450/[D,9'WJXC]
MO^T\37_[6GP"M_!M[9Z;XID$JZ==Z@I:WBF\Y=K. K97_@)H Q_VD_V5=2_8
M_P#AM<_%/X7_ !6\96MYHES;FXL=8OUGCN4DF2(* B(K ,ZDHZL" ?2ON[X-
M^-I_B1\)?!GBNZ@6VNM;T>TU":% 0J/+"KL%R3\N2<>V*_-SX_+\3[?XQ>!O
M!G[5'C%YOA9J5P)Q?>%8D@L))0" LK^4C *Q7=N!*JVY?4?J-H=A8:5HNGV6
ME10P:7;6\<-I%;X\M(54! N/X0H&/:@"]1110 5Y_P##?_D:O&G_ %^_^U):
M] KS_P"&_P#R-7C3_K]_]J2T >@5\,_\%4GN9/"7PNLH+ZZL([[Q(+:62SF,
M;[&CP>1WY[YK[FKX:_X*E?\ (%^#W_8V1_\ H(H T=2_X)FZ?I,!N/!'QB^(
M/AS68_F@NKG45G1&'<K$L+?DU6_V2/V@?'^F?&#Q%\!/C)<1:AXQTB$W.F:Y
M& /[0@ #8) &\E&5U; . X?YEY^R:^ KS48_B'_P5KT6707CNK?PGH4L&J3V
MS!U5A;3HP8CNLEU%&1V(QU% 'K?PMTSX=V_[<GQ1GTC7/$EU\0/[)3^U=,O%
M3^S(87%HP:$@;BW$74_Q/5WXK_\ !03X4_"CQG>^%)'UKQ1KUBQ2\M?#EB+G
M[,X^\K,SHI*]PI.#D'!!%><_!+_E*!\=_P#L 6O_ *+L*X;PQX-^/W[$_P 2
M_B#?^&/AQ;_%3P;XEU)M1^U6,V+[&]V53MS(& D(8&-U)&5/7(!]<_L^_M1>
M!/VF+#5KCP9=7K3Z2T2W]GJ%HT$L'F[_ "\]5;/E/]UCC;SC(SY[\3/^"B?P
M@^&OBJ]\._:=7\5:G8L4NU\-V0N8[=E.&#2,Z*2O?:3CIU!%<=X0_:N\-_%G
MX/?'77_#'A"X\!_%/1O#]S+J]G-"J79DB@G\F0RA5:3RF,@^9593QCD5O_\
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MY,_9:\16?[(_[0?QJ^$6OW/V'PG%%+XMT660_*MLD>^0+_>;R-H/O;/74_\
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M\EI3&=K,HR<KNRN?53Z5\$?$[]JK4?CI^QC\-? NA7'VOXA^.KZ/PSJ$:O\
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M%OAW#_PCVB,>4:Y^='=3T89-RV?^FL1]*\G^#6O?%O5/VN?V@?$W@;P7X?\
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MQ_\ XF@#W&BO#O\ AM_X$?\ 13M#_P"_C_\ Q-'_  V_\"/^BG:'_P!_'_\
MB: /<:*\._X;?^!'_13M#_[^/_\ $T?\-O\ P(_Z*=H?_?Q__B: /<:*\._X
M;?\ @1_T4[0_^_C_ /Q-'_#;_P "/^BG:'_W\?\ ^)H ]QHKP[_AM_X$?]%.
MT/\ [^/_ /$T?\-O_ C_ **=H?\ W\?_ .)H ]QHKP[_ (;?^!'_ $4[0_\
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M?_?Q_P#XF@#W&BO#O^&W_@1_T4[0_P#OX_\ \31_PV_\"/\ HIVA_P#?Q_\
MXF@#W&BO#O\ AM_X$?\ 13M#_P"_C_\ Q-'_  V_\"/^BG:'_P!_'_\ B: /
M<:*\._X;?^!'_13M#_[^/_\ $T?\-O\ P(_Z*=H?_?Q__B: /<:*\._X;?\
M@1_T4[0_^_C_ /Q-'_#;_P "/^BG:'_W\?\ ^)H ]QHKP[_AM_X$?]%.T/\
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MX_\ \31_PV_\"/\ HIVA_P#?Q_\ XF@#W&BO#O\ AM_X$?\ 13M#_P"_C_\
MQ-'_  V_\"/^BG:'_P!_'_\ B: /<:*\._X;?^!'_13M#_[^/_\ $T?\-O\
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MT?\ #;_P(_Z*=H?_ '\?_P")H ]QHKP[_AM_X$?]%.T/_OX__P 31_PV_P#
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M6=ZTC7C0&-1$!M3[-P<0)SGU]:^C?^&W_@1_T4[0_P#OX_\ \31_PV_\"/\
MHIVA_P#?Q_\ XF@#N]3\!S_$;X-OX0\?&VN[[5M%6PUJ33,B$W#PA9I(-PR
M'RR$C(PO%?(OAC]GG]K'X.^%9OAYX$\>^$;SP:#-%IVJZD)4O;"%R3P/*;:>
M20!Y@4G@@8KW_P#X;?\ @1_T4[0_^_C_ /Q-'_#;_P "/^BG:'_W\?\ ^)H
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M*=H?_?Q__B: /'-0^#/[9OC"%M/UCXS>$O#^FS?)-/X?M7^TJO<HWV:-@?\
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M:>&M6\"7URUS;Z5XJ20363MP<%4(. %R0PW8SL!SGW3_ (;?^!'_ $4[0_\
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M7Q'^SKX=\:V'B2^TN^FUK7Y=5MVTN6215B9%4!]\:8;*G@9'O6Q_PV_\"/\
MHIVA_P#?Q_\ XFC_ (;?^!'_ $4[0_\ OX__ ,30!ZSXR_L?_A$=<_X2'R?[
M ^PS_P!H_:/]7]F\MO-W?[.S=GVKX!_X)/?!&SLQXR^*?D3?9+J>31M!:Z4"
M7[,KAY9#CC)(B3([QR#O7OGQ/_:;_9V^+/@+6?".L?%73[?2M6A$%RUA=-%,
M8]P+*&V' 8#:>.02.].^&?[37[-OPD\!Z-X0\.?$;1;;1M)@\BW1YG9SR69F
M.WEF8LQ/<DT ?3%%>'?\-O\ P(_Z*=H?_?Q__B:/^&W_ ($?]%.T/_OX_P#\
M30![C17AW_#;_P "/^BG:'_W\?\ ^)H_X;?^!'_13M#_ ._C_P#Q- #?VS/@
M9KW[1/P-O_!GAN[TZRU2>\M[A9M4DDC@"QON8$HCMG'3Y:\5T_X*_MGP>'['
M0(_BQX%T72[6V2S233K9GG6)%"##/9@[L <@@^]>V?\ #;_P(_Z*=H?_ '\?
M_P")H_X;?^!'_13M#_[^/_\ $T 8?[,G[&.C_ +7-4\7ZQKUYX[^(FK!A=^(
M=24AE#$%Q&I9B"Q R[,6( ' R#)XF_9U\1ZU^VWX2^,4%[I:>&=(T!]*GM))
M9!>-*PN@"J",H5_?IR7!X;CIG8_X;?\ @1_T4[0_^_C_ /Q-'_#;_P "/^BG
M:'_W\?\ ^)H X?XG?#?]IK0OBQXA\3_"_P <^']1\+ZJ\4J^&?$WFE;1EB1"
M(OD;:I*,QVN@RQX)YJE\&_V7?B1JGQ_LOC1\:O$FC:CXFTJQ>PTG2O#L3+;V
MZ,LBY=V52<":;"X;EP=W %>B_P##;_P(_P"BG:'_ -_'_P#B:/\ AM_X$?\
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M Z?X,\+?$7X?:3H5BTK0?NI;B5/,D:1^9+(Y^9V/->A_!G]A:[TKXG6GQ/\
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M@@ &6*J_)5(P5*X)16!5AD^@_P##;_P(_P"BG:'_ -_'_P#B:/\ AM_X$?\
M13M#_P"_C_\ Q- ''_"?X?\ [2VK?%;0?$WQ3\;>'K+PQI/GL?#/AE9 MZ[P
M21*9B57(4NK@,SC*#"@\UQ-U^RO\9?@#\2/%'B#]G_Q#X=_X1GQ).;N[\+^(
MT=8[:8L3F(JI!4;FP=R$ A2&V@U[-_PV_P# C_HIVA_]_'_^)H_X;?\ @1_T
M4[0_^_C_ /Q- '%_LY?LJ^+?#/Q9UGXP?%[Q'8^*/B+?P&TM8M,0BSTZ$@#$
M995.[:-F H !;EBQ-=3^VA^S?=_M+?">+1=$O+33/%6F7\.H:3?WDCQQQR*=
MKAG169049CP#\RIZ9%O_ (;?^!'_ $4[0_\ OX__ ,31_P -O_ C_HIVA_\
M?Q__ (F@"S^R'^S^W[-OP3TSPG=SVUYKCS2WVJWEF6:*>YD;JI958A46- 2
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M /$UYA\)_BM^RW\'/%7C'Q+HGQ-L;G7/%=U]KU.^U&\::1FWN^U#L&U=TC'
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M7QC_ -%"T/\ \ YJ/^'.OC'_ **%H?\ X!S5^J=% 'Y6?\.=?&/_ $4+0_\
MP#FH_P"'.OC'_HH6A_\ @'-7ZIT4 ?E9_P .=?&/_10M#_\  .:C_ASKXQ_Z
M*%H?_@'-7ZIT4 ?E9_PYU\8_]%"T/_P#FH_X<Z^,?^BA:'_X!S5^J=% 'Y6?
M\.=?&/\ T4+0_P#P#FH_X<Z^,?\ HH6A_P#@'-7ZIT4 ?E9_PYU\8_\ 10M#
M_P# .:C_ (<Z^,?^BA:'_P" <U?JG10!^5G_  YU\8_]%"T/_P  YJ/^'.OC
M'_HH6A_^ <U?JG10!^5G_#G7QC_T4+0__ .:C_ASKXQ_Z*%H?_@'-7ZIT4 ?
ME9_PYU\8_P#10M#_ / .:C_ASKXQ_P"BA:'_ . <U?JG10!^5G_#G7QC_P!%
M"T/_ , YJ/\ ASKXQ_Z*%H?_ (!S5^J=% 'Y6?\ #G7QC_T4+0__  #FH_X<
MZ^,?^BA:'_X!S5^J=% 'Y6?\.=?&/_10M#_\ YJO:)_P1WU]=4A.L>/]-ET[
MYO-6QMI$F/RG;M+ @?-C.1TS7ZBT4 ?E=XC_ ."9WASP[K-QITGB;5)GAVY=
M9(P#E0W_ #R]ZS?^'=/AG_H8=6_[^Q?_ !JON?XH?\CUJ?\ VR_]%)7*U]91
MR_#SI1E):M+J? XG-L73KSA&6B;6R[GR%_P[I\,_]##JW_?V+_XU1_P[I\,_
M]##JW_?V+_XU7U[16W]FX;^7\6<W]M8W^;\$?(7_  [I\,_]##JW_?V+_P"-
M4?\ #NGPS_T,.K?]_8O_ (U7U[11_9N&_E_%A_;6-_F_!'R%_P .Z?#/_0PZ
MM_W]B_\ C5'_  [I\,_]##JW_?V+_P"-5]>T4?V;AOY?Q8?VUC?YOP1\A?\
M#NGPS_T,.K?]_8O_ (U1_P .Z?#/_0PZM_W]B_\ C5?7M%']FX;^7\6']M8W
M^;\$?(7_  [I\,_]##JW_?V+_P"-4?\ #NGPS_T,.K?]_8O_ (U7U[11_9N&
M_E_%A_;6-_F_!'R%_P .Z?#/_0PZM_W]B_\ C5'_  [I\,_]##JW_?V+_P"-
M5]>T4?V;AOY?Q8?VUC?YOP1\A?\ #NGPS_T,.K?]_8O_ (U1_P .Z?#/_0PZ
MM_W]B_\ C5?7M%']FX;^7\6']M8W^;\$?(7_  [I\,_]##JW_?V+_P"-4?\
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M=% 'YR?\.?=&_P"ATOOS3_XU1_PY]T;_ *'2^_-/_C5?HW10!^<G_#GW1O\
MH=+[\T_^-4?\.?=&_P"ATOOS3_XU7Z-T4 ?G)_PY]T;_ *'2^_-/_C5'_#GW
M1O\ H=+[\T_^-5^C=% 'YR?\.?=&_P"ATOOS3_XU1_PY]T;_ *'2^_-/_C5?
MHW10!^<G_#GW1O\ H=+[\T_^-4?\.?=&_P"ATOOS3_XU7Z-T4 ?G)_PY]T;_
M *'2^_-/_C5'_#GW1O\ H=+[\T_^-5^C=% 'YR?\.?=&_P"ATOOS3_XU1_PY
M]T;_ *'2^_-/_C5?HW10!^<G_#GW1O\ H=+[\T_^-4?\.?=&_P"ATOOS3_XU
M7Z-T4 ?G)_PY]T;_ *'2^_-/_C5'_#GW1O\ H=+[\T_^-5^C=% 'YR?\.?=&
M_P"ATOOS3_XU1_PY]T;_ *'2^_-/_C5?HW10!^<G_#GW1O\ H=+[\T_^-4?\
M.?=&_P"ATOOS3_XU7Z-T4 ?G)_PY]T;_ *'2^_-/_C5'_#GW1O\ H=+[\T_^
M-5^C=% 'YR?\.?=&_P"ATOOS3_XU1_PY]T;_ *'2^_-/_C5?HW10!^<G_#GW
M1O\ H=+[\T_^-4?\.?=&_P"ATOOS3_XU7Z-T4 ?G)_PY]T;_ *'2^_-/_C5'
M_#GW1O\ H=+[\T_^-5^C=% 'YR?\.?=&_P"ATOOS3_XU1_PY]T;_ *'2^_-/
M_C5?HW10!^<G_#GW1O\ H=+[\T_^-4?\.?=&_P"ATOOS3_XU7Z-T4 ?G)_PY
M]T;_ *'2^_-/_C5'_#GW1O\ H=+[\T_^-5^C=% 'YR?\.?=&_P"ATOOS3_XU
M1_PY]T;_ *'2^_-/_C5?HW10!^<G_#GW1O\ H=+[\T_^-4?\.?=&_P"ATOOS
M3_XU7Z-T4 ?G)_PY]T;_ *'2^_-/_C5'_#GW1O\ H=+[\T_^-5^C=% 'YR?\
M.?=&_P"ATOOS3_XU1_PY]T;_ *'2^_-/_C5?HW10!^<G_#GW1O\ H=+[\T_^
M-4?\.?=&_P"ATOOS3_XU7Z-T4 ?G)_PY]T;_ *'2^_-/_C5'_#GW1O\ H=+[
M\T_^-5^C=% 'YR?\.?=&_P"ATOOS3_XU1_PY]T;_ *'2^_-/_C5?HW10!^<G
M_#GW1O\ H=+[\T_^-4?\.?=&_P"ATOOS3_XU7Z-T4 ?G)_PY]T;_ *'2^_-/
M_C5'_#GW1O\ H=+[\T_^-5^C=% 'YR?\.?=&_P"ATOOS3_XU1_PY]T;_ *'2
M^_-/_C5?HW10!^<G_#GW1O\ H=+[\T_^-4?\.?=&_P"ATOOS3_XU7Z-T4 ?G
M)_PY]T;_ *'2^_-/_C5'_#GW1O\ H=+[\T_^-5^C=% 'YR?\.?=&_P"ATOOS
M3_XU1_PY]T;_ *'2^_-/_C5?HW10!^<G_#GW1O\ H=+[\T_^-4?\.?=&_P"A
MTOOS3_XU7Z-T4 ?G)_PY]T;_ *'2^_-/_C5'_#GW1O\ H=+[\T_^-5^C=% '
MYR?\.?=&_P"ATOOS3_XU1_PY]T;_ *'2^_-/_C5?HW10!^<G_#GW1O\ H=+[
M\T_^-4?\.?=&_P"ATOOS3_XU7Z-T4 ?G)_PY]T;_ *'2^_-/_C5'_#GW1O\
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M\:H_X=T^&?\ H8=6_P"_L7_QJOKVBC^S<-_+^+#^VL;_ #?@CY"_X=T^&?\
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M^S<-_+^+#^VL;_-^"/D+_AW3X9_Z&'5O^_L7_P :H_X=T^&?^AAU;_O[%_\
M&J^O:*/[-PW\OXL/[:QO\WX(^0O^'=/AG_H8=6_[^Q?_ !JC_AW3X9_Z&'5O
M^_L7_P :KZ]HH_LW#?R_BP_MK&_S?@CY"_X=T^&?^AAU;_O[%_\ &J/^'=/A
MG_H8=6_[^Q?_ !JOKVBC^S<-_+^+#^VL;_-^".W_ &._A19_!CX+6WAJQNI[
MRWCO;B<2W!4MEV!(X4#]*]OKB_A'_P B='_UVD_G7:5\KB(*G5E".R9]YA*D
MJN'A4GNT@KYAKZ>KYCVUZN5_;^7ZGS?$'_+KY_H-HIVVC;7O7/D!M%.VT;11
M<!M=/\,_^1VTW_MI_P"BGKFAA@"#D5T_PT'_ !6VF_\ ;3_T4]<^(?[F?H_R
M.S!_[S2_Q+\T>ZT445\8?J04444 %%%% !1110 4444 %%%% !1110 4444
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MX"_Y$[2O^N(_F:WZ^ K?Q9>K/UK"_P "GZ+\@HHHK$Z0HHHH **** "BBB@
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M_L\_#'3/!>@2SW-K:EY9;NZ(\VXF<Y>1L<#)X '0 #GK7HE% !1110 4444
M%%%% !1110 4444 %%%% !1110!X'\4/^1ZU/_ME_P"BDKE:ZKXH?\CUJ?\
MVR_]%)7*U][AOX$/1?D?E.-_WJK_ (G^84445T'$%%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 5WOB+_D9O%G_8,A_]MZX*N]\1?\C-XL_[!D/_
M +;UXN8?Q:/K^J/I<I_@8G_#^C."HHHKVCYH**** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH ^A_ 7_(G:5_UQ'\S6_6!X"_Y$[2O^N(_F:WZ
M^ K?Q9>K/UK"_P "GZ+\@HHHK$Z0HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MFPHHHKVCYH**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KWW2_\
MDFL7_8,/_HLUX%7ONE_\DUB_[!A_]%FO%S/X:?J?2Y)\57_">!4445[1\T%%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >Y?"/_ )$Z/_KM
M)_.NTKB_A'_R)T?_ %VD_G7:5\+B_P#>)^K/U3+_ /=*7H@KYSVU]&5\Z[37
M1@W\7R/%SS_EW\_T.<^(VC6_B#X?>)]+NKY-+MKW2[JVEOI&"K;H\3*9"21@
M*"3U[5\M:3X)^*'B;1->\/0^#-+M=*\3Z+I>CCQ';:M!-I\=K DBM<PQK\[B
M1) R+@8.,G%?6GBC2I-<\,ZOIT2V[RWEG-;JMTK-"2Z%0'"D$KSS@@XS@U\^
M^"9?B7X1\)0:'8?$CX97UEX=BAT^6>Y29Y+<?<B29EG 5CMVC(!.WN<UU5-6
MKGD8:3C!I6O=;W_3SMN?1]K:K:VT4"%BD:! 6.3@#'-?%7[37PCTV\^--S<:
ME\2?#_AKPSXCEL+[6])U"Z$=VQMD:)&C0*<@H7QDJ-S'.<"OMM5;:-V"V.<=
M*^!?CI?>#/#O[57C.]\;>!]8\;Z?-8V:V\=OO"6\PACSMPP#*5QU/#%N.]+$
M-<JOW+R[F]K)Q?3I;NN_W_(^A/V3]/@.E>/-:AU;1]3&M^)KF_":'<>?!;*R
M1E8RVT?. >>.A%?3'P\'_%8:?_VT_P#1;5\Z?LIZUX0U[P%J<_@OP?>>"],7
M4W26QO<[Y)?*B)D&6;@J5'7^$U]&?#T?\5AI_P#VT_\ 1;47_<OT8E?Z]&Z^
MTOT/:****\,^^"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** .0U[X8Z7XBU:?4+FXO$FFV[EB=
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M1P/_  I?1/\ GZU#_OXG_P 11_PI?1/^?K4/^_B?_$5WU%'UW$?SL/[-P?\
MS[1P/_"E]$_Y^M0_[^)_\11_PI?1/^?K4/\ OXG_ ,17?44?7<1_.P_LW!_\
M^T<#_P *7T3_ )^M0_[^)_\ $4?\*7T3_GZU#_OXG_Q%=]11]=Q'\[#^S<'_
M ,^T<#_PI?1/^?K4/^_B?_$4?\*7T3_GZU#_ +^)_P#$5WU%'UW$?SL/[-P?
M_/M' _\ "E]$_P"?K4/^_B?_ !%<WX@MU;QGXMAR=O\ 9T:Y[\&WKV*O(M>_
MY'OQ;_UX1_SMZGV]6K.+G*]F$\+1P]"I[*-KI_DSC/[)A_O/^8_PH_LF'^\_
MYC_"KM%>U[>K_,? >SAV*7]DP_WG_,?X4?V3#_>?\Q_A5VBCV]7^8/9P[%+^
MR8?[S_F/\*/[)A_O/^8_PJ[11[>K_,'LX=BE_9,/]Y_S'^%']DP_WG_,?X5=
MHH]O5_F#V<.Q2_LF'^\_YC_"C^R8?[S_ )C_  J[11[>K_,'LX=BE_9,/]Y_
MS'^%']DP_P!Y_P Q_A5VBCV]7^8/9P[%+^R8?[S_ )C_  H_LF'^\_YC_"KM
M%'MZO\P>SAV*7]DP_P!Y_P Q_A1_9,/]Y_S'^%7:*/;U?Y@]G#L4O[)A_O/^
M8_PH_LF'^\_YC_"KM%'MZO\ ,'LX=BE_9,/]Y_S'^%']DP_WG_,?X5=HH]O5
M_F#V<.Q['X5/V/P79%.3';DC=[9-<;_PM+5?^?>S_P"^'_\ BJ['P_\ \B3;
M_P#7JW\C7CM>53BIRDY*^I]1C:]6A2HJG*VG^1V/_"TM5_Y][/\ [X?_ .*H
M_P"%I:K_ ,^]G_WP_P#\57'45T>QAV/)^O8G^=G8_P#"TM5_Y][/_OA__BJ/
M^%I:K_S[V?\ WP__ ,57'44>QAV#Z]B?YV=C_P +2U7_ )][/_OA_P#XJC_A
M:6J_\^]G_P!\/_\ %5QU%'L8=@^O8G^=G8_\+2U7_GWL_P#OA_\ XJC_ (6E
MJO\ S[V?_?#_ /Q5<=11[&'8/KV)_G9V/_"TM5_Y][/_ +X?_P"*H_X6EJO_
M #[V?_?#_P#Q5<=11[&'8/KV)_G9V/\ PM+5?^?>S_[X?_XJC_A:6J_\^]G_
M -\/_P#%5QU%'L8=@^O8G^=G8_\ "TM5_P"?>S_[X?\ ^*H_X6EJO_/O9_\
M?#__ !5<=11[&'8/KV)_G9V/_"TM5_Y][/\ [X?_ .*H_P"%I:K_ ,^]G_WP
M_P#\57'44>QAV#Z]B?YV=C_PM+5?^?>S_P"^'_\ BJ/^%I:K_P ^]G_WP_\
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MC^R8?[S_ )C_  J[11[>K_,'LX=BE_9,/]Y_S'^%>V:=$%^'T<?.W^SROO\
M<->05[%I_P#R(<?_ %X'_P! -<.*J3FH\SZGO93&,95++H>(?V3#_>?\Q_A1
M_9,/]Y_S'^%7:*[O;U?YCP?9P[%+^R8?[S_F/\*/[)A_O/\ F/\ "KM%'MZO
M\P>SAV*7]DP_WG_,?X4?V3#_ 'G_ #'^%7:*/;U?Y@]G#L4O[)A_O/\ F/\
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MBMXE^+OA/Q9JOBC?%=VWB*YM(+*6)(WLH1'$RP-M12Q0NP+,-QQS7TQ\/?\
MD;[#_MI_Z+:N.T;PYI/AT7@TK3+/3!>7#7=S]C@2+SYFQNE?:!N<X&6/)Q79
M_#__ )&ZP_[:?^BVI2NJ33?0TI2C/%PE!67,M/FCV2BBBO%/OPHHHH ****
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M2UY37JWPQ_Y%MO\ KNW\EKFQ'P'LY3_O/R9UM%%%>6?:!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !7A5Y_R$O%/_ &%!_P"A3U[K7A5Y_P A+Q3_
M -A0?^A3UM1_B(\_'_[K/T*-%%%>N?!!1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% 'L7C_ /Y%&_\ ^V?_ *,6O':]B\?_ /(HW_\ VS_]
M&+7CM<F&^!^I[N<?[Q'T_5A11176>$%%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 5[%I_\ R(<?_7@?_0#7CM>Q:?\ \B''_P!>!_\ 0#7)B-EZ
MGNY5\53T/':***ZSP@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110![%X__ .11O_\
MMG_Z,6O':]B\?_\ (HW_ /VS_P#1BUX[7)AO@?J>[G'^\1]/U84445UGA!11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %>Q:?_R(<?\ UX'_ - -
M>.U[%I__ "(<?_7@?_0#7)B-EZGNY5\53T/':***ZSP@HHHH **** "BBB@
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MAO+U/=S+^'1]/\@HHHKK/""BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M /(AQ_\ 7@?_ $ UR8C9>I[N5?%4]#QVBBBNL\(**** "BBB@ HHHH ****
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MN;;5O"VF^&/$?A/4)M%NK"P@1(8)$ R80"=BG<00"1D'D@BOHKP&/^*KL?\
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M%MO^N[?R6N;$? >SE/\ O/R9UM%%%>6?:!1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !7A5Y_R$O%/_84'_H4]>ZUX5>?\A+Q3_P!A0?\ H4];4?XB
M//Q_^ZS]"C1117KGP04444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M DCG@@\X !]@45\W?LO_ !\\6^,/'WCCX8?$5='N?&/A40W*:MH)/V34;64
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M%% !1110 4444 %%%% !7D^J?\E"\5_]>$?_ +0KUBO)]4_Y*%XK_P"O"/\
M]H5RXK_=ZGH_R%+9F91117YB<84444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110!ZAHO\ R*</_7NW\C7E]>H:+_R*</\ U[M_(UY?7T.:_P .
MA_A_R-9[(****^>,@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MO1O '_(";_KLW\A7G->C> /^0$W_ %V;^0KW<F_WKY,TI_$=+1117W9TA111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 <'\1O^/VS_P"N9_G7
M(5U_Q&_X_;/_ *YG^=<A7YUF?^]U/ZZ(Y9_$PHHHKS" HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** -'P[_R';#_ *[+_.LU/^0MXK_["8_]"FK2
M\._\AVP_Z[+_ #K-3_D+>*_^PF/_ $*:OH<)_P B^O\ UV-(_ Q:***^>,PH
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#U#QI_R+5Y_P
M_P#0UKR^O4/&G_(M7G_ /_0UKR^OH<\_WF/^%?FS6IN%%%%?/&04444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !7J%E_R)Z?]>9_] KR^O4++_D3T
M_P"O,_\ H%?0Y/\ %4_PFE/=GE]%%%?/&84444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110!Z3X$_Y%]/^NC5T5<[X$_Y%]/\ KHU=%7Z5@?\
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MT*]8KR?5/^2A>*_^O"/_ -H5RXK_ '>IZ/\ (4MF9E%%%?F)QA1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% 'J&B_\ (IP_]>[?R->7UZAH
MO_(IP_\ 7NW\C7E]?0YK_#H?X?\ (UGL@HHHKYXR"BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH *]&\ ?\@)O^NS?R%><UZ-X _Y 3?]=F_D*]W)
MO]Z^3-*?Q'2T445]V=(4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MC_A7YLUJ;A1117SQD%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M&\=3NTEC83")LQR0D';*V0-[ECP"<@[D^O\ ]C'QOXP^)/[-_A'Q1XZO#?\
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MR-9[(****^>,@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O1O
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MAVP_Z[+_ #K-3_D+>*_^PF/_ $*:OH<)_P B^O\ UV-(_ Q:***^>,PHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#U#QI_R+5Y_P  _P#0
MUKR^O4/&G_(M7G_ /_0UKR^OH<\_WF/^%?FS6IN%%%%?/&04444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !7J%E_R)Z?]>9_] KR^O4++_D3T_P"O
M,_\ H%?0Y/\ %4_PFE/=GE]%%%?/&84444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110!Z3X$_Y%]/^NC5T5<[X$_Y%]/\ KHU=%7Z5@?\ =J?H
MCKCL@KQ':*]NKD[KP#IUXOF6D[P!NF")$_Q_6N+,L-5Q')[+I?\ 0RJP<[6/
M/=HHVBNCOO FIVN3$J72?],VP?R-8-Q:S6<GESQ/"_\ =D4@U\I5IU:/\2+1
MRN#6Y%M%&T45;L]+O-0Q]GMI)AG&Y5./SZ5C%RD[1U8N4J;16WX*'_%36?\
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MZ]V_D:\OKU#1?^13A_Z]V_D:\OKZ'-?X=#_#_D:SV04445\\9!1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %>C> /\ D!-_UV;^0KSFO1O '_("
M;_KLW\A7NY-_O7R9I3^(Z6BBBONSI"BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MG_\ X3+]H?\ Z$3P_P#]_P!/_DNC_A,OVA_^A$\/_P#?]/\ Y+KZ HH ^?\
M_A,OVA_^A$\/_P#?]/\ Y+H_X3+]H?\ Z$3P_P#]_P!/_DNOH"B@#Y__ .$R
M_:'_ .A$\/\ _?\ 3_Y+H_X3+]H?_H1/#_\ W_3_ .2Z^@** /G_ /X3+]H?
M_H1/#_\ W_3_ .2Z/^$R_:'_ .A$\/\ _?\ 3_Y+KZ HH ^?_P#A,OVA_P#H
M1/#_ /W_ $_^2Z/^$R_:'_Z$3P__ -_T_P#DNOH"B@#Y_P#^$R_:'_Z$3P__
M -_T_P#DNC_A,OVA_P#H1/#_ /W_ $_^2Z^@** /G_\ X3+]H?\ Z$3P_P#]
M_P!/_DNC_A,OVA_^A$\/_P#?]/\ Y+KZ HH ^?\ _A,OVA_^A$\/_P#?]/\
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MG_\ X3+]H?\ Z$3P_P#]_P!/_DNC_A,OVA_^A$\/_P#?]/\ Y+KZ HH ^?\
M_A,OVA_^A$\/_P#?]/\ Y+H_X3+]H?\ Z$3P_P#]_P!/_DNOH"B@#Y__ .$R
M_:'_ .A$\/\ _?\ 3_Y+H_X3+]H?_H1/#_\ W_3_ .2Z^@** /G_ /X3+]H?
M_H1/#_\ W_3_ .2Z/^$R_:'_ .A$\/\ _?\ 3_Y+KZ HH ^?_P#A,OVA_P#H
M1/#_ /W_ $_^2Z/^$R_:'_Z$3P__ -_T_P#DNOH"B@#Y_P#^$R_:'_Z$3P__
M -_T_P#DNC_A,OVA_P#H1/#_ /W_ $_^2Z^@** /G_\ X3+]H?\ Z$3P_P#]
M_P!/_DNC_A,OVA_^A$\/_P#?]/\ Y+KZ HH ^?\ _A,OVA_^A$\/_P#?]/\
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M?_/F'W/_ .2#^RZ'=_A_D>._VY\8/^A5TG_OZO\ \D4?VY\8/^A5TG_OZO\
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MH_M5_P#/F'W/_P"2#^RZ'=_A_D>._P!N?&#_ *%72?\ OZO_ ,D4?VY\8/\
MH5=)_P"_J_\ R17L5%']JO\ Y\P^Y_\ R0?V70[O\/\ (\=_MSXP?]"KI/\
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MK5RU.),7&;BHQT?9_P"9UQRZDTG=_A_D<+_PN#XX_P#0G>'_ /OO_P"ZJ/\
MA<'QQ_Z$[P__ -]__=5=U16?^LV,_EC]S_S*_LVEW?X?Y'"_\+@^./\ T)WA
M_P#[[_\ NJC_ (7!\<?^A.\/_P#??_W57=44?ZS8S^6/W/\ S#^S:7=_A_D<
M+_PN#XX_]"=X?_[[_P#NJC_A<'QQ_P"A.\/_ /??_P!U5W5%'^LV,_EC]S_S
M#^S:7=_A_D<+_P +@^./_0G>'_\ OO\ ^ZJ/^%P?''_H3O#_ /WW_P#=5=U1
M1_K-C/Y8_<_\P_LVEW?X?Y'"_P#"X/CC_P!"=X?_ .^__NJC_A<'QQ_Z$[P_
M_P!]_P#W57=44?ZS8S^6/W/_ ##^S:7=_A_D<+_PN#XX_P#0G>'_ /OO_P"Z
MJ/\ A<'QQ_Z$[P__ -]__=5=U11_K-C/Y8_<_P#,/[-I=W^'^1PO_"X/CC_T
M)WA__OO_ .ZJ/^%P?''_ *$[P_\ ]]__ '57=44?ZS8S^6/W/_,/[-I=W^'^
M1PO_  N#XX_]"=X?_P"^_P#[JH_X7!\<?^A.\/\ _??_ -U5W5%'^LV,_EC]
MS_S#^S:7=_A_D<+_ ,+@^./_ $)WA_\ [[_^ZJ/^%P?''_H3O#__ 'W_ /=5
M=U11_K-C/Y8_<_\ ,/[-I=W^'^1R.G_$GX^:IYGV7P3X?E\O&[]ZHQG..MU[
M&H;OXJ?':QN'@G\&>'TE7&5\P'&1GM=>]>Q_#_\ Y?\ _MG_ .S5D>+?^1@N
M_P#@'_H"U[E;.*]/+:>,45S2=NMOM>?EW.*.$A+$2HMNR7^1Y;_PN#XX_P#0
MG>'_ /OO_P"ZJ/\ A<'QQ_Z$[P__ -]__=5=U17A_P"LV,_EC]S_ ,SM_LVE
MW?X?Y'"_\+@^./\ T)WA_P#[[_\ NJC_ (7!\<?^A.\/_P#??_W57=44?ZS8
MS^6/W/\ S#^S:7=_A_D<+_PN#XX_]"=X?_[[_P#NJC_A<'QQ_P"A.\/_ /??
M_P!U5W5%'^LV,_EC]S_S#^S:7=_A_D<+_P +@^./_0G>'_\ OO\ ^ZJ/^%P?
M''_H3O#_ /WW_P#=5=U11_K-C/Y8_<_\P_LVEW?X?Y'"_P#"X/CC_P!"=X?_
M .^__NJC_A<'QQ_Z$[P__P!]_P#W57=44?ZS8S^6/W/_ ##^S:7=_A_D<+_P
MN#XX_P#0G>'_ /OO_P"ZJ/\ A<'QQ_Z$[P__ -]__=5=U11_K-C/Y8_<_P#,
M/[-I=W^'^1PO_"X/CC_T)WA__OO_ .ZJ/^%P?''_ *$[P_\ ]]__ '57=44?
MZS8S^6/W/_,/[-I=W^'^1PO_  N#XX_]"=X?_P"^_P#[JH_X7!\<?^A.\/\
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MY\8/^A5TG_OZO_R11_;GQ@_Z%72?^_J__)%>Q44?VJ_^?,/N?_R0?V70[O\
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M +^K_P#)%>Q44?VJ_P#GS#[G_P#)!_9=#N_P_P CQW^W/C!_T*ND_P#?U?\
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M>J?=]FCBPN#IXB#G.][GCO\ ;GQ@_P"A5TG_ +^K_P#)%']N?&#_ *%72?\
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M?_/F'W/_ .2#^RZ'=_A_D>._VY\8/^A5TG_OZO\ \D4?VY\8/^A5TG_OZO\
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M *ZM_,U6KYZM_$EZL[X?"@HHHK$L**** "BBB@ HHHH **** "BBB@ HHHH
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M1?N_^ ?^AK7G-?6\3?[Y'_"OS9Y66_PGZ_H@HHHKY(]4**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ KT:S_ .153_KU/_H-><UZ-9_\BJG_ %ZG
M_P!!KZWA[XZW^$\K'[0]3SFBBBODCU0HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@#T'P7_ ,@-/]]OYUNUA>"_^0&G^^W\ZW:_9<L_W*C_
M (4?(8G^-/U"O#LU[C7A637SW$:O[+_M[]#V<H_Y>?+]23-&:CR:,FOC.4^B
ML29HS4>31DT<H6),UN>"?^1GLO\ @?\ Z U<_DUN^!S_ ,519?\  _\ T!J[
M<"O]JI?XH_FCGQ*_<3]'^1ZQ7(_$[XL>$O@UX=37O&>M0Z%I#W"VJW4T;NIE
M8,57"*3R%;MVKKJ^/_\ @J!9PZE\!?#-I<)YEO<>,-/BD7)&59)P1D<C@U^M
M'P9]7>&_$6F^+O#^G:WHUY'J&DZC;I=6MU"<I+$ZAE8?4$=>:Y'PG\?/A_XZ
M^(&L^!] \36NJ>*M'65K_3H4DW0"*18Y,L5VG:[JIP3R?K7QAX&^/UW^QO\
M#OXN_"'6)WNO$G@^<MX)68;I-1MKQ_\ 1@J_QF-Y [ =F91]VJ/[$_PBN/@E
M^VUJ_AK4)Y+G6_\ A7BWVJS22%R]Y/<V<LW/<!FVY[[<]2: /T=HKY NOC1\
M9?V@OBUXW\-?!R[\/^$_"G@N[_LR]\0:Y;-<RWMZI(>.-,%0JLK#ITPV?F '
M:?LQ_'[Q;XP\;^-?A=\3=.L+'XA^$C'++<Z5N%IJ-K( 4F0-RO#1Y]?,' ((
M !ZA\%_C1X:^/7@I?%7A26YETEKB2U#74)B??&0&^4]N:[NO@?\ 8K^+VF_
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M.MVL+P7_ ,@-/]]OYUNU^RY9_N5'_"CY#$_QI^H5X-D5[S7@>ZO"X@5_9?\
M;WZ'N9-_R\^7ZC\BC(IFZC=7Q_*?2V'Y%?(/Q8\3?%WQM^T3XB\&>$_'.F^
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MLR?76/\ T0M?7=%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M,%W_ , _] 6M?X?_ /+_ /\ ;/\ ]FK(\6_\C!=_\ _] 6OK<3_R(Z'^)_\
MMYY5/_?9^G^1CT445\D>J%%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 5O>"_P#D.+_US:L&M[P7_P AQ?\ KFU>GEG^^T?\2.;$_P &?H6_'O\
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M "BBB@"_H/\ R&K+_KJO\ZR+/_D,^+/^PD/_ $*:M?0?^0U9?]=5_G619_\
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MVL4PJC)/^H[5ZE7G^C?\EEU[_KR7^4-8UJ:K4Y4W]I-?>7"7))2[&;_8]_\
M\^-S_P!^6_PH_L>__P"?&Y_[\M_A7J5%?(_ZL4?^?C^Y'K?VE/\ E/+?['O_
M /GQN?\ ORW^%']CW_\ SXW/_?EO\*]2HH_U8H_\_']R#^TI_P IY;_8]_\
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M']CW_P#SXW/_ 'Y;_"O4J*/]6*/_ #\?W(/[2G_*>6_V/?\ _/C<_P#?EO\
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M_LV'\P?4X]SL_P"T+7_GYA_[[%']H6O_ #\P_P#?8KC**/[-A_,'U./<[/\
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MS'H_4X]SL_[0M?\ GYA_[[%']H6O_/S#_P!]BN,HH_LV'\P?4X]SL_[0M?\
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M[%']H6O_ #\P_P#?8KC**/[-A_,'U./<[/\ M"U_Y^8?^^Q1_:%K_P _,/\
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M7T=JG_(-N_\ KB__ *":^<:^<S;XH?,^RR#X:GR_4****^?/JPHHHH ****
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M%*/_ *[/_.NPK[G"_P "'HC\QQ_^]5/5A7S1NKZ7KYDS7CYNK^S^?Z'O\/\
M_+WY?J9'CKQ-_P (;X)\0:_Y/VG^RM/N+[R<X\SRHV?;GWVXKY@U#XM?&.V\
M/^+]7D\1>&H'\/Z?8ZK+91:4S"2"YC$A\MFEYV8=1G[Q3&1FOIWQKJ&FZ3X-
MUZ]UJ+S]&MK">:]B*[]\"QL9%V]\J",5\WZKX7O?B9%X?UEOV?8;NRMK."/3
MFN/%<=JS6B@/#'+$@(*C@A'+8Z>HKS,,HI-RC]]OU:/:QG.VE"36FRO]^B?]
M(^J+6X6ZM89D;>DB*X;&,@C.<5X5\7/VQ/#'PG\;S>%&T;5]>U>WB26X73HT
M*Q;E#*IRV2=I4],88<U[JK':,C:<<C/2OE+XG>&/BYX-^._B;QIX&LO#\.G:
MQ:VMF;C5;F)/.*1H,D,ZD,&!7C@@#CO6>&ITYS:J=N]C7&3JTZ:=+OK97T]#
MW'X)_&2U^-GAF\UFTT?4-%CMKQK,P:DH5V(1'W#!Z?.!^!KV?X;M_P 5IIW_
M &T_]%M7B?P3O/B'>^%[J3XD6^G6VL&[;[.NF,IC:WV)M)(9AG=O[],5[3\-
M?^1VT[_MI_Z+>JIQ4<5%1VNO/KW(JN4L%-RWY7NK='T/=*CDN(H9(HY)41Y6
MVQJS %R 20!W. 3] :DKS+X]_L_^'?VB/"]AHOB&\U731I]ZNH6=]HUT+>YM
MYU5E#JQ5AT=NHK[<_-3Y&_;)_9]\._LT6=U^T%X(U>ZL/'EOKD=S]GU=H[VV
MNWN)B9(T21"48 LP*MD(K 8X([#]O/5)-<\.?L[ZC+;M:RWGC72[AX&ZQLZ;
MBI^F<?A76Z#_ ,$]O"7_  DVE:OXU\;^-OB;'I,HEL-,\5:L;BTB8$$93;EL
M$#C(4]"I'%>H?M#_ +-OAS]I30=%TKQ#JFM:/'I%^-1M;C0KB."990C*#N>-
M\ ;LC !R!S0!Z'XK\6:/X'\.ZAKVOZC!I6D6$33W-W<OM2- ,D^Y] .2>!S7
MR-_P33TZ[U;1/BO\0/LCV.B^,/%=Q>:7"RE0T*NY+*/[N92GUC8=JZ.V_P""
M;_PUN]2M[GQ3XC\<^/H8'\Q;+Q-KQFAW>I$:1M_X]7T]HFAZ?X:TBSTK2;*W
MTW3;.)8;>TM8Q'%$BC 55'  % %;Q=_R*>M?]>4__HMJ_.?]BGX4_'3Q]^S;
MI4?A#XOV?@7P;=7%Y$MK#HL=Q>Q'S6$A64X8$MD@AP1V(K])M2L8]4T^ZLY2
MRQ7$30N4.& 8$''OS7#_  )^"6A_L]_#>Q\%>'+K4+W2K26:9)M4DCDG)D<N
MV2B(N,GCY>E 'R_^TQ\ O#_[.'_!.GQ]X3\/R7%XK2V5Y>ZA=D&:\N7U"T#2
M-C@<*J@#H%').2?<='\&:9X%_93E'@[0['2=0B\)/=6@L;=8V-U]C++)E1DN
M7.=W7)S7<?&OX1:/\>/ACK7@77[F^L](U;R1/-ILB).OES),NUG1U'S1J#E3
MP3]:ZG0='A\.Z'IVE6S2/;V-M':QM*07*HH4%B !G [ 4 ?-G_!./2]!_P"&
M/?"?]GPVTIO6O&U3Y0QEG-Q(K"4=SL"#G^$+VKYP^$^Q?V(_VI[+2#YGA*UU
M[5$T;RV+(L 6,X3_ &=NP\>I-?1.O?\ !/7PA<:MK4GACQOXX\ :'KDK2ZIX
M=\-ZN(+"<L,-B,H< ]P=PP<  <5[3X5^!/@GP;\(W^&FF:-''X0EM)K*>S=V
M9ITE!$K.^=Q9MQ);/';&!@ X+X7WU_;_ +"?AJZT1V.JP_#R%K-HF(83KIPV
M8(Z$.!^-?-/[#N@_'"]_9ST*?X<>)/AQ9Z!--<F:'4M/N9;T7'G,'^TLAP7Q
MMQG^ IVQ7TA\#_V.-)^ _BBTU'1O'_CG4]'L8YH[+PWJNJB73;<2 [B(0@&1
MDD$8YZYK U__ ()_^$&\2:KK'@OQGXW^&/\ :TGFW^G^$M8-K:3,22Q\O:2,
MY/&=H[*!0!YE?? G7_V??V'/CSH6OZOH^J37\UWJB0Z&KK!:>;'#F(*P!0#:
M"%[!AZUSW[2EK#??L)?LP6US$D]O-J?A>.2*10RNITV4%2#U!!QBOJ#PW^R+
MX-\+_ _Q3\+[;4=>GTCQ-++<:GJ=W>K-?S32)&CR>8R;0Q$2?P8XZ<U;\:?L
ML^%/'7PJ\ ^ +_4-9BT;P7<6%SI\]O-$MQ*UG"T,0F8Q%6!5B6VJN3TQTH \
MJ_X*9>']-A_8YUB.&QMX(M,O+!K*.*)56W_?I'\@ PHV.R\=C7U3X=F>X\/Z
M9+(Q>22UB9F/4DH"37(?'3X*Z)^T%\-M1\$^(KK4++2KZ2&22;3)$CG!CD61
M=I='7JHSE3Q7<6-FFGV-O:QEC'!&L2ENI"@ 9]^* /D?]N[Q1<Z[XQ^#_P '
M)[YM(\+^/]6:'6[Q0HDE@B>';;QL00I=I!R.0=G8D'Q/XV?#S5_^"?ND^/9O
M"FGPZY\(_'VGW6E-'*5%_HM]+;R)"/./SR0Y/&2> <X8!G^W/C]^SKX._:0\
M*P:)XMM[A6M)OM%CJ5A*(KNSEQ@M&Y!'(QE6!!P#C(!'G?@_]A7PCINN6&J^
M-?%'BSXL3Z<&%C:^-=3-[9VV1C*P%=I;''S9'? (& #K?V-=%B\/_LM_#2SB
MO8-1']CQ3M/;2B5-\A,CJ&!P2K.RGW4U[-7D_P #?V;_  _^SU+KD'A/6->&
M@:I.URGAZ^NHYK&QD)R3;CRQ(G'&"[9 &<D UZQ0 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 5Y_HW_)9=>_Z\E_E#7H%>?Z-_R677O^O)?Y0T >@4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 5=4_Y!MW_UQ?\ ]!-?.-?1VJ?\
M@V[_ .N+_P#H)KYQKYS-OBA\S[+(/AJ?+]0HHHKY\^K"BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH *]C^$O_(K/_P!?+_R6O'*]C^$O_(K/_P!?
M+_R6O6RS_>/DSP<[_P!T^:/*M>_Y#FH_]?,G_H1JC5[7O^0YJ/\ U\R?^A&J
M->9/XF>U3^"/H%%%%0:!1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 >F?!?_ )C'_;'_ -GKF?B3_P CIJ/_ &S_ /1:UTWP7_YC'_;'_P!GKF?B
M3_R.FH_]L_\ T6M>S5_Y%]/U_P SYRA_R-JO^'_Y$YFBBBO&/HPHHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "NO^%?_ "-L?_7%_P"5<A77_"O_
M )&V/_KB_P#*NO"_QX>J.''_ .ZU/1FG\9/^0EIW_7%O_0J\]KT+XR?\A+3O
M^N+?^A5Y[6F._P!YG_70QRO_ '.G_75A1117 >H%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110!K^#_\ D:=*_P"OE/YT_6O^/[Q/_P!A4?SGIG@_
M_D:=*_Z^4_G3]:_X_O$__85'\YZ]G#_[G5/G,9_R,:']=S%HHHKQCZ,****
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M_D4H_P#KL_\ .NPK[G"_P(>B/S''_P"]5/5A7S)7TW7S)7E9K]CY_H?0</\
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M^'!)1QP2<<;:] _:Q^-SZ;\#?A3XQTG1M(U*'Q-X@TD+;Z[8I>)##<V\LNY
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M_,^<H?\ (VJ_X?\ Y$YFBBBO&/HPHHHH **** "BBB@ HHHH **** "BBB@
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MQ3]#YS.OAI?XCPVBBBO&/HPHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MP@<<GAQ75W%E;W;1M/!%,T;;D,B!BI]1GH:GH ^1O^"F7_)$O"/_ &.FF_\
MH,U>L_$G]EOP7\4OC'X)^).LQ7!USPM_J(HRHANMK%X?.!4D^5(2ZX(Y)SD<
M5[!10!\=^#?^4IGCK_L0(_\ T?9UP'[-OQQ\,?L1R^._A3\6Y;SPO+;Z[<ZK
MH^J/8SSV^IVDH4*T;1HQ)_=YR1CYMN05(K] ZKWFGVNH*BW5M#<JC!U6:,.
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MC_X#)_A1_9,_YD']O4OY&?/5>Q_"7_D5G_Z^7_DM=%_PB^C?] FQ_P# 9/\
M"KEI8V^GQ>5:V\5M'G.R% @SZX%=F$P,L/4YW*YYN/S2&,H^RC%K4^?->_Y#
MFH_]?,G_ *$:HU]#2>&])ED9WTNR=V.69K="23U).*3_ (1?1O\ H$V/_@,G
M^%<DLJFVWS([XY[3C%+D>A\]45]"_P#"+Z-_T";'_P !D_PH_P"$7T;_ *!-
MC_X#)_A2_LF?\R+_ +>I?R,^>J*^A?\ A%]&_P"@38_^ R?X4?\ "+Z-_P!
MFQ_\!D_PH_LF?\R#^WJ7\C/GJBOH7_A%]&_Z!-C_ . R?X4?\(OHW_0)L?\
MP&3_  H_LF?\R#^WJ7\C/GJBOH7_ (1?1O\ H$V/_@,G^%'_  B^C?\ 0)L?
M_ 9/\*/[)G_,@_MZE_(SYZHKZ%_X1?1O^@38_P#@,G^%'_"+Z-_T";'_ ,!D
M_P */[)G_,@_MZE_(SYZHKZ%_P"$7T;_ *!-C_X#)_A1_P (OHW_ $";'_P&
M3_"C^R9_S(/[>I?R,^>J*^A?^$7T;_H$V/\ X#)_A1_PB^C?] FQ_P# 9/\
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M(PF<4\/0C2<&['SU17T+_P (OHW_ $";'_P&3_"C_A%]&_Z!-C_X#)_A7/\
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M^7\P6):*BW'UHW'UH_L^7\P6/;?A7_R*4?\ UV?^==A7'?"G_D48_P#KL_\
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MNX&L=AD^U"5?*VCJV[.,>]4M!\8:#XJ\[^Q-;T[6/).)?L%W'/L/HVPG'XT
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?/^N_\
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MV_&*R_:>L/BY\2_%GAO7G_L&73)+728Y8?LC,[%(85,8#QC);>S!LNPP0 2
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MR).I?]L__1J5X36];XCYO(?]VE_B?Y(****P/I HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "O=]-_Y)Q%_V#3_ .BS7A%>[Z;_ ,DXB_[!I_\
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MV-Y"]O<6\HRDD;J592.X()'XU:HH SO#OAW2_".AV.C:+86^EZ58Q"&VL[5
MD<2#HJ@=!6C110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !7G^C?\EEU[_KR7^4->@5Y_HW_)9=>_Z\E_E#0!Z!1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MO$'PM\,^)+74?ACX]"W$6@7D[37GAV2.XBFD=%&6,+!2 3UYS\R[G_1KXR?
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ KY_UW_C\\3_]A8?SGKZ KY_U
MW_C\\3_]A8?SGK.I\+/3RS_?*?J8-%%%<!^FA1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% 'NWQ,_Y$G4O^V?\ Z-2O":]V^)G_ ").I?\
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M 'T!17S_ /\ #-_CC_HM/B#_ +YG_P#DFC_AF_QQ_P!%I\0?]\S_ /R30!]
M45\__P##-_CC_HM/B#_OF?\ ^2:/^&;_ !Q_T6GQ!_WS/_\ )- 'T!17S_\
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M/^&;_''_ $6GQ!_WS/\ _)- 'T!17S__ ,,W^./^BT^(/^^9_P#Y)H_X9O\
M''_1:?$'_?,__P DT ?0%%?/_P#PS?XX_P"BT^(/^^9__DFC_AF_QQ_T6GQ!
M_P!\S_\ R30!] 45\_\ _#-_CC_HM/B#_OF?_P"2:/\ AF_QQ_T6GQ!_WS/_
M /)- 'T!17SQ??L\^.+.SN+C_A<WB!_*C:3;B<9P,X_X^:\>V^./^BC^(/\
MP,G_ /CM:1IRG\*/0PN7XG&IO#QO;?5+\V?=%%?"^WQQ_P!%'\0?^!D__P =
MHV^./^BC^(/_  ,G_P#CM7["IV._^P<Q_P"?7XQ_S/NBBOA?;XX_Z*/X@_\
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MCC_HM/B#_OF?_P"2:/\ AF_QQ_T6GQ!_WS/_ /)-9'E'T!17S_\ \,W^./\
MHM/B#_OF?_Y)H_X9O\<?]%I\0?\ ?,__ ,DT ?0%%?/_ /PS?XX_Z+3X@_[Y
MG_\ DFC_ (9O\<?]%I\0?]\S_P#R30!] 45\_P#_  S?XX_Z+3X@_P"^9_\
MY)H_X9O\<?\ 1:?$'_?,_P#\DT ?0%%?/_\ PS?XX_Z+3X@_[YG_ /DFC_AF
M_P <?]%I\0?]\S__ "30!] 45\__ /#-_CC_ *+3X@_[YG_^2:/^&;_''_1:
M?$'_ 'S/_P#)- 'T!17S_P#\,W^./^BT^(/^^9__ ))H_P"&;_''_1:?$'_?
M,_\ \DT ?0%%?/\ _P ,W^./^BT^(/\ OF?_ .2:/^&;_''_ $6GQ!_WS/\
M_)- 'T!17S__ ,,W^./^BT^(/^^9_P#Y)H_X9O\ ''_1:?$'_?,__P DT ?0
M%%?/_P#PS?XX_P"BT^(/^^9__DFC_AF_QQ_T6GQ!_P!\S_\ R30!] 45\_\
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M_P#)- 'T!17S_P#\,W^./^BT^(/^^9__ ))H_P"&;_''_1:?$'_?,_\ \DT
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M/7J*\A_X177O^APU'_OJ3_XY1_PBNO?]#AJ/_?4G_P <H^I50YL9_P! [_\
M H_YGKU%>0_\(KKW_0X:C_WU)_\ '*/^$5U[_H<-1_[ZD_\ CE'U*J'-C/\
MH'?_ (%'_,]>HKR'_A%=>_Z'#4?^^I/_ (Y1_P (KKW_ $.&H_\ ?4G_ ,<H
M^I50YL9_T#O_ ,"C_F>O45Y#_P (KKW_ $.&H_\ ?4G_ ,<H_P"$5U[_ *'#
M4?\ OJ3_ ..4?4JH<V,_Z!W_ .!1_P S[4^)G_(DZE_VS_\ 1J5X36M?_LV>
M+9;4QWOQGUI[=V5"MPLQ1F+ *,&YP26QCWQ6'KW[*OBO3=,FNK'XB7^H31*S
MFW:&5&90I.$Q*V6)  &!G/6HG3<WH?'Y9F,<+3]BXW;?=+MW)J*XOP=\(]1\
M2:G+IE]\1M4T3448J(KB%MK,&5=F3<*?,W$_+M[=>U==KW[*OBO3=,FNK'XB
M7^H31*SFW:&5&90I.$Q*V6)  &!G/6I>&E%V9[M7-)4*BI5*34GYK\]B:BN+
M\'?"/4?$FIRZ9??$;5-$U%&*B*XA;:S!E79DW"GS-Q/R[>W7M77:]^RKXKTW
M3)KJQ^(E_J$T2LYMVAE1F4*3A,2MEB0 !@9SUH>&E%V85<TE0J*E4I-2?FOS
MV)J*XOP=\(]1\2:G+IE]\1M4T3448J(KB%MK,&5=F3<*?,W$_+M[=>U==KW[
M*OBO3=,FNK'XB7^H31*SFW:&5&90I.$Q*V6)  &!G/6AX:479A5S25"HJ52D
MU)^:_/8FHKB_!WPCU'Q)J<NF7WQ&U31-11BHBN(6VLP95V9-PI\S<3\NWMU[
M5UVO?LJ^*]-TR:ZL?B)?ZA-$K.;=H949E"DX3$K98D  8&<]:'AI1=F%7-)4
M*BI5*34GYK\]B:BN+\'?"/4?$FIRZ9??$;5-$U%&*B*XA;:S!E79DW"GS-Q/
MR[>W7M77:]^RKXKTW3)KJQ^(E_J$T2LYMVAE1F4*3A,2MEB0 !@9SUH>&E%V
M85<TE0J*E4I-2?FOSV)J*XOP=\(]1\2:G+IE]\1M4T3448J(KB%MK,&5=F3<
M*?,W$_+M[=>U==KW[*OBO3=,FNK'XB7^H31*SFW:&5&90I.$Q*V6)  &!G/6
MAX:479A5S25"HJ52DU)^:_/8FHKB_!WPCU'Q)J<NF7WQ&U31-11BHBN(6VLP
M95V9-PI\S<3\NWMU[5UVO?LJ^*]-TR:ZL?B)?ZA-$K.;=H949E"DX3$K98D
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*\_T;_DLNO?]>2_RAKT"O/\ 1O\ DLNO?]>2_P H: /0**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** *6M_P#(%O\ _KWD_P#037QY
M7V'K?_(%O_\ KWD_]!-?'E>AA=F?H/"WP5?5?J%%%%=I]T%%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 5]$? 3_ )$>3_K\D_\ 04KYWKZ(^ G_
M "(\G_7Y)_Z"E<V(^ ^6XC_W'YK]3TBBBBO+/RT**** "BBB@ HHHH ****
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M(%8NVXS%BV1CG%'Q/^&']IYUS0Q]DU:W_>LD V>9MWN64(NXS%BN#GG%:?\
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M8@5B[;C,6+9&.<4?$_X8?VGG7-#'V35K?]ZR0#9YFW>Y90B[C,6*X.><4?\
M3NI\F&W_  GYAI;X9=O^ 'Q/^&']IYUS0Q]DU:W_ 'K) -GF;=[EE"+N,Q8K
M@YYQ1\,/B?\ VEC0]</V35K?]TKS_)YFW8@5B[;C,6+9&.<4?##XG_VEC0]<
M/V35K?\ =*\_R>9MV(%8NVXS%BV1CG%'Q/\ AA_:>=<T,?9-6M_WK) -GF;=
M[EE"+N,Q8K@YYQ1_T[J?)AM_PGYAI;X9=O\ @!\3_AA_:>=<T,?9-6M_WK)
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MXS%BN#GG%'PP^)_]I8T/7#]DU:W_ '2O/\GF;=B!6+MN,Q8MD8YQ1\,/B?\
MVEC0]</V35K?]TKS_)YFW8@5B[;C,6+9&.<4?$_X8?VGG7-#'V35K?\ >LD
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M_H)KX\K[#UO_ ) M_P#]>\G_ *":^/*]#"[,_0>%O@J^J_4****[3[H****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KZ(^ G_(CR?]?DG_H*5\[U
M]$? 3_D1Y/\ K\D_]!2N;$? ?+<1_P"X_-?J>D4445Y9^6A1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 >%?M$?\AK2/^O=O_0J\DKUO]HC_
M )#6D?\ 7NW_ *%7DE>O1_AH_8,E_P"1?2]'^;"BBBMCVPHHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** .@^'O_(\:%_U^1_^A"MOQ]_K/$7_ &&!
M_P"UZQ/A[_R/&A?]?D?_ *$*V_'W^L\1?]A@?^UZY*G\6)\CC_\ D;X;T_S.
M$HHHKK/K@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#ZL^
M(NGWNI^"]2ATYF6]54GB,98/NC=9,+M&=WR\8[XKE?AA\3_[2QH>N'[)JUO^
MZ5Y_D\S;L0*Q=MQF+%LC'.*]*FGCMU#2R+&I94#.P W,0JCZDD >I(KS7XG_
M  P_M/.N:&/LFK6_[UD@&SS-N]RRA%W&8L5P<\XKR:;BUR2/R' U*%6F\)B5
M9-W4NST_ /B?\,/[3SKFAC[)JUO^]9(!L\S;O<LH1=QF+%<'/.*/AA\3_P"T
ML:'KA^R:M;_NE>?Y/,V[$"L7;<9BQ;(QSBCX8?$_^TL:'KA^R:M;_NE>?Y/,
MV[$"L7;<9BQ;(QSBCXG_  P_M/.N:&/LFK6_[UD@&SS-N]RRA%W&8L5P<\XK
M3_IW4^3/1V_X3\PTM\,NW_ #XG_##^T\ZYH8^R:M;_O62 ;/,V[W+*$7<9BQ
M7!SSBCX8?$_^TL:'KA^R:M;_ +I7G^3S-NQ K%VW&8L6R,<XH^&'Q/\ [2QH
M>N'[)JUO^Z5Y_D\S;L0*Q=MQF+%LC'.*/B?\,/[3SKFAC[)JUO\ O62 ;/,V
M[W+*$7<9BQ7!SSBC_IW4^3#;_A/S#2WPR[?\ /B?\,/[3SKFAC[)JUO^]9(!
ML\S;O<LH1=QF+%<'/.*/AA\3_P"TL:'KA^R:M;_NE>?Y/,V[$"L7;<9BQ;(Q
MSBCX8?$_^TL:'KA^R:M;_NE>?Y/,V[$"L7;<9BQ;(QSBCXG_  P_M/.N:&/L
MFK6_[UD@&SS-N]RRA%W&8L5P<\XH_P"G=3Y,-O\ A/S#2WPR[?\  #XG_##^
MT\ZYH8^R:M;_ +UD@&SS-N]RRA%W&8L5P<\XH^&'Q/\ [2QH>N'[)JUO^Z5Y
M_D\S;L0*Q=MQF+%LC'.*/AA\3_[2QH>N'[)JUO\ NE>?Y/,V[$"L7;<9BQ;(
MQSBCXG_##^T\ZYH8^R:M;_O62 ;/,V[W+*$7<9BQ7!SSBC_IW4^3#;_A/S#2
MWPR[?\ /B?\ ##^T\ZYH8^R:M;_O62 ;/,V[W+*$7<9BQ7!SSBCX8?$_^TL:
M'KA^R:M;_NE>?Y/,V[$"L7;<9BQ;(QSBCX8?$_\ M+&AZX?LFK6_[I7G^3S-
MNQ K%VW&8L6R,<XH^)_PP_M/.N:&/LFK6_[UD@&SS-N]RRA%W&8L5P<\XH_Z
M=U/DPV_X3\PTM\,NW_ #XG_##^T\ZYH8^R:M;_O62 ;/,V[W+*$7<9BQ7!SS
MBCX8?$_^TL:'KA^R:M;_ +I7G^3S-NQ K%VW&8L6R,<XH^&'Q/\ [2QH>N'[
M)JUO^Z5Y_D\S;L0*Q=MQF+%LC'.*/B?\,/[3SKFAC[)JUO\ O62 ;/,V[W+*
M$7<9BQ7!SSBC_IW4^3#;_A/S#2WPR[?\ /B?\,/[3SKFAC[)JUO^]9(!L\S;
MO<LH1=QF+%<'/.*/AA\3_P"TL:'KA^R:M;_NE>?Y/,V[$"L7;<9BQ;(QSBCX
M8?$_^TL:'KA^R:M;_NE>?Y/,V[$"L7;<9BQ;(QSBCXG_  P_M/.N:&/LFK6_
M[UD@&SS-N]RRA%W&8L5P<\XH_P"G=3Y,-O\ A/S#2WPR[?\  #XG_##^T\ZY
MH8^R:M;_ +UD@&SS-N]RRA%W&8L5P<\XH^&'Q/\ [2QH>N'[)JUO^Z5Y_D\S
M;L0*Q=MQF+%LC'.*/AA\3_[2QH>N'[)JUO\ NE>?Y/,V[$"L7;<9BQ;(QSBC
MXG_##^T\ZYH8^R:M;_O62 ;/,V[W+*$7<9BQ7!SSBC_IW4^3#;_A/S#2WPR[
M?\ /B?\ ##^T\ZYH8^R:M;_O62 ;/,V[W+*$7<9BQ7!SSBCX8?$_^TL:'KA^
MR:M;_NE>?Y/,V[$"L7;<9BQ;(QSBCX8?$_\ M+&AZX?LFK6_[I7G^3S-NQ K
M%VW&8L6R,<XH^)_PP_M/.N:&/LFK6_[UD@&SS-N]RRA%W&8L5P<\XH_Z=U/D
MPV_X3\PTM\,NW_ #XG_##^T\ZYH8^R:M;_O62 ;/,V[W+*$7<9BQ7!SSBNV\
M'R74OA726O?,^V?9HUF\[._>% .[/.[(YSWKB?AA\3_[2QH>N'[)JUO^Z5Y_
MD\S;L0*Q=MQF+%LC'.*[[75E70=2%J'%Q]GE,?DYW[]IQMQSG/IWK.?,K0D>
M=C'B(*."Q'V7H_)^?8X'XG_##^T\ZYH8^R:M;_O62 ;/,V[W+*$7<9BQ7!SS
MBCX8?$_^TL:'KA^R:M;_ +I7G^3S-NQ K%VW&8L6R,<XH^&'Q/\ [2QH>N'[
M)JUO^Z5Y_D\S;L0*Q=MQF+%LC'.*/B?\,/[3SKFAC[)JUO\ O62 ;/,V[W+*
M$7<9BQ7!SSBM/^G=3Y,]';_A/S#2WPR[?\ /B?\ ##^T\ZYH8^R:M;_O62 ;
M/,V[W+*$7<9BQ7!SSBCX8?$_^TL:'KA^R:M;_NE>?Y/,V[$"L7;<9BQ;(QSB
MCX8?$_\ M+&AZX?LFK6_[I7G^3S-NQ K%VW&8L6R,<XH^)_PP_M/.N:&/LFK
M6_[UD@&SS-N]RRA%W&8L5P<\XH_Z=U/DPV_X3\PTM\,NW_ #XG_##^T\ZYH8
M^R:M;_O62 ;/,V[W+*$7<9BQ7!SSBCX8?$_^TL:'KA^R:M;_ +I7G^3S-NQ
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M(QSBCXG_  P_M/.N:&/LFK6_[UD@&SS-N]RRA%W&8L5P<\XH_P"G=3Y,-O\
MA/S#2WPR[?\  #XG_##^T\ZYH8^R:M;_ +UD@&SS-N]RRA%W&8L5P<\XH^&'
MQ/\ [2QH>N'[)JUO^Z5Y_D\S;L0*Q=MQF+%LC'.*/AA\3_[2QH>N'[)JUO\
MNE>?Y/,V[$"L7;<9BQ;(QSBCXG_##^T\ZYH8^R:M;_O62 ;/,V[W+*$7<9BQ
M7!SSBC_IW4^3#;_A/S#2WPR[?\ /B?\ ##^T\ZYH8^R:M;_O62 ;/,V[W+*$
M7<9BQ7!SSBCX8?$_^TL:'KA^R:M;_NE>?Y/,V[$"L7;<9BQ;(QSBCX8?$_\
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MJG !/&#-\4_V;?VG/VBM'T2/QQXL\"Z5:Z7JMM?)H.EQW"PS;-P::28H["0
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M* "BBB@ KS_1O^2RZ]_UY+_*&O0*\_T;_DLNO?\ 7DO\H: /0**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *6M_\ (%O_ /KWD_\
M037QY7V'K?\ R!;_ /Z]Y/\ T$U\>5Z&%V9^@\+?!5]5^H4445VGW04444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !7T1\!/^1'D_Z_)/_04KYWKZ
M(^ G_(CR?]?DG_H*5S8CX#Y;B/\ W'YK]3TBBBBO+/RT**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@#PK]HC_D-:1_U[M_Z%7DE>M_M$?\AK
M2/\ KW;_ -"KR2O7H_PT?L&2_P#(OI>C_-A1116Q[84444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% '0?#W_D>-"_Z_(__ $(5M^/O]9XB_P"PP/\
MVO6)\/?^1XT+_K\C_P#0A6WX^_UGB+_L,#_VO7)4_BQ/D<?_ ,C?#>G^9PE%
M%%=9]<%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?5GQ%T
M^]U/P7J4.G,RWJJD\1C+!]T;K)A=HSN^7C'?%<K\,/B?_:6-#UP_9-6M_P!T
MKS_)YFW8@5B[;C,6+9&.<5Z5-/';J&ED6-2RH&=@!N8A5'U)( ]217FOQ/\
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M=[EE"+N,Q8K@YYQ1_P!.ZGR8;?\ "?F&EOAEV_X ?$_X8?VGG7-#'V35K?\
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MMD8YQ1\3_AA_:>=<T,?9-6M_WK) -GF;=[EE"+N,Q8K@YYQ1_P!.ZGR8;?\
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MC,6*X.><4?##XG_VEC0]</V35K?]TKS_ ">9MV(%8NVXS%BV1CG%'PP^)_\
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M4^PZ***\(_. HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MM"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MXS%BN#GG%'PP^)_]I8T/7#]DU:W_ '2O/\GF;=B!6+MN,Q8MD8YQ1\,/B?\
MVEC0]</V35K?]TKS_)YFW8@5B[;C,6+9&.<4?$_X8?VGG7-#'V35K?\ >LD
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M (8?VGG7-#'V35K?]ZR0#9YFW>Y90B[C,6*X.><4?##XG_VEC0]</V35K?\
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M_P#[71_PTY_U+?\ Y/\ _P!KI_5:W;\A_4J_\OXH]SHKPS_AIS_J6_\ R?\
M_M='_#3G_4M_^3__ -KH^JUNWY!]2K_R_BCW.BO#/^&G/^I;_P#)_P#^UT?\
M-.?]2W_Y/_\ VNCZK6[?D'U*O_+^*/<Z*\,_X:<_ZEO_ ,G_ /[71_PTY_U+
M?_D__P#:Z/JM;M^0?4J_\OXH]SHKPS_AIS_J6_\ R?\ _M='_#3G_4M_^3__
M -KH^JUNWY!]2K_R_BCW.BO#/^&G/^I;_P#)_P#^UT?\-.?]2W_Y/_\ VNCZ
MK6[?D'U*O_+^*/<Z*\,_X:<_ZEO_ ,G_ /[71_PTY_U+?_D__P#:Z/JM;M^0
M?4J_\OXH]SHKPS_AIS_J6_\ R?\ _M='_#3G_4M_^3__ -KH^JUNWY!]2K_R
M_BCW.BO#/^&G/^I;_P#)_P#^UT?\-.?]2W_Y/_\ VNCZK6[?D'U*O_+^*/<Z
M\_T;_DLNO?\ 7DO\H:XS_AIS_J6__)__ .UUK:AXG_X1GQSXGUK[-]I\G3HI
M/(\S9G=]G&-V#Z^E9RHS@TI+<RGAZM-I26YZ[17AG_#3G_4M_P#D_P#_ &NC
M_AIS_J6__)__ .UUI]5K=OR-?J5?^7\4>YT5X9_PTY_U+?\ Y/\ _P!KH_X:
M<_ZEO_R?_P#M='U6MV_(/J5?^7\4>YT5X9_PTY_U+?\ Y/\ _P!KH_X:<_ZE
MO_R?_P#M='U6MV_(/J5?^7\4>YT5X9_PTY_U+?\ Y/\ _P!KH_X:<_ZEO_R?
M_P#M='U6MV_(/J5?^7\4>YT5X9_PTY_U+?\ Y/\ _P!KH_X:<_ZEO_R?_P#M
M='U6MV_(/J5?^7\4>YT5X9_PTY_U+?\ Y/\ _P!KH_X:<_ZEO_R?_P#M='U6
MMV_(/J5?^7\4>YT5X9_PTY_U+?\ Y/\ _P!KH_X:<_ZEO_R?_P#M='U6MV_(
M/J5?^7\4>YT5X9_PTY_U+?\ Y/\ _P!KH_X:<_ZEO_R?_P#M='U6MV_(/J5?
M^7\4>YT5X9_PTY_U+?\ Y/\ _P!KH_X:<_ZEO_R?_P#M='U6MV_(/J5?^7\4
M>YT5X9_PTY_U+?\ Y/\ _P!KH_X:<_ZEO_R?_P#M='U6MV_(/J5?^7\4>S:W
M_P @6_\ ^O>3_P!!-?'E?5MCKW_"2^ SJOD?9OM5G))Y._=M^4\9P,_E7R/]
MN_V/UKHPL7[R/K.'<13PT:L:KL[K]>Q;HJI]N_V/UH^W?['ZUW<K/L/[1PO\
M_P"#_P BW153[=_L?K1]N_V/UHY6']HX7^?\'_D6Z*J?;O\ 8_6C[=_L?K1R
ML/[1PO\ /^#_ ,BW153[=_L?K1]N_P!C]:.5A_:.%_G_  ?^1;HJI]N_V/UH
M^W?['ZT<K#^T<+_/^#_R+=%5/MW^Q^M'V[_8_6CE8?VCA?Y_P?\ D6Z*J?;O
M]C]:/MW^Q^M'*P_M'"_S_@_\BW153[=_L?K1]N_V/UHY6']HX7^?\'_D6Z*J
M?;O]C]:/MW^Q^M'*P_M'"_S_ (/_ "+=?1'P$_Y$>3_K\D_]!2OFS[=_L?K7
MT?\ L^R^=X$D;&/],D'_ (ZE<N)BU3U/G<^Q=&M@^6G*[NNC/3**\7U;]HW^
MR]5O;+_A'O-^S3O#YGVW&[:Q&<>7QTJI_P -.?\ 4M_^3_\ ]KKC^K57T_(^
M%6#KM74?Q1[G17AG_#3G_4M_^3__ -KH_P"&G/\ J6__ "?_ /M='U6MV_(/
MJ5?^7\4>YT5X9_PTY_U+?_D__P#:Z/\ AIS_ *EO_P G_P#[71]5K=OR#ZE7
M_E_%'N=%>&?\-.?]2W_Y/_\ VNC_ (:<_P"I;_\ )_\ ^UT?5:W;\@^I5_Y?
MQ1[G17AG_#3G_4M_^3__ -KH_P"&G/\ J6__ "?_ /M='U6MV_(/J5?^7\4>
MYT5X9_PTY_U+?_D__P#:Z/\ AIS_ *EO_P G_P#[71]5K=OR#ZE7_E_%'N=%
M>&?\-.?]2W_Y/_\ VNC_ (:<_P"I;_\ )_\ ^UT?5:W;\@^I5_Y?Q1[G17AG
M_#3G_4M_^3__ -KH_P"&G/\ J6__ "?_ /M='U6MV_(/J5?^7\4>YT5X9_PT
MY_U+?_D__P#:Z/\ AIS_ *EO_P G_P#[71]5K=OR#ZE7_E_%'N=%>&?\-.?]
M2W_Y/_\ VNC_ (:<_P"I;_\ )_\ ^UT?5:W;\@^I5_Y?Q1[G17"_#'XG?\+&
M_M+_ (EO]G_8_*_Y;^;OW[_]E<8V?K6'XW^.O_"&^*+W1_[$^V?9MG[[[7LW
M;D5_N[#C[V.O:LU1FY."6J,EAZKFZ:6J/5J*\,_X:<_ZEO\ \G__ +71_P -
M.?\ 4M_^3_\ ]KK3ZK6[?D:_4J_\OXH]SHKPS_AIS_J6_P#R?_\ M='_  TY
M_P!2W_Y/_P#VNCZK6[?D'U*O_+^*/<Z*\,_X:<_ZEO\ \G__ +71_P -.?\
M4M_^3_\ ]KH^JUNWY!]2K_R_BCW.BO#/^&G/^I;_ /)__P"UT?\ #3G_ %+?
M_D__ /:Z/JM;M^0?4J_\OXH]SHKPS_AIS_J6_P#R?_\ M='_  TY_P!2W_Y/
M_P#VNCZK6[?D'U*O_+^*/<Z*\,_X:<_ZEO\ \G__ +71_P -.?\ 4M_^3_\
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M,J^7DR*?,+$C9M_AZ]J[+Q#\ ;[2]*GNM/U--2FA5I#;M;M&SJ%)PF"VYB0
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M!3[-J]O^^>.'Y/-V[W+*$0LTQ8K@YYKS*?+)<DC\YP57#SI/"XG1-W4NST_
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ME"(6:8L5P<\T6:_=U/DPA6ISC]2QST7PR[?\ =\3_AA_:>=<T,?9-6M_WK)
M-GF;=[EE"+N,Q8K@YYQ1\,/B?_:6-#UP_9-6M_W2O/\ )YFW8@5B[;C,6+9&
M.<5!\*_BP-68:#KW^A:Q;_N4:X.SS=NQ C%VW&8L6R,<XJ7XI?#$ZBK:[H*?
M9M7M_P!\\</R>;MWN64(A9IBQ7!SS19K]W4^3"%:G./U+'/1?#+M_P  =\3_
M (8?VGG7-#'V35K?]ZR0#9YFW>Y90B[C,6*X.><4?##XG_VEC0]</V35K?\
M=*\_R>9MV(%8NVXS%BV1CG%0?"OXL#5F&@Z]_H6L6_[E&N#L\W;L0(Q=MQF+
M%LC'.*E^*7PQ.HJVNZ"GV;5[?]\\</R>;MWN64(A9IBQ7!SS19K]W4^3"%:G
M./U+'/1?#+M_P!WQ/^&']IYUS0Q]DU:W_>LD V>9MWN64(NXS%BN#GG%'PP^
M)_\ :6-#UP_9-6M_W2O/\GF;=B!6+MN,Q8MD8YQ4'PK^+ U9AH.O?Z%K%O\
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M=T%/LVKV_P"^>.'Y/-V[W+*$0LTQ8K@YYHLU^[J?)A"M3G'ZECGHOAEV_P"
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M1"S3%BN#GFBS7[NI\F$*U.<?J6.>B^&7;_@#OB?\,/[3SKFAC[)JUO\ O62
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M1110 45PEU\:/#5G\9K/X7R2W(\5W>DG6HHQ"3#]G#NF2_9LHW%=W0 4444
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M0_WF7I_D>73_ -]GZ?Y'"T445WGJ!1110 4444 %%%% !1110 4444 %%%%
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MZT?"CXK_ -J8T#7S]CUBV_<I)<'9YNW8@1B[[FF+%LC'./6CXK_"C^U,Z_H
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M?].*_P F==\3--OM5\#ZI#IK.M^JI/"8RP?='(LF$VC.[Y.,=\5R/PH^*_\
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M ^QZQ;?OGCMQL\W;O<NH1-S3%BN#GG'K1_TZJ_)A_P!.*_R8?%?X4?VIG7]
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M_P"G%?Y,/BO\*/[4SK^@#['K%M^^>.W&SS=N]RZA$W-,6*X.><>M'PH^*_\
M:F- U\_8]8MOW*27!V>;MV($8N^YIBQ;(QSCUH^%'Q7_ +4QH&OG['K%M^Y2
M2X.SS=NQ C%WW-,6+9&.<>M'Q7^%']J9U_0!]CUBV_?/';C9YNW>Y=0B;FF+
M%<'/./6C_IU5^3#_ *<5_DP^*_PH_M3.OZ /L>L6W[YX[<;/-V[W+J$3<TQ8
MK@YYQZT?"CXK_P!J8T#7S]CUBV_<I)<'9YNW8@1B[[FF+%LC'./6CX4?%?\
MM3&@:^?L>L6W[E)+@[/-V[$",7?<TQ8MD8YQZT?%?X4?VIG7] 'V/6+;]\\=
MN-GF[=[EU")N:8L5P<\X]:/^G57Y,/\ IQ7^3#XK_"C^U,Z_H ^QZQ;?OGCM
MQL\W;O<NH1-S3%BN#GG'K1\*/BO_ &IC0-?/V/6+;]RDEP=GF[=B!&+ON:8L
M6R,<X]:/A1\5_P"U,:!KY^QZQ;?N4DN#L\W;L0(Q=]S3%BV1CG'K1\5_A1_:
MF=?T ?8]8MOWSQVXV>;MWN74(FYIBQ7!SSCUH_Z=5?DP_P"G%?Y,/BO\*/[4
MSK^@#['K%M^^>.W&SS=N]RZA$W-,6*X.><>M'PH^*_\ :F- U\_8]8MOW*27
M!V>;MV($8N^YIBQ;(QSCUH^%'Q7_ +4QH&OG['K%M^Y22X.SS=NQ C%WW-,6
M+9&.<>M'Q7^%']J9U_0!]CUBV_?/';C9YNW>Y=0B;FF+%<'/./6C_IU5^3#_
M *<5_DP^*_PH_M3.OZ /L>L6W[YX[<;/-V[W+J$3<TQ8K@YYQZT?"CXK_P!J
M8T#7S]CUBV_<I)<'9YNW8@1B[[FF+%LC'./6CX4?%?\ M3&@:^?L>L6W[E)+
M@[/-V[$",7?<TQ8MD8YQZT?%?X4?VIG7] 'V/6+;]\\=N-GF[=[EU")N:8L5
MP<\X]:/^G57Y,/\ IQ7^3#XK_"C^U,Z_H ^QZQ;?OGCMQL\W;O<NH1-S3%BN
M#GG'K1\*/BO_ &IC0-?/V/6+;]RDEP=GF[=B!&+ON:8L6R,<X]:/A1\5_P"U
M,:!KY^QZQ;?N4DN#L\W;L0(Q=]S3%BV1CG'K1\5_A1_:F=?T ?8]8MOWSQVX
MV>;MWN74(FYIBQ7!SSCUH_Z=5?DP_P"G%?Y,/BO\*/[4SK^@#['K%M^^>.W&
MSS=N]RZA$W-,6*X.><>M'PH^*_\ :F- U\_8]8MOW*27!V>;MV($8N^YIBQ;
M(QSCUH^%'Q7_ +4QH&OG['K%M^Y22X.SS=NQ C%WW-,6+9&.<>M'Q7^%']J9
MU_0!]CUBV_?/';C9YNW>Y=0B;FF+%<'/./6C_IU5^3#_ *<5_DP^*_PH_M3.
MOZ /L>L6W[YX[<;/-V[W+J$3<TQ8K@YYQZT?"CXK_P!J8T#7S]CUBV_<I)<'
M9YNW8@1B[[FF+%LC'./6CX4?%?\ M3&@:^?L>L6W[E)+@[/-V[$",7?<TQ8M
MD8YQZT?%?X4?VIG7] 'V/6+;]\\=N-GF[=[EU")N:8L5P<\X]:/^G57Y,/\
MIQ7^3/4+>T@LU<00QP"1VD<1H%W.QRS''4D]3WJ:N.^%&MZAKG@VW?5$*7UL
M[6DF\,)"8\+E]Q)W\<^^:[&N*47&33/.G%QDXOH%?#-?<U?#&ZO2P/VOE^I[
M>5NW/\OU,_Q+;I>>'-5@EQY4MI*C;I!&,%"#\Q^[]>U>/_#?7/B3H?@+0-/L
M_!6B:M9VMG'##?6NOHL<\:J K@"-AR "2#R<GO7M&HPM=:?=0((V>2)D43 E
M"2"/F ZCUKP;PA<>,_!MI8>#;+Q[\/Y[JQ'V:&RN/,:Z !.V,J)@3M&%'&<
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MMNXX#QY\;O"?P#_X*/>)?$/C.[N+#1KCP/#8&Z@M9+@12-/ ZEUC!8+^[(R
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MCUH^%'Q7_M3&@:^?L>L6W[E)+@[/-V[$",7?<TQ8MD8YQZT?\,M_##_H6?\
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M9YNW8@1B[[FF+%LC'./6C_AEOX8?]"S_ .3]U_\ ':/^&6_AA_T+/_D_=?\
MQVCVMX<DE</;\U/V<U?MY!\5_A1_:F=?T ?8]8MOWSQVXV>;MWN74(FYIBQ7
M!SSCUH^%'Q7_ +4QH&OG['K%M^Y22X.SS=NQ C%WW-,6+9&.<>M'_#+?PP_Z
M%G_R?NO_ ([1_P ,M_##_H6?_)^Z_P#CM'M;PY)*X>WYJ?LYJ_;R.N^)FFWV
MJ^!]4ATUG6_54GA,98/NCD63";1G=\G&.^*Y'X4?%?\ M3&@:^?L>L6W[E)+
M@[/-V[$",7?<TQ8MD8YQZT?\,M_##_H6?_)^Z_\ CM'_  RW\,/^A9_\G[K_
M ..U$9KD<&B(U$J;A*-P^*_PH_M3.OZ /L>L6W[YX[<;/-V[W+J$3<TQ8K@Y
MYQZT?"CXK_VIC0-?/V/6+;]RDEP=GF[=B!&+ON:8L6R,<X]:/^&6_AA_T+/_
M )/W7_QVC_AEOX8?]"S_ .3]U_\ ':OVMX<DE<OV_-3]G-7[>0?%?X4?VIG7
M] 'V/6+;]\\=N-GF[=[EU")N:8L5P<\X]:/A1\5_[4QH&OG['K%M^Y22X.SS
M=NQ C%WW-,6+9&.<>M'_  RW\,/^A9_\G[K_ ..T?\,M_##_ *%G_P G[K_X
M[1[6\.22N'M^:G[.:OV\@^*_PH_M3.OZ /L>L6W[YX[<;/-V[W+J$3<TQ8K@
MYYQZT?"CXK_VIC0-?/V/6+;]RDEP=GF[=B!&+ON:8L6R,<X]:/\ AEOX8?\
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MK1\*/BO_ &IC0-?/V/6+;]RDEP=GF[=B!&+ON:8L6R,<X]:/^&6_AA_T+/\
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MNO\ X[1_PRW\,/\ H6?_ "?NO_CM'M;PY)*X>WYJ?LYJ_;R#XK_"C^U,Z_H
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M$OAGI_PU\)-%9:LWB"?4IC?7.K,0?M3L!AE()^7'/4YR3GFO7_ ?_(\^'?\
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M<K(#'LQG=NSC&.<UEZEX\\,Z.MHU_P"(M)L5O.;8W-]%&)O]S+#=^% &X %
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M7_(\3HHHKO/4"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M/JSP1_R1^R_[!S_R:OE.OJSP1_R1^R_[!S_R:OE.N#"_%/U/+P?QU/7_ #"B
MBBN\]0**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KZ7_9W_ .1!
MD_Z_9/\ T%*^:*^E_P!G?_D09/\ K]D_]!2N+&?PCSL?_!^9\_>+?^1JUG_K
M]F_]&-636MXM_P"1JUG_ *_9O_1C5DUUQ^%'?#X4%%%%44%%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110![G^S'_S,G_;M_[5KAOC=_R5#6O^V/\
MZ(CKN?V8_P#F9/\ MV_]JUPWQN_Y*AK7_;'_ -$1UP0_WF7I_D>73_WV?I_D
M<+1117>>H%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Z1\ /\
MDHD/_7M+_(5YO7I'P _Y*)#_ ->TO\A6-;^'+T.?$?P9>AZI\9/ %YXFM;;6
M-)FDCU7309$568%D4%OW852QDW!=O(JG\*/BO_:F- U\_8]8MOW*27!V>;MV
M($8N^YIBQ;(QSCUKOKWQ5I^G>(+71[J86]S=1&6%I654<[U4("3DN2W  YP:
MX'XK_"C^U,Z_H ^QZQ;?OGCMQL\W;O<NH1-S3%BN#GG'K7DPDI15.I\F>%3D
MIP5*KHNC&?#6WBMOCI\7DAC2)"VE.510!N:W=F/'<DDGU)->LUX%^S?J5]JO
MC[XD3:DKK?JNEP3"0,'W1PR1Y?<<[ODYSWS7OM<LERMIG%*+C)Q?0****D@*
M*** "BBB@ HHHH **** "OCC_@I-<R^*?"_PP^%UI(R7?C?Q9;6KA3R;>,@.
M?H'FA;/;;7V/7C7Q _9U_P"%A?M$?#WXF7OB#98>#K>X2WT#[%N$T\JN/.\[
MS!MQF,[=AYB'//  G[6GQ&NO@?\ LR^-/$FAE;2^T^P2UL&4<022R);QLH]4
M,@8?[HK@?@C^S9\,_ ?[+<,WB;1-,U275=!.K>(M=U&!)KB9I8/-F<RN"0$!
M.W!XV[NI)/NOQ<^&&C_&CX;Z_P""M>$HTO6+?R)'@($D;!@Z2+GC<KJK#((R
MHR"*^:-/_8A^(^J>$-/^'WBWX[W^J_#"P2.V71-.T:*TN;FU3&V"2Y#%P@ "
MX.X8^@P ;/\ P3%M]3@_9%\.MJ#2&&6]O7LEDS\L'G,,#/;>)#^-=9^WKX\_
MX5_^R?\ $"[239<W]F-)A ."QN76%P/I&\A_X#7MWAGPWIG@WP[INA:+9QZ?
MI.FV\=I:6L6=L42*%51GDX ZGD]Z\D_:O_9ON/VGO!>B>&T\6/X4M+'58]4F
MDBL1=/.41U5!F1 N/,)R=PR!QQ0!Y=>?LP?"KX/_ +%^LQZ]X.T5=1M_";SZ
MGJEU:(]VU]]FR769P75O./R!3\I( %?.FN:KXSL_V,_V;OA%ID<EQJ/C^YNG
MN+5[HVCW5BMR9DMO./\ JTD2XBY]% Y!(/TK>?L;_$+XH3V&F_&/XV7OCCP7
M93I,?#^GZ1%IBW^SE?M$D39(SC(Y/&0P/->D?M'?LMZ/\??#/ARTMM6NO!NO
M>%[@76@:SI: M8. HVB/*Y3Y(S@%2#&N".00#YJ^,7P1^+'Q0^#$_P /=._9
MV\%^$K9?)-C?Z?K]NTEDT;JVY?W:DEE#*26R0Y)S7W3X,TV\T;P?H6GZC-]H
MU"TL((+B8G.^18U5VSWR037SUH?[-OQGU;7]&F\>?M!ZAK>@Z;=P73:3H^B0
MZ:;X1.'"32QL&*-MPRX.037T]0!\??MHX^(7QX_9V^%R_OH+WQ _B"_@[&&T
M7< ?9D^T#\*D_P""C<\GBCPC\-?A?:NRW7CGQ;9V4BJ>3;(P,A^BO)"V>V*[
M']I;]E76?C#\0/!WQ \&>.9/ GC7PS');V]Z;,74;Q/GC:2,$;Y!R&#!R"*P
M?"7[%.OV_P <O!WQ/\<?%S5?'^J: DQ-C?Z<D-N9G1T5H%23; J[E;:%;<R9
MR,X !R?QB\)Z'\5/^"A'PK\)2Z/87FF^%?#MQK.I1O;(PD5MT<,4F1\RHRPD
M*<@"0XZFG?MY>%M%;0_A7\(_#>D6&B)XZ\86RW<&FVJ6ZR6\.!*[*@&=IEB;
M/HE=Y\6_V3?%/B+XZ'XK_#GXG2_#_P 37.G)I5ZLNDQ:A%-"".BNP ^Y'\I!
MY0$$5TE[^S5?:]\9?A;X_P!?\9R:U-X'T=['[)+IRH;^\DB:.6\9UDVQELJW
MEA" 4'S>@!YC\5HU^)/_  4,^$?A2-1)IO@?0[KQ'<QH/ECDD)CC&.Q#);-_
MP*E_9[_XN5^W1\>O')^>S\.P6OA.R8\@,,&<#W$EN2?^NE>P^!?V??\ A$OV
MAOB!\5[S7O[6OO$]K;6-M8_8_*&GP1*JE _F-YFXQQG[JX(/7-<!X?\ V-];
M\*_ OQWX&TGXES6'B'QCK,VK:CXJ@TG;+ME*>9"L7GY (1AN\S/SMQS0!Y;\
M5;/1OVHO'U_\(_@WX7\.Z;H-E)Y?B_X@6^D0%+52?FM;5POS2M@@L#ZX( 9J
MR/VJO!)\$W'P7_9M^&&@17.B:I--JNI:/)?_ &-M82W'F&.>Y_Z:!)F8]250
M#&%%>C?#7]C/XP_!_P )VWAKP=^T7%H6BV[,Z6T'@&Q8EF.69G:4L['^\Q)P
M ,X KT7X_?LIGXX6?@S5(?&5_P"&OB'X3PVG^*[.W4LSD+YADA!52&9=V 0!
MDCD$@@'SK\=O@9\8?C3\-K'PAI_P%\'>!FL+J&XL-4TK7K<26>S@A L:G!4G
M(SV!Y(%=EXHT*U_::_;NNO!'BO;JO@GX::-#?G1Y>8+[4)UB8/,G1P%E'RG(
M^3&,,P/H?A#]G?XO7'C+0]8^(?QYO_$NEZ1=QW::)I.CPZ9#=.AROGM$PWKN
M )0@@XK-^+7['_BC6OCM=?%?X8_$V;X=>(]4LX['5E;34O8[A$5$#!68+]V.
M/Y2#R@((- '!?'#X>>%=<_;I^ ?@_0O#6D:0VCP7'B349=.L8H6,41S;*Y11
ME1);$ '@>97W#7S?\"_V0;WX3_&O7?B7K_Q%U/X@ZUJ>EKIJOJUJ$E@RT;R,
MKB0C:6C^5%50BMMRW)/TA0!\?_%+XO-\7OC+J/A/X<_!K1OBCK_@TM:7_B/Q
M0T<5AI,SM\\4>]26;*8.T@_(< @9KS;]GWP[XGUK_@HAJ\_B7P_X4\+ZKX5\
M+XO[?P9&Z6DKS;#$)2WWI2D^2< 8B7TKTT_L7_$/P?\ %#QKKWPT^-$_@G0?
M&&H/J6I:>VBQ7LJ2N[.WEO(V!R[X8!2 0#NQFNL^!_['3_!U/BI-<^/]6\3Z
MQXZ3R3KEY#MOK- DJH?,+MYD@\W.["C*+\H Q0!\_77A[QU^RY\7OBEXR\7?
M!6'XP>'-?U.;5(_%5HT=Q=V-H6<^68W1V5%C(!7"*-OWBH&/KG]F74/ASXE^
M%\'BOX8:)!H'A[Q)<R:C+:0VZVY%R,0R;HU)5&!A"D+\ORY&<Y/D2_LJ?'*X
M\/OX2O\ ]I2^NO",D1MI?^*=@.HRV[ JT1N6D+@E21OW$^W:OHGX5?#'0_@W
M\/=$\&>&X9(-&TF'RH?.;=(Y+%W=S@99G9F. !EC@ <4 >5?MZ^//^%?_LG_
M ! NTDV7-_9C280#@L;EUA<#Z1O(?^ UP%]^S#\*O@[^Q=K4>O>#M$34;?PH
M\^IZI=6B27;7WV;EUF<%U;SC\@4_*2 !5'_@H98W'Q2\2_!3X.V-Z]C-XH\0
MM>W-Q"H=X(+>/#2;>^%FD8 \$Q^U;=S^Q?XX^)5Q86'QB^-NI_$#P?8SI,/#
M]GI,6EQWFSE?M$D3;G&>QR>.&!Y !\]>+EUFQ_X)J_!CX=-)(-:\>:S;:=!'
M(#N^SRWLMS$<'JH_T<#V8=J]Y^.7P9^&7[(7[-7B;Q=X)\%:1:>)=#M8TTW7
M+JW%Q?PW4LB0).)GRP93+NX(&1TQQ7K/Q._9Q@^)/Q6^%/BI]933M%\ S37$
M&@16(*7$K*@C(D$@$8C,<9 V-T(XS7;_ !<^&&C_ !H^&^O^"M>$HTO6+?R)
M'@($D;!@Z2+GC<KJK#((RHR"* /"O@C^S9\,_ ?[+<,WB;1-,U275=!.K>(M
M=U&!)KB9I8/-F<RN"0$!.W!XV[NI)/R3X0\4>)]/_8(^%7P_M]4FTEOB1XP?
M0X[PDJT&FO<E9 IR, R'GL59AWKZ4T_]B'XCZIX0T_X?>+?CO?ZK\,+!([9=
M$T[1HK2YN;5,;8)+D,7"  +@[ACZ#&M^UYX)^!Z_#WP1\-_&/BQ?AD;,_:/"
MUY:AP;3[,JH?GP5"XD7[[*6(R#E2: ,']L[X7?#3X#?L8^)+#0O!>AVT@BM]
M-T^22QBDN#-)*BF4RLI<RA/,;?G.5KDOVI/ ITGX%_LW_L_Q%H+GQ!JNG6-]
MY9PQB@C473_]_)P__ :\O7X;VOQ[^/'PW\'Z)\7/%'QNL]%O$U7Q'JU]*W]E
M6%I$5*QHIR&EE(*E]S'E>OS8^ZO&G[/?_";?M&>!/BA>:_BS\)6-Q;VV@FSW
M"2>99%:<S>9Q@,GR[#S&#GT .8\0?#_X%_L7_#V7Q]'X)TS3!X>3]QJ%O9K/
MJ4DD@\D(DSY<L^\J<L!AB3@ U\[>.)_B!'\"_%/B:T_9U^&?@'P2VES7DL?B
M$B?4)860D/MB12)FR,!\$,1D]Z^NOVG?@#9?M*?"/4/!5WJ<NC22S1W5M?QQ
M^;Y,T9RI9,C<I!8$9'7KQ7@OC#]A_P"+7Q:\!R>&O'G[16I:A:J(TAM;/0XH
MK9E4@_Z0$D1K@\<;FX(!^:@#S#Q/)?\ PK_X)/\ A30%:1M8\7>19VD>>6%[
M=O=!%'O!N'_ B:[?]K/X"_#']GW]AW7K"P\(:.NKK#96D6I&U5KN:\::,--Y
MS R9P)&QG&,J!CBO>/BK^S!:_$JX^$5M'KG]E>'OA_J,&H?V3]C\X7_D+&L*
M%_,7RPH1@?E;(<\#'.C^TA^S[_PT1IOA#2KK7O[(TC1=>M]:O+46?G_V@L08
M>1N\Q?+!#M\V&Z@X.* /G_XL?L_?#C]GW]@GQ&]UX-T?_A(5\.0PWFI7%JLE
MW)J4HCC\SS6RX(G?<%!PN. !6/\ $C]G'X@^)/V2OV?[/PWIEMXKF\*+9ZOJ
MOA'49Q%%J0,:R>4VXA6";G0J2,J[8R>#]-?M0? %OVD_AU:^#W\0MX>L?[4M
M[Z]=;3[0;F&+<3!CS$VY8J=V3C9T.>,+XM? CXD>(?B%#XN^'7Q@N_ CK81:
M?+HD^EQWUA(D;.RL(W8*K?.W.TGH 0* /-/@G\4_AW\3_B]I'@OQ=\#E^%WQ
M-T.+^U-)M[JRB50J @F"9$C8C&X@;=AV$Y)6OL:O!/@U^R_>^"OB-=_$CQ[X
MXO/B1\0IK+^S8=2GLX[*WLK7<6,<,$9(7))R<]S@#<V?>9(UEC9&&58%2/8T
M ?%-U\6-3_:*^(6M:S\(_@=X9\8VVER_V1)X^\9M''%*T>3Y4"%3(4!8G*G^
M($@9%<#^RGJ>J>#OB;^U+\3M9TCP_HLWA>P-I<Z7X91X]+>ZMXY'E$8;G.;8
M;CQEI6(ZUZ1\/?V&?B3\*X=0\+^$OCUJ7A[X<75W)=?V=9Z1";] ^ 52Y8DQ
MM@ ;TQR,[0:].^ ?[(NF?!SX+^+OA[J^O3>+T\57%Y+JNJ26YMIIUN(5A93F
M20Y"@G=NY+$T >??L-_!#P[XE^$L7Q5\<:78>+/'7C::?5+[5-7MTN6BC,CJ
MD4>\$(NU<D+CKCHJ@<[^P'X!TCQUX!^.7B>TT^VTO1_'>OWUA9VMK L4,=@J
MN(U15  4?:9%P/[M7?"O[!_Q.\,^"[[P#:?M#:OIW@#RYTLM/T_28X[B/S-Q
M :;S-X0,V616 <%A\F<CZ/\ V=_@S:_L_?![P]X#M;_^U5TM)?,O_(\@W$DD
MKR,Y3<VWER,;CP!S0!\-?!G]HK6? ?[#?AGP#X75[GXK:IK5_P"$M&LXS^]@
MD,YDDG/H(EN% )X!*$\ U[AKD/@K]B']G/PW\-YO#<OQ!U_Q5(UB-#MT^;Q!
M?2A1<-(Q!Q'\R+R&.W8N#R:Z/X&?L-^'_@S\<O&'Q,DU@Z[?:M=W5QI5F]D(
M4TA;B1GD"GS&\QMI6,/A/E#<?-QM_M3?LPW_ ,>[[P5X@\.>+Y?!?C'PA=27
M6F:B+87$?[SRRP9"1SF)"#R,;@5(/ !\<?M@:3\2K'X$PV6O?!GX9^ ](U?4
MK73;"VTC$VK6]PS>8BQ/$!&"5B96(ZJ6&.:]E_:_\)Q>,/$W[-7P%N9'U&RO
M=12ZU5%=E:6ULH%1R6!!&^-KCD<C;FNFN/V(_&GC?QQX$\5?$CXV:CXSN/#>
MJQZF^E-I$=O82F-U>-(XHY%6-LJ0TA5BP(&!CGUJ_P#V??[6_:ATWXPWNO>>
MNEZ$VC6&A_8\"%V=BT_G>9R2LDB[=@ZCGC% 'S3^WE\$_ 6A>%_@_P""/!OA
M#1O#VOZWXOM+*RNM-LHX9TAVLLI,BC<PW20D[B<D!CR,UT/BC1;3]IK]OC4?
M!GBM5U'P/\-='AOX]#DR;>\OYUB</,F<. LHX/'[L C#,#[K\1?V??\ A8WQ
MY^&_Q#O=>\O3_!2730:%]CWB>>9-OF^=Y@V[2(SC8<^7UYXXSXN?LEZYK_QF
M;XK_  S^(EQ\.?&ES9K8ZBS:>E];7T:A57?&[  [40<AA^[4@ C) -OX\^%/
M!'P7^'^O?%?1_!VB6/BWPEI%U)I%]:V:PF.1X6B16$87>F7QM;( )QCK7S/^
MS'X0^*OA_P"%MCK4'P*\+>.[[Q7#_:][XHUSQ% UYJ:W \Q3('C8HH1U'EYQ
MG)(R37TSX(_9IU=O#_C:Q^*7Q$U3XGS^++%=.NO.MUL+:T@ DRMO!&Q6-B9,
MEAU**<#%>;>%_P!C_P",_P .="C\(^#OVC+O2O!,+,MK;7/ARWN+NUB))\M)
MF?/?J"H'8#I0!UW["/P5\5_ OX7^(]'\66%OH\U]XCN=2LM+M;M;J.UMGBA"
MH''H4;\L]Z^DJY;X8^"'^''@/2/#DNM:AXCGL8V$NK:I*9+FZD9V=Y'8DDDL
MQ[\# KJ: "BBB@ HHHH **** "BBB@ HHHH Y3XL_P#)*_&7_8%O?_1#UY_^
MSY\5[;5/"NBZ!J1BL[RVLH(;:3(2.6-4C1$RSY:4DG@#! XKT#XL_P#)*_&7
M_8%O?_1#UY2OPH_M3X5^#M?T ?8]8MM%LYGCMQL\W;!O+J$3<TQ8K@YYQZUO
M24)-QGU.FBJ<FXU.O4ZOXK_"C^U,Z_H ^QZQ;?OGCMQL\W;O<NH1-S3%BN#G
MG'K1\*/BO_:F- U\_8]8MOW*27!V>;MV($8N^YIBQ;(QSCUH^%'Q7_M3&@:^
M?L>L6W[E)+@[/-V[$",7?<TQ8MD8YQZT?%?X4?VIG7] 'V/6+;]\\=N-GF[=
M[EU")N:8L5P<\X]:Z/\ IU5^3.O_ *<5_DSU"WM(+-7$$,< D=I'$:!=SL<L
MQQU)/4]ZFKCOA1K>H:YX-MWU1"E];.UI)O#"0F/"Y?<2=_'/OFNQKBE%QDTS
MSIQ<9.+Z!7PI7W77PEDUZF ^U\OU/1P/VOE^IQWQ$^)UG\-[C0Q?6=S=6^I7
M$D!>TC:62+;$S@B-5)?)7''3.>U<->_'?P5X?DUWQ%9Z+KCZM<6JF=I-+N8E
MG\E7,:LS+M0#<PW8XSD]*[OXB^./#O@&#3=1UV%[BZ:<Q:=';VAN+AIF4@K$
M .&*DCJ,@XSS7GNJ?$+QWX[\00>%+'PS:>$[75+*:X^T>) +F62W4JC@VZ':
MI/F ;7)!&:[:DFG9/\+G9.;3LG^!ZU?27OB#P;.^F3#3M1OK!C:S-\P@E>/Y
M&/'.UB#T[5\Q^+T^)'@&ZAMO$'QNTC3+F9/,2&5"7*Y(W;1$2!D'D^AKZLL8
M&L[&W@9U=HHU0LJ! < #(4< >PZ5\N?'3X2ZSXG^('C+7(_#UQK'V>PL;G33
MM+1R^7(@GA '5BNXXQDX..34XB+Y4UO_ %V)KWY4UO\ UV/4?V==9U+6=!U:
M34O&UKXWD2Y55N;1&40C8/D.47D]:]X\!?\ (]>'?^PE;?\ HU:^</V6=-O+
M72O%=^_AJ3PIIFH:J9[+3ID99$38 P^902N>G&/O8KZ.\ D_\)UX<_["5M_Z
M-6KAK1U+A+]UJ?9]%%%?-GSP4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\I_&[_DJ&M?]L?\
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M>X_9V\1VMO+,][II2-2Y$;3.Q &>%6(DGV )-$JL(NTG8/K5'^8\LHKK-+\
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MDG&33.*2Y9-!1114DA1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MIMJEO'G&,[4 &< 51U3XD>&=%\;:-X0OM9MK?Q-K$<DUAIC$^=<)&K,[*,=
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M3LN7<Z;]FGQ-=^+E\<:DEYJ%[X>DUI_[*?4)7D98\9*J7)(7!7 [9]<U]$>
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MC>X5GN9)2_D';]S[S=>M>Y^ 6_XKKPY_V$K;_P!&K7@O[.MG+9Z#JRR^ _\
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MP/\ $3PQ\2]'&K>%/$&G>(M.)VFXTVY295;^ZVT_*WL<&NBH **** "BN/\
MB9\7?"/P=TO3]1\8ZRFBV6H7J:=;2O#)*)+AU9E3$:L1D(QR<#CK784 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110!\C_';_DJNN?\ ;#_T1'7
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MW1K"RO;6+Y[.WM4CCEC4.QVHD>6E)*@<X(&*'0<:GLYNWF%M;'HO_"V? _\
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M:Q?/9V]JD<<L:AV.U$CRTI)4#G! Q0Z#C4]G-V\PMK8]%_X6SX'_ .AR\/\
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M[42/+2DE0.<$#%#H.-3V<W;S"VMCT7_A;/@?_H<O#_\ X-(/_BZ/^%L^!_\
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M6+Y[.WM4CCEC4.QVHD>6E)*@<X(&*'0<:GLYNWF%M;'HO_"V? __ $.7A_\
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M_P 77D?PBD\#ZMM\.^(O!WA^SUJV_<I)<:7!'YNW9&$8O\S3EBV1CG'K6O\
M%W]GG1=6L&U3P[HUA97MK%\]G;VJ1QRQJ'8[42/+2DE0.<$#%#H.-3V<W;S"
MVMCT7_A;/@?_ *'+P_\ ^#2#_P"+H_X6SX'_ .AR\/\ _@T@_P#BZ\C^$4G@
M?5MOAWQ%X.\/V>M6W[E)+C2X(_-V[(PC%_F:<L6R,<X]:]+\2?"?P?\ \([J
MGV7P;H?VK[++Y7DZ7#OW[#MVX3.<XQBHJ4I4Y\D@L:/_  MGP/\ ]#EX?_\
M!I!_\71_PMGP/_T.7A__ ,&D'_Q=>1_"*3P/JVWP[XB\'>'[/6K;]RDEQI<$
M?F[=D81B_P S3EBV1CG'K6O\7?V>=%U:P;5/#NC6%E>VL7SV=O:I''+&H=CM
M1(\M*25 YP0,5;H.-3V<W;S"VMCT7_A;/@?_ *'+P_\ ^#2#_P"+H_X6SX'_
M .AR\/\ _@T@_P#BZ\C^$4G@?5MOAWQ%X.\/V>M6W[E)+C2X(_-V[(PC%_F:
M<L6R,<X]:U_B[^SSHNK6#:IX=T:PLKVUB^>SM[5(XY8U#L=J)'EI22H'."!B
MAT'&I[.;MYA;6QZ+_P +9\#_ /0Y>'__  :0?_%T?\+9\#_]#EX?_P#!I!_\
M77D?PBD\#ZMM\.^(O!WA^SUJV_<I)<:7!'YNW9&$8O\ ,TY8MD8YQZUK_%W]
MGG1=6L&U3P[HUA97MK%\]G;VJ1QRQJ'8[42/+2DE0.<$#%#H.-3V<W;S"VMC
MT7_A;/@?_H<O#_\ X-(/_BZ/^%L^!_\ H<O#_P#X-(/_ (NO(_A%)X'U;;X=
M\1>#O#]GK5M^Y22XTN"/S=NR,(Q?YFG+%LC'./6M?XN_L\Z+JU@VJ>'=&L+*
M]M8OGL[>U2..6-0[':B1Y:4DJ!S@@8H=!QJ>SF[>86UL>B_\+9\#_P#0Y>'_
M /P:0?\ Q='_  MGP/\ ]#EX?_\ !I!_\77D?PBD\#ZMM\.^(O!WA^SUJV_<
MI)<:7!'YNW9&$8O\S3EBV1CG'K6O\7?V>=%U:P;5/#NC6%E>VL7SV=O:I''+
M&H=CM1(\M*25 YP0,4.@XU/9S=O,+:V/1?\ A;/@?_H<O#__ (-(/_BZ/^%L
M^!_^AR\/_P#@T@_^+KR/X12>!]6V^'?$7@[P_9ZU;?N4DN-+@C\W;LC",7^9
MIRQ;(QSCUK7^+O[/.BZM8-JGAW1K"RO;6+Y[.WM4CCEC4.QVHD>6E)*@<X(&
M*'0<:GLYNWF%M;'HO_"V? __ $.7A_\ \&D'_P 71_PMGP/_ -#EX?\ _!I!
M_P#%UY'\(I/ ^K;?#OB+P=X?L]:MOW*27&EP1^;MV1A&+_,TY8MD8YQZUK_%
MW]GG1=6L&U3P[HUA97MK%\]G;VJ1QRQJ'8[42/+2DE0.<$#%#H.-3V<W;S"V
MMCT7_A;/@?\ Z'+P_P#^#2#_ .+H_P"%L^!_^AR\/_\ @T@_^+KR/X12>!]6
MV^'?$7@[P_9ZU;?N4DN-+@C\W;LC",7^9IRQ;(QSCUK7^+O[/.BZM8-JGAW1
MK"RO;6+Y[.WM4CCEC4.QVHD>6E)*@<X(&*'0<:GLYNWF%M;'0?$[XG>#M0^&
MWBRUM?%FAW-S-I-W'%##J4+/(YA<!5 ;)))  %<_^SS\7;75O#.C>'=4:&SO
M;:SAAM9,B..6-4CC1,L^6E))X P0.*R/A%)X'U;;X=\1>#O#]GK5M^Y22XTN
M"/S=NR,(Q?YFG+%LC'./6NH^+'P=2^B77?#,2Z=JUDOF>1:+Y0<)O?<BQIN,
MQ8J <]A6L:,83=.MI?9CMT8_XN_"+^UMWB+PZOV+6K7]\\=N/+\W;OD+J$3<
MTY8K@YYQZT?"+XN_VMM\.^(F^QZU;?N4DN#Y?F[=D81B[[FG+%LC'./6CX1?
M%W^UMOAWQ$WV/6K;]RDEP?+\W;LC",7?<TY8MD8YQZT?%WX1?VMN\1>'5^Q:
MU:_OGCMQY?F[=\A=0B;FG+%<'/./6M_^H?$?)_UT'Y,]6MK."S606\$< D=I
M7$:!=SL<LQQU)/)/>IJXOX1ZYJ6O>"K:35D9+ZV=K23S PD)CPN7W$G?QSGO
MFNTKS9Q<).+Z$A7P=CWK[QKX-R:];+OM_+]3KP[M<7'O1CWI,FC)KVCLYC/\
M26]Y<^'=4AT^\6POY+65+>ZD^[#(4(5S[ X/X5\S>"]+^*_Q"TF;4] ^+-O?
MV,4C0M-]AEC!8 $A=\ +=1TS7TYK5@=6T:_L0_EFYMY(0_\ =W*1G]:^4/AW
M^T*_P$\+KX&\4^%=0CU32Y)5A:WVJLX:1G!.['&6.&7((P:X:[BIQYW9?,PJ
M25U?8]B_9SUK5=>\.ZO/JGB^/Q=)'>^0)5MY(&MRJ#=&R/&C9R<]*]Y\ C_B
MN_#G/_,2MO\ T:M?.G[+^CZQ_9/BGQ1K%@VDR^)=5>_ALV4J4C.2#@@'!+'!
M/4 'O7T5X )_X3SPW_V$K;_T:M:4[^PU[%1E[A]J5A:[X#\,^*+Q+K6?#NDZ
MO=(@B6>^L8IW5 20H9E) R2<>YK=HKY8\P^&_P!BGX>^%M8^,G[3%O?^&M'O
MH++QG)#:Q7-A%(L$?FW/R("I"KP.!QP*=I7QV^.&K_&CXI_"WX4>#?";Z9X8
MOH(;.^OD-I9:5"XD9A)'&097D;E=HXV.2K9XWOV&/^2V?M2?]CO+_P"CKFK/
M[)/_ "=K^U;_ -A72?\ T"[H B\;?$+X@^#?B!^S/H/C[3?".I^*_$&J:G;Z
MM>6MAYZP".2(PM:2/AHB8W3<0.2/:NY_: F^-]OXL$W@_P ;^!? 7@:.TC#:
MAXD3=</<EFW@;@4VA0N,D'KUKB_VOO\ DZG]E/\ [#6I?^@VE>(?&C7/A[I'
M[<'C.X_:3M=0N?"L6GV__"(1SQ7$^GK'Y:>85CBR22V[/!7?NW?PD 'O/[*/
M[3'BSQS\7/%WPK\;ZIX7\4ZKHU@FJ6?B7PC.)+6\@+HKJV"0'4RH. N,,"#P
M34_87_Y*E^TY_P!E O/_ $;-7EG['NN^"_$G[>7BZ_\ A[X5F\)>$I/ Q%E:
MRV'V(7"B[M ;A(_[KG.&/)QSCI7JG["__)4OVG/^R@7G_HV:@#Z[KX;_ .":
M_P /O"WB[X!^(Y==\-:/K4I\5W\9?4+"*=MHC@PN74\<GCWK[DK\R?V(?VS?
MAC\ ?A3KWAKQ;J-_%K<GB.\O([6ST^6<M&ZQ*I#*-N<HW&: ._\ BQX)L?V-
M?VK/A5XG^',1T+PQ\0-370?$'A^WPMD29(D21(_X2/.+@#&#&<8#L#Z=\6OV
M@/'GBGXZZA\)/A5>>'_#USH5G%>:_P"*/$>7CMFE4-'!#%T=RK(V3D<D<;>?
M/=(C\6?MQ_M%> _&MQX1U3P?\(O 4YU+3IM<@,%UJUV61U94R05WQ1GC*A48
M%LO@</\ '7X?^ ?A/^V!XN\5?&WP5<:_\,_&-O;S:=XACBGFBTV[2-$>.41$
M$;BCG R<;, _-@ ]W^#/Q^\?:!\=+KX1_%&]T/Q->W&D-K6C>(O#<>T7,:$A
MX9(@<!_D<@ #[O<,"."^$WQF_:*_:JT75/&?P^\3> O"FCP7DMO:^'+^"2XN
ME53\OVEPK%2P[KC/4 "K7[/WBS]F*X^+\?\ PI?P+>7^N:?I]W=/KUG:7<=O
M;J(B#'F=@=\@)4#9CWKPKXC^*/V1?'&FZOXJT>;Q1\+OBBR221:7I%M=6]RM
M_@[4\M5:%<N!G8R=>JDT ?37[2WQ1\<> _@%\+]5\7^&_#$OC'4/%=CINJ6-
MS9K>V<)=;C,D 9FVL512&R2-Q%=)^TA\?/'&D_%3PK\'OA/8:=/X\UZT;4KG
M4]8#&TTRS5F7S&"]23&_7.,*-K%QCYW^.%WXXU#]A_X W'Q&-VWBV3QOI[7+
M:@I%RT9-YY!E!YWF+R\YY]><UZ5^T9>:M^SW^U_X9^-LWAW5/$/@>]\/OX?U
M:72(#/-82!V=9"N>%/[ODD [7[X! %'Q2_:#^#_Q[^$_@7X@^(/"7B71O&-Y
M<Q_;=+L'BN=L2(75@0JK@NFTJ"3EL]JT_BG\=_C9<?M7:M\)?AC8^&[F-?#T
M6I+=:Z'1+#=(BO<.RG=(!N"!%4G,@/(4UY=XV_: M/V@OVP/V<KO1?"WB+1]
M$T_4-06WU'7+/[,+]FBB,GDKDDJ@1<MG^/H,<^K>%O\ E*)XP_[)U'_Z56M
M$GP;^-'Q>\&_M+Q_!WXPW.A:]+K&COJ^D:SH<)A'R%MT; A>,1R?PY!4<D-Q
M];U\A_$S_E)=\(/^Q3O_ .5U7UY0 4444 %%%% !1110 4444 %%%% !1110
M!\C_ !V_Y*KKG_;#_P!$1UP-=]\=O^2JZY_VP_\ 1$=<#7V-#^%#T7Y&ZV"B
MBBMQA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>\?$#_7^,O\
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M[+/_ #,__;K_ .UJ])L_B58?\)YJGA>^=+6Z@:,VTDA5$E5HXB$R6RTA>1L
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MY/\ KH'DS;\2?">TU#QCH_B/35BL[RVNXY+J, )'*@9F=\*F6E+$<DX(%5?
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M\"?\D9L?^P:__H+5\C5Y6!^.IZ_YD1ZA1117JEA1110 4444 %%%% !1110
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M_P#X R__ !-;^TAW&8%%;_\ PK_Q1_T+>K_^ ,O_ ,31_P *_P#%'_0MZO\
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M_P# &7_XFO4]I#N68%%;_P#PK_Q1_P!"WJ__ ( R_P#Q-'_"O_%'_0MZO_X
MR_\ Q-'M(=P,"BM__A7_ (H_Z%O5_P#P!E_^)H_X5_XH_P"A;U?_ , 9?_B:
M/:0[@8%%;_\ PK_Q1_T+>K_^ ,O_ ,31_P *_P#%'_0MZO\ ^ ,O_P 31[2'
M<# HK?\ ^%?^*/\ H6]7_P# &7_XFC_A7_BC_H6]7_\  &7_ .)H]I#N!@45
MO_\ "O\ Q1_T+>K_ /@#+_\ $T?\*_\ %'_0MZO_ . ,O_Q-'M(=P,"BM_\
MX5_XH_Z%O5__  !E_P#B:/\ A7_BC_H6]7_\ 9?_ (FCVD.X&!16_P#\*_\
M%'_0MZO_ . ,O_Q-'_"O_%'_ $+>K_\ @#+_ /$T>TAW P**W_\ A7_BC_H6
M]7_\ 9?_ (FC_A7_ (H_Z%O5_P#P!E_^)H]I#N!@45O_ /"O_%'_ $+>K_\
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M;_\ PK_Q1_T+>K_^ ,O_ ,31_P *_P#%'_0MZO\ ^ ,O_P 31[2'<# HK?\
M^%?^*/\ H6]7_P# &7_XFC_A7_BC_H6]7_\  &7_ .)H]I#N!@45O_\ "O\
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M2Q/&"!FLCXN_"+^UMWB+PZOV+6K7]\\=N/+\W;OD+J$3<TY8K@YYQZT*2?\
ML]=^C#R8?%WX1?VMN\1>'5^Q:U:_OGCMQY?F[=\A=0B;FG+%<'/./6CX1?%W
M^UMOAWQ$WV/6K;]RDEP?+\W;LC",7?<TY8MD8YQZUK_"+Q;KVK6"Z7XBT74;
M.]MHODO+BUDCCEC4(HW.YRTI)8GC! S61\7?A%_:V[Q%X=7[%K5K^^>.W'E^
M;MWR%U")N:<L5P<\X]:%)/\ V>N_1AY,/B[\(O[6W>(O#J_8M:M?WSQVX\OS
M=N^0NH1-S3EBN#GG'K1\(OB[_:VWP[XB;['K5M^Y22X/E^;MV1A&+ON:<L6R
M,<X]:U_A%XMU[5K!=+\1:+J-G>VT7R7EQ:R1QRQJ$4;G<Y:4DL3Q@@9K(^+O
MPB_M;=XB\.K]BUJU_?/';CR_-V[Y"ZA$W-.6*X.><>M"DG_L]=^C#R8?%WX1
M?VMN\1>'5^Q:U:_OGCMQY?F[=\A=0B;FG+%<'/./6CX1?%W^UMOAWQ$WV/6K
M;]RDEP?+\W;LC",7?<TY8MD8YQZUK_"+Q;KVK6"Z7XBT74;.]MHODO+BUDCC
MEC4(HW.YRTI)8GC! S61\7?A%_:V[Q%X=7[%K5K^^>.W'E^;MWR%U")N:<L5
MP<\X]:%)/_9Z[]&'DP^+OPB_M;=XB\.K]BUJU_?/';CR_-V[Y"ZA$W-.6*X.
M><>M'PB^+O\ :VWP[XB;['K5M^Y22X/E^;MV1A&+ON:<L6R,<X]:U_A%XMU[
M5K!=+\1:+J-G>VT7R7EQ:R1QRQJ$4;G<Y:4DL3Q@@9K(^+OPB_M;=XB\.K]B
MUJU_?/';CR_-V[Y"ZA$W-.6*X.><>M"DG_L]=^C#R8?%WX1?VMN\1>'5^Q:U
M:_OGCMQY?F[=\A=0B;FG+%<'/./6CX1?%W^UMOAWQ$WV/6K;]RDEP?+\W;LC
M",7?<TY8MD8YQZUK_"+Q;KVK6"Z7XBT74;.]MHODO+BUDCCEC4(HW.YRTI)8
MGC! S61\7?A%_:V[Q%X=7[%K5K^^>.W'E^;MWR%U")N:<L5P<\X]:%)/_9Z[
M]&'DSLOBEIE_JW@/5H-+9UU!%2XA,98/NCD63";1G?\ )\N.^.E<;\(OB[_:
MVWP[XB;['K5M^Y22X/E^;MV1A&+ON:<L6R,<X]:]7BN$F;"B0'&?FC91^HKR
MCXN_"+^UMWB+PZOV+6K7]\\=N/+\W;OD+J$3<TY8K@YYQZUA1E"4?8U-+[,2
M[,/B[\(O[6W>(O#J_8M:M?WSQVX\OS=N^0NH1-S3EBN#GG'K1\(OB[_:VWP[
MXB;['K5M^Y22X/E^;MV1A&+ON:<L6R,<X]:U_A%XMU[5K!=+\1:+J-G>VT7R
M7EQ:R1QRQJ$4;G<Y:4DL3Q@@9K(^+OPB_M;=XB\.K]BUJU_?/';CR_-V[Y"Z
MA$W-.6*X.><>M;J2?^SUWZ,?DP^+OPB_M;=XB\.K]BUJU_?/';CR_-V[Y"ZA
M$W-.6*X.><>M'PB^+O\ :VWP[XB;['K5M^Y22X/E^;MV1A&+ON:<L6R,<X]:
MU_A%XMU[5K!=+\1:+J-G>VT7R7EQ:R1QRQJ$4;G<Y:4DL3Q@@9K(^+OPB_M;
M=XB\.K]BUJU_?/';CR_-V[Y"ZA$W-.6*X.><>M"DG_L]=^C#R8?%WX1?VMN\
M1>'5^Q:U:_OGCMQY?F[=\A=0B;FG+%<'/./6CX1?%W^UMOAWQ$WV/6K;]RDE
MP?+\W;LC",7?<TY8MD8YQZUK_"+Q;KVK6"Z7XBT74;.]MHODO+BUDCCEC4(H
MW.YRTI)8GC! S61\7?A%_:V[Q%X=7[%K5K^^>.W'E^;MWR%U")N:<L5P<\X]
M:%)/_9Z[]&'DP^+OPB_M;=XB\.K]BUJU_?/';CR_-V[Y"ZA$W-.6*X.><>M'
MPB^+O]K;?#OB)OL>M6W[E)+@^7YNW9&$8N^YIRQ;(QSCUK7^$7BW7M6L%TOQ
M%HNHV=[;1?)>7%K)''+&H11N=SEI22Q/&"!FLCXN_"+^UMWB+PZOV+6K7]\\
M=N/+\W;OD+J$3<TY8K@YYQZT*2?^SUWZ,/)A\7?A%_:V[Q%X=7[%K5K^^>.W
M'E^;MWR%U")N:<L5P<\X]:/A%\7?[6V^'?$3?8]:MOW*27!\OS=NR,(Q=]S3
MEBV1CG'K6O\ "+Q;KVK6"Z7XBT74;.]MHODO+BUDCCEC4(HW.YRTI)8GC! S
M61\7?A%_:V[Q%X=7[%K5K^^>.W'E^;MWR%U")N:<L5P<\X]:%)/_ &>N_1AY
M,/B[\(O[6W>(O#J_8M:M?WSQVX\OS=N^0NH1-S3EBN#GG'K1\(OB[_:VWP[X
MB;['K5M^Y22X/E^;MV1A&+ON:<L6R,<X]:U_A%XMU[5K!=+\1:+J-G>VT7R7
MEQ:R1QRQJ$4;G<Y:4DL3Q@@9K(^+OPB_M;=XB\.K]BUJU_?/';CR_-V[Y"ZA
M$W-.6*X.><>M"DG_ +/7?HP\F'Q=^$7]K;O$7AU?L6M6O[YX[<>7YNW?(74(
MFYIRQ7!SSCUH^$7Q=_M;;X=\1-]CUJV_<I)<'R_-V[(PC%WW-.6+9&.<>M:_
MPB\6Z]JU@NE^(M%U&SO;:+Y+RXM9(XY8U"*-SN<M*26)XP0,UD?%WX1?VMN\
M1>'5^Q:U:_OGCMQY?F[=\A=0B;FG+%<'/./6A23_ -GKOT8>3#XN_"+^UMWB
M+PZOV+6K7]\\=N/+\W;OD+J$3<TY8K@YYQZT?"+XN_VMM\.^(F^QZU;?N4DN
M#Y?F[=D81B[[FG+%LC'./6M?X1>+=>U:P72_$6BZC9WMM%\EY<6LD<<L:A%&
MYW.6E)+$\8(&:R/B[\(O[6W>(O#J_8M:M?WSQVX\OS=N^0NH1-S3EBN#GG'K
M0I)_[/7?HP\F'Q=^$7]K;O$7AU?L6M6O[YX[<>7YNW?(74(FYIRQ7!SSCUH^
M$7Q=_M;;X=\1-]CUJV_<I)<'R_-V[(PC%WW-.6+9&.<>M:_PB\6Z]JU@NE^(
MM%U&SO;:+Y+RXM9(XY8U"*-SN<M*26)XP0,UD?%WX1?VMN\1>'5^Q:U:_OGC
MMQY?F[=\A=0B;FG+%<'/./6A23_V>N_1AY,/B[\(O[6W>(O#J_8M:M?WSQVX
M\OS=N^0NH1-S3EBN#GG'K7H'@>6[F\':*U^)1?"TC6?S\^9O"@-OSSNR.<\Y
MS7+?"+Q;KVK6"Z7XBT74;.]MHODO+BUDCCEC4(HW.YRTI)8GC! S79>(EF7P
M[JHLQ(+G[+,8O(SOWE3C;CG.?3G-<]64[*C/IU%Y'FWQ=^$7]K;O$7AU?L6M
M6O[YX[<>7YNW?(74(FYIRQ7!SSCUH^$7Q=_M;;X=\1-]CUJV_<I)<'R_-V[(
MPC%WW-.6+9&.<>M:_P (O%NO:M8+I?B+1=1L[VVB^2\N+62..6-0BC<[G+2D
MEB>,$#-9'Q=^$7]K;O$7AU?L6M6O[YX[<>7YNW?(74(FYIRQ7!SSCUKH4D_]
MGKOT8_)A\7?A%_:V[Q%X=7[%K5K^^>.W'E^;MWR%U")N:<L5P<\X]:/A%\7?
M[6V^'?$3?8]:MOW*27!\OS=NR,(Q=]S3EBV1CG'K6O\ "+Q;KVK6"Z7XBT74
M;.]MHODO+BUDCCEC4(HW.YRTI)8GC! S61\7?A%_:V[Q%X=7[%K5K^^>.W'E
M^;MWR%U")N:<L5P<\X]:%)/_ &>N_1AY,/B[\(O[6W>(O#J_8M:M?WSQVX\O
MS=N^0NH1-S3EBN#GG'K1\(OB[_:VWP[XB;['K5M^Y22X/E^;MV1A&+ON:<L6
MR,<X]:U_A%XMU[5K!=+\1:+J-G>VT7R7EQ:R1QRQJ$4;G<Y:4DL3Q@@9K(^+
MOPB_M;=XB\.K]BUJU_?/';CR_-V[Y"ZA$W-.6*X.><>M"DG_ +/7?HP\F'Q=
M^$7]K;O$7AU?L6M6O[YX[<>7YNW?(74(FYIRQ7!SSCUH^$7Q=_M;;X=\1-]C
MUJV_<I)<'R_-V[(PC%WW-.6+9&.<>M:_PB\6Z]JU@NE^(M%U&SO;:+Y+RXM9
M(XY8U"*-SN<M*26)XP0,UD?%WX1?VMN\1>'5^Q:U:_OGCMQY?F[=\A=0B;FG
M+%<'/./6A23_ -GKOT8>3#XN_"+^UMWB+PZOV+6K7]\\=N/+\W;OD+J$3<TY
M8K@YYQZT?"+XN_VMM\.^(F^QZU;?N4DN#Y?F[=D81B[[FG+%LC'./6M?X1>+
M=>U:P72_$6BZC9WMM%\EY<6LD<<L:A%&YW.6E)+$\8(&:R/B[\(O[6W>(O#J
M_8M:M?WSQVX\OS=N^0NH1-S3EBN#GG'K0I)_[/7?HP\F'Q=^$7]K;O$7AU?L
M6M6O[YX[<>7YNW?(74(FYIRQ7!SSCUH^$7Q=_M;;X=\1-]CUJV_<I)<'R_-V
M[(PC%WW-.6+9&.<>M:_PB\6Z]JU@NE^(M%U&SO;:+Y+RXM9(XY8U"*-SN<M*
M26)XP0,UD?%WX1?VMN\1>'5^Q:U:_OGCMQY?F[=\A=0B;FG+%<'/./6A23_V
M>N_1AY,/B[\(O[6W>(O#J_8M:M?WSQVX\OS=N^0NH1-S3EBN#GG'K1\(OB[_
M &MM\.^(F^QZU;?N4DN#Y?F[=D81B[[FG+%LC'./6M?X1>+=>U:P72_$6BZC
M9WMM%\EY<6LD<<L:A%&YW.6E)+$\8(&:R/B[\(O[6W>(O#J_8M:M?WSQVX\O
MS=N^0NH1-S3EBN#GG'K0I)_[/7?HP\F'Q=^$7]K;O$7AU?L6M6O[YX[<>7YN
MW?(74(FYIRQ7!SSCUH^$7Q=_M;;X=\1-]CUJV_<I)<'R_-V[(PC%WW-.6+9&
M.<>M:_PB\6Z]JU@NE^(M%U&SO;:+Y+RXM9(XY8U"*-SN<M*26)XP0,UD?%WX
M1?VMN\1>'5^Q:U:_OGCMQY?F[=\A=0B;FG+%<'/./6A23_V>N_1AY,/B[\(O
M[6W>(O#J_8M:M?WSQVX\OS=N^0NH1-S3EBN#GG'K1\(OB[_:VWP[XB;['K5M
M^Y22X/E^;MV1A&+ON:<L6R,<X]:U_A%XMU[5K!=+\1:+J-G>VT7R7EQ:R1QR
MQJ$4;G<Y:4DL3Q@@9K(^+OPB_M;=XB\.K]BUJU_?/';CR_-V[Y"ZA$W-.6*X
M.><>M"DG_L]=^C#R8?%WX1?VMN\1>'5^Q:U:_OGCMQY?F[=\A=0B;FG+%<'/
M./6CX1?%W^UMOAWQ$WV/6K;]RDEP?+\W;LC",7?<TY8MD8YQZUK_  B\6Z]J
MU@NE^(M%U&SO;:+Y+RXM9(XY8U"*-SN<M*26)XP0,UD?%WX1?VMN\1>'5^Q:
MU:_OGCMQY?F[=\A=0B;FG+%<'/./6A23_P!GKOT8>3/5K:S@LUD%O!' )':5
MQ&@7<['+,<=23R3WJ:N.^%6K:OJ?A"T&NVMQ:ZE"/)87$,B.ZJ  [%^K'J3W
M.:[&O.G%QDXLD****@05G:UX>TSQ%;B#5+"WOXE.56>,-M/J">A]Q1133:=T
M!Q$'[/O@V'4#<FSN)8\<6LEPWE*<YSQ\Q].6(XKOM/TNSTFV2WLK6&T@086.
M% J@?0445I.K.I\;N.[9:HHHK(04444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6+:^%K>T\4WFNK
M+(;BZB$31G&P !!D<9_@'YT44 ;5%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !6+H7A:WT'4=5O(99)'U&7S9%?&%.6.!@?[1HHH VJ*** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
=BB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Oct. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40323<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">RECURSION PHARMACEUTICALS, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">46-4099738<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">41 S Rio Grande Street<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Salt Lake City,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">UT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">84101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">269 - 0203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class A Common Stock, par value $0.00001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RXRX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001601830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">514,895,802<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,747,334<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 659,836<span></span>
</td>
<td class="nump">$ 594,350<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash</a></td>
<td class="nump">3,136<span></span>
</td>
<td class="nump">3,045<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">21,910<span></span>
</td>
<td class="nump">49,166<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid data assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">29,601<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">29,223<span></span>
</td>
<td class="nump">38,107<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">714,105<span></span>
</td>
<td class="nump">714,269<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash, non-current</a></td>
<td class="nump">4,173<span></span>
</td>
<td class="nump">5,629<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">111,706<span></span>
</td>
<td class="nump">141,063<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">47,812<span></span>
</td>
<td class="nump">65,877<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Financing lease right-of-use assets</a></td>
<td class="nump">21,726<span></span>
</td>
<td class="nump">26,273<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">322,344<span></span>
</td>
<td class="nump">335,855<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">162,042<span></span>
</td>
<td class="nump">148,873<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets</a></td>
<td class="nump">957<span></span>
</td>
<td class="nump">1,934<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets, non-current</a></td>
<td class="nump">14,661<span></span>
</td>
<td class="nump">8,825<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">1,399,526<span></span>
</td>
<td class="nump">1,448,598<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">13,935<span></span>
</td>
<td class="nump">21,613<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses and other liabilities</a></td>
<td class="nump">53,102<span></span>
</td>
<td class="nump">81,872<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_AccruedDataCurrent', window );">Accrued data liability</a></td>
<td class="nump">20,258<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Unearned revenue</a></td>
<td class="nump">47,364<span></span>
</td>
<td class="nump">61,767<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="nump">11,525<span></span>
</td>
<td class="nump">13,795<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Notes payable and financing lease liabilities</a></td>
<td class="nump">8,919<span></span>
</td>
<td class="nump">8,425<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">155,103<span></span>
</td>
<td class="nump">187,472<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Unearned revenue, non-current</a></td>
<td class="nump">111,204<span></span>
</td>
<td class="nump">118,765<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, non-current</a></td>
<td class="nump">50,028<span></span>
</td>
<td class="nump">67,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Notes payable and financing lease liabilities, non-current</a></td>
<td class="nump">11,902<span></span>
</td>
<td class="nump">19,022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liabilities</a></td>
<td class="nump">23,312<span></span>
</td>
<td class="nump">16,575<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities, non-current</a></td>
<td class="nump">1,029<span></span>
</td>
<td class="nump">4,732<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">352,578<span></span>
</td>
<td class="nump">413,816<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note&#160;7)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.00001 par value; 2,000,000,000 shares (Class A 1,989,032,117 and Class B 10,967,883) authorized as of September&#160;30, 2025 and December&#160;31, 2024; 491,800,501 shares (Class A 485,213,547, Class B 5,967,334 and Exchangeable 619,620) and 396,802,394 shares (Class A 389,547,223, Class B 6,958,575 and Exchangeable 296,596) issued and outstanding as of September&#160;30, 2025 and December&#160;31, 2024, respectively</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">2,980,729<span></span>
</td>
<td class="nump">2,473,698<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(1,967,879)<span></span>
</td>
<td class="num">(1,431,283)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (loss)</a></td>
<td class="nump">34,093<span></span>
</td>
<td class="num">(7,637)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">1,046,948<span></span>
</td>
<td class="nump">1,034,782<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 1,399,526<span></span>
</td>
<td class="nump">$ 1,448,598<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_AccruedDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Data, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_AccruedDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480870/815-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 64<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481620/480-10-55-64<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 19: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 35: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-41<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478064/805-740-55-13<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 39<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-39<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 64<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481620/480-10-55-64<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 31: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482955/340-10-05-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483032/340-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -SubTopic 210<br> -Topic 954<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477220/954-210-45-5<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (unaudited) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">2,000,000,000<span></span>
</td>
<td class="nump">2,000,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">491,800,501<span></span>
</td>
<td class="nump">396,802,394<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common sock, shares outstanding (in shares)</a></td>
<td class="nump">491,800,501<span></span>
</td>
<td class="nump">396,802,394<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">1,989,032,117<span></span>
</td>
<td class="nump">1,989,032,117<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">485,213,547<span></span>
</td>
<td class="nump">389,547,223<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common sock, shares outstanding (in shares)</a></td>
<td class="nump">485,213,547<span></span>
</td>
<td class="nump">389,547,223<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">10,967,883<span></span>
</td>
<td class="nump">10,967,883<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">5,967,334<span></span>
</td>
<td class="nump">6,958,575<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common sock, shares outstanding (in shares)</a></td>
<td class="nump">5,967,334<span></span>
</td>
<td class="nump">6,958,575<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=rxrx_ExchangeableStockMember', window );">Exchangeable Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">619,620<span></span>
</td>
<td class="nump">296,596<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common sock, shares outstanding (in shares)</a></td>
<td class="nump">619,620<span></span>
</td>
<td class="nump">296,596<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=rxrx_ExchangeableStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=rxrx_ExchangeableStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations (unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 5,175<span></span>
</td>
<td class="nump">$ 26,082<span></span>
</td>
<td class="nump">$ 39,143<span></span>
</td>
<td class="nump">$ 54,293<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating costs and expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of revenue</a></td>
<td class="nump">14,687<span></span>
</td>
<td class="nump">12,079<span></span>
</td>
<td class="nump">56,678<span></span>
</td>
<td class="nump">32,444<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">121,062<span></span>
</td>
<td class="nump">74,600<span></span>
</td>
<td class="nump">379,331<span></span>
</td>
<td class="nump">216,087<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">41,628<span></span>
</td>
<td class="nump">37,757<span></span>
</td>
<td class="nump">142,932<span></span>
</td>
<td class="nump">100,998<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating costs and expenses</a></td>
<td class="nump">177,377<span></span>
</td>
<td class="nump">124,436<span></span>
</td>
<td class="nump">578,941<span></span>
</td>
<td class="nump">349,529<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(172,202)<span></span>
</td>
<td class="num">(98,354)<span></span>
</td>
<td class="num">(539,798)<span></span>
</td>
<td class="num">(295,236)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">9,952<span></span>
</td>
<td class="nump">2,679<span></span>
</td>
<td class="nump">3,005<span></span>
</td>
<td class="nump">9,347<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income tax benefit</a></td>
<td class="num">(162,250)<span></span>
</td>
<td class="num">(95,675)<span></span>
</td>
<td class="num">(536,793)<span></span>
</td>
<td class="num">(285,889)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (expense)</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(167)<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="nump">1,134<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (162,253)<span></span>
</td>
<td class="num">$ (95,842)<span></span>
</td>
<td class="num">$ (536,637)<span></span>
</td>
<td class="num">$ (284,755)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Per share data</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share of class A, B and Exchangeable common stock, basic (in dollars per share)</a></td>
<td class="num">$ (0.36)<span></span>
</td>
<td class="num">$ (0.34)<span></span>
</td>
<td class="num">$ (1.27)<span></span>
</td>
<td class="num">$ (1.12)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share of class A, B and Exchangeable common stock, diluted (in dollars per share)</a></td>
<td class="num">$ (0.36)<span></span>
</td>
<td class="num">$ (0.34)<span></span>
</td>
<td class="num">$ (1.27)<span></span>
</td>
<td class="num">$ (1.12)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average shares (Class A, B and Exchangeable) outstanding, basic (in shares)</a></td>
<td class="nump">446,988,046<span></span>
</td>
<td class="nump">282,583,048<span></span>
</td>
<td class="nump">422,642,653<span></span>
</td>
<td class="nump">253,447,099<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares (Class A, B and Exchangeable) outstanding, diluted (in shares)</a></td>
<td class="nump">446,988,046<span></span>
</td>
<td class="nump">282,583,048<span></span>
</td>
<td class="nump">422,642,653<span></span>
</td>
<td class="nump">253,447,099<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_LicenseAndServiceMember', window );">Operating revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 4,983<span></span>
</td>
<td class="nump">$ 26,082<span></span>
</td>
<td class="nump">$ 38,905<span></span>
</td>
<td class="nump">$ 53,977<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_GrantMember', window );">Grant revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 192<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 238<span></span>
</td>
<td class="nump">$ 316<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-7<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_LicenseAndServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_LicenseAndServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_GrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_GrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Loss (unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (162,253)<span></span>
</td>
<td class="num">$ (95,842)<span></span>
</td>
<td class="num">$ (536,637)<span></span>
</td>
<td class="num">$ (284,755)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Currency translation adjustments</a></td>
<td class="num">(9,527)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">41,730<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="num">(9,527)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">41,730<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (171,780)<span></span>
</td>
<td class="num">$ (95,842)<span></span>
</td>
<td class="num">$ (494,907)<span></span>
</td>
<td class="num">$ (284,755)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Stockholders&#8217; Equity (unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock (Class A, B and Exchangeable)</div></th>
<th class="th"><div>Additional Paid-in-Capital</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Accumulated other comprehensive income (loss)</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">234,270,384<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2023</a></td>
<td class="nump">$ 463,436<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 1,431,056<span></span>
</td>
<td class="num">$ (967,622)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(284,755)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(284,755)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock option exercises and other (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,827,268<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock option exercises and other</a></td>
<td class="nump">5,586<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,586<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">50,904<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,904<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Common stock sales issuances, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,026,627<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Common stock sales issuances, net of issuance costs</a></td>
<td class="nump">289,388<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">289,387<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">286,124,279<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2024</a></td>
<td class="nump">524,559<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">1,776,933<span></span>
</td>
<td class="num">(1,252,377)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Jun. 30, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">280,968,276<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Jun. 30, 2024</a></td>
<td class="nump">584,449<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">1,740,981<span></span>
</td>
<td class="num">(1,156,535)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(95,842)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(95,842)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock option exercises and other (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,689,679<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock option exercises and other</a></td>
<td class="nump">732<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">732<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">18,252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Common stock sales issuances, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,466,324<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Common stock sales issuances, net of issuance costs</a></td>
<td class="nump">16,968<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,968<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">286,124,279<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2024</a></td>
<td class="nump">$ 524,559<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">1,776,933<span></span>
</td>
<td class="num">(1,252,377)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2024</a></td>
<td class="nump">396,802,394<span></span>
</td>
<td class="nump">396,802,394<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2024</a></td>
<td class="nump">$ 1,034,782<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">2,473,698<span></span>
</td>
<td class="num">(1,431,283)<span></span>
</td>
<td class="num">(7,637)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(536,637)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(536,637)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="nump">41,730<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,730<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock option exercises and other (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,645,465<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock option exercises and other</a></td>
<td class="nump">3,813<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,772<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">87,460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87,460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Common stock sales issuances, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79,497,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Common stock sales issuances, net of issuance costs</a></td>
<td class="nump">395,485<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">395,484<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Class A shares issued for asset acquisition (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,854,975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Class A shares issued for asset acquisition</a></td>
<td class="nump">$ 20,315<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,315<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2025</a></td>
<td class="nump">491,800,501<span></span>
</td>
<td class="nump">491,800,501<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2025</a></td>
<td class="nump">$ 1,046,948<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">2,980,729<span></span>
</td>
<td class="num">(1,967,879)<span></span>
</td>
<td class="nump">34,093<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Jun. 30, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">432,830,642<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Jun. 30, 2025</a></td>
<td class="nump">919,146<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">2,681,111<span></span>
</td>
<td class="num">(1,805,589)<span></span>
</td>
<td class="nump">43,620<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(162,253)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(162,253)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="num">(9,527)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,527)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock option exercises and other (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,871,306<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock option exercises and other</a></td>
<td class="num">(438)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(401)<span></span>
</td>
<td class="num">(37)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">25,244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Common stock sales issuances, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,243,578<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Common stock sales issuances, net of issuance costs</a></td>
<td class="nump">254,461<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">254,460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Class A shares issued for asset acquisition (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,854,975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Class A shares issued for asset acquisition</a></td>
<td class="nump">$ 20,315<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,315<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2025</a></td>
<td class="nump">491,800,501<span></span>
</td>
<td class="nump">491,800,501<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2025</a></td>
<td class="nump">$ 1,046,948<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 2,980,729<span></span>
</td>
<td class="num">$ (1,967,879)<span></span>
</td>
<td class="nump">$ 34,093<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (536,637)<span></span>
</td>
<td class="num">$ (284,755)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">64,223<span></span>
</td>
<td class="nump">23,543<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">87,460<span></span>
</td>
<td class="nump">50,904<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TangibleAssetImpairmentCharges', window );">Asset impairment</a></td>
<td class="nump">5,956<span></span>
</td>
<td class="nump">108<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Lease expense</a></td>
<td class="nump">17,019<span></span>
</td>
<td class="nump">11,155<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Loss on disposal of a business</a></td>
<td class="nump">4,502<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff', window );">Acquired IPR&amp;D</a></td>
<td class="nump">22,082<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other, net</a></td>
<td class="nump">6,655<span></span>
</td>
<td class="num">(650)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other receivables and assets</a></td>
<td class="nump">33,775<span></span>
</td>
<td class="num">(4,173)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_IncreaseDecreaseInPrepaidDataAssets', window );">Prepaid data assets</a></td>
<td class="nump">29,601<span></span>
</td>
<td class="nump">2,930<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_IncreaseDecreaseInAccruedDataLiability', window );">Accrued data liability</a></td>
<td class="nump">20,258<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Unearned revenue</a></td>
<td class="num">(30,014)<span></span>
</td>
<td class="num">(22,374)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(7,035)<span></span>
</td>
<td class="num">(1,687)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_IncreaseDecreaseInAccruedDevelopmentExpense', window );">Accrued development expense</a></td>
<td class="num">(4,210)<span></span>
</td>
<td class="num">(2,623)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="num">(23,246)<span></span>
</td>
<td class="num">(5,001)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_IncreaseDecreaseInLeaseLiability', window );">Lease liabilities</a></td>
<td class="num">(16,124)<span></span>
</td>
<td class="num">(11,121)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(325,735)<span></span>
</td>
<td class="num">(243,744)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(5,225)<span></span>
</td>
<td class="num">(12,397)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Purchase of an intangible asset</a></td>
<td class="num">(2,158)<span></span>
</td>
<td class="num">(3,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested', window );">Decrease in cash related to disposal of a business</a></td>
<td class="num">(4,438)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Purchases of investments</a></td>
<td class="num">(3,806)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(15,627)<span></span>
</td>
<td class="num">(15,397)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common shares, net of issuance costs</a></td>
<td class="nump">395,484<span></span>
</td>
<td class="nump">289,387<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Proceeds from equity incentive plans</a></td>
<td class="nump">3,300<span></span>
</td>
<td class="nump">6,433<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities', window );">Repayment of long-term debt and finance lease liabilities</a></td>
<td class="num">(6,258)<span></span>
</td>
<td class="num">(2,339)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_PaymentsToAcquireIntangibleAssetsFinancialActivities', window );">Purchase of an intangible asset</a></td>
<td class="num">(3,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">389,526<span></span>
</td>
<td class="nump">293,481<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash, cash equivalents and restricted cash</a></td>
<td class="nump">15,957<span></span>
</td>
<td class="nump">66<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net change in cash, cash equivalents and restricted cash</a></td>
<td class="nump">64,121<span></span>
</td>
<td class="nump">34,406<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash, beginning of period</a></td>
<td class="nump">603,024<span></span>
</td>
<td class="nump">401,425<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash, end of period</a></td>
<td class="nump">667,145<span></span>
</td>
<td class="nump">435,831<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental schedule of non-cash investing and financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Issuance of shares for the acquisition of an asset</a></td>
<td class="nump">20,315<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Accrued property and equipment</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">236<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_PurchaseOfAnEquityInvestmentNonCash', window );">Purchase of an equity investment</a></td>
<td class="nump">4,438<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1', window );">Purchase of an intangible asset</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_IncreaseDecreaseInAccruedDataLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Accrued Data liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_IncreaseDecreaseInAccruedDataLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_IncreaseDecreaseInAccruedDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Accrued Development Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_IncreaseDecreaseInAccruedDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_IncreaseDecreaseInLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Lease Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_IncreaseDecreaseInLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_IncreaseDecreaseInPrepaidDataAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Prepaid Data Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_IncreaseDecreaseInPrepaidDataAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_PaymentsToAcquireIntangibleAssetsFinancialActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments to Acquire Intangible Assets, Financial Activities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_PaymentsToAcquireIntangibleAssetsFinancialActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_PurchaseOfAnEquityInvestmentNonCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase Of An Equity Investment, Non-Cash</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_PurchaseOfAnEquityInvestmentNonCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate change on cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; held in foreign currency; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478345/912-310-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in other expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of intangibles that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the cash inflow during the period from the sale of a component of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for debt, mandatory redeemable security, and principal payment for finance lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of writeoff for research and development asset acquired in transaction other than business combination or from joint venture formation or both.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TangibleAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TangibleAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of the Business<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Description of the Business</a></td>
<td class="text">Description of the Business <div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recursion Pharmaceuticals, Inc. (&#8220;Recursion&#8221; or the &#8220;Company&#8221;) is a clinical stage TechBio company decoding biology and chemistry to industrialize drug discovery. The Recursion Operating System (OS), a platform built across diverse technologies, enables the Company to map and navigate trillions of biological and chemical relationships within the Recursion Data Universe, one of the world&#8217;s largest proprietary biological and chemical datasets. The Company integrates physical and digital components as iterative loops of atoms and bits scaling wet lab biology and chemistry data organized into virtuous cycles with computational tools to rapidly translate </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in silico </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">hypotheses into validated insights and novel chemistry.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2025, the Company had an accumulated deficit of $2.0 billion. The Company expects to incur substantial operating losses in future periods and will require additional capital to advance its drug candidates. The Company does not expect to generate significant revenue until the Company successfully completes significant drug development milestones or in collaboration&#160;with third parties, which the Company expects will take a number of years. In order to commercialize its drug candidates, the Company or its partners need to complete clinical development and comply with comprehensive regulatory requirements. The Company is subject to a number of risks and uncertainties similar to those of other companies of the same size within the biotechnology industry, such as the uncertainty of clinical trial outcomes, uncertainty of additional funding and a history of operating losses. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has funded its operations to date primarily through the issuance of Class A common stock (see Note 8, &#8220;Common Stock&#8221; for additional details). Additionally, the Company has received payments from its strategic partnerships (see Note 9, &#8220;Collaborative Development Contracts&#8221; for additional details). Recursion will likely be required to raise additional capital. As of September&#160;30, 2025, the Company did not have any unconditional outstanding commitments for additional funding. If the Company is unable to access additional funds when needed, it may not be able to continue the development of its products or the Company could be required to delay, scale back or abandon some or all of its development programs and other operations. The Company&#8217;s ability to access capital when needed is not assured and, if not achieved on a timely basis, could materially harm its business, financial condition and results of operations. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recursion believes that the Company&#8217;s existing cash and cash equivalents will be sufficient to fund the Company&#8217;s operating expenses and capital expenditures for at least the next 12 months.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482836/275-10-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482836/275-10-55-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Basis of Presentation</a></td>
<td class="text">Basis of Presentation<div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited interim condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC). Accordingly, certain information and footnote disclosures normally included in annual financial statements prepared in accordance with generally accepted accounting principles in the United States (U.S. GAAP) have been condensed or omitted. These unaudited interim condensed consolidated financial statements should be read in conjunction with the Company&#8217;s audited consolidated financial statements and notes for the year ended December&#160;31, 2024. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is management&#8217;s opinion that these condensed consolidated financial statements include all normal and recurring adjustments necessary for a fair statement of the financial position, results of operations and cash flows for the periods presented. Revenue and net loss for any interim period are not necessarily indicative of future or annual results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2025, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2025-06, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for internal-use software costs (Topic 350)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The new standard amends specific aspects of the accounting for internal-use software costs including the criteria for capitalizing software costs. It also amends the related disclosure requirements. This standard will be effective for Recursion starting the annual period ending </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;15, 2028 and for interim reporting periods within that annual reporting period. Early adoption is permitted. The amendments can be applied on a prospective, modified prospective or retrospective basis. Recursion is currently assessing the impact of adopting this guidance on its consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2024-03, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Income Statement Expenses (Topic 220)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The standard requires new disclosures in the notes to the financial statements about certain caption expenses presented on the face of the Income Statement including information on: purchases of inventory; employee compensation; depreciation and intangible asset amortization. Recursion must also disclose a qualitative description of the amounts remaining in expense captions that are not separately disaggregated. This standard will be effective for Recursion starting the annual period ending December 31, 2027 and for interim reporting periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The amendments can be applied on a prospective or retrospective basis. Recursion is currently assessing the impact of adopting this guidance on its consolidated financial statements. </span></div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU No. 2023-09, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740)</span>. The new standard updates disclosure requirements for Accounting Standards Codification (ASC) 740 primarily by requiring additional information in the income tax rate reconciliation and additional disclosures about income taxes paid. This standard will be effective for Recursion starting the annual period ending December 31, 2025. The amendments can be applied on a prospective or retrospective basis. The Company is in process of evaluating the impact of adoption of ASU 2023-09 on the Company's consolidated financial statements and disclosures. We do not expect the adoption of this ASU to have a material impact on our consolidated financial statements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Financial Information<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_SupplementalFinancialInformationAbstract', window );"><strong>Supplemental Financial Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_SupplementalBalanceSheetAndIncomeStatementInformationTextBlock', window );">Supplemental Financial Information</a></td>
<td class="text">Supplemental Financial Information <div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tempus agreement</span></div><div><span><br/></span></div><div><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">November 2023</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Recursion entered into a </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">five</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-year agreement </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(the Tempus Agreement) </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with Tempus AI, Inc. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;Tempus&#8221;) t</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o purchase access to their records of patient-centric multimodal oncology data and use rights for therapeutic development purposes. This data will be used to improve the training of Recursion&#8217;s artificial intelligence and machine learning models and is expected to accelerate Recursion&#8217;s drug discovery process. Recursion is making annual payments, ranging between </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$22.0&#160;million</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$42.0&#160;million</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, up to </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$160.0&#160;million</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in aggregate, to Tempus in cash or equity at the Company&#8217;s option. The equity value is determined by using the <span style="-sec-ix-hidden:f-388">seven</span>-trading day period dollar volume-weighted average price (VWAP) for Recursion Class A common stock ending on the day immediately preceding the date that is <span style="-sec-ix-hidden:f-389">five</span> business days prior to the payment date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recursion is expensing the record purchases based on a contractually agreed price as &#8220;Research and Development&#8221; expenses in the Condensed Consolidated Statements of Operations as the records are downloaded. To the extent that the Recursion payments to Tempus are greater than or less than the records purchased amount, Recursion records the applicable amount to &#8220;Prepaid data assets&#8221; or &#8220;Accrued data liability&#8221; on the Condensed Consolidated Balance Sheet, respectively. The expense for the record purchases was $49.9 million and $2.9 million for the nine months ended September 30, 2025 and 2024. There was no expense recorded for the three months ended September 30, 2025 and 2024</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accrued Expenses and Other Liabilities</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.660%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.521%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,056&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,853&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,812&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued early discovery expenses</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,840&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,095&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,956&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">787&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Materials received not invoiced</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,590&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued license fees</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued other expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,547&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,735&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expense and other liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,102&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,872&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restructuring</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2025, Recursion announced a reduction in personnel program to help streamline the Company's operating strategy and post-integration efficiencies. These changes resulted in a workforce reduction of approximately 20%. The Company estimates that it will incur approximately $9.5 million in charges for the workforce reduction, consisting of severance payments and employee benefits. Recursion expects to incur all of these expenses in the year ending December&#160;31, 2025. Recursion records these costs in &#8220;General and Administrative&#8221; on the Condensed Consolidated Statement of Operations as incurred. The following summarizes the activity related to these restructuring actions and the related accrual as of September&#160;30, 2025:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"><tr><td style="width:1.0%"></td><td style="width:77.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.212%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,717)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2025</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">799&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Income, Net</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,540&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,826&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,541&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(833)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(553)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,821)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(967)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,707&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,273&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,720&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,171&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September 30, 2025 and 2024, interest income primarily related to earnings on cash and cash equivalents in money market funds. Interest expense primarily related to the Company&#8217;s supercomputer financing lease. Interest income, net was included in &#8220;Other income (loss), net&#8221; on the Condensed Consolidated Statements of Operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_SupplementalBalanceSheetAndIncomeStatementInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supplemental Balance Sheet And Income Statement Information</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_SupplementalBalanceSheetAndIncomeStatementInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_SupplementalFinancialInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supplemental Financial Information</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_SupplementalFinancialInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Acquisitions</a></td>
<td class="text">Acquisitions<div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RE Ventures I</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2025, Recursion acquired Rallybio&#8217;s interest in the joint venture, RE Ventures I, such that Recursion now owns 100% of the interest in RE Ventures I for total consideration of $20.2 million. Recursion determined that this </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">transaction met the criteria for as an asset acquisition since the lead asset, ENPP1 (Rec-102), an inhibitor program for the treatment of hypophosphatasia (HPP), represented substantially all of the fair value of the gross assets acquired. For the three months ended September 30, 2025, Recursion recorded an expense of $20.2 million, representing an acquired in-process research and development (IPR&amp;D) asset with no alternative future use, to &#8220;Research and Development&#8221; on the Condensed Consolidated Statements of Operations. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to closing, in August 2025, Recursion issued additional consideration as part of a required milestone payment related to the RE Ventures I transaction for the initiation of an additional preclinical study. This included the settlement of the previously recorded contingent consideration liability. As a result, Recursion recorded an additional expense of $2.4 million acquired IPR&amp;D, which was recorded to &#8220;Research and Development&#8221; on the Condensed Consolidated Statements of Operations. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the total consideration transferred at acquisition date:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recursion Class A common stock</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,815&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liability</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transactions costs</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,153&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the consideration transferred for the milestone:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recursion Class A common stock</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,768&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,268&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the agreement, Rallybio is eligible to receive additional milestone payments under certain conditions. Milestone payment obligations that are incurred prior to regulatory approval of the compound will be expensed as acquired IPR&amp;D when recognized.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sale of Exscientia GmbH</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2025, Recursion completed the sale of its Austrian operations (Exscientia GmbH) to a newly formed company, Alpha Biotechnology GmbH (Alpha). As part of the sale, Recursion obtained a 49% equity interest in Alpha. Recursion entered into this transaction as part of focusing its efforts and moderating spend. Alpha is a company leveraging a patient-tissue platform for the development of precision therapeutics for the treatment of hematological and solid cancers. For the nine months ended September 30, 2025, Recursion recorded a loss on the disposal of Exscientia GmbH of $4.5 million, which was classified as &#8220;Other income (loss), net&#8221; on the Condensed Consolidated Statement of Operations. Recursion also recorded a $4.4 million investment on the Condensed Consolidated Balance Sheet within &#8220;Other assets, non-current&#8221; related to its 49% equity interest in Alpha, which was determined to be an equity method investment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Exscientia plc</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, Recursion acquired all of the outstanding equity interests of Exscientia plc (&#8220;Exscientia&#8221;), a United Kingdom based public company that was registered on the Nasdaq Global Select Market. Exscientia is a drug design company utilizing its artificial intelligence platform to efficiently design and develop differentiated medicines for diseases with high unmet patient needs. Their focus is on utilizing their platform to develop best in class molecules with improvements to known or likely points of failure to improve the probability of developmental success. The Company believes the combination of the Recursion and Exscientia platforms and pipelines will position it to be a leader of the AI-enabled drug discovery and development space.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition of Exscientia was accounted for as a business combination using the acquisition method of accounting. The consideration transferred of approximately $630.1 million consisted of $616.9 million in Recursion Class A shares and $13.2 million related to the portion of Exscientia share based awards that were replaced with Recursion share based awards that is attributable to pre-combination service. Approximately 102.1 million Recursion Class A shares were issued in exchange for Exscientia ordinary shares using a fixed exchange ratio of one Exscientia ordinary share converts to 0.7729 Recursion Class A shares (the &#8220;Exchange Ratio&#8221;). In addition, Recursion replaced all outstanding Exscientia share based awards with Recursion share based awards wherein the vesting schedule and other applicable terms were carried over except for the exercise price of share options which were adjusted using the 0.7729 exchange ratio. This included Exscientia&#8217;s stock options and restricted stock units. Recursion used $6.04, the Company&#8217;s share price on November&#160;20, 2024 to calculate the consideration transferred. See Note 10, &#8220;Stock-Based Compensation&#8221; for additional information on the Exscientia share based awards.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the nine months ended September 30, 2025, Recursion updated the deferred tax liabilities from the acquisition, which were incomplete as of December&#160;31, 2024. As a result, Recursion adjusted the provisional deferred tax liabilities to reflect the additional information obtained about the facts and circumstances that existed as of the acquisition date. As a result, deferred tax liabilities and goodwill increased by $6.0 million. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of assets acquired and liabilities assumed as of the acquisition date:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:79.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.373%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(in thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">277,104&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">48,408&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">12,843&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">61,961&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">20,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Intangible assets, technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">182,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Intangible assets, indefinite-lived</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">129,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1,934&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other assets, non-current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">930&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Accounts payable and accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(40,780)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(21,679)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(120,905)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(23,077)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(1,572)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Total identifiable net assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">526,438&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">103,686&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Total assets acquired and liabilities assumed</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">630,124&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquired contract liabilities in the scope of ASC 606 are an exception to the ASC 805 fair value measurement principle and were measured as if Recursion had originated the acquired contract. Two acquired customer contracts had contract liabilities and for each contract Recursion reassessed the identification of performance obligations, determination of transaction price, allocation of transaction price and measure of progress for each performance obligation as if Recursion has been party to the original contract and recognized the resulting contract liability as a liability assumed. No contract assets in the scope of ASC 606 were acquired.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The intangible assets of Exscientia consist of the Exscientia artificial intelligence platform and four clinical stage oncology in process research and development (IPR&amp;D) assets. The operating system is a critical tool used for both designing molecules for fulfilling collaboration agreements and Exscientia&#8217;s own research and development projects. The fair value of each intangible asset was valued based on the present value of future discounted cash flows prepared under the multi-period excess earnings method with the significant inputs being the estimates of future revenues, future expenses, the discount rate of 10.5% and probabilities of technological and regulatory success. The platform asset is being amortized on a straight line basis ove</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">r a six year useful life. The IPR&amp;D assets </span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">have been assigned an indefinite useful life and will be tested for impairme</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nt prospectively and, if regulatory approval is achieved, will be assigned a useful life and amortization will commence.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill was calculated based on the excess of the consideration transferred over net assets acquired. The goodwill recognized represents the assembled workforce, future research and development projects enabled by the platform that do not yet have sufficient substance to meet the definition of in-process research and development assets and expected synergies such as the integration of Recursion and Exscientia platforms. The goodwill is not deductible for tax purposes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recursion&#8217;s consolidated statement of operations for the nine months ended September 30, 2025 includes $16.8 million of revenue and $139.4 million of operating loss from Exscientia operations. As the business combination occurred in November 2024, Recursion is still finalizing the allocation of the purchase price to assets acquired and liabilities assumed. The preliminary purchase price allocation reflected in the September&#160;30, 2025 balance sheet is based on the current best estimate of management and subject to change. The Company will finalize the amounts recognized as the information necessary to complete the analysis is obtained and management estimates are further refined. The primary areas subject to finalization are the valuation of intangible assets, right-of-use assets, property and equipment and the valuation of tax assets and liabilities. The Company expects to finalize the purchase price allocation soon but will do so no later than one year from the acquisition date. External specialists have been engaged to assist with certain elements of applying the acquisition method of accounting.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pro forma financial information </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following pro forma summary presents consolidated revenue and earnings of Recursion as if the Exscientia business combination had occurred on January&#160;1, 2023</span><span style="color:#008080;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:51.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.795%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.797%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Three months ended September 30, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Nine months ended September 30, 2024</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(in thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">32,048&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">75,643&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Operating loss</span></td><td style="border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(202,645)</span></td><td style="border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td style="border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(512,213)</span></td><td style="border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pro forma amounts have been calculated after converting the Exscientia financial information to U.S. GAAP, applying Recursion accounting policies and applying the acquisition method of accounting at January&#160;1, 2023. The pro forma financial information is not necessarily indicative of what the consolidated results of operations would have been had the acquisition been completed on January&#160;1, 2023. In addition, the pro forma financial information is not a projection of the future results of operations of the combined company nor does it reflect the expected realization of any cost savings or synergies associated with the acquisition.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 38<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-38<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 46<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-46<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 43<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-43<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 45<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-45<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 29<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-29<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 29<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-29<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-4<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-4<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479326/805-40-45-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/805-30/tableOfContent<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/805-20/tableOfContent<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-5<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/805-10/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases <div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into various long-term real estate operating leases primarily related to office, research and development and operating activities and an equipment financing lease related to the supercomputer. The Company&#8217;s leases have remaining terms from under one year to eight years and some of those leases include options that provide Recursion with the ability to extend the lease term, generally for 5 years. The options are included in the lease term when it is reasonably certain that the option will be exercised. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September 30, 2025, Recursion entered into lease modifications and terminations resulting in a decrease to the right-of-use asset and lease liability of $10.1&#160;million.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This impact included the lease surrender of the Vienna facilities of Exscientia GmbH in </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 2025</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which resulted in a $5.2 million reduction to both the right-of-use asset and lease liability. In connection with this surrender, the Company also incurred a lease termination fee of $5.2 million, which was classified as &#8220;Other income (loss), net&#8221; on the Condensed Consolidated Statement of Operations. Additionally, the Company entered into a lease modification related to the Schrodinger leases to decrease the lease terms, which now ended during the second quarter of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This resulted in a decrease to both the right-of-use asset and lease liability by $4.9 million. As a part of the lease modifications and termination, Recursion recorded leasehold impairments of $6.0 million. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended September 30, 2024,</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Recursion entered into operating lease modifications and additions resulting in an increase to the right-of-use asset and lease liability of $19.5 million. The modifications had </span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">no impact to the Condensed Consolidated Statements of Operations. For the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended September 30, 2024,</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Recursion entered into finance lease additions resulting in an increase to the right-of-use asset and lease liability of $29.3 million. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases were:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.666%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.199%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amount included in the measurement of lease liabilities: </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,756&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from financing leases</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,368&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from financing leases</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,261&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets additions, modifications and termination:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,084)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,455&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing leases</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,342&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases <div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into various long-term real estate operating leases primarily related to office, research and development and operating activities and an equipment financing lease related to the supercomputer. The Company&#8217;s leases have remaining terms from under one year to eight years and some of those leases include options that provide Recursion with the ability to extend the lease term, generally for 5 years. The options are included in the lease term when it is reasonably certain that the option will be exercised. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September 30, 2025, Recursion entered into lease modifications and terminations resulting in a decrease to the right-of-use asset and lease liability of $10.1&#160;million.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This impact included the lease surrender of the Vienna facilities of Exscientia GmbH in </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 2025</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which resulted in a $5.2 million reduction to both the right-of-use asset and lease liability. In connection with this surrender, the Company also incurred a lease termination fee of $5.2 million, which was classified as &#8220;Other income (loss), net&#8221; on the Condensed Consolidated Statement of Operations. Additionally, the Company entered into a lease modification related to the Schrodinger leases to decrease the lease terms, which now ended during the second quarter of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This resulted in a decrease to both the right-of-use asset and lease liability by $4.9 million. As a part of the lease modifications and termination, Recursion recorded leasehold impairments of $6.0 million. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended September 30, 2024,</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Recursion entered into operating lease modifications and additions resulting in an increase to the right-of-use asset and lease liability of $19.5 million. The modifications had </span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">no impact to the Condensed Consolidated Statements of Operations. For the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended September 30, 2024,</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Recursion entered into finance lease additions resulting in an increase to the right-of-use asset and lease liability of $29.3 million. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases were:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.666%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.199%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amount included in the measurement of lease liabilities: </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,756&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from financing leases</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,368&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from financing leases</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,261&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets additions, modifications and termination:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,084)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,455&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing leases</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,342&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Intangible Assets</a></td>
<td class="text">Goodwill and Intangible Assets <div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in the carrying amount of goodwill: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.836%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148,873&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,947&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2025</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,042&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No goodwill impairment was recorded during the three and nine months ended September 30, 2025 and 2024.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets, Net</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes intangible assets:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross carrying amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net carrying amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross carrying amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net carrying amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Definite-lived technology intangible assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,806)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178,637&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224,362&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,544)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,818&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Definite-lived licensed intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,679)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,829&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,088)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,878&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,878&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,775&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,775&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385,829&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63,485)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322,344&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362,487&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,632)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335,855&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense was $13.4 million and $37.4 million during the three and nine months ended September 30, 2025, respectively. Amortization expense was $4.1 million and $11.3 million during the three and nine months ended September 30, 2024, respectively. Amortization expense was included in &#8220;Research and Development&#8221; and &#8220;Cost of Revenue&#8221; in the Condensed Consolidated Statements of Operations. No indefinite-lived intangible asset impairment charges were recorded during the three and nine months ended September 30, 2025 and 2024.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Obligations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company enters into contracts with clinical research organizations, drug manufacturers and other vendors&#160;for preclinical and clinical research studies, research and development supplies and other services and products for operating purposes. These contracts generally provide for termination on notice and are cancellable contracts.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indemnification</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has agreed to indemnify its officers and directors for certain events or occurrences, while the officer or director is or was serving at the Company&#8217;s request in such capacity. The Company purchases directors and officers liability insurance coverage that provides for reimbursement to the Company for covered obligations and this is intended to limit the Company&#8217;s exposure and enable it to recover a portion of any amount it pays under its indemnification obligations. The Company had no liabilities recorded for these agreements as of September&#160;30, 2025 and December&#160;31, 2024, as no amounts were probable. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Agreements </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has signed employment agreements with certain key employees pursuant to which, if their employment is terminated following a change of control of the Company, the employees are entitled to receive certain benefits, including accelerated vesting of equity incentives. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Matters</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may, from time to time, be involved in various legal proceedings arising in the normal course of business. An unfavorable resolution of any such matter could materially affect the Company&#8217;s future financial position, results of operations or cash flows. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April 2024</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a putative class action complaint was filed in the U.S. District Court for the District of New Jersey against Exscientia plc, Andrew Hopkins, Ben R. Taylor and David Nicholson (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Campanile v. Exscientia plc, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Case No. 1:24-cv-05692). In </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June 2024</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a separate complaint was filed against the same defendants in the U.S. District Court for the District of New Jersey (Case 1:24-cv-07181). Both complaints allege that the defendants violated federal securities laws by, among other things, making materially false and misleading statements regarding Exscientia&#8217;s business, operations and prospects. The complaints seek unspecified compensatory damages, as well as an award of reasonable attorneys&#8217; fees and other costs, on behalf of persons and/or entities which purchased Exscientia securities between </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 2022</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 2024</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The cases were consolidated and plaintiffs filed an amended complaint on November 11, 2024 against Exscientia plc, Andrew Hopkins and David Nicholson, and the Company moved to dismiss on January 21, 2025. On </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">October&#160;7, 2025</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that motion to dismiss was granted and the District Court dismissed the plaintiff&#8217;s claims without prejudice; permitting leave to re-file the complaint within 30 days. As of </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;30, 2025</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company had no liability recorded for these events as an unfavorable outcome was not probable.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, the Company entered into a lease agreement for laboratory and office space (the Industry Lease) with Industry Office SLC, LLC (the landlord). In March 2023, the Company sent a letter to the landlord detailing numerous construction delays and irregularities, deficiencies and deviations from applicable structural drawings and/or non-conforming conditions with applicable building codes (collectively, the Claims). On June&#160;23, 2023, the landlord filed a lawsuit against the Company (Industry Office SLC, LLC v. Recursion Pharmaceuticals, Inc., Case No. 230904627) amended in October 2023, in the Third District Court for Salt Lake County, State of Utah (the Court), alleging anticipatory repudiation, breach of contract and breach of the implied covenant of good faith and fair dealing and seeks monetary damages and attorney&#8217;s fees. As of September&#160;30, 2025, the Company had no liability recorded for these events as an unfavorable outcome was not probable. In September 2023, the Company filed claims in the Court against the landlord alleging, among other things, breach of contract and fraudulent misrepresentation (the Counterclaims). In October 2023, the landlord filed an answer and denied the Company&#8217;s allegations asserted in the Counterclaims. In </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">October 2025</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company filed a motion for summary judgment against the Claims and in favor of a number of its Counterclaims, which remains pending. The Company is unable to estimate the possible amount or range of damages associated with the Counterclaims.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pledged Assets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2025, assets pledged as collateral against finance leases totaled $19.5 million. Assets pledged as collateral are Lab Equipment reported in &#8220;Property and Equipment, net&#8221; on the Condensed Consolidated Balance Sheet. As of September&#160;30, 2025, the liabilities associated with collateral pledged were solely comprised of a finance lease and had a carrying value of $20.5 million. The collateral pledged under the lease agreement may only be operated by the Company within the continental United States and must maintain a good title. The assets cannot be sold, disposed of or repledged by the Company.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Common Stock</a></td>
<td class="text">Common Stock <div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each share of Class A common stock entitles the holder to one vote per share and each share of Class B common stock entitles the holder to 10 votes per share on all matters submitted to a vote of the Company&#8217;s stockholders. Common stockholders are entitled to receive dividends, as may be declared by the Company&#8217;s Board of Directors. As of September&#160;30, 2025 and December&#160;31, 2024, no dividends had been declared. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">At-The-Market Offering (Citi)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 2025</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, following the termination of the Jefferies Sales Agreement, the Company entered into a Sales Agreement (the Citi Sales Agreement) with Citigroup Capital Markets Inc. (Citi) to provide for the offering, issuance and sale of up to an aggregate amount of $500 million of its Class A common stock from time to time in &#8220;at-the-market&#8221; offerings (the Citi ATM Offering). The Citi ATM Offering was made under a prospectus supplement dated February&#160;28, 2025 and related prospectus filed with the Securities and Exchange Commission pursuant to the Company&#8217;s automatically effective shelf registration statement on Form S-3 (Registration No. 333-284878). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September 30, 2025, the Company sold 74.6&#160;million shares and received net proceeds of $358.2 million under the agreement. As of&#160;September&#160;30, 2025, an amount of $136.4 million remained available for future sales under the Sales Agreement. The remaining amount was fully utilized during October 2025, see Note 15, &#8220;Subsequent Events</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; for additional details.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">At-The-Market Offering (Jefferies)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">August 2023</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company entered into an Open Market Sales Agreement (the &#8220;Jefferies Sales Agreement&#8221;) with Jefferies LLC ( &#8220;Jefferies&#8221;), to provide for the offering, issuance and sale of up to an aggregate amount of $300.0 million of its Class A common stock from time to time in &#8220;at-the-market&#8221; (ATM) offerings. In </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 2025</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company terminated the Jefferies Sales Agreement. In total, the Company sold 26.8&#160;million shares and received net proceeds of $199.1 million under the agreement through its termination. Of the total sales and net proceeds, the Company sold 4.9&#160;million shares and received net proceeds of $36.9 million under the agreement in 2025,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">prior to its termination. The Company paid Jefferies a commission of up to 3% of the aggregate gross proceeds received from all sales of Class A common stock. The Jefferies ATM Offering was made under a prospectus supplement dated August&#160;8, 2023 and related prospectus filed with the Securities and Exchange Commission pursuant to the Company&#8217;s automatically effective shelf registration statement on Form S-3ASR (Registration No. 333-264845). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Public Offering of Common Stock</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2024, the Company closed its public offering of Class A common stock and issued 35.4&#160;million shares at a price of $6.50 per share for net proceeds of approximately $216.4 million, after deducting transaction costs of $13.6 million. In connection with the public offering of Class A common stock, the Company entered into an underwriting agreement for the offering and sale of 30.8&#160;million shares. The Company also granted the Underwriters a 30 day option from the date of the underwriting agreement to purchase up to an additional 4.6&#160;million shares of Class A Common Stock, which was exercised in full. The public offering was made pursuant to the Company's effective registration statement on Form S-3 (File No. 333-264845) and a related prospectus supplement and accompanying prospectus dated June&#160;26, 2024.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Valence Acquisition Exchangeable Shares</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May 2023</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, in connection with the acquisition of Valence, the Company entered into an agreement to issue up to 5.9&#160;million shares of Class A common stock (the &#8220;Exchangeable Shares&#8221;), that may be issued upon exchange, retraction or redemption of exchangeable shares of a subsidiary of Recursion. Each exchangeable share of the subsidiary of Recursion entitles the holder to exchange those shares on a one-for-one basis for Recursion&#8217;s Class A common stock. The shares are entitled to receive dividends economically equivalent to dividends declared by Recursion, are non-voting and are subject to customary adjustments for stock splits or other reorganizations. In addition, the Company may require all outstanding exchangeable shares to be exchanged into an equal number of Class A common stock upon the occurrence of certain events and at any time following the seventh anniversary of the closing of the Valence acquisition. The exchangeable shares are substantially the economic equivalent of the Class A shares and classified as common stock within the Company&#8217;s stockholders&#8217; equity. The Company&#8217;s calculation of weighted-average shares outstanding includes the exchangeable shares. As of September&#160;30, 2025, 5.0&#160;million Exchangeable shares have been redeemed for Class A shares.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Registration Rights Agreements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Tempus agreement</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">November 2023</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, in connection with the Tempus Agreement, the Company agreed to prepare and file a registration statement (or a prospectus supplement to an effective registration statement on Form S-3ASR that will become automatically effective upon filing with the SEC pursuant to Rule 462(e)) with the SEC, for resale of the shares of Class A common stock issued or issuable under the Tempus Agreement. A prospectus supplement to a registration statement (File No. 333-264845) was subsequently filed in December 2023 to register shares issued to Tempus for the initial license fee under the Tempus Agreement for resale. In December 2024, a prospectus supplement to a registration statement (File No. 333-264845) was filed to register shares issued to Tempus in payment for the 2024 annual fee. Such registration statement (File No. 333-264845) expired.  A new registration statement (333-284878) was filed in February 2025 and a prospectus supplement covering all shares that have been issued under the Tempus Agreement and remained held by Tempus was filed in May 2025.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After registration of any shares issued to Tempus under the Tempus Agreement, the Company has agreed to use commercially reasonable efforts to keep such registration statement effective until such date that all shares issued to Tempus covered by such registration statement have been sold or are able to be publicly sold by relying on Rule 144 of the Securities Act without registration.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Acquisitions</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, in connection with the acquisition of Exscientia, the Company filed a Registration Statement on Form S-8 (File No. 333-283347) to register the shares of Class A common stock issuable upon exercise or settlement, as applicable, of Recursion stock options and RSUs issued under the assumed Exscientia plans and the Inducement awards. The Company has agreed to use commercially reasonable efforts to maintain the effectiveness of such registration statement as long as such Recursion stock options and RSUs issued under the assumed Exscientia plans remain outstanding.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2023, in connection with the acquisition of Valence, the Company entered into a Registration Agreement providing for the registration for resale of the shares of Class A common stock and Exchange Shares issued or issuable in such transaction. A registration statement on Form S-3ASR (File No. 333-272281) was filed to register the shares for resale by the holders. The registration statement must remain effective for a period of not less than three years. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Class A and B Common Shares Authorization</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, the Company&#8217;s Board of Directors authorized two classes of common stock, Class A and Class B. The rights of the holders of Class A and B common stock are identical, except with respect to voting and conversion. Each share of Class A common stock is entitled to one vote per share. Each share of Class B common stock is entitled to 10 votes per share and is convertible at any time into one share of Class A common stock.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All Class B common stock is held by Christopher Gibson, Ph.D., the Company&#8217;s Chief Executive Officer (CEO), or his affiliates. As of September&#160;30, 2025, Dr. Gibson and his affiliates held outstanding shares of Class B common </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">stock representing approximately 12% of the voting power of the Company&#8217;s outstanding shares. This voting power may increase over time as Dr. Gibson vests in and exercises equity awards outstanding. If all the exchangeable equity awards held by Dr. Gibson had been fully vested, exercised and exchanged for shares of Class B common stock as of September&#160;30, 2025, Dr. Gibson and his affiliates would hold approximately 13% of the voting power of the Company&#8217;s outstanding shares. As a result, Dr. Gibson will be able to significantly influence any action requiring the approval of Recursion stockholders, including the election of the Board of Directors; the adoption of amendments to the Company&#8217;s certificate of incorporation and bylaws; and the approval of any merger, consolidation, sale of all or substantially all of the Company&#8217;s assets, or other major corporate transaction.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaborative Development Contracts<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Collaborative Development Contracts</a></td>
<td class="text">Collaborative Development Contracts <div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sanofi</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Description</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">January 2022</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company and Sanofi entered into a collaboration agreement to develop an AI-driven pipeline of precision-engineered medicines. The research is focused on up to 15 novel small molecule candidates across oncology and immunology and utilizes the Company&#8217;s AI platform. The Company is leading small molecule drug design and lead optimization activities with Sanofi assuming responsibility for preclinical and clinical development, manufacturing and commercialization.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Pricing</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company received a $100.0 million non-refundable upfront payment. In </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April 2025</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Recursion received a $7.0 million payment related to the achievement of a milestone for one of the performance obligations. The Company has also received multiple other milestone payments related to this agreement totaling approximately $30.0 million. These related to the advancement of several of the discovery programs within the collaboration and the addition of an existing Company program into the collaboration. Recursion is eligible for additional milestone payments based on performance progress of the collaboration and tiered royalties ranging from high-single-digits to mid-teens. Recursion could earn a maximum of $555.0 million from all research milestones and $1.8 billion from all development and regulatory milestones.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Accounting</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">November 2024</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Recursion acquired Exscientia as part of an acquisition. See Note 4, &#8220;Acquisitions&#8221; for additional information. As such, the initial Recursion accounting analysis for this transaction was done as of the business combination date as if Recursion had originated the contract. This agreement represents a transaction with a customer and therefore is accounted for in accordance with ASC 606. Recursion has determined that it has at least eight performance obligations related to the small molecule projects. These performance obligations are for performing research and development services for Sanofi to design small molecules and perform lead optimization activities. The performance obligations also include potential licenses related to the intellectual property. The Company concluded that licenses within the contract are not distinct from the research and development services as they are interrelated due to the fact that the research and development services significantly impact the potential licenses. Any additional services are considered customer options and will be considered as separate contracts for accounting purposes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has determined the transaction price to be $152.9 million, for the initial performance obligations, comprised of the upfront payment, several milestones that have been achieved and estimated additional target exercises. Prior to the three months ended June 30, 2025, Recursion had fully constrained the $7.0 million variable consideration milestone. Recursion is now recognizing the milestone as part of the transaction price over the completion period for the related performance obligation. Recursion has fully constrained the amounts of remaining variable consideration to be received from potential milestones considering the stage of development and the risks associated with the remaining development required to achieve each milestone. Recursion will re-evaluate the transaction price each reporting period. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction price was generally allocated to the performance obligations based on the estimated relative stand-alone selling price of each performance obligation as determined using an expected cost plus margin approach. The milestone fees were allocated to related performance obligation as the terms of the variable consideration related specifically to Recursion&#8217;s efforts to satisfy the related performance obligation. The Company recognizes revenue over time based on costs incurred relative to total expected costs to perform the research and development services. Recursion determined that this method provides a faithful depiction of the transfer of control to the </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">customer. This method of recognizing revenue requires the Company to make estimates of total costs to provide the services required under the performance obligations. Significant inputs used to determine the total costs included the number of projects to be performed, the number of substitutions related to those projects, length of time required, service hours performed by Company employees and materials costs. A significant change in these estimates could have a material effect on the timing and amount of revenue recognized in future periods. Recursion is unable to estimate the completion date of the performance obligations due to the current stage of work.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Merck KGaA (Merck)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Description</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September 2023</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company and Merck entered into a collaboration agreement to discover novel small molecule drug candidates across oncology, neuroinflammation and immunology. The collaboration utilizes the Company&#8217;s AI platform and the Company is performing drug design and discovery while Merck will be assuming responsibility for the preclinical and clinical development.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Pricing</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company received a $20.1 million non-refundable upfront payment. Recursion is eligible for additional milestone payments based on performance progress of the collaboration and tiered royalties from the mid-single-digits to low-double-digits. The Company could earn a maximum of $73.0 million for discovery, development and sales milestones per project.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Accounting</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">November 2024</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Recursion acquired Exscientia as part of an acquisition. See Note 4, &#8220;Acquisitions&#8221; for additional information. As such, the initial Recursion accounting analysis for this transaction was done as of the business combination date as if Recursion had originated the contract. This agreement represents a transaction with a customer and therefore is accounted for in accordance with ASC 606. Recursion has determined that it has three performance obligations related to each project in the partnership. These performance obligations are for performing research and development services for Merck to design small molecules and perform lead optimization activities. The performance obligations also include potential licenses related to the intellectual property. The Company concluded that licenses within the contract are not distinct from the research and development services as they are interrelated due to the fact that the research and development services significantly impact the potential licenses. Any additional services are considered customer options and will be considered as separate contracts for accounting purposes. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has determined the transaction price to be $20.1 million, for the initial performance obligations, comprised of the upfront payment. Recursion will fully constrain the amounts of remaining variable consideration to be received from potential milestones considering the stage of development and the risks associated with the remaining development required to achieve each milestone. Recursion will re-evaluate the transaction price each reporting period. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction price was allocated to the performance obligations based on the estimated relative stand-alone selling price of each performance obligation as determined using an expected cost plus margin approach. The Company recognizes revenue over time based on costs incurred relative to total expected costs to perform the research and development services. Recursion determined that this method provides a faithful depiction of the transfer of control to the customer. This method of recognizing revenue requires the Company to make estimates of total costs to provide the services required under the performance obligations. Significant inputs used to determine the total costs included the number of projects to be performed, the number of substitutions related to those projects, length of time required, service hours performed by Company employees and materials costs. A significant change in these estimates could have a material effect on the timing and amount of revenue recognized in future periods. Recursion was unable to estimate the completion date of the performance obligations due to the current stage of work.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Roche and Genentech</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Description</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, Recursion entered into a collaboration and license agreement with Roche and Genentech (collectively referred to as Roche). Recursion is constructing, using the Company&#8217;s imaging technology and proprietary machine-learning algorithms, unique maps of the inferred relationships amongst perturbation </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">phenotypes in a given cellular context with the goal to discover and develop therapeutic small molecule programs in a gastrointestinal cancer indication and in key areas of neuroscience. Roche and Recursion will collaborate to select certain novel inferences with respect to small molecules or targets generated from the Phenomaps for further validation and optimization as collaboration programs. Roche and Recursion may also combine sequencing datasets from Roche with Recursion&#8217;s Phenomaps and collaborate to generate new algorithms to produce multi-modal maps from which additional collaboration programs may be initiated. For every collaboration program that successfully identifies potential therapeutic small molecules or validates a target, Roche will have an option to obtain an exclusive license to develop and commercialize such potential therapeutic small molecules or to exploit such target in the applicable exclusive field.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Pricing</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, Recursion received a $150.0 million non-refundable upfront payment from the Company&#8217;s collaboration with Roche. In September 2024, Recursion received a $30.0 million milestone payment (the &#8220;acceptance fee&#8221;), which was an acceptance fee related to the first accepted neuroscience Phenomap. Recursion is eligible for additional milestone payments based on performance progress of the collaboration. Each of the Phenomaps requested by Roche and created by Recursion may be subject to either an initiation fee, acceptance fee or both. Such fees could exceed $250.0 million for 16 accepted Phenomaps. In addition, for a period of time after Roche&#8217;s acceptance of certain Phenomaps, Roche will have the option to obtain, subject to payment of an exercise fee, rights to use outside the collaboration the raw images generated in the course of creating those Phenomaps. If Roche exercises its external use option for all 12 eligible Phenomaps, Roche&#8217;s associated exercise fee payments to Recursion could exceed $250.0 million. Under the collaboration, Roche may initiate up to 40 programs, each of which, if successfully developed and commercialized, could yield more than $300.0&#160;million in development, commercialization and net revenue milestones for Recursion, as well as tiered royalties on net revenue.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Accounting</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This agreement represents a transaction with a customer and therefore is accounted for in accordance with ASC 606. Recursion has determined that it has three performance obligations, one related to gastrointestinal cancer and two in neuroscience. These performance obligations are for performing research and development services for Roche to identify targets and medicines. The performance obligations also include potential licenses related to the intellectual property. The Company concluded that licenses within the contract are not distinct from the research and development services as they are interrelated due to the fact that the research and development services significantly impact the potential licenses. Any additional services are considered customer options and will be considered as separate contracts for accounting purposes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has determined the transaction price to be $180.0 million, comprised of the upfront payment and the acceptance fee. Prior to the three months ended September 30, 2024, Recursion had fully constrained the $30.0 million variable consideration acceptance fee. As a result of Roche&#8217;s acceptance of the neuroscience Phenomap, Recursion is now recognizing the acceptance fee as part of the transaction price over the completion period of one of the neuroscience performance obligations. Recursion has fully constrained the remaining amounts of variable consideration to be received from potential milestones considering the stage of development and the risks associated with the remaining development required to achieve each milestone. Recursion will re-evaluate the transaction price each reporting period. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction price was generally allocated to the performance obligations based on the estimated relative stand-alone selling price of each performance obligation as determined using an expected cost plus margin approach. The acceptance fee was allocated to one of the neuroscience performance obligations as the terms of the variable consideration related specifically to Recursion&#8217;s efforts to satisfy this performance obligation. The Company recognizes revenue over time based on costs incurred relative to total expected costs to perform the research and development services. Recursion determined that this method provides a faithful depiction of the transfer of control to the customer. This method of recognizing revenue requires the Company to make estimates of total costs to provide the services required under the performance obligations. Significant inputs used to determine the total costs included the length of time required, service hours performed by Company employees and materials costs. A significant change in these estimates could have a material effect on the timing and amount of revenue recognized in future periods. Recursion has estimated the completion of the performance obligations by 2026.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Additional Revenue Disclosures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Of the revenue recognized during the three and nine months ended September 30, 2025, $4.5 million and $36.6 million was included in the unearned revenue balance as of December&#160;31, 2024, respectively. Of the revenue recognized during the three and nine months ended September 30, 2024, $4.1 million and $29.0 million was included in the unearned revenue balance as of December&#160;31, 2023, respectively. Revenue recognized was from the upfront and variable consideration payments received from the related contracts, which decreased the aggregate unearned revenue recognized. As of September&#160;30, 2025, the Company had $5.6 million of costs incurred to fulfill a contract on its Condensed Consolidated Balance Sheet within &#8220;Other Current Assets.&#8221;</span></div>Unearned revenue was classified as short-term and long-term on the Condensed Consolidated Balance Sheets based on the Company&#8217;s estimate of revenue that will be recognized during the next twelve months.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org/808/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text">Stock-Based Compensation <div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, the Board of Directors and the stockholders of the Company adopted the 2021 Equity Incentive Plan (the 2021 Plan). The Company may grant stock options, restricted stock units (RSUs), stock appreciation rights, restricted stock awards and other forms of stock-based compensation. As of September&#160;30, 2025, 13.3&#160;million shares of Class A common stock were available for grant in the 2021 plan. In November 2024, the Board of Directors and the stockholders of the Company adopted the 2024 Inducement Equity Incentive Plan (the 2024 Plan) as part of the Exscientia acquisition. See Note 4, &#8220;Acquisitions&#8221; for additional information. As of September&#160;30, 2025, 11.3&#160;million shares of Class A common stock were available for grant in the 2024 plan.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the classification of stock-based compensation expense for employees and non-employees within the Condensed Consolidated Statements of Operations: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:51.259%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.109%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.109%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.782%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.964%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">964&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,153&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,727&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,906&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,795&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,911&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,470&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,044&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,743&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,433&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,211&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options are primarily granted to executive leaders at the Company, generally vest over four years and expire no later than 10 years from the date of grant.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option activity during the nine months ended September 30, 2025 was as follows: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.499%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;(in thousands except share data and per share amounts)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares&#160;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Exercise</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Price </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Remaining&#160;Contractual Life (in years) </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,941,495&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.40&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,685&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,340,822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.08&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,305,626)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,519,592)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.08&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of September 30, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,457,099&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.52&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,246&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable as of September 30, 2025</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,189,094&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.64&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,363&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of options granted to employees is calculated on the grant date using the Black-Scholes option valuation model. The weighted-average grant-date fair values of stock options granted during the nine months ended September 30, 2025 and 2024 were $4.47 and $5.88, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following weighted-average assumptions were used to calculate the grant-date fair value of stock options: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2025, $36.7 million of unrecognized compensation cost related to stock options is expected to be recognized as expense over approximately the next three years. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RSUs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity awards granted to employees primarily consist of RSUs and generally vest over four years. The weighted-average grant-date fair value of RSUs generally is determined based on the number of units granted and the quoted price of Recursion&#8217;s common stock on the date of grant.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes Recursion&#8217;s RSU activity during the nine months ended September 30, 2025: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock units</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average grant date fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,304,229&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.47&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,980,106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,742,946)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,898,723)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of September 30, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,642,666&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.61&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair market value of RSUs vested was $50.8 million during the nine months ended September 30, 2025. As of September&#160;30, 2025, $188.1 million of unrecognized compensation cost related to RSUs is expected to be recognized as expense over approximately the next three years.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes <div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not record any U.S. income tax expense during the three and nine months ended September 30, 2025 and 2024. The Company has historically incurred operating losses and maintains a full valuation allowance against its U.S. net deferred tax assets. Foreign taxes were insignificant during the three and nine months ended September 30, 2025 and 2024. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. net operating losses (NOLs) and tax credit carry-forwards are subject to review and possible adjustment by the Internal Revenue Service (&#8220;IRS&#8221;) and may become subject to annual limitation due to ownership changes that occur under Section 382 of the Internal Revenue Code, as amended and similar state provisions. These ownership changes may limit the amount of carryforwards that can be utilized annually to offset future taxable income. In general, an ownership change, as defined by Section 382, results from transactions increasing the ownership of certain shareholders or public groups in the stock of a corporation by more than 50% over a three-year period. As of December&#160;31, 2024, the Company completed a Section 382 study and did not identify ownership changes that would subject its NOLs or tax credit carry-forwards to Section 382 limitations. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files income tax returns in the United States, Canada and United Kingdom. The Company files state income tax returns in multiple states in the United States among others Utah, California and Massachusetts. The </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company is not currently under examination in any of these jurisdictions. The Company is subject to income tax examinations for all US federal and state returns filed since the 2016 tax year, Canadian income tax returns since the 2021 tax year, and UK income tax returns since the 2021 tax year.</span></div>In July 2025, congress approved the One Big Beautiful Bill Act (OBBBA), which extends, with modifications, many of the expiring provisions of the Tax Cuts and Jobs Act (TCJA) and makes additional changes to tax laws and regulations. OBBBA includes a broad array of changes including new and modified incentives for business investment and Inflation Reduction Act (IRA) tax credits and various limits on business tax deductions. It also impacts the deduction of research and development costs and property, plant and equipment costs. This act did not have a material impact on Recursion&#8217;s consolidated balance sheet and statement of operations. The Company will continue to monitor the impact of this Act in future periods.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477617/942-740-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478822/944-740-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Share</a></td>
<td class="text">Net Loss Per Share<span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September 30, 2025 and 2024, Recursion calculated net loss per share of Class A, Class B and the Exchangeable common stock. Basic net loss per share is computed using the weighted-average number of shares outstanding during the period. Diluted net loss per share is computed using the weighted-average number of shares and the effect of potentially dilutive securities outstanding during the period. Potentially dilutive securities consist of stock options and other contingently issuable shares. For periods presented in which the Company reports a net loss, all potentially dilutive shares are anti-dilutive and as such are excluded from the calculation. </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended September 30, 2025 and 2024</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company reported a net loss and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">therefore basic and diluted loss per share were the same.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rights, including the liquidation and dividend rights, of the holders of the Company&#8217;s Class A, Class B and the Exchangeable common stock are identical, except with respect to voting. As a result, the undistributed earnings for each period are allocated based on the contractual participation rights of the Class A, Class B and the Exchangeable common stock as if the earnings for the period had been distributed. As the liquidation and dividend rights are identical, the undistributed earnings are allocated on a proportionate basis and the resulting amount per share for Class A, Class B and the Exchangeable common stock was the same during the three and nine months ended September 30, 2025 and 2024.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth the computation of basic and diluted net loss per share of Class A, Class B and Exchangeable common stock:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.057%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.057%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.377%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162,253)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95,842)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(536,637)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(284,755)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446,988,046&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282,583,048&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">422,642,653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253,447,099&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share, basic and diluted</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.36)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.34)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.27)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.12)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company excluded the following potential common shares from the computation of diluted net loss per share for the periods indicated because including them would have had an anti-dilutive effect: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.736%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.375%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Stock based compensation</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,675,698&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,869,795&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,696,773&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,098,979&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Tempus agreement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,582,331&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,694,934&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,582,331&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,694,934&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Contingent stock relating to RE Ventures I transaction</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250,621&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421,455&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,508,650&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,564,729&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,700,559&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,793,913&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value hierarchy consists of the following three levels:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8212; Valuations based on unadjusted quoted prices in active markets for identical assets that the company has the ability to access;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8212; Valuations based on quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-based valuations in which all significant inputs are observable in the market; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8212; Valuations using significant inputs that are unobservable in the market and include the use of judgment by the company's management about the assumptions market participants would use in pricing the asset or liability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to maintain a cash balance in a collateralized account to secure the Company&#8217;s credit cards. Additionally, the Company holds restricted cash related to an outstanding letter of credit issued by J.P. Morgan, which was obtained to secure certain Company obligations relating to tenant improvements. Recursion also holds restricted cash as required by a lease agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the Company&#8217;s assets and liabilities that are measured at fair value on a recurring basis:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:1.0%"></td><td style="width:43.727%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.741%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.745%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2025</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of fair value measurement</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436,675&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436,675&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223,161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223,161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,309&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,309&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">667,145&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">667,145&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.452%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of fair value measurement</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198,050&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198,050&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235,812&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235,812&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank deposits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,487&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,487&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,675&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,675&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">603,024&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">603,024&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the financial instruments that are recognized at fair value on the Condensed Consolidated Balance Sheet, the Company has certain financial instruments that are recognized at amortized cost or some basis other than fair value. The carrying amount of these instruments are considered to be representative of their approximate fair values. </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the Company&#8217;s financial instruments that are not measured at fair value: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.531%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.448%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Book values</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair values</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable and financing lease liabilities, current</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,919&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,425&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,919&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,425&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable and financing lease liabilities, non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,821&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,447&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,821&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,447&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 107<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-107<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 940<br> -SubTopic 820<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478119/940-820-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Information</a></td>
<td class="text">Segment Information<div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment loss</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recursion operates as a single operating segment that is managed on a consolidated basis. The Company&#8217;s chief operating decision maker is its Chief Executive Officer. The Company&#8217;s chief operating decision maker uses segment net loss to evaluate the performance of its segment, analyze financial trends, compare the budget to the actual operating results and make resource allocation decisions. Segment net loss represents the Company&#8217;s consolidated net loss. All corporate costs, global function support costs, overhead costs and other shared costs are included within this segment. Other segment items primarily include general and administrative expenses including facilities, information technology, professional fees (including auditing, tax and legal) and insurance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents Recursion&#8217;s segment net loss: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,175&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">26,082&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">39,143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">54,293&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Significant segment expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Salaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">55,515&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">235,190&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">156,171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Consumables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,928&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">19,419&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">92,725&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">54,176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Platform</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,377&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">8,330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">36,934&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">13,102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Discovery</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,049&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3,375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">58,716&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">19,115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Clinical development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,814&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">9,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">33,338&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">31,966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,708&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">6,637&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">64,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">22,982&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other segment items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">22,110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">57,815&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">52,017&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Loss from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,202&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,354&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">539,798&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295,236&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other non-operating income (loss), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,952&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,005&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(167)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1,134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Total segment loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">162,253&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">95,842&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">536,637&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">284,755&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Supplemental asset information</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Total expenditures for additions to long-lived assets</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4,248&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5,283&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">12,633&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Additional Segment Disclosures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recursion&#8217;s revenues are attributed to the following geographic areas based on the location the services are performed: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.885%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,110&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,082&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,393&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,293&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,065&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,175&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,082&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,143&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,293&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recursion generates revenue primarily from a single service, research and development services, therefore, the Company does not report additional information on revenue from external customers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recursion&#8217;s long-lived assets are attributed to the following geographic areas based on their location: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.936%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,571&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,471&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">United Kingdom</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Canada</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2,631&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,629&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text">Subsequent Events<div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Roche and Genentech</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October&#160;27, 2025, Recursion received notice that Roche accepted the second neuroscience Phenomap under the December 2021 collaboration and license agreement which resulted in a $30 million milestone which is an acceptance fee accounted for as variable consideration under ASC 606. See Note 9, &#8220;Collaborative Development Contracts&#8221; for additional information on the collaboration with Roche. This milestone payment was fully constrained variable consideration at September&#160;30, 2025 due to the uncertainty of the development. The variable consideration is no longer constrained and will be recognized as &#8220;Operating Revenue&#8221; in the Condensed Consolidated Statements of Operations as part of the transaction price over the completion period of the neuroscience performance obligation. The amount to be earned over the remaining estimated completion period will be recorded in &#8220;Unearned Revenue&#8221; and &#8220;Unearned Revenue, Non-Current&#8221; on the Consolidated Balance Sheet, classified as short-term and long-term based on the Company&#8217;s estimate of revenue that will be recognized during the next twelve months.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">At-The-Market Offering (Citi)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2025, Recursion</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sold 25.3 million shares and received net proceeds of $133.5 million under the Sales Agreement. Pursuant to its terms, the Sales Agreement has completed and no amount remained available for future sales. In total, the Company sold 99.9 million shares and received net proceeds of $491.7 million under the agreement.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2025 </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2025 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=rxrx_BlakeBorgesonMember', window );">Blake Borgeson [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MtrlTermsOfTrdArrTextBlock', window );">Material Terms of Trading Arrangement</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 31, 2025, Blake Borgeson, a member of our Board of Directors, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the potential sale of up to 3,868,000 shares of the Company&#8217;s Class A common stock, a majority of which will not execute absent a significant increase in the market price of the Company&#8217;s Class A common stock. The plan is effective until no later than December&#160;01, 2026</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndName', window );">Name</a></td>
<td class="text">Blake Borgeson<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndTitle', window );">Title</a></td>
<td class="text">a member of our Board of Directors<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrAdoptionDate', window );">Adoption Date</a></td>
<td class="text">August 31, 2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrDuration', window );">Arrangement Duration</a></td>
<td class="text">457 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrSecuritiesAggAvailAmt', window );">Aggregate Available</a></td>
<td class="nump">3,868,000<span></span>
</td>
<td class="nump">3,868,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=rxrx_NajatKhanMember', window );">Najat Khan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MtrlTermsOfTrdArrTextBlock', window );">Material Terms of Trading Arrangement</a></td>
<td class="text"><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 22, 2025, Najat Khan, Chief R&amp;D Officer, Chief </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Officer, and a member of our Board of Directors, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">299,317</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shares of the Company&#8217;s Class A common stock until December 22, 2026.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndName', window );">Name</a></td>
<td class="text">Najat Khan<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndTitle', window );">Title</a></td>
<td class="text">Chief R&D Officer, Chief Commercial Officer, and a member of our Board of Directors<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrAdoptionDate', window );">Adoption Date</a></td>
<td class="text">September 22, 2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrExpirationDate', window );">Expiration Date</a></td>
<td class="text">December 22, 2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrDuration', window );">Arrangement Duration</a></td>
<td class="text">456 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrSecuritiesAggAvailAmt', window );">Aggregate Available</a></td>
<td class="nump">299,317<span></span>
</td>
<td class="nump">299,317<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=rxrx_BenTaylorMember', window );">Ben Taylor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MtrlTermsOfTrdArrTextBlock', window );">Material Terms of Trading Arrangement</a></td>
<td class="text"><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 30, 2025, Ben Taylor, Chief Financial Officer and President of Recursion UK, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">defense</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of Rule 10b5-1(c) for the sale of up to </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">293,321</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shares of the Company&#8217;s Class A common stock until December 29, 2026.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndName', window );">Name</a></td>
<td class="text">Ben Taylor<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndTitle', window );">Title</a></td>
<td class="text">Chief Financial Officer and President of Recursion UK<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrAdoptionDate', window );">Adoption Date</a></td>
<td class="text">September 30, 2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrExpirationDate', window );">Expiration Date</a></td>
<td class="text">December 29, 2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrDuration', window );">Arrangement Duration</a></td>
<td class="text">455 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrSecuritiesAggAvailAmt', window );">Aggregate Available</a></td>
<td class="nump">293,321<span></span>
</td>
<td class="nump">293,321<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MtrlTermsOfTrdArrTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MtrlTermsOfTrdArrTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrAdoptionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrAdoptionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrDuration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrDuration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrIndName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrIndName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrIndTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrIndTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrSecuritiesAggAvailAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrSecuritiesAggAvailAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=rxrx_BlakeBorgesonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=rxrx_BlakeBorgesonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=rxrx_NajatKhanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=rxrx_NajatKhanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=rxrx_BenTaylorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=rxrx_BenTaylorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited interim condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC). Accordingly, certain information and footnote disclosures normally included in annual financial statements prepared in accordance with generally accepted accounting principles in the United States (U.S. GAAP) have been condensed or omitted. These unaudited interim condensed consolidated financial statements should be read in conjunction with the Company&#8217;s audited consolidated financial statements and notes for the year ended December&#160;31, 2024. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is management&#8217;s opinion that these condensed consolidated financial statements include all normal and recurring adjustments necessary for a fair statement of the financial position, results of operations and cash flows for the periods presented. Revenue and net loss for any interim period are not necessarily indicative of future or annual results.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2025, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2025-06, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for internal-use software costs (Topic 350)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The new standard amends specific aspects of the accounting for internal-use software costs including the criteria for capitalizing software costs. It also amends the related disclosure requirements. This standard will be effective for Recursion starting the annual period ending </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;15, 2028 and for interim reporting periods within that annual reporting period. Early adoption is permitted. The amendments can be applied on a prospective, modified prospective or retrospective basis. Recursion is currently assessing the impact of adopting this guidance on its consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2024-03, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Income Statement Expenses (Topic 220)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The standard requires new disclosures in the notes to the financial statements about certain caption expenses presented on the face of the Income Statement including information on: purchases of inventory; employee compensation; depreciation and intangible asset amortization. Recursion must also disclose a qualitative description of the amounts remaining in expense captions that are not separately disaggregated. This standard will be effective for Recursion starting the annual period ending December 31, 2027 and for interim reporting periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The amendments can be applied on a prospective or retrospective basis. Recursion is currently assessing the impact of adopting this guidance on its consolidated financial statements. </span></div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU No. 2023-09, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740)</span>. The new standard updates disclosure requirements for Accounting Standards Codification (ASC) 740 primarily by requiring additional information in the income tax rate reconciliation and additional disclosures about income taxes paid. This standard will be effective for Recursion starting the annual period ending December 31, 2025. The amendments can be applied on a prospective or retrospective basis. The Company is in process of evaluating the impact of adoption of ASU 2023-09 on the Company's consolidated financial statements and disclosures. We do not expect the adoption of this ASU to have a material impact on our consolidated financial statements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Financial Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_SupplementalFinancialInformationAbstract', window );"><strong>Supplemental Financial Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Expenses and Other Liabilities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accrued Expenses and Other Liabilities</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.660%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.521%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,056&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,853&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,812&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued early discovery expenses</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,840&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,095&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,956&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">787&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Materials received not invoiced</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,590&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued license fees</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued other expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,547&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,735&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expense and other liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,102&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,872&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Schedule of Restructuring Actions and the Related Accrual</a></td>
<td class="text">The following summarizes the activity related to these restructuring actions and the related accrual as of September&#160;30, 2025:<div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"><tr><td style="width:1.0%"></td><td style="width:77.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.212%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,717)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2025</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">799&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock', window );">Schedule of Interest Income, Net</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Income, Net</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,540&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,826&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,541&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(833)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(553)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,821)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(967)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,707&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,273&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,720&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,171&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_SupplementalFinancialInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supplemental Financial Information</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_SupplementalFinancialInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of interest income and expense, including, but not limited to, interest income and expense from investments, loans, and securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionTableTextBlock', window );">Schedule of Asset Acquisition</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the total consideration transferred at acquisition date:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recursion Class A common stock</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,815&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liability</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transactions costs</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,153&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock', window );">Schedule of Contingent Consideration Transferred</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the consideration transferred for the milestone:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recursion Class A common stock</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,768&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,268&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Fair Value of Assets Acquired and Liabilities Assumed</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of assets acquired and liabilities assumed as of the acquisition date:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:79.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.373%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(in thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">277,104&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">48,408&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">12,843&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">61,961&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">20,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Intangible assets, technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">182,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Intangible assets, indefinite-lived</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">129,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1,934&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other assets, non-current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">930&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Accounts payable and accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(40,780)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(21,679)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(120,905)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(23,077)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(1,572)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Total identifiable net assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">526,438&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">103,686&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Total assets acquired and liabilities assumed</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">630,124&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Schedule of Pro Forma Financial Information</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following pro forma summary presents consolidated revenue and earnings of Recursion as if the Exscientia business combination had occurred on January&#160;1, 2023</span><span style="color:#008080;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:51.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.795%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.797%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Three months ended September 30, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Nine months ended September 30, 2024</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(in thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">32,048&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">75,643&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Operating loss</span></td><td style="border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(202,645)</span></td><td style="border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td style="border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(512,213)</span></td><td style="border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of contingent consideration in asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 15<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480123/805-50-15-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 15<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480123/805-50-15-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma revenue and earnings for business combination or aggregate of series of individually immaterial business combinations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-49<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-3<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -SubTopic 10<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -SubTopic 10<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of asset acquired and liability assumed in business combination and recognized at acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Components of Lease Cost and Supplemental Cash Flow Information Related to Leases and Lease Term and Discount Rates</a></td>
<td class="text"><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases were:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.666%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.199%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amount included in the measurement of lease liabilities: </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,756&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from financing leases</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,368&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from financing leases</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,261&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets additions, modifications and termination:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,084)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,455&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing leases</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,342&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in the carrying amount of goodwill: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.836%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148,873&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,947&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2025</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,042&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes intangible assets:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross carrying amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net carrying amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross carrying amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net carrying amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Definite-lived technology intangible assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,806)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178,637&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224,362&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,544)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,818&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Definite-lived licensed intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,679)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,829&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,088)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,878&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,878&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,775&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,775&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385,829&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63,485)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322,344&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362,487&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,632)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335,855&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Indefinite-Lived Intangible Assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes intangible assets:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross carrying amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net carrying amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross carrying amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net carrying amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Definite-lived technology intangible assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,806)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178,637&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224,362&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,544)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,818&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Definite-lived licensed intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,679)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,829&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,088)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,878&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,878&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,775&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,775&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385,829&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63,485)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322,344&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362,487&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,632)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335,855&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1A<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Stock-Based Compensation Expense</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the classification of stock-based compensation expense for employees and non-employees within the Condensed Consolidated Statements of Operations: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:51.259%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.109%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.109%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.782%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.964%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">964&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,153&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,727&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,906&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,795&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,911&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,470&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,044&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,743&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,433&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,211&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Activity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option activity during the nine months ended September 30, 2025 was as follows: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.499%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;(in thousands except share data and per share amounts)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares&#160;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Exercise</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Price </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Remaining&#160;Contractual Life (in years) </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,941,495&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.40&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,685&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,340,822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.08&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,305,626)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,519,592)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.08&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of September 30, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,457,099&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.52&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,246&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable as of September 30, 2025</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,189,094&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.64&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,363&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Weighted-Average Assumptions Used to Calculate Grant-Date Fair Value of Stock Options</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following weighted-average assumptions were used to calculate the grant-date fair value of stock options: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock', window );">Schedule of RSU Activity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes Recursion&#8217;s RSU activity during the nine months ended September 30, 2025: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock units</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average grant date fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,304,229&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.47&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,980,106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,742,946)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,898,723)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of September 30, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,642,666&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.61&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Subparagraph (c)<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Computation of Basic and Diluted Net Loss Per Share</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth the computation of basic and diluted net loss per share of Class A, Class B and Exchangeable common stock:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.057%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.057%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.377%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162,253)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95,842)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(536,637)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(284,755)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446,988,046&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282,583,048&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">422,642,653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253,447,099&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share, basic and diluted</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.36)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.34)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.27)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.12)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Net Loss Per Share</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company excluded the following potential common shares from the computation of diluted net loss per share for the periods indicated because including them would have had an anti-dilutive effect: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.736%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.375%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Stock based compensation</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,675,698&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,869,795&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,696,773&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,098,979&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Tempus agreement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,582,331&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,694,934&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,582,331&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,694,934&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Contingent stock relating to RE Ventures I transaction</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250,621&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421,455&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,508,650&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,564,729&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,700,559&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,793,913&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the Company&#8217;s assets and liabilities that are measured at fair value on a recurring basis:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:1.0%"></td><td style="width:43.727%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.741%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.745%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2025</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of fair value measurement</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436,675&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436,675&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223,161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223,161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,309&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,309&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">667,145&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">667,145&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.452%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of fair value measurement</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198,050&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198,050&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235,812&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235,812&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank deposits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,487&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,487&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,675&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,675&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">603,024&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">603,024&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock', window );">Schedule of Financial Instruments Not Measured at Fair Value</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the Company&#8217;s financial instruments that are not measured at fair value: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.531%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.448%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Book values</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair values</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable and financing lease liabilities, current</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,919&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,425&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,919&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,425&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable and financing lease liabilities, non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,821&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,447&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,821&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,447&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information about fair value of asset and liability not measured at fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Net Loss and Reconciliations of Segment Operating Loss to Loss Before Income Tax Benefit</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents Recursion&#8217;s segment net loss: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,175&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">26,082&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">39,143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">54,293&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Significant segment expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Salaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">55,515&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">235,190&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">156,171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Consumables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,928&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">19,419&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">92,725&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">54,176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Platform</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,377&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">8,330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">36,934&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">13,102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Discovery</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,049&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3,375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">58,716&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">19,115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Clinical development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,814&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">9,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">33,338&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">31,966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,708&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">6,637&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">64,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">22,982&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other segment items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">22,110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">57,815&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">52,017&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Loss from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,202&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,354&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">539,798&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295,236&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other non-operating income (loss), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,952&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,005&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(167)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1,134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Total segment loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">162,253&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">95,842&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">536,637&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">284,755&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Supplemental asset information</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Total expenditures for additions to long-lived assets</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4,248&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5,283&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">12,633&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock', window );">Schedule of Long-Lived Assets Based on Geographic Areas</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recursion&#8217;s revenues are attributed to the following geographic areas based on the location the services are performed: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.885%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,110&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,082&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,393&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,293&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,065&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,175&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,082&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,143&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,293&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recursion&#8217;s long-lived assets are attributed to the following geographic areas based on their location: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.936%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,571&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,471&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">United Kingdom</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Canada</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2,631&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,629&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Description of the Business (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="nump">$ 1,967,879<span></span>
</td>
<td class="nump">$ 1,431,283<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Financial Information - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Nov. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_LicenseAgreementIncreaseDecreaseAccruedLiabilities', window );">License Agreement, increase (decrease) prepaid expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 49.9<span></span>
</td>
<td class="nump">$ 2.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent', window );">Workforce reduction percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Expected cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=rxrx_TempusLabsIncMember', window );">Tempus Labs, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_LicenseAgreementTerm', window );">License agreement, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_LicenseAgreementTradingPeriodUsedForEquityValueDetermination', window );">Trading period used for equity value determination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_LicenseAgreementAmountOfTimePriorToThePaymentDate', window );">Business days prior to the payment date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=rxrx_TempusLabsIncMember', window );">Tempus Labs, Inc | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_LicenseAgreementAnnualPayments', window );">Annual payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=rxrx_TempusLabsIncMember', window );">Tempus Labs, Inc | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_LicenseAgreementAnnualPayments', window );">Annual payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_LicenseAgreementAggregatePayments', window );">Aggregate amount payable in cash or equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 160.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_LicenseAgreementAggregatePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>License Agreement, Aggregate Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_LicenseAgreementAggregatePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_LicenseAgreementAmountOfTimePriorToThePaymentDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>License Agreement, Amount Of Time Prior To The Payment Date</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_LicenseAgreementAmountOfTimePriorToThePaymentDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_LicenseAgreementAnnualPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>License Agreement, Annual Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_LicenseAgreementAnnualPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_LicenseAgreementIncreaseDecreaseAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>License Agreement, Increase (Decrease) Accrued Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_LicenseAgreementIncreaseDecreaseAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_LicenseAgreementTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>License Agreement, Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_LicenseAgreementTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_LicenseAgreementTradingPeriodUsedForEquityValueDetermination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>License Agreement, Trading Period Used For Equity Value Determination</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_LicenseAgreementTradingPeriodUsedForEquityValueDetermination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostExpectedCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount expected to be recognized in earnings for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostExpectedCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of positions eliminated during the period as a percentage of total positions eliminated during the period in connection with the restructuring plan(s).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=rxrx_TempusLabsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=rxrx_TempusLabsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Supplemental Financial Information - Schedule of Accrued Expenses and Other Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_SupplementalFinancialInformationAbstract', window );"><strong>Supplemental Financial Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation</a></td>
<td class="nump">$ 24,056<span></span>
</td>
<td class="nump">$ 50,853<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_AccruedDevelopmentCostsCurrent', window );">Accrued development expenses</a></td>
<td class="nump">2,497<span></span>
</td>
<td class="nump">5,812<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_AccruedEarlyDiscoveryExpensesCurrent', window );">Accrued early discovery expenses</a></td>
<td class="nump">7,840<span></span>
</td>
<td class="nump">3,095<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued professional fees</a></td>
<td class="nump">1,956<span></span>
</td>
<td class="nump">787<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_MaterialsReceivedNotInvoiced', window );">Materials received not invoiced</a></td>
<td class="nump">1,206<span></span>
</td>
<td class="nump">1,590<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_AccruedLicenseFeeCurrent', window );">Accrued license fees</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Accrued other expenses</a></td>
<td class="nump">12,547<span></span>
</td>
<td class="nump">16,735<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses and other liabilities</a></td>
<td class="nump">$ 53,102<span></span>
</td>
<td class="nump">$ 81,872<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_AccruedDevelopmentCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Development Costs, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_AccruedDevelopmentCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_AccruedEarlyDiscoveryExpensesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Early Discovery Expenses, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_AccruedEarlyDiscoveryExpensesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_AccruedLicenseFeeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued License Fee, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_AccruedLicenseFeeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_MaterialsReceivedNotInvoiced">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Materials Received Not Invoiced</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_MaterialsReceivedNotInvoiced</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_SupplementalFinancialInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supplemental Financial Information</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_SupplementalFinancialInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Financial Information - Schedule of Restructuring Actions and the Related Accrual (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2025 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance as of December 31, 2024</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Expense</a></td>
<td class="nump">8,516<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments</a></td>
<td class="num">(7,717)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance as of September 30, 2025</a></td>
<td class="nump">$ 799<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482047/420-10-45-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-21<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Financial Information - Schedule of Interest Income, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_SupplementalFinancialInformationAbstract', window );"><strong>Supplemental Financial Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNonoperating', window );">Interest income</a></td>
<td class="nump">$ 5,540<span></span>
</td>
<td class="nump">$ 3,826<span></span>
</td>
<td class="nump">$ 16,541<span></span>
</td>
<td class="nump">$ 11,138<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseNonoperating', window );">Interest expense</a></td>
<td class="num">(833)<span></span>
</td>
<td class="num">(553)<span></span>
</td>
<td class="num">(1,821)<span></span>
</td>
<td class="num">(967)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest income, net</a></td>
<td class="nump">$ 4,707<span></span>
</td>
<td class="nump">$ 3,273<span></span>
</td>
<td class="nump">$ 14,720<span></span>
</td>
<td class="nump">$ 10,171<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_SupplementalFinancialInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supplemental Financial Information</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_SupplementalFinancialInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as nonoperating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income (expense) classified as nonoperating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income from investments (for example, dividends) not considered a component of the entity's core operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions - Narrative (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Aug. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 30, 2024 </div>
<div>USD ($) </div>
<div>contract </div>
<div>inProcessResearchAndDevelopmentAsset </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th">
<div>Nov. 20, 2024 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Combination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Loss on disposal of a business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,502<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.04<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,947<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rxrx_ExscientiaPlcMember', window );">Exscientia Plc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Combination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business combination, consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 630,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Recursion Class A common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">616,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_BusinessCombinationConsiderationTransferredEquityInterestsIssuable', window );">Fair value of stock and equity awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Equity interest issued or issuable (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes', window );">Increase deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_NumberOfAcquiredCustomerContractsWithContractLiabilities', window );">Number of acquired customer contracts with contract liabilities | contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_NumberOfInProcessResearchAndDevelopmentAssets', window );">Number of in-process research and development assets | inProcessResearchAndDevelopmentAsset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_FiniteLivedIntangibleAssetDiscountRate', window );">Discount rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual', window );">Net revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual', window );">Operating loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">139,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rxrx_ExscientiaPlcMember', window );">Exscientia Plc | Definite-lived technology intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Combination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful life (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rxrx_ExscientiaPlcMember', window );">Exscientia Plc | Class A Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Combination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_BusinessCombinationEquityInterestIssuedOrIssuableSharesOfAcquirerStockPerShareOfAcquireeStockOutstanding', window );">Shares of acquirer stock per share of acquiree stock outstanding (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.7729<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposal Group, Disposed of by Sale, Not Discontinued Operations | Exscientia GmbH</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Combination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Loss on disposal of a business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rxrx_AlphaBiotechnologyGmbHAlphaMember', window );">Alpha Biotechnology GmbH (Alpha)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Combination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,400<span></span>
</td>
<td class="nump">$ 4,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=rxrx_REVenturesIMember', window );">RE Ventures I</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Combination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_AssetAcquisitionEquityOwnershipPercentage', window );">Interest acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferred', window );">Asset acquisition, consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment', window );">Payments to acquire IPR&amp;D</a></td>
<td class="nump">$ 2,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_AssetAcquisitionEquityOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Equity Ownership, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_AssetAcquisitionEquityOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_BusinessCombinationConsiderationTransferredEquityInterestsIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Equity Interests Issuable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_BusinessCombinationConsiderationTransferredEquityInterestsIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_BusinessCombinationEquityInterestIssuedOrIssuableSharesOfAcquirerStockPerShareOfAcquireeStockOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Equity Interest Issued Or Issuable, Shares of Acquirer Stock Per Share of Acquiree Stock Outstanding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_BusinessCombinationEquityInterestIssuedOrIssuableSharesOfAcquirerStockPerShareOfAcquireeStockOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_FiniteLivedIntangibleAssetDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Asset, Discount Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_FiniteLivedIntangibleAssetDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_NumberOfAcquiredCustomerContractsWithContractLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Acquired Customer Contracts With Contract Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_NumberOfAcquiredCustomerContractsWithContractLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_NumberOfInProcessResearchAndDevelopmentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of In Process Research And Development Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_NumberOfInProcessResearchAndDevelopmentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479908/805-50-55-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480060/805-50-25-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480027/805-50-30-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480027/805-50-30-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interest issued or issuable by acquirer as part of consideration transferred in business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-41<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-42<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-47<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-4A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-4<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-4A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-4A<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-4<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 37: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-41<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-41<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-42<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of acquiree's earnings (loss) since acquisition date of business combination included in consolidated statement of income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of acquiree's revenue since acquisition date of business combination included in consolidated statement of income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481664/323-10-45-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflows from the purchase of net carrying value allocated to in-process research and development costs and materials acquired in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rxrx_ExscientiaPlcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rxrx_ExscientiaPlcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=rxrx_ExscientiaGmbHMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=rxrx_ExscientiaGmbHMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rxrx_AlphaBiotechnologyGmbHAlphaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rxrx_AlphaBiotechnologyGmbHAlphaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=rxrx_REVenturesIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=rxrx_REVenturesIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions - Schedule of Asset Acquisition (Details) - RE Ventures I - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2025</div></th>
<th class="th"><div>Jul. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionLineItems', window );"><strong>Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable', window );">Recursion Class A common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,815<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration', window );">Contingent consideration liability</a></td>
<td class="nump">$ 14,268<span></span>
</td>
<td class="nump">11,875<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost', window );">Transactions costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">292<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Cash paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">171<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferred', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,153<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479908/805-50-55-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480060/805-50-25-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480027/805-50-30-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480027/805-50-30-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contingent consideration recognized as part of consideration transferred in asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480060/805-50-25-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480027/805-50-30-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480027/805-50-30-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of acquirer's equity interest issued and issuable as part of consideration transferred in asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480060/805-50-25-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480027/805-50-30-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480027/805-50-30-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction cost incurred as part of consideration transferred in asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479908/805-50-55-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480060/805-50-25-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480027/805-50-30-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480027/805-50-30-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 15<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480123/805-50-15-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480060/805-50-25-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480027/805-50-30-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480027/805-50-30-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=rxrx_REVenturesIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=rxrx_REVenturesIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions - Schedule of Contingent Consideration Transferred (Details) - RE Ventures I - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2025</div></th>
<th class="th"><div>Jul. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionLineItems', window );"><strong>Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_AssetAcquisitionContingentConsiderationEquityInterestIssuedAndIssuable', window );">Recursion Class A common stock</a></td>
<td class="nump">$ 12,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_AssetAcquisitionContingentConsiderationCashPaid', window );">Cash paid</a></td>
<td class="nump">1,768<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration', window );">Contingent consideration liability</a></td>
<td class="nump">$ 14,268<span></span>
</td>
<td class="nump">$ 11,875<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_AssetAcquisitionContingentConsiderationCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Contingent Consideration, Cash Paid</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_AssetAcquisitionContingentConsiderationCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_AssetAcquisitionContingentConsiderationEquityInterestIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Contingent Consideration, Equity Interest Issued and Issuable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_AssetAcquisitionContingentConsiderationEquityInterestIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contingent consideration recognized as part of consideration transferred in asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480060/805-50-25-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480027/805-50-30-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480027/805-50-30-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 15<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480123/805-50-15-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=rxrx_REVenturesIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=rxrx_REVenturesIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisitions - Schedule of Fair Value of Assets Acquired and Liabilities Assumed (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Nov. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Combination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 162,042<span></span>
</td>
<td class="nump">$ 148,873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rxrx_ExscientiaPlcMember', window );">Exscientia Plc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Combination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 277,104<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables', window );">Other receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,408<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther', window );">Other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,843<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61,961<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,271<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets, technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">182,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Intangible assets, indefinite-lived</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">129,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,934<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other assets, non-current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">930<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable and accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(40,780)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21,679)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(120,905)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23,077)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,572)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Total identifiable net assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">526,438<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,686<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total assets acquired and liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 630,124<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Operating Lease Right-Of-Use Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Receivables</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-47<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-4A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-4<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-4A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-4A<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-4<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 37: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent acquired in business combination and recognized at acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset acquired in business combination and recognized at acquisition date, classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accounts payable assumed in business combination and recognized at acquisition date, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue assumed in business combination and recognized at acquisition date, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax asset acquired in business combination and recognized at acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability assumed in business combination and recognized at acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of identifiable indefinite-lived intangible asset acquired in business combination and recognized at acquisition date. Excludes goodwill and financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of identifiable finite-lived intangible asset acquired in business combination and recognized at acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset acquired in excess of (less than) liability assumed in business combination and recognized at acquisition date. Excludes goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-41<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability assumed in business combination and recognized at acquisition date, classified as other and noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset acquired in business combination and recognized at acquisition date, classified as other and noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of property, plant, and equipment acquired in business combination and recognized at acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-41<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset acquired in excess of (less than) liability assumed plus goodwill in business combination and recognized at acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-41<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478064/805-740-55-13<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 39<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-39<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rxrx_ExscientiaPlcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rxrx_ExscientiaPlcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions - Schedule of Pro Forma Financial Information (Details) - Exscientia Plc - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Combination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Revenue</a></td>
<td class="nump">$ 32,048<span></span>
</td>
<td class="nump">$ 75,643<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Operating loss</a></td>
<td class="num">$ (202,645)<span></span>
</td>
<td class="num">$ (512,213)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-47<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-4A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-4<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-4A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-4A<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-4<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 37: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of pro forma income (loss) of combined entity as if acquisition date of business combination occurred as of beginning of period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-50<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of pro forma revenue of combined entity as if acquisition date of business combination occurred as of beginning of period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rxrx_ExscientiaPlcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rxrx_ExscientiaPlcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Operating lease, renewal term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets', window );">Increase (decrease) in operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (10,084)<span></span>
</td>
<td class="nump">$ 19,455<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications', window );">Increase (decrease) in operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,100)<span></span>
</td>
<td class="nump">19,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_TerminationOfLeaseFee', window );">Termination of lease fee</a></td>
<td class="nump">$ 5,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_IncreaseDecreaseInRightOfUseAssetsForFinanceLeases', window );">Increase (decrease) in finance lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">29,342<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_LesseeFinanceLeaseIncreaseDecreaseInFinanceLeaseLiabilityDueToLeaseModifications', window );">Increase (decrease) in finance lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_LeaseDescriptionAxis=rxrx_ViennaFacilitiesOfExscientiaGmbHMember', window );">Vienna facilities of Exscientia GmbH</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets', window );">Increase (decrease) in operating lease right-of-use assets</a></td>
<td class="num">(5,200)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications', window );">Increase (decrease) in operating lease liabilities</a></td>
<td class="num">$ (5,200)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_LeaseDescriptionAxis=rxrx_SchrodingerLeasesMember', window );">Schrodinger Leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets', window );">Increase (decrease) in operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,900)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications', window );">Increase (decrease) in operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,900)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLeasehold', window );">Impairment of leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Remaining operating lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Remaining operating lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Operating Lease Right-Of-Use Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_IncreaseDecreaseInRightOfUseAssetsForFinanceLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Right Of Use Assets For Finance Leases</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_IncreaseDecreaseInRightOfUseAssetsForFinanceLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_LesseeFinanceLeaseIncreaseDecreaseInFinanceLeaseLiabilityDueToLeaseModifications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Finance Lease, Increase (Decrease) In Finance Lease Liability Due To Lease Modifications</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_LesseeFinanceLeaseIncreaseDecreaseInFinanceLeaseLiabilityDueToLeaseModifications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Increase (Decrease) In Operating Lease Liability Due To Lease Modifications</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_TerminationOfLeaseFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Termination Of Lease Fee</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_TerminationOfLeaseFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLeasehold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The adjustment to reduce the value of existing agreements that specify the lessee's rights to use the leased property. This expense is charged when the estimates of future profits generated by the leased property are reduced.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLeasehold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_LeaseDescriptionAxis=rxrx_ViennaFacilitiesOfExscientiaGmbHMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_LeaseDescriptionAxis=rxrx_ViennaFacilitiesOfExscientiaGmbHMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_LeaseDescriptionAxis=rxrx_SchrodingerLeasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_LeaseDescriptionAxis=rxrx_SchrodingerLeasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Schedule of Supplemental Cash Flow Information Related to Leases (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_CashPaidForAmountIncludedInTheMeasurementOfLeaseLiabilitiesAbstract', window );"><strong>Cash paid for amount included in the measurement of lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows from operating leases</a></td>
<td class="nump">$ 14,756<span></span>
</td>
<td class="nump">$ 10,742<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Operating cash flows from financing leases</a></td>
<td class="nump">1,368<span></span>
</td>
<td class="nump">379<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Financing cash flows from financing leases</a></td>
<td class="nump">6,174<span></span>
</td>
<td class="nump">2,261<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract', window );"><strong>Right-of-use assets additions, modifications and termination:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets', window );">Operating leases</a></td>
<td class="num">(10,084)<span></span>
</td>
<td class="nump">19,455<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_IncreaseDecreaseInRightOfUseAssetsForFinanceLeases', window );">Financing leases</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 29,342<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_CashPaidForAmountIncludedInTheMeasurementOfLeaseLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash Paid For Amount Included In The Measurement Of Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_CashPaidForAmountIncludedInTheMeasurementOfLeaseLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Operating Lease Right-Of-Use Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_IncreaseDecreaseInRightOfUseAssetsForFinanceLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Right Of Use Assets For Finance Leases</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_IncreaseDecreaseInRightOfUseAssetsForFinanceLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Right-Of-Use Assets Obtained In Exchange For Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets - Schedule of Changes in the Carrying Amount of Goodwill (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2025 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">$ 148,873<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Additions</a></td>
<td class="nump">5,947<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments</a></td>
<td class="nump">7,222<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">$ 162,042<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-41<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478064/805-740-55-13<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 39<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-39<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) asset representing future economic benefit from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">13,400,000<span></span>
</td>
<td class="nump">4,100,000<span></span>
</td>
<td class="nump">37,400,000<span></span>
</td>
<td class="nump">11,300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Impairment of indefinite-lived intangible assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-11<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-12<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Intangible Assets - Schedule of Intangible assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">$ (63,485)<span></span>
</td>
<td class="num">$ (26,632)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangible assets</a></td>
<td class="nump">137,878<span></span>
</td>
<td class="nump">128,775<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, gross</a></td>
<td class="nump">385,829<span></span>
</td>
<td class="nump">362,487<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">322,344<span></span>
</td>
<td class="nump">335,855<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Definite-lived technology intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross carrying amount</a></td>
<td class="nump">236,443<span></span>
</td>
<td class="nump">224,362<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(57,806)<span></span>
</td>
<td class="num">(24,544)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net carrying amount</a></td>
<td class="nump">178,637<span></span>
</td>
<td class="nump">199,818<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Definite-lived licensed intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross carrying amount</a></td>
<td class="nump">11,508<span></span>
</td>
<td class="nump">9,350<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(5,679)<span></span>
</td>
<td class="num">(2,088)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net carrying amount</a></td>
<td class="nump">$ 5,829<span></span>
</td>
<td class="nump">$ 7,262<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 928<br> -SubTopic 340<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478859/928-340-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Oct. 07, 2025</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Loss contingency accrual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_FinanceLeasesAssetsPledgedAsCollateral', window );">Finance leases, assets pledged as collateral</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Finance lease liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_DurationOfTimeForPlaintiffToRefileClaim', window );">Duration of time for plaintiff to refile claim</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_DurationOfTimeForPlaintiffToRefileClaim">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Duration Of Time For Plaintiff To Refile Claim</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_DurationOfTimeForPlaintiffToRefileClaim</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_FinanceLeasesAssetsPledgedAsCollateral">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Leases, Assets Pledged As Collateral</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_FinanceLeasesAssetsPledgedAsCollateral</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 720<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483359/720-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 27<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482395/460-10-55-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2025 </div>
<div>USD ($) </div>
<div>vote</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsStock', window );">Dividends declared | $</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_CommonStockVotePerShare', window );">Vote per share of common stock (in votes)</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_CommonStockVotePerShare', window );">Vote per share of common stock (in votes)</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_CommonStockVotePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Vote Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_CommonStockVotePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid stock dividends declared for classes of stock, for example, but not limited to, common and preferred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -SubTopic 405<br> -Topic 942<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477787/942-405-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock - At-The-Market Offering (Narrative) (Details) - Class A Common Stock - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">19 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Aug. 31, 2023</div></th>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Feb. 28, 2025</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">At-The-Market Offering Program Citi</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_SaleOfStockValueAuthorized', window );">Sale of stock, value authorized</a></td>
<td class="nump">$ 500.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Net proceeds received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 358.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_SaleOfStockValueRemainingAuthorized', window );">Sale of stock, value remaining authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 136.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">At-The-Market Offering Program Jefferies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_SaleOfStockValueAuthorized', window );">Sale of stock, value authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Net proceeds received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 199.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_SaleOfStockPercentageOfCommission', window );">Sale of stock, percentage of commission</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_SaleOfStockPercentageOfCommission">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Percentage Of Commission</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_SaleOfStockPercentageOfCommission</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_SaleOfStockValueAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Value, Authorized</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_SaleOfStockValueAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_SaleOfStockValueRemainingAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock Value Remaining Authorized</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_SaleOfStockValueRemainingAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=rxrx_AtTheMarketOfferingProgramCitiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=rxrx_AtTheMarketOfferingProgramCitiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=rxrx_AtTheMarketOfferingProgramJefferiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=rxrx_AtTheMarketOfferingProgramJefferiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Common Stock - Public Offering of Common Stock (Narrative) (Details)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th">
<div>Jun. 26, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=rxrx_PublicOfferingOfCommonStockMember', window );">Public Offering of Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_SaleOfStockUnderwritersOptionPeriodFromTheDateOfTheAgreement', window );">Sale of stock, underwriters option period from the date of the agreement</a></td>
<td class="text">30 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock | Public Offering of Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued (in shares)</a></td>
<td class="nump">35.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per share (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 6.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Net proceeds received | $</a></td>
<td class="nump">$ 216.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Underwriting discounts and commissions | $</a></td>
<td class="nump">$ 13.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock | Public Offering of Common Stock, Underwriting Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued (in shares)</a></td>
<td class="nump">30.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock | Over-Allotment Option</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued (in shares)</a></td>
<td class="nump">4.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_SaleOfStockUnderwritersOptionPeriodFromTheDateOfTheAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Underwriters Option Period From The Date Of The Agreement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_SaleOfStockUnderwritersOptionPeriodFromTheDateOfTheAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=rxrx_PublicOfferingOfCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=rxrx_PublicOfferingOfCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=rxrx_PublicOfferingOfCommonStockUnderwritingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=rxrx_PublicOfferingOfCommonStockUnderwritingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock - Valence Acquisition Exchangeable Shares (Narrative) (Details)<br> shares in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>May 31, 2023 </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2025 </div>
<div>shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=rxrx_ExchangeableStockMember', window );">Exchangeable Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Shares issued in the period, upon conversion (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_CommonStockConversionRatio', window );">Common stock, conversion ratio</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rxrx_ValenceDiscoveryIncMember', window );">Valence Discovery Inc | Exchangeable Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares', window );">Equity interest issued or issuable (in shares)</a></td>
<td class="nump">5.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition , Contingent Consideration, Equity Interests Issuable, Number Of Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_CommonStockConversionRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Conversion Ratio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_CommonStockConversionRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=rxrx_ExchangeableStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=rxrx_ExchangeableStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rxrx_ValenceDiscoveryIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rxrx_ValenceDiscoveryIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock - Registration Rights Agreements (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr><th class="th"><div>May 31, 2023</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rxrx_ValenceDiscoveryIncMember', window );">Valence Discovery Inc</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_RegistrationRightsAgreementTerm', window );">Registration rights agreement term</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_RegistrationRightsAgreementTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Registration Rights Agreement, Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_RegistrationRightsAgreementTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rxrx_ValenceDiscoveryIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rxrx_ValenceDiscoveryIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Common Stock - Class A and B Common Shares Authorization (Narrative) (Details)<br></strong></div></th>
<th class="th">
<div>Sep. 30, 2025 </div>
<div>vote</div>
</th>
<th class="th"><div>May 31, 2023</div></th>
<th class="th">
<div>Apr. 30, 2021 </div>
<div>class</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_NumberOfClassesOfCommonStockAuthorized', window );">Number of classes of common stock authorized | class</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=rxrx_CEOAndAffiliatesMember', window );">CEO and Affiliates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_AffiliatedHoldersOwnershipPercentage', window );">Affiliated holders, ownership percentage</a></td>
<td class="nump">0.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_AffiliatedHoldersPotentialOwnershipPercentageWhenOutstandingEquityAwardsVest', window );">Affiliated holders, potential ownership percentage when outstanding equity awards vest</a></td>
<td class="nump">0.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_CommonStockVotePerShare', window );">Vote per share of common stock (in votes)</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_CommonStockConversionRatio', window );">Common stock, conversion ratio</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_CommonStockVotePerShare', window );">Vote per share of common stock (in votes)</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_AffiliatedHoldersOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Affiliated Holders, Ownership Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_AffiliatedHoldersOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_AffiliatedHoldersPotentialOwnershipPercentageWhenOutstandingEquityAwardsVest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Affiliated Holders, Potential Ownership Percentage When Outstanding Equity Awards Vest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_AffiliatedHoldersPotentialOwnershipPercentageWhenOutstandingEquityAwardsVest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_CommonStockConversionRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Conversion Ratio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_CommonStockConversionRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_CommonStockVotePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Vote Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_CommonStockVotePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_NumberOfClassesOfCommonStockAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Classes Of Common Stock Authorized</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_NumberOfClassesOfCommonStockAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=rxrx_CEOAndAffiliatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=rxrx_CEOAndAffiliatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaborative Development Contracts (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Apr. 30, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 30, 2024 </div>
<div>USD ($) </div>
<div>performance_obligation</div>
</th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 31, 2022 </div>
<div>USD ($) </div>
<div>program </div>
<div>performance_obligation </div>
<div>phenomap </div>
<div>candidate</div>
</th>
<th class="th">
<div>Sep. 30, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.5<span></span>
</td>
<td class="nump">$ 4.1<span></span>
</td>
<td class="nump">$ 36.6<span></span>
</td>
<td class="nump">$ 29.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Cost incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=rxrx_SanofiMember', window );">Sanofi | Collaborative Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_ContractWithCustomerNumberOfNovelSmallMoleculeCandidates', window );">Maximum number of novel small molecule candidates | candidate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Remaining unearned revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized</a></td>
<td class="nump">$ 30.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_CollaborativeArrangementMilestonePaymentReceived', window );">Milestone payment received</a></td>
<td class="nump">7.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_RevenuePerformanceObligationNumberOfObligations', window );">Number of performance obligations under the agreement (in performance obligations) | performance_obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligation revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 152.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=rxrx_SanofiMember', window );">Sanofi | Collaborative Arrangement | Research Milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Remaining unearned revenue</a></td>
<td class="nump">555.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=rxrx_SanofiMember', window );">Sanofi | Collaborative Arrangement | Development And Regulatory Milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Remaining unearned revenue</a></td>
<td class="nump">$ 1,800.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=rxrx_MerckKGaAMerckMember', window );">Merck KGaA (Merck) | Collaborative Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Remaining unearned revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_RevenuePerformanceObligationNumberOfObligations', window );">Number of performance obligations under the agreement (in performance obligations) | performance_obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligation revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=rxrx_MerckKGaAMerckMember', window );">Merck KGaA (Merck) | Collaborative Arrangement | Discovery, Development And Sales Milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Remaining unearned revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 73.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=rxrx_RocheAndGenentechMember', window );">Roche and Genentech | Collaborative Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Remaining unearned revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_RevenuePerformanceObligationNumberOfObligations', window );">Number of performance obligations under the agreement (in performance obligations) | performance_obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligation revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 180.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=rxrx_RocheAndGenentechMember', window );">Roche and Genentech | Collaborative Arrangement | Phenomaps Creation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_RevenueRemainingPerformanceObligationVariableConsiderationAmount', window );">Research project, fees and milestones payments receivable for an option on a lead series</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_ContractWithCustomerMaximumAcceptedProduct', window );">Number of eligible phenomaps | phenomap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=rxrx_RocheAndGenentechMember', window );">Roche and Genentech | Collaborative Arrangement | Phenomaps Raw Images</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_RevenueRemainingPerformanceObligationVariableConsiderationAmount', window );">Research project, fees and milestones payments receivable for an option on a lead series</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_ContractWithCustomerMaximumAcceptedProduct', window );">Number of eligible phenomaps | phenomap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=rxrx_RocheAndGenentechMember', window );">Roche and Genentech | Collaborative Arrangement | Developed and Commercialized Programs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_RevenueRemainingPerformanceObligationVariableConsiderationAmount', window );">Research project, fees and milestones payments receivable for an option on a lead series</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated', window );">Number of projects that may be initiated | program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=rxrx_RocheAndGenentechMember', window );">Roche and Genentech | Collaborative Arrangement | Gastrointestinal Cancer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_RevenuePerformanceObligationNumberOfObligations', window );">Number of performance obligations under the agreement (in performance obligations) | performance_obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=rxrx_RocheAndGenentechMember', window );">Roche and Genentech | Collaborative Arrangement | Neuroscience</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_RevenuePerformanceObligationNumberOfObligations', window );">Number of performance obligations under the agreement (in performance obligations) | performance_obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_CollaborativeArrangementMilestonePaymentReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Milestone Payment Received</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_CollaborativeArrangementMilestonePaymentReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_ContractWithCustomerMaximumAcceptedProduct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Maximum Accepted Product</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_ContractWithCustomerMaximumAcceptedProduct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_ContractWithCustomerNumberOfNovelSmallMoleculeCandidates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Number Of Novel Small Molecule Candidates</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_ContractWithCustomerNumberOfNovelSmallMoleculeCandidates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_RevenuePerformanceObligationNumberOfObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue, Performance Obligation, Number Of Obligations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_RevenuePerformanceObligationNumberOfObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue, Remaining Performance Obligation, Number Of Projects That May Be Initiated</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_RevenueRemainingPerformanceObligationVariableConsiderationAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue, Remaining Performance Obligation, Variable Consideration Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_RevenueRemainingPerformanceObligationVariableConsiderationAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=rxrx_SanofiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=rxrx_SanofiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_MilestoneTypeAxis=rxrx_ResearchMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_MilestoneTypeAxis=rxrx_ResearchMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_MilestoneTypeAxis=rxrx_DevelopmentAndRegulatoryMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_MilestoneTypeAxis=rxrx_DevelopmentAndRegulatoryMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=rxrx_MerckKGaAMerckMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=rxrx_MerckKGaAMerckMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_MilestoneTypeAxis=rxrx_DiscoveryDevelopmentAndSalesMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_MilestoneTypeAxis=rxrx_DiscoveryDevelopmentAndSalesMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=rxrx_RocheAndGenentechMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=rxrx_RocheAndGenentechMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_RevenueRemainingPerformanceObligationAxis=rxrx_PhenomapsCreationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_RevenueRemainingPerformanceObligationAxis=rxrx_PhenomapsCreationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_RevenueRemainingPerformanceObligationAxis=rxrx_PhenomapsRawImagesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_RevenueRemainingPerformanceObligationAxis=rxrx_PhenomapsRawImagesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_RevenueRemainingPerformanceObligationAxis=rxrx_DevelopedAndCommercializedProgramsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_RevenueRemainingPerformanceObligationAxis=rxrx_DevelopedAndCommercializedProgramsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_RevenueRemainingPerformanceObligationAxis=rxrx_GastrointestinalCancerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_RevenueRemainingPerformanceObligationAxis=rxrx_GastrointestinalCancerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_RevenueRemainingPerformanceObligationAxis=rxrx_NeuroscienceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_RevenueRemainingPerformanceObligationAxis=rxrx_NeuroscienceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Narrative (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Options granted in period, weighted average grant date fair value (in dollars per share)</a></td>
<td class="nump">$ 4.47<span></span>
</td>
<td class="nump">$ 5.88<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unvested stock options, unamortized stock-based compensation cost</a></td>
<td class="nump">$ 36.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unvested stock options, unamortized stock-based compensation cost, weighted average period recognition</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock options, vesting period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Stock options, expiration period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock options, vesting period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unvested stock options, unamortized stock-based compensation cost, weighted average period recognition</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Fair market value of vested shares</a></td>
<td class="nump">$ 50.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized compensation cost</a></td>
<td class="nump">$ 188.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=rxrx_A2021EquityIncentivePlanMember', window );">2021 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant (in shares)</a></td>
<td class="nump">13.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=rxrx_A2024InducementEquityIncentivePlanMember', window );">2024 Inducement Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant (in shares)</a></td>
<td class="nump">11.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=rxrx_A2021EquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=rxrx_A2021EquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=rxrx_A2024InducementEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=rxrx_A2024InducementEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of Stock-Based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based payment arrangement, expense</a></td>
<td class="nump">$ 25,044<span></span>
</td>
<td class="nump">$ 17,743<span></span>
</td>
<td class="nump">$ 86,433<span></span>
</td>
<td class="nump">$ 49,211<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based payment arrangement, expense</a></td>
<td class="nump">964<span></span>
</td>
<td class="nump">1,153<span></span>
</td>
<td class="nump">4,727<span></span>
</td>
<td class="nump">2,600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based payment arrangement, expense</a></td>
<td class="nump">14,906<span></span>
</td>
<td class="nump">9,194<span></span>
</td>
<td class="nump">46,795<span></span>
</td>
<td class="nump">25,141<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based payment arrangement, expense</a></td>
<td class="nump">$ 9,174<span></span>
</td>
<td class="nump">$ 7,396<span></span>
</td>
<td class="nump">$ 34,911<span></span>
</td>
<td class="nump">$ 21,470<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479983/718-10-S45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of Stock Option Activity (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares&#160;</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning balance (in shares)</a></td>
<td class="nump">21,941,495<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">3,340,822<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Cancelled (in shares)</a></td>
<td class="num">(2,305,626)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(4,519,592)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending balance (in shares)</a></td>
<td class="nump">18,457,099<span></span>
</td>
<td class="nump">21,941,495<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable (in shares)</a></td>
<td class="nump">10,189,094<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted-Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning balance (in dollars per share)</a></td>
<td class="nump">$ 5.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="nump">7.08<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Cancelled (in dollars per share)</a></td>
<td class="nump">8.81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="nump">1.08<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending balance (in dollars per share)</a></td>
<td class="nump">6.52<span></span>
</td>
<td class="nump">$ 5.40<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable (in dollars per share)</a></td>
<td class="nump">$ 6.64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Options, outstanding, weighted average remaining contractual life</a></td>
<td class="text">7 years 2 months 12 days<span></span>
</td>
<td class="text">7 years 10 months 24 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Options, exercisable, weighted average remaining contractual life</a></td>
<td class="text">5 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Options, outstanding, intrinsic value</a></td>
<td class="nump">$ 20,246<span></span>
</td>
<td class="nump">$ 62,685<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Exercise, intrinsic value</a></td>
<td class="nump">24,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Exercise, intrinsic value</a></td>
<td class="nump">$ 14,363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of Weighted-Average Assumptions Used to Calculate Grant-Date Fair Value of Stock Options (Details) - Stock based compensation<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">6 years 2 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">66.00%<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.20%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of RSU Activity (Details) - RSUs<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2025 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward', window );"><strong>Stock units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Beginning balance, (in shares) | shares</a></td>
<td class="nump">27,304,229<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">14,980,106<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(6,742,946)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(4,898,723)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Ending balance, (in shares) | shares</a></td>
<td class="nump">30,642,666<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-average grant date fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Beginning balance, (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 7.47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">5.86<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share) | $ / shares</a></td>
<td class="nump">7.62<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share) | $ / shares</a></td>
<td class="nump">7.72<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Ending balance, (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 6.61<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations', window );">U.S. income tax expense</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current and deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current and deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10B<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share - Schedule of Computation of Basic and Diluted Net Loss Per Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (162,253)<span></span>
</td>
<td class="num">$ (95,842)<span></span>
</td>
<td class="num">$ (536,637)<span></span>
</td>
<td class="num">$ (284,755)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding, basic (in shares)</a></td>
<td class="nump">446,988,046<span></span>
</td>
<td class="nump">282,583,048<span></span>
</td>
<td class="nump">422,642,653<span></span>
</td>
<td class="nump">253,447,099<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding, diluted (in shares)</a></td>
<td class="nump">446,988,046<span></span>
</td>
<td class="nump">282,583,048<span></span>
</td>
<td class="nump">422,642,653<span></span>
</td>
<td class="nump">253,447,099<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share, basic (in dollars per shares)</a></td>
<td class="num">$ (0.36)<span></span>
</td>
<td class="num">$ (0.34)<span></span>
</td>
<td class="num">$ (1.27)<span></span>
</td>
<td class="num">$ (1.12)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share, diluted (in dollars per shares)</a></td>
<td class="num">$ (0.36)<span></span>
</td>
<td class="num">$ (0.34)<span></span>
</td>
<td class="num">$ (1.27)<span></span>
</td>
<td class="num">$ (1.12)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Computation of Net Loss Per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of loss per share, amount (in shares)</a></td>
<td class="nump">14,508,650<span></span>
</td>
<td class="nump">12,564,729<span></span>
</td>
<td class="nump">15,700,559<span></span>
</td>
<td class="nump">14,793,913<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember', window );">Stock based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of loss per share, amount (in shares)</a></td>
<td class="nump">6,675,698<span></span>
</td>
<td class="nump">5,869,795<span></span>
</td>
<td class="nump">8,696,773<span></span>
</td>
<td class="nump">8,098,979<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=rxrx_TempusAgreementMember', window );">Tempus agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of loss per share, amount (in shares)</a></td>
<td class="nump">6,582,331<span></span>
</td>
<td class="nump">6,694,934<span></span>
</td>
<td class="nump">6,582,331<span></span>
</td>
<td class="nump">6,694,934<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=rxrx_ContingentStockRelatingToREVentures1AgreementMember', window );">Contingent stock relating to RE Ventures I transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of loss per share, amount (in shares)</a></td>
<td class="nump">1,250,621<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">421,455<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=rxrx_TempusAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=rxrx_TempusAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=rxrx_ContingentStockRelatingToREVentures1AgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=rxrx_ContingentStockRelatingToREVentures1AgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - Fair Value, Recurring - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure', window );">Restricted cash</a></td>
<td class="nump">$ 7,309<span></span>
</td>
<td class="nump">$ 8,675<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">667,145<span></span>
</td>
<td class="nump">603,024<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">436,675<span></span>
</td>
<td class="nump">198,050<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">223,161<span></span>
</td>
<td class="nump">235,812<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Bank deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">160,487<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure', window );">Restricted cash</a></td>
<td class="nump">7,309<span></span>
</td>
<td class="nump">8,675<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">667,145<span></span>
</td>
<td class="nump">603,024<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1 | Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">436,675<span></span>
</td>
<td class="nump">198,050<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">223,161<span></span>
</td>
<td class="nump">235,812<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1 | Bank deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">160,487<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure', window );">Restricted cash</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2 | Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2 | Bank deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure', window );">Restricted cash</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 3 | Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 3 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 3 | Bank deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restricted Cash And Cash Equivalents, Fair Value Disclosure</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482881/825-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482881/825-10-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_BankTimeDepositsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_BankTimeDepositsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Financial Instruments Not Measured at Fair Value (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Notes payable and financing lease liabilities, current</a></td>
<td class="nump">$ 8,919<span></span>
</td>
<td class="nump">$ 8,425<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Notes payable and financing lease liabilities, non-current</a></td>
<td class="nump">11,902<span></span>
</td>
<td class="nump">19,022<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember', window );">Book values</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">20,821<span></span>
</td>
<td class="nump">27,447<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember', window );">Book values | Notes Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Notes payable and financing lease liabilities, current</a></td>
<td class="nump">8,919<span></span>
</td>
<td class="nump">8,425<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Notes payable and financing lease liabilities, non-current</a></td>
<td class="nump">11,902<span></span>
</td>
<td class="nump">19,022<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Fair values</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">20,821<span></span>
</td>
<td class="nump">27,447<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Fair values | Notes Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Notes payable and financing lease liabilities, current</a></td>
<td class="nump">8,919<span></span>
</td>
<td class="nump">8,425<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Notes payable and financing lease liabilities, non-current</a></td>
<td class="nump">$ 11,902<span></span>
</td>
<td class="nump">$ 19,022<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Schedule of Segment Net Loss and Reconciliations of Segment Operating Loss to Loss Before Income Tax Benefit (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 5,175<span></span>
</td>
<td class="nump">$ 26,082<span></span>
</td>
<td class="nump">$ 39,143<span></span>
</td>
<td class="nump">$ 54,293<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_SignificantSegmentExpensesAbstract', window );"><strong>Significant segment expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="nump">172,202<span></span>
</td>
<td class="nump">98,354<span></span>
</td>
<td class="nump">539,798<span></span>
</td>
<td class="nump">295,236<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other non-operating income (loss), net</a></td>
<td class="nump">9,952<span></span>
</td>
<td class="nump">2,679<span></span>
</td>
<td class="nump">3,005<span></span>
</td>
<td class="nump">9,347<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (expense)</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(167)<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="nump">1,134<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Total segment loss</a></td>
<td class="nump">162,253<span></span>
</td>
<td class="nump">95,842<span></span>
</td>
<td class="nump">536,637<span></span>
</td>
<td class="nump">284,755<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=rxrx_ReportableSegmentMember', window );">Reportable Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">5,175<span></span>
</td>
<td class="nump">26,082<span></span>
</td>
<td class="nump">39,143<span></span>
</td>
<td class="nump">54,293<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_SignificantSegmentExpensesAbstract', window );"><strong>Significant segment expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LaborAndRelatedExpense', window );">Salaries</a></td>
<td class="nump">68,600<span></span>
</td>
<td class="nump">55,515<span></span>
</td>
<td class="nump">235,190<span></span>
</td>
<td class="nump">156,171<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_ConsumableExpense', window );">Consumables</a></td>
<td class="nump">8,928<span></span>
</td>
<td class="nump">19,419<span></span>
</td>
<td class="nump">92,725<span></span>
</td>
<td class="nump">54,176<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_PlatformFeeExpense', window );">Platform</a></td>
<td class="nump">14,377<span></span>
</td>
<td class="nump">8,330<span></span>
</td>
<td class="nump">36,934<span></span>
</td>
<td class="nump">13,102<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_DiscoveryExpense', window );">Discovery</a></td>
<td class="nump">37,049<span></span>
</td>
<td class="nump">3,375<span></span>
</td>
<td class="nump">58,716<span></span>
</td>
<td class="nump">19,115<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_ClinicalDevelopmentExpense', window );">Clinical development</a></td>
<td class="nump">10,814<span></span>
</td>
<td class="nump">9,050<span></span>
</td>
<td class="nump">33,338<span></span>
</td>
<td class="nump">31,966<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">18,708<span></span>
</td>
<td class="nump">6,637<span></span>
</td>
<td class="nump">64,223<span></span>
</td>
<td class="nump">22,982<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherItemAmount', window );">Other segment items</a></td>
<td class="nump">18,901<span></span>
</td>
<td class="nump">22,110<span></span>
</td>
<td class="nump">57,815<span></span>
</td>
<td class="nump">52,017<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="nump">172,202<span></span>
</td>
<td class="nump">98,354<span></span>
</td>
<td class="nump">539,798<span></span>
</td>
<td class="nump">295,236<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other non-operating income (loss), net</a></td>
<td class="nump">9,952<span></span>
</td>
<td class="nump">2,679<span></span>
</td>
<td class="nump">3,005<span></span>
</td>
<td class="nump">9,347<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (expense)</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(167)<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="nump">1,134<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Total segment loss</a></td>
<td class="nump">162,253<span></span>
</td>
<td class="nump">95,842<span></span>
</td>
<td class="nump">536,637<span></span>
</td>
<td class="nump">284,755<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_SupplementalAssetInformationAbstract', window );"><strong>Supplemental asset information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentExpenditureAdditionToLongLivedAssets', window );">Total expenditures for additions to long-lived assets</a></td>
<td class="nump">$ 39<span></span>
</td>
<td class="nump">$ 4,248<span></span>
</td>
<td class="nump">$ 5,283<span></span>
</td>
<td class="nump">$ 12,633<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_ClinicalDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Clinical Development Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_ClinicalDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_ConsumableExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Consumable Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_ConsumableExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_DiscoveryExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discovery Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_DiscoveryExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_PlatformFeeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Platform Fee Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_PlatformFeeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_SignificantSegmentExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Significant Segment Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_SignificantSegmentExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_SupplementalAssetInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supplemental Asset Information</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_SupplementalAssetInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for allocation of cost of tangible and intangible assets over their useful lives directly used in production of good and rendering of service.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LaborAndRelatedExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(14)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LaborAndRelatedExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-7<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentExpenditureAdditionToLongLivedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenditure for addition to long-lived assets included in determination of segment assets by chief operating decision maker (CODM) or otherwise regularly provided to CODM. Excludes expenditure for addition to financial instrument, long-term customer relationship of financial institution, mortgage and other servicing rights, deferred policy acquisition cost, and deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentExpenditureAdditionToLongLivedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingOtherItemAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingOtherItemAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=rxrx_ReportableSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=rxrx_ReportableSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Schedule of Revenue and Long-Lived Assets Based on Geographic Areas (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 5,175<span></span>
</td>
<td class="nump">$ 26,082<span></span>
</td>
<td class="nump">$ 39,143<span></span>
</td>
<td class="nump">$ 54,293<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">1,110<span></span>
</td>
<td class="nump">26,082<span></span>
</td>
<td class="nump">22,393<span></span>
</td>
<td class="nump">54,293<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">66,571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 78,471<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_GB', window );">United Kingdom</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">4,065<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">16,750<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">42,655<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,655<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,332<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">Canada</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">2,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,631<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=rxrx_OtherCountriesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,629<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-7<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=rxrx_OtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=rxrx_OtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="3">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 27, 2025</div></th>
<th class="th"><div>Oct. 31, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Oct. 31, 2025</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.5<span></span>
</td>
<td class="nump">$ 4.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36.6<span></span>
</td>
<td class="nump">$ 29.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=rxrx_AtTheMarketOfferingProgramCitiMember', window );">At-The-Market Offering Program Citi | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Net proceeds received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 133.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 491.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=rxrx_RocheAndGenentechMember', window );">Roche and Genentech | Collaborative Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=rxrx_RocheAndGenentechMember', window );">Roche and Genentech | Collaborative Arrangement | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized</a></td>
<td class="nump">$ 30.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=rxrx_AtTheMarketOfferingProgramCitiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=rxrx_AtTheMarketOfferingProgramCitiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=rxrx_RocheAndGenentechMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=rxrx_RocheAndGenentechMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>226</ContextCount>
  <ElementCount>341</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>69</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>12</UnitCount>
  <MyReports>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>9952151 - Statement - Condensed Consolidated Balance Sheets (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited</Role>
      <ShortName>Condensed Consolidated Balance Sheets (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>9952152 - Statement - Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>9952153 - Statement - Condensed Consolidated Statements of Operations (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited</Role>
      <ShortName>Condensed Consolidated Statements of Operations (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>9952154 - Statement - Condensed Consolidated Statements of Comprehensive Loss (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/CondensedConsolidatedStatementsofComprehensiveLossunaudited</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Loss (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>9952155 - Statement - Condensed Consolidated Statements of Stockholders??? Equity (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited</Role>
      <ShortName>Condensed Consolidated Statements of Stockholders??? Equity (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>9952156 - Statement - Condensed Consolidated Statements of Cash Flows (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>9952157 - Disclosure - Description of the Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/DescriptionoftheBusiness</Role>
      <ShortName>Description of the Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>9952158 - Disclosure - Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/BasisofPresentation</Role>
      <ShortName>Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>9952159 - Disclosure - Supplemental Financial Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/SupplementalFinancialInformation</Role>
      <ShortName>Supplemental Financial Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>9952160 - Disclosure - Acquisitions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/Acquisitions</Role>
      <ShortName>Acquisitions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>9952161 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>9952162 - Disclosure - Goodwill and Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/GoodwillandIntangibleAssets</Role>
      <ShortName>Goodwill and Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>9952163 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>9952164 - Disclosure - Common Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/CommonStock</Role>
      <ShortName>Common Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>9952165 - Disclosure - Collaborative Development Contracts</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/CollaborativeDevelopmentContracts</Role>
      <ShortName>Collaborative Development Contracts</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>9952166 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/StockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>9952167 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>9952168 - Disclosure - Net Loss Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/NetLossPerShare</Role>
      <ShortName>Net Loss Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>9952169 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>9952170 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/SegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>9952171 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>9955511 - Disclosure - Basis of Presentation (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/BasisofPresentationPolicies</Role>
      <ShortName>Basis of Presentation (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>9955512 - Disclosure - Supplemental Financial Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/SupplementalFinancialInformationTables</Role>
      <ShortName>Supplemental Financial Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.recursion.com/role/SupplementalFinancialInformation</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>9955513 - Disclosure - Acquisitions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/AcquisitionsTables</Role>
      <ShortName>Acquisitions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.recursion.com/role/Acquisitions</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>9955514 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.recursion.com/role/Leases</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>9955515 - Disclosure - Goodwill and Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/GoodwillandIntangibleAssetsTables</Role>
      <ShortName>Goodwill and Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.recursion.com/role/GoodwillandIntangibleAssets</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>9955516 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/StockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.recursion.com/role/StockBasedCompensation</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>9955517 - Disclosure - Net Loss Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/NetLossPerShareTables</Role>
      <ShortName>Net Loss Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.recursion.com/role/NetLossPerShare</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>9955518 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.recursion.com/role/FairValueMeasurements</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9955519 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/SegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.recursion.com/role/SegmentInformation</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9955520 - Disclosure - Description of the Business (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/DescriptionoftheBusinessDetails</Role>
      <ShortName>Description of the Business (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.recursion.com/role/DescriptionoftheBusiness</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9955521 - Disclosure - Supplemental Financial Information - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/SupplementalFinancialInformationNarrativeDetails</Role>
      <ShortName>Supplemental Financial Information - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9955522 - Disclosure - Supplemental Financial Information - Schedule of Accrued Expenses and Other Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails</Role>
      <ShortName>Supplemental Financial Information - Schedule of Accrued Expenses and Other Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9955523 - Disclosure - Supplemental Financial Information - Schedule of Restructuring Actions and the Related Accrual (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/SupplementalFinancialInformationScheduleofRestructuringActionsandtheRelatedAccrualDetails</Role>
      <ShortName>Supplemental Financial Information - Schedule of Restructuring Actions and the Related Accrual (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9955524 - Disclosure - Supplemental Financial Information - Schedule of Interest Income, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/SupplementalFinancialInformationScheduleofInterestIncomeNetDetails</Role>
      <ShortName>Supplemental Financial Information - Schedule of Interest Income, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9955525 - Disclosure - Acquisitions - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/AcquisitionsNarrativeDetails</Role>
      <ShortName>Acquisitions - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9955526 - Disclosure - Acquisitions - Schedule of Asset Acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/AcquisitionsScheduleofAssetAcquisitionDetails</Role>
      <ShortName>Acquisitions - Schedule of Asset Acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9955527 - Disclosure - Acquisitions - Schedule of Contingent Consideration Transferred (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/AcquisitionsScheduleofContingentConsiderationTransferredDetails</Role>
      <ShortName>Acquisitions - Schedule of Contingent Consideration Transferred (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9955528 - Disclosure - Acquisitions - Schedule of Fair Value of Assets Acquired and Liabilities Assumed (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails</Role>
      <ShortName>Acquisitions - Schedule of Fair Value of Assets Acquired and Liabilities Assumed (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9955529 - Disclosure - Acquisitions - Schedule of Pro Forma Financial Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/AcquisitionsScheduleofProFormaFinancialInformationDetails</Role>
      <ShortName>Acquisitions - Schedule of Pro Forma Financial Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9955530 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9955531 - Disclosure - Leases - Schedule of Supplemental Cash Flow Information Related to Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/LeasesScheduleofSupplementalCashFlowInformationRelatedtoLeasesDetails</Role>
      <ShortName>Leases - Schedule of Supplemental Cash Flow Information Related to Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9955532 - Disclosure - Goodwill and Intangible Assets - Schedule of Changes in the Carrying Amount of Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofChangesintheCarryingAmountofGoodwillDetails</Role>
      <ShortName>Goodwill and Intangible Assets - Schedule of Changes in the Carrying Amount of Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9955533 - Disclosure - Goodwill and Intangible Assets - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/GoodwillandIntangibleAssetsNarrativeDetails</Role>
      <ShortName>Goodwill and Intangible Assets - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9955534 - Disclosure - Goodwill and Intangible Assets - Schedule of Intangible assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails</Role>
      <ShortName>Goodwill and Intangible Assets - Schedule of Intangible assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9955535 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.recursion.com/role/CommitmentsandContingencies</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9955536 - Disclosure - Common Stock - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/CommonStockNarrativeDetails</Role>
      <ShortName>Common Stock - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9955537 - Disclosure - Common Stock - At-The-Market Offering (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/CommonStockAtTheMarketOfferingNarrativeDetails</Role>
      <ShortName>Common Stock - At-The-Market Offering (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9955538 - Disclosure - Common Stock - Public Offering of Common Stock (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/CommonStockPublicOfferingofCommonStockNarrativeDetails</Role>
      <ShortName>Common Stock - Public Offering of Common Stock (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>9955539 - Disclosure - Common Stock - Valence Acquisition Exchangeable Shares (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/CommonStockValenceAcquisitionExchangeableSharesNarrativeDetails</Role>
      <ShortName>Common Stock - Valence Acquisition Exchangeable Shares (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>9955540 - Disclosure - Common Stock - Registration Rights Agreements (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/CommonStockRegistrationRightsAgreementsNarrativeDetails</Role>
      <ShortName>Common Stock - Registration Rights Agreements (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>9955541 - Disclosure - Common Stock - Class A and B Common Shares Authorization (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/CommonStockClassAandBCommonSharesAuthorizationNarrativeDetails</Role>
      <ShortName>Common Stock - Class A and B Common Shares Authorization (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>9955542 - Disclosure - Collaborative Development Contracts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails</Role>
      <ShortName>Collaborative Development Contracts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.recursion.com/role/CollaborativeDevelopmentContracts</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>9955543 - Disclosure - Stock-Based Compensation - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/StockBasedCompensationNarrativeDetails</Role>
      <ShortName>Stock-Based Compensation - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>9955544 - Disclosure - Stock-Based Compensation - Schedule of Stock-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails</Role>
      <ShortName>Stock-Based Compensation - Schedule of Stock-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>9955545 - Disclosure - Stock-Based Compensation - Schedule of Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails</Role>
      <ShortName>Stock-Based Compensation - Schedule of Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>9955546 - Disclosure - Stock-Based Compensation - Schedule of Weighted-Average Assumptions Used to Calculate Grant-Date Fair Value of Stock Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/StockBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoCalculateGrantDateFairValueofStockOptionsDetails</Role>
      <ShortName>Stock-Based Compensation - Schedule of Weighted-Average Assumptions Used to Calculate Grant-Date Fair Value of Stock Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>9955547 - Disclosure - Stock-Based Compensation - Schedule of RSU Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/StockBasedCompensationScheduleofRSUActivityDetails</Role>
      <ShortName>Stock-Based Compensation - Schedule of RSU Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>9955548 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.recursion.com/role/IncomeTaxes</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>9955549 - Disclosure - Net Loss Per Share - Schedule of Computation of Basic and Diluted Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/NetLossPerShareScheduleofComputationofBasicandDilutedNetLossPerShareDetails</Role>
      <ShortName>Net Loss Per Share - Schedule of Computation of Basic and Diluted Net Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>9955550 - Disclosure - Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Computation of Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossPerShareDetails</Role>
      <ShortName>Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Computation of Net Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>9955551 - Disclosure - Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>9955552 - Disclosure - Fair Value Measurements - Schedule of Financial Instruments Not Measured at Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Financial Instruments Not Measured at Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>9955553 - Disclosure - Segment Information - Schedule of Segment Net Loss and Reconciliations of Segment Operating Loss to Loss Before Income Tax Benefit (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails</Role>
      <ShortName>Segment Information - Schedule of Segment Net Loss and Reconciliations of Segment Operating Loss to Loss Before Income Tax Benefit (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>9955554 - Disclosure - Segment Information - Schedule of Revenue and Long-Lived Assets Based on Geographic Areas (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/SegmentInformationScheduleofRevenueandLongLivedAssetsBasedonGeographicAreasDetails</Role>
      <ShortName>Segment Information - Schedule of Revenue and Long-Lived Assets Based on Geographic Areas (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="rxrx-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>9955555 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.recursion.com/role/SubsequentEvents</ParentRole>
      <Position>68</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" isDefinitelyFs="true" isUsgaap="true" original="rxrx-20250930.htm">rxrx-20250930.htm</File>
    <File>rxrx-20250930.xsd</File>
    <File>rxrx-20250930_cal.xml</File>
    <File>rxrx-20250930_def.xml</File>
    <File>rxrx-20250930_lab.xml</File>
    <File>rxrx-20250930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>rxrx-20250930_g1.jpg</File>
    <File>rxrx-20250930_g2.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="729">http://fasb.org/us-gaap/2025</BaseTaxonomy>
    <BaseTaxonomy items="30">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="26">http://xbrl.sec.gov/ecd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>87
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "rxrx-20250930.htm": {
   "nsprefix": "rxrx",
   "nsuri": "http://www.recursion.com/20250930",
   "dts": {
    "inline": {
     "local": [
      "rxrx-20250930.htm"
     ]
    },
    "schema": {
     "local": [
      "rxrx-20250930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "rxrx-20250930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "rxrx-20250930_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "rxrx-20250930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "rxrx-20250930_pre.xml"
     ]
    }
   },
   "keyStandard": 283,
   "keyCustom": 58,
   "axisStandard": 27,
   "axisCustom": 3,
   "memberStandard": 35,
   "memberCustom": 34,
   "hidden": {
    "total": 10,
    "http://xbrl.sec.gov/ecd/2025": 3,
    "http://www.recursion.com/20250930": 2,
    "http://xbrl.sec.gov/dei/2025": 5
   },
   "contextCount": 226,
   "entityCount": 1,
   "segmentCount": 69,
   "elementCount": 646,
   "unitCount": 12,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2025": 729,
    "http://xbrl.sec.gov/dei/2025": 30,
    "http://xbrl.sec.gov/ecd/2025": 26
   },
   "report": {
    "R1": {
     "role": "http://www.recursion.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited",
     "longName": "9952151 - Statement - Condensed Consolidated Balance Sheets (unaudited)",
     "shortName": "Condensed Consolidated Balance Sheets (unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical",
     "longName": "9952152 - Statement - Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)",
     "shortName": "Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited",
     "longName": "9952153 - Statement - Condensed Consolidated Statements of Operations (unaudited)",
     "shortName": "Condensed Consolidated Statements of Operations (unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-20",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-20",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.recursion.com/role/CondensedConsolidatedStatementsofComprehensiveLossunaudited",
     "longName": "9952154 - Statement - Condensed Consolidated Statements of Comprehensive Loss (unaudited)",
     "shortName": "Condensed Consolidated Statements of Comprehensive Loss (unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-20",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-20",
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited",
     "longName": "9952155 - Statement - Condensed Consolidated Statements of Stockholders\u2019 Equity (unaudited)",
     "shortName": "Condensed Consolidated Statements of Stockholders\u2019 Equity (unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-58",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-58",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited",
     "longName": "9952156 - Statement - Condensed Consolidated Statements of Cash Flows (unaudited)",
     "shortName": "Condensed Consolidated Statements of Cash Flows (unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.recursion.com/role/DescriptionoftheBusiness",
     "longName": "9952157 - Disclosure - Description of the Business",
     "shortName": "Description of the Business",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.recursion.com/role/BasisofPresentation",
     "longName": "9952158 - Disclosure - Basis of Presentation",
     "shortName": "Basis of Presentation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.recursion.com/role/SupplementalFinancialInformation",
     "longName": "9952159 - Disclosure - Supplemental Financial Information",
     "shortName": "Supplemental Financial Information",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "rxrx:SupplementalBalanceSheetAndIncomeStatementInformationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "rxrx:SupplementalBalanceSheetAndIncomeStatementInformationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.recursion.com/role/Acquisitions",
     "longName": "9952160 - Disclosure - Acquisitions",
     "shortName": "Acquisitions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.recursion.com/role/Leases",
     "longName": "9952161 - Disclosure - Leases",
     "shortName": "Leases",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LesseeFinanceLeasesTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LesseeFinanceLeasesTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.recursion.com/role/GoodwillandIntangibleAssets",
     "longName": "9952162 - Disclosure - Goodwill and Intangible Assets",
     "shortName": "Goodwill and Intangible Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.recursion.com/role/CommitmentsandContingencies",
     "longName": "9952163 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.recursion.com/role/CommonStock",
     "longName": "9952164 - Disclosure - Common Stock",
     "shortName": "Common Stock",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.recursion.com/role/CollaborativeDevelopmentContracts",
     "longName": "9952165 - Disclosure - Collaborative Development Contracts",
     "shortName": "Collaborative Development Contracts",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.recursion.com/role/StockBasedCompensation",
     "longName": "9952166 - Disclosure - Stock-Based Compensation",
     "shortName": "Stock-Based Compensation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.recursion.com/role/IncomeTaxes",
     "longName": "9952167 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.recursion.com/role/NetLossPerShare",
     "longName": "9952168 - Disclosure - Net Loss Per Share",
     "shortName": "Net Loss Per Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.recursion.com/role/FairValueMeasurements",
     "longName": "9952169 - Disclosure - Fair Value Measurements",
     "shortName": "Fair Value Measurements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.recursion.com/role/SegmentInformation",
     "longName": "9952170 - Disclosure - Segment Information",
     "shortName": "Segment Information",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.recursion.com/role/SubsequentEvents",
     "longName": "9952171 - Disclosure - Subsequent Events",
     "shortName": "Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-20",
      "name": "ecd:NonRule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:NonRule10b51ArrTrmntdFlag",
       "ecd:Rule10b51ArrTrmntdFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-20",
      "name": "ecd:NonRule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:NonRule10b51ArrTrmntdFlag",
       "ecd:Rule10b51ArrTrmntdFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.recursion.com/role/BasisofPresentationPolicies",
     "longName": "9955511 - Disclosure - Basis of Presentation (Policies)",
     "shortName": "Basis of Presentation (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.recursion.com/role/SupplementalFinancialInformationTables",
     "longName": "9955512 - Disclosure - Supplemental Financial Information (Tables)",
     "shortName": "Supplemental Financial Information (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.recursion.com/role/AcquisitionsTables",
     "longName": "9955513 - Disclosure - Acquisitions (Tables)",
     "shortName": "Acquisitions (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AssetAcquisitionTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AssetAcquisitionTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.recursion.com/role/LeasesTables",
     "longName": "9955514 - Disclosure - Leases (Tables)",
     "shortName": "Leases (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.recursion.com/role/GoodwillandIntangibleAssetsTables",
     "longName": "9955515 - Disclosure - Goodwill and Intangible Assets (Tables)",
     "shortName": "Goodwill and Intangible Assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.recursion.com/role/StockBasedCompensationTables",
     "longName": "9955516 - Disclosure - Stock-Based Compensation (Tables)",
     "shortName": "Stock-Based Compensation (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.recursion.com/role/NetLossPerShareTables",
     "longName": "9955517 - Disclosure - Net Loss Per Share (Tables)",
     "shortName": "Net Loss Per Share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.recursion.com/role/FairValueMeasurementsTables",
     "longName": "9955518 - Disclosure - Fair Value Measurements (Tables)",
     "shortName": "Fair Value Measurements (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.recursion.com/role/SegmentInformationTables",
     "longName": "9955519 - Disclosure - Segment Information (Tables)",
     "shortName": "Segment Information (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.recursion.com/role/DescriptionoftheBusinessDetails",
     "longName": "9955520 - Disclosure - Description of the Business (Details)",
     "shortName": "Description of the Business (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:RetainedEarningsAccumulatedDeficit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R34": {
     "role": "http://www.recursion.com/role/SupplementalFinancialInformationNarrativeDetails",
     "longName": "9955521 - Disclosure - Supplemental Financial Information - Narrative (Details)",
     "shortName": "Supplemental Financial Information - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c-20",
      "name": "rxrx:LicenseAgreementIncreaseDecreaseAccruedLiabilities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "rxrx:LicenseAgreementIncreaseDecreaseAccruedLiabilities",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-20",
      "name": "rxrx:LicenseAgreementIncreaseDecreaseAccruedLiabilities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "rxrx:LicenseAgreementIncreaseDecreaseAccruedLiabilities",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails",
     "longName": "9955522 - Disclosure - Supplemental Financial Information - Schedule of Accrued Expenses and Other Liabilities (Details)",
     "shortName": "Supplemental Financial Information - Schedule of Accrued Expenses and Other Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofRestructuringActionsandtheRelatedAccrualDetails",
     "longName": "9955523 - Disclosure - Supplemental Financial Information - Schedule of Restructuring Actions and the Related Accrual (Details)",
     "shortName": "Supplemental Financial Information - Schedule of Restructuring Actions and the Related Accrual (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:RestructuringReserve",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:RestructuringReserve",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofInterestIncomeNetDetails",
     "longName": "9955524 - Disclosure - Supplemental Financial Information - Schedule of Interest Income, Net (Details)",
     "shortName": "Supplemental Financial Information - Schedule of Interest Income, Net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-20",
      "name": "us-gaap:InvestmentIncomeNonoperating",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-20",
      "name": "us-gaap:InvestmentIncomeNonoperating",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.recursion.com/role/AcquisitionsNarrativeDetails",
     "longName": "9955525 - Disclosure - Acquisitions - Narrative (Details)",
     "shortName": "Acquisitions - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GainLossOnSaleOfBusiness",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-78",
      "name": "us-gaap:SharePrice",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.recursion.com/role/AcquisitionsScheduleofAssetAcquisitionDetails",
     "longName": "9955526 - Disclosure - Acquisitions - Schedule of Asset Acquisition (Details)",
     "shortName": "Acquisitions - Schedule of Asset Acquisition (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c-70",
      "name": "us-gaap:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AssetAcquisitionTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-70",
      "name": "us-gaap:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AssetAcquisitionTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.recursion.com/role/AcquisitionsScheduleofContingentConsiderationTransferredDetails",
     "longName": "9955527 - Disclosure - Acquisitions - Schedule of Contingent Consideration Transferred (Details)",
     "shortName": "Acquisitions - Schedule of Contingent Consideration Transferred (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c-72",
      "name": "rxrx:AssetAcquisitionContingentConsiderationEquityInterestIssuedAndIssuable",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AssetAcquisitionContingentConsiderationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-72",
      "name": "rxrx:AssetAcquisitionContingentConsiderationEquityInterestIssuedAndIssuable",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AssetAcquisitionContingentConsiderationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.recursion.com/role/AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails",
     "longName": "9955528 - Disclosure - Acquisitions - Schedule of Fair Value of Assets Acquired and Liabilities Assumed (Details)",
     "shortName": "Acquisitions - Schedule of Fair Value of Assets Acquired and Liabilities Assumed (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:Goodwill",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-80",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.recursion.com/role/AcquisitionsScheduleofProFormaFinancialInformationDetails",
     "longName": "9955529 - Disclosure - Acquisitions - Schedule of Pro Forma Financial Information (Details)",
     "shortName": "Acquisitions - Schedule of Pro Forma Financial Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c-82",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-82",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.recursion.com/role/LeasesNarrativeDetails",
     "longName": "9955530 - Disclosure - Leases - Narrative (Details)",
     "shortName": "Leases - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LesseeOperatingLeaseRenewalTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LesseeOperatingLeaseRenewalTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.recursion.com/role/LeasesScheduleofSupplementalCashFlowInformationRelatedtoLeasesDetails",
     "longName": "9955531 - Disclosure - Leases - Schedule of Supplemental Cash Flow Information Related to Leases (Details)",
     "shortName": "Leases - Schedule of Supplemental Cash Flow Information Related to Leases (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofChangesintheCarryingAmountofGoodwillDetails",
     "longName": "9955532 - Disclosure - Goodwill and Intangible Assets - Schedule of Changes in the Carrying Amount of Goodwill (Details)",
     "shortName": "Goodwill and Intangible Assets - Schedule of Changes in the Carrying Amount of Goodwill (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:Goodwill",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GoodwillForeignCurrencyTranslationGainLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.recursion.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
     "longName": "9955533 - Disclosure - Goodwill and Intangible Assets - Narrative (Details)",
     "shortName": "Goodwill and Intangible Assets - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c-20",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:GoodwillImpairmentLoss",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-20",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:GoodwillImpairmentLoss",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails",
     "longName": "9955534 - Disclosure - Goodwill and Intangible Assets - Schedule of Intangible assets (Details)",
     "shortName": "Goodwill and Intangible Assets - Schedule of Intangible assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.recursion.com/role/CommitmentsandContingenciesDetails",
     "longName": "9955535 - Disclosure - Commitments and Contingencies (Details)",
     "shortName": "Commitments and Contingencies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LossContingencyAccrualAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LossContingencyAccrualAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.recursion.com/role/CommonStockNarrativeDetails",
     "longName": "9955536 - Disclosure - Common Stock - Narrative (Details)",
     "shortName": "Common Stock - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DividendsStock",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:DividendsStock",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DividendsStock",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:DividendsStock",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.recursion.com/role/CommonStockAtTheMarketOfferingNarrativeDetails",
     "longName": "9955537 - Disclosure - Common Stock - At-The-Market Offering (Narrative) (Details)",
     "shortName": "Common Stock - At-The-Market Offering (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c-95",
      "name": "rxrx:SaleOfStockValueAuthorized",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-95",
      "name": "rxrx:SaleOfStockValueAuthorized",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.recursion.com/role/CommonStockPublicOfferingofCommonStockNarrativeDetails",
     "longName": "9955538 - Disclosure - Common Stock - Public Offering of Common Stock (Narrative) (Details)",
     "shortName": "Common Stock - Public Offering of Common Stock (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c-104",
      "name": "rxrx:SaleOfStockUnderwritersOptionPeriodFromTheDateOfTheAgreement",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-104",
      "name": "rxrx:SaleOfStockUnderwritersOptionPeriodFromTheDateOfTheAgreement",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.recursion.com/role/CommonStockValenceAcquisitionExchangeableSharesNarrativeDetails",
     "longName": "9955539 - Disclosure - Common Stock - Valence Acquisition Exchangeable Shares (Narrative) (Details)",
     "shortName": "Common Stock - Valence Acquisition Exchangeable Shares (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c-108",
      "name": "us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-108",
      "name": "us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.recursion.com/role/CommonStockRegistrationRightsAgreementsNarrativeDetails",
     "longName": "9955540 - Disclosure - Common Stock - Registration Rights Agreements (Narrative) (Details)",
     "shortName": "Common Stock - Registration Rights Agreements (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c-109",
      "name": "rxrx:RegistrationRightsAgreementTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-109",
      "name": "rxrx:RegistrationRightsAgreementTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.recursion.com/role/CommonStockClassAandBCommonSharesAuthorizationNarrativeDetails",
     "longName": "9955541 - Disclosure - Common Stock - Class A and B Common Shares Authorization (Narrative) (Details)",
     "shortName": "Common Stock - Class A and B Common Shares Authorization (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c-110",
      "name": "rxrx:NumberOfClassesOfCommonStockAuthorized",
      "unitRef": "class",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-110",
      "name": "rxrx:NumberOfClassesOfCommonStockAuthorized",
      "unitRef": "class",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails",
     "longName": "9955542 - Disclosure - Collaborative Development Contracts (Details)",
     "shortName": "Collaborative Development Contracts (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c-20",
      "name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-112",
      "name": "rxrx:ContractWithCustomerNumberOfNovelSmallMoleculeCandidates",
      "unitRef": "candidate",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.recursion.com/role/StockBasedCompensationNarrativeDetails",
     "longName": "9955543 - Disclosure - Stock-Based Compensation - Narrative (Details)",
     "shortName": "Stock-Based Compensation - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.recursion.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails",
     "longName": "9955544 - Disclosure - Stock-Based Compensation - Schedule of Stock-Based Compensation Expense (Details)",
     "shortName": "Stock-Based Compensation - Schedule of Stock-Based Compensation Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c-20",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-20",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://www.recursion.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails",
     "longName": "9955545 - Disclosure - Stock-Based Compensation - Schedule of Stock Option Activity (Details)",
     "shortName": "Stock-Based Compensation - Schedule of Stock Option Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "unique": true
     }
    },
    "R59": {
     "role": "http://www.recursion.com/role/StockBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoCalculateGrantDateFairValueofStockOptionsDetails",
     "longName": "9955546 - Disclosure - Stock-Based Compensation - Schedule of Weighted-Average Assumptions Used to Calculate Grant-Date Fair Value of Stock Options (Details)",
     "shortName": "Stock-Based Compensation - Schedule of Weighted-Average Assumptions Used to Calculate Grant-Date Fair Value of Stock Options (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "c-145",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-145",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://www.recursion.com/role/StockBasedCompensationScheduleofRSUActivityDetails",
     "longName": "9955547 - Disclosure - Stock-Based Compensation - Schedule of RSU Activity (Details)",
     "shortName": "Stock-Based Compensation - Schedule of RSU Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "c-148",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-148",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R61": {
     "role": "http://www.recursion.com/role/IncomeTaxesDetails",
     "longName": "9955548 - Disclosure - Income Taxes (Details)",
     "shortName": "Income Taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "c-20",
      "name": "us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations",
       "us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-20",
      "name": "us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations",
       "us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://www.recursion.com/role/NetLossPerShareScheduleofComputationofBasicandDilutedNetLossPerShareDetails",
     "longName": "9955549 - Disclosure - Net Loss Per Share - Schedule of Computation of Basic and Diluted Net Loss Per Share (Details)",
     "shortName": "Net Loss Per Share - Schedule of Computation of Basic and Diluted Net Loss Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "c-20",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R63": {
     "role": "http://www.recursion.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossPerShareDetails",
     "longName": "9955550 - Disclosure - Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Computation of Net Loss Per Share (Details)",
     "shortName": "Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Computation of Net Loss Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "c-20",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-20",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R64": {
     "role": "http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
     "longName": "9955551 - Disclosure - Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)",
     "shortName": "Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "c-170",
      "name": "rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-170",
      "name": "rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R65": {
     "role": "http://www.recursion.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails",
     "longName": "9955552 - Disclosure - Fair Value Measurements - Schedule of Financial Instruments Not Measured at Fair Value (Details)",
     "shortName": "Fair Value Measurements - Schedule of Financial Instruments Not Measured at Fair Value (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-194",
      "name": "us-gaap:LiabilitiesFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "unique": true
     }
    },
    "R66": {
     "role": "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails",
     "longName": "9955553 - Disclosure - Segment Information - Schedule of Segment Net Loss and Reconciliations of Segment Operating Loss to Loss Before Income Tax Benefit (Details)",
     "shortName": "Segment Information - Schedule of Segment Net Loss and Reconciliations of Segment Operating Loss to Loss Before Income Tax Benefit (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "c-20",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-198",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "unique": true
     }
    },
    "R67": {
     "role": "http://www.recursion.com/role/SegmentInformationScheduleofRevenueandLongLivedAssetsBasedonGeographicAreasDetails",
     "longName": "9955554 - Disclosure - Segment Information - Schedule of Revenue and Long-Lived Assets Based on Geographic Areas (Details)",
     "shortName": "Segment Information - Schedule of Revenue and Long-Lived Assets Based on Geographic Areas (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "c-20",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-202",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "unique": true
     }
    },
    "R68": {
     "role": "http://www.recursion.com/role/SubsequentEventsDetails",
     "longName": "9955555 - Disclosure - Subsequent Events (Details)",
     "shortName": "Subsequent Events (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "c-20",
      "name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-219",
      "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20250930.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "rxrx_A2021EquityIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "A2021EquityIncentivePlanMember",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2021 Equity Incentive Plan",
        "label": "2021 Equity Incentive Plan [Member]",
        "documentation": "2021 Equity Incentive Plan"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_A2024InducementEquityIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "A2024InducementEquityIncentivePlanMember",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024 Inducement Equity Incentive Plan",
        "label": "2024 Inducement Equity Incentive Plan [Member]",
        "documentation": "2024 Inducement Equity Incentive Plan"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Accounts Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r886"
     ]
    },
    "rxrx_AccruedDataCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "AccruedDataCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued data liability",
        "label": "Accrued Data, Current",
        "documentation": "Accrued Data, Current"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_AccruedDevelopmentCostsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "AccruedDevelopmentCostsCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued development expenses",
        "label": "Accrued Development Costs, Current",
        "documentation": "Accrued Development Costs, Current"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_AccruedEarlyDiscoveryExpensesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "AccruedEarlyDiscoveryExpensesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued early discovery expenses",
        "label": "Accrued Early Discovery Expenses, Current",
        "documentation": "Accrued Early Discovery Expenses, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited",
      "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses and other liabilities",
        "totalLabel": "Accrued expenses and other liabilities",
        "label": "Accrued Liabilities, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "rxrx_AccruedLicenseFeeCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "AccruedLicenseFeeCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued license fees",
        "label": "Accrued License Fee, Current",
        "documentation": "Accrued License Fee, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccruedProfessionalFeesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued professional fees",
        "label": "Accrued Professional Fees, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated other comprehensive income (loss)",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r18",
      "r60",
      "r123",
      "r626",
      "r664",
      "r665",
      "r1186"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated other comprehensive income (loss)",
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r9",
      "r18",
      "r494",
      "r497",
      "r556",
      "r660",
      "r661",
      "r1021",
      "r1022",
      "r1023",
      "r1079",
      "r1080",
      "r1081",
      "r1082"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional 402(v) Disclosure",
        "label": "Additional 402(v) Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r951"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r886",
      "r1242"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid-in-Capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r676",
      "r1079",
      "r1080",
      "r1081",
      "r1082",
      "r1187",
      "r1244"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation, Amount",
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r964"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation:",
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r964"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote",
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r964"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment To PEO Compensation, Footnote",
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r964"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r350"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:",
        "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_AffiliatedHoldersOwnershipPercentage": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "AffiliatedHoldersOwnershipPercentage",
     "presentation": [
      "http://www.recursion.com/role/CommonStockClassAandBCommonSharesAuthorizationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Affiliated holders, ownership percentage",
        "label": "Affiliated Holders, Ownership Percentage",
        "documentation": "Affiliated Holders, Ownership Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_AffiliatedHoldersPotentialOwnershipPercentageWhenOutstandingEquityAwardsVest": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "AffiliatedHoldersPotentialOwnershipPercentageWhenOutstandingEquityAwardsVest",
     "presentation": [
      "http://www.recursion.com/role/CommonStockClassAandBCommonSharesAuthorizationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Affiliated holders, potential ownership percentage when outstanding equity awards vest",
        "label": "Affiliated Holders, Potential Ownership Percentage When Outstanding Equity Awards Vest",
        "documentation": "Affiliated Holders, Potential Ownership Percentage When Outstanding Equity Awards Vest"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table",
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r997"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Amount",
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r923",
      "r933",
      "r943",
      "r975"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined",
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r926",
      "r936",
      "r946",
      "r978"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Pension Adjustments Service Cost",
        "label": "Aggregate Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r998"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Adjustments to Compensation",
        "label": "All Adjustments to Compensation [Member]"
       }
      }
     },
     "auth_ref": [
      "r964"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Executive Categories",
        "label": "All Executive Categories [Member]"
       }
      }
     },
     "auth_ref": [
      "r971"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Individuals",
        "label": "All Individuals [Member]"
       }
      }
     },
     "auth_ref": [
      "r927",
      "r937",
      "r947",
      "r971",
      "r979",
      "r983",
      "r991"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Trading Arrangements",
        "label": "All Trading Arrangements [Member]"
       }
      }
     },
     "auth_ref": [
      "r989"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based payment arrangement, expense",
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r380",
      "r386",
      "r387"
     ]
    },
    "rxrx_AlphaBiotechnologyGmbHAlphaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "AlphaBiotechnologyGmbHAlphaMember",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Alpha Biotechnology GmbH (Alpha)",
        "label": "Alpha Biotechnology GmbH (Alpha) [Member]",
        "documentation": "Alpha Biotechnology GmbH (Alpha)"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AmortizationOfIntangibleAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization expense",
        "label": "Amortization of Intangible Assets",
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r140",
      "r250",
      "r258",
      "r782",
      "r788",
      "r789",
      "r791",
      "r793"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.recursion.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive securities excluded from computation of loss per share, amount (in shares)",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r178"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://www.recursion.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities [Axis]",
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r178"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://www.recursion.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r178"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://www.recursion.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities, Name [Domain]",
        "label": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r178"
     ]
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails",
      "http://www.recursion.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r482"
     ]
    },
    "us-gaap_AssetAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetAcquisitionAxis",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails",
      "http://www.recursion.com/role/AcquisitionsScheduleofAssetAcquisitionDetails",
      "http://www.recursion.com/role/AcquisitionsScheduleofContingentConsiderationTransferredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset Acquisition [Axis]",
        "label": "Asset Acquisition [Axis]",
        "documentation": "Information by asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r247",
      "r251",
      "r252",
      "r253",
      "r254",
      "r256",
      "r668",
      "r1178"
     ]
    },
    "us-gaap_AssetAcquisitionConsiderationTransferred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetAcquisitionConsiderationTransferred",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/AcquisitionsScheduleofAssetAcquisitionDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails",
      "http://www.recursion.com/role/AcquisitionsScheduleofAssetAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset acquisition, consideration transferred",
        "totalLabel": "Total",
        "label": "Asset Acquisition, Consideration Transferred",
        "documentation": "Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer."
       }
      }
     },
     "auth_ref": [
      "r873",
      "r1179",
      "r1180",
      "r1181"
     ]
    },
    "us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetAcquisitionConsiderationTransferredContingentConsideration",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/AcquisitionsScheduleofAssetAcquisitionDetails": {
       "parentTag": "us-gaap_AssetAcquisitionConsiderationTransferred",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.recursion.com/role/AcquisitionsScheduleofContingentConsiderationTransferredDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsScheduleofAssetAcquisitionDetails",
      "http://www.recursion.com/role/AcquisitionsScheduleofContingentConsiderationTransferredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent consideration liability",
        "totalLabel": "Contingent consideration liability",
        "label": "Asset Acquisition, Consideration Transferred, Contingent Consideration",
        "documentation": "Amount of contingent consideration recognized as part of consideration transferred in asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r1179",
      "r1180",
      "r1181"
     ]
    },
    "us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/AcquisitionsScheduleofAssetAcquisitionDetails": {
       "parentTag": "us-gaap_AssetAcquisitionConsiderationTransferred",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsScheduleofAssetAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recursion Class A common stock",
        "label": "Asset Acquisition, Consideration Transferred, Equity Interest Issued and Issuable",
        "documentation": "Amount of acquirer's equity interest issued and issuable as part of consideration transferred in asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r1179",
      "r1180",
      "r1181"
     ]
    },
    "us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetAcquisitionConsiderationTransferredTransactionCost",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/AcquisitionsScheduleofAssetAcquisitionDetails": {
       "parentTag": "us-gaap_AssetAcquisitionConsiderationTransferred",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsScheduleofAssetAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Transactions costs",
        "label": "Asset Acquisition, Consideration Transferred, Transaction Cost",
        "documentation": "Amount of transaction cost incurred as part of consideration transferred in asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r873",
      "r1179",
      "r1180",
      "r1181"
     ]
    },
    "rxrx_AssetAcquisitionContingentConsiderationCashPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "AssetAcquisitionContingentConsiderationCashPaid",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/AcquisitionsScheduleofContingentConsiderationTransferredDetails": {
       "parentTag": "us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsScheduleofContingentConsiderationTransferredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid",
        "label": "Asset Acquisition, Contingent Consideration, Cash Paid",
        "documentation": "Asset Acquisition, Contingent Consideration, Cash Paid"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_AssetAcquisitionContingentConsiderationEquityInterestIssuedAndIssuable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "AssetAcquisitionContingentConsiderationEquityInterestIssuedAndIssuable",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/AcquisitionsScheduleofContingentConsiderationTransferredDetails": {
       "parentTag": "us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsScheduleofContingentConsiderationTransferredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recursion Class A common stock",
        "label": "Asset Acquisition, Contingent Consideration, Equity Interest Issued and Issuable",
        "documentation": "Asset Acquisition, Contingent Consideration, Equity Interest Issued and Issuable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetAcquisitionContingentConsiderationTableTextBlock",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Contingent Consideration Transferred",
        "label": "Asset Acquisition, Contingent Consideration [Table Text Block]",
        "documentation": "Tabular disclosure of contingent consideration in asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r1178"
     ]
    },
    "us-gaap_AssetAcquisitionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetAcquisitionDomain",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails",
      "http://www.recursion.com/role/AcquisitionsScheduleofAssetAcquisitionDetails",
      "http://www.recursion.com/role/AcquisitionsScheduleofContingentConsiderationTransferredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset Acquisition [Domain]",
        "label": "Asset Acquisition [Domain]",
        "documentation": "Asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r247",
      "r251",
      "r252",
      "r253",
      "r254",
      "r256",
      "r668",
      "r1178"
     ]
    },
    "rxrx_AssetAcquisitionEquityOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "AssetAcquisitionEquityOwnershipPercentage",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest acquired",
        "label": "Asset Acquisition, Equity Ownership, Percentage",
        "documentation": "Asset Acquisition, Equity Ownership, Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetAcquisitionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetAcquisitionLineItems",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsScheduleofAssetAcquisitionDetails",
      "http://www.recursion.com/role/AcquisitionsScheduleofContingentConsiderationTransferredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset Acquisition [Line Items]",
        "label": "Asset Acquisition [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r247",
      "r1178"
     ]
    },
    "us-gaap_AssetAcquisitionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetAcquisitionTable",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsScheduleofAssetAcquisitionDetails",
      "http://www.recursion.com/role/AcquisitionsScheduleofContingentConsiderationTransferredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset Acquisition [Table]",
        "label": "Asset Acquisition [Table]",
        "documentation": "Disclosure of information about asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r247",
      "r1178"
     ]
    },
    "us-gaap_AssetAcquisitionTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetAcquisitionTableTextBlock",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Asset Acquisition",
        "label": "Asset Acquisition [Table Text Block]",
        "documentation": "Tabular disclosure of asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r1178"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r89",
      "r98",
      "r119",
      "r144",
      "r145",
      "r146",
      "r182",
      "r193",
      "r211",
      "r215",
      "r228",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r483",
      "r486",
      "r531",
      "r613",
      "r614",
      "r620",
      "r714",
      "r805",
      "r806",
      "r815",
      "r886",
      "r901",
      "r902",
      "r914",
      "r1129",
      "r1130",
      "r1202"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r126",
      "r144",
      "r145",
      "r146",
      "r228",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r483",
      "r486",
      "r531",
      "r886",
      "r1129",
      "r1130",
      "r1202"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current assets",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Assets, Fair Value Disclosure",
        "documentation": "Fair value portion of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r508",
      "r509",
      "r878"
     ]
    },
    "rxrx_AtTheMarketOfferingProgramCitiMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "AtTheMarketOfferingProgramCitiMember",
     "presentation": [
      "http://www.recursion.com/role/CommonStockAtTheMarketOfferingNarrativeDetails",
      "http://www.recursion.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "At-The-Market Offering Program Citi",
        "label": "At-The-Market Offering Program Citi [Member]",
        "documentation": "At-The-Market Offering Program Citi"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_AtTheMarketOfferingProgramJefferiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "AtTheMarketOfferingProgramJefferiesMember",
     "presentation": [
      "http://www.recursion.com/role/CommonStockAtTheMarketOfferingNarrativeDetails",
      "http://www.recursion.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "At-The-Market Offering Program Jefferies",
        "label": "At-The-Market Offering Program Jefferies [Member]",
        "documentation": "At-The-Market Offering Program Jefferies"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price",
        "label": "Award Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r986"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value as of Grant Date",
        "label": "Award Grant Date Fair Value"
       }
      }
     },
     "auth_ref": [
      "r987"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r982"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing, How MNPI Considered",
        "label": "Award Timing, How MNPI Considered [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r982"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Method",
        "label": "Award Timing Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r982"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Considered",
        "label": "Award Timing MNPI Considered [Flag]"
       }
      }
     },
     "auth_ref": [
      "r982"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Disclosure",
        "label": "Award Timing MNPI Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r982"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Predetermined",
        "label": "Award Timing Predetermined [Flag]"
       }
      }
     },
     "auth_ref": [
      "r982"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.recursion.com/role/StockBasedCompensationScheduleofRSUActivityDetails",
      "http://www.recursion.com/role/StockBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoCalculateGrantDateFairValueofStockOptionsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Axis]",
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Securities",
        "label": "Award Underlying Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r985"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r984"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures",
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r983"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table",
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r983"
     ]
    },
    "us-gaap_BankTimeDepositsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BankTimeDepositsMember",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bank deposits",
        "label": "Bank Time Deposits [Member]",
        "documentation": "Certificates of deposit (CD) or savings accounts with a fixed term or understanding the customer can only withdraw by giving advanced notice with a bank or other financial institution. A CD is a short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest."
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.recursion.com/role/BasisofPresentationPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": [
      "r1074"
     ]
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.recursion.com/role/BasisofPresentation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r1073"
     ]
    },
    "rxrx_BenTaylorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "BenTaylorMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ben Taylor [Member]",
        "documentation": "Ben Taylor"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_BlakeBorgesonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "BlakeBorgesonMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Blake Borgeson [Member]",
        "documentation": "Blake Borgeson"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails",
      "http://www.recursion.com/role/AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.recursion.com/role/AcquisitionsScheduleofProFormaFinancialInformationDetails",
      "http://www.recursion.com/role/CommonStockRegistrationRightsAgreementsNarrativeDetails",
      "http://www.recursion.com/role/CommonStockValenceAcquisitionExchangeableSharesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Combination [Domain]",
        "label": "Business Combination [Domain]",
        "documentation": "Business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r247",
      "r251",
      "r252",
      "r253",
      "r254",
      "r256",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r474",
      "r475",
      "r476",
      "r668",
      "r825",
      "r826",
      "r1171",
      "r1173",
      "r1175"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails",
      "http://www.recursion.com/role/AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.recursion.com/role/AcquisitionsScheduleofProFormaFinancialInformationDetails",
      "http://www.recursion.com/role/CommonStockRegistrationRightsAgreementsNarrativeDetails",
      "http://www.recursion.com/role/CommonStockValenceAcquisitionExchangeableSharesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Combination [Axis]",
        "label": "Business Combination [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r247",
      "r251",
      "r252",
      "r253",
      "r254",
      "r256",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r474",
      "r475",
      "r476",
      "r668",
      "r825",
      "r826",
      "r1171",
      "r1173",
      "r1175"
     ]
    },
    "rxrx_BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares",
     "presentation": [
      "http://www.recursion.com/role/CommonStockValenceAcquisitionExchangeableSharesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity interest issued or issuable (in shares)",
        "label": "Business Acquisition , Contingent Consideration, Equity Interests Issuable, Number Of Shares",
        "documentation": "Business Acquisition , Contingent Consideration, Equity Interests Issuable, Number Of Shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity interest issued or issuable (in shares)",
        "label": "Business Combination, Consideration Transferred, Equity Interest, Share Issued, Number of Shares",
        "documentation": "Number of shares of equity interest issued or issuable by acquirer as part of consideration transferred in business combination."
       }
      }
     },
     "auth_ref": [
      "r831",
      "r836",
      "r837",
      "r871",
      "r872"
     ]
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessAcquisitionLineItems",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails",
      "http://www.recursion.com/role/AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.recursion.com/role/AcquisitionsScheduleofProFormaFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Combination [Line Items]",
        "label": "Business Combination [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r247",
      "r416",
      "r417",
      "r418",
      "r419",
      "r425",
      "r426",
      "r427",
      "r428",
      "r434",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r470",
      "r471",
      "r472",
      "r476",
      "r831",
      "r841",
      "r1171",
      "r1173",
      "r1175"
     ]
    },
    "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessAcquisitionProFormaInformationTextBlock",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Pro Forma Financial Information",
        "label": "Business Combination, Pro Forma Information [Table Text Block]",
        "documentation": "Tabular disclosure of pro forma revenue and earnings for business combination or aggregate of series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r831",
      "r842",
      "r1006",
      "r1007",
      "r1172"
     ]
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsScheduleofProFormaFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating loss",
        "label": "Business Combination, Pro Forma Information, Pro Forma Income (Loss), after Tax",
        "documentation": "Amount, after tax, of pro forma income (loss) of combined entity as if acquisition date of business combination occurred as of beginning of period."
       }
      }
     },
     "auth_ref": [
      "r431",
      "r432",
      "r434",
      "r831",
      "r842",
      "r843"
     ]
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsScheduleofProFormaFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue",
        "label": "Business Combination, Pro Forma Information, Pro Forma Revenue",
        "documentation": "Amount of pro forma revenue of combined entity as if acquisition date of business combination occurred as of beginning of period."
       }
      }
     },
     "auth_ref": [
      "r431",
      "r432",
      "r434",
      "r831",
      "r842"
     ]
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessCombinationConsiderationTransferred1",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business combination, consideration transferred",
        "label": "Business Combination, Consideration Transferred",
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer."
       }
      }
     },
     "auth_ref": [
      "r460",
      "r472",
      "r831",
      "r836"
     ]
    },
    "rxrx_BusinessCombinationConsiderationTransferredEquityInterestsIssuable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuable",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of stock and equity awards",
        "label": "Business Combination, Consideration Transferred, Equity Interests Issuable",
        "documentation": "Business Combination, Consideration Transferred, Equity Interests Issuable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recursion Class A common stock",
        "label": "Business Combination, Consideration Transferred, Equity Interest",
        "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination."
       }
      }
     },
     "auth_ref": [
      "r831",
      "r836",
      "r837",
      "r871",
      "r872"
     ]
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessCombinationDisclosureTextBlock",
     "presentation": [
      "http://www.recursion.com/role/Acquisitions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquisitions",
        "label": "Business Combination [Text Block]",
        "documentation": "The entire disclosure for business combination."
       }
      }
     },
     "auth_ref": [
      "r415",
      "r416",
      "r420",
      "r429",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r440",
      "r441",
      "r447",
      "r450",
      "r451",
      "r457",
      "r458",
      "r459",
      "r467",
      "r471",
      "r472",
      "r473",
      "r475",
      "r477",
      "r831",
      "r832",
      "r833",
      "r834",
      "r838",
      "r839",
      "r840"
     ]
    },
    "rxrx_BusinessCombinationEquityInterestIssuedOrIssuableSharesOfAcquirerStockPerShareOfAcquireeStockOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "BusinessCombinationEquityInterestIssuedOrIssuableSharesOfAcquirerStockPerShareOfAcquireeStockOutstanding",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares of acquirer stock per share of acquiree stock outstanding (in shares)",
        "label": "Business Combination, Equity Interest Issued Or Issuable, Shares of Acquirer Stock Per Share of Acquiree Stock Outstanding",
        "documentation": "Business Combination, Equity Interest Issued Or Issuable, Shares of Acquirer Stock Per Share of Acquiree Stock Outstanding"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Operating loss",
        "label": "Business Combination, Acquiree's Earnings (Loss) since Acquisition Date, Actual",
        "documentation": "Amount of acquiree's earnings (loss) since acquisition date of business combination included in consolidated statement of income."
       }
      }
     },
     "auth_ref": [
      "r430",
      "r434",
      "r831",
      "r842"
     ]
    },
    "us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net revenues",
        "label": "Business Combination, Acquiree's Revenue since Acquisition Date, Actual",
        "documentation": "Amount of acquiree's revenue since acquisition date of business combination included in consolidated statement of income."
       }
      }
     },
     "auth_ref": [
      "r430",
      "r434",
      "r831",
      "r842"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Business Combination, Recognized Asset Acquired, Cash and Cash Equivalent",
        "documentation": "Amount of cash and cash equivalent acquired in business combination and recognized at acquisition date."
       }
      }
     },
     "auth_ref": [
      "r1174",
      "r1176"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other current assets",
        "label": "Business Combination, Recognized Asset Acquired, Other Asset, Current",
        "documentation": "Amount of asset acquired in business combination and recognized at acquisition date, classified as other and current."
       }
      }
     },
     "auth_ref": [
      "r1174",
      "r1176"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Accounts payable and accrued liabilities",
        "label": "Business Combination, Recognized Liability Assumed, Accounts Payable, Current",
        "documentation": "Amount of accounts payable assumed in business combination and recognized at acquisition date, classified as current."
       }
      }
     },
     "auth_ref": [
      "r1174",
      "r1176"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Deferred revenue",
        "label": "Business Combination, Recognized Liability Assumed, Deferred Revenue, Current",
        "documentation": "Amount of deferred revenue assumed in business combination and recognized at acquisition date, classified as current."
       }
      }
     },
     "auth_ref": [
      "r1174",
      "r1176"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax assets",
        "label": "Business Combination, Recognized Asset Acquired, Deferred Tax Asset",
        "documentation": "Amount of deferred tax asset acquired in business combination and recognized at acquisition date."
       }
      }
     },
     "auth_ref": [
      "r1174",
      "r1176"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Deferred tax liability",
        "label": "Business Combination, Recognized Liability Assumed, Deferred Tax Liability",
        "documentation": "Amount of deferred tax liability assumed in business combination and recognized at acquisition date."
       }
      }
     },
     "auth_ref": [
      "r1174",
      "r1176"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets, indefinite-lived",
        "label": "Business Combination, Recognized Asset Acquired, Identifiable Intangible Asset, Indefinite-Lived",
        "documentation": "Amount of identifiable indefinite-lived intangible asset acquired in business combination and recognized at acquisition date. Excludes goodwill and financial asset."
       }
      }
     },
     "auth_ref": [
      "r1174",
      "r1176"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets, technology",
        "label": "Business Combination, Recognized Asset Acquired, Identifiable Intangible Asset, Finite-Lived",
        "documentation": "Amount of identifiable finite-lived intangible asset acquired in business combination and recognized at acquisition date."
       }
      }
     },
     "auth_ref": [
      "r1174",
      "r1176"
     ]
    },
    "rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Lease liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Lease Liabilities",
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Lease Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total identifiable net assets",
        "label": "Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less)",
        "documentation": "Amount of asset acquired in excess of (less than) liability assumed in business combination and recognized at acquisition date. Excludes goodwill."
       }
      }
     },
     "auth_ref": [
      "r831",
      "r836",
      "r1174",
      "r1176"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other liabilities",
        "label": "Business Combination, Recognized Liability Assumed, Other Liability, Noncurrent",
        "documentation": "Amount of liability assumed in business combination and recognized at acquisition date, classified as other and noncurrent."
       }
      }
     },
     "auth_ref": [
      "r1174",
      "r1176"
     ]
    },
    "rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease right-of-use assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Operating Lease Right-Of-Use Assets",
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Operating Lease Right-Of-Use Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other assets, non-current",
        "label": "Business Combination, Recognized Asset Acquired, Other Asset, Noncurrent",
        "documentation": "Amount of asset acquired in business combination and recognized at acquisition date, classified as other and noncurrent."
       }
      }
     },
     "auth_ref": [
      "r1174",
      "r1176"
     ]
    },
    "rxrx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other receivables",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Receivables",
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Receivables"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment, net",
        "label": "Business Combination, Recognized Asset Acquired, Property, Plant, and Equipment",
        "documentation": "Amount of property, plant, and equipment acquired in business combination and recognized at acquisition date."
       }
      }
     },
     "auth_ref": [
      "r831",
      "r836",
      "r1174",
      "r1176"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets acquired and liabilities assumed",
        "label": "Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less), and Goodwill",
        "documentation": "Amount of asset acquired in excess of (less than) liability assumed plus goodwill in business combination and recognized at acquisition date."
       }
      }
     },
     "auth_ref": [
      "r1174",
      "r1176"
     ]
    },
    "country_CA": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2025",
     "localname": "CA",
     "presentation": [
      "http://www.recursion.com/role/SegmentInformationScheduleofRevenueandLongLivedAssetsBasedonGeographicAreasDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Canada",
        "label": "CANADA"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_CEOAndAffiliatesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "CEOAndAffiliatesMember",
     "presentation": [
      "http://www.recursion.com/role/CommonStockClassAandBCommonSharesAuthorizationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CEO and Affiliates",
        "label": "CEO And Affiliates [Member]",
        "documentation": "CEO And Affiliates"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued property and equipment",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r25",
      "r26"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalent",
        "documentation": "Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r115",
      "r783"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsAxis",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents [Axis]",
        "label": "Cash and Cash Equivalents [Axis]",
        "documentation": "Information by type of cash and cash equivalent balance."
       }
      }
     },
     "auth_ref": [
      "r115"
     ]
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash equivalents",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r527",
      "r528",
      "r529",
      "r1188",
      "r1189"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash, cash equivalents and restricted cash, beginning of period",
        "periodEndLabel": "Cash, cash equivalents and restricted cash, end of period",
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation",
        "documentation": "Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r73",
      "r143"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net change in cash, cash equivalents and restricted cash",
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation",
        "documentation": "Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r73"
     ]
    },
    "us-gaap_CashMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashMember",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash",
        "label": "Cash [Member]",
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r115"
     ]
    },
    "rxrx_CashPaidForAmountIncludedInTheMeasurementOfLeaseLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "CashPaidForAmountIncludedInTheMeasurementOfLeaseLiabilitiesAbstract",
     "presentation": [
      "http://www.recursion.com/role/LeasesScheduleofSupplementalCashFlowInformationRelatedtoLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid for amount included in the measurement of lease liabilities:",
        "label": "Cash Paid For Amount Included In The Measurement Of Lease Liabilities [Abstract]",
        "documentation": "Cash Paid For Amount Included In The Measurement Of Lease Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changed Peer Group, Footnote",
        "label": "Changed Peer Group, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r962"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year",
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r959"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested",
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r957"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails",
      "http://www.recursion.com/role/CommonStockAtTheMarketOfferingNarrativeDetails",
      "http://www.recursion.com/role/CommonStockClassAandBCommonSharesAuthorizationNarrativeDetails",
      "http://www.recursion.com/role/CommonStockNarrativeDetails",
      "http://www.recursion.com/role/CommonStockPublicOfferingofCommonStockNarrativeDetails",
      "http://www.recursion.com/role/CommonStockValenceAcquisitionExchangeableSharesNarrativeDetails",
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical",
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Domain]",
        "label": "Class of Stock [Domain]",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r120",
      "r121",
      "r122",
      "r144",
      "r146",
      "r172",
      "r173",
      "r175",
      "r177",
      "r184",
      "r185",
      "r228",
      "r285",
      "r287",
      "r288",
      "r289",
      "r292",
      "r293",
      "r299",
      "r300",
      "r302",
      "r303",
      "r305",
      "r307",
      "r310",
      "r311",
      "r314",
      "r317",
      "r324",
      "r531",
      "r670",
      "r671",
      "r672",
      "r673",
      "r676",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r702",
      "r722",
      "r740",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r1001",
      "r1076",
      "r1077",
      "r1083"
     ]
    },
    "us-gaap_ClassOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockLineItems",
     "presentation": [
      "http://www.recursion.com/role/CommonStockAtTheMarketOfferingNarrativeDetails",
      "http://www.recursion.com/role/CommonStockClassAandBCommonSharesAuthorizationNarrativeDetails",
      "http://www.recursion.com/role/CommonStockNarrativeDetails",
      "http://www.recursion.com/role/CommonStockPublicOfferingofCommonStockNarrativeDetails",
      "http://www.recursion.com/role/CommonStockRegistrationRightsAgreementsNarrativeDetails",
      "http://www.recursion.com/role/CommonStockValenceAcquisitionExchangeableSharesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Line Items]",
        "label": "Class of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r121",
      "r122",
      "r184",
      "r302",
      "r310",
      "r311",
      "r312",
      "r314",
      "r317",
      "r322",
      "r324",
      "r492",
      "r670",
      "r671",
      "r672",
      "r673",
      "r816",
      "r1001",
      "r1075",
      "r1076"
     ]
    },
    "rxrx_ClinicalDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "ClinicalDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Clinical development",
        "label": "Clinical Development Expense",
        "documentation": "Clinical Development Expense"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Amount",
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r963"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Name",
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r963"
     ]
    },
    "us-gaap_CollaborativeArrangementDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CollaborativeArrangementDisclosureTextBlock",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContracts"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Development Contracts",
        "label": "Collaborative Arrangement Disclosure [Text Block]",
        "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r480",
      "r481"
     ]
    },
    "us-gaap_CollaborativeArrangementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CollaborativeArrangementMember",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails",
      "http://www.recursion.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement",
        "label": "Collaborative Arrangement [Member]",
        "documentation": "Contractual arrangement that involves two or more parties that both: (i) actively participate in a joint operating activity and (ii) are exposed to significant risks and rewards that depend on the commercial success of the joint operating activity."
       }
      }
     },
     "auth_ref": [
      "r482"
     ]
    },
    "rxrx_CollaborativeArrangementMilestonePaymentReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "CollaborativeArrangementMilestonePaymentReceived",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Milestone payment received",
        "label": "Collaborative Arrangement, Milestone Payment Received",
        "documentation": "Collaborative Arrangement, Milestone Payment Received"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r482"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and contingencies (Note\u00a07)",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r90",
      "r624",
      "r701"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://www.recursion.com/role/CommitmentsandContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r277",
      "r278",
      "r766",
      "r1118",
      "r1124"
     ]
    },
    "us-gaap_CommonClassAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonClassAMember",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails",
      "http://www.recursion.com/role/CommonStockAtTheMarketOfferingNarrativeDetails",
      "http://www.recursion.com/role/CommonStockClassAandBCommonSharesAuthorizationNarrativeDetails",
      "http://www.recursion.com/role/CommonStockNarrativeDetails",
      "http://www.recursion.com/role/CommonStockPublicOfferingofCommonStockNarrativeDetails",
      "http://www.recursion.com/role/CommonStockValenceAcquisitionExchangeableSharesNarrativeDetails",
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical",
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Class A Common Stock",
        "terseLabel": "Class A Common Stock",
        "label": "Common Class A [Member]",
        "documentation": "Classification of common stock representing ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r1244"
     ]
    },
    "us-gaap_CommonClassBMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonClassBMember",
     "presentation": [
      "http://www.recursion.com/role/CommonStockClassAandBCommonSharesAuthorizationNarrativeDetails",
      "http://www.recursion.com/role/CommonStockNarrativeDetails",
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical",
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Class B Common Stock",
        "terseLabel": "Class B",
        "label": "Common Class B [Member]",
        "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r1244"
     ]
    },
    "rxrx_CommonStockConversionRatio": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "CommonStockConversionRatio",
     "presentation": [
      "http://www.recursion.com/role/CommonStockClassAandBCommonSharesAuthorizationNarrativeDetails",
      "http://www.recursion.com/role/CommonStockValenceAcquisitionExchangeableSharesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, conversion ratio",
        "label": "Common Stock, Conversion Ratio",
        "documentation": "Common Stock, Conversion Ratio"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock (Class A, B and Exchangeable)",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r904",
      "r905",
      "r906",
      "r908",
      "r909",
      "r910",
      "r911",
      "r1079",
      "r1080",
      "r1082",
      "r1187",
      "r1241",
      "r1244"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par value (in dollars per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares authorized (in shares)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r702"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares issued (in shares)",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical",
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Common sock, shares outstanding (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "periodEndLabel": "Ending balance (in shares)",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r54",
      "r702",
      "r720",
      "r1244",
      "r1245"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, $0.00001 par value; 2,000,000,000 shares (Class A 1,989,032,117 and Class B 10,967,883) authorized as of September\u00a030, 2025 and December\u00a031, 2024; 491,800,501 shares (Class A 485,213,547, Class B 5,967,334 and Exchangeable 619,620) and 396,802,394 shares (Class A 389,547,223, Class B 6,958,575 and Exchangeable 296,596) issued and outstanding as of September\u00a030, 2025 and December\u00a031, 2024, respectively",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r300",
      "r306",
      "r625",
      "r886"
     ]
    },
    "rxrx_CommonStockVotePerShare": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "CommonStockVotePerShare",
     "presentation": [
      "http://www.recursion.com/role/CommonStockClassAandBCommonSharesAuthorizationNarrativeDetails",
      "http://www.recursion.com/role/CommonStockNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vote per share of common stock (in votes)",
        "label": "Common Stock, Vote Per Share",
        "documentation": "Common Stock, Vote Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure",
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r968"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Net Income",
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r967"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Other Measure",
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r969"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return",
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r966"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofComprehensiveLossunaudited": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofComprehensiveLossunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Comprehensive loss",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r129",
      "r131",
      "r135",
      "r611",
      "r634",
      "r635"
     ]
    },
    "rxrx_ConsumableExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "ConsumableExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consumables",
        "label": "Consumable Expense",
        "documentation": "Consumable Expense"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_ContingentStockRelatingToREVentures1AgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "ContingentStockRelatingToREVentures1AgreementMember",
     "presentation": [
      "http://www.recursion.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent stock relating to RE Ventures I transaction",
        "label": "Contingent Stock Relating To RE Ventures 1 Agreement [Member]",
        "documentation": "Contingent Stock Relating To RE Ventures 1 Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContractWithCustomerAssetNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ContractWithCustomerAssetNetCurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost incurred",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Current",
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current."
       }
      }
     },
     "auth_ref": [
      "r326",
      "r328",
      "r329",
      "r333"
     ]
    },
    "us-gaap_ContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ContractWithCustomerLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remaining unearned revenue",
        "label": "Contract with Customer, Liability",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r326",
      "r327",
      "r329",
      "r333"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ContractWithCustomerLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unearned revenue",
        "label": "Contract with Customer, Liability, Current",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r326",
      "r327",
      "r329",
      "r333"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unearned revenue, non-current",
        "label": "Contract with Customer, Liability, Noncurrent",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r326",
      "r327",
      "r329",
      "r333"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails",
      "http://www.recursion.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue recognized",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due."
       }
      }
     },
     "auth_ref": [
      "r334"
     ]
    },
    "rxrx_ContractWithCustomerMaximumAcceptedProduct": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "ContractWithCustomerMaximumAcceptedProduct",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of eligible phenomaps",
        "label": "Contract With Customer, Maximum Accepted Product",
        "documentation": "Contract With Customer, Maximum Accepted Product"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_ContractWithCustomerNumberOfNovelSmallMoleculeCandidates": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "ContractWithCustomerNumberOfNovelSmallMoleculeCandidates",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum number of novel small molecule candidates",
        "label": "Contract With Customer, Number Of Novel Small Molecule Candidates",
        "documentation": "Contract With Customer, Number Of Novel Small Molecule Candidates"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CostOfGoodsAndServicesSold",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of revenue",
        "label": "Cost of Product and Service Sold",
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r64",
      "r571",
      "r789",
      "r794",
      "r875",
      "r1064"
     ]
    },
    "us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CostOfGoodsAndServicesSoldDepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization",
        "label": "Cost, Depreciation and Amortization",
        "documentation": "Amount of expense for allocation of cost of tangible and intangible assets over their useful lives directly used in production of good and rendering of service."
       }
      }
     },
     "auth_ref": [
      "r1024"
     ]
    },
    "us-gaap_CostOfSalesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CostOfSalesMember",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of revenue",
        "label": "Cost of Sales [Member]",
        "documentation": "Primary financial statement caption encompassing cost of sales."
       }
      }
     },
     "auth_ref": [
      "r876"
     ]
    },
    "us-gaap_CostsAndExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CostsAndExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating costs and expenses",
        "label": "Costs and Expenses",
        "documentation": "Total costs of sales and operating expenses for the period."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "srt_CounterpartyNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "CounterpartyNameAxis",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails",
      "http://www.recursion.com/role/SubsequentEventsDetails",
      "http://www.recursion.com/role/SupplementalFinancialInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Axis]",
        "label": "Counterparty Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r144",
      "r151",
      "r152",
      "r294",
      "r312",
      "r559",
      "r568",
      "r619",
      "r785",
      "r786",
      "r787",
      "r1012",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1017",
      "r1018",
      "r1019",
      "r1020",
      "r1182",
      "r1183",
      "r1184",
      "r1185"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredIncomeTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax assets",
        "label": "Deferred Income Tax Assets, Net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r392",
      "r393"
     ]
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax liabilities",
        "label": "Deferred Income Tax Liabilities, Net",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r392",
      "r393",
      "r621"
     ]
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DepreciationDepletionAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization",
        "label": "Depreciation, Depletion and Amortization",
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r141",
      "r182",
      "r198",
      "r215",
      "r788",
      "r805",
      "r806"
     ]
    },
    "rxrx_DevelopedAndCommercializedProgramsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "DevelopedAndCommercializedProgramsMember",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Developed and Commercialized Programs",
        "label": "Developed And Commercialized Programs [Member]",
        "documentation": "Developed And Commercialized Programs"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_DevelopmentAndRegulatoryMilestonesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "DevelopmentAndRegulatoryMilestonesMember",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Development And Regulatory Milestones",
        "label": "Development And Regulatory Milestones [Member]",
        "documentation": "Development And Regulatory Milestones"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-Based Compensation",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r348",
      "r352",
      "r381",
      "r382",
      "r384",
      "r828"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_DiscoveryDevelopmentAndSalesMilestonesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "DiscoveryDevelopmentAndSalesMilestonesMember",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discovery, Development And Sales Milestones",
        "label": "Discovery, Development And Sales Milestones [Member]",
        "documentation": "Discovery, Development And Sales Milestones"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_DiscoveryExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "DiscoveryExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discovery",
        "label": "Discovery Expense",
        "documentation": "Discovery Expense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisposalGroupClassificationAxis",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal Group Classification [Axis]",
        "label": "Disposal Group Classification [Axis]",
        "documentation": "Information by disposal group classification."
       }
      }
     },
     "auth_ref": [
      "r111"
     ]
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisposalGroupClassificationDomain",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal Group Classification [Domain]",
        "label": "Disposal Group Classification [Domain]",
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal Group, Disposed of by Sale, Not Discontinued Operations",
        "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]",
        "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r14"
     ]
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal Group Name [Domain]",
        "label": "Disposal Group Name [Domain]",
        "documentation": "Name of disposal group."
       }
      }
     },
     "auth_ref": [
      "r266",
      "r267",
      "r825",
      "r826"
     ]
    },
    "us-gaap_DividendsStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DividendsStock",
     "crdr": "debit",
     "presentation": [
      "http://www.recursion.com/role/CommonStockNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends declared",
        "label": "Dividends, Stock",
        "documentation": "Amount of paid and unpaid stock dividends declared for classes of stock, for example, but not limited to, common and preferred."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r84"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Line Items]",
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Table]",
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Quarterly Report",
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r918"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r950"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_DurationOfTimeForPlaintiffToRefileClaim": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "DurationOfTimeForPlaintiffToRefileClaim",
     "presentation": [
      "http://www.recursion.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Duration of time for plaintiff to refile claim",
        "label": "Duration Of Time For Plaintiff To Refile Claim",
        "documentation": "Duration Of Time For Plaintiff To Refile Claim"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year",
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r961"
     ]
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareAbstract",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Per share data",
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited",
      "http://www.recursion.com/role/NetLossPerShareScheduleofComputationofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net loss per share of class A, B and Exchangeable common stock, basic (in dollars per share)",
        "terseLabel": "Net loss per share, basic (in dollars per shares)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r136",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r170",
      "r172",
      "r175",
      "r176",
      "r177",
      "r181",
      "r298",
      "r385",
      "r413",
      "r479",
      "r505",
      "r506",
      "r612",
      "r636",
      "r795"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited",
      "http://www.recursion.com/role/NetLossPerShareScheduleofComputationofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net loss per share of class A, B and Exchangeable common stock, diluted (in dollars per share)",
        "terseLabel": "Net loss per share, diluted (in dollars per shares)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r136",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r172",
      "r175",
      "r176",
      "r177",
      "r181",
      "r298",
      "r385",
      "r413",
      "r479",
      "r505",
      "r506",
      "r612",
      "r636",
      "r795"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://www.recursion.com/role/NetLossPerShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Loss Per Share",
        "label": "Earnings Per Share [Text Block]",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r169",
      "r178",
      "r179",
      "r180"
     ]
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of exchange rate changes on cash, cash equivalents and restricted cash",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation",
        "documentation": "Amount of increase (decrease) from effect of exchange rate change on cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; held in foreign currency; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r535"
     ]
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued compensation",
        "label": "Employee-related Liabilities, Current",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r1162"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unvested stock options, unamortized stock-based compensation cost, weighted average period recognition",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r383"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "crdr": "debit",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized compensation cost",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r1163"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "crdr": "debit",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unvested stock options, unamortized stock-based compensation cost",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1163"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.recursion.com/role/StockBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoCalculateGrantDateFairValueofStockOptionsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stock Options",
        "terseLabel": "Stock based compensation",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": [
      "r1136",
      "r1137",
      "r1138",
      "r1139",
      "r1140",
      "r1141",
      "r1142",
      "r1143",
      "r1144",
      "r1145",
      "r1146",
      "r1147",
      "r1148",
      "r1149",
      "r1150",
      "r1151",
      "r1152",
      "r1153",
      "r1154",
      "r1155",
      "r1156",
      "r1157",
      "r1158",
      "r1159",
      "r1160",
      "r1161"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r916"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r916"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r916"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r1000"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r916"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r916"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r916"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r916"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Footnote",
        "label": "Equity Awards Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r955"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table",
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r996"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments",
        "label": "Equity Awards Adjustments [Member]"
       }
      }
     },
     "auth_ref": [
      "r996"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table",
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r996"
     ]
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component [Domain]",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r107",
      "r108",
      "r109",
      "r132",
      "r133",
      "r134",
      "r153",
      "r154",
      "r155",
      "r157",
      "r164",
      "r166",
      "r168",
      "r183",
      "r229",
      "r230",
      "r263",
      "r297",
      "r325",
      "r385",
      "r402",
      "r403",
      "r410",
      "r411",
      "r412",
      "r414",
      "r478",
      "r479",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r504",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r543",
      "r545",
      "r556",
      "r633",
      "r660",
      "r661",
      "r662",
      "r676",
      "r740"
     ]
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "EquityMethodInvesteeNameDomain",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment, Name [Domain]",
        "label": "Investment, Name [Domain]"
       }
      }
     },
     "auth_ref": [
      "r225",
      "r226",
      "r227",
      "r409",
      "r531",
      "r1003",
      "r1004",
      "r1005",
      "r1166",
      "r1167",
      "r1168",
      "r1169"
     ]
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity method investment ownership percentage",
        "label": "Equity Method Investment, Ownership Percentage",
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting."
       }
      }
     },
     "auth_ref": [
      "r225",
      "r531"
     ]
    },
    "us-gaap_EquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityMethodInvestments",
     "crdr": "debit",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity method investments",
        "label": "Equity Method Investments",
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized."
       }
      }
     },
     "auth_ref": [
      "r182",
      "r203",
      "r215",
      "r224",
      "r1010",
      "r1091"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Valuation Assumption Difference, Footnote",
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r965"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneous Compensation Analysis",
        "label": "Erroneous Compensation Analysis [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r923",
      "r933",
      "r943",
      "r975"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneously Awarded Compensation Recovery",
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r920",
      "r930",
      "r940",
      "r972"
     ]
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair values",
        "label": "Estimate of Fair Value Measurement [Member]",
        "documentation": "Measured as an estimate of fair value."
       }
      }
     },
     "auth_ref": [
      "r295",
      "r527",
      "r528",
      "r530",
      "r779",
      "r813",
      "r814"
     ]
    },
    "rxrx_ExchangeableStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "ExchangeableStockMember",
     "presentation": [
      "http://www.recursion.com/role/CommonStockValenceAcquisitionExchangeableSharesNarrativeDetails",
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exchangeable Stock",
        "label": "Exchangeable Stock [Member]",
        "documentation": "Exchangeable Stock"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Executive Category:",
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r971"
     ]
    },
    "rxrx_ExscientiaGmbHMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "ExscientiaGmbHMember",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exscientia GmbH",
        "label": "Exscientia GmbH [Member]",
        "documentation": "Exscientia GmbH"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_ExscientiaPlcMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "ExscientiaPlcMember",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails",
      "http://www.recursion.com/role/AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.recursion.com/role/AcquisitionsScheduleofProFormaFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exscientia Plc",
        "label": "Exscientia Plc [Member]",
        "documentation": "Exscientia Plc"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r527",
      "r528",
      "r529",
      "r779",
      "r885",
      "r1195"
     ]
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueByBalanceSheetGroupingTable",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities."
       }
      }
     },
     "auth_ref": [
      "r527",
      "r529",
      "r779",
      "r885",
      "r1194",
      "r1195"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r295",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r343",
      "r344",
      "r507",
      "r509",
      "r510",
      "r511",
      "r512",
      "r518",
      "r519",
      "r521",
      "r527",
      "r563",
      "r564",
      "r565",
      "r779",
      "r813",
      "r814",
      "r820",
      "r821",
      "r822",
      "r823",
      "r824",
      "r878",
      "r881",
      "r885"
     ]
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueByMeasurementBasisAxis",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Basis [Axis]",
        "label": "Measurement Basis [Axis]",
        "documentation": "Information by measurement basis."
       }
      }
     },
     "auth_ref": [
      "r295",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r779",
      "r813",
      "r814",
      "r1195"
     ]
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueByMeasurementFrequencyAxis",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Frequency [Axis]",
        "label": "Measurement Frequency [Axis]",
        "documentation": "Information by measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r508",
      "r509",
      "r510",
      "r512",
      "r878",
      "r1191",
      "r1193"
     ]
    },
    "us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]",
        "label": "Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r518"
     ]
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueDisclosureItemAmountsDomain",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurement [Domain]",
        "label": "Fair Value Measurement [Domain]",
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value."
       }
      }
     },
     "auth_ref": [
      "r295",
      "r813",
      "r814"
     ]
    },
    "us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table]",
        "label": "Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table]",
        "documentation": "Disclosure of information about fair value of asset and liability not measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r518"
     ]
    },
    "us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Financial Instruments Not Measured at Fair Value",
        "label": "Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table Text Block]",
        "documentation": "Tabular disclosure of information about fair value of asset and liability not measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r518"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements",
        "label": "Fair Value Disclosures [Text Block]",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r510",
      "r514",
      "r516",
      "r517",
      "r518",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r608",
      "r878",
      "r882"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 1",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r295",
      "r336",
      "r341",
      "r343",
      "r509",
      "r519",
      "r527",
      "r563",
      "r779",
      "r820",
      "r821",
      "r822",
      "r823",
      "r824",
      "r878",
      "r885"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 2",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r295",
      "r336",
      "r341",
      "r343",
      "r345",
      "r509",
      "r510",
      "r519",
      "r527",
      "r564",
      "r779",
      "r813",
      "r814",
      "r820",
      "r821",
      "r822",
      "r823",
      "r824",
      "r878",
      "r885"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 3",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r295",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r343",
      "r344",
      "r509",
      "r510",
      "r511",
      "r512",
      "r519",
      "r527",
      "r565",
      "r779",
      "r813",
      "r814",
      "r820",
      "r821",
      "r822",
      "r823",
      "r824",
      "r878",
      "r881",
      "r885"
     ]
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementFrequencyDomain",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Frequency [Domain]",
        "label": "Measurement Frequency [Domain]",
        "documentation": "Measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r508",
      "r509",
      "r510",
      "r512",
      "r878",
      "r1191",
      "r1193"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r295",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r343",
      "r344",
      "r507",
      "r509",
      "r510",
      "r511",
      "r512",
      "r518",
      "r519",
      "r521",
      "r527",
      "r563",
      "r564",
      "r565",
      "r779",
      "r813",
      "r814",
      "r820",
      "r821",
      "r822",
      "r823",
      "r824",
      "r878",
      "r881",
      "r885"
     ]
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementsRecurringMember",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Recurring",
        "label": "Fair Value, Recurring [Member]",
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r878",
      "r1188",
      "r1189",
      "r1190",
      "r1191",
      "r1192",
      "r1193"
     ]
    },
    "us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FederalIncomeTaxExpenseBenefitContinuingOperations",
     "crdr": "debit",
     "presentation": [
      "http://www.recursion.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "U.S. income tax expense",
        "label": "Federal Income Tax Expense (Benefit), Continuing Operations",
        "documentation": "Amount of current and deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current and deferred national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r144",
      "r147",
      "r394",
      "r395"
     ]
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/LeasesScheduleofSupplementalCashFlowInformationRelatedtoLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating cash flows from financing leases",
        "label": "Finance Lease, Interest Payment on Liability",
        "documentation": "Amount of interest paid on finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r549",
      "r552"
     ]
    },
    "us-gaap_FinanceLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinanceLeaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Finance lease liability",
        "label": "Finance Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease."
       }
      }
     },
     "auth_ref": [
      "r547",
      "r553"
     ]
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinanceLeasePrincipalPayments",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/LeasesScheduleofSupplementalCashFlowInformationRelatedtoLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Financing cash flows from financing leases",
        "label": "Finance Lease, Principal Payments",
        "documentation": "Amount of cash outflow for principal payment on finance lease."
       }
      }
     },
     "auth_ref": [
      "r548",
      "r552"
     ]
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinanceLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing lease right-of-use assets",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease."
       }
      }
     },
     "auth_ref": [
      "r546"
     ]
    },
    "rxrx_FinanceLeasesAssetsPledgedAsCollateral": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "FinanceLeasesAssetsPledgedAsCollateral",
     "crdr": "debit",
     "presentation": [
      "http://www.recursion.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance leases, assets pledged as collateral",
        "label": "Finance Leases, Assets Pledged As Collateral",
        "documentation": "Finance Leases, Assets Pledged As Collateral"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_FiniteLivedIntangibleAssetDiscountRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "FiniteLivedIntangibleAssetDiscountRate",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discount rate (as a percent)",
        "label": "Finite-Lived Intangible Asset, Discount Rate",
        "documentation": "Finite-Lived Intangible Asset, Discount Rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Useful life (in years)",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0,
       "order": 1.0
      },
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails_1": {
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Accumulated Amortization",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r117",
      "r233",
      "r257",
      "r782"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails",
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "documentation": "Information by major type or class of finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r249",
      "r251",
      "r252",
      "r253",
      "r256",
      "r257",
      "r260",
      "r261",
      "r572",
      "r573",
      "r668",
      "r778",
      "r782",
      "r844",
      "r845",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails": {
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross carrying amount",
        "label": "Finite-Lived Intangible Assets, Gross",
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r233",
      "r257",
      "r573",
      "r782"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails",
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "auth_ref": [
      "r249",
      "r251",
      "r252",
      "r253",
      "r256",
      "r257",
      "r260",
      "r261",
      "r668",
      "r778",
      "r782",
      "r844",
      "r845",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails": {
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net carrying amount",
        "label": "Finite-Lived Intangible Assets, Net",
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r572",
      "r1113"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r927",
      "r937",
      "r947",
      "r979"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount",
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r927",
      "r937",
      "r947",
      "r979"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r927",
      "r937",
      "r947",
      "r979"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery, Explanation of Impracticability",
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r927",
      "r937",
      "r947",
      "r979"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r927",
      "r937",
      "r947",
      "r979"
     ]
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year",
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r960"
     ]
    },
    "country_GB": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2025",
     "localname": "GB",
     "presentation": [
      "http://www.recursion.com/role/SegmentInformationScheduleofRevenueandLongLivedAssetsBasedonGeographicAreasDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "United Kingdom",
        "label": "UNITED KINGDOM"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainLossOnSaleOfBusiness": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GainLossOnSaleOfBusiness",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails",
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Loss on disposal of a business",
        "label": "Gain (Loss) on Disposition of Business",
        "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant."
       }
      }
     },
     "auth_ref": [
      "r485",
      "r1071"
     ]
    },
    "rxrx_GastrointestinalCancerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "GastrointestinalCancerMember",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gastrointestinal Cancer",
        "label": "Gastrointestinal Cancer [Member]",
        "documentation": "Gastrointestinal Cancer"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative",
        "label": "General and Administrative Expense",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r724"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative",
        "label": "General and Administrative Expense [Member]",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "us-gaap_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited",
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill",
        "periodStartLabel": "Goodwill, beginning balance",
        "periodEndLabel": "Goodwill, ending balance",
        "label": "Goodwill",
        "documentation": "Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r234",
      "r609",
      "r806",
      "r811",
      "r831",
      "r835",
      "r836",
      "r874",
      "r879",
      "r886",
      "r1095",
      "r1102",
      "r1177"
     ]
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GoodwillAcquiredDuringPeriod",
     "crdr": "debit",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails",
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additions",
        "label": "Goodwill, Acquired During Period",
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination."
       }
      }
     },
     "auth_ref": [
      "r238",
      "r469",
      "r472",
      "r476",
      "r811"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "presentation": [
      "http://www.recursion.com/role/GoodwillandIntangibleAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill and Intangible Assets",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "documentation": "The entire disclosure for goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r1093",
      "r1105"
     ]
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Foreign currency translation adjustments",
        "label": "Goodwill, Foreign Currency Translation, Gain (Loss)",
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) asset representing future economic benefit from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r242",
      "r476"
     ]
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GoodwillImpairmentLoss",
     "crdr": "debit",
     "presentation": [
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill impairment",
        "label": "Goodwill, Impairment Loss",
        "documentation": "Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r235",
      "r241",
      "r246",
      "r248",
      "r476",
      "r811",
      "r879"
     ]
    },
    "us-gaap_GoodwillLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GoodwillLineItems",
     "presentation": [
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill [Line Items]",
        "label": "Goodwill [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r811"
     ]
    },
    "us-gaap_GoodwillRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GoodwillRollForward",
     "presentation": [
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill [Roll Forward]",
        "label": "Goodwill [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GrantMember",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grant revenue",
        "label": "Grant [Member]",
        "documentation": "Award of money not required to be repaid."
       }
      }
     },
     "auth_ref": [
      "r1132",
      "r1133"
     ]
    },
    "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of indefinite-lived intangible assets",
        "label": "Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)",
        "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value."
       }
      }
     },
     "auth_ref": [
      "r250",
      "r1071",
      "r1114",
      "r1117"
     ]
    },
    "us-gaap_ImpairmentOfLeasehold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ImpairmentOfLeasehold",
     "crdr": "debit",
     "presentation": [
      "http://www.recursion.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of leasehold improvements",
        "label": "Impairment of Leasehold",
        "documentation": "The adjustment to reduce the value of existing agreements that specify the lessee's rights to use the leased property. This expense is charged when the estimates of future profits generated by the leased property are reduced."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r32"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss before income tax benefit",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r92",
      "r97",
      "r613",
      "r615",
      "r631",
      "r790",
      "r792",
      "r794",
      "r800",
      "r805",
      "r1086",
      "r1087",
      "r1088",
      "r1089",
      "r1090"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal Group Name [Axis]",
        "label": "Disposal Group Name [Axis]",
        "documentation": "Information by name of disposal group."
       }
      }
     },
     "auth_ref": [
      "r266",
      "r267",
      "r825",
      "r826"
     ]
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Axis]",
        "label": "Statement of Income Location, Balance [Axis]",
        "documentation": "Information by location in statement of income where disaggregated amount is reported."
       }
      }
     },
     "auth_ref": [
      "r264",
      "r268",
      "r271",
      "r488",
      "r489",
      "r490",
      "r491",
      "r513",
      "r515",
      "r520",
      "r532",
      "r533",
      "r534",
      "r657",
      "r659",
      "r725",
      "r778",
      "r779",
      "r831",
      "r836",
      "r876",
      "r877",
      "r880",
      "r885",
      "r1170",
      "r1172",
      "r1212"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Domain]",
        "label": "Statement of Income Location, Balance [Domain]",
        "documentation": "Location in statement of income where disaggregated amount is reported."
       }
      }
     },
     "auth_ref": [
      "r268",
      "r271",
      "r488",
      "r489",
      "r490",
      "r491",
      "r513",
      "r515",
      "r520",
      "r532",
      "r533",
      "r534",
      "r657",
      "r659",
      "r725",
      "r778",
      "r779",
      "r831",
      "r836",
      "r876",
      "r877",
      "r880",
      "r885",
      "r1170",
      "r1172",
      "r1212"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.recursion.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r144",
      "r148",
      "r391",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r404",
      "r406",
      "r407",
      "r408",
      "r618",
      "r667",
      "r675",
      "r830"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited",
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Income tax benefit (expense)",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r104",
      "r144",
      "r167",
      "r168",
      "r182",
      "r201",
      "r215",
      "r394",
      "r396",
      "r405",
      "r637",
      "r790",
      "r792",
      "r794",
      "r830"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Increase (Decrease) in Accounts Payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "rxrx_IncreaseDecreaseInAccruedDataLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "IncreaseDecreaseInAccruedDataLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued data liability",
        "label": "Increase (Decrease) In Accrued Data liability",
        "documentation": "Increase (Decrease) In Accrued Data liability"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_IncreaseDecreaseInAccruedDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "IncreaseDecreaseInAccruedDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued development expense",
        "label": "Increase (Decrease) In Accrued Development Expense",
        "documentation": "Increase (Decrease) In Accrued Development Expense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unearned revenue",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r570",
      "r1070"
     ]
    },
    "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInDeferredIncomeTaxes",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase deferred tax liabilities",
        "label": "Increase (Decrease) in Deferred Income Taxes",
        "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "rxrx_IncreaseDecreaseInLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "IncreaseDecreaseInLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liabilities",
        "label": "Increase (Decrease) In Lease Liability",
        "documentation": "Increase (Decrease) In Lease Liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in operating assets and liabilities:",
        "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "IncreaseDecreaseInOperatingLeaseRightOfUseAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.recursion.com/role/LeasesNarrativeDetails",
      "http://www.recursion.com/role/LeasesScheduleofSupplementalCashFlowInformationRelatedtoLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Increase (decrease) in operating lease right-of-use assets",
        "terseLabel": "Operating leases",
        "label": "Increase (Decrease) in Operating Lease Right-Of-Use Assets",
        "documentation": "Increase (Decrease) in Operating Lease Right-Of-Use Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOtherAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInOtherAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses and other current liabilities",
        "label": "Increase (Decrease) in Other Accrued Liabilities",
        "documentation": "The increase (decrease) during the reporting period in other expenses incurred but not yet paid."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other receivables and assets",
        "label": "Increase (Decrease) in Other Operating Assets",
        "documentation": "Amount of increase (decrease) in operating assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "rxrx_IncreaseDecreaseInPrepaidDataAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "IncreaseDecreaseInPrepaidDataAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid data assets",
        "label": "Increase (Decrease) In Prepaid Data Assets",
        "documentation": "Increase (Decrease) In Prepaid Data Assets"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_IncreaseDecreaseInRightOfUseAssetsForFinanceLeases": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "IncreaseDecreaseInRightOfUseAssetsForFinanceLeases",
     "crdr": "debit",
     "presentation": [
      "http://www.recursion.com/role/LeasesNarrativeDetails",
      "http://www.recursion.com/role/LeasesScheduleofSupplementalCashFlowInformationRelatedtoLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Increase (decrease) in finance lease right-of-use assets",
        "terseLabel": "Financing leases",
        "label": "Increase (Decrease) In Right Of Use Assets For Finance Leases",
        "documentation": "Increase (Decrease) In Right Of Use Assets For Finance Leases"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails": {
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Indefinite-lived intangible assets",
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)",
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit."
       }
      }
     },
     "auth_ref": [
      "r233",
      "r259",
      "r782"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Individual:",
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r927",
      "r937",
      "r947",
      "r971",
      "r979",
      "r983",
      "r991"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r989"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r919",
      "r995"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Adopted",
        "label": "Insider Trading Policies and Procedures Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r919",
      "r995"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted",
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r919",
      "r995"
     ]
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails_1": {
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Intangible assets, gross",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill."
       }
      }
     },
     "auth_ref": [
      "r116"
     ]
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 7.0
      },
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited",
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets, net",
        "totalLabel": "Intangible assets, net",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges."
       }
      }
     },
     "auth_ref": [
      "r249",
      "r1113",
      "r1114"
     ]
    },
    "us-gaap_InterestExpenseNonoperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestExpenseNonoperating",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofInterestIncomeNetDetails": {
       "parentTag": "us-gaap_InterestIncomeExpenseNonoperatingNet",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofInterestIncomeNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Interest expense",
        "label": "Interest Expense, Nonoperating",
        "documentation": "Amount of interest expense classified as nonoperating."
       }
      }
     },
     "auth_ref": [
      "r197",
      "r790",
      "r794",
      "r1026"
     ]
    },
    "us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestIncomeAndInterestExpenseDisclosureTableTextBlock",
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Interest Income, Net",
        "label": "Interest Income and Interest Expense Disclosure [Table Text Block]",
        "documentation": "Tabular disclosure of interest income and expense, including, but not limited to, interest income and expense from investments, loans, and securities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestIncomeExpenseNonoperatingNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestIncomeExpenseNonoperatingNet",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofInterestIncomeNetDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofInterestIncomeNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Interest income, net",
        "label": "Interest Income (Expense), Nonoperating",
        "documentation": "Amount of interest income (expense) classified as nonoperating."
       }
      }
     },
     "auth_ref": [
      "r805",
      "r875",
      "r1026",
      "r1087"
     ]
    },
    "us-gaap_InvestmentIncomeNonoperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InvestmentIncomeNonoperating",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofInterestIncomeNetDetails": {
       "parentTag": "us-gaap_InterestIncomeExpenseNonoperatingNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofInterestIncomeNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income",
        "label": "Investment Income, Nonoperating",
        "documentation": "The aggregate amount of income from investments (for example, dividends) not considered a component of the entity's core operations."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "us-gaap_LaborAndRelatedExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LaborAndRelatedExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Salaries",
        "label": "Labor and Related Expense",
        "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit."
       }
      }
     },
     "auth_ref": [
      "r610",
      "r792",
      "r1025"
     ]
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://www.recursion.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Components of Lease Cost and Supplemental Cash Flow Information Related to Leases and Lease Term and Discount Rates",
        "label": "Lease, Cost [Table Text Block]",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r1200"
     ]
    },
    "rxrx_LeaseDescriptionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "LeaseDescriptionAxis",
     "presentation": [
      "http://www.recursion.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease Description [Axis]",
        "label": "Lease Description [Axis]",
        "documentation": "Lease Description"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_LeaseDescriptionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "LeaseDescriptionDomain",
     "presentation": [
      "http://www.recursion.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease Description [Domain]",
        "label": "Lease Description [Domain]",
        "documentation": "Lease Description [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_LesseeFinanceLeaseIncreaseDecreaseInFinanceLeaseLiabilityDueToLeaseModifications": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "LesseeFinanceLeaseIncreaseDecreaseInFinanceLeaseLiabilityDueToLeaseModifications",
     "crdr": "debit",
     "presentation": [
      "http://www.recursion.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (decrease) in finance lease liabilities",
        "label": "Lessee, Finance Lease, Increase (Decrease) In Finance Lease Liability Due To Lease Modifications",
        "documentation": "Lessee, Finance Lease, Increase (Decrease) In Finance Lease Liability Due To Lease Modifications"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeFinanceLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeFinanceLeasesTextBlock",
     "presentation": [
      "http://www.recursion.com/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Finance Leases [Text Block]",
        "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r544"
     ]
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeLeaseDescriptionLineItems",
     "presentation": [
      "http://www.recursion.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Lease, Description [Line Items]",
        "label": "Lessee, Lease, Description [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r551",
      "r555"
     ]
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeLeaseDescriptionTable",
     "presentation": [
      "http://www.recursion.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Lease, Description [Table]",
        "label": "Lessee, Lease, Description [Table]",
        "documentation": "Disclosure of information about lessee's leases."
       }
      }
     },
     "auth_ref": [
      "r551",
      "r555"
     ]
    },
    "rxrx_LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications",
     "crdr": "debit",
     "presentation": [
      "http://www.recursion.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (decrease) in operating lease liabilities",
        "label": "Lessee, Operating Lease, Increase (Decrease) In Operating Lease Liability Due To Lease Modifications",
        "documentation": "Lessee, Operating Lease, Increase (Decrease) In Operating Lease Liability Due To Lease Modifications"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseRemainingLeaseTerm",
     "presentation": [
      "http://www.recursion.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remaining operating lease term",
        "label": "Lessee, Operating Lease, Remaining Lease Term",
        "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r555",
      "r1198"
     ]
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "presentation": [
      "http://www.recursion.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease, renewal term",
        "label": "Lessee, Operating Lease, Renewal Term",
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1199"
     ]
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://www.recursion.com/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Operating Leases [Text Block]",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r544"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52",
      "r144",
      "r145",
      "r146",
      "r228",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r484",
      "r486",
      "r487",
      "r531",
      "r700",
      "r799",
      "r815",
      "r914",
      "r1129",
      "r1202",
      "r1203"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities and stockholders\u2019 equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r91",
      "r628",
      "r886",
      "r901",
      "r902",
      "r1075",
      "r1078",
      "r1092",
      "r1196"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities and stockholders\u2019 equity",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r114",
      "r144",
      "r145",
      "r146",
      "r228",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r484",
      "r486",
      "r487",
      "r531",
      "r886",
      "r1129",
      "r1202",
      "r1203"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current liabilities",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities, Fair Value Disclosure",
        "documentation": "Fair value of financial and nonfinancial obligations."
       }
      }
     },
     "auth_ref": [
      "r509",
      "r1188"
     ]
    },
    "rxrx_LicenseAgreementAggregatePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "LicenseAgreementAggregatePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate amount payable in cash or equity",
        "label": "License Agreement, Aggregate Payments",
        "documentation": "License Agreement, Aggregate Payments"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_LicenseAgreementAmountOfTimePriorToThePaymentDate": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "LicenseAgreementAmountOfTimePriorToThePaymentDate",
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business days prior to the payment date",
        "label": "License Agreement, Amount Of Time Prior To The Payment Date",
        "documentation": "License Agreement, Amount Of Time Prior To The Payment Date"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_LicenseAgreementAnnualPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "LicenseAgreementAnnualPayments",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Annual payments",
        "label": "License Agreement, Annual Payments",
        "documentation": "License Agreement, Annual Payments"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_LicenseAgreementIncreaseDecreaseAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "LicenseAgreementIncreaseDecreaseAccruedLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "License Agreement, increase (decrease) prepaid expenses",
        "label": "License Agreement, Increase (Decrease) Accrued Liabilities",
        "documentation": "License Agreement, Increase (Decrease) Accrued Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_LicenseAgreementTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "LicenseAgreementTerm",
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "License agreement, term",
        "label": "License Agreement, Term",
        "documentation": "License Agreement, Term"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_LicenseAgreementTradingPeriodUsedForEquityValueDetermination": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "LicenseAgreementTradingPeriodUsedForEquityValueDetermination",
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading period used for equity value determination",
        "label": "License Agreement, Trading Period Used For Equity Value Determination",
        "documentation": "License Agreement, Trading Period Used For Equity Value Determination"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LicenseAndServiceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LicenseAndServiceMember",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating revenue",
        "label": "License and Service [Member]",
        "documentation": "Right to use intangible asset and performance of related service. Intangible asset includes, but is not limited to, patent, copyright, technology, manufacturing process, software or trademark."
       }
      }
     },
     "auth_ref": [
      "r1132",
      "r1133"
     ]
    },
    "us-gaap_LicensingAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LicensingAgreementsMember",
     "presentation": [
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Definite-lived licensed intangible assets",
        "label": "Licensing Agreements [Member]",
        "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory)."
       }
      }
     },
     "auth_ref": [
      "r390",
      "r856",
      "r1106",
      "r1107",
      "r1108",
      "r1109",
      "r1110",
      "r1111",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1165"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails": {
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited",
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Notes payable and financing lease liabilities, non-current",
        "terseLabel": "Notes payable and financing lease liabilities, non-current",
        "label": "Long-Term Debt and Lease Obligation",
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r622"
     ]
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails": {
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited",
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Notes payable and financing lease liabilities",
        "terseLabel": "Notes payable and financing lease liabilities, current",
        "label": "Long-Term Debt and Lease Obligation, Current",
        "documentation": "Amount of long-term debt and lease obligation, classified as current."
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Axis]",
        "label": "Long-Term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r1119",
      "r1120",
      "r1121"
     ]
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Domain]",
        "label": "Long-Term Debt, Type [Domain]",
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r34",
      "r1119",
      "r1120",
      "r1121"
     ]
    },
    "us-gaap_LossContingenciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LossContingenciesLineItems",
     "presentation": [
      "http://www.recursion.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss Contingencies [Line Items]",
        "label": "Loss Contingencies [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r188",
      "r279",
      "r280",
      "r281",
      "r284",
      "r388",
      "r812",
      "r1125",
      "r1126"
     ]
    },
    "us-gaap_LossContingenciesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LossContingenciesTable",
     "presentation": [
      "http://www.recursion.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss Contingencies [Table]",
        "label": "Loss Contingencies [Table]",
        "documentation": "Disclosure of information about loss contingency. Excludes environmental contingency, warranty, and unconditional purchase obligation."
       }
      }
     },
     "auth_ref": [
      "r188",
      "r279",
      "r280",
      "r281",
      "r284",
      "r388",
      "r812",
      "r1125",
      "r1126"
     ]
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LossContingencyAccrualAtCarryingValue",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss contingency accrual",
        "label": "Loss Contingency Accrual",
        "documentation": "Amount of loss contingency liability."
       }
      }
     },
     "auth_ref": [
      "r279",
      "r1002"
     ]
    },
    "rxrx_MaterialsReceivedNotInvoiced": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "MaterialsReceivedNotInvoiced",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Materials received not invoiced",
        "label": "Materials Received Not Invoiced",
        "documentation": "Materials Received Not Invoiced"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.recursion.com/role/LeasesNarrativeDetails",
      "http://www.recursion.com/role/SupplementalFinancialInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r188",
      "r280",
      "r281",
      "r282",
      "r283",
      "r347",
      "r376",
      "r377",
      "r378",
      "r388",
      "r512",
      "r569",
      "r656",
      "r658",
      "r666",
      "r692",
      "r693",
      "r746",
      "r748",
      "r750",
      "r751",
      "r753",
      "r761",
      "r762",
      "r764",
      "r765",
      "r776",
      "r777",
      "r810",
      "r816",
      "r827",
      "r831",
      "r838",
      "r841",
      "r881",
      "r882",
      "r883",
      "r884",
      "r896",
      "r1131",
      "r1204",
      "r1205",
      "r1206",
      "r1207",
      "r1208",
      "r1209"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measure:",
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r963"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Measure Name"
       }
      }
     },
     "auth_ref": [
      "r963"
     ]
    },
    "rxrx_MerckKGaAMerckMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "MerckKGaAMerckMember",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Merck KGaA (Merck)",
        "label": "Merck KGaA (Merck) [Member]",
        "documentation": "Merck KGaA (Merck)"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_MilestoneTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "MilestoneTypeAxis",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Milestone, Type [Axis]",
        "label": "Milestone, Type [Axis]",
        "documentation": "Milestone, Type"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_MilestoneTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "MilestoneTypeDomain",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Milestone, Type [Domain]",
        "label": "Milestone, Type [Domain]",
        "documentation": "Milestone, Type [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.recursion.com/role/LeasesNarrativeDetails",
      "http://www.recursion.com/role/SupplementalFinancialInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r188",
      "r280",
      "r281",
      "r282",
      "r283",
      "r347",
      "r376",
      "r377",
      "r378",
      "r388",
      "r512",
      "r569",
      "r656",
      "r658",
      "r666",
      "r692",
      "r693",
      "r746",
      "r748",
      "r750",
      "r751",
      "r753",
      "r761",
      "r762",
      "r764",
      "r765",
      "r776",
      "r777",
      "r810",
      "r816",
      "r827",
      "r831",
      "r838",
      "r841",
      "r881",
      "r882",
      "r883",
      "r896",
      "r1131",
      "r1204",
      "r1205",
      "r1206",
      "r1207",
      "r1208",
      "r1209"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MNPI Disclosure Timed for Compensation Value",
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]"
       }
      }
     },
     "auth_ref": [
      "r982"
     ]
    },
    "us-gaap_MoneyMarketFundsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MoneyMarketFundsMember",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Money market funds",
        "label": "Money Market Funds [Member]",
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities."
       }
      }
     },
     "auth_ref": [
      "r1134",
      "r1135"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Material Terms of Trading Arrangement",
        "label": "Material Terms of Trading Arrangement [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r990"
     ]
    },
    "rxrx_NajatKhanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "NajatKhanMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Najat Khan [Member]",
        "documentation": "Najat Khan"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Named Executive Officers, Footnote",
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r964"
     ]
    },
    "us-gaap_NatureOfOperations": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NatureOfOperations",
     "presentation": [
      "http://www.recursion.com/role/DescriptionoftheBusiness"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Description of the Business",
        "label": "Nature of Operations [Text Block]",
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r186",
      "r797",
      "r798"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by financing activities",
        "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from financing activities",
        "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in investing activities",
        "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from investing activities",
        "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in operating activities",
        "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r74",
      "r75"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from operating activities",
        "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofComprehensiveLossunaudited": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited",
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofComprehensiveLossunaudited",
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited",
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited",
      "http://www.recursion.com/role/NetLossPerShareScheduleofComputationofBasicandDilutedNetLossPerShareDetails",
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss",
        "terseLabel": "Net loss",
        "verboseLabel": "Net loss",
        "negatedTotalLabel": "Total segment loss",
        "label": "Net Income (Loss) Attributable to Parent",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r75",
      "r93",
      "r109",
      "r112",
      "r127",
      "r130",
      "r134",
      "r144",
      "r145",
      "r146",
      "r150",
      "r156",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r167",
      "r168",
      "r174",
      "r228",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r298",
      "r301",
      "r304",
      "r308",
      "r385",
      "r413",
      "r479",
      "r506",
      "r531",
      "r632",
      "r721",
      "r738",
      "r739",
      "r790",
      "r792",
      "r794",
      "r912",
      "r1129"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLossAvailableToCommonStockholdersDilutedAbstract",
     "presentation": [
      "http://www.recursion.com/role/NetLossPerShareScheduleofComputationofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Numerator:",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_NeuroscienceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "NeuroscienceMember",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Neuroscience",
        "label": "Neuroscience [Member]",
        "documentation": "Neuroscience"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.recursion.com/role/BasisofPresentationPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recent Accounting Pronouncements",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-GAAP Measure Description",
        "label": "Non-GAAP Measure Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r963"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-NEOs",
        "label": "Non-NEOs [Member]"
       }
      }
     },
     "auth_ref": [
      "r927",
      "r937",
      "r947",
      "r971",
      "r979"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r954"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount",
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r953"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO",
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r971"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted",
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r990"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated",
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r990"
     ]
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental schedule of non-cash investing and financing activities",
        "label": "Noncash Investing and Financing Items [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1",
     "crdr": "debit",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase of an intangible asset",
        "label": "Noncash or Part Noncash Acquisition, Intangible Assets Acquired",
        "documentation": "The amount of intangibles that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r25",
      "r26"
     ]
    },
    "us-gaap_NoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NoncurrentAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.recursion.com/role/SegmentInformationScheduleofRevenueandLongLivedAssetsBasedonGeographicAreasDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-lived assets",
        "label": "Long-Lived Assets",
        "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r221"
     ]
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited",
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other income, net",
        "verboseLabel": "Other non-operating income (loss), net",
        "label": "Nonoperating Income (Expense)",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NonvestedRestrictedStockSharesActivityTableTextBlock",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of RSU Activity",
        "label": "Nonvested Restricted Stock Shares Activity [Table Text Block]",
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock shares."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "us-gaap_NotesPayableOtherPayablesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NotesPayableOtherPayablesMember",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notes Payable",
        "label": "Notes Payable, Other Payables [Member]",
        "documentation": "A written promise to pay a note to a third party."
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_NumberOfAcquiredCustomerContractsWithContractLiabilities": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "NumberOfAcquiredCustomerContractsWithContractLiabilities",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of acquired customer contracts with contract liabilities",
        "label": "Number Of Acquired Customer Contracts With Contract Liabilities",
        "documentation": "Number Of Acquired Customer Contracts With Contract Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_NumberOfClassesOfCommonStockAuthorized": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "NumberOfClassesOfCommonStockAuthorized",
     "presentation": [
      "http://www.recursion.com/role/CommonStockClassAandBCommonSharesAuthorizationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of classes of common stock authorized",
        "label": "Number Of Classes Of Common Stock Authorized",
        "documentation": "Number Of Classes Of Common Stock Authorized"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_NumberOfInProcessResearchAndDevelopmentAssets": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "NumberOfInProcessResearchAndDevelopmentAssets",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of in-process research and development assets",
        "label": "Number Of In Process Research And Development Assets",
        "documentation": "Number Of In Process Research And Development Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating costs and expenses",
        "label": "Operating Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited",
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss from operations",
        "negatedTotalLabel": "Loss from operations",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r790",
      "r794",
      "r800",
      "r1086",
      "r1087",
      "r1088",
      "r1089",
      "r1090"
     ]
    },
    "us-gaap_OperatingLeaseExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Lease expense",
        "label": "Operating Lease, Expense",
        "documentation": "Amount of operating lease expense. Excludes sublease income."
       }
      }
     },
     "auth_ref": [
      "r1197"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r547"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities, non-current",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r547"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/LeasesScheduleofSupplementalCashFlowInformationRelatedtoLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating cash flows from operating leases",
        "label": "Operating Lease, Payments",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r550",
      "r552"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease right-of-use assets",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r546"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued other expenses",
        "label": "Other Accrued Liabilities, Current",
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "us-gaap_OtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other current assets",
        "label": "Other Assets, Current",
        "documentation": "Amount of current assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r886"
     ]
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other assets, non-current",
        "label": "Other Assets, Noncurrent",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofComprehensiveLossunaudited": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofComprehensiveLossunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Currency translation adjustments",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r9",
      "r88"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofComprehensiveLossunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive income (loss):",
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofComprehensiveLossunaudited": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofComprehensiveLossunaudited",
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Other comprehensive income (loss)",
        "terseLabel": "Other comprehensive income (loss)",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r9",
      "r88",
      "r128",
      "r131",
      "r164"
     ]
    },
    "rxrx_OtherCountriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "OtherCountriesMember",
     "presentation": [
      "http://www.recursion.com/role/SegmentInformationScheduleofRevenueandLongLivedAssetsBasedonGeographicAreasDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other Countries [Member]",
        "documentation": "Other Countries"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other liabilities, non-current",
        "label": "Other Liabilities, Noncurrent",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherNoncashIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other, net",
        "label": "Other Noncash Income (Expense)",
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Performance Measure, Amount",
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r963"
     ]
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherReceivablesNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other receivables",
        "label": "Other Receivables, Net, Current",
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount",
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r925",
      "r935",
      "r945",
      "r977"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Amount",
        "label": "Outstanding Recovery Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r928",
      "r938",
      "r948",
      "r980"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r928",
      "r938",
      "r948",
      "r980"
     ]
    },
    "us-gaap_OverAllotmentOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OverAllotmentOptionMember",
     "presentation": [
      "http://www.recursion.com/role/CommonStockPublicOfferingofCommonStockNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Over-Allotment Option",
        "label": "Over-Allotment Option [Member]",
        "documentation": "Right given to the underwriter to sell additional shares over the initial allotment."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r952"
     ]
    },
    "us-gaap_PaymentsForRestructuring": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsForRestructuring",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofRestructuringActionsandtheRelatedAccrualDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments",
        "label": "Payments for Restructuring",
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r270",
      "r1069"
     ]
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsOfStockIssuanceCosts",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/CommonStockPublicOfferingofCommonStockNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underwriting discounts and commissions",
        "label": "Payments of Stock Issuance Costs",
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security."
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsToAcquireInProcessResearchAndDevelopment",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payments to acquire IPR&amp;D",
        "label": "Payments to Acquire in Process Research and Development",
        "documentation": "The cash outflows from the purchase of net carrying value allocated to in-process research and development costs and materials acquired in a business combination."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsToAcquireIntangibleAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchase of an intangible asset",
        "label": "Payments to Acquire Intangible Assets",
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "rxrx_PaymentsToAcquireIntangibleAssetsFinancialActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "PaymentsToAcquireIntangibleAssetsFinancialActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchase of an intangible asset",
        "label": "Payments to Acquire Intangible Assets, Financial Activities",
        "documentation": "Payments to Acquire Intangible Assets, Financial Activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsToAcquireInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsToAcquireInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchases of investments",
        "label": "Payments to Acquire Investments",
        "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsToAcquireProductiveAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/AcquisitionsScheduleofAssetAcquisitionDetails": {
       "parentTag": "us-gaap_AssetAcquisitionConsiderationTransferred",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsScheduleofAssetAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid",
        "label": "Payments to Acquire Productive Assets",
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r1179",
      "r1180",
      "r1181"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchases of property and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Issuers, Footnote",
        "label": "Peer Group Issuers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r962"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Total Shareholder Return Amount",
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r962"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Actually Paid Compensation Amount",
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r954"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO",
        "label": "PEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r971"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Name",
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r964"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Total Compensation Amount",
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r953"
     ]
    },
    "rxrx_PhenomapsCreationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "PhenomapsCreationMember",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Phenomaps Creation",
        "label": "Phenomaps Creation [Member]",
        "documentation": "Phenomaps Creation"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_PhenomapsRawImagesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "PhenomapsRawImagesMember",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Phenomaps Raw Images",
        "label": "Phenomaps Raw Images [Member]",
        "documentation": "Phenomaps Raw Images"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Axis]",
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1136",
      "r1137",
      "r1138",
      "r1139",
      "r1140",
      "r1141",
      "r1142",
      "r1143",
      "r1144",
      "r1145",
      "r1146",
      "r1147",
      "r1148",
      "r1149",
      "r1150",
      "r1151",
      "r1152",
      "r1153",
      "r1154",
      "r1155",
      "r1156",
      "r1157",
      "r1158",
      "r1159",
      "r1160",
      "r1161"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Domain]",
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1136",
      "r1137",
      "r1138",
      "r1139",
      "r1140",
      "r1141",
      "r1142",
      "r1143",
      "r1144",
      "r1145",
      "r1146",
      "r1147",
      "r1148",
      "r1149",
      "r1150",
      "r1151",
      "r1152",
      "r1153",
      "r1154",
      "r1155",
      "r1156",
      "r1157",
      "r1158",
      "r1159",
      "r1160",
      "r1161"
     ]
    },
    "rxrx_PlatformFeeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "PlatformFeeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Platform",
        "label": "Platform Fee Expense",
        "documentation": "Platform Fee Expense"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Prior Service Cost",
        "label": "Pension Adjustments Prior Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r955"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Service Cost",
        "label": "Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r999"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Benefits Adjustments, Footnote",
        "label": "Pension Benefits Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r954"
     ]
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Portion at Fair Value Measurement",
        "label": "Portion at Fair Value Measurement [Member]",
        "documentation": "Measured at fair value for financial reporting purposes."
       }
      }
     },
     "auth_ref": [
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r779",
      "r1195"
     ]
    },
    "us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PortionAtOtherThanFairValueFairValueDisclosureMember",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Book values",
        "label": "Portion at Other than Fair Value Measurement [Member]",
        "documentation": "Not measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r526"
     ]
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrepaidExpenseCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid data assets",
        "label": "Prepaid Expense, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r231",
      "r232",
      "r784"
     ]
    },
    "us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromDivestitureOfBusinessesNetOfCashDivested",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Decrease in cash related to disposal of a business",
        "label": "Proceeds from Divestiture of Businesses, Net of Cash Divested",
        "documentation": "This element represents the cash inflow during the period from the sale of a component of the entity."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of common shares, net of issuance costs",
        "label": "Proceeds from Issuance of Common Stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from equity incentive plans",
        "label": "Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised",
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r13"
     ]
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Axis]",
        "label": "Product and Service [Axis]"
       }
      }
     },
     "auth_ref": [
      "r218",
      "r571",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r780",
      "r789",
      "r792",
      "r794",
      "r817",
      "r818",
      "r895",
      "r896",
      "r897",
      "r900",
      "r903",
      "r1008",
      "r1027",
      "r1028",
      "r1029",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1127",
      "r1128",
      "r1211",
      "r1213",
      "r1214",
      "r1215",
      "r1216",
      "r1217",
      "r1218",
      "r1219",
      "r1220",
      "r1221",
      "r1222",
      "r1223",
      "r1224",
      "r1225",
      "r1226",
      "r1227",
      "r1228",
      "r1229",
      "r1230",
      "r1231",
      "r1232",
      "r1233",
      "r1234",
      "r1235",
      "r1236",
      "r1237",
      "r1238",
      "r1239",
      "r1240"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Domain]",
        "label": "Product and Service [Domain]"
       }
      }
     },
     "auth_ref": [
      "r218",
      "r571",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r780",
      "r789",
      "r792",
      "r794",
      "r817",
      "r818",
      "r895",
      "r896",
      "r897",
      "r900",
      "r903",
      "r1008",
      "r1027",
      "r1028",
      "r1029",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1127",
      "r1128",
      "r1211",
      "r1213",
      "r1214",
      "r1215",
      "r1216",
      "r1217",
      "r1218",
      "r1219",
      "r1220",
      "r1221",
      "r1222",
      "r1223",
      "r1224",
      "r1225",
      "r1226",
      "r1227",
      "r1228",
      "r1229",
      "r1230",
      "r1231",
      "r1232",
      "r1233",
      "r1234",
      "r1235",
      "r1236",
      "r1237",
      "r1238",
      "r1239",
      "r1240"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Line Items]",
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r554"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment, net",
        "label": "Property, Plant and Equipment, Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r554",
      "r617",
      "r630",
      "r886"
     ]
    },
    "rxrx_PublicOfferingOfCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "PublicOfferingOfCommonStockMember",
     "presentation": [
      "http://www.recursion.com/role/CommonStockPublicOfferingofCommonStockNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Public Offering of Common Stock",
        "label": "Public Offering Of Common Stock [Member]",
        "documentation": "Public Offering Of Common Stock"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_PublicOfferingOfCommonStockUnderwritingAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "PublicOfferingOfCommonStockUnderwritingAgreementMember",
     "presentation": [
      "http://www.recursion.com/role/CommonStockPublicOfferingofCommonStockNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Public Offering of Common Stock, Underwriting Agreement",
        "label": "Public Offering Of Common Stock, Underwriting Agreement [Member]",
        "documentation": "Public Offering Of Common Stock, Underwriting Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_PurchaseOfAnEquityInvestmentNonCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "PurchaseOfAnEquityInvestmentNonCash",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase of an equity investment",
        "label": "Purchase Of An Equity Investment, Non-Cash",
        "documentation": "Purchase Of An Equity Investment, Non-Cash"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure",
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r952"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure, Table",
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r952"
     ]
    },
    "rxrx_REVenturesIMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "REVenturesIMember",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails",
      "http://www.recursion.com/role/AcquisitionsScheduleofAssetAcquisitionDetails",
      "http://www.recursion.com/role/AcquisitionsScheduleofContingentConsiderationTransferredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RE Ventures I",
        "label": "RE Ventures I [Member]",
        "documentation": "RE Ventures I"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.recursion.com/role/LeasesNarrativeDetails",
      "http://www.recursion.com/role/SupplementalFinancialInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Axis]",
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r188",
      "r280",
      "r281",
      "r282",
      "r283",
      "r335",
      "r347",
      "r376",
      "r377",
      "r378",
      "r384",
      "r388",
      "r512",
      "r566",
      "r567",
      "r569",
      "r656",
      "r658",
      "r666",
      "r692",
      "r693",
      "r746",
      "r748",
      "r750",
      "r751",
      "r753",
      "r761",
      "r762",
      "r764",
      "r765",
      "r776",
      "r777",
      "r810",
      "r816",
      "r827",
      "r831",
      "r838",
      "r841",
      "r881",
      "r882",
      "r883",
      "r884",
      "r896",
      "r906",
      "r1122",
      "r1131",
      "r1191",
      "r1205",
      "r1206",
      "r1207",
      "r1208",
      "r1209"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RangeMember",
     "presentation": [
      "http://www.recursion.com/role/LeasesNarrativeDetails",
      "http://www.recursion.com/role/SupplementalFinancialInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Domain]",
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "auth_ref": [
      "r188",
      "r280",
      "r281",
      "r282",
      "r283",
      "r335",
      "r347",
      "r376",
      "r377",
      "r378",
      "r384",
      "r388",
      "r512",
      "r566",
      "r567",
      "r569",
      "r656",
      "r658",
      "r666",
      "r692",
      "r693",
      "r746",
      "r748",
      "r750",
      "r751",
      "r753",
      "r761",
      "r762",
      "r764",
      "r765",
      "r776",
      "r777",
      "r810",
      "r816",
      "r827",
      "r831",
      "r838",
      "r841",
      "r881",
      "r882",
      "r883",
      "r884",
      "r896",
      "r906",
      "r1122",
      "r1131",
      "r1191",
      "r1205",
      "r1206",
      "r1207",
      "r1208",
      "r1209"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r920",
      "r930",
      "r940",
      "r972"
     ]
    },
    "rxrx_RegistrationRightsAgreementTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "RegistrationRightsAgreementTerm",
     "presentation": [
      "http://www.recursion.com/role/CommonStockRegistrationRightsAgreementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Registration rights agreement term",
        "label": "Registration Rights Agreement, Term",
        "documentation": "Registration Rights Agreement, Term"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://www.recursion.com/role/CommonStockClassAandBCommonSharesAuthorizationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party [Domain]",
        "label": "Related and Nonrelated Parties [Domain]",
        "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r144",
      "r149",
      "r150",
      "r223",
      "r342",
      "r346",
      "r557",
      "r558",
      "r623",
      "r629",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r719",
      "r745",
      "r1243"
     ]
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://www.recursion.com/role/CommonStockClassAandBCommonSharesAuthorizationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party [Axis]",
        "label": "Related and Nonrelated Parties [Axis]",
        "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r144",
      "r149",
      "r150",
      "r223",
      "r342",
      "r346",
      "r557",
      "r558",
      "r623",
      "r629",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r719",
      "r745",
      "r1201",
      "r1243"
     ]
    },
    "us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RepaymentsOfLongTermDebtAndCapitalSecurities",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Repayment of long-term debt and finance lease liabilities",
        "label": "Repayment of Long-Term Debt, Long-Term Lease Obligation, and Capital Security",
        "documentation": "Amount of cash outflow for debt, mandatory redeemable security, and principal payment for finance lease obligation."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r72"
     ]
    },
    "rxrx_ReportableSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "ReportableSegmentMember",
     "presentation": [
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reportable Segment",
        "label": "Reportable Segment [Member]",
        "documentation": "Reportable Segment"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails",
      "http://www.recursion.com/role/SubsequentEventsDetails",
      "http://www.recursion.com/role/SupplementalFinancialInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Domain]",
        "label": "Counterparty Name [Domain]"
       }
      }
     },
     "auth_ref": [
      "r144",
      "r151",
      "r152",
      "r294",
      "r312",
      "r559",
      "r568",
      "r619",
      "r785",
      "r786",
      "r787",
      "r1012",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1017",
      "r1018",
      "r1019",
      "r1020",
      "r1182",
      "r1183",
      "r1184",
      "r1185"
     ]
    },
    "us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquired IPR&amp;D",
        "label": "Research and Development Asset Acquired in Transaction Other than Business Combination or Joint Venture Formation, Writeoff",
        "documentation": "Amount of writeoff for research and development asset acquired in transaction other than business combination or from joint venture formation or both."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r255",
      "r778",
      "r1164"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "label": "Research and Development Expense",
        "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r389",
      "r778",
      "r790",
      "r791",
      "r805",
      "r1210"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "label": "Research and Development Expense [Member]",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_ResearchMilestonesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "ResearchMilestonesMember",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research Milestones",
        "label": "Research Milestones [Member]",
        "documentation": "Research Milestones"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date:",
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r921",
      "r931",
      "r941",
      "r973"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date",
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r922",
      "r932",
      "r942",
      "r974"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement does not require Recovery",
        "label": "Restatement Does Not Require Recovery [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r929",
      "r939",
      "r949",
      "r981"
     ]
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents [Domain]",
        "label": "Cash and Cash Equivalents [Domain]",
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r115"
     ]
    },
    "rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "RestrictedCashAndCashEquivalentsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash",
        "label": "Restricted Cash And Cash Equivalents, Fair Value Disclosure",
        "documentation": "Restricted Cash And Cash Equivalents, Fair Value Disclosure"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestrictedCashCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestrictedCashCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash",
        "label": "Restricted Cash, Current",
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r1009",
      "r1072"
     ]
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestrictedCashNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash, non-current",
        "label": "Restricted Cash, Noncurrent",
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r1011",
      "r1072"
     ]
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.recursion.com/role/StockBasedCompensationScheduleofRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RSUs",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": [
      "r1136",
      "r1137",
      "r1138",
      "r1139",
      "r1140",
      "r1141",
      "r1142",
      "r1143",
      "r1144",
      "r1145",
      "r1146",
      "r1147",
      "r1148",
      "r1149",
      "r1150",
      "r1151",
      "r1152",
      "r1153",
      "r1154",
      "r1155",
      "r1156",
      "r1157",
      "r1158",
      "r1159",
      "r1160",
      "r1161"
     ]
    },
    "us-gaap_RestructuringAndRelatedCostExpectedCost1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestructuringAndRelatedCostExpectedCost1",
     "crdr": "debit",
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected cost",
        "label": "Restructuring and Related Cost, Expected Cost",
        "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost."
       }
      }
     },
     "auth_ref": [
      "r269",
      "r272",
      "r274",
      "r276"
     ]
    },
    "us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent",
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Workforce reduction percentage",
        "label": "Restructuring and Related Cost, Number of Positions Eliminated, Period Percent",
        "documentation": "The number of positions eliminated during the period as a percentage of total positions eliminated during the period in connection with the restructuring plan(s)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestructuringCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestructuringCharges",
     "crdr": "debit",
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofRestructuringActionsandtheRelatedAccrualDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expense",
        "label": "Restructuring Charges",
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r138",
      "r139",
      "r273",
      "r274",
      "r791",
      "r1123"
     ]
    },
    "us-gaap_RestructuringReserve": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestructuringReserve",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofRestructuringActionsandtheRelatedAccrualDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance as of December 31, 2024",
        "periodEndLabel": "Balance as of September 30, 2025",
        "label": "Restructuring Reserve",
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan."
       }
      }
     },
     "auth_ref": [
      "r270",
      "r275"
     ]
    },
    "us-gaap_RestructuringReserveRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestructuringReserveRollForward",
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofRestructuringActionsandtheRelatedAccrualDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring Reserve [Roll Forward]",
        "label": "Restructuring Reserve [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited",
      "http://www.recursion.com/role/DescriptionoftheBusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated deficit",
        "negatedLabel": "Accumulated deficit",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r84",
      "r627",
      "r663",
      "r665",
      "r674",
      "r703",
      "r886"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Deficit",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r108",
      "r109",
      "r153",
      "r154",
      "r155",
      "r157",
      "r164",
      "r166",
      "r168",
      "r229",
      "r230",
      "r263",
      "r297",
      "r385",
      "r402",
      "r403",
      "r410",
      "r411",
      "r412",
      "r414",
      "r478",
      "r479",
      "r493",
      "r495",
      "r496",
      "r498",
      "r504",
      "r543",
      "r545",
      "r660",
      "r662",
      "r676",
      "r1244"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited",
      "http://www.recursion.com/role/SegmentInformationScheduleofRevenueandLongLivedAssetsBasedonGeographicAreasDetails",
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "netLabel": "Total revenue",
        "verboseLabel": "Revenue",
        "terseLabel": "Revenue",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r96",
      "r182",
      "r194",
      "r195",
      "r209",
      "r215",
      "r218",
      "r220",
      "r222",
      "r330",
      "r331",
      "r332",
      "r571",
      "r790",
      "r794"
     ]
    },
    "rxrx_RevenuePerformanceObligationNumberOfObligations": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "RevenuePerformanceObligationNumberOfObligations",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of performance obligations under the agreement (in performance obligations)",
        "label": "Revenue, Performance Obligation, Number Of Obligations",
        "documentation": "Revenue, Performance Obligation, Number Of Obligations"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenueRemainingPerformanceObligation",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remaining performance obligation revenue",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue."
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "rxrx_RevenueRemainingPerformanceObligationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "RevenueRemainingPerformanceObligationAxis",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue, Remaining Performance Obligation [Axis]",
        "label": "Revenue, Remaining Performance Obligation [Axis]",
        "documentation": "Revenue, Remaining Performance Obligation"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_RevenueRemainingPerformanceObligationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "RevenueRemainingPerformanceObligationDomain",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue, Remaining Performance Obligation [Domain]",
        "label": "Revenue, Remaining Performance Obligation [Domain]",
        "documentation": "Revenue, Remaining Performance Obligation [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of projects that may be initiated",
        "label": "Revenue, Remaining Performance Obligation, Number Of Projects That May Be Initiated",
        "documentation": "Revenue, Remaining Performance Obligation, Number Of Projects That May Be Initiated"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_RevenueRemainingPerformanceObligationVariableConsiderationAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "RevenueRemainingPerformanceObligationVariableConsiderationAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research project, fees and milestones payments receivable for an option on a lead series",
        "label": "Revenue, Remaining Performance Obligation, Variable Consideration Amount",
        "documentation": "Revenue, Remaining Performance Obligation, Variable Consideration Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenuesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenuesAbstract",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue",
        "label": "Revenues [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "presentation": [
      "http://www.recursion.com/role/SegmentInformationScheduleofRevenueandLongLivedAssetsBasedonGeographicAreasDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenues from External Customers and Long-Lived Assets [Line Items]",
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract",
     "presentation": [
      "http://www.recursion.com/role/LeasesScheduleofSupplementalCashFlowInformationRelatedtoLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use assets additions, modifications and termination:",
        "label": "Right-Of-Use Assets Obtained In Exchange For Lease Liabilities [Abstract]",
        "documentation": "Right-Of-Use Assets Obtained In Exchange For Lease Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_RocheAndGenentechMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "RocheAndGenentechMember",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails",
      "http://www.recursion.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Roche and Genentech",
        "label": "Roche and Genentech [Member]",
        "documentation": "Roche and Genentech"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Adopted",
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r990"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Terminated",
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r990"
     ]
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "crdr": "debit",
     "presentation": [
      "http://www.recursion.com/role/CommonStockAtTheMarketOfferingNarrativeDetails",
      "http://www.recursion.com/role/CommonStockPublicOfferingofCommonStockNarrativeDetails",
      "http://www.recursion.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net proceeds received",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "documentation": "Cash received on stock transaction after deduction of issuance costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://www.recursion.com/role/CommonStockAtTheMarketOfferingNarrativeDetails",
      "http://www.recursion.com/role/CommonStockPublicOfferingofCommonStockNarrativeDetails",
      "http://www.recursion.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock [Domain]",
        "label": "Sale of Stock [Domain]",
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "presentation": [
      "http://www.recursion.com/role/CommonStockAtTheMarketOfferingNarrativeDetails",
      "http://www.recursion.com/role/CommonStockPublicOfferingofCommonStockNarrativeDetails",
      "http://www.recursion.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares issued (in shares)",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_SaleOfStockPercentageOfCommission": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "SaleOfStockPercentageOfCommission",
     "presentation": [
      "http://www.recursion.com/role/CommonStockAtTheMarketOfferingNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of stock, percentage of commission",
        "label": "Sale Of Stock, Percentage Of Commission",
        "documentation": "Sale Of Stock, Percentage Of Commission"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockPricePerShare",
     "presentation": [
      "http://www.recursion.com/role/CommonStockPublicOfferingofCommonStockNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Price per share (in dollars per share)",
        "label": "Sale of Stock, Price Per Share",
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_SaleOfStockUnderwritersOptionPeriodFromTheDateOfTheAgreement": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "SaleOfStockUnderwritersOptionPeriodFromTheDateOfTheAgreement",
     "presentation": [
      "http://www.recursion.com/role/CommonStockPublicOfferingofCommonStockNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of stock, underwriters option period from the date of the agreement",
        "label": "Sale Of Stock, Underwriters Option Period From The Date Of The Agreement",
        "documentation": "Sale Of Stock, Underwriters Option Period From The Date Of The Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_SaleOfStockValueAuthorized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "SaleOfStockValueAuthorized",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/CommonStockAtTheMarketOfferingNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of stock, value authorized",
        "label": "Sale Of Stock, Value, Authorized",
        "documentation": "Sale Of Stock, Value, Authorized"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_SaleOfStockValueRemainingAuthorized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "SaleOfStockValueRemainingAuthorized",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/CommonStockAtTheMarketOfferingNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of stock, value remaining authorized",
        "label": "Sale Of Stock Value Remaining Authorized",
        "documentation": "Sale Of Stock Value Remaining Authorized"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_SanofiMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "SanofiMember",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sanofi",
        "label": "Sanofi [Member]",
        "documentation": "Sanofi"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accrued Expenses and Other Liabilities",
        "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://www.recursion.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "label": "Antidilutive Security, Excluded EPS Calculation [Table]",
        "documentation": "Disclosure of information about security that could potentially dilute basic earnings per share (EPS) in future that was not included in calculation of diluted EPS."
       }
      }
     },
     "auth_ref": [
      "r178"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://www.recursion.com/role/NetLossPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Net Loss Per Share",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails",
      "http://www.recursion.com/role/AcquisitionsScheduleofFairValueofAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.recursion.com/role/AcquisitionsScheduleofProFormaFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Combination [Table]",
        "label": "Business Combination [Table]",
        "documentation": "Disclosure of information about business combination. Includes, but is not limited to, recognized asset and liability."
       }
      }
     },
     "auth_ref": [
      "r247",
      "r416",
      "r417",
      "r418",
      "r419",
      "r425",
      "r426",
      "r427",
      "r428",
      "r434",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r470",
      "r471",
      "r472",
      "r476",
      "r831",
      "r841",
      "r1171",
      "r1173",
      "r1175"
     ]
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r482"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://www.recursion.com/role/NetLossPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Computation of Basic and Diluted Net Loss Per Share",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r1084"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock-Based Compensation Expense",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment, Name [Axis]",
        "label": "Investment, Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r225",
      "r226",
      "r227",
      "r409",
      "r531",
      "r1003",
      "r1004",
      "r1005",
      "r1166",
      "r1167",
      "r1168",
      "r1169"
     ]
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r1188",
      "r1189"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "presentation": [
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Finite-Lived Intangible Assets",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment."
       }
      }
     },
     "auth_ref": [
      "r782",
      "r1112"
     ]
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfGoodwillTable",
     "presentation": [
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill [Table]",
        "label": "Goodwill [Table]",
        "documentation": "Disclosure of information about goodwill, including, but not limited to, change from acquisition, sale, impairment, and other reason."
       }
      }
     },
     "auth_ref": [
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r811"
     ]
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfGoodwillTextBlock",
     "presentation": [
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Goodwill",
        "label": "Schedule of Goodwill [Table Text Block]",
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule."
       }
      }
     },
     "auth_ref": [
      "r811",
      "r1094",
      "r1095",
      "r1096",
      "r1097",
      "r1098",
      "r1099",
      "r1100",
      "r1101",
      "r1102",
      "r1103",
      "r1104"
     ]
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
     "presentation": [
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Indefinite-Lived Intangible Assets",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]",
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment."
       }
      }
     },
     "auth_ref": [
      "r782",
      "r1114"
     ]
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Table]",
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r554"
     ]
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Fair Value of Assets Acquired and Liabilities Assumed",
        "label": "Business Combination, Recognized Asset Acquired and Liability Assumed [Table Text Block]",
        "documentation": "Tabular disclosure of asset acquired and liability assumed in business combination and recognized at acquisition date."
       }
      }
     },
     "auth_ref": [
      "r1174",
      "r1176"
     ]
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Restructuring Actions and the Related Accrual",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r78",
      "r79"
     ]
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
     "presentation": [
      "http://www.recursion.com/role/SegmentInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Long-Lived Assets Based on Geographic Areas",
        "label": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]",
        "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r61"
     ]
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "presentation": [
      "http://www.recursion.com/role/SegmentInformationScheduleofRevenueandLongLivedAssetsBasedonGeographicAreasDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "documentation": "Disclosure of information about revenue from external customer and long-lived asset by geographical area. Long-lived asset excludes financial instrument, customer relationship with financial institution, mortgage and other servicing right, deferred policy acquisition cost, and deferred tax asset."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r61"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "presentation": [
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "documentation": "Disclosure of information about profit (loss) and total assets by reportable segment."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r29",
      "r30"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://www.recursion.com/role/SegmentInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Net Loss and Reconciliations of Segment Operating Loss to Loss Before Income Tax Benefit",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r29",
      "r30"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.recursion.com/role/StockBasedCompensationScheduleofRSUActivityDetails",
      "http://www.recursion.com/role/StockBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoCalculateGrantDateFairValueofStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r349",
      "r351",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r384"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock Option Activity",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r12",
      "r85"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Weighted-Average Assumptions Used to Calculate Grant-Date Fair Value of Stock Options",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfStockByClassTable",
     "presentation": [
      "http://www.recursion.com/role/CommonStockAtTheMarketOfferingNarrativeDetails",
      "http://www.recursion.com/role/CommonStockClassAandBCommonSharesAuthorizationNarrativeDetails",
      "http://www.recursion.com/role/CommonStockNarrativeDetails",
      "http://www.recursion.com/role/CommonStockPublicOfferingofCommonStockNarrativeDetails",
      "http://www.recursion.com/role/CommonStockRegistrationRightsAgreementsNarrativeDetails",
      "http://www.recursion.com/role/CommonStockValenceAcquisitionExchangeableSharesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock by Class [Table]",
        "label": "Stock, Class of Stock [Table]",
        "documentation": "Disclosure of information about stock by class. Includes, but is not limited to, common, convertible, and preferred stocks."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r82",
      "r83",
      "r84",
      "r120",
      "r121",
      "r122",
      "r184",
      "r310",
      "r311",
      "r312",
      "r314",
      "r317",
      "r322",
      "r324",
      "r492",
      "r670",
      "r671",
      "r672",
      "r673",
      "r816",
      "r1001",
      "r1075",
      "r1076"
     ]
    },
    "rxrx_SchrodingerLeasesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "SchrodingerLeasesMember",
     "presentation": [
      "http://www.recursion.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schrodinger Leases",
        "label": "Schrodinger Leases [Member]",
        "documentation": "Schrodinger Leases"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r915"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r917"
     ]
    },
    "us-gaap_SegmentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentDomain",
     "presentation": [
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Domain]",
        "label": "Segments [Domain]",
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r96",
      "r97",
      "r98",
      "r182",
      "r190",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r215",
      "r216",
      "r217",
      "r222",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r262",
      "r272",
      "r276",
      "r469",
      "r472",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r802",
      "r805",
      "r806",
      "r811",
      "r899",
      "r1211",
      "r1213",
      "r1214",
      "r1215",
      "r1216",
      "r1217",
      "r1218",
      "r1219",
      "r1220",
      "r1221",
      "r1222",
      "r1223",
      "r1224",
      "r1225",
      "r1226",
      "r1227",
      "r1228",
      "r1229",
      "r1230",
      "r1231",
      "r1232",
      "r1233",
      "r1234",
      "r1235",
      "r1236",
      "r1237",
      "r1238",
      "r1239",
      "r1240"
     ]
    },
    "us-gaap_SegmentExpenditureAdditionToLongLivedAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentExpenditureAdditionToLongLivedAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total expenditures for additions to long-lived assets",
        "label": "Segment, Expenditure, Addition to Long-Lived Assets",
        "documentation": "Amount of expenditure for addition to long-lived assets included in determination of segment assets by chief operating decision maker (CODM) or otherwise regularly provided to CODM. Excludes expenditure for addition to financial instrument, long-term customer relationship of financial institution, mortgage and other servicing rights, deferred policy acquisition cost, and deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r182",
      "r204",
      "r215",
      "r805",
      "r806"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://www.recursion.com/role/SegmentInformationScheduleofRevenueandLongLivedAssetsBasedonGeographicAreasDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Domain]",
        "label": "Geographical [Domain]"
       }
      }
     },
     "auth_ref": [
      "r187",
      "r220",
      "r221",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r613",
      "r614",
      "r615",
      "r616",
      "r689",
      "r690",
      "r691",
      "r747",
      "r749",
      "r752",
      "r754",
      "r761",
      "r763",
      "r764",
      "r765",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r781",
      "r796",
      "r817",
      "r819",
      "r887",
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r898",
      "r906",
      "r1211",
      "r1213",
      "r1214",
      "r1216",
      "r1217",
      "r1218",
      "r1219",
      "r1220",
      "r1221",
      "r1222",
      "r1223",
      "r1224",
      "r1225",
      "r1226",
      "r1227",
      "r1228",
      "r1229",
      "r1230",
      "r1231",
      "r1232",
      "r1233",
      "r1234",
      "r1235",
      "r1236",
      "r1237",
      "r1238",
      "r1239",
      "r1240"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://www.recursion.com/role/SegmentInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Information",
        "label": "Segment Reporting Disclosure [Text Block]",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r98",
      "r182",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r205",
      "r207",
      "r208",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r222",
      "r801",
      "r803",
      "r804",
      "r805",
      "r807",
      "r808",
      "r809"
     ]
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingInformationLineItems",
     "presentation": [
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting Information [Line Items]",
        "label": "Segment Reporting Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingOtherItemAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingOtherItemAmount",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other segment items",
        "label": "Segment Reporting, Other Segment Item, Amount",
        "documentation": "Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss)."
       }
      }
     },
     "auth_ref": [
      "r182",
      "r207",
      "r208",
      "r215",
      "r805"
     ]
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock options, vesting period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r828"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Forfeited (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r369"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forfeited (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event."
       }
      }
     },
     "auth_ref": [
      "r369"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r367"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r367"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance, (in shares)",
        "periodEndLabel": "Ending balance, (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r364",
      "r365"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance, (in dollars per share)",
        "periodEndLabel": "Ending balance, (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r364",
      "r365"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average grant date fair value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Vested (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r368"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "crdr": "debit",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair market value of vested shares",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash."
       }
      }
     },
     "auth_ref": [
      "r371"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement."
       }
      }
     },
     "auth_ref": [
      "r368"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoCalculateGrantDateFairValueofStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected dividend yield",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r377"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoCalculateGrantDateFairValueofStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected volatility",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r376"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoCalculateGrantDateFairValueofStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk-free interest rate",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r378"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.recursion.com/role/StockBasedCompensationScheduleofRSUActivityDetails",
      "http://www.recursion.com/role/StockBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoCalculateGrantDateFairValueofStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r349",
      "r351",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r384"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock units",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares available for grant (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r358"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r358"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise, intrinsic value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares."
       }
      }
     },
     "auth_ref": [
      "r371"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Cancelled (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r362"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r360"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options granted in period, weighted average grant date fair value (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r370"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options, outstanding, intrinsic value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance (in shares)",
        "periodEndLabel": "Ending balance (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r356",
      "r357"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance (in dollars per share)",
        "periodEndLabel": "Ending balance (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r356",
      "r357"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-Average Exercise Price",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.recursion.com/role/StockBasedCompensationScheduleofRSUActivityDetails",
      "http://www.recursion.com/role/StockBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoCalculateGrantDateFairValueofStockOptionsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Domain]",
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercised (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r361"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cancelled (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r362"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r360"
     ]
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharePrice",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share price (in dollars per share)",
        "label": "Share Price",
        "documentation": "Price of a single share of a number of saleable stocks of a company."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock options, expiration period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r829"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoCalculateGrantDateFairValueofStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected term (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r375"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "crdr": "debit",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise, intrinsic value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options, exercisable, weighted average remaining contractual life",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options, outstanding, weighted average remaining contractual life",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "rxrx_SignificantSegmentExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "SignificantSegmentExpensesAbstract",
     "presentation": [
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Significant segment expenses",
        "label": "Significant Segment Expenses [Abstract]",
        "documentation": "Significant Segment Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementBusinessSegmentsAxis",
     "presentation": [
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Axis]",
        "label": "Segments [Axis]",
        "documentation": "Information by business segments."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r96",
      "r97",
      "r98",
      "r110",
      "r182",
      "r190",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r215",
      "r216",
      "r217",
      "r222",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r262",
      "r265",
      "r272",
      "r276",
      "r469",
      "r472",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r802",
      "r805",
      "r806",
      "r811",
      "r899",
      "r1211",
      "r1213",
      "r1214",
      "r1215",
      "r1216",
      "r1217",
      "r1218",
      "r1219",
      "r1220",
      "r1221",
      "r1222",
      "r1223",
      "r1224",
      "r1225",
      "r1226",
      "r1227",
      "r1228",
      "r1229",
      "r1230",
      "r1231",
      "r1232",
      "r1233",
      "r1234",
      "r1235",
      "r1236",
      "r1237",
      "r1238",
      "r1239",
      "r1240"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails",
      "http://www.recursion.com/role/CommonStockAtTheMarketOfferingNarrativeDetails",
      "http://www.recursion.com/role/CommonStockClassAandBCommonSharesAuthorizationNarrativeDetails",
      "http://www.recursion.com/role/CommonStockNarrativeDetails",
      "http://www.recursion.com/role/CommonStockPublicOfferingofCommonStockNarrativeDetails",
      "http://www.recursion.com/role/CommonStockValenceAcquisitionExchangeableSharesNarrativeDetails",
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical",
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Axis]",
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r120",
      "r121",
      "r122",
      "r144",
      "r146",
      "r172",
      "r173",
      "r175",
      "r177",
      "r184",
      "r185",
      "r228",
      "r285",
      "r287",
      "r288",
      "r289",
      "r292",
      "r293",
      "r299",
      "r300",
      "r302",
      "r303",
      "r305",
      "r307",
      "r310",
      "r311",
      "r314",
      "r317",
      "r324",
      "r531",
      "r670",
      "r671",
      "r672",
      "r673",
      "r676",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r702",
      "r722",
      "r740",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r1001",
      "r1076",
      "r1077",
      "r1083"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components [Axis]",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r54",
      "r57",
      "r58",
      "r107",
      "r108",
      "r109",
      "r132",
      "r133",
      "r134",
      "r153",
      "r154",
      "r155",
      "r157",
      "r164",
      "r166",
      "r168",
      "r183",
      "r229",
      "r230",
      "r263",
      "r297",
      "r325",
      "r385",
      "r402",
      "r403",
      "r410",
      "r411",
      "r412",
      "r414",
      "r478",
      "r479",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r504",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r543",
      "r545",
      "r556",
      "r633",
      "r660",
      "r661",
      "r662",
      "r676",
      "r740"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://www.recursion.com/role/SegmentInformationScheduleofRevenueandLongLivedAssetsBasedonGeographicAreasDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Axis]",
        "label": "Geographical [Axis]"
       }
      }
     },
     "auth_ref": [
      "r187",
      "r220",
      "r221",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r613",
      "r614",
      "r615",
      "r616",
      "r689",
      "r690",
      "r691",
      "r747",
      "r749",
      "r752",
      "r754",
      "r761",
      "r763",
      "r764",
      "r765",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r781",
      "r796",
      "r817",
      "r819",
      "r887",
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r898",
      "r906",
      "r1211",
      "r1213",
      "r1214",
      "r1216",
      "r1217",
      "r1218",
      "r1219",
      "r1220",
      "r1221",
      "r1222",
      "r1223",
      "r1224",
      "r1225",
      "r1226",
      "r1227",
      "r1228",
      "r1229",
      "r1230",
      "r1231",
      "r1232",
      "r1233",
      "r1234",
      "r1235",
      "r1236",
      "r1237",
      "r1238",
      "r1239",
      "r1240"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical",
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited",
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r154",
      "r155",
      "r183",
      "r299",
      "r300",
      "r302",
      "r305",
      "r545",
      "r571",
      "r669",
      "r677",
      "r688",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r702",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r723",
      "r724",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r740",
      "r792",
      "r794",
      "r907",
      "r1243"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementTable",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical",
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited",
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Presentation of information about comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r154",
      "r155",
      "r183",
      "r223",
      "r299",
      "r300",
      "r302",
      "r305",
      "r545",
      "r571",
      "r669",
      "r677",
      "r688",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r702",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r723",
      "r724",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r740",
      "r792",
      "r794",
      "r907",
      "r1243"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Price or TSR Estimation Method",
        "label": "Stock Price or TSR Estimation Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r924",
      "r934",
      "r944",
      "r976"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": [
      "r1136",
      "r1137",
      "r1138",
      "r1139",
      "r1140",
      "r1141",
      "r1142",
      "r1143",
      "r1144",
      "r1145",
      "r1146",
      "r1147",
      "r1148",
      "r1149",
      "r1150",
      "r1151",
      "r1152",
      "r1153",
      "r1154",
      "r1155",
      "r1156",
      "r1157",
      "r1158",
      "r1159",
      "r1160",
      "r1161"
     ]
    },
    "us-gaap_StockCompensationPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockCompensationPlanMember",
     "presentation": [
      "http://www.recursion.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock based compensation",
        "label": "Share-Based Payment Arrangement [Member]",
        "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares."
       }
      }
     },
     "auth_ref": [
      "r1085"
     ]
    },
    "us-gaap_StockIssued1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssued1",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of shares for the acquisition of an asset",
        "label": "Stock Issued",
        "documentation": "The fair value of stock issued in noncash financing activities."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r25",
      "r26"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class A shares issued for asset acquisition (in shares)",
        "label": "Stock Issued During Period, Shares, Acquisitions",
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r54",
      "r84"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "presentation": [
      "http://www.recursion.com/role/CommonStockValenceAcquisitionExchangeableSharesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issued in the period, upon conversion (in shares)",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r37",
      "r54",
      "r57",
      "r84",
      "r296"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock sales issuances, net of issuance costs (in shares)",
        "label": "Stock Issued During Period, Shares, New Issues",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r53",
      "r54",
      "r84",
      "r670",
      "r740",
      "r756"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock option exercises and other (in shares)",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r53",
      "r54",
      "r84"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Exercised (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r53",
      "r54",
      "r84",
      "r361"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class A shares issued for asset acquisition",
        "label": "Stock Issued During Period, Value, Acquisitions",
        "documentation": "Value of stock issued pursuant to acquisitions during the period."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r54",
      "r57",
      "r58",
      "r84"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock sales issuances, net of issuance costs",
        "label": "Stock Issued During Period, Value, New Issues",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r53",
      "r54",
      "r84",
      "r676",
      "r740",
      "r756",
      "r913"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock option exercises and other",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r53",
      "r54",
      "r84"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited",
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total stockholders\u2019 equity",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r57",
      "r58",
      "r76",
      "r704",
      "r720",
      "r741",
      "r742",
      "r886",
      "r914",
      "r1075",
      "r1077",
      "r1078",
      "r1092",
      "r1196",
      "r1244"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders\u2019 equity",
        "label": "Equity, Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://www.recursion.com/role/CommonStock"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock",
        "label": "Equity [Text Block]",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r309",
      "r311",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r323",
      "r325",
      "r492",
      "r503",
      "r743",
      "r744",
      "r760"
     ]
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://www.recursion.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Line Items]",
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r542",
      "r561"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://www.recursion.com/role/CommitmentsandContingenciesDetails",
      "http://www.recursion.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event",
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r542",
      "r561"
     ]
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://www.recursion.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Table]",
        "label": "Subsequent Event [Table]",
        "documentation": "Disclosure of information about significant event or transaction occurring between statement of financial position date and date when financial statements were issued."
       }
      }
     },
     "auth_ref": [
      "r542",
      "r561"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://www.recursion.com/role/CommitmentsandContingenciesDetails",
      "http://www.recursion.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Axis]",
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r542",
      "r561"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://www.recursion.com/role/CommitmentsandContingenciesDetails",
      "http://www.recursion.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Domain]",
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r542",
      "r561"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://www.recursion.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Events",
        "label": "Subsequent Events [Text Block]",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r560",
      "r562"
     ]
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://www.recursion.com/role/CommonStockAtTheMarketOfferingNarrativeDetails",
      "http://www.recursion.com/role/CommonStockPublicOfferingofCommonStockNarrativeDetails",
      "http://www.recursion.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock [Axis]",
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_SupplementalAssetInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "SupplementalAssetInformationAbstract",
     "presentation": [
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental asset information",
        "label": "Supplemental Asset Information [Abstract]",
        "documentation": "Supplemental Asset Information"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_SupplementalBalanceSheetAndIncomeStatementInformationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "SupplementalBalanceSheetAndIncomeStatementInformationTextBlock",
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental Financial Information",
        "label": "Supplemental Balance Sheet And Income Statement Information [Text Block]",
        "documentation": "Supplemental Balance Sheet And Income Statement Information"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_SupplementalFinancialInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "SupplementalFinancialInformationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Financial Information [Abstract]",
        "documentation": "Supplemental Financial Information"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tabular List, Table",
        "label": "Tabular List [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r970"
     ]
    },
    "us-gaap_TangibleAssetImpairmentCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TangibleAssetImpairmentCharges",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset impairment",
        "label": "Tangible Asset Impairment Charges",
        "documentation": "The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r77"
     ]
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails",
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Definite-lived technology intangible assets",
        "label": "Technology-Based Intangible Assets [Member]",
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights."
       }
      }
     },
     "auth_ref": [
      "r865",
      "r1106",
      "r1107",
      "r1108",
      "r1109",
      "r1111",
      "r1113",
      "r1115",
      "r1116"
     ]
    },
    "rxrx_TempusAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "TempusAgreementMember",
     "presentation": [
      "http://www.recursion.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tempus agreement",
        "label": "Tempus Agreement [Member]",
        "documentation": "Tempus Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_TempusLabsIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "TempusLabsIncMember",
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tempus Labs, Inc",
        "label": "Tempus Labs, Inc [Member]",
        "documentation": "Tempus Labs, Inc"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_TerminationOfLeaseFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "TerminationOfLeaseFee",
     "crdr": "debit",
     "presentation": [
      "http://www.recursion.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination of lease fee",
        "label": "Termination Of Lease Fee",
        "documentation": "Termination Of Lease Fee"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Amount",
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r962"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Vs Peer Group",
        "label": "Total Shareholder Return Vs Peer Group [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r969"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangement:",
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r989"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangements, by Individual",
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r991"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adoption Date",
        "label": "Trading Arrangement Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r992"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Arrangement Duration",
        "label": "Trading Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r993"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration Date",
        "label": "Trading Arrangement Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r993"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r991"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title",
        "label": "Trading Arrangement, Individual Title"
       }
      }
     },
     "auth_ref": [
      "r991"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Available",
        "label": "Trading Arrangement, Securities Aggregate Available Amount"
       }
      }
     },
     "auth_ref": [
      "r994"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination Date",
        "label": "Trading Arrangement Termination Date"
       }
      }
     },
     "auth_ref": [
      "r992"
     ]
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails",
      "http://www.recursion.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r482"
     ]
    },
    "country_US": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2025",
     "localname": "US",
     "presentation": [
      "http://www.recursion.com/role/SegmentInformationScheduleofRevenueandLongLivedAssetsBasedonGeographicAreasDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "United States",
        "label": "UNITED STATES"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Security Market Price Change",
        "label": "Underlying Security Market Price Change, Percent"
       }
      }
     },
     "auth_ref": [
      "r988"
     ]
    },
    "rxrx_ValenceDiscoveryIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "ValenceDiscoveryIncMember",
     "presentation": [
      "http://www.recursion.com/role/CommonStockRegistrationRightsAgreementsNarrativeDetails",
      "http://www.recursion.com/role/CommonStockValenceAcquisitionExchangeableSharesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Valence Discovery Inc",
        "label": "Valence Discovery Inc [Member]",
        "documentation": "Valence Discovery Inc"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_ViennaFacilitiesOfExscientiaGmbHMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20250930",
     "localname": "ViennaFacilitiesOfExscientiaGmbHMember",
     "presentation": [
      "http://www.recursion.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vienna facilities of Exscientia GmbH",
        "label": "Vienna Facilities Of Exscientia GmbH [Member]",
        "documentation": "Vienna Facilities Of Exscientia GmbH"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year",
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r958"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited",
      "http://www.recursion.com/role/NetLossPerShareScheduleofComputationofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted-average shares (Class A, B and Exchangeable) outstanding, diluted (in shares)",
        "terseLabel": "Weighted average common shares outstanding, diluted (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r171",
      "r177"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "presentation": [
      "http://www.recursion.com/role/NetLossPerShareScheduleofComputationofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Denominator:",
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited",
      "http://www.recursion.com/role/NetLossPerShareScheduleofComputationofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted-average shares (Class A, B and Exchangeable) outstanding, basic (in shares)",
        "terseLabel": "Weighted average common shares outstanding, basic (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r170",
      "r177"
     ]
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested",
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r956"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "SubTopic": "405",
   "Topic": "942",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477787/942-405-45-2"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-20"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-5"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2A"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Subparagraph": "(c)",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-4"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "420",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-5"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481142/505-10-45-2"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-10"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-4"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-5"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-2"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-1"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479024/942-230-45-1"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "SubTopic": "210",
   "Topic": "954",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477220/954-210-45-5"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "808",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/808/tableOfContent"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5C",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5C"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/260/tableOfContent"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-2"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26A"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481664/323-10-45-1"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482955/340-10-05-5"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483032/340-10-45-1"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480265/350-10-S45-1"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-1"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-2"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1A"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-4"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-6"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-2"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3A"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3A"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-1"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.b.1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.b.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-3"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-1"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-2"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-3"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-1"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-2"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-3"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3A",
   "Subparagraph": "(24)(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-1"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-2"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-3"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-11"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-7"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "17",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480336/718-10-65-17"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479983/718-10-S45-1"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483041/730-20-50-1"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-4"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-6"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10B"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478758/740-323-25-1"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/805-10/tableOfContent"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-4"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-5"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-7"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/805-20/tableOfContent"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-2"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-3"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4A"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4A"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4A"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/805-30/tableOfContent"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-2"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-3"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479326/805-40-45-1"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1B"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4F"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8A"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482736/825-10-45-2"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-30"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-32"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482804/825-20-50-1"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/842-20/tableOfContent"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-9"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478345/912-310-45-11"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483154/926-20-50-5"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "340",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478859/928-340-50-1"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478934/932-220-50-1"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-19"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-20"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-20"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-28"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-28"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-6"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-7"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "280",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478657/932-280-50-1"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478988/932-323-50-1"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "940",
   "SubTopic": "820",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478119/940-820-50-1"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(14)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478671/942-235-S50-1"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477617/942-740-50-1"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column J))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column K))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478822/944-740-50-1"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "805",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478072/944-805-50-1"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-6"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-2"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478322/948-310-S50-2"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-10"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "40",
   "SubTopic": "30",
   "Topic": "350",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482640/350-30-55-40"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-16"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-21"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-12"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-11"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-14"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-18"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-21"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-24"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-4"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-18"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-2"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-4"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482395/460-10-55-27"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "64",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481620/480-10-55-64"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-8"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-29"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-29"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-38"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "39",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-39"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-41"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-42"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "43",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-43"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "45",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-45"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "46",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-46"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-47"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-49"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-50"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-29"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-29"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-2"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479908/805-50-55-1"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478064/805-740-55-13"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "182",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-182"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "184",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-184"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-12"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-17"
  },
  "r888": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-21"
  },
  "r889": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-29"
  },
  "r890": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-3"
  },
  "r891": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-2"
  },
  "r892": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-4"
  },
  "r893": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-5"
  },
  "r894": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-6"
  },
  "r895": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2"
  },
  "r896": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r897": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r898": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r899": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r900": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E"
  },
  "r901": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-11"
  },
  "r902": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-14"
  },
  "r903": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18"
  },
  "r904": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r905": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r906": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r907": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r908": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r909": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r910": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r911": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r912": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r913": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r914": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r915": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r916": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r917": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r918": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r919": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r920": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r921": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r922": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r923": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r924": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r925": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r926": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r927": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r928": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r929": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r930": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r931": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r932": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r933": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r934": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r935": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r936": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r937": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r938": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r939": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r940": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r941": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r942": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r943": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r944": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r945": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r946": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r947": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r948": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r949": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r950": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r951": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r952": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r953": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r954": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r955": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r956": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r957": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r958": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r959": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r960": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r961": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r962": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r963": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r964": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r965": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r966": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r967": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r968": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r969": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r970": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r971": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r972": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r973": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r974": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r975": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r976": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r977": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r978": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r979": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r980": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r981": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r982": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r983": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r984": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r985": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r986": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r987": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r988": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r989": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r990": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r991": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r992": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r993": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r994": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r995": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r996": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r997": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r998": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r999": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-10"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "SubTopic": "10",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(3)",
   "SubTopic": "10",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-10"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-12"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(m)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(m)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(o)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(p)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(q)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(r)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(s)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(t)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(u)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-30"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-31"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-32"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-33"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r1067": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r1068": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r1069": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r1070": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r1071": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r1072": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r1073": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r1074": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r1075": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r1076": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1077": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1078": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1079": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r1080": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r1081": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r1082": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r1083": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r1084": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r1085": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r1086": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r1087": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r1088": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r1089": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1090": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1091": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r1092": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r1093": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-20/tableOfContent"
  },
  "r1094": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1095": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1096": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1097": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1098": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1099": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1100": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1101": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1102": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1103": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1A"
  },
  "r1104": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2"
  },
  "r1105": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-30/tableOfContent"
  },
  "r1106": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r1107": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1108": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1109": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1110": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1111": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1112": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1113": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1114": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1115": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1116": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1117": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r1118": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r1119": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1120": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1121": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1122": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r1123": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482047/420-10-45-3"
  },
  "r1124": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r1125": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r1126": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r1127": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r1128": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r1129": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1130": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1131": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r1132": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r1133": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r1134": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1135": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r1136": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1137": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1138": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1139": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1140": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1141": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1142": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1143": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1144": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1145": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1146": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1147": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1148": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1149": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1150": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1151": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1152": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1153": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1154": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1155": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1156": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1157": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1158": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1159": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1160": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1161": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1162": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1163": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1164": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r1165": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "730",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483041/730-20-50-1"
  },
  "r1166": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1167": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1168": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1169": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1170": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r1171": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r1172": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r1173": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r1174": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r1175": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r1176": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-2"
  },
  "r1177": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4"
  },
  "r1178": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "15",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480123/805-50-15-3"
  },
  "r1179": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480060/805-50-25-1"
  },
  "r1180": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480027/805-50-30-1"
  },
  "r1181": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480027/805-50-30-2"
  },
  "r1182": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-7A"
  },
  "r1183": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r1184": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r1185": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r1186": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r1187": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r1188": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1189": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1190": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1191": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1192": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1193": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r1194": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r1195": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-13"
  },
  "r1196": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r1197": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-4"
  },
  "r1198": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r1199": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r1200": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r1201": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r1202": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1203": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1204": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1205": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1206": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1207": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1208": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1209": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1210": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1"
  },
  "r1211": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r1212": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1213": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1214": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1215": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r1216": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r1217": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r1218": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1219": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1220": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1221": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1222": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1223": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1224": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1225": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1226": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1227": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1228": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1229": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1230": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1231": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1232": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1233": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1234": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1235": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1236": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1237": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1238": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1239": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1240": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1241": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r1242": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1243": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r1244": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1245": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>88
<FILENAME>0001601830-25-000166-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001601830-25-000166-xbrl.zip
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MV%+'4(CS=B94E)'WTBUY2BEO*4;$>D^/WQ2$P9$FYH4N9#+MD <PK<)R2**
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MWQ $2!/4ZN#N\J ?+P_.@MH=N[KL7PT>'Q[TA^NQL[AWNS\T\+6L7AV-CAY
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MEVE:LV_U6\V.T;$,H]\G_8XIVY>MOF528@YTI:,8W8%FME5[8)C];JNCJ^;
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M'@GP=7='CZW3JL0%#R6V>]J:\-,*.-)'*)AM"Z>N1LCBS@/$3AG7. F$!F,
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M0NS7AM[(+AH3VP:[_E(;OTGJ(HA<.EC=D3]N[ !D?&MV!RS"#R[_HE+\]_,
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M0N853=$VC^"?E&7SIW:%P&=)EILW"+)RQVG,<"ZTG%[GO4Q/XVAZ3(2G0'[
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M-U2>\/KTZJ2N^"<;13]GG>*-K. G]4_>W=*0NG:2=#Y7PI \8PY^*2-A<@4
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MFK7<O%E#XKU0@@P'BF?DX^I\ZX<L]4GH6$EO8L>-(VH7C=J=DT%3;,NU,VA
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MJQF$B]OTK49/ETW@EVYG=1J0B* <71L)F/)@/Q=GL3F%U :%I,BZ*OA+\)>
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MB44\OQ:"L30!M,#;EF'?QR> 4RXVRX*-&*)B\2HV#Y3:.+%A2X.QTZ]%VTN
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M&[O$ #[RW2)R0GOA65C=Z)J\M)?Z-*A^&)[E\S8"D>7U0?]A2U"Z###REU[
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MF9A1AV/-Y&0C/NDI$%-AQ+0EG)S]$QC#9,K:$$YR"6OZ92\X2$,I?_*AJCD
MD+'*H]W\E&#E/J]=2U2&8O'3-WK>W>R[Z!@-OCCVPG;QU]\)G +^--7<%V+C
M2H;%MNY\'.)OF?G!04B[$BC,=LB1F/@LX?2N]QB1/*BPYR\"E G_WLFWJ_<[
MW8NK22OO8L3MZH@G,J>1YW&[<\&MZH2]*<8<P@TC"HA/@ 0Q] *24@RC/64N
MF]EA"O0I-WQ9S+WD YJR$!)R,I4*EYH:335H%>,T!,G $@F\\!L? T9+O+:
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MC> )VLQV#==$' V'&0%3'JP$!K1G#B+B1!8'U1&0)7Q*NMCC.\<+@O?T^8J
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M3UR\\1[\@DY8I87)BT+L;4*C-WO!04;6P;ZU=X*^DQ\+@L:F*^U/H%IX_/_
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MX.HRE)ZX4WRPQ)BE[\.S5N@PH<\4P[QBT"Q96.*I8N!U%OD"T&J&'Y:'"9]
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M4B^H?^ L7T+!PKI-&$.+FT?1K]U-03P9Z=%PIYA7L%:2W7++ST6UZ,"91GY
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M>X;T8?OJPT"@2/5-)"1'_QCHAP-9(_60UO8<_*LB:KAAE+P0=3T\T0X=+IN
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M.,!#STL07 \&F,4VJ9JQ8->?ZM_U9*==YW<&C-G)#Q"AC07*SK"_TW%$R4D
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MO3R,Y.XL[T9K D-9>7=/(7F0&NL%'T:%>L-UB# \MH_QH"?#YAV&*.E%#79
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M<&L_QFU5J_=*T$QMER<T>24.K\'24Z7-ZH(D7<#+#6<E6]%(J:FX(EB38Z$
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M?!;(9X&\ES-4#T.DG:%.56]HU*%!);WA81"1CB>;MT!FP7_C-=EN1.>]&==
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M[].*!TT1('BU9A31EF6/UK:DE>1UO)\F0*!(8@0"'!S=HC\\O_W-S"I<)'B
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M&^/?L3U!2E%&B[Q<^#\A/.>!,4C?F2,_YF(#Q$@\F_/MB(73P?!(;KS1 >^
M0'0J6B!P^8-$ZCI"U%095'[&;A).J 3L/[$38$,)'P[M>)&)O*E89C@%IG9-
MSZ+CF@IU7 "K&8S\OW!8@F71B'AX+$2_CP->+$SX[;\.%0M6=B)8+;##EO(
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M<:V-MFVGTSB/709Z:C=U:J 6[>9-IZ<..P?/EY8!GJ/;.C6@6P=UT%&U,[?
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MYB[CWP!C^W;R3(&Y1.-EHA]_!)J7WL.!8<Z0E!!\<#IF!GC@=/F S0 $>##
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MQ\=Y>Y.+76"<NT04Y$&B%J6-D F %LN94]8@>*%LQA,;H\2?S9")8,\L6SL
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MOQ$("."=.RIIS<SHEO(E%_-7$V#_\CZ_%@]^BDU$&1(9^:9F$ #U*+>]X0\
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M?5S!"_+A9DV8KWK(!X=S?5W2M"I^FPG:"58SVID9!(2Q4KXS,4&I8"<''&6
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MF:!9O#@_/O]P&L,744UA)I;KG7SF4C'9+-/3SE^IH8!'2K5YHI#39 R0XW_
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M/>=. E1QEP?;\HG7GFL\+I[KJS,#%O_ GH!L@"C@A/L<CBLJ('1!3/>@&%F
MOX+MF$W8A@(T/?['S=^<[L@:,',P[K3[;6,XU@<]S1X;@]&PV^]H@_'@7_V;
M-U])-@+3O847HK3]^ROS31GR3BR%Q@R[RW$F10GB,A*XL%%3^31E'H!N3C\
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MT'5FX%T '0%:4A G[@A\%@)3,X]LUW&*XBP. [L(_'@R5:; ^ X*73H5-X2
MH@$C;N@G>PY+7_$5G)0X)-X+;"(4"_=LOU;2V:M5=[VZFW2C2Z&+["C< D_F
M)U5]X]IE:=416_B>W6HN/?X,3(0$!5!B3)G![Z?H,MIPN"]L'K'9""SL3EM5
M]+;>5>FG@%.PEX@@=XB.(Y&; 8<5/@T Q0 #[-8'P6KF(6P'8(!Z2,?F2B/X
ME#J(5U[H>FN@ !#<Q-06&W/C4 C9=]]#"T,=CDEU]/W7H3#^Q0+#5B]9H,GR
M(L$/<&)ST%-@W"7,&+W6, &L6ADM@VY+*^"U$B54161JWIO!!"S\[+:Q;D>%
MUKE'[]^Q"DCOER+]%Z[D"0 /-I@.3A@%Y)X!_(KE&8TCV*\%[41WFJ"S9TA#
M?R'*P+J9Y(YG%H\GZ++J]=:;OXL7);XJW0_#05US#JLE?WEM.^'<-1?WCD<;
MIX=>%[&/[MURMP'T+/C7PO,;#EO]=A^=/U%9)%XL_,(6 .+5ZN<@<_2N5OI5
MNU7^^;JE!BVC4_[-^5;JMS2MGM-57VG]YP.]5].>!H91TTK=FJB@U^KUZUNI
MNW$E44>W%$32#1*62]FZ@?^TG %SQK*XY12(%9G+:^');?5C6,(&+XQ]MT"_
MHB+$T)4Y8>%*H7QZXMXNI^01L%-FGI3KEJ];#+WK..7;*7J6.V24;RSTOZ@C
M?]AL(5XM7LL%DZ:7"::B?5"M>K<I($!+?Y=2B0L_HW&L,VY4-\>_O=@- "^6
M#.!G"80?=@?"1C%^/4PA&?_::5XR_CK&W[?%X)4W\M@>3*G:YT76UQP!'@VL
M03 TM:?OV5JIB>5ADGR?%?EV^FI_WRE7DGPE^9Z;?-5!?\^9,DVO;3PV)3<$
M@UK5-D+G1%_C&WG4!)R=&GE(4?NL1*UFZ.JPL^>8.6DJ2/H]-_VVV^IPWR:X
MDGXE_9X_T##L[#GN5=JZS4#A)6G/1O;Q:$!JWI]I2'A3U#@I9<P5,?RR-<:<
M=;/(\D7]<5K"^CI759)4IJ95K1N+67=[>3[7?$.!GN-A)KQ("V?6U -P3Q8J
MIK>/61CR0N@Q%LU2WQ#8;UKY')G?5<5ED_P/+#^8^]0<@LH@3*Q=PJ+M"!/'
M"_5_'*C7FP:^_1*BD&B\4Y)QA=3AZTW@/C-@>89U)\OHYAOQ"GM,F)R^>\)4
M.7I,Z[;::6+V?GG9SZ5259>5JM=7J7K>$@(:6:>\]T Z,.7V-S\,7ZH QJC!
MDG*'RH%BQ1PO_W?$&5U^1H]%3:\> &YLM3E'5BH?P+3X>I+9![!27>4#>K>N
M!'N]TSG32NO?H&F;T^)/#Z=>:VC45;#1U>LZW3;*E.4#UY& +<L'9/G Y1Y2
ME@_(+.+GD$ KLXAE^8!D_&=(\Y+QCU0^<#B88(53WDR]1ZBS,!+QD;5<L?OE
MY@5?7W;5KG%8MEYCKI@O& L==:#O.6Q<8J'& >5][;!D#(F%&A(JC-9A"5U7
MDS11NSXN->*?!5%I/=!SAQ452-ZN 0V:JG6:Q=W/$0U=U6AW)!;.K>@&K6ZC
MD'#>[, J'JB8A78A?N:::O.=J+WDI$VFZ=M!I[-RGU<1C<>>+'@QL.QV)2SK
M@J4^:$M8UF0]M%M[SJZ\3.VTIU*J[&Q=&!G<:NI UR13U03-8:\O85F7$=(U
M)"SK@>5@T*KJ*5ZTL-_W,JS9K@CE/!]RT74IY-I5=6-/I_K$\8M+@>AM=UA!
MF$I8;J;.06=X?NH\3)PU!);>J]DAER6'7HE<"LG=:GBKV9,<7)=IJ4MI6!MI
MMM7!4#\K.*]"%/[7)'J-?ZLEIGZBIK#G,(!+"N*J.C6R,<L1X-% EAJJPV[5
MQA[U,E"M;84D]3XKZM757K^JGR&I5U)O,ZBWK^K]/6..3>B)=1X;JR&X*S5%
M3PR=G1J=2IGRK&1*1VVWJZ9VGU^F2.J5U,N]D8Y1M9^_I%Y)O<V@WML>D&_U
M3+8FV'([7.1?>W_3VUZ_-;P,Y#6RN^F!VUGNL5/>(,Q[-5/^H7SP(V7&3 \
M.([=&MJ9:0S_M_MF*S9^3#91 YAV?//N33PW[.U(4#D#./*]*M>UC%O?19/:
M3?+/E_I>%M82[36S?INC!?:(A7UX"K71]:R%,C$=+^D,^\A"WES6BIQ'ZE9;
MM8MI KUB![H.-:XY"4([9R-S>O,N'55/2N"TJVU\=21@K*?,JE2.?1;Q$<7W
M%.QXZ(>F6^P2J_PR&_V3>KP:K6ZA,RP^^[_P(\]47-I,Q(*9X_&.RV-&K3-?
M=%MZVA=6^3IU0L5FR=Y#!?8'KW"I?_0XA#T#(RTQGE-L;9!K;8OOS_^2F0'J
M"3J+9893VB3]A?TG=AY-%UM)5FU.Z]C_N-G>+738OSEZ'\WR]A>_.7 VVXD6
M=-JWYAR;ABJ?60C0L5AX>@%<5:[M!F P4<X%X2\<DDC-&;";VUCU3Z9,S4>F
M>& Y+;@4F+' @G5A$6SGO, .Z'9LB5[LMD\_Q8(N*T*1P+M01PS$!#!:S)1Q
MX,](ZH-LX'#(+0(,YMF.#;\7?=0C$@9@ </3V,QZ 6P)VN[M.H:$5P+%PLY>
M]+K#UJ @85YTAT:KDWU$+T_E/H\>),*?'OB)6?FO-/K*4+'#-1X/)(>[:'+_
M\ 1Y23=^Q9\C+M!T0"DMVFXCK@(0O!;\P&,3WB$\^R5!>.SZ3Z))-W:L!]?"
MP9[U@$? $"+S+6H'P.,3 !?[^<.C@.O(Y^].7E= :40]>P&6C%$+W7$<Q0%K
M*1_A]ZAP2)%@(_(76D_/XXU0V>FU>NE'=AQ0W]^T"SW^9K>NZ>6X/)U1NW+:
MT\O8%\-NQBEG,.L166<XM3XPSGKL'-&>R\_;D4V,TT.GR)BGAT]+>=BD'E24
M@U.3YAF8EA7/8FX#VVP,HC'BLP]:;664V*K-51)?'!PR<GH, Q@[I\>K0!QH
MN#'X%J3ST/ 7ZL[W\F,O@$?\>#)5WKHFR.8'LGU\W*=O?0-W(XSQ^7 W2GE$
M \AB0,TVB7NP=RS&;#[N8J!W<LJ,#*1M[_P"W/O!!PT\4!6<O*&W7[_E/_V"
M/Z6/M->H@+EV!L;V<#X._(V"B42M/Q,( *;P$'PP(P.*=+1MT_0+^,9FD>FX
MY 5MA4/ZE+M0-YM7)5 I0,0PL@$@'""()9I?PB:.19X>V)7AU)GG@3', <-U
MS9$OYIW\!-:CZ\_Q@#1^(3#!7CT*C,BP+=_FD3R9SKD\&;+!?T;#L+G"K6PN
MA .&K!@.08.F-B _AW(<W)$>F B F=8T>9Z'0E!X@#GKX:,C(+BGTFD2%S$P
MHM=K:=VJ P_*E]*Z+;UOU+?4YK$#6[*Z+Z'I^G;^:Y=V72=V6]]Y?4?(G.&Z
M>(\Q">M'(NQTHB8@L4IGY0LYBE&%X([?-O>H0"B_]B0=$:,BP5AZ&D3);FJ.
MT\GJ+%D>.X)DWUFVC4KDV/&LMQVP;?N=;N62K28,4Y8T=ADTIAL=M6]4K[(\
M'HV=J#W=N>5YV<W[9?>LVY7DM*[:TV7[G3KAV1F>'IX'6F3"[[Q,HVP>^(\.
MAK<QNX8'=0YGY*KP:315=@9#M7M@E_V=2.1$G6\O'!WZL*,:@\-:<A\''>>?
M54_KE$VTK3I(^&/JHCVL2H)S1"PS@P-SDDH<R#1)R<[?(.YRV8TA>5.,Y\;
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MO%\YUV2I1>?]C.-D[W[0P[H\=7FUR[-Q[UMS^&L<3=S/_P=02P,$%     @
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MGSF=2H$_E1PJ"A!+4GJ?P-9T,D<;@I!YV%;@B]TA_"I[^-.3ZT<>]<:"SY:
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MBZ-7<;?)+O8,N5QK8?W::5[YSC(8A3 ;H@Y)2C:HU[1E7LCTM=OD(N:N4R!
MU*$/XH-_,+[GMW3,?'H.#ZISI:SI7S^-8FE@U& -?>I-\+B/NM,MA-G4KPO<
M69&WU!'-WHG*0YI$VBO5K2S_VO'7DGN;AP+/0\W.H6\9-F"M:-NP *^6]/^H
M^FUR+QHP:(.^=\2G@W%R96]$D^LQ:_([ZDA:&__,"WU+L8'PTSW-%2ZE;6MT
M)B/\8M-YH.[C9E+692]:4+9BLV3YJO%!]JKQ^JYJ0=B&+EHCYM? H^(1[R !
M8TQR"U=6NI9;&UHB8Y&IK%1(?=N:SJJ]%'P& S"FD,+2:+K(N+0Q\Q68OO[R
M*K[S/$TN-!X6J"%H \A)$+WI_F2:+I+L:^M,!V.P?FWUO':"1/;6;1X LCA&
MWV*%-HO- LEFUIMS\%=M7,;J6^-KCY 8Z5Z_OYY_&O0#KS\>JPLM3,O)JM)M
MZ*E)!U#7K>,>0?8K+^9EE2WYJSL^2>-[_^2^AU-#DSQ *^)7[6L%$8?@=^)&
MCU\BZZ]3&F32PO30V'\DPI/?8'"T;X<75?*J[75' CXV.+S+9=K066^@=;__
MZS/IJS_JI2\OVP8M;KD+RZ_ ^TP#>$[=J2&1O:IX&W2Y83X8,WAR6*YNT[RD
M8'MVS)>$J]\N+RW:!B22Q,=40,.D7%V^#=ID<S?QNJ\)7E'#Q;.M=O;TK= V
M<6.6Q4:O3EIKW(A'&[2.+ZQ*(U$P=ZJ3[.#7#<"_GQ!3(DX#!NT9:ZR$KA^#
M&K%H ])#6 M!V;D\%U1590CO5!5OE2ZWY/%J!@L]0[^L+M\&;>+!0N7OH>L"
M:R58SJ+/$@?\[<99"_HV:/N9@ X<O29@'Q#_'+N,J->PGJ8-6GVAD> JL<VE
M];J4E6R#!LD!%758)3[!DGC67V!2\^]FQ/=ON$_=R*?GZ%%Y&$BHB0FMRG!#
ML15[3WWI"V%](3 +0,6PDSD\OF @.9A<TP9-&;5VXRN>\$KGN036Q9-JLVC,
MY]6MP6JJ_T:$RLA>"OCJ5!M34[R <6LSF4KZ_@UY8K-HUG==.@_5W.1%;G7C
M-&'QQS"1Q+I![/]0-Y3W4Q+>D.<S>H5W>&)(ZV668L/_U5NJ?[!WL)]LA&"8
M#H:](9BD(1G"0-6&"11E/+H*P"+5BY5TM*-O@[;WZJ8PR[WBBL)MT&.Q51=_
M9=A7"=GW?'%WQ;ZEEBNQ:D,;W%+TG%T8(#!-%+T(^ ?M[P%W>$.Y^(1 >FMR
MS4BU J^6IMS=TCD7H3KLKF_^-D7S*HJW >,[-@E4#C18IY8NN3S(> VD!>5K
M9\'BXBB:H02F*VY+2K9U$05#?HBS_"4U:E56M*UJY6^OJDY-+A1LJTKG/JS*
M7.(WN&JYCJ2M:F;O0U4)U"M>)EM-^]KCB#H<?HZ^E3E!M[QL&\;Z,Y]\IV=<
M3*@TA7E+B[9!AR_D/R3\U]2T:"X4:X/L9S2X)\\^-T0U"\5^J.SJFP_2G8)+
M^?&G_P=02P,$%     @ "35E6Y@P:5I:(@  )UT! !4   !R>')X+3(P,C4P
M.3,P7V-A;"YX;6SM?5EO6TF2[GO_"E_?UQOEW)="5P^\5<. NVS8KNEY(W*)
MM'B;(C4D95O]ZR>2BZR%DD@Q#W4D#&#(%DGS1&1\&5M&1OSU/WX<CYY]P^EL
M.!G_]IS_PIX_PW&:Y.'XZV_/__SR.[CG__&WO_SEK_\'X+]>?7K_[,TDG1[C
M>/[L]13#'/.S[\/YT;/Y$3[[YV3ZK^&W\.SC*,S+9'H,\+?%?WL].3F;#K\>
MS9\))O3Z8^MWI[\ZA2)GQ\'K(D%9'\'5'XECD!*U<C+_OZ^_!F:P))[ 1^[I
M8T) 3%&#538I%6.(UBV^=#0<_^O7^B.&&3XC]L:SQ:^_/3^:ST]^??'B^_?O
MO_R(T]$OD^G7%X(Q^6+]Z>>KC_^X]OGO<O%I[KU_L7CW_*.SX:8/TM?R%__U
MC_>?TQ$>!QB.9_,P3O4!L^&OL\6+[R<IS!>K?B==SV[\1/T-UA^#^A)P 9+_
M\F.6G__M+\^>+9=C.AGA)RS/ZM]_?GIWZ9%33*<+\?^2)L<OZB=>O)Z,,XYG
MF.D?L\EHF*ND7X519>'S$>)\=CH.IWE(KQ)'BR?,ST[PM^>SX?')"->O'4VQ
M_/9\^F/Z ZKHF9>LTO5_=_GZ%S^92&&43D>+-7M/OZ\>4@GNC!_\,4?ZK\NE
M7-,QFJ1+'QI504ZFZ_\Y"A%'BU<'IS/X&L+)X/TPQ.%H.!_B;""]D3%J![XX
M 4J)!,$;!E;87(1E011[>0$K;S-B;B'Y$F9Q(?[5=[^H*_L"1_/9^I7%6B_6
M></CE^O9A)/7I],I*8*!"BQ[1?M7&6U ,57 NU*@F!!%\IPKWB%#*RHN\W4!
M*2^GZ=EDFG%*RNWYL^]8%=%*SRU)"M-T#4*7]]CJ$R]FI\?'B^\$ LKQ^O^7
MZ>2XC;3GDZ9KO10I$;^OS&G3S*<AS?])FO[UZ6P^.<;IFK:S/R;CM"(NI,28
M+QZ*BJ2AB5EPDBM22-QS8YE6C#<&PI:D;8,.\<C0T854FD'FPPE.:3'&7]\C
MV:5-9"66N$$9(>A0B"R9P.E4P#H3N'32.=9::]Q)U#8PD8\,)FTET0P@;[ @
M/3Z_(U_S&+^$'Q?X_0/G _0EN,0Y!/+L0+D0P">C"<1*%A><BEHTAL<=)&T#
M#O7(P-%2"NUT!P43TXN$7-!EI9CL? ;%-='#4!-E)0-'R;-AB87V2N-&:K8!
MA'YD@&BT]LVP\'XR_OH%I\=O,,Y?CO/K<#*<A]%"E7V(H^'7Q=K,!CS;:'CP
M8#*G$%)$0U&BM9!<DIQ'Q8K+K5W0K2C;!B/FD6&D YFTP\MUESD77U65 &%8
M!%4D V=<AH*TB-X&(XHY<'BR.U\O4YJ<CN>SC^$LQ!&N>1,J*QZ0@4%M005A
MP<N,$&F!-1<.LPV->=M,24_#K_M@X"K<&RQ],W@3+=-3S!LX3(9QR9R$:#1M
MZ& B>.T*2$U$NF1ML+$]$C83T]-HJQ$8&@A@;SS4E-J:EC=A'M9$R*!*RII!
M8(9 *6,"G\F?CT2!TX(LM;NB#ZXGYV[X[I[&1OL(M<4J'B;)LJ;,B>#0.P6R
M1 K5> K@LC8@'"^:/# LJK4MVX:NGH9&+39\<[%TG6)9T^0QJ(0L *?@'I2.
MBIC.#H(K1)06.J$\3'YE!Y \0+C4 B0-17'@R&E-(LM&.EE(T05/W LL$$50
MI %9LDE*#-X]2 "U W@>((YJ 9[N!-7.[9S-<#X;:+)\GJ, B9:!RKD0A VO
M9I(>J[P5O+F/N7AR\V3C\FMKAHL5&SBZ "%R1VX;9HB.;#WCD=%:E\RQ=01U
M,S5]BJ+N(?,[LXOW6_9F,/XXG9"BGI]]'(5QW6IO__MT>%)K&2I%6NML.05P
M 179<(<:/)<64/"0N(]>&]\8"+?1TZ<8J@$4FBU],S!\PME\.DQS)(T[.[J0
MYW1%"\&07#A+@%2!"P@RD/%FI3"G61&B]2GF3;3T*>9J ((F2][VF&&ED7Z2
M0C&\X(4IP)3K:6G4X&0@)I$C_1',J-;2WTA(GT*J!J+??[&;R?WODTG^/AR-
M!DC.D_$!@2=C*&H3Y)$;*X$[AB8I8W5I+>KUL_L4"S60[KV6M)E ?Q^.:QW7
MPF/^5!?L0_ESA@NV!M%(%F7QX*J+H92D?Z%TP,A93S$;A[QU7',+.7V*8AJ(
MO=7"-T/"N_$\C+\.XPC//<VW/]+HM!:SGF/41B8+F@@\9T&QFHK@B3X(&E/R
M:*1GK1V];>C:!AOV\6"CN2@:![/K>-JFX+G !"%4U\,A1>[!1<A!*)L="JVZ
MB6EW2&RXQR/V^R]N1WG1JWH)?1"2$3<L,DT6*GJ(MI"90J,P%A5$UIVF1>]A
M$OSCD7^[Q6^&A\_S2?K7T61$2SFK8>?\;%"4,06%!^F\JZ6TDB*/(D%8ZT24
M(6=L[?E=IV)O/9;SL HUC#Z&87XW7B4.!SIHXUA,4"0CYABYU][K!-K7$"O[
M8AEKK=$VD]*G=-:>*+BFYQHL?LNJ@-/CNK28%W'6Z\GQR12/<#P;?L-E\NW]
M9%9-\(?R)?P8:)X<]Z2'6;*^JN5ZOBD**'+?N36\GE:WKQ78A<0^9;]:(Z=#
M835,CLW#<(SY;9B.29G/+A#]!LLP#><#Y[6/PD<H61%=S"5PN3"0'(LO0CII
M6Y?<W4U5GQ)FC7'36"0-ZQ:.CR?C!;/_&4:G.(A2,:6Y(2HH\E<N&P@>%23G
MHPE%LQA5\QJ%RS3T*7G6& 9[+7=',90121;R#"%ESBF,0UY+96*]9A)MBCJQ
MTEH5W!)#W>=<"$_(BK_]<5+O")Y7 6EILBH:L.:C%=/DIVI#7K&G5S&SS%SK
MR' C(7WRHNXO]^L'0ONN>=N#@$^8</BM%GA6T[NF!R66D)P QXDOQ4PAYF(@
M6\RYB"ZC<*US13=3TR>GJ!T0&JU^.WL69D>+,HS94577W\*(2)F]G+\.T^D9
M&=ZEUM5!H#84OTIDJ98(4GC,HP%.7K[43$476[O06Q'6)P>H'4;:RZ2C8^0U
MLR&;P)UT%/>5 (I+XA,3!Z<4N?+H5!&M;<=&0OKD"+6#P_YKWL4A\GDAN-#%
M"UG 2U8O2]7KE"+0#R-9H#=#S*UK=*]3T;\#QF:VXOZKW<4M(U)+&SQ\[S-;
M'&<G6ZE*64(,%+YSKS)ZJTWVK?V&NVAJR/.@Q!"+309$HBA&E:C 4X0))LKL
MM90^NN;5HC>UL.C-7:/]D7!+_X>=EKQI;#^<'R^,[;CV3JF9?1RG2I"C/;RX
MZE*2K<X95G5K-&01N":OK<A2.@CS;R"G3[YQIYAH)9(NCU>"+-H$G0 -)SJP
M%.(O1TA(.#4EN\Q;GT#<I>]Z<U^I/2+V%, 5(/SUQ=7U>D^_MVTD]7E./Q<0
MGI35@2&]V[ZCU%W/Z:ZUU$X<-NHQ]?/LX'<"X%(SG))R^/G\5U@F4SROQL;9
MVQ_S::"],!R'Z=D[HGA1G%=O/$U&])BO[\9SG)*S/?#94(2N!.12^T!H I1C
M@M2+LP8YD][EUN%NA^SLJ_+H6R?K<^[EXU=IK$&].Q_X8L]5YY9[#='3MLZ&
M\1PR5U:V[EIR(S%]<I/Z@LVKNK.-)-N7KOQ<KP%+*3,N A0>B1ICJRY7!72D
MR"<JRP.V3JYO(*-/_E5?P;2O])K!Z ^<7R A>!]-= RLXJGV_T)P.C+0UE),
MX5F.H74^XA(!^Q=U=B=NDX4(@6?P.>E:@*CI7\@!(QKG19(8TF.U:P^K\>^/
MP>N5I/V0?\,JY16A*UOS"L=8AO.!L,5KP0(]/=7C>Z8A<&>A9$U:Q&K+0FM-
M?P,I.VI[>%1(VF_A.[7UPOF<$V; Y,GI"%J!ERJ!SA3'2<51R=;'!G?:^OL<
MB7S#\2FN=^O5[@GG9> UD4M_<JURBH);XZ4'G:0@.UD<<2X,I.1C=;>LC^TO
MW>U,9I\4[+[XN7ZHTJW4&B8E9XO<UVH3SP98!"O!)C !+:F$G,"A-J!Y0EEJ
MO;)JG6R_2D.O%&9K9.RUX-V)W3J6@X@6N#8,5/*U)T+FP"D^P\19IJ#MH&*_
M'T\?2KT.L\@+XO3;,.'L\V24!S$RQ1 #9"8RJ*P]>&4=&28CBO#"L=0^O7X3
M-7W2>WOA8!.T&PB@934!TM?48H<WI(]'D\4=^75.(G)FR$_U8&J5@[(2(3B*
M52WM9U+%FKS6UBU];B6H3TF!IK!H)X9VMY;)5YV&$5'T,A\/Q\/9O.KX;^?Y
M*F3>66L5V*0C*$F*.3*?P44>!%-&Q=@Z\W@'27TZ@&F*CI:B>.#3ETN7#ZJC
MT.TAS"V/.\Q9S+;\-CJ2V>:"Q\?)=+$IYO/I,)[.:PWDE\G'L)SV8#TYU:*6
M-)E%H3@C39,9R)R4(0!SY,TO*^Y'<I-ZJ@V/_WTR)3TQ7E;]I+,OTS">4812
MJ1CGQ6\KW9+_/P4LJ\8R=ZYO+@)IPULPF$@+1%IDGSE""IYY+I&BFM9.UD$9
M[)/?=LB]L+%NK)>H:EFJ<Y6[\RMD0>LB<R@0L2 %?Y9<V2(U2!&$2M%@S*W+
MM6XAI_'IAM,\U.X2PM"**^8U^)0*2-1"V*R%:M[=^Y;3C8<.C=I@X-HIZ;U7
MO&V=[3[:HV01#'J0JE2?S$APM>%4#%8)'A"M:-WFKZDE?>C@JAM@'5*J#^UI
MA]G1[Z/)]ZX][.N/.9!G?0=_C3SJ>CN(GO1Q.ODVI&][=?;GK/:77'8BJMEI
MLM[?EA6S7FF-=?Z$0$_ M!2P.\\,9)T]8U%['EIG2[:GKD$KRX28%T>B[RB,
MJ7V8/I0+ET,'QOO@=1$4W#I5LQ0> K.X2&*IXB3&U/I$Y4ZB^F0L.T+2AL:7
M#075LA7J!K(^'Y%>G?U)^W1*BI@V-FGDFA>M+[\*B]U_7',<B_6MK3QG]+'E
ML=""EP\GR]$OFG$I);/@8RUGM;6?(P_U;#T$X7D)L7D+S4X9ZI,M?E#</@1
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M1*T044E+7U+)N;7?WHCT7IT =('(:YF>!Q!YN\3AEL37&]FDPQ=)[PN?&+#
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M6@D3,K"8F-+>%&]:6\]'GFAJ#K &Z:9=I'AH3U6J7+CT9-<Y^<Y*Y-H%AZP
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M92CF7O]6B?XF.@XX//$&+)$"%QH'-A8'/H-A:!?0PVSL;2-? -55A+J!Z67
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M&4][[\>C-(M3-(!A_+D?81X%DT9)H&CCR!!PXT,SF#@T=HB-UBM%.5C>*'*
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M2 XYHZFD$\T/XK);XFV;OOW$AF=7O(QJ"K4#&W.#A3)7>& Z@U:,E"L"1/I
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M^4=0C"/T"-M[IG/_>KVY@Z9 M?>9I/EU].P#\4RC6Q(B9.6U\W;O'HG54%Z
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M1WC<'\(Z"\VH8Z76)N'(>H)N_]LA>J!0F@;W@N0I)1Y)#BH2:2,"C:C57N9
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M%VL">BW+E\KG6"\%T"RAS<<$Q]DF9,8%:8D)8+.).O%$G\O#L7&&?SXEYZ-
M%6_Y'2SLU:'V9#J>S0-H[Z8W,/YXXX?+A>#WN7Q6>^E<0O<;I] \)2O4\@1
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M)8%.LCZXDD 70?65#ON8=+);PW3#B*TNCYKC_B'//_/SX#5CE@7(M:B6BJQ
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MX5/^'>=_Y>7;4O)\,OWXY[P&-7S^[[SZ_#8401A$1L<=6!%J&%"20,\JP%A
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M$+5T%T5A%/#5_<6]6/LVE41**;A#I&W#G[3*@"GO*)(CK5((<UN,A8:.C$M
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M(2RHA;>9"+<>!UVH"-+NPR4-F>ZR$.U)\4'EUJW^QJIG#2GCCX^+QMYFXCO
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M^XJ"8&TM172ZES?E#@V8]YEPR B9"!U3V*^X_R,@\NX-Y94C;"J+BM9?;F4
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M/J;SZ&8N<SG6"4P#US6\Y401@9[J=JR)R3K'28)'2:>=-0_1#K6!B* ZC77
M8NP% R"W^3$ KJG/@Y=5):P>R95@4W]*"\_<&:WGO7C'_)J#M*]/RO[J1WH8
M+TA!="1V_N1[U,1O8#1Y^!9J Q6._AEF#R7S0AG 80R&/@1.T;EUJ 8#,-E
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M\J;W'YP&=CG%G1H "]]Z"?+?^D0/09H@_^2=13'=RP"@-V"+),=?O*[%.8Y
M\:\0]T&%R?'1&0"HV*8<_>7822(#4/SSRD=HR6G8QA8WS:H-!>H][&:>+XRJ
M! L'K2#Q ?4+^ G:*RH,'$7LSU%0C^YAYQ8A.]5)O_R"/\.J9*&3WH$\EMPL
MB#QD,2;[Z-"PNT;R-]O8[XJ&L@79K*WMRW5#0DULTZ0Q2*'=7P?7;3N-VMCB
M>DK_76KS,!*&_  GB.K4UV, V T4\2,4'XNPW&4O^(?(J&(":H-XJ!P%NAWZ
MH*95?'4:_3"T$;?)VX7ZI8R$OY]FS-Z!_B0'TF!MT+F&:$%S<](SR@ER)3U
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MQM,NL^>]20^UV>!T_6S]\0ZB]E+[V=D:*J8%C/OA=44(8UI9/E(*SEHGJ'V
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MUH]8T-_A7@38-G\)@B;(=,BPXG^TE!J4_<OD#S#D IHT:&59+&@E %H))]@
MQHQP#R9 ,M/QO;W_*YG:?Y,)^@\9V.#Q'<@O>J< "XF#(+T(/9!>U"]Z"YDW
M:O\QR>R[S/'K#.?-R'^6T?F?R\3_+9.]]!Y]DMHX7X'>V@3C:YDFC]D++F5L
M)AI?^RN^_IQ"_\\I?*Y?^8?$1NWT QPX)YCMG&_Y-2>.:8PM<(T1'@^N&#8*
M&K3EBD%IWB_[":#]8]2D+C 1^$S.I7.)J#.XB']&ER_!=%M U8LFV,SD74]/
M8BAW%5ZMDP^&!<;]IX$F&"HS#9@U!9<I0!FT.#H;E/'[%QG=?Y?1!F66_UD&
M#*^I</BL92^.C!!DAA<W7Z UYBN#O%T(8P1A/XMMTN1QG.B>(J;QRK^,#^8#
MC7?\93P"-%[UZL93QAV8.1@<W:6;DAG_#J+W;Y4[$(#E+QU&.Y"3?UO?C6ZH
M8AJO 6= ])BXM2D'ZVI%BP T,?"5%]3UQN:!.;^K!JHWKLAG<KR(N"IX**Q+
M+X#_7YN39_\%!I0P]0BESGR,K5%074>BKU!)IF_I=K+KW;?.S+?_-14:R?Z1
M-HLFV#']D@XN?<@1D'4WY7^[V7]E29;V]3_9F_W+%(/?[!1G@GO/[E]L@!(3
MD8,N:!#$$2Y-^2"-(4UWPR.E97$>A@YGHS)[6.KR9M\6:UPULF+>G6KX]:[R
M_XM/=3<"+ ">D67I,?:'F>^%$:A1^<_O0K15_JN)_G=\BK0<\.FLQ/U1V_#H
MDD!%OXM)0P:?!@Y;O;US[;FTY4W\JHV/V:YCX6:0.C'(41>PY&FAF(;Y*(N.
MCELCPPR+ASP\"AVK(T1';I@GW&XS@F@+W[\7>*?,Y?\5L-"3]%SX]!A#@=E=
MDH^>$RN=>_X#73)#>X5HQE#Y2KWHDBDU*O]EQ?8?%5RW*=-7P^C%J_T[D+5/
M&TSW_<=7_[UI?P3+HMO4*,[T4"50WGC8Q+:[:7E+IA:$_E%OBA$= -$1 O=H
M-3*&'JH(7[MH 0YHA($##C('Y#*B+\Z]@[R-D?N__<&>'-Z!3'_7 G?!6ZE1
MZ+5B/>RE__SN-?32?V?2?_NP=C/44??(N$4J_@T1(VCL*Y#LF5DRX<KRDM:Z
MS^([>VZ[/Y:C"-Q/,U%LU94)PFKQMSK%0TYV9[5?T>Z::(6==3_)X*S9@<@4
M8C9@8!;8(XT-U?*G;)ZC0!>;\5/A132%TC[:^:+Q%S1$<-'YE?=?'DA=-A/'
M;AH7+[$^# J!VU?[4L\BY>M@'*9-XYV7IH#36;P&03FRF!\*GXX=-H/"3^[;
M?I#QG  CKT,?P5?IA>"2S\,![U>[$S%[EQD<Z'J%[K!2XW=8-7E849NW='6$
M85AGGD+SE:)V[,L2GOJ6P.$(1J??E-@;X"BAB8Q>W,1[B2'O!>4N5FX4Y>BI
M#0YO7ZK:K+(]K(D(@#Z[%_)@* 1^L10W)EEG+P@89*,N#JN-K'EQSJ<\F;0V
M068[O71*_!K/>SC%E7.U])R61%T:N4:=P9E.EJ%:"ER=<B\3^%ZV W&QG;M[
M<YL@C(&1.;<"&9S:#]ZY8P1J.0!EFT=:FF_2][<;Q\H?ERPK3@L,XZ^+9SG$
M,:3*6@B!)<Y>QE(54#)#M%T9W)_) E&J<H256PFB>@DN'T_4R)B)&4TA/9IF
MI*9[V'-')W7?6=7[>AU*F?2Q<DP*4/GX!1ZEUHQR!D8)\!![+B\^H'W#1ER^
MV_BZB^*D<_*-?>:[WFD]*6BK(Q4@G5M-QP--Z&DH#]@C0<)RE):N^//XJM;
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MZ4DH+\)6J5?D*F#B(54YF%-:6N-QE3ZIIW)I5=,AVS'Q9<1Q" 3"!@GR]B;
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MZWH]]^_UW+_[]?MC_G#.\7D?[\]R?([/X9SC.&K]7)#R**4W9'0,^HZ,A,$
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MB$:,$,YV4[ZI1BIY9,PT?7&6U=ONK&29V%'<D;&7WO,H) -@>4]I"8'-$5^
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MN9)!N<*QI>R2Q8F*5)U8CM )[5L9L3L!_[CO2"E/:])D\2CN"Y9J348&+<?
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MJ7+UWDSV#2\-=QOA^]J/=.8<1M%A-:J;R;+2:L=),4!10IZ!#W>5=:$]'Y]
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M+ 80$DK380 9<D$X\IXI!A OJ4/CT2*I,(!G<E"Q].<SJ8G*JR]7U+;ZBIW
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M3H>0 =0[JFO7&DA<H<U[7L-]9A9UBFQ*\4JD^7N3(:NQ>M:NZ_HO+-FI9OV
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M*-"F$1FP&4H&3,H!">>CCNXBB&EDP)Z^;[T6:$RI>('(M0\\>MA%!BQLD/1
MFV ABO<Z((8HC>$WROCN_11EEI$!RQF(.>"Q,M?&Q$E]K0C(#/IK\4ZX'!F
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MY74&>[O#!(%L*T,'-[R$5@B6GO>"M1T\_T(CW=RJ%L#'AF/>Z5 /?BD.<TC
MP!VRD/2BTS_X[D],74<"]GUEDUG&:@X-!>RY2*>A7...PP,$FX+(='FE:7>(
MW2F+#J3&1Z25.+5G&&:G.&**%K?0? CB7_8[7U**>X=[,^[8?WG3AO5Q%K-L
M#]"QFX XU(5+$S+S(R2:4E7Z/ J- FQ* A?I)ZAB[_$Q_N!/I@X#;.=)?(/;
M'-Z%BQ*\L4F]3(2X]A<&$46F;[DXC6]?J3/OL_1R#7AGH^XSXHN!<"]:J7V?
M&88K%IBLU-S<W]R0.PQ./"^<,_'I3>1LSH8&'[LQ&.Z+P<RFS?2N.2$(-_0#
MAB!?FMD41Z_M^SD()+BVNO]/[/]C2CH[0LFC#/8O0DKS+76L,Y=V-RTM+?7V
MA%ZSEU;O M@(MV%>+68NX64"$/.^#>%!N<*K--7E-2_G1"-"[H66G/27LR_R
M:42<45/%L[8=;#6_*$>5.%M[GT>Z256+:+D**K8]5XEHWBH*^=,&!D5ZE(:*
M0TUQ5H875MF4J+\RX>3'X0/;L>>ETV0P>(,'M-#"\Y U!I>[ 1YE?W_T9A%?
MC[_3[,=+",8@:):YBH&OB#<2KCC$I]/9?'">W1(5;1BKLO)[)#OFKS)V3$9"
MHL7J8A]<V(YIN+; Q+ZBU""^SY"BOE-;RDW:!3]/=$>R/_>Y7_C[Z,;RL[VO
M!7D)#S/'',$7AF;Z"HK69S\'.C2?V>I(B7E#W3&&N+AD_U]>-J 4X0Z]^PKH
M<,CN!<?IXYVK;+PKUR[S=1\J$N]'4N(30;_\+2]#),Y.&B!8CB!QM3<;'HBG
MLE/2[R0E'7 9<]^ GJ[^Y-"#8#2GA$@(&1"\AALAA8&"(3@O9S*@M8]BNW%,
M\1$[Y'C!?WV<# C/V[T'>7?4>F15N0FI3NGF:$8T[1 HL%H,36B""B6/89<0
MF!=P!3(@/1@#)0J8(_#N/A>1WTB8OZ&T<E!JAJ;M7SAT?^ L4D@OX*9)8<!@
M!,[CF'3_KAO)> ^X/$0I,(ZZUL6+A$E<"<V( W$P)X7]H6/V=8@R,J&@[5MJ
ME 8N*-^%)!UE!YE[N&-&!FRM'76M+1ZC1#5''8@+_AWE^ "X9DS[$3OP>,5Z
M_EB@C-'>?1-2_O')="[K=LY:KA!<'?AXQVPR (,@\H]3^$<T;1#<R #*I'>\
MJN_V2S.K"\0"Q-T61&^U;]=:3I$8B0O1C#P $2FS<E 2A9<$$I=7<_$!J.Z/
M&[\SIV9(/$R8Z!D.PZ(Q7G 5,B#M\'A!2_D/)4SB5DBA&W]A+OOX2+_;AQ_&
M^BR,B=(;H=!MR/%:'9W"--$2A*OU$Z!P>X2)^IU9'^7=7V0._B#C"5>ED-EK
M!OU.A6*>O]Q9W'5;;=^1-/Z%TA]&*0+^!*%4^3?.1G$;I-!I1L0,=OIWQDJ!
M.5CTPB :QT72<=!R1>!JP<>,'!XS0BG+C]6V>KQM][6-$ C.U>5WI8V&#KHB
MMI:A!(J(PB!#,B#N[0AB]?8 &;#]9;?^2MWY=FQ[(-=NP' Y)SXA=,0PKFE7
M8<G3X[I:UKNGZZ/18"(GU=N89/^&/8Y%*(6@(.)/]"B26Q]$RI!\*5:F0OST
M?&M,J6(92C$+1\#CQ<7&5O0OIY'N#45N@X\+/3J*7Q M!7M\W_OJ4$#!-F2
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MSH?B OQ@0'$(D>T3PMGIFG%%S:',V,/*HS')@"3WHOPV3)M;-RRA)8H@1LK
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MK'J8J(.3P9Q/<!$+5I.0#G_H)1C;&F:FJQ;Q-&SNLTE3S+L%FJ<N9@=;QF1
MX%,BXR#Q1"I?:--&]J0.\]>=%9^$0U@<:,7T]<665,\O[Q;\E=II#\W]VDD*
M1SE@;AA=JZ-D&33\0.$#Z[(*(IEURLX&*'+Y:\%R0>SZ#R\.U4CS-/Z'(V2
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MU96O>?B(7O^3AI^+T*331UB&PVX[C,O+VQC,@#13]VHN$7C!'JL-SKSWB0Q
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M:D-RU+GB9;"@UI3STTU<?I*X68*.(6XM9<Q*]V&V$MA:]V)$P>J/AU&[7^@
M@.<OQ,(A#@@!.%_"K&W2+!2XI/#%3*_@!Q'BS'0^Q$FD\Z+ZZ$/QF#Y=[IEU
M_B(_2W3X=+G8FQV7(,0)HCFN:^G MGAVS:]=W\?22D;EAUS>\O=:JJJS[YZ9
M7OK!_V!$_:,IJ6_J!$%8K%'",(33K/6GPNW%1$2D]<C9R ;3*O'2.JG#AJ\1
M$54=8\P#W^=)_5"@#(F:"#I*(%[X:-Z.57=J)BGT]T]-SG/BIZVHA-]-Z:P/
MS8D\7K!_ZA8&6'6I\\(W[WH3RG'SH%<HV3ZB[\P&GV/'QTZ!U!B!EXDV$U5G
M]FV\W:4F.V84 3,C?!@HD'@/#UGS/M3Y 5? 6T7-Y-O6]B%O#VU0"MQ*2R'.
M2*'KYUPFH]V$'DTJ%*DDKA?!Q? NN^\I!/9NX7N;"7[<,.%&E<25K"G?1TS:
M*[=1;_Q^RKR]]*IP1#C:@%Z)&D40PC6W3 &/,OS L SC ;^.-%CZPO6XZS5;
M6$19 6?_I^Q')8_'NNAZN)1GY:CF4=1'!7#S&6@@FK<8)7P4U2)XD6"=BTIT
M>9+.B7?4^I99>@5PXFF,OZK&_O59X>0-3ECE;BP!@LL:GQ5$S^HSM,2?:7=!
MY!.8U5E586N%-C:,T9/YWA'GZ$ ^46\W"<V.H%'C%I1*/\1A ^@4WY$^2M@P
M#MNZBHJUG].%?Q0)T[YK^]CHW/EK@!\]M(]@/;V[881>7 @PZ$5QLP244=^+
M Y520)AR=ISRD77FDUY*"P"^-],(FEO@>Z74<Y?:93?R**O\$$AIPYGJ1#%H
M7@<0@YHBMIY[17_6]WF']%L[L,6IV$NOS?GTN)2.L)N70Y:26A$<8 %2+XA=
M[5X!_"INHX5SH.RU"U$1JR[8IE3Y14L(H2+2I</(QJ=+EWQP=YJW#,$%\SJD
M;JKQ:C@"S<HTJTH)3HT^JJNM"-OM7[ZR:-#1: R]\+"ME49@8IL#6P-L.'Y3
MY.)1$MJAWLT$-X1N7N-J&;M;NN1'7X'FRM W69LS]HS1M>SGM&+'5W(#  #Y
M<D,>TB"O88.ZXNSC5%5<??=;7O6B2LC+LWUW==QL^SZ]V7CFYWKA6OT[A1S1
MP%1:D&"=$=;E-:B,;K42*Q/*ZE#C65^\:):YBY2N*!3A[.M]%+FZG%PJ8O"3
M.3@PJ,TQY+4W?F56;+46 PJN@32-0Y@6Q] AVT=@0SZK%9RARU&R\ZR@X[CX
M%G4=G.-GKO6.8'LAG&9X&QHU79JR$;J]6XNS\]]VUKE1C_;&:@>8M6BZO)7D
M">>@_GDGDL!.%8=K;I_F1/'[#51 &<"BL%)#_'H*ENFT)=1@R-F]:E6T(EY,
M*/T"B/897US<GH'.N2I@))2GS@&WT"IXP2=J+*X1!:HOKZF.,\2Y^PF$[,2>
M;4T+G+<Y:3)M^[W=Y;:^3^@;%!<AZ?[1%Q0(-C^BOZ4FE0E[<="V=6L+*WBW
MG_,'RM1Y+3GR:K1JXO[&S$CS= 2E2I$#L1* -PEBZ02D!0I5\PY\SM*)$]?\
M/#:NPC3AI.WX4</=K>\>9WD@90DM+ARD[] OP$9#D/GR_42JP;IKSAQ'@:;[
MN:*+*6EA[K9/\H2;99\L/(L^X6>!S-X1 &)[ U',A#Q]+^Q&* (C!&0<]A,;
M=+<O>%+VE3H[^;'^:M$-E\9')Z\7LT!'0[%RR,_ 0#@#9PQM98LAX[*UB3ZE
MV&.-4_,:^%;BG3>O5O8\$/S$+E!':8) !F"0E.P&;#"NJ"98H5B'RYS].N\8
M,CFJ3-;WKU3@)?8_)^CG^9>^.2FLJO(F#(!1$SXTAT4U@?C4J#%MA#D,&1 Q
M9OQ:WG[;YU / LQ*44CM_WQ]+O+ZEUCQY[*QL+4>S!#\ZM%'-1=LU-B=-C3S
M&E@*YC5CB\14K6F%KY@]YKKCI"_YZ&IC$8_1W<>,%R9#^-F2C?!BP20YN"W>
MN'&):\8S"3?>!&;'>R+S)L?;"\8ZGPE'H+PYV#J-6*4Q92=6;ZQQ=WM"^-?4
MW+!H#J<7QJ\1MOI ;,_++W(O.*N9"QV<59J:A42VW$3TD^>^YRP%3/D#HP0O
M$X)QT[M^./7>L(TZ>:PAVP0,U?;-^>JT0:237KB#:+1(.'_8U>O6X_%&C6(.
M[?*5AW=@ RVI3/A[+S\3$;B1QE[FC@>9SC)EK^3Y#O,#A#<\(J\"$\K:KE0W
M,B5N41U>(.KV'7^%'#I%<RCW OVJ;(/;;,6+UUTQYE79N*9<9)](K!+S&04#
M>I$2ZF<\JDA6E"!<F])@4'2+]8S I??.,L<4+\57Q)\^B*@O.)"+T<[YEO7@
M&7_NHP8$:(K[K+\'N@2XQE= ?!;5/G:^NL@!)8ULJORNY8)UENXK/#=8.&]Z
M6OEE0$G ZRU_NK.>'0<AJ(='L20!X@W<1JM+A* ,(1R3#V+2QW9&2/N(NZ_\
M6'\XSBXK?/9B:X!&7S[G:9Y*CJ_%V3G_I:>\P00\&2"BBA4["D^,(L7I0B/R
MH5^@@I"?H<>?%)2X&9$!_0X2^'*GE2M03._@X3H?B</PWCZKC*/O99\[*XL\
M>Y<%RW:RI-0=38=8IMXNNV2JI*48"=8[:N6,%%XO9UQ^53:7-1"?F>(J6']A
MNW7),%?E'/N!#3A.)5VU*CT2&Q:7+HP.B8\C.#CJ8V5P_<4W##&95F\_U&FE
MO>B[NI.K^ K=JJ=+O%MVP/<Q/>P"+^5'7$&34AW:!\8X.'#F#)V:M$^KZ;O9
M=VI0\09OR)*FO;-?#1&$0MXFZ,TD=>::^>1',+>9VD3/I8Q-,EP&?XIUVE3@
M%JGY(!2B$._ ?4Z'-][VT3, =>YYM*4?FX.7F5@3^N32R'?Y\IW4<!L7-5;?
MQ9_764P-J\Y&-=4]&<"\)F2',4/N-4O7]>^4QPSU:7%L96]]_>O:Q%_W+:QQ
M_,MY5M^I<.T4@)>4RI;%@0)Q^QB"FPSHD,<ACP*E(-LWC/7_:^=/_.N6?B]L
M_H-M_E[8_*\><,'13?@&XM(7R,&EK(?;G)7:#1E^,E_%J#1V1D<2INX6ZV,L
M<X3$AY."4'24?DMJ@0P0_4Z7961E]]>[??\&^S?8O\'^SX!E3)J'YSL\M'4W
M/9-F_R.#\<UCEJ]@;+5+,.)TG2P.VNB9RH&+1QZE9)BKQ7[2E_BVNCXW^6$B
M_I'NLJ$&G88$W2%DENN(#@XD P+->TEZ&7_Y_Y%IT8^#\'P:^XD,8+G=HXFM
MWHY)5Y]./=3/>7N#K;-G8@.PWN9C6[.\!5DE ]Y MP5P$!*]"V1?.NHO__W5
MKU2#0' )W$)+9S'C!"RP1Z\:KIQ_K7"I(*[.[]Z@Z8\%!S[_WDEENO[/B%+2
M9<1WKX;CI]9U9,#/&LA?;P"VOTETD0'_.^%:\=E!V^A7@JQ#1/G"AA$5[4(G
MT90)"6%M*[';!=07:)Z]"+)PV46TR1PP$T!D $TEDIB@\Y?_&@+MP7#%AS.]
MC Z"H/Y']G+UYWOX&*Y_Z'P;(G(JS"0Y^6) 7$?AC?\9987]&^C?0/_;@(!_
M?2G92@)/3>D36I&O_*@IE;T+7'>FTTG=3;]ZX'PB$^=&5Z1RNOUH@N)O3ZE>
M\]#85J+_#P3@O^'^;X*3(P/VE?6]2*U2$#) 3\9I0*+U 0&!MP4)6A%R8'&-
M(9LK^D$W+Y$!CR;WG?AO=Y]U(1ST8&V%BR[1NB#LB(_(@(\; 60 3L^;4O6Z
M4RV]-?Y !OS+_7]#_O>$?-=%-" #8IVPO8<TEF3 8D*1W5\JASR5O1"P-"ST
MVJ![/O(,[(+41N'/BICTOF+J8(^+-^+<M9_Y!&D(9/]UK?\K416#""<)X$@?
M,G6P(!I]@8B"^_G"]@G^GW\[34_QQ&57,] H&<"-7E2=01!9IQ";EI2FAV,>
M\9>;_P;ZOP#H7QO4OP(]F()#"*6^L]V@5D.LX4FI^0]9TPXQ3352T_%]DWH.
MPJ6(3+MG"O8GF2]U)^/]@8[I=;W_HY(5>//?0/]-@(JU2K@DK)_*F(G5;8[T
MVK,7V-YD:M44">YQC340/_'BC[<R)7K( 'L@AR$&^/)@;BZE>6SZ6ZZ3L^13
MHZ&?SZKO"YRZW:Y>8F4_A0@A.L^$@^@)AZ;X^_EN7KS+P[*.")<*\UMT*<+,
MO_GBXU)A2QH@G3ZH,E$/GY7DC?^R=WVX#EH$<_JM?[LJP39<;=&FQG,Z?O,=
M>BZ).>/S?+',F[*-DP0%7\/&U',C<&B>XQYNL8(>R_#A4Z1J_,\S7RY&GZC0
M%3#H6]$0/-+R-B2*'QYV4LGOM0#9P2ACU_H*U&6-6(_]L]3V-\D H.N$L5OV
M2HUG@HM#%M1IUTOET^5VFFX1_*?8KP":M[VT44I['YG&)+K 0D2#VDAGG:NX
MA 1POAVU8:YC+-/PV$U-7<FC1 OJ"D@+3N(=;N.5_#0SJ9-+96TW#8$HFC+3
MDS-F_;9YLU#V[<LT,6&J&'\!<>HI^V(DBLL!Q8^W:0TN@[*J/?3"\ID\JJH=
M6)?7>W7MTFDHRU?_+W;?4X%F_801,N#4>E">KB\6P@=+,*BJTSQ*R7)0E&&T
MOZ?Q+9C/BW/![3/_X2VZRCZHFF/J6;Q?Z PR9(H;SUQ[/B9W982U/==)]^*'
MM&"#.4T936&)](T= </S%<2+T$8$GS-<,1,6>6C95\XDK9<4;GXXX#E<*LRH
M].AY;<#2M,C! ^IQ\2)KK%UX%DXLP,/WQ5075,\&^%[(@<8ZAT=DEZ>'3HQ;
MP*D%!9JV@+$O)6958[J-[^)WJ]Y_N9-/GTA4FA9FG_Q"$^&YV2P,;@> ;AA9
M>6$,PV\[OJBHS2"$7DUH-D/%.,ID!A3=GE>L%#YZ]/4C=>2L *FJ$$<&8-=+
M\%1R24DNU,OWS2SG9Z73/%QY6\_L?_X&[#Y[EEF#6FHM$; ])O&6$($_/8Z9
M?V?G*O5I+'CN:,)3X?ZM*_GZL@N.\=;!_,_;,VU'B5=') L\:GO98-I0X+A#
MA0Q<S)RP;OU67.3CQ9-\D2]OT?EHP0K090JYUEGV9JUD0/.1P<C5H<S(4T_O
MKXNE?(IF#1 Z[.*CHWG7BY7(P$VW.NO=P@\*\HS +[AB.L-K=>I*8_6^KJL-
MWJ9B9%L7K'N\?7Q>6%U"&YJWO)BZ_&AH+^ARAMG-6Y,*)2=Z)1_NOF9E?'IV
M!Q#]S&%*;1#9,LV&XEVL^'(]OG5N1/HN:_9C5]+*LVW)ED?^ZH_"-F6"#GYR
M&0LJX:TR<W2<'7)78LW&U <;SS2?6(UZ.OL&F12P9!D:#CZ_F,KQG>T.9=IV
MW-\J3"FL2.Z42U!DVGMTD]]N_Q:=N9;W'+IE#:IW:-,;#A=5#)$+=]*I57F-
MBIP#W,[H?! 4JAK"E;S;_;BXG>G&\.QO-8-$'J\LF)=);5C_^*WXW?,?S* [
MSB(,WZAW9C>_TA7T6<GZ8J^@>=3L"CLD!!2;! 5-QJ3:'R9J#,1%+CQ:*TJ:
M.9_DED4\CSNTZA392XA.6GK\[K7ME9)H.\CJEZ@F?_438?C\:;93?K*P3HM4
M79 >#A':KQ@,/3V@^^'U]F2)YXA^(?P^KUBSND3K\Z4K<@?1%9P'=LG4I3W&
MCNOMMYA?>'YD)H5M(5GAQH.4LIA_@F!\%5<X\EJ>P4>N)O[ZTXQ I0\_, +(
MX'UMMP[E-M5!7L-V?879!D62R.#V2LH5'[Z%_OG^H9<#\F/1:CE?&Y[K 4?Z
M_=45PC9S_"[!0D9:!07[=I G.C\)/+>-'+Z6VRI+>V]B=3$_^MYUI2.G_G++
MVR._#3PM9UB*'^L9/I_H@$P_]R9N_Q9MC437-C)L2F@$U8C()M#=2FBN_)*N
ME:/KS:H_5PLXOZGLG+R@O-1KX"@C +<8@;-)9ZH2Y/0S1FTB?M:TG.F0L\YO
MIZ=]M=).@_57UZ;(QP9_I"\H<XI)]FK=B(R:/GWJ< _=W7>WM(OC)QL:7).C
M3]+WLL.,L?N#,D2]AUA+CKH+/A\;$KPDI/HM='Y^EN1787074%^D[LLIENWW
MDX"%6AW2DI S E>AS%/?7G.FB?[458Q?!21]G:MP2U[(5E?.2\QN9^A(&]JH
MD\?H$K72':3.63IJ'Z@^=N/N2KWQ64K<:.(!/[]=%5U^GY5E'M&],G"VZ?,2
M[\F,XFXLP\E!X< !^WCNW<#:@%G:R'Y=P(/4%\8>&.<[1L/NL/5R2T']T_@/
M0::Z*C>_49UE[6@73E6WI[8*V]1W* )+$Z_6XE;=NETP(*":W1U[_@SH)$OU
M@PGE'T&TGU_@%YVDX!ZS?%$19FLA$9A]#R:^JU_".E;9;H5QOXQ5V$[^Z2%^
MN>PY8-Y?'16VN?$_4F[F"$I!*VL:9C9P$[>;433A-$QW*Y)!/]W$6CR3(:B!
MIH)>A+9QI?]7(\]7''[P2=;$@06FLHS@FM3>8TJ76C6I###)B3?=O\>H0XV<
M>^_N$EERA&R-@R7\AF J#B%FUE+*8KV43=W8DK1;U()<I .>5L"+3(ZY"C2/
MO+FOCV;Y")S/+6UI; ([UH/?2/_04D"O%2O*<S/*+:JI1$UY=H-G!<JE=K>B
MAG%DC!,I^<(N[BB#W77\L[+#*XAWV,S,<SH!>^IQ^R(70_R]M;U(>77Z,HE.
M'P9QUGO#HC2:JI_OE%RI$CGQ7%/IHI8C+,@DO'F,.3//D)35-J:70 9XL)>0
M[E*E:7D?O^F\IHOBL/=*[%[K)F7 ([Q%1FZ7153H2/ISB@&$+$YO'IFW[(*%
M".^PEK+M?E>&B""F=[UQF4O#"5(V--^M7R=J7/J9+'B]#0&@V@[FP B"*P?K
MJ'%93DQ\;;Q9E5Y8IMMCO;J#TM)U'1C6*\3<B\F5I\B 2^U3NS\)[S 1+C-D
M0+ =_FG0K/,+?-E(1/; SGAO>>/SB'-IT/<VAMV#_ ?6A0"?>HX%-&?YD6,S
M)F*J/FWYV6(Q;8;EUQ'.*;?/%]Y%^#W@"#]S1?/@?G93/M\X-,1/,/1>=>K!
M@9Y(_+QY-:\NSR>^'[*7168]P8'^*LL2WTBTN@KQI"NXYF[1UJ+0@@Z.C&]S
MHP^BZ3D8!*M$2!Z%^"2S< -<?6KRIB.+8:&CPMAC8*9%N$^P%WS.(O_!0P/8
MXO59.:II(RMKQ59G@P6+H3(7>L)M!!L34_S8[KRSMNK#>>MU:6*"&G]<0+3W
MSK8 [X&SH>Z7VJK2.,-4V&WCLO>!N!+ VR=> N(GUCCF#MK;S/>E=S)QE2^+
MX$8VZ;5:OO!*U_'?1(P2KN^=>&PCH 'JLCFH;)>00## ]$SZM\.[;0U9>LY5
M?'Z9UW.2WJV7)I=;+6#Z["VZK#XKWYGB,"[26?R[O> =-),^IMMLJMME-J*H
M?\[F9=7-=4W_YZZ1/B.:LQM\)G!57.8N.I=><'A09AW#XV7[("]C(E:<.BV]
M2@K8#I9$U9GLR%!U9YGKNHCT64CG,JY4&S_/F&$*KK$3<;,0:T*&I5ZHP:$J
ML2DN6HD(YE[Y]4SF-%$BK*(RPOP)O:#B&=XK'_<F$P%[81)=<"F\$Q1OBSR9
MYHP[O!O29*Y39;HN_4A__<R7<Q=4WRL#3IX%)JE?9)*9-4A7L\Y8Y-T+3M#Q
MO3<EX>V\8^)RNB;WD<AO@.(1Y(*&8+X6+"J4=!;6?I]0CD67+MZ>6N1]4K*4
M)9S3RG^_B]G,&EEWXS@^Z!+1N7"?6A7]770Z3'O!!)<9I_@A7W[U&0\'LP#V
M56#/QZ!>GL:/0&AZW<)] LIVL&"[^/2BL:#X4)'D[*!(L)V>?6%:](D04SXA
MTP",AAA'RD-\6KGA2=CTG<%MW6UMW%+LL/ULG:YI-L/6.27+CR$7J18VF%5O
M'6=&HRS"-D%'!S<2XEZH>!^O\_II 2=A='(JOYM&?XNSJNH!@"K)7FD!0-5?
MZT)+"#+&TZ8,.%D))C4GQ&]Y6_V60*_R52&H7D"#UKO=X&/D(-5WBF%G@6'&
MB< (9Z)4!L%QH>7%IPK(4YM C)!)G+=F/=*?GB[YX)F;(0[2RH#DMK<2^D"$
MJ$?6I^N+UK>%[[Z,&=/2_Y9__D3*)-52>_8OY[V72708U'GC[DMMA?NRN)%7
MV^HBA<IGPAC?D_SME3_'P19QA>*2+3XN;.:P]*W5;J?L1:^!4?E.I8>*L1]K
M R(!O?4 3W;C=S+MT#("HNG.&.P%=L4*?^G=JGO \]<OK^IZO?,'.#<NQ27?
M3T9R2,-5,=V&=_&(4&DUE>'8=D8%O(7H:)W783Z]Q=-'L$9J@0->P/;%X]DS
M_$4.WC,B'1;:) OS]8@Y6U)U"#=6=K=L%;D+$FJO7MEIS_I_\;7F?Z^++HEH
M@;/-F*VW;C1[85(X%>"2YXN^ZR"@0!MAT/+8.H'9- 0 WD'2-4]>PTRW<LM'
MG7)X5AFR\\[<UUJ_TAYC?A]:[<H;>U)9^=Y",4U,E$FZOYI8TS4L79":[JR4
M!E$]P3C.;$AP3IK+I#S\C$PGZX,2-4:2KT0Z)3>[L!)6FD@\PT_D%MVGV>TK
M\<L.GR8M)%^UZIX4/D>L%J935WD36;[\EL+C$ND2(;APVF0\ZD3[1PU;PPHK
M1]ZW=RYJ<[NP?(*7<O30-_3(6K)/,]:)@<N/BL5"Y4;E#94L? L+HSOFJ:,/
M2Y(7DD?TM0 PNY:H41(?@G8E=P:?WU$ [4"O9AC#9F(^/1.UN_^L<//I5W48
MQW!%4@%<%#<5DT6XHU&#MTRVB9]7WCD;]UO:79GXQTKC[1/\S$.+@[?H8NRG
M^/ Z82AAG=D(N]]"-4B= W-E ^YMU;IV*=/*WI;@>U;7J7-Z_,K@ICGPWPBO
M,>:]#)TSI]R]-V8/U=LRO'*O295=?/$UK]H6[,\8%#167Q0&V)+ALG_N &;#
M[06GXW2(8A4*N[E4#@LAHJ_3M7ZSGA=D8)J(?-^NG'>\^1L+&= $RG<$BPS*
M':GJ#;FDF\/<UZ0 (6T MU(O?.T9ALOK '[CO#X-05\\NNF@,J*.CSDH<_S#
M+'I0*@/U\%SV.T<1H#"QQ8[/."#6K?\+^*R]GW"?GY@]^-+W,@CA>L%:V;[<
MZ#:AB)5':&+\Y6LT8)=[FV.%XC0O5\#4^-1R#!D@2 CS55 BWL$RR U(EL&>
M6I\;'A$RD?L4+'E-EI_?M=T":(.;B@"%PM6S'&[-?BLI#QMU77S%=7 _@IUJ
M <HEN>'Q2DIN5(T!%.%^X9IZD]3$,WV:C)>/)W0>-5_47-C:>@_FA/5#@DD2
M?84%\Z51%G6!JE*<SEI/F3\X\GL7/+9M_-K[C7YM<*3/_19=,FR\T?A@)!PL
M:#9F2@:T*J9/U*\-HAX%\+5RCGN<-C#L,M1LM7,B,>+!A7BVUH.U3X^^72>J
M'R6D3<KEAWS84ZT"S)U&<4G256B]:&6GVLPA0(J<I@3ZRHP)#BY9$^635<-J
MFCXYUUP]+H:>=#@3:\X4: "\YG^JH]BD"H=^I=-2S$-(EX*X::9E):4!52[O
MA@A]>G!R(VXOR5@J$O5N^2Z%10(=!IQDARMN3N7'"\8X(423KSH4KL?8FJR#
MW"!J@9J>/!P1>"Y,_52$XDMY"/4BIYO.Q^D.#^EP:M$O/2(:F6^1;R^U(ZP(
MK2^.V*EF46I]1#N\&Z;WE7MM%+ 54_U^O,/:V0,6I]ZAJU@5G?W-?^W6R1<[
M#06]M 1^"UBHKE-4T N7D-:Z0/,(;?.O-ILIFA)S%Y^W/[,RI)ZJ'PX#X-2O
M8=#A+B@!POJD^X:,%=Z@RC)AC<5OOK-+XU/%*K]V89O;EGNQYY?2<,/2P&':
M41J6 J/B])P&4'1NSD<@'8H Q:;<P82VO(_(&X?%42:1A,L: T+=-5]3+7R"
M.'BT'G:0I%WOG^\G.N"I6P1I@V[CGA-<FLW4EZ<-T;?"[+:$WNQ?>X2LK9JQ
M%JMN6%EG_Z6R9I6V&"SD%?C<8($GU#'A\ EFR^A-Q7>="K;HZY:C:OPLTQP+
M$;CVEAI(LR%MGHZ=6+BD?'/1I$."U_7 =<OU&_D_<Q_P>/>H'!KWR??"FC%[
MH7!?CC*_L_UI@_T_2D*[)4]SMCW3%'@&N0C8+*993AQI<8DLS''B]4UY">8>
M2)4+[%E9TV-J^7FB\"R5WBI3=/TE.HN1#$KB3%F(!/.MU @B+[;Z>)W\\:&'
M_?.#<=U5Y@F[J8HZ98RO<!.O_><^]Q5?A:[++A<G3P2VYX*SL\52)>[[J]4V
MO]AK8=(SJ.BWQ3WQX[]L6G?%47:9Y4;XN9;?_"SL=<^B!GH!C]VL((I-4/85
MP=/.O(:A9Z)8++Z%Y\ RC 8?5*64GI41\7F?FOKR&:RCN,#^(U"I%&=Y"+<-
M,HGMNH8Y$KYFSJ1.;%7-LNN,_KC.K<$5+1$_Y,=."&KE-6S-E3YGSG2G1?$"
M4^B'BY]]G)ZAC$1UQT T#V8BL?5-E#P$/;F2JC@X.U 6H=<8U%P1,_[^Z<[)
MP7-O3PA?1-T0$IFK2(51JSM]4Y/!9=_%M875"*;A0F_BSV<_[8E9<4:<OJ82
M+VK9N!]"1<W=T>YX$$(9$7**P'FH3RC)7Y%=PO]PX#33*HKZ="KEAISU0H)C
MX(W@9W1=)WU7!L1_'52,<.6HC)2<GS4*;=GK=L_.Y[QX#[^H,;/7F =FZZNS
MPZ"Y8//CAW3/5RKWN#RGA XM_"PNS+&<*#.=NA&=P4TZ]^+T#I\,X](+S^H<
M)\YAU\9<Q]/A'L]>!EW2#)Z0#=2852J\ =A7<7F)NC"LQCXFAV06$CQ7_8[K
M%EX[(Z?15=56P^KZWF5U]5,S^#BK(4PQ[?08\<'PSG@2I-1!H4:_*.83^GTA
MZO)61S#-NV: ,K5Z?M_B1R K_@P>%$"Z0$AH-;N7%5>PE##\[-KSD1>)9BE*
M+>CV:(-^\!.J.&1O=+^?H!,9P (^->F('S?O+G(RP^,93'H\M=RX'^4SFZ=S
M\/"LZJB-E"U/GR1R%#O%.O%&A4INR/.8J,7=S*R,"8BW6%.G,[)\:?3I\B?7
M]'9>0%[8)79F?^ - !X!($@KXK61;F)-ZI F5W-;XT&1VC '5@VP$6NVNNL6
MOZL9A&X;S0[3,\,S)^3#/(+K284>N0HUE:[<<U/:#<)T?M>I@_KK'<, \W5,
M.82D.U_0"2T']U!1*E/7XS]KBD>75U%;ES VNRY$JK@7("+-P-58F>"#GCC,
MN*Q/[O1%C9+7MR'155//5^DF:3PV+-?8J>;]N/!<$85KJV51!&.I3Z:-SC^U
M/,"E+A=UOEQA>Y[=I2FD(U@>Y5L,VVKAU5M*G&X*E]+>3HOJ23"J]#EGR+=;
M(LF%FC*L]Q%EI]HJ0)\FFL^D*&)24[(7U["U+D!]UQRHI'&)>5K5\YN.(??I
M3IE6MX-;1NX4P S;H-S2!85J][+-".9-GEN2>[P6QH^6L?MO _/6/U[,TC90
M/CJURRM.W4Y2,R'4MHX)M =O&](;^F9U2]7JPRMW\9(Q^73V0SS-U.^HQ2++
MQQVME$*;_&A<SL#".LIDSE^!&E[Y5,0G(N)X:\WVZ26JC56GO((4ZZ9$ S0B
MVVI9X?*4A<.F=T76HQLM9, 40[+=Q)LPP!SX-,'I5A]<UBO/R<A;91[M?3[?
M&TC$7[%^#,5Q,+0_TA>4PQ7E8J&OITY5<XZ7,?%/3%G<?&S!\XTVV'/!4[/C
M*_=>L6:Z/_@I/M2_3F\VO+VJD@";XL2_C"W:8#-=N1']D5%6R&3<+3:#>[SJ
ML5NK+X\S7[,+JZY0HI9&H1"WI,;/V:E,"CX"UQ..YVLDL0W5L3S$O+>-]TF*
M$FZ)A6I_/C7_Z&8!$OZ9+DN566DAX[L?Q]2BGQI.C9X^KCF5LR_K>C'/P%YE
M;$JD@MVS;W.E;]S>C!0=5QF47OOT<C3Q+K[XM8>>RSF&S(HO [HQ)F4L:=(3
MK!IVRHV-V&+B+4OM6<W(_I&F:$)3V[Q^PA@\@9Y^LR2Z$QW8&(BT4EI(7*7,
M)"=Q7,T05@>'61[W([#+J27%@[OQB4^#W7*2ZA-$#<3$W&@$/C-[@P/3H(S'
MIS$RD^BBF@PSK+0X"D.31W!*']2Z>L6IJK@M9I*1LF^P]21*_@%&I+(/EQM2
M+[VP"Y42J2^MJ M:&WO,=6YRO>#[F>^OZ;E[.TDPM6)_%"^44E@-]\N/JM%9
MSQ1RZ7U.^FHB%F)JDX)#UE_HN<HIK$P](L:Q(7>++@P&;"))##S$%X>4"] 7
M9@P7RS,4$Z['KRM$O.DL/_5&8'^IW7&6*(%#&_5O^ZAS&1&4,Y=Y/W$'[^3*
MI!VJY3&K#8/@R0CF*[XUP"Q* CF!0IR!B^"](G:ZA0W[/-1/[)^U=@-_JB #
M'ES2^JR]%-@=&6"<FM)S,3(<1P9 \3(-SF*&YK*BTZ]WW@[NQ-5;;Z[]3.IR
M #^BW[\M\_;Q5G^]V<H,.F"C?,DC"<ED,N$H>\,VUN%ME9>8:%A<6?*AL3W@
M%H";4D@<5,1A>VF)%L-J>I]@+B36"!F3+X'3C[E<-:7R6RYQ,6O?W9D=&4?J
MX[J'\WW3QBV</"\[)+Y-2C17LMVZ+U2U9CD;HNKY,U(V^7XF)4;70[%05EV\
M-?8D.@VF;<BFN?MJV\3.G% X?#) YWTV0H3SR4_W5IE7*'9"S0B&F'G&B;>G
MN$@Z'\L$;EM8Q6(G@FK&E.E!XE0ZN0OXW2-@<XU+2.%"T,TRO>M9*>N/[W9,
M"R>7\J=FE>50-\+I</U$XMU^^1&<0%1@F>65)A>A!ZD\-O%>37[;:1U"#"S)
M 2MQ8<T#1'6\JC;!L !V;J Q5WZMV4)DK-GQ6=Z$9+] URL#+^<GS[4!.UA4
M/&7Z,6\' U,*W*.8#7$8^,,TAXI;S38^+CDZSFI7\H(?=DJ(JQI'^[@E+LB#
M@OPN51'NI)M.MG+6YCB,C>QF[W*L+;P/&:?5*DZ>8*522P5;1P:BWE &]<(4
M!UE'M=Z"5C;5@NBTG!B^0-4'[QC8G)4>O+MX"3HO/T6@,\)+YZ;K0L+*\GWY
MC!2968>GC,Z>>>,LV?C^J=HV^%U_W__:6[[_OOY]_?_UXFB#/\*73S<C0U70
MKPH^ALPO]W:,<K1Y*NS'RB:?>:%,S"_]3\]B_6][E<IOL#FD<E=&^MY><SX7
MLRMQ)2Z^S;5!/=AA),ZO#[$IN83<V2<#OLA[*U=<@3%RW-272PI;J?AI8%'B
M+.!;V2ISVK*K1*=P/-0Z8/ZIYO[G$S71UP":7^4W>U^[J$FX8M1YF<X/:XW<
ML^:ZG??YONJEAI^;>M8?5YT&Y"6B6& (#!D0(AQN6O[]\9EWU;&$B!\-XA\Y
M'EWGF6$>VN)F/I=_;V@7?_M6V+NEM?P;O1_&E@]6^MZWY7NA9UY,<LP(<A-R
MBTT);<T&5<,/1@JDQ2(Y8\Y=/+EY4E.\, :9Z42H;4^5*B>D>:0MQHDVP<.9
MDF/: V]>;)\_*T@OM5?[PM6R#POGS_'QH(?X7NTXOS[@9&=;MCB^*3&N/:+N
M=']$[N@D>X)17<@W,>>P+:5;!K*1CD/U+5[W\;T,!9^_IO4-_KP2$ZV#@:H2
M;X:V07&1)IU8;^PF:?#;9_$HS[5/(=\8K7D$W-8L[W*E7J+T\@SUMQ?N5\#B
M^[\O_3_LO7=4T]VV-AJ*@B(@O1,1%*2(TGNPT$2(6$!I03I$")V (4&JU(@(
M* A101%ITD0!"3TH*-(A("&)5$$2D!A)X?*>[]O?.7OO<\=^S[W?&.>[=[QC
ML/[Y 9ESS377,Y\Y\EO/^G[H@K/8R43^!X#B,H'P&U=()VQ%',54;,X*+8X?
M._;\Z_A/_,!0Z&TW9W^:JMK2!Z8/]2"$IYNDN:Z2:^\TY6Q0*GQZSBF<_VT?
MG/EVP\VQCAJV!:;[E:X.]TJ--W%2.0<V3UBJ#J$[/"*6*#7IKK:)A8_+I<Y8
MJB(WG7L;\ZH(CO?&_;=-?=-_][:KTG/WJ@R!;KT>B3: %?:?0VO&1S7WO_W.
M5'Y94TY2[HE#V5,MDP62#5QN?S<X*3Y.MA36;@7P">7<$PVQ(MXXEQYR^;E1
M6_TOURO.^AM!4+WWD=A[M_WQ2_7#[H:OX#B<NR"E_6E<=:=D2R%))4A&2.OL
MP7=>2=^_<+S]587F@W?WQO:.9]Z#O^E:#?"!Z-L_<C346[JG;\EAP%[9\6TJ
M$+Y)=-1Q.['5=%LGUWG&=S1NK?;);9_;UW^]4GG6_GI6Y3^(\?Y7AEHZ_1&U
MM!.X?WU->8^(JK<9\F^UN)@2CUSXR.%Q2M"\>ZMFXBTX'<-E<H#:,F/?3,6E
M!C'/"91L''OE:G/T]\7Y_8I> D^M(!< >RG\]V)X@3!9Y/0?=U+3P=WNQ\=-
M'.O]S12A>:.:54''W]DF<B45_5!0A!XVQ!G^K!T"3Y?/6\6W01D(A!WE9#-Q
M(.Y<5ZSK3M?T2IC-D6PA?A+N,/<IKR8;V5PW#%/,J\,,2(?, Q/EI2AO'LFC
MGUX?J(HK^2CN>_U74R,ZH:?$;6KS]A>>U:.O(P\9<GM?GES4[!W"9]">LAXA
ME>#&E^A9MY_8$#]%#@X\68FBM'&*>HM8+*YM.5K<D.!_GV+-F$W?UIP)ITU0
M0=W #&GEKB'.P%AP\C;?76+1%:IEDV2^FM )8_/+D@#18$^'M$-/+6/CXX8M
MD##D$/ - ;T&"LA2)-9F,".?,*]2%IN/SKA =RQ>G?GV<?7B[2@K>>0M1;43
MJ[PF?YPL@X+Q5WI1C;A>8"I(8+UQ2.1-7O3+,UY^,?L:.?MX:R9.&^:DPU3+
MCAS"';]X+]0<^/R!4P]*HBV(<89^C@CJSBB&D,")[6+0D9FO@L(0>%KU@?SY
M"R8/FL^G7PM?V#SOM6H1X[0VP A%7'S+>MX(2Y77H.:G4O6[=QH)WG90VX;#
MW%%WZW5N*20]/G6P<W22Y^D1X L=IR58!BA $R_8"WGCE-DNQ#2>C)"!:^"O
MUKL%?N!V[']=6J"EJMW ::\EZ;W)6[D+:!!<1U&MSM)9I#_.<\G"-'35/NF-
MK"X'BM,H/103H9@UCC0'=[TD;4ZGD*Z=QP#DG6'(@RM( E"L_12!7NDR;*8"
M!Q/E<U_X_'S/<[DQ&YI!X1*SVSCT[A: S\<I'+!?RZH"?HZV01W*!MW$WFTW
MN*'^<Q=PUUVHI:Y)GS*C:&%D%\YYX*)=WJ%KSR^?SLS,C   GT:FD39DX+<[
MI,&T\K3MK_K=+7X/Z^(:KK5FX^66#-Q^F'_H))M6DC_L @+V/FMO+3IUY^EM
MNOX@HG%T)Y8AZPYA)G]JWJEN!8T?BOCUW5V$X03_3@+W"4YI$F'9NEE^X+<C
MM;7'V;.I_=?+W[9(B!RK[!,W??4JIU_FT+MC<--XT 43&RJXBRU!#X\F#[QW
MEV(J!_EK%EVIV\N/>8/N\H+B^6]QL^/@Q%V 5)LR=:8+1,F%:U_*O3S,_D)K
MC\C?-$?T %[C5P6I J$0$83R+B!Y=!XS5>Y.!:;K#O%!W;G0G7SZJ3KHU\][
M7I^:\F)<L '8 ,S/['OL)Q<[T=Q!P+<O$3%K_*\0%\=TXH[;N9LZWU;3 -F.
M$D?7?=[Z6F0VAJB>Y%'OX>\YKCT7;[;S#&N$E*57TB;IK91% JD@M0U,?/I\
M3DJYGM+VYI*5QF#@VEN[+Y0#ER4B.NYIEUBBSD5,OLVU;[K=(_2UT=K78KGV
MSEN!N'!S2<QA,R6X'Q&2"G&C!C=!GZSP'>T*_C&5-$>(A'_+3?PMG4$D] H>
M1#A_@3A3D*T!)/Z3AOCI'U53]56O1!\8<G'OO_+SZ!]'>!(>P^LW2.6]&RE
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MX1@NYY7,C.^<^U<AJP?U4CR#O NW'7%,44$:B I<YVV7HD(2^/-PZ0BS:I&
MPCL6V33ASO$SH0UA;T%JQ.N&'R0[=XS_3!ADOC!YJ(2>V#<9+T!K6$I#%Z?:
M6X&GM2=SRK75 U?=GNVW MP3M @?DEQ503BS"M@GZ=&T_DFV8@#FT$]8IK1
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MQF%4WU=/OO7W9_JPRMKU7=AX"<)!,_E :=M.G=!C>?D54."#*CS\T=?G?;N
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M2,*=P-3)I.U:@<#AQA;W6A_=Y!'%("_1EPX=IMF26_CVBW0HC'$&.= N"P8
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MG^(B3DE\BS '-P%"-:A\I%_K(E0_W(Y$-TP\ ,//5)@OVEB+:8)F'3>]L.&
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MWX2?^-X]2.!C3*/_MEKU99)L3 W;"Y!3/)#0-D_F3@@D9)GX4 4[VT^Q'NN
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MC-PABGZ!AJ":5!SK0IK)VQ7[\YXW%^Z3=C!\$0;UP\7A8HFW<NWO=G[V*-!
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M1%2 .$A])3;48K*7Y?VZT1_2JF$W4Q1Z^%[?BPQ7V6:,T,!<I0^)BY.@;4>
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M\>8#?O<"96K4,5^UH281Y@SV]<EAY3KTE/>S/;>"O?(J[IX>#F;#OTK;B^Z
M79M QNS( UE_:04D%=N6%^>6S!BZ>IX(G2(D77N7\A# ]_9_1JT7'[)Z PJV
M.@)@4J@C2"?<$6!(Y0@0"B17GJ-VD;=;CP",?MKYYETY2\UO8XMG3K^W1&?[
MGA*1&/RY:JP#.$DI1T:U\.S $L491] P_,_\G5 CHXD-7X%LF5XI@^D'Y&TI
MRZPU@TE*,-+^!JQG)V5]!O;G)V2SD*[Z;\$^R<F%57'^@$WV*/_P.@+\FR>%
M!^J3]*"4@U]'@*1'9H83$K2$_3^G:$D+_WN&9/<[(6E(V+F6M*;#7/<C  A[
MN(/L_B^X:E'Z0*N8+>6U'P);&LAJ3^3RJW\&/_QOWO[\H7"-BZY_B(B@&VQ2
M/"MIV\"]X2. ,.2_O#[!QQOJ .QIJ4R%]<S1!XY)6($C?1]"-/F7F2, F4A7
MB[3)D9G+)=%KR[522\^+WSCS"L4#YH4[$[ 1N\HL\*RN3573&Y*S>J*;9R\9
M\^MW7#R)Z"F)Q!52'4DQQX+B-.AL"17:P<_YY)V5$!N7,2C]RY]TU:1M%>FE
M_!299B W6-X5R.:%5O'^...FP4E@OZLH^7W*YG6$J41[S7M@FHYM;8#_7*^(
M35?F\4!;EK/IH']FPOO/TA$@!4@N6;"_@'+T\3_GE'P:9W'Z<J>L]&(@R/+5
MRK&6P3[W @O\L@>/*6W6B#':M @_*:$4H"X/>@E;QID5ZCO9#8@\+%"),!I0
M=N9<NE:U@IRN6]CN.P*(0X@64DD.NO&7"M]47"=,=NG(+"Y$5"#,RF?<!&Q"
MT6F=Y)6 8L(SNXC$<Z#$ O?*I,ZTLD1\M(';2T>Q5*R9V=!E6SWI$?4IXMWU
MJ4& T(6O"]%' !Z0)MFW+3@P 23SX0C@#D?>V08/!/TPYGR]U#,,Z94L8].Z
M](/C]4KD/6;3?\I[@C93,*JN$$ZP) ),"MW-7.HZ7C]*2N6?2NI/.T2]2;)+
M?/WPZ74V3Z9FEG 6^4220)>G%$&IGC"@?*MN[&$#:>(-SI,(LWEUUYCAX:U;
MT$'4Q3\QM0%^ #/]9ZBSX(MPR\7-*"60,5',;>;ZB(0V8BW"5RK5*%E5R/D9
M0_L'F4@L4[A6H_Q/]6.M'$6[5+WEY6]ZI=OF0LP56=,0,])29X "YS71$U-'
M@/!).[(MI87$V78 X5QP9RVW7PG>>*^1)9R57=3KXREG@I(-B@1H,Z26I)\F
MA.LTQG>28/$;:!^\IX9]=2WF2RTF82!YX6Z=>\@+(2E.D6<ER=%UOP"58&H?
M"=B& JIJ*\ITYWC@HLJ3L+@-&]:OG@5" 9FSPNIWX0Z7GFG^O387U+*XN3Y*
MVES4Z3I<B-SAK'*SB7C1-%91\:2Q\;4!QZCTITXE76U+0"K'U7(B*:6#DVR%
M,$SO-D;;Y'A3;EBF#ZZGSGC/WY>2<4OWS6($%02I39OIBNXE@X%4),$B23R#
MX'E9Q]8T^:=(F_N52]<5;HE?;C.:900$Y$4FZU5$QQ/!@C2+$; \;BU;6*>N
MT",'7*J>]E1-Q)S!]1V+=>K9;8G92W-_WG ,_K,'NCTSE"1LFH+UA. =I^W5
M:T/>8M#9\6?7"7RO.N_DS]0O&1\T8(-;2%A"71K9?O)!P_!&K<CCX5WCFH3G
M'W"O6$VY[O:'HUYSX*,W!P !_Y0_62J2KQ "H\,XX5K;7?;*8RU?5$74DV2:
MML[G/@H\'?G8K?]9/S-CLS8!UJFH@8<]WX7RN9'L9U=PSPI-^%%>SOF11A_4
MWZSU<7:H,HP.WZNQLQ +-*P:*Y^X$;%U^K>4=89[E#\;(P>6.<W2Y;_U@I[_
MS[5/0&$X9P>2N\;\/;Q$;Q2M7_3Z9,OCL8UT>$>X[E-!T4LG%Y.#P+7-^H!G
M8 :JX2(JJFJP@(M4D(*OK'EX&_?DY5-TPR^QET^J9J0)-14@3OQ!I< ,_*.G
M<#>,!S<C(JOF_-RT_PZ/<1),B,5$@W%L8NG_L*J2X=\G1/M_GS+'&)91-3*=
MGI9X8!N2']YQXS@!U->:7A@=BN@X69:_6O2*,?V#8)-CWL6NH,EU[8,;5!0E
MBVH82(#QN5CLZ^S6O:.8#3B*8#T#XF-GANU>1[/R@=+2VE:9AWFGB%:.]_3O
MZ0NR% )8 /['61B(^OO?=.5S,">::DF QO-,W9I7J>&W2+,/+=:-N/(L+D59
M&_IM8U![LA39!D'^^(X!(B>UAPX5&RK,*>U41C*6.+Y$?XY'\E/=.O#C/_CI
M7AD?F8QQ\(4@SQ6/=::EZQV4%4NDX\+S%A'PJ1JP.+DDGJ;Y$0&N&OV9 !W9
M21U0U5#6ZA%MLC7H>CKJ[]O'<978DW$[,Z_V*^KZZDU:Q>&K42)J ^I-9C3]
M3)VK@(>J1A[GZ98L:WOGU$%N_OM/294],_'+F@]*6[&K26&Z]*XP(>H0 4FU
M_HP DI72\-/'/T!SK1S\#TL-2?4X6JGZ%P(4BC[]@^5>F!!$U_ #?0A2@^U4
MYJ(/P$1WDGP[ _>"CP O=H9J71M'9_F;$H+2K&^U!-5].?')&*(BU"KX]4!^
M!5F#PGJS46V[5!!WDR&G77&+&A:3DZ,),YW)]US3YAP\OUG*?1RJSVCM55N#
ML" ?*1KB4]87R"+M\I^FW,0UR?FH-)TU(9YO8F]?F$7C'GQ06H<]E'GZ)\S,
MOO) E,8QB71NB;Q$->FT#/;__3Y[>T[([ZMTNEB%):-2K"\6='_P/4^VL@_J
M AS2U<)[!/!23@F[.K)3&==8WY%R!H[L5__\J^)70-PM'R9N])/INFPGIZO=
M $9!W-\BVB$QJM(1@ AY3@LM;4E41C,6K=IDEN^.\F<9?DG%2BM>T-!JNIPZ
M\"T\2$IPQ3]E:IFPT+:0B)$BM[2V\+K4U=F?NRR2I&%S4A"!G;]S(KGBXQ'@
M<MW]\#]/@V0J#U\C'_VAB]I0MRVH*9_:"#!>*FZ0"!W+Z:Q_F;5=Y=H:<%]A
M2^5D?J&(P96)O")H)F5T3!7L2OU[4<@0)8+J3A8@\F&[\P,[4N%AVG4QIE]<
M00FO)>JWY]7B'AL1[GR*%W$7S=L5W9=9WR0G8,4E#R/HRM1"<[)].9*@J/Y[
M0V'7)*$^),'?UM;I3O)M Z%7Y-F</^4P4^J31:B@%15(28A"RWRT'13I(*W4
MI]G#M"7TSK:37UQKE5-]3J[7T66%W0[K0C'7;@J'M86!2+N?H]OWNNHG8TQS
MC@"(IR\OM7$]NU8U@Y$1 NR4NTEGSD_:,0V&4"S_[L]"DN>%2/7Q#M0BT3"N
MT=I6K_+*RA*!^CC1#Z-2C9TS+RONWT=YRSQ/=P=2$LECZD@^!.PDL@:;Z# .
M7M"8HFGBY4U*R]>?WIX2UF](8E6>TV; Z0T:26)Z#I/#F-U;JA?:7B'.$^2;
MM?;NFOSYG=CX(-V88U+^>?8-36*!_'(*$[T;(@IF/9;9MRM)RUUTH=IAM)YT
M/*ZXC!4:>%)1 KGK*<2D+U/MZ<!P=2.]5$!]9TO 7(.B>5@("B&?I3RC+@G$
M@O0"2]W"^(;MUTS'BY$[#?U9]3<892SD)O"1HG56VZ/B>HMB)L2A+N5I5#>,
M^Q%UJ'QZ99Z_^64N9^VM>DN%M&N;]-1/@K*6=A^,A=A;>V56H-/9E(MD;%O*
M,9$2!D$JW'"GEO:25#,_CRY];L@O3-9CQ_&_JI&[YX0'__)B]!G50IUJ<5P0
M0F@>IM.E:,ICM3HLH<C.C#D35U]WT(!;A G< ::2<_YAX(WI=O'3:R.Y>9(S
M2?5Z;[=OS2M1_Y"U*>:-U&J9KJ8YC=ND_C('U3G5YO*!*6O'ZZK5W?>:Z+MP
MCP@!$(_OWN:Z#%G9AEI[H$Z%==I+?M5H'$M0JQT8!@@EFO<*?\62^>[W_G[F
MW@T2.1"G]G6T5%G&AW$]6 T^2\V^UQB$;XP/2LHIS1)@R.L4%368X]K2#ZE<
M=R0AK:F<)&5CDE.+KV/01ZN^IUNFQ3V;##Q0Z82:1BF_1WD?EM7*-0WN?MFD
M6CE9;@01/4/:<,NM/34Z-FLF*1;4F&+7R35W"3U?CZ7Z3NIJB6C\=B6W*QA"
MQ1X\1AB3U%*Z8-QPF79A^XSBN5[7=U_B7O7RD-F24.>RSK]^R1-L64T?1C&I
MM23@2MK+\L57VZ=!%XGRG%SS"2MB;%DD?J4J3X/^&"F&NA0+7OB5Q>YZ_ (N
M@2#3F9!;QOR=IE\T986S[9+*?0GG9;Y\4?>-J$^TS!C+;]EM[VEDI[TR:2@9
MK(U0) LD^"L+=BQF5Z-N3J@%@?H6Y%9QQ@'&,A;RM9HZ?7Z"C#\W8\_"$PC+
MZP(D^2Z;(T!B[71M$.B.I](3@7.'1>_'9)(UWTOS/(YZ=.)*@88&$V:8)--Z
M^'<30PRC01U9W81FW"1W:CT.]KO4*U$@Y>WVO7?YQ'-+A=:D3]-B/B/H=N6I
MR2[/ QZX,_[*6K!I91)-!^%OHG.-/]WD[-/Z:JB@=#?0U?CI[4%.!^9S7&%C
M-C+QQZJN9?I*=W!R$EF[6_AWS1Z%DZG\$TQ^%E?VX$9BVA=)O-79M,WCKM8!
MXQ J)=2.CIRP:K(OMH '4S \T!(%%LNF?\?\&=J<<5!AW<H4"6=V?Y@G:DIV
M7MSL7L")4'S(EI&@Q_-,(PC3D""G_1#7*W,)>KQWL=+13GX!; 'Y;^\EO]XM
M PJ 3]/NCT!<.JG-I(+E]KV]R4;A7S;1F8063<>DD\\[4]$/$C<>)";';'HM
M,O8?=QHI"B\C\!T!NE%1C3'Q:'BC3G2N=U"AV[Q</7^81+6Q64*,PAG-<YY.
MHI7GV*=XD&TZ=)%9%TAU2P3]_"Q"E_QH9'UCUR0.=$&)2._%9<P9(/VK QUE
MY@]H.X1F\T6!5F@<F(\Z3&;$'LN<W2&.-4NPW*BG(IL-BPE/ZW $VR,QYIZR
M<,$JIVXCOOP#51H?%4NZ/ FE>I<^H"H_H!HZ*OZR7?2RM$R?]U;73W$Z^0@]
MS>"1KIX%R(@'_,GN:!&KH%^&:YN3Z^/"%!!W2/6)RH^_9AL,@R2*YXX #E/O
MJA6X>Z3JGS0PN\S.5$=&]JBM":=LL)*U"1IMR/ "@=KFW#84%T;:?LYUO^ +
MI> !)=7ZJVU<86PXO[& 8^)#MM2F9RR[F--4Q8-K88.-^D.184)N]%-DC>=W
M"=9^2*H)9I+O9TZZMF8<.JWN!ALV[T?Z;5Y$80@!M;Y]#,+9<02(T1HF>R7^
MC4U\I2:E,ZO>7L,KV6#'?$K7_4"Y( ?IN9IT*<VE! "G++FRS78S\@A0Z[Q.
MJ =R(QX1&Y1K%6]]A'^AV:M5EW_Q<LEUD1-Y^N>V3XWE?.:63DOKL<Y%<F/4
M$<KDO4Y/VU9*#O)%Q>\B+6!,5X_LEW:NAG1]1ZEJADR%CV_U3J;KA_KH GEM
M$??((7!F2EL36&K,="C:7YZZXXK8;H+>>_[ZAB%5]QQW/(%FM]B2("Y\^-*O
M)1E":J;9!1'*3,_>GB@<97QOXWA=LAU1^I"1I\'PI^$@Y63:MF5MVX$RO!AR
MFCXB;#:FBJQ!&#4W?1T1-%7JX;=ZS?L *"_W+&@*F&*SBG G 6%DF75W@79;
M]P$UD %&\,NPZ=@7(T70+\<XZ_J3RI]?#7+T;UWE95B;9YN$=8ES?J_-3G((
M-6AGK4L*OIBN]HQY5&UK <NNOH!=J)]LJV2A1JL$X@<@U]&3BA[.?]XT8,S/
MG:PTD)4T%-K9T]R/:6T4I0N0#&-JW$N23?*U;]?79.*E"T$^<BIW=:_V7.WA
M6T+6U*_C(=W1I,E8FAJ!B83LA++,JDTD5"A(WA>)&6 KI9G5,043"TX[W66P
M)$YNF.&/ )&6N*PT C0F3)/,D<*76K!];Z2&KW&D\Q;'4KIEFN7SO>>"0I5R
MA[5JH5*=P"_8]B3S#@ILNI%],U:5-1\\],T*G>"<E"-+N2C7=.<#[@RC(%\9
M$15S['G#KDK&U?F39#%L>[.&X;AG4B:ENN008Q(3U>#(ZW$B!EO!7'QQH89S
M?8@,[5Y@H8O0M$A.A?@SJLHL;<7&:O3&/8N]*W/6)5E%=Z73;MQJD#[;()JX
M]X:S0OZG-RZD.TQQDJZ,4*&JX8'<#^ ZZ'M*F[N> 9V<M1VN7KFT!F.@O":;
M!H>!0)W>WN:I^MC<=IP/V6W%E0"5/]3TLTC[U/D:LIH8KOG <9-MM_+\86'8
M*6HV=EZ:!$W! -WVPY+(S&VC_1,PW*^-)R'>EU_DG*E[\I([[]+)K8[$Z#N<
MVM\?D[W7!PYNPQE; \-TR,PI-';BFLFOC2, 7OZK0" N=.F3P]V^JW>L!2]7
MS#)LGYV1B:/*_-W]AFS(ALG:K2)%04_PS4!#<D59D>N$L"A!R%'EI9P]$C,,
MZ#EY'>#IB'HU60YG7LSN'!)&^ Z#+R(>-I-V:^A"7PHF=8_M1-NX2D0;3SX>
M[9-^P]-UQJY0ZG=>!'KW[^W/;4GNBQ49Q ,[K]7VWU N.-:,S%XZ^B/PC/?5
M6$G,S@,C=='G:3UMJ@S;D]$M;D.B<',*VQC:%AF0,YE2,V<#8\6M:LARYD-P
M)UVO)#YZ;5;=\R>>?;I79IPF=:!$TR/-E^-;N$S)V]TYQ?7>@=X^Y5:K/._W
M[^_HC0V=M*"*&SV9??O%J.?J3C<)NPX+"CE0IF+QT 0U]ZO>:OENFQ8U8S7%
M01;C.4^RF"3&SYQ[,UOX09IITS:,<QCI]F2,IE$$3["EAO!'ELS-U)64NZ[X
M7WA;:FNP:J\B&K=4V!->IL[$^L0G'K!_$W/&.U%<_7@JKA\6@?2. &<,2@[K
MW\*)9I]'-NG?Y_WS&TU=>&1GJ/>8GP+HY,KFLA\!AVFT1T< MN5C<@[$V<A0
ML,F@^R$5KJ-_MD,+9"]DS0T[><L_:^"JNU;&82B3!PBJ[TYAI=VGBI&43:F+
M8 UX6:>XU.@@*C"H</:+_OL'UU73WKZPJ10-BF=--VX#G4U;0]8 XVDPLA1Q
M+P+, C?ITL P58VI!B&,*]QMK%D1GO=Q5_%11X"EUTHQ"AQ!8KIR<\@-D>-
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M:!>7';XPKEI6R7-;24U$Y)7QMI1K1*0D[]T@K/1#-IX9Y-D69V\19+L>:9G
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M<3;9T0CM=VL?)NDB=<\+V(VDS9H$'LD]SY0((SZ%L.C$FV5XW^.'0%TJ^X\
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M'F_]A"=O?#*\<-F \YK\$G1*&:_VZS"/=IZ(I$(1]SSHO1^/ %WRE!IZ[Q'
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M0+--0G38;^)LVB3.D[]:*N8W,.C>.2TT)+JW/GEPD08_S ,];+3()BRPS2)
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M8&'RSZCRV:D5R*/)=<2M)!_WTH&?5_XT2<?KWA94NCT:)4J,/V#^-WBHJMS
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MLMZ#G:8^5WT<:7QZB7I[BH">ZEV4.2;*MO$&%D0$+@1=Q;M*9H._5:YQU1B
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M3'LX45X2B5R0I&3Y?U)Z+Z$<I1PGDR)=\NW;D)U.%A0K).4['194947]"[%
MYP%Z(JF+;XNPUPZ>.VU#L+)+2IC^ 15NY]^,<[G=#'EB__O/A5EE&.\F!:F\
M7MF^/E:;KJW9YZ;&/22^]35\5:*1."7<EP!*#%ASV(J#.?KB0S4O/KN^9/$^
MML;16N+Z"6XM@^$\TKYE>.>_;/+\YU-E1H'?HU>R8# Z:HH@52@Q68\Z-0?5
M[E\0:_%Y#80T1'FH;@',I3+43ER?9LK^\F=.@)>O%S33ZC+6(6],NH"W32_
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MO2XG\$W7VD3G2KTL=!*&?S*&[*2E"9^OQ9^DTU1ZBAXACY0]@FG&:S?&E4%
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M_31]5+>(.!F9  \J=_AG6I_WDV;>C,O<Q3YQV.\3%ZHE0=_L)J$!4H5X6G
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MY!P0$Q9M^<D%!ZO=WAJMI]E'_,,F9W!U^(Q]OA[C3=1YM"PUBFRQA25;L?/
MKXR'#E)\U=.<7LC&^4E->,0CZIVOK7K8>?5(,V_%(MI<'U"L@8B;Y.3^;1Y(
M!OH4;#;Z1XN2/:RF.\G&Q8B;[IXW)R'W8O?5TP6Y( 969MP1D@:BVM8?O8A5
M7H_ZD;F?\X!@+N7KPGA],MWX4K/25Y8_ <C+SNT^IJ!/SCEQ*L$]RE9-=]>M
M3H;L#XP08I.7UN6VJ++E@Z2B,*>V3*>^NH6+\XZM<U5*G']*4@3=5HQBR;O+
MF^F0.<&EQI+(T]6=?2XB3JD+][/4(P95A4#ZKBO3@XB/$:FZWJ1EBX $$5G
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M(6]"^53^687=/ERH^X-'Q;*!L/D^T16BX+.7K(5[O@A <FCU4\ ;[V)%8($
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MAPT(6ZSTNH@T4%$)=+J0)Y]H6/MJ9]:9[JNGW."]K];W\8B\')5U1MDUDZ)
M/8DY2;Z '6\"I F!OS@3J8Z;0V/WG?\\^Q,>B9P0CK!D7%M[%'M^/G84UP3&
MH,XL IW.I/W<)NV.$Y:>L3OM"!NGJ7-D![>I_/PN>M2]QP^N#>C6<UM6S$!?
MI IU LD$8<$> :XA58>-7&+6JM?J;^[G?-F\+:Z <)?Z@7'W"=4?T+@A1.EE
M9#J$E'\,\D'TW%0TWC?>#\C;#ZAWQD(.M]6;B+_WC_J'0S#*QEM$BLC?A)A
MRS+JA)5[G/X*?B;E9T?)%,VMOQ_2!:TAWN] 8_6W%Z!0']"?&AI3PG)5$6\/
M@C\4PN$;W(M'L,_U1Z_>^#IPO\W_G]^B*W&VZO<9#_3,X2.$;4: T95DV_&!
MJD$:Z5?D,"]M_$/UKC1C_H[Y<J?.))531N-EG#NKYF7]IX=B)/%]MH_ ]3*J
MY7B#!<\ P4\3&XZXUYPEK[,5X,?/=49F\>&+%UR!@4IV'9'8Y,ZE0K3\*%RZ
M!E!ASXHJ+XAOD(I$U+[?':^2>PP2N+UV-T/FU^W,.>.+<;HC+B?DI,B/Z):;
MOCVYY]M&O#7BF-4?4/X\8^B\<^8CE-85MB;IC]RK8"Z(9^1NP'=*%XX?AYG=
M+_U@)L$I^71^[E5]8N'5*KKA%9DO[,Y"Q:=C6GBWP#]BOW#!N?^J 'V/BJ/2
MHY:CO(F#1_N1(HA&U4Y2-8Z?AL&1"F*_1#%V(P SVL#1D]&F_;5]CV.0YF!X
MP)Y((";";?OE_3A]QZ-WNR@NV,2^ 2!/+F:[M4,[+W_QRRSN3D>:+;N,/D-(
MB_"-KPG%JR$.N OZ<LZT!:@0F@FF:-!>R*9(T18<"G3X_%FL^*I$AY4![2R!
MN>P8Q.76$8,@BW>A10!I"MOF(B?9\!BTC\DLA?F8,;9QI @0K)A[;%B4[%3J
MHR.O/+0;QI%,H0F(!^/PVV3M0U;34-SW63>EM4&K&AWD_47'A&/0S7E+QO7'
M',:^K(%]\5=*+5/2E+BO=ITJ^V^^;?T?RRI:')#4%X<I6I,V-P4^Q"G:@+[5
MFZ'J%IUJ6YN]5KIG@U^%KIO42)QX\)CR=;3:F.YM0HTPK)>@7UKRV6.\A*SQ
M6JJQKH#O_/M[1NY"]U)UXX*RSQZ>2@/MU*2#&4)1&8Z=\;_"VBB3'TG#;UO[
MHIPE]4<B ^,BC>[>R>5:[6+PC!SV'?/Z7R=X5];UPWM1 _#R3E<++#O'2[_Y
M+<[CO$,B-2W]^7!<2\1[WX0$R&!V&D;;/59B3!W!![]&[NSSVM5YVCY1CSOO
M<]_7I,+5RO;JJ[;*=5/L_;,UK[U>L6L#DR1C4V"S;#WJ5@<B^@RRPN>C3]YW
MQR><N&>ILJQS3_+X!S[S$4=.=?#\]R>$T \>@[R1?R[J2QR#F@*.+J=U7&OO
MW#\1_KGB!(N_.\W'GU5]^V_.%]$&I/]V1+S,-WR*]Z"UG];TSN*]C_:;,LMY
MY_D;1F;<-GQ\2W3SA].OQ_ZW$DVP/5@LB_H&?0"UMAYS^/)2:EM"EB/F:8PY
M^#]^N;UU>9_E(GMM367I5M5/GZA+^Q<HIW,89^R^C>W;[*GK78AFCHG_G'!2
MYT61.2PL3M-+U.]V-SBI4_O;B(6A2 _J;JWHWSK]+^@W%:^1]RP^.OP+@/''
MBN]R*7_KD"<@E>NEWZVW>/[Y6V=\ O)M]__2#@B!,8C' IX87%(4+K[!=[!-
M&&)CG^^4KO+ZSHS,#8U?#&%7M829WJ+/POG&:0Q4Y7%=SC*H*W3CT/L9-BC*
M\LNB^\CEA7JZ[NQ'CT:9=P5D.I[(#_J=^M=NH/YSG$$(_EAV;["0OL"F/M/4
MKQH_M2'+?R0+N\<\H IWGM[(MP5'J0\;+.MI3T<8JAL51IC((3/J+0#)FM[H
M&)]ABBM9,ZW]=H!/%]8-$<&7^@1!SVT^%_.D.B;1K[S;,X"[HU6.XUK\E?\W
M(Q$S:!U$M%U_]_3*(,'@_G_-FLS_WM]2W6S$*)U6F"9KTJ-DF\9WVY#[[O_4
M3CM79(F3RX8>%E\0.)O.ZB_HX%U[RV@T7KEK,]<B:$(HSGO,F7T?@6'?AHD?
M@Z0OT4: [J-M!L3*#U#$-SOZ(Q0Y@;)X]A@T\ 521U-"1'>#_VA=%=[C[CH&
M>5+OT@[B(;^#D2?Q,P.\2#*FW;)DC#$,A,P<@_@@'4M(ZLM2"F29\:"=\QB4
M]X0.=_O?4/]KJ+"@ .YY^0MDB3'-.SG7+V^/CCO-7?<\^R])A)L#_NOZV_\"
M -I^^X'Q7[J&^$^ .)V?LH_^JV?@_QK*JW.':4N(_^R9\;^,A![]NAG\;Z1_
M(_U?@,2*^Q_W'XD R:1MPG2?(N-/$7!S&\FE3+/8=>.U4^U@K6%07,PT.#,4
M\7_YI/P;Z=](_T;Z-]+_220]QS1W@RFU\RKMSP2?VWE)M]!+TY/5#O^WW?6_
MR_^9<CSS_P!02P,$%     @ "35E6XPL9GY_TP$ +E4# !0   !R>')X+3(P
M,C4P.3,P7V<R+FIP9]2[!U13;[0G>I!>I*AT(4B7*KT34&DB(DA16D2DBXBT
M )%0!*0+*"@H01 1:=);('0$!:09.B1!>DF4$B D+_^[9MZ[=]:];^;.FGEO
MS4?V6EDKY^3L_>WV^WT[4*8H2P#G#6,S8X"&A@:X3_T#*+/ -8#VS)E_7M1%
M1WW1,]'3T]'1LS R,C"QL;"QL;*PLIYE/\=YEIV+G965DX>3Z_P%;FYN-@Y>
M/IX+?.<N<%_XYTMH:*GWT-$ST],S7SC+>O;"?WI1.@ N)MJ[C+JT-*+ &2X:
M6BX:2@\  @ :>II_6<!_631GJ#HR,#(QL[!2+ZCG!,[0T-*>H:/]1VOJI\^H
MGP-T7/3G+BD9,IRW<F44#;B@')WQ@4GL:G4GM_4H7ESEP=,89A8>7CY^ 0E)
M*>G+,JIJZAJ:6MK7KAL9FYB:W;AC8VMG?_>>@]M#=P]/+V^?P*#@D%!H6'CL
M\[CXA!>)29E9KUYGY[QYFUM8]+'X4\GGTB\UM77U#8U-S2U=W3V]??W?!@;'
MQB<F?Z&GIF<P6-SR[Y75M?4-PI^_>_L'A\2CXW_LH@%H:?[K^G?MXJ+:=8:.
MCI:.\1^[:,Z$_G,!%QW])26&<X96C*X!YT65HYDN7,WX4-W)+*9BC>=^\'24
MA4=<%2-!^,>T?['L?\RPF/\IR_YOP_X?NV8 -EH:JO-HN0 P<'JG,$D:H IM
MZJ](J1EO[?V5+/;D"A^T^@,5'>^&!P_3PW=NW\),1,!ERB@ JQOYXRX/?*F*
M M06=8'^V+2+P.? %."Z6N@KFDX*T#5% 4IU>A%$60JPM48!XJHI@'5H,AAO
M3P&FT6%6<Q8'$6'NTG^8)AJ^H0/5&9XP!AI<!)/DTX^SD/<H0 R*/)Q.= 3M
M2T%K*0 ]_/2]/5ZC;TBG_WCOV#8^%LOJ[?<>VYQ_,."6M&!$]RHC]GU%GU+*
M2FEC?ZI:Y,7-?"7MX/XIU<V5FB2]S99-]L]">C3R%" M%YCX;U09_;>F5"[\
M\FRJC[=_T;63-"1X\97XP]B]4B_:V/_.77^^5NAZ%R]"VT^Z;P_N?IF:+?ZQ
M_OO]BXI4E,;-=[%)0,=_[_XD8(D"8![!)]YC1TC<%. @"/YO=G"S$AU<9GEV
MK7&F@I1O^_J58H!*=":WH11M,Z[8"L)[;VAI%.L(?5Q9+O!]>]2(37Q$+D(C
MJG3^11]C&Q!( ? -X(U;!$\R"P4XT0;_Z^<$3Q(C[D&XO+(=,AV<[U9,7+7R
MC^!+\^K<VF#N/!CR^LG(^-_XFLS3?VJV($<!.B$4P-/Y]X7_ 6\; 8&17(2A
MDN25"7EL#6J\LOSF@XAGQC07DI'G2OCU#-3&[!DQ'$<R$$[P#H@"% JT#@+2
MA4G_L53Q$%9[+07OD>Y2@.<J70YV&7"I*9[#D(+ADM*SWY[HZ=B068E#6!K<
M)IR>N-E=[17>MFPA_WKH7?O#\U',_7?2N)OGPOA$;C-66[FXXN']+8TIND:$
M,^,VN5KR>WX>CCH&&<]GS[5&,0M!K08J)Z"SW9_6_8S;/@EFZUP'/TH/T\\+
M]8A2_URI@T7W<!/=EIRO03B-PO2:4XQ\Q=LAN0[7K])TZC)(1<]4>;OHCBF2
M=!A*)3]X"C_ZM>.5C>'K88DQ7*W6/,9&:6O+KB[&Z^L3XPCF-C5HT5\D\,>U
M\RY+7N6TSF9G]"\&287\?/)4.:R#>_LX(4G53W)=WC_85U GY^3KG%.ASK,+
M[W*!\<+"W W!NP)AQ:8?K)H_AK 4A&?Z\$R6W]G"5,E/S+D-_"@[F=N;'=$Z
M*& -L@M&)ZKF\7GDKMK4-,;S_OF=Z?C<-A75TI//P1B[?BNK1\#)P6L"8EUG
MH=?B7+<A"L;KXO8+6/=L_<!W:B>W[5;Z=EAG/4YJ';_57#KF#+ EF01\=B#"
MK1!F29?W-2N6([P\Z(J^77A])X:=N6-S(4K5JY)U"='SB5BZI//, UK8B+KW
ML+$UAFW+[,*RFWB^S8?57Y^)Z=B0(G]"5C>9:73;[_$Y['SE_N45-@>F>%/6
M&$#*_TGD\4_&XE$7J2^DNX2J9*1?Q1J(0S55 3M[W95[IZA,YY'W4\/K+-U-
MKHL?UGN#X(SM,L[$H_H**:?Q+%.">O*5^(-?ZC\>,6L&#4B!+N]$7/QK()QE
MQ(VE ((HKV"BI] .XI.WO4;NA#S?W\J*O*T;?+)/,=%N=4LTB^M)P$&23$->
M$+K%KZ([JDK5[!+KSW,T9:J E=&%_PT"M:  O>DO6E ]B/-$WZY<R80(]J2!
M[+90$YE!IE4HW:K>9]KYSU4R1 @AV8I@DJ0&9B(672-W$(R>NX0E:6ETJX;Q
MN^NU_SG4HGM'L(X<@7,&@T$P=?(L>N>2[^N6;/775@\,DE,\+X;J_F3\/'KW
M(%+IIQIK;UT]6G4VKT&3\UJH8#,%B(K-_4U6@ME"XL)OO0YI^+EH$?'9Q.-^
M)ERN4+E9.4B+UDOXW7X!AT%A,X07=GT,IH(1@CBF'8P=;O%L2\?KQ.DL>DN_
M$RXW!FO_78QM%R7&X<Q/51PG28:8@]''6-^$T4<3SPHU!]\G?!")EWWI6(*Z
M0+/]RLXI7WJT<"(^_[@M"9(5[8.6EACY-+>Z5]:8\^L8)NE;]J*B<%AWX)WH
MZKADE%1A6<,'GT9?'_25BG&V<DE#9(KGI<#<XD!LV[GA&9WD5#?+F 7CJ<R!
MH*24A:BLF+ +-&5&GHO$!/.Q"K&6MHGRK>V'OR6;WG,)KO4L3;8Z?O;WP^4O
M>*W&&#:+)\;*<MPV<0"RDW[K7X8FV^'3H^J?^5YO:&QM_YJ\+6PQ5FV<:JH,
M>A7;M:,789N>H'\EN7^!<;2>&/.AK=$^XWRAJ?Z]"Q$,;& 68&VM2G4L4LI'
M7X0X_85HW/5K<L]"=/1A&_)^GZ4FCNFC$*I'.WW)9R7R4N08")].++/ DU,_
M.ID%'7^9FI_W41]^2;]8C2SD>_SH#\=-]J,"CH#"I*N=AN)+[)^B>)+PYJ#D
M1:Y(,6>?Q@6:GT&)NCJN.H9"?9]W5UR4TT)<H_CIA)^9Z!F%<W3N)HZ2K/%E
M/AQ>0:?&OSSJVFJE])V^T&B.:&KM[NC<9@PVNG";YO\7X<[ ;C^ <! M'29%
MKF=&"%ZN=#-3J7\KY@'@&HP WU&(+C0">]B[RPDU7NSEB>3\N2\D>CWL>LA?
M[>'!E,&I.Y=69:  PJ<-9YE^J+%XQHU0%0^,[UK,A=1T/TE6?'5TA,Z(G8I-
M>_Y$^S8C<M1&4:U,2'+X\K[@K"_?%,>"TXWJ4LU]<:N/F\<>;8+M;S_/^$B_
M4W&X51-WO"UU@28RZ>]S8J^/OJ(+4=V]+F9LIGO;\W9$ 3BLV:;'<(FKZ7!$
M2%819]_[?83U&N94L0NM_:AEN#EPN3<P6-K+#\?'8-RYGGWQ70K#TD_&BE$G
MD^Y[NF9^'Q8LL2.<WMJCYQXG[5K0/+C.HL&@21N+Z&KQ4^QQN-4TII!7.KUQ
M%K3(T\A\&5(Y%F @H&IS%NXG-#-3WV,>]!UYU8E1=K.Q4E/WQ!:^O:WR7?&T
MR/NKV6^>OVC!$?S^9B<V2G'TWD]BNEG3!.)6LDUMUFW+-J\<)G>0S3#\AB71
M+"A]V_ 3!?"9AGNM@AZ>7 U;/.P+/+[-\/J"_1O236)Q*4R',!*[+5%?#S^[
MJ2+HF%QR=J53P8!1IR'NZ-4?;=G;C"56MFI^UHO7QW;5!!O_;/M="OL-OVXK
M9[DL.Z![F>#81Y8EFD@E/4)J>$>4.;N\"3IA,O^BJA,3EG:O]0KL#P.C#W#@
M([LZPDFR(U;CAQ?.^O8N7!Q5@.F[VS21OV<\__I8\V(.^%O*TD./MC]]?^2-
M!Q=V&!;I".75C5^^TH&^_:3;LY<EZ/0?(-B0_/"J^;['=#1VLL%^G^[Q86R$
M%SX> +E__*Y1HP;,L-:0+T/0B-N+Q;QU4-'EN87=F=$0D55?%=.-3@D6$:JC
MV1/BAEBB8FW&MZO\'IZ;=>JI-1+=>WB?!='#9?<O8/@_*[2Q^ 32:\47H$,.
M"C!ZUOGWDTA."I!93* E8RC \:4R9,&9,A][@G?XL\GM;K^8&<E<XSU;NJPC
MEEJG])X1Q@VR%GZKQ?@MEO[GI1:3^.VAE\TJUP=M"KY7+I1D# %AGEW/;D&8
MR<-D<<+KD9W=?9/VR63A3\828OR'[HQD^KN!T-"M10Y]5BCO8Y =*MVZ-;TY
MT3#?%GQX2 &$JDR;B+)P.#Y,ESX8ZRI^8U1JUFV\!]Z4^OJY(^W^X"FVY^]8
MBVQ5 G,P0=&$<,<EKG&L[K"F8?RYKEBUR  J]/#6?&M$\+;!Q<6H??.1<Z0G
MA/W%F54_6;.D1?.8Q1_^LC_$@BH:->?X _*;U/IG-ET4" RIA-@>?8'\C9VC
M>N[QH";N[TQC9\O$NA)2>P7%A$SW*_,M8UPNC9,LL((C'-"-9XPWT(\=_NS\
MTKF0:9M1V_2Q?-HI,PQP2[\Y^5YL:;@: P'6!7@32.[Z.:5WY\U#%3[*=5?,
M:CTJS^#5XKNO);43^RM*,_WY*-'1B6#\FDWX$B'^+?;D=B.O0V1]@$S>#X[W
M]V[95#Y]PJ2Y%?8))DJ$N.(J(OKR)1"VOW")]<U^?@\;)US4<Z5?=(9<_+H,
MZ- D[2%82)<G_)#>',FZMEAU@G"]W^-?#0]DC>KCIP5UOGZYM:+EFC5UJF1)
M=6^7$!PSA[:S$U9:Q/2%_8ZU?*;%VO>'-L9]OBE.7%CI74@!NTI'._=D^Y5-
M8=5?.S"W*F\'MA9D0W9#N//(*V=1C)/6\(7XDR\,I@/#].[$S$T#@L7I5JZ-
MBQ[!_5,>RTS][[C#+#?>UWS6WR^)!1*:\]YEY<>W-6)*NJ<B+Q+/C71[AZ 7
M3+-^M$[_5BW?^>'(KWDRM1'.\C=5YR""8)R%B4"Q3)&,<T>ZK9GI[ CK&4<=
M6N)E9DU*_%*:8EI;F@7LM#;(29+)B3PT4NB:=7O31'VJZZ,M8;.I =&ZRJ2:
M_,I66R)XZYAE6U^:J*?/#=/RT^C.[:L]+:I<N+?.4Q$(%X\'(<"M_(+*7TR$
MOLI6$4"=H&WP&:+YM7&U[+%ZCK/F]+WY!?(]T<6I <U%\FF.*QL!NW8[[3P;
M+?NKL0HD0ZS5%R<OWLQ%BX;.!XZE',?E](]$TM=Z3FXS")>5@V,B];T30TM'
MA&-#,:6VV=@0);F72B$O8P):'Z3D(W-_H_MG>JOB=1T)X80=ZS'3WIR$ND1Q
M]T0W9;I["[I+M4KSFU%3FJ)MC-C#3D=(<DX[*'?5.LLR_6:FI=JE]$ G(\D.
MPLZ<^K*"2NP$P9DW-5)X/5(=KS<25W+-N\3LG!'O= >#T/,+,MI/; +6>P$8
MIMR[7:(%/PB974>=@V#/O,H[N6HS[24^QUJ0^K CG1^@W_O6S[W_+/;F@?KV
MTP^/V7S<K7ZJ,YBLNK@6DI0(O^L:>(X1/0.[JGEF;H%GVW-?CFB7,KH-\GVE
M8Q/^N+S2YA#%(ET8I0EF@@]8$Z,IP!,*<,HYN?"?HTI'1?WYHI,PQ1.KTT83
M/&E! DGNMCEA.\^4YRTEWU2Z=#]DUYDQ'GD)9_EBD4<5)4!L-$WH%@A)/2^1
MG2MUKSCCC?#=M.E'?]-; "&+X$5\13V8" 'A\\(.$-.0:;CKG]!&!$IK6'U[
ME@*<&:D/MP"@C)WFL_(:MD1T:*GYLC=^,]3:R33P3Y_ @_ZT<,_BL(I?J1CX
M.:C);7\FF/#$SMXH6[Y=6W#DSRLR'+OV 7Y38CJ&G7VR,S =_*T#5E#B@7;Q
M[Y99:,U!1'*8//];C(F"39,[Z,J<)ET:A]KWM44VLO)=J#V9<QD=Q"I_3MIE
M7C%#:%7I(JF &R>"T_PFM$;[!OTAO1=2'8(H\TGR5Q-2I:]ORIBJ@[9Q'O\]
M0>7D[KT77$J/D6\7:%MVH),-C"@L;<H:RE*&)2H>-AV-.J;?J"XDG4="IK=(
M>A.[\ME'1:^>?9JJ[;DXISJ*>'-93">P8]>2",<@$K,%'N5*)5;N\==!5?MK
M&C-_?/,,G>%1?VK#1L^H2[OE11M-9*22?(XU!#V.<.RM-(#UTY\A8W6ZAF_=
M&;JMOC-[:*QM.Q(#IR.I$&@QY2ZB!*.RS?"%IG$+O:UQ\)LW&2_]1/"13JL3
MN(+><$\JZ4[0T&<D.OIB_/PJ_"6LM"T/[#P2QTS<HN[9G/[JQ#;)\V(0O?[Q
M#1HNPOC(V@_SQ' SH0K)2>[>WC=N65$T+B7@'N:!CF%IV@S\3AELL3:GI^W,
MG_7=.P;-N7TS85J2(M_C1JH9A:.B?]I[XB,.X/BZ!3Y\3I(:1Z-/^'1#'2H)
MBUTGT,J4]2451%<_ 1AU6:;&R71#'V#G?Y$NN<.Y?]67,69CR<LU_>);]N)+
M2BQGHG]FH=O"I:)5+Y,4E][3FK1 EYO'MT3J7V/$/SQ,N2QCRL@OU%' D=]^
M@22.1_=8OH"<VX5=\Y8LE-L_>8%I]'XK*EC\,ON2J3@A[9;>E\8N>*SP10)O
MCS_(*[P\U'X&E%"5LR7@.V\J8JDZD"W":4XCD++Z+C#W !('8@]6/+.9K]&&
MRO_E53_D8'[BWACB83K]+NK(*OXHX69ZN/Y%DM8$-0UV0;XY63/?O:OFNM6^
M&&P]-+)4N=1YF^:H_VJX ( ATZ]S0J5P&CWIK-YYV-$"GD/.V=ILKNS;T!$]
MD'"35?[KW<E5_?/$P%(O,)^N&[9YM?Z9SMTDIFULZM1@,9?A DN4UIV4\RZI
M!B P3#U#GQ<624A_ON+J7^QK10$>W7VL:2LFMQ0.L,6N<Y:!:\L5<98\T%FL
M7M<[GU"/OHZOO_UP_7M<Z5\$)HD4  ^Q(^:IIWZ&AARC+7[)9?N&239GX#CH
MDF.:;=TR,K6#0BI/,*C8(CQC=)W?&>7R7R$8]Z"3JLM''UVW[E:3O&B_H]PA
MQ'T")@?DJR^2-[2_!J[<T&7NWX80> ?[LT[?^Z/\+<C.* K@?F<#P@H+7$J_
MZ-NRVSU[*E%>WW_>>;WEZY-2=3.%/!/=6N&BRBM/9#\2=? U%*!CW#<<_4*-
M*1AR?C.0^?%JM&DB(,7T%L A#*?<DH"]%L+(S#C9-+^4 D!XJ*!(S;<(;QD'
M@Q013WH%LNLKBLFQX<OK#>:Z:7[H,$V906YHQQ*5D:J3](C)! 6A:]?'*TD:
MC/&27OF*]:J;(2QQ4@$V[B=+>]M)P/Y[1K)!>.AIA D%*$A".7EV.X($O0_L
M><A7\JZ_,:Z6>#M*6FRA.;OB3XMH38E >QK07[#Z7R^PQF)BJPL>T4\!$CD*
MB+=PO7=N_2S/Z'QRZ8^!58S9G<Z1=8BU?1Y4#--0@JE*6E CJ/TXR+SKZV(_
MC8N;&FPUT>F\S;AD 02B6)',V I+K%T9@:-/_:778>#,:=K(C7C#2TGZ^A[W
M3=?:FR72:0%[,;S.[9]!B]/PNSD]0Z)K?@$!0M^2=>:4C%B:5L5?,J+KGUWQ
M[5*%3"]:0Z(:%^@GZEE-]R\KY.X(YMF%/K_B+B,H4\)()ZPY'%; (4)H2/^X
M >+8J5=D)XE.J,KR67G&0II07@MJ;%=.!"4ZA5<K#2M'< T(/RPD%LX&,_S<
M??#>9<-9G_GQV[Q $_E6W:2PG8Z+^Q45]IBJ/G\^J#J$;2-W-6$K:#G:=9ZE
M.7--0;VL8>35$V4#QK2$W$VD+]Z# O0BZ(,XF(OWVRKKB[J]?LZYITA"'TR%
M]6V7R,>F[.'J@8<D!Z+2$HJ5)$IP:G&)._LQ&6AAJ_D6(.X:HR$7S@SZ6\[*
MP;Y& =C@GG:$AN@2^9S$2E5IMPCB_/<5-SX/H(%FX&P'CGL&'*<O >WNB+P\
MJFL;7,":MZG66.U[7O1S9*CJQ](E$BHH1)=EO6XDX3*X2Q!,[ZN0Z7;3G#51
M?D"&__;9;Z:,\4!*VKPT[0^2WHDF\9H-4<LW,-C+'>U?-]GNYUP<*#-,.(I.
MT.R0XNL7"1P8>K(@1S Z3 :[S6MO6KW>4<"@S.URKYJ;?MZZD#6WW3$"LP_V
MQR_B>'(P(7CG_-8"_=C?>7?WS7BL0H6:<??Y.G2@0@'3"0P-)&\\C^](#(\^
M+7Y[LL7"3^YI7M[*PWM\*JHI(66<YDHB(>NY !ION44!,/X,&]GAQ\]:K0AL
MES[ZW3A8GU_VO%I^+[!N66D;$?X'/%VV!'\."\;O6$!<JG.L6S.QCD$<3]9>
M?NZ?8S&1TAH8>F;]V8[S_0%NKTJ/R('?M"8Z+UT85;NW_5BA]T<6;VV(UT'#
M%>7!$MWPVXRIY.%%!J06;H1] ^TBF;3IX*=BG6=>%X_=,+S )5,$2_IX/TOL
M_.Q/VJ&0Q9H6_==N.#\:B3"YH/<A7O+/4S/+WKE1:<G(!,)A,Y()IC71+K#F
M,)E=HE?^9V%C'-+W*^U'H88-(#2(TO@6_C!H)?TY@EK(@0T7Y:8)J?JW:N^I
MA3S@T5:OF\<#VM_&@OG3PGLT:QKJ!!?'[_[:<E\'XS6,UP:-F<!QL%T\N&<
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M^<9G6B"2 H"=[-?:BSP_K:/8'E>H!L7+BRZ:>)6/+0H[='W-X'."L_]4VC8
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M-PRX-N[@?JO2;".J$>FZP=3P/,@D)E([;7_/H;!JS?_%WIM'-;&]:X.%(*.
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MO/I:6<57K+?U9NR!=5[M05MGC4LU X%]%GK=7#45U3'J^(<G8E*UK-^^" ,
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M-)]X\Y-*+B\HLP@)*IDZFK)Q(?M*9T$:_(FB+>=B>.Y&_P,]V^(HMNHI@LM
M%5\X%>%B_:L/U\B4&>[EXKO;_KEW8FCM^N>H5*Y'UCPC..[(DPA?4O^#=W0X
M03_!<_".6\;>8XKKLRD#B96-/_!DX8&H-8=[S*_3(O4@.QGI>[0T4@+%X?X-
MU_RVG2;.OS^UH=3_\8(;";(^$.'[HW_,M],.50E;X:&4$L1Q 50(7Y<H5GW
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MN"SCU),7$D[J]\BON?RBP*AYC.=8-5# @9Q:0;&WJANL\3HGH7XS<."2ZZ3
M8;\XC@?CB!\B^D-8*>80O,J_W8IC87HO>;[33WS"9/#&NOK 7'! KX>'?JC'
MK4]6]RV B!/G$2%_\-F?D 2$IX@19O[R[@(S$YIXCQ;:.3H;^9ZQJYM+ZE?"
M^\)C\JYF7, +R*S>N*A8>V]H%B,VQ.1GCI$1D3UGTH@]48'.QT;&U 8M],;R
M@Q)$Y3L,GNJ_YY&/7G,9^^LJ((FJ4EEV+:3O&M6VDEB2WII/92KXM,7,Q <=
M.OC;B=V=/@[Q:F?ZJL3E.5H_G$3D48,H<C4T/]"<)"K1Z(CPO/ 5<C%_T,Q-
M(D55X 7_B^0"^$SQH39"_<_G?R.:"$P5I"[C=;5&DMQ!RN\3@ ^ J,MD[%O*
M1:P413?7;B!+Z:S"+QF?C.0>WQ=]<GQS;Y!L!A.IY(.&+&.UD#X4Y902,.]B
M1;B@RD7R\J5:ZD*?PNS4$[/6W-O'9+)Y0@#[EW\SM64B^JCF8"$91]*(9RHB
M 8I=RBM,PO7^=PC/SGVX,??L0TD';6_/CGT7?OS&@^/]A.D]LCT!WLTP[78<
M::#@NG:4JPIFO(:\3R!,C4W%+QY"))DIVW+J# ?.AW;&[>$V6O@[=*J]^?<,
M.X"J.C>.BV,*(NK:=WH>8,ISY[[T=PG(UP^-,2DR5Z.3A8SW=GK>4)H?P;G-
MC'E>!A5#B2A)Q"@\K0LM0K?5R'GK<[=@;V=34NAE$=''3ES/WQI>Y3CC$LP"
M_H8)?2S@3O_W8A?&:VV4 !C=%O8Z^R4BSNJAG]Z.WT7OFPXKD$-7M2XW*(G_
MYB>_Z]#M_)Z?,[',W4-829"G@[E_T/X.NO!:E_N^;H%'U@)HZM/9M ;M.?A?
M)S52;O%R L45G];9OP^!H893(I.*O:;EGT[YR(E21/VI[IE*:8??ZDIY]$P>
M%9I\7[Z$QW6@Q_5(Q*"X1$,U<-M8;_=O-FJ1DN0?=RHNKL887PQ6#LY,K\=9
M'@\M+_ZK_':"N8N=JQ1!)YH1TITR4AI1-.DM=[(I,<)0YK2;-]$V5#(AVN1M
ML9#ADF[8CO*?5(D#4YY1@=V%2#(:KGX3>?1G< 7<R<QG8_SZ20OIQB=J*=4K
M-X2,EN^=@1R)[(!Q(76):Q/[B7&=5L)M<PC%]IWGP](R)]/45SU"I-(JSJ5]
MFICD4S#PW6S$6H(02A,5SLBG\^?O)\=U^BD+'K]N%K@6='_00@V37%7;EOG@
M[:F%ERV<?PQI.=+?RTCW4>)TE1#26HRA%KD;K71\9LE1?37/_U"?6();+D^*
M^6,^?H$]^/VIW<U+?^5#PV"V^[28HS,\2,YB4+-]9E\DQ%M/+.GBU\A%IP2;
M3^FO(MTJ3_]ZGJ:]@.)&W?1M424&%7>R@"2F;@.81\J[I)W[,49M^;G9T0]\
MOVHS+CXH>6NF'_#00.8O;QX+\-48&^U$R6FOQ=@W[J9F>TK$!&U^\[>_DG7.
M6T%02D$]'>OT ZHS\&&NE(X$_2G,):)?71)S+V+-[/T0KJJPLHG<'\^5XJM8
M^&':!TCEW+O()R.TUSV>V"C\UQEL79V'"@=[*9DDB8?((,IHI\L!<V'N24;3
MQ:]TS?WTH373OJ;#[6N)"I&>'RX)-BC7&>I%]D9JYY%N(5U!56(9K!VKDS_E
M%V0NZZBC$_80X+[V%G?HRO&KY7SG;]C&6KWXF^D+0D836,"*>BG2[BO2@F+5
M/2U72>[.G*\@]\?:G:DK)YN)Y"38?KBRB-<\]7'/8>CH_B":*MT=Y*0H=LG)
M,]!T8\(,:((T.]W41,;%#XSH>R?M?YKX9K?)7-ODHUVBL>."X;I_":A[J*KL
MY5+BS!ZZPTCD<:0+138MT5!AIM5/_=;0WB0#/1&@T_V)Y4JAQZX'''>N56@/
M,\<A51$S*^KD?'6)<\W50U#;U_".$F_=[0SHO1Z%Y^52 PZ_B7I .3>.AKDY
M_2U^* "KA"PS9ZK\VPPTVT,")EQ\T[3JQLMF<SP2PW-DWF;9WA(3U^)Z8/D)
M[]&,(8XN)Y&F)$CNVUVX*,-C0\WJ1 L''5]IPPH9&9GI&/31M#ZQ*U<QTWW<
M5RS"X'\Y_-"UAX8'F-]<#H/1A!4;(B2M6;, M+=H25V=/T_^Y#\'YSJ]/E5[
MY/M4V^/44!MG^W@6P&9)2Y#:F1CL">.((DQL8 O'YILRI2PCQ&#Z?8ZK^Y95
M:;,_ZJ%R>IZN?RVI<%J11^C[R#,]5N"136F[)\+C6BLG!T?M*5[C>UP"CPIG
M+QA'>Z7,'&.T83!_+$;:<Q ^IFID'XH':DN"B"R@]]^^$]0O-A6!L<$.^TM[
M2]4UK1B_]W,>/-%*W13EH.[^.UR&8U7+7A</B9^6!HL(PZ-(E7=.OHW&'[Z6
MS;XY)/"F0T/^ONJK%[NPUS$E2[,[.WN*5^@X&U)]'-,9-3'SXN.13?NOUT':
MGI?H\Q(">\J+"6GT-&E_1@T+&+"Z_CD(L@?W S&$6BEF)H;-=\(F^P>8IAY\
MJ)HKOZOC?@3F,<QO[7O<=48IU)909G^1<@Q=8/IJS,R',FVD%'NVOTG1WP@.
M'X +1;Z-M$-U/$>ZLH$EP 96Z^D2%A"G!_8P$\79J'H08+_X7)3CEP,+$ JB
MI#%$U859 #!7R#RP1(+L'':$,#D^P]\&6O/,>M)/CW;#-JVK873.W#0P ).,
M6BCP0H$\VI%O!LY GJ#)\W!)MO%GV?XA"_G "%^P[-3U,H8=UO@#WW:*SP/_
M&/+_A"$8+S39-"(BZ()E!8FAXZP_MV'7/7[N*;WXSF!KU(;K:5E->$DUNU,(
M.SSQ.=,'R*M5]XK-B'Y7/./N.+LE<SX19 '0EB5=INP0 ;TC&>1/HTFP &E,
M _,PZL/6&Q8PH<$0??)Q=.1R'WFC2,K,9W 1*:2BTS6$.67BJ#S2U[ N0=<O
M[H!M'E^<V:9J,+5-__5?N,N $\J#@,NF>.I21W1_X;B0,>P1_B3W,_;HU3$8
M22P@Y?(?3]B/5E]FY,4RX5UQ__3Y7]_'_CVBE'ID2,-P[QA2#7V]2=Q%*IOF
MX*_HOG'HV)?@#!LVZLUA[89K\TLUTV 2T\1?'/7])(11A]&4>%1XL>AP&](*
MWDI=IW?LBR]RM)6KL'<,0^]B,X%&)%OY&@N5L:O=+19 NHKZXQG;K16QGRS@
MW^&3P*A)8?JW00[^J=E_VE'TWU%W\Y]>_RU[&2Z@R6:R^QT'_3"9W=*/S/3\
M>3\]2J/'V*,(_8VZ#*'LF5P4Y2UMHQ6^KN(-W^I$:3IMK=O>*KQRV5D&=J9
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M#OD2MMK* II;US>LMO7RXTZSG3^!?OIW5@&5^T4Q9IYSMF*.H1:&,9P8)%C
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MW:=*VFR3[;DR?3^[G2AQH16]ZHDIC9#%J&VG_:>A(K8>^5ZFUS9PUC]1NA$
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M2>6E@B=9AP]F.-_0G<.^QGQ48V$ DIZAOZ<[=%1^C*5]=HV.*=M,F*ET\A.
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MEZP7O+QF6C2'PQVU5F]-<F^!92^(H2TC\ V6TCD9I7GW<LUMG?4Y8(M^F7!
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MKYX\![-Z$Y[BYFH7U9BK5A1K;_[**VI3E7[3YI:5MQ<M9EA-Q8N&N[F ZV<
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MP0N1]/7001:POH?9F#3$A(W[+E*G:GDW!#UQM TB/=K@#R7K&CU8/YZ)JEK
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MK;K_$\+G^-!JN8=)905\9Z-C1&LGMY:[8_XF[<,LH!:QOM-A>+6&N')XN7]
MZ5-MKF+*8#$+D+&-';W\VQ&9X=5_VCV\PF;__.'__83T?ZW"%SH\P&5C(BR;
MHB3Z%)#@\\O^<"!*TJ8FQ,"LHO-NXR_P,,<Z,H8>J6'*0*4MI\TB*0S(+>'$
M3FD'"O'O%+'M^C:, 3F"PZK22>F5M%?PORGJX-\?;&DKN$SL>\>T&=IX'1"/
M^WLWX/^"=J)Z,*C"M3^_#TA@ :2=0@H\5OGO],05F^[H;/2\A&#L7R".!4!
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MA6"7K')GTM# J+IX !\BUCBAK[PG5]SJL7)BIN,W#/FCH<G.5[RD]_LF2$Q
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MC5-#5-85%@E<<RGY7ZTB$1J0X:YV18X&/"'7:L/.T,$._+8/OU7"[[3X&RM
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M7F3!H?5Q\##R=1P-N/CA]@''56)&6SJ^)4)E0Z5D^87C-Y7BR:ASU_8)]-(
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MQKV,0V(;AU_9*FWMG"QQVGWA$%3:/5%R0/J/=L=<8BZN=4EL_'L@XM'P*A6
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MQ;\K$5WEOLTTC'[<^N#I9+=.OJ:TF=Z>E;4D7Y% 3EGR]3X=<M=EOO;L472
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MNZ/OB@_/K-,46,F3,]5DH(J#)'8<^E9HLP*:N\[$]>FB'V^\5LXB@66#$*X
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MK_,/PNBJD$01*K RC!ML1]'+HG@=8.R5*+PQ ME#J$GHE:G3.QC6?_P=YL8
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M%A!("7K[4\J"I35#$O \F?@)L89R4T^NS:+#:TAI4(V>,_ITH3/>@D\P4+#
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MB*,+&XT+T%?%6!MO)TRP+4/KR\_YL+ A,BAYWHDT:Q<FOKPSV;6V.B?BIRA
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MT"W[\>=3%>=T3BK=;YMN@I0-RMID\$N5H*D)/$G4"D<@AQ] QR6J.I02Z0;
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ML,-KUGC7'>\DK.A 'DK=7:\DW7YZ)9V".*32BQ5;B!J'^&T6/2880G$2F.0
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MX'_&IG(-=K,"<YTHVP[OMS"UPHSOMCE%/EK7'XF>5N#;3I87RQ$J3["?73]
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M(>L1%/-#&;4Y=^9:KO38BJ0M.ZL?3 L+#=#D.LTF_PA\&(,8A^!3B7[E$!(
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M_<XR\&YA$>R!D6U!P8G;;/<XJ4 8N7?DY\@^F][[N;:D/)V0>2/EJ?'VMYO
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M%'4X<>LML]^-6&6'#S+C_&3-O+V)G2E!P-#/J*?^FR\RTN#_ U!+ P04
M"  )-65;?J%54B@: 0 ^/0L %0   ')X<G@M,C R-3 Y,S!?;&%B+GAM;-2]
M>7/D.)(O^/_[%-@>L[?59D(7#_#J-S//E,K,&MEFI629JNHW6[86AE-B=XC4
MD"%E:C[] CPB&!<#0(!4MK5UED(BX>X_!!SN@!__^K^_/R[!"Z_JO"S^[4_^
M7[P_ 5[0DN7%_;_]Z;>[CS#]T__^]__Q/_[U_X+P_[S[\@F\+^GS(R]6X*KB
M>,49^):O'L#J@8._E=4_\A<,;I=X)<KJ$<)_;UZ[*I]>J_S^804"+XCZQ_J_
M5G]-$0\82WV812*$*,D(3-4_U.<X#'F$TI!=W/\5>S$7U*<P(WXF'PL"2"B)
M8((2BA AF"1I,^@R+_[Q5_4/P34'4KRB;C[^VY\>5JNGO_[\\[=OW_[RG53+
MOY35_<^!YX4_]T__J7O\^][SW\+F:3_+LI^;OZX?K?-##\IA_9__SZ^?OM('
M_HAA7M0K7%!%H,[_6C>__%12O&I0/\D7./J$^@3[QZ#Z%?0#&/I_^5ZS/_W[
M_P"@A:,JE_P+%T#]][<OUT=)9C^K)WXN^+V:VUM>Y27[NL+5ZA,F?"FY;T9;
MO3[Q?_M3G3\^+7G_NX>*B\/#+JMJ:U3%9::X]&/%Y;\<(_;S&>P[XG>USZL#
MYAIQ/[OB<0S3S\[8O9,:@D_/\(#,V2RW7Z@/!9OKN[LF=3;KTW/LZFM1KO!R
MAJ_%ALR Y:7ZQ2?Y4T=&#32B3!LZG>H>L,J_KWC!>*LMMX8&.?NW/\F?%M7W
MZOOB?5[34FZ4KQ^^/_&BYHO$9XPPCF'(0@H1R1#,?!K"+ F8G\8>B0A=K-9?
MZ 4OX&]?>]H-@9'1_V0@T^K(VJQX73Y7M-W5)$6UH[=,_/N:W+_^O&''%(#E
MM&(M[20"':ES)&.=D=/LS]-)N$5F DE+NC7F4AD<9;4K24G')6E7KWH$*@/.
MRT*O69N'7_IY#^O+JF<#5_0$+-T3/]-2&DM/*[CU'1!5^:C![ZK4F)X6$4GN
M3Z"L&*^DZ7N ]?77Y+F&]Q@_+3[F1;[BG_(7SJ[EO!7W.5GRR[KFJ_J2RLE\
M7BIU=?E85JO\O]MO3^1'),X"#WH)DN9MQD)(D!=!''/N15F6^KZWV-O^CG[I
M[#G1^F;J[?HCW\X!<3"DKK<<S\!Y7!M-#)N5RFIY@0TS8,,-:-FY ,90:J_W
M\]'8;.FUA*.!0N":-'ATH_^LM,7/?+FJ^]\T^J/1'6<P,(N".1^@7@LY&,E,
M535J[U*(?)FK$?^C7,IWZIMOA?SW(7^2IBI56\X]7R 4<A93!(E'&414!#"C
M00)#+I)$A&$<9*FV :-#<6*C9L,">&AYN !ESP5X6K-A8!EHX:AA![E&QTS1
M#(#YCQZ8-0/@=C)@#,PHUP#9F59G V5F<9D(/6J%:0TTGV5F(M>6M6;THIE:
MK*O5XHN<:_XK?R2\6O@A$T$2>Y"B*(/("Z4:C)F 7&1!)B(OQ1[147X[XTZL
MXKZJ+W2]RBE>@E\YKI\KWAS&_O&^?,1Y\?_IK>!=+,85V!D2FJDI:^&T5]T1
M4<:,&?G*P)"1GS9&S.YHLRRP(R+TR^C8G^W<G7?/=5[PNKXJ'TE>-+KT"Z?E
M?9'_MS1CF)R<7.1X8,C\UW->22NF8)_DK^527N6\EG^3JIC=5J7<@E>OMW+.
M5_*)#_+9)S6_"TYI0$)!I GB<8C\-((IDL8(\K.8^C0+1:QUD#(KUQ,O])XN
MP 4#O"=Z 0J^,O.DYIE"/>?KAYL8,_W4LP\&_%^ C02MXP9ZMB] S^,%:+B\
M:"9SS:@[-VY67!UY?O/P/*NS..LT[/J7\Q*W<$D_Y50=P%W>5[S9UJ\+6LE-
MGK_G[7^E%UP]\R$WBQ!E*$2A-,I((!U4GS"8^8S"5&X8OD<1CEBD[:":TY]8
MQ7<,@35'%R#O> (_L8ZK/X.GBC_A7&X"[0%F;>"D64"NX<M."Z292CZ X?4:
MP_=K##N6P("G:6$T\'RGA=/.#YX 5C//V!Z443_98MCYO&9[F;=\Z#.&L7,2
MOO!Z5>54.NU7N'ZX>JXJ91&BU*>8IC$,(XP@0K$/4R82& I!4XJS&!'?Q*@_
M2&5B#;VA":@D:F9X'X9%SU ^6U@S+3J04]&[ !U%=Q;JJ$".+,K#-&:U $?%
MW+78QA\V6XN<LL7E-URQN\?[6VG6K:K'@GU<XGN=)7;TY:G/ZQ5-<)<_YL4]
M4(2Y'$1^X$QOI1T7>GR5.9'7\ 3^J*C@#T79P=G62:D.++.:T[_<ER\_RW>[
M%4;99F$='W&61752H'Y!G7[0PEWI_:G&4:IS93Y=E=*)*N[E*I4_U;D<J+&J
ME'>T>KTNY(S*%5U?2Q]*^5F?G]4!W(WX^H#E[Q=Q&HHHBS/(LIA %$8(9JD7
MP)@$E/HQ\REBVKZ,8^8F7N<M#]*Y:9D N61"?O'+JOE)L0-^R@M0-[S\V< P
M=SU'&L[/&R)O>5@UX!3(G7W-+-CB]@)TL[1F&/0<7X"69W C0,OU&TZ1@6/U
MAE-EYW6]R929^64383KJM+FF.9]'-Q%:6^[>5#3L?,'=T)9?JK*N/WRGRV>5
M4/)+6;)O^5*JV!0CEB8^S&(J-T.1<.D<9A[$6>8E @F1!>%BM0[Z/>DOZ9$U
MVN:.!#:/+-]!!!?N(KCN%1]F;J,F@GI^I'M<S#:A T%M#0O@IS43H.?B^,9O
M[&V:B>W(_=0D.JL_:@;$KH-J^+:9QF \7WR0>FKU^C'OE= "8S^0EK$/4T]P
MB))40)P&TE)."!=,I'&(M0Z-#@T^M9';D .*7K?YZJW[@SB,K^YSI3-;PP:"
M:2_4,0E&W%3Y6KL2Y0^;!7APL%F6V9@8_6(:?<9ND[UDK-GG\?(6Y^RZN,)/
MN=RMNF">V/,\&L<(QFF<0I3Y$<S"4+KU@6"A%_#($\+DX'64VM0G1&O:0!&'
M>0$[\F:;ZCAB>GNI,QP,3X[V(  =9?!'2]O!V9&1C([VRW%:LVZ36F+O[HYZ
M+UF</-T^\*)\Q$_U%_SM^A'?\[I?V3[R THHE-:S7-D!\6 6T1@FR&,BXS%&
MF&L?(1VC,G5<4T\62+J@)6QPG' 4&XVC&Q<2FZW=0\*>7K4&4AN<AKB0WNY8
MPVC*S8XC3@DU>JYP].7Y#@A.\;_EZ9]\V/S*Z Z3YR6N/N7UZDZ=!=SQ[ZMW
MDKM_Z%X;'1U@8C72T06*\ 5H2.O?&1V7^O2]D1.!S;3(4%;P1T,5*+*@H>OH
MYNBD7%:W1\='G>T&Z:1@PUNDTP_;6>R?5.!%?4GJ586I;A# ]DL3QE U=, ?
M/26']N1A$1P9D#N#SVHQ'A9LUT0\\M1YL?B#@]X#)[J<W52'3W;;OR[B(!2(
MA1R&@<I[H1Z#A*O+2!;Z/,3<QU0KZ<\M6_^$-Y".YT5/)\R/MIDN.1PBOW4-
M >XJ7-2"5TV(_,X5UD5[705:/M?76*6[:ZQID'0<%'\F4V\2]>X&R&-A[8Y&
MMU.]G_FW2TK+Y^9:[;8J"_DC;8(KZ]MRF=/7]M^-'1EF#"7$%Y#YH0=1Q)BJ
M54:@[PN6)3%+4!J:*%E3!B96IU^XRL4$&Y; -D]F"M0873U5.25F9DI1<G(<
MJPO0\@'^Z/[KU+0_%PQ'>LV8_*P:S!:<75UE/8Z=5I(4*.>L_B@%>I^_2%V8
MKYXK?B-ZG<GKSWQU(U1T:?MW:69$/B5QZ F8LC" *&58FG^,PBC.?)9& D78
MR/RS86)B[=0'NDMSKPG;!A5O:ZBL2L#R^JFL\5)9%!B0CD<S?66%NY[.FAI-
MP^/+CAN@E@P8\*/0VW DK32^4K]27(&>+7>ZZQQ0'.DO*Q9FU6'G@+2KQ\X:
MRS9N:#M)Y;KH-&E]BU^55;= <4P(\C.8!7X$$<((XBC%D#*/8D*D4149Y9.<
MI#CUU69'#3RUY$RCA$[AI:=PG*)@IET.)91)C;W&Y?8$+A9109JR.@L(.D5O
MYE@@3?'WPX!T7[1;^RI<49V/_2U?/5P]UZORD5=-P)%4,GW:%(E\AH5@,$IC
M:;:0-(,XH0%D(6%<!&F$N%%0@P;-B=?_5:G.H0JJB&GFNY@ IK?\'<-@I@!Z
MXFT%\9[\11LI> &PD*B"R^6R_*8J9P-15JKF.,M7X%-9UQ,DJ1F@X4A%Z%"<
M54D80+"K)DQ>M5,4TM;(&2]8_76EC@$2CGQ.$(%I3'R($NG/8#^3K@Q-:9RI
MFC(B,]$)V\-/[:3TQ #C=(F-=< .%GK+W5Y"LY6]IG,!&DKNENAA"1RMQIW!
M9UUXAP7;76-'GK*.U6].4.7^+M=J5Q_W<UFHVA]8'6'(A;L(/4P]'&109"R#
MB%$*"4I4"8Z0>7*Y>9Z7&D;JGR1JM/2LXO2[6Z"&!XN:2EK(Z1K@;O$PM<$[
M*%KR*BR_8>#/TJ<?\. T,E];7'=Q^:=)SAV5KPW"@9A\_7?M]$*C6Z[*1S5T
M<V.GR@#U51-]+\Q2SB#.8@^BE"=RSV4,,H*8EP:I\#VM$$0-6A-OP UEH+JF
M,$ '#)AI@C&L]!2 (P3,UGUS-P;?-<)+)ZZILGA95:IN8%MQT7EDL8:8CM;[
M&*59E[F&R+NK6^<5NT7=9^M\R@M^O>*/]4+@Q"=4KF*"XTA%$W.8!E$,4QP0
MPD488(1,EO(>A8D7<$\/_*$H@H:D9E#M<5#TUNQ9HIJM5#,IC9?E44D<+<;]
M\6==@D?%VUUXQQ^T"*JML,J/D_KTW>MUP9I 0NUXV@/O3KR..I)#_2_]-J)B
M<IAR-YYUDVV.RCZ^J%R(;;:F-"3NXFQ=!=>.B&<75WMHP/E":D?$V8JF'7O.
MLO\*SJO?\?*9OWL=5(B6ADQ>7W[/Y:86ASSTLA2F!#/IKJIBD2&AD"5I[,4H
M1"@TNMX^06_BI3DL@MW0!'\HJH:[W"G,]/8\ATB8K59C$,R[H.B)YJKER0EJ
M\_8WT1-]KYF)YFMVB_P#K@JI-^I;7C6.BAJ7+A+*240##%&$$$191*!T/S,H
M A;Y/H]YY-'%"Z](J;NX#](Q^2(/J1E$@ZW 4M5 D!Y[&W&L8B?H$JO"+Q?@
M75LD^CM]4'M3$YHLW=/'L@"U<@XNE,N:TR9<F97+):X& QE&+A_&&2>82+W)
M8>*)1*I0C\$,A1SZ&<,HQD$2Z.7@.T/90G'N8SR*FVG(]V'@]/3HV7"8:<^>
MG&I>TL907S1:E+I3GZ,2.5*:AVG,JBI'Q=Q5D.,/6]1V9'^_*]7!0+-CZ]9T
M'+XT=3@+^_MSO6HVZ54)AD<8?S4HYK@EY6FWP5I LS5T7#9GILA1:>R*-FZ-
M-%^QQD,";!5I//B 18K\E=+@I%0GWB]\X,;]FB^YW"8+WAUJJD!UU7%MX2,_
MQ33ED"0\A$A$<E/# L$P9#CS,6(TT>KV8T5]:B^A)ZM"R9IO:=41-D@Q-T9T
M?'5.CI/9"M[B9.CW7X ->OU!^)<9T#-(W)\21;N$?K=HFF7\VZ(Q6@G >-#Y
M*@38RKM5.<!Z$'-#Y3-^Y.S#=TZ?%:T;(7(J-=K'PKBRP,F!IG8A%'VP9@#T
M'%R CV6Y*LJ50<&!TZ"<MG6<XF&F/4]# ?YP7I! 6UXK"^GTZ+-93=J"#BTI
M_9<<=.JYX]7C@K' CP,L<0Q]"A'&'&:,R7^()T<(54:C5DKC40H3K^>^I0G>
MM#11)=C/: /3P*)A!ITKK-EB/="ZY<Z!G&<TM#&5UUG+FE&YS^M',Y3)J.-,
M\^+;]909\CW:-6;K09LB9L]DF5.IF'B5%_<WXJHYPVSB&WXKY!C?JEQ%*ZWI
M=3$S//;]U/,3&/E$2"T31Q#3*(%I)B(N?XH2YNF7.+/B86(]U#(%>JZ:O+GV
M?/=K>[X[9&WS;3:I%F8'O88FFQY0,UVWB^6-'I96)=CL0#4IT#8YN);EV^Q
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M:)NWWX;XX/I!]2'Z6%8M^M>%ZM.GMNZ[!SY(TK@1357Z3SDF^3)?Y8.V!)Y
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M7.&T,7HM24-'XSA 7HJE]44$)#2-(4HE5)G'/>A1%&+BB8QZS*A^B MXWJQ
MZ'&<]+2N$^D=&V$M&Q,4"3TIK*MJ(D?IS%M1Y)2X>U5%3KY@<8WV#5?L[O'^
MU^(I5_?ZQHFZ1P>8^H)-T05W^:/:WW_]?'O=Q(8L2W5N97"U=E1\C7LV%Y(;
M7KJ-"#U!$NY)">UNXHZ..M^UW"G!MN[H3CY\;BSU;:7J=Z]>5;G?U67!5(O3
MIR8:L0G[#V)?D( 2Z 4$0^1C(LV-%,/4$VF<)4'BQ]0N>'J<\,0KN"=^ 1KR
M;>&SGH%SDR=.0*IY_C$!4&8+_CR,SHA2UA/8>5CR";)O%(>L!\;QP&/-]^W4
MR*7T?EB^;"H!?.7TN6HN:3Y\;Z]S5!,_=7;SW-X,WHB]TF2OAP=H:G!AQD0<
M!QF,! ZEYDDRB#,J8*@.8V*$_01IA03,P.O4YL: ,-A0MJK(.N6,Z2FV'V0>
M#(T?NRDP5H(S@.-(;T[)Z:RJ=@;(=[7S'"3/:,#R4"[E&W7;[%X=JI T3@7T
M/(]#A(,(IA%)(*<T"^2GE'B>21NF?1)&ZM.\Z=*=>J4M8=N1_9__D@9^\K\
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M:.EI@'VQQ]?W6<*8GJLU9!RNT:/,CZU ^=)@]<E/FY6W/]XLZ^JH&/VJ.?[
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M\XR1+(_-V@#0+_Q)I2 6]TWTMJI9T'5+C<,LBQ+DP2A5/859FD)"&(510OU
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M2IEQ"TIYF&),H=QS&40L]N1R%0$,HX0C$<2^GQJE5IZ@-_&RW:(..O+@#\4
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M$0G2:AI\BM#$5LGA0E"*>EL_X[P"6!NXQM6)2Q#,5(>]_.=6P]H3SE5%K,W
M;UD5:T^\$Y6Q]I^W/9K<[A3TF:_V>UYY+ D\%OE0B(!)YR+U8*8:B\5AB,+,
M\WQ.F%GQ@]-$)U[(U[MMPRY P0V#B[6P2W@J:$:EXLL$4=W2?8C# ,$L0@%.
MTBP.J73,5%+K&V&W)OWC8:=[TNL6$=-CWYUV:A=-+8BI>ZKIB^SL2%B#Y,SG
MP_H@[!\6&[QK47>PJ(M+]O?ZZPN]JE>&)0@/O#NQ,KSE1=TD<ZZ+F]32OJ]>
M<NE$J1 D@U*%AP0?7\8N9#9;LJ?$=5W=<$0XNT*'AP:<K^;AB#A;Y0_'GC-;
M4G6U6MQ6)7NFJUHZ+=U<U=T17AABGC!&H<]H"%$H.,RRA$'F1YF7T3A&L=:M
MPRB5J5=@2[?QL/NOHMF9YSA&XTO0F>2&Z]!&:.VEIR74V.8H!QALC/+39A6.
MCSW+4M02KU^/>@_;>1#K-.EWK^L?_R/GE1SHX?43?Y'2JXX72"1IY/D$LBB+
M5"] :0*G00!%%A(>IBA*N5;A:S.R$R_;04V#->WFZ_SY\G>K)B&:8.H9QNXA
M,EO?YZ!C;!*;">O(*-8D.JM9; ;$KF%L^+9%P8.ON"A%WD<,^#@1(>(P#A(.
MD1=Z4%6Y@7Y*&/5XFK),ZV1A;^3);R<5*8-$_RVIQY?O6;*8K="6BDWA@BUY
M# H6V,IE5ZC@Q#29%2<XQ/IH48*M%^8K1G"(SZTB! <?."^+LN3UYW+UA3=-
MAE55S!=>O=[Q[ZMWDJU_V.14CH\X\?(>)ADRR4E3D*YJ>0$],W:)EB>0.NTK
M3P.2F=[82L)4^$@NP)<=?, ?BA/0L.+(E3:7_>PTS1-DWB1I4T_T8RF<FF_;
M>0.?-K?MA[I >1'"(4\YQ(A[T@M0$8+8$S".*.*8".7'FYR&CY.;^!R\+45I
M'5]P BH]&]\= &8:8$!WLJY79C(Z,NE/$)O5E-<3?->$UWS+,A2QZ[YQ(]X]
MUWG!Z_J22D52YTUYM'>O@T]M.Z<(>S%"D8"$9P0B)O_)TE2U*$&AB+BT_^/4
M*##1D(&)+86>"15(3?I*!$;-L*R1U5,04^)EIC*LH#(/9[24UU5PHRGY>4,=
M+<'9"WRT'<=.Z=Q4][C(_[OYQEQ) N4R9VT5QX+=RF]<[Q?>B*X/"EZN4[@V
MQ2)X%+.0A"$D4O- %*  IH(*&&9I$B><!(%>+Q.G7$VLGH8\-AFW&RZ;D[@A
MGRH:<,WI)@-1JR?0A-.FI^9FGPPSW3?7/!BK2Z>X.=*A;GB:5;$ZA7%7V[H=
MW.+(ME?R@XU;^8WWDBG.KIDDDXL<KX,I&NU?<2;9&]BB315=SM:=,)KPXB_Y
M_</J1OQ6=Z\N(A$&,4H\F/HJCX70!!+, ^D@1LSWF<A2'&H?",_']]1J?-T)
MIHUIKQ1Y6 KX7/<Q6 9GMS-.I\9)]X\Y2>>;MA=@(P88RM'%B8%>DJ:5]$ 6
MT ES,6@ U,;B-P+!&P&E2-TH/^:T&UP(_)C3;W?=\ -^#<RN..:?C-$+E!G9
MF>]Z9GZ,MRY_WH"\A<7QX7M-<\4+OEW2/N\^23PO( $,!$,0I2B!:48PQ'Z2
M>0QG(A-:_MLQ A/OX1N*0)(TT-N'L-#85\^4T&P#W!;.YD+YD)0&V\B9TMKI
M>\TI-=/!(Y*,*LM#[\VGU4:XWE(_8\_9!),,.D._PTN5]OGU@7.5VK93RF?8
M57Y]VTJPR)) I#!!JF"%YR%(>!#!A$>$\P!GE&AES3O@9>J E6$+[<WIPH 3
MD^"/\U#74%[S86FFY[9@[!@##6>-^;97O6LK34[G.MPYV":Q.;.!;AG-8P^^
MJQ @)PB-!PV=1V+&,",G6&P')KD9TNZ2X7.YXO4M?E6V;]-[LOMYW5#%0XS%
M,8$L58V9*"$PBRF!H<CB%"<A3;%10Y43]";>#QKJH"-I=JQ_"BB] WN'XINI
M\"W)+[I^I#WQ"0HC:0KJZ.S\%+593\4U1=\][]9][=P(AGV_5_JYI[W>YD9S
ML\'&F&5^)&*8"H] )'  ,2*J\E(64L]'@B=&1<\<\S>U7=EQVUQ:;<* Y*?=
MXRU\^'C+-DC"S>29QE#,/B6.SZ$;7@_/R6L_(UU,!G :O3DQE,ZC-]QP]T;!
M'4ZA/1[[X9:,>0"Z:IAP25?/>+E\57W$?Z^ORJ^\;17^*\<JVLTX!-UDS(E5
MZW:?W8ZGMF'Z2_V7I@TO+EY!SQWHV-,/2S?";UQ33@F=F0JT1&V"8'4;/*S"
MU8T(S1:P;B/^,&3=ZGT[D["O^-"KK??/55[<WS9M(1:,I%Y(4@&EVT>E?<<B
MF'H"0Y)F*?*BC/* FMAW8\0FUBB7C+41>F9&UR@\>A:4*Z'-=$%/]6)C\;2$
MP>UXRP]CLT9'/D<VRBBI60T.':%WK0>M=\QKSUVI)H$5QTW?R%B02%T)PH2P
MIL%F"@GE(8Q9*++4Y[&(M9)*=P>>>K]O;'!)R["#YI;LX\OQ'(D,MV$]88RJ
MPAWBW*H*W-9 LU5].\3^L,K;P;^;6\5-[_J[Q_O_*+_]6CSE5T7-Y&=3.WA\
ME*GW*44<W.6/4C5< ,D"^/7S[743-IM+$'0/#330.&W5N@/"; &=Q& "BU5/
M5BL;]<30LUFE>B(.[5#--RP6ZG)Y5V%5<6S0]+$_1-==IB-C3+U(ETO0T1YV
MK=2T+4\"H+$R'<ENN"Z/B.VX:)B.<'8+<6S@^9:AAGA;BU#G>?,E^.&_Y);[
MK6+U)?O[Q\)XDSSR^M2!9-)R5L:5TDOUL(C=!?A8EJNB-.D!?0R!T\O/@?!F
M*T]#[@GVQ!-B6JW!8V/.MOQ."#5<>:<>-5]T3=I\T]3VH5S*5[ZLBM_K6\ZK
M7ZKR^<EX$6H.-_&B;&L!#-@ 7_CJN2K [S50S("&&_UUJ0O2Z74Z 3YFZU8/
MF@F6KJ'D5DM9E\9L2]M0Z.%2-WW5[K#UDM+JF0_OA:Z>JTKJ\87(&(M]SJ$(
M_!@BSBG,<"H!)]2/<!:G-(E-3EJ/4IK:,F[I@J[M8=M\N&SB3*R+A1Q'+8B2
M*"!>!KGP(HA\+X IX0$,6!#'F,1I((Q*JKA!S;R:RKRHZ1U;.\'"T+_H8-@J
ML-)1=7=>?5(P1X?5Q^G,>E)]4MS=8^K3+U@&'RGM^@[7G WO*0<^S;O7S2.W
M;=>6QN!MC=_KHEY5SVTK%[4R[AYP<?/47.E\+HL77J\X^_S<^,]AH$(410J)
MZDV)(I))M4 QC/U4A"R,1.)'7>_WKRM<K?24PVS\FRRP72GTPV7X?5X4RI,G
M;;3I!?@I+T"M)*@-N]7.-[-88,Q"WX<D$1@BJ>)AED4"TH0RCPDO#7S6S>R'
M@OW3SVLO@[Z?6+!_MBG5VXU^R$DRV]T:_F##(-B.U-A( <@K&#[72=(Z_A>@
M.P882-/%\*ZD/* 3Z *L19(_-D(YC&&;>QY<1;?-QO>\<6]S3\=>1-SL#-CW
MLL[;(S/5^JTL5.HN+ZBT;C;UX0SK[AB-.6G45\]&VZ5PR,B@*.$D-72L,'#8
M%5F?]NP-DXUA.=1+V7P0RPP@OKK"]<-M5;[DC+-WK[_)]7I=7#=K4%T]T%7^
MTD:R]HN$"$9$2!A$(I3.=Z3:+D?8AT&"(HZ1'"73*E=CS\+402F2&R"6Y;<:
MJ!D&><\)P&M6#-.'S%'64T738F>HCQ1L/2?*H/E),2/1^S-8\P,ZAEXO5.IB
MURQ,?:F;+[DZ ^CJ*ZC<T0G4ECU>KG*5S!F8-WW)&J"]C";[D2PC6GDAOSI+
MJ3(OV6->Y&I028)_: _7%DE*/,(2#@,221_22Q%,F1=!YN,P]E*1A9%1-Y83
M]"964AWU9N?'6_0- UU/H*:GAQQB8:9TAC!LDP8=;8<!KWI"NHIY/4%MWK!7
M/='W(E\U7[/-7BYH>T+9E>!*/!^GU/>D41(AN<)Q"+/,DVL]]6,_0(R$9CU;
M=PE,O*2;-N1+"0\SJF]W% Y-$^(,(<W6:B/?IT8^5Q6\3@GA+,-X9_B94XH/
M"[>?0WSD.;OE]>'Q:5F^<MYU3COL\:^]]39$I;E.'?Y=]9;\7*[^DZ\VF7-?
M5R7]1^?M+XAT)E(BO8F8L10B$C*8T8A#ST^9P-1#/C.JE3X+UQ,K@M\Z[D"M
M:(*R/]][+O!C6:V:K-;F3Y TIX5T>*I(M9N7SCO1>MKHAYL^^[/>]1GNYE!L
M<$3;'^VV+%VT35A52YE7OAID+U^ R\?RV>4UZ*P(.]*_\_ \JU*?=1IV=XIY
MB5OTDGYY:OL]Z/:/[IZ?6"_+%0U>5 !7U53B4:68-'J_')=N7"7:"F:FL49E
M<M>JXI P=HV@^T'F:_Z\P_96P^?=OSD]A5W7&MV<E2Q\$:,X]'S(L/)L"*80
M>YD':91A%'@T\[/$)/1)G_3$L5"2$4#5$>)S>VHHS9Z^!+#C8]=#L)YUW'HF
M6,Z.63=%D_6/62<_6QT!9]HSU4.$?X2SU!% -,]0QT:P*2A*'ZI2?45XU10U
M[M.1TC"(6, B&#*?J/;5#*8>)C 2C/DI#EGB:[EF8T0FWK$'5-M"XB;%XX_A
M,JXK7$EKZ'CL"6K5X?:(Q"8%-<^7W+)2IOY4&Q; ')=HO++ED7=G+%DYSOUV
M+<H3S]H9-W+?>2IKO&PBZML/G-V(=Z]?\9)+!V*X+ZVWI?Z;1UF:("_-H$BY
M:J5'?(@1C6#F)X+[48!X0$R.A\YA9F)=U;/6YH9<@)X[55A.A8=A5;I1G1 <
MWL@-;:.S9D7/6IH+:S-->2[,$Y3+= &4(UOJ+%9FM:Y<@+9K;SD9TTY+?N$O
M7 Y;?Y2"?O@NU4>!EU?/]:I\E)I$U90KB_OF[J0]V_^4%_QZQ1_K!44)]1'"
M,.:,20V)."2<A3 6<1@+1K,TP28:TI:1B;5CSU8;DM,S!M:<M74==V^8P!^*
M/] P:-C)SWI"])3C'#";*<8I$396B>?"XT@=6K,QJRH\%ZQ=-7CV>):)0L^D
MYO_U+"W_#Y+^JK,UXC 1-/)]Z/G(ARA-/55U&$$2L=##/J&),,J0/$AE:C=T
M31,T1 US,@[BHJ=FSI;6T W=$70"8VE4(E=9 P=IS!OA/R;F7C3^Z,/GU@P_
M',@_O.I1!;#;! !5[K;]W4[5:<&(7+%1#+.(RF6<8 $SPD/H(^Z)B"<Q3Y%=
MR7 7[$U_#+6N&/XWKGJ&<08O7Z0!><_!@"G0'.6N2G"%E_1YB5=<>BFX6,'W
MZL?M6N.-@'WNCVU%<2=3JZF)WFS"C$_2UG,UDI*U!?\%6'.\-9WS5!5WB:?S
MHN).F'NCFN(N@3U>4MPI%3M=[[)!XM4P!*U)[EKX28BQ[Z<P#KB*R\QBB%F6
MP2Q)1)#B./0"(Q-N6G8GW@O:Q,TN4,\JT'/BV=)3YS_.')BI=\-V$7VSG.:W
M$Q2EF =&1UI]8F9GU?+S +^K]6>B:ILK6Z_D=H0W;:TRS%7)]T"E^J40A9A!
M[#$"(QX'(O!PB$*C/C][%";6M4U0I;3CJO9 PTS-[L.AIQG/$M),F?7R-<0F
M\+6/BN(LDW=W_)FS=8^(MY^1>^S!\YHO+"BG.&%>"),82Z\X#J5EE&4"!GX4
MA8E/D/__<_>FS8WC6H+H7T'$3,Q410@37,!M^I,KEVJ_SDI[,EUUXT9]4(!8
M;/6513<EN]+WUS^ BT1M) X$TK[=T;?2MDB<!3H'!V=E1O.=#Q<>6:Y:,'8S
M%>:*3"_.(X)%YH>8!$F*,R^@V$LR+G+),H\Q>)\>&]JMV^CLQBSDAPUU+)F2
M4Q(3(A(LJ&YQDP0!INH;@.,\3W.21,3W,FB+&WN6@#O0[!@B]GK16'+#3-7:
MT ?3L(/?=.NQ&8Y5Z7;9-QF'<4YQ'GUNTZ]8-PPY<07^N)!2* N(":LVQI!5
M1U:G37N?4SXDM,/'KM4QB'G]4C<NWV!R"679*%V2;5AAV3P9!&K"GLHV+-AO
MM6RU@IW9526U:5ONP($M0A%+&O@X8WZ"2:K8GT<BTAD5&0T"*2.:0:RP,W F
M##+H.IUB5;4&4K]5^-059CJ&OS=3O$HG_[PL_MJ;V_Y-Z.!#%8IHLDFKX'^U
MSITH'ZM?JVR8Y]4&?5// GU8Y[;"[-QWP&"8NJD -D5Z8SKU!PAS9"N<@S*I
MZ3! ZJ$E,?2X19&9*+8U;5>/&^-:L_W71A;JVT\WJ&XFOM\ZL+\H=)#6X8/^
M C)AHF5'(:SP[#0M=O5G!VM-5X9VFHB]:K0SCUB>EL7J7GUC'S^*?'.GEKCZ
ML5C/:4JR),@R/0J2J:N[%^+<%P13X0=Y&.3$"V!'Y0D@(XM4E<*F82(-=(8T
M6/2G!@S,$#S)(,,#[$*R@:>7IO@.1C'\Z.HAR=6Y=0K$M(=6#Y%')U;?LW8B
M^9NRZ5Y_H^4_Q.;S\XJW?FFB)#!/F<0LTNWP\RC'U%?V:^9%4J0>XQPVKO4T
MF)'%L@**'BNH2&JP,&D\PQLS>;R<8IA$UL36 %$%<03O?3]1CF3R#)!)I;*?
MT$.Y''C:IH"25GD<.F.C2L_Z)A[I0KN$KYXW#T6I8WMSC\DPCB..]>@*K+O:
MX)R'/J9)2M0M,XMI8-0UTQ3@V)=-6E\TJS8T,_129:65+1J(;O& 5!\:L+%?
MG,=@#DRP*[[<M-EY=;+>%@%T-19;( 6:;MEC6:QY*9N )9SF-/>7<QJL,V%I
MISE5^V6>@/?L[)0[M=>+-HOA^O&)+DK]'?GP0,M[L9[G01+Q,(UPXBM3A:1>
MCK,D#W5R/Y<R]@G)0#V_^L&-K GK?*'%%BK,:AG@E)GUXHY^F+)KX38Y4SO(
MJ 'MSI8Q(]&133, ;%+;QHSP0QO'\"WK;C77*U8\BB_%>GWU0A?+RB57Z+[E
MQ:K2*_4PM?7'Q?)9-Y!JFUH'(>&Y4JDXYIF/":49SE+?P]0C$<\\YLD8VCK<
M#I.1=<)7=226^AO]?\$-:RPY:Z8H)N$73(?HMC\U3N@GC=7/:(M750A188:Z
MJ.F2[0JYL3J$7\8B=TUM+/&8NL?-9>PZT?+FP@4MRYV4!5O%Q.J(Y"Z 5GGU
M4L$]D2<"9UQJBX6KBUNFTY8B7V8\#7/!)*AZJ0_:--D&G1"AC?.SGU]FZL@9
M%V J!\P >&V."6&N2FUZ84U;.6-"]E$AC-%+=D)]6^HF<IO76[7_FZM5-7SH
M2</ZLJW6IS2*_)CY.$F8GF;B>3B7>82CA 0R8"D+,U!MRC#(L2.&#0(S5*%0
M1>JW2%S0#\& EV92[Y9#,-%WP!RP,C"GUY%&,  XJ5HP9\"A;@"\:7F5H9OG
M4MS(73.7>4HC+];S0ZE/8DR"6!WZ)$[4147J80)I''"00C@&,;("^"C6K%S4
MJ7"%1)L'@=JR$^!MY)@YAM>,BT@&WA\J6)K0;HNF49)SSI/ERN8_!C"M,7^6
MP",K_?R3\$2<K\7JV_-2^%X>^5=E><6+)V77?U[2>].<G/,KC'W1+U980T8:
M-/;W1GHV6)@GZ?3PH5_NW+$ *'O#U*,_-0J.,FZ':;1*Z>E9=K+LGF'2NHD^
M!D];A#&_BN>R6+.%3KIMHN=1(DF0ISGV_3S )&.Q;KXC<1Z'0<I9Z,>^49/V
M,^N/+9T=@(" VPD^],N? ^J@3K,=+)L^KR<H!$00+Z/4+F!HM)6PH.!Y,GIC
M@"=>FR[D=Q[GO0A?SV/PX[DJ+=;S 7X3M)H\:IXK>^+5D46^KM;O3C-H0 \.
M4C&B>_@<OI!DF!ZPIQ9T[O;09'7@GEIOLI.VAYCN$=OWF*6'V79D=M,%YN9Y
ML][0JKBR[2'5M)#Z]$.4;+$6M^6"B6_%<JF^#OK%>1IP+PY"'\<D5,<W$03G
M4NJZ6REX$'A9FH+B;=.3,+*Z.&K&U>*!*D2 +O'I-]C0S_ZNMPVF\KHMN?8+
M!CJ7#]W'^7SKKFW3K@Y=LVU?-G3ZJS!*L/'M-L95\&%Z J:-:+S9!AV%2=X.
M$]AQQ\5B_FFU66Q>KSA7@KRN CPW937$1#%]GK*8QSX1.*&48J)NL3A/U1F5
MAU&>2)YXB31J*C,$:.PP:@4:-;!U0T#=H[$H40O?[/ 89%>_BG?)!)@BMJ??
M6$V:$M=CA*HE:CVF?MBIK\&%)U$RIN2UJL#X>3O[]/-BI:\05:&ET@4KMGBB
MRT:3K)5-+$F6QSX.TYA@XDN&LX#Y.%,_2N)1&63^7"F4O# U)GOA0;ZW7:C&
M7]\:NLXVKH:.R67Q5]/Y7&X_60(F!IEQT<Q><\89F$0W8%%3[+R%W-I/#M,Y
MC2AT9*/TPYK4G# B^_#D-WOITB;/5TJQ<)U1M7@1WP5[+JM6<Y]^Z.EQ@NM.
M\-KN>*[==C?R$RUUQOA:W9 KLZ,>:"F#F*5)+'"<)UPWC<NQNFGZ.(UCRF/!
MDTR"JD/=HC>R0=#MO]!%%^WP12W"M:;IH*Q?:I'6#IWZ_C(X?W.*336\8[[9
M5L&4W*F=>9WM-N;3[?=M]VV]+\XFH([+*.=]FYT@]T9]FUTR]GS?9J=0;(<&
M56U:;FFY>?U8Z"J>>1P'7BB"'+.$Q\I.RR2F89Q@'E"9QAGG(0&. SH$,;(:
M;5O/5!#1GS5,\.R>([Z8:;'+J(5IHI90G8/VM5B5';KU43%(N<5,G7/$.9N6
M<P1@XCDXYP@\GG!S]DG+9AF[]KQ-7]YYG/A)*&2 <^K[2A+#!&<Y\3 +$RIH
M% 2"@"8U'X, 22)\(G/=E:7M5+[<@0>VR3AFC9DP7D8P3!@[L$;H\GV>$E>=
M,8X!3-L7XRR!1UTQSC]I)WDWZOI_M5P6&WT?JIV=[>0H&OB!2!A.9)+6(V?2
M7,DCRSWA)5XD2 HJVC@+:>R8MH*+MX";\ 5,!L\SR4P4G9 .C&V?HGJ$+AF#
MI#D2T?-P)I7407(/!7;X!8M4LP^?;JY6_$I*I0IT\\#FRR@#F7*F)#8.I,!*
M/'5+QE2[$S*6I5Z:^9EOG&YV&L;(LJJ 5@;=#BP@+>L,5_I%U!&M,.'49%[M
MD6F3AG:&7D JVN5TVZ6C'=/O*"FMGZ#>Q+0SKTZ7G-:/^UZ"VL"CMK?A]:9\
M9AMU$U_=J^4;(U\WC?SZK->_D;?%>E&%0S\M%X]Z (>Z U3]SM5_666TIRFE
M6OD$F? P85Z&TX3[6##F2<Z\-,@]V/7Y8IS&3H$IRG_(0GV&2L$5IOJ4?:HA
MTWM@!HR+'3"]J$_*5^C-OH-<=1RT=WV-WPS5&&J7[Q9'M$-RAFHT48.G2P>
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M_)'U]ZFQ&HO&6=R@]+]1FQZJT4(-7L#+.93K9N;DB+R$*?41V @V+RV9X<C
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MS*,LXIR1 .?J!TQBEF#*TPA'(LP9C862_AQV=@\#'?T4WZ%0I??0#FSH>6[
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MZP6KD\%)D(=Q1"3.4D8Q(5&&4Y_E..?"2V*?99'O35(:,(3IR!)\NHQXT:*
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MXR\& 7>'_+9Z6FBK\6[Q*/CGHKJ;*E/R\Y+>FX9]>Y886<O]]O7VNNO>J#!
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M^/2#/>B@L?995!-TFL8 61:)+(TE]KV<8>*Q%.>Z\)#X)%6&1BRDC(Q-C3-
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M"[$,. TED2(,014KI\%,=OG48]607!9_K9'F/"IVUU*-#_!B>H9G9F?9Y9R
MZ98=$RJ ,S0X#!)\EO63Y.@L.P-DTK.LG]##LVS@:<LJ%-U8\>KIJ11L47=)
MT^-1U]^OOGTW3]<V7FQD :U[Q'810#4&Z">% [3=SS!KS"34*5=@PCK$$(>A
M4S"UKHHY!N%-6[9A2OY1@8;QBQ9&JW9)%R^B?/TH7L2R>*KF)J_X=[H4Z]\6
MZC^;8J5^JK_5:9+ED4Q"3$E&U.TR37#FQ1E.8Y'[$0UBSZS # QY9.VP146/
MS=LB@Q0VJ$('[? !6,H@UAI<%,9B&$QQ 'AE<[T ,0UP[QB+>787$A=?.-AM
MQ8;^WFL,:,'I[C<V=.Y=?*P6L*B!6RX__1#L>;-X$1_H1MP7Y6+[O3:M@^M9
M8VP7W7*)MK#1#CB@\JV/ <.N=5>T ]UU9\AV7>]F0)Q=S5O?PM/5O1F0MU?[
M9O*\A>VS%><[]7*5JAQ'*?&$)#B+=2U*Z@GU4TS5?WB<^$'$:&@^ ^1H^9%E
M<@MOAC1$4%[W&7X86"4740F3OA$(!%@0%Q%J9R8<$.S(%#A+2.]Y?_S6=(?Z
M68SW3N[S3]DY0#X4CX_%JKI]U3,</!&'))8"^[&(,6&ICVF0I#C(1)H%L? S
MF4*<(H< 1M8/-3BTUO!FZ']Z_\=3_^>C)UJB%PW^WU P4W]I_X?6NE?^&OU4
M%SM<(7^6I=G,"X.9[R=5L6?]R2_(]V99G,S2-/P9T>?-@]+/>B0Y7>O&$M_5
M[E:J^G_]#S_V_BWT9DA_NZH%/@K6_<BO/B+_ADCFSU*%1J3P.T2#I-$L\,-9
M1)+9%H.H0B ,2;7LWG"<V,]F<>#]7'T29K%:.)B%&3E:.%34Z46#(-PM',^R
M*)U%272\<*#6BK+X9[18KW4S=/U \;Q9;]0/V@MJ2_X,*;2>!-/'W=)P[N'9
M[ZR9(^J2;R),AS=?PN_UE[ "-D/7%0/=>9K.D>/(L72T_*1^I'/$';J-SCYG
M75FGFTU5'N;* 74C?U_7=33S1+(\%(' 'LDR3"3W,-5]A&4>AH%@A*=Y *RD
M.P=K9!WY^:!!<*FAXT+B9_4+M>@HU,<V,]ETQ R8F#9 VTC.MY8-"G)=#-?F
M!G9;PU\]%N5F\4_'/8(-Z'=7!7<6TM15;T,DGZAR&WS%3O!_+0K^UV*Y_%8L
MEY^+\B]:<CV#C.=^P+ O<]T(A"9*X+,0ARQD01AG01Z DHA/P!A9T%N(Z$\-
M$S5 @;4$IUAC)M07$@P39BBM8!'MH<:1:)Z",*E(]I!X*(I]C]K?1!9UFR7=
MWKM8Z5BO4.>46.]*"G;=Z!B-DE07G@9QD&(2QARG81YC3T2">)ZN  )UUH6!
MG^ 6TR!3WT&ZZ,"-90!;S4WI<9@%-[3/\@GM4$%_CM+/SXX-#@UT /#)S7<X
M8TX9]Q:KV*F?OPEM4 A^]2)*>B^^/NL[ZXW\N%@^J[]6(_76-[N+[YP++\K4
MG0![H0PPB9B',YE[F"129C3B4H8"-K0%B %$JJRFM[3X8%HC=.A+F*%?COP%
M/W>= S/$:]S13XM5\S8P"06Z*U10XA&>8QYF I,L%IBF,L4L"R2G+/>H![JD
MC;@G%L="BPUJ=X0UWJYZ8]Z6]68GQX@,A1T=6UXVF* :E<J;5;/SILO.!D%W
M9X<E(QP='E#HDYX>EJPY/#YLEW%NOLYIQGE(\A!S/TXP\?T<IS0@RG0-N9_$
M(<W,NK\9P)K8,&5[!M=/>AA5[>=-@-JFCWT7VZ1O9(!.8FA.9U6^&Q/2PEZ\
M((GE:['Z5:W>M!_H]'+;79H,4UF&5QI9>A4"^->KJ]MM$Y0.#N9)+08,Z9=8
M][R "6T?&QS?%&&D6J6[&"P_6=*+.:G=U!? 6Y<UCNBT"6CFGO]3\&NN%,9"
M+NBV8UI595XJPV'%O^QF)ZK/GA^[[=76<^)%GA0BT'W/""8\CC#-/8&YNG-$
M@C :^Z#;QDAXCJQ5.BT$Z^#1#&T$>U@5R^(>&-D=:Z/,+(AWP'Z8(CO=_V*'
M<QW%0BVB,]0EXJCUXPQU.T.Z;X8Q$EL=M\YPC>6;--H8B=7GVG*,!<Y9FZ"Z
M%6[NAYGN!T0#*96VSCC.A!_C(&-^2@55__ +FP)-D !Y2N:MNMN>8Q-,5UY
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MB_$M!T-/<\IZ._3!"?S,U?EC*9<ZPZO)/VZ+YWF/P:6HU-^>'Y57V223]/_
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M,U:U\%X>7GTWL+R<?&LS2?>$F/>+U3K,_K_IEPNWB]PMZ:T!S05QP7V :'@
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ME-&!_7E"0LD)C)EYD-DH4#X0)Z6V(0[.Z1*M-<V+[(XLFAJL#/,DJ&JDB@Y
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M;+$947PIK$FR11KA.3BG Z@Z:]W+&C)R59S5)@?>_@'R$P2-:XF&P5([#70
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MHUDY)SR)P"96I\$$DH,N 3(R91+R+%CK3B2[43:N%S4@FNYY5NT5U:UAVC1
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M&;5EK<?>'GR"#5:[??(3;!^I'WF"_3P?LX/830CVMO:-(%F\G=,_QM]P?9+
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M$(IW _D+NWSI4MT=6/0-.^^7TX03:5P40?+-D E0(B3BP6H(%C7+]4FR:?W
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MI>X&DAT+#'."](**&B)L(*6]_51]R,CRS(,.S* I+>\* I7$QP0D*OR16>!
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MHZM]S+U,41L>>?_HJJB7!E#VN.Q]DY</>$+DT62T@#&>(^G=W^4&&..2>\>
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MV^D$PP]8/>3Y#!%*3ZN/3YC+4B?-;"9!448D+6-BP1FB7 HI,VFEJ9Z<WH?
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MHN'E==K P2'JF_8CRQ9@(3],TDU<FM/=3#D?E9&@<;-P121P0[P*FFB>O3$
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MI]-; ^#<C!67M< /KQ$OM7<J0BR#>SR>PBDD8E7@A#+.=4A: M2>RO *29T
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MMP>;W^X+6A1SV5N!? 2D7CH.Q"-+Q#&&(O,F.EJ]L=8.6H;I('BJ$^LPD3<
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M:70S,3$M<3 S,C4N:'1M4$L! A0#%     @ "35E6WOZ=UT[!P  '!T  !0
M             ( !>P<  &5X:&EB:70S,3(M<3 S,C4N:'1M4$L! A0#%
M  @ "35E6V:P7<H7!   )0\  !0              ( !Z X  &5X:&EB:70S
M,C$M<3 S,C4N:'1M4$L! A0#%     @ "35E6\KOV>X,5P$ 4+L1 !$
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M2P$"% ,4    "  )-65;?J%54B@: 0 ^/0L %0              @ $*;P8
M<GAR>"TR,#(U,#DS,%]L86(N>&UL4$L! A0#%     @ "35E6]7/E'/ I@
M0<P' !4              ( !98D' ')X<G@M,C R-3 Y,S!?<')E+GAM;%!+
4!08     "P + -0"  !8, @    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>rxrx-20250930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2025"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:rxrx="http://www.recursion.com/20250930"
  xmlns:srt="http://fasb.org/srt/2025"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="rxrx-20250930.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-10-31</instant>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-10-31</instant>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rxrx:ExchangeableStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rxrx:ExchangeableStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:TempusLabsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-01</startDate>
            <endDate>2023-11-30</endDate>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:TempusLabsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-30</instant>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:TempusLabsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-30</instant>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
        </entity>
        <period>
            <startDate>2025-06-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">rxrx:REVenturesIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-31</instant>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">rxrx:REVenturesIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-07-31</endDate>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">rxrx:REVenturesIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">rxrx:REVenturesIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-01</startDate>
            <endDate>2025-08-31</endDate>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rxrx:AlphaBiotechnologyGmbHAlphaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">rxrx:ExscientiaGmbHMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rxrx:AlphaBiotechnologyGmbHAlphaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rxrx:ExscientiaPlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rxrx:ExscientiaPlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
        </entity>
        <period>
            <instant>2024-11-20</instant>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rxrx:ExscientiaPlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rxrx:ExscientiaPlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rxrx:ExscientiaPlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rxrx:ExscientiaPlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rxrx:ExscientiaPlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="rxrx:LeaseDescriptionAxis">rxrx:ViennaFacilitiesOfExscientiaGmbHMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
        </entity>
        <period>
            <startDate>2025-03-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="rxrx:LeaseDescriptionAxis">rxrx:SchrodingerLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-07</startDate>
            <endDate>2025-10-07</endDate>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rxrx:AtTheMarketOfferingProgramCitiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rxrx:AtTheMarketOfferingProgramCitiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rxrx:AtTheMarketOfferingProgramCitiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rxrx:AtTheMarketOfferingProgramJefferiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-01</startDate>
            <endDate>2023-08-31</endDate>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rxrx:AtTheMarketOfferingProgramJefferiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rxrx:AtTheMarketOfferingProgramJefferiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rxrx:PublicOfferingOfCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-26</startDate>
            <endDate>2024-06-26</endDate>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rxrx:PublicOfferingOfCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-26</instant>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rxrx:PublicOfferingOfCommonStockUnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-26</startDate>
            <endDate>2024-06-26</endDate>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rxrx:PublicOfferingOfCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-26</startDate>
            <endDate>2024-06-26</endDate>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-26</startDate>
            <endDate>2024-06-26</endDate>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rxrx:ValenceDiscoveryIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rxrx:ExchangeableStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-05-31</endDate>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-31</instant>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rxrx:ExchangeableStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rxrx:ValenceDiscoveryIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-05-31</endDate>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">rxrx:CEOAndAffiliatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:SanofiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:SanofiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:SanofiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:SanofiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rxrx:MilestoneTypeAxis">rxrx:ResearchMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-30</instant>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:SanofiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rxrx:MilestoneTypeAxis">rxrx:DevelopmentAndRegulatoryMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-30</instant>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:SanofiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:SanofiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:MerckKGaAMerckMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:MerckKGaAMerckMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rxrx:MilestoneTypeAxis">rxrx:DiscoveryDevelopmentAndSalesMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:MerckKGaAMerckMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:MerckKGaAMerckMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:RocheAndGenentechMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:RocheAndGenentechMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:RocheAndGenentechMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rxrx:RevenueRemainingPerformanceObligationAxis">rxrx:PhenomapsCreationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:RocheAndGenentechMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rxrx:RevenueRemainingPerformanceObligationAxis">rxrx:PhenomapsRawImagesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:RocheAndGenentechMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rxrx:RevenueRemainingPerformanceObligationAxis">rxrx:DevelopedAndCommercializedProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:RocheAndGenentechMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:RocheAndGenentechMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rxrx:RevenueRemainingPerformanceObligationAxis">rxrx:GastrointestinalCancerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:RocheAndGenentechMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rxrx:RevenueRemainingPerformanceObligationAxis">rxrx:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxrx:A2021EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxrx:A2024InducementEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">rxrx:TempusAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">rxrx:TempusAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">rxrx:TempusAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">rxrx:TempusAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">rxrx:ContingentStockRelatingToREVentures1AgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">rxrx:ContingentStockRelatingToREVentures1AgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">rxrx:ContingentStockRelatingToREVentures1AgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">rxrx:ContingentStockRelatingToREVentures1AgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-193">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-196">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-197">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rxrx:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rxrx:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rxrx:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rxrx:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rxrx:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rxrx:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:RocheAndGenentechMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-27</startDate>
            <endDate>2025-10-27</endDate>
        </period>
    </context>
    <context id="c-219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rxrx:AtTheMarketOfferingProgramCitiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-01</startDate>
            <endDate>2025-10-31</endDate>
        </period>
    </context>
    <context id="c-220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rxrx:AtTheMarketOfferingProgramCitiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-01</startDate>
            <endDate>2025-10-31</endDate>
        </period>
    </context>
    <context id="c-221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">rxrx:BlakeBorgesonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">rxrx:BlakeBorgesonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">rxrx:NajatKhanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">rxrx:NajatKhanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">rxrx:BenTaylorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">rxrx:BenTaylorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="contract">
        <measure>rxrx:contract</measure>
    </unit>
    <unit id="inprocessresearchanddevelopmentasset">
        <measure>rxrx:inProcessResearchAndDevelopmentAsset</measure>
    </unit>
    <unit id="vote">
        <measure>rxrx:vote</measure>
    </unit>
    <unit id="class">
        <measure>rxrx:class</measure>
    </unit>
    <unit id="candidate">
        <measure>rxrx:candidate</measure>
    </unit>
    <unit id="performance_obligation">
        <measure>rxrx:performance_obligation</measure>
    </unit>
    <unit id="phenomap">
        <measure>rxrx:phenomap</measure>
    </unit>
    <unit id="program">
        <measure>rxrx:program</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-26">0001601830</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-27">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-28">2025</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-29">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-30">--12-31</dei:CurrentFiscalYearEndDate>
    <rxrx:LicenseAgreementTradingPeriodUsedForEquityValueDetermination contextRef="c-65" id="f-388">P7D</rxrx:LicenseAgreementTradingPeriodUsedForEquityValueDetermination>
    <rxrx:LicenseAgreementAmountOfTimePriorToThePaymentDate contextRef="c-65" id="f-389">P5D</rxrx:LicenseAgreementAmountOfTimePriorToThePaymentDate>
    <ecd:TrdArrDuration contextRef="c-221" id="f-899">P457D</ecd:TrdArrDuration>
    <ecd:TrdArrDuration contextRef="c-223" id="f-900">P456D</ecd:TrdArrDuration>
    <ecd:TrdArrDuration contextRef="c-225" id="f-901">P455D</ecd:TrdArrDuration>
    <dei:DocumentType contextRef="c-1" id="f-1">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="c-1" id="f-2">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-3">2025-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-4">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-40323</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-6">RECURSION PHARMACEUTICALS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-7">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-8">46-4099738</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-9">41 S Rio Grande Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-10">Salt Lake City,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-11">UT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-12">84101</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-13">385</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-14">269 - 0203</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-15">Class A Common Stock, par value $0.00001</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-16">RXRX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-17">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-18">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-19">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-20">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-21">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-22">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="c-1" id="f-23">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-2" decimals="INF" id="f-24" unitRef="shares">514895802</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-3" decimals="INF" id="f-25" unitRef="shares">5747334</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-3" id="f-31" unitRef="usd">659836000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-5" decimals="-3" id="f-32" unitRef="usd">594350000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent contextRef="c-4" decimals="-3" id="f-33" unitRef="usd">3136000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent contextRef="c-5" decimals="-3" id="f-34" unitRef="usd">3045000</us-gaap:RestrictedCashCurrent>
    <us-gaap:OtherReceivablesNetCurrent contextRef="c-4" decimals="-3" id="f-35" unitRef="usd">21910000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent contextRef="c-5" decimals="-3" id="f-36" unitRef="usd">49166000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="c-4" decimals="-3" id="f-37" unitRef="usd">0</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="c-5" decimals="-3" id="f-38" unitRef="usd">29601000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c-4" decimals="-3" id="f-39" unitRef="usd">29223000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c-5" decimals="-3" id="f-40" unitRef="usd">38107000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-4" decimals="-3" id="f-41" unitRef="usd">714105000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-5" decimals="-3" id="f-42" unitRef="usd">714269000</us-gaap:AssetsCurrent>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-4" decimals="-3" id="f-43" unitRef="usd">4173000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-5" decimals="-3" id="f-44" unitRef="usd">5629000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="-3" id="f-45" unitRef="usd">111706000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-5" decimals="-3" id="f-46" unitRef="usd">141063000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-4" decimals="-3" id="f-47" unitRef="usd">47812000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-5" decimals="-3" id="f-48" unitRef="usd">65877000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset contextRef="c-4" decimals="-3" id="f-49" unitRef="usd">21726000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset contextRef="c-5" decimals="-3" id="f-50" unitRef="usd">26273000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-4" decimals="-3" id="f-51" unitRef="usd">322344000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-5" decimals="-3" id="f-52" unitRef="usd">335855000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill contextRef="c-4" decimals="-3" id="f-53" unitRef="usd">162042000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-5" decimals="-3" id="f-54" unitRef="usd">148873000</us-gaap:Goodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="c-4" decimals="-3" id="f-55" unitRef="usd">957000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="c-5" decimals="-3" id="f-56" unitRef="usd">1934000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-4" decimals="-3" id="f-57" unitRef="usd">14661000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-5" decimals="-3" id="f-58" unitRef="usd">8825000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="c-4" decimals="-3" id="f-59" unitRef="usd">1399526000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-5" decimals="-3" id="f-60" unitRef="usd">1448598000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c-4" decimals="-3" id="f-61" unitRef="usd">13935000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-5" decimals="-3" id="f-62" unitRef="usd">21613000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-63" unitRef="usd">53102000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-64" unitRef="usd">81872000</us-gaap:AccruedLiabilitiesCurrent>
    <rxrx:AccruedDataCurrent contextRef="c-4" decimals="-3" id="f-65" unitRef="usd">20258000</rxrx:AccruedDataCurrent>
    <rxrx:AccruedDataCurrent contextRef="c-5" decimals="-3" id="f-66" unitRef="usd">0</rxrx:AccruedDataCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-4" decimals="-3" id="f-67" unitRef="usd">47364000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-5" decimals="-3" id="f-68" unitRef="usd">61767000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-4" decimals="-3" id="f-69" unitRef="usd">11525000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-5" decimals="-3" id="f-70" unitRef="usd">13795000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent contextRef="c-4" decimals="-3" id="f-71" unitRef="usd">8919000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent contextRef="c-5" decimals="-3" id="f-72" unitRef="usd">8425000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-73" unitRef="usd">155103000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-74" unitRef="usd">187472000</us-gaap:LiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent contextRef="c-4" decimals="-3" id="f-75" unitRef="usd">111204000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent contextRef="c-5" decimals="-3" id="f-76" unitRef="usd">118765000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-4" decimals="-3" id="f-77" unitRef="usd">50028000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-5" decimals="-3" id="f-78" unitRef="usd">67250000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations contextRef="c-4" decimals="-3" id="f-79" unitRef="usd">11902000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations contextRef="c-5" decimals="-3" id="f-80" unitRef="usd">19022000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-4" decimals="-3" id="f-81" unitRef="usd">23312000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-5" decimals="-3" id="f-82" unitRef="usd">16575000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-4" decimals="-3" id="f-83" unitRef="usd">1029000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-5" decimals="-3" id="f-84" unitRef="usd">4732000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="c-4" decimals="-3" id="f-85" unitRef="usd">352578000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-5" decimals="-3" id="f-86" unitRef="usd">413816000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-4" id="f-87" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-5" id="f-88" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-5"
      decimals="INF"
      id="f-89"
      unitRef="usdPerShare">0.00001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-90"
      unitRef="usdPerShare">0.00001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-4" decimals="INF" id="f-91" unitRef="shares">2000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-5" decimals="INF" id="f-92" unitRef="shares">2000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-6" decimals="INF" id="f-93" unitRef="shares">1989032117</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-7" decimals="INF" id="f-94" unitRef="shares">1989032117</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-8" decimals="INF" id="f-95" unitRef="shares">10967883</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-9" decimals="INF" id="f-96" unitRef="shares">10967883</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-4" decimals="INF" id="f-97" unitRef="shares">491800501</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-4" decimals="INF" id="f-98" unitRef="shares">491800501</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-6" decimals="INF" id="f-99" unitRef="shares">485213547</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-6" decimals="INF" id="f-100" unitRef="shares">485213547</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-9" decimals="INF" id="f-101" unitRef="shares">5967334</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-9" decimals="INF" id="f-102" unitRef="shares">5967334</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-10"
      decimals="INF"
      id="f-103"
      unitRef="shares">619620</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="c-10"
      decimals="INF"
      id="f-104"
      unitRef="shares">619620</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-5" decimals="INF" id="f-105" unitRef="shares">396802394</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-5" decimals="INF" id="f-106" unitRef="shares">396802394</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-7" decimals="INF" id="f-107" unitRef="shares">389547223</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-7" decimals="INF" id="f-108" unitRef="shares">389547223</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="c-8" decimals="INF" id="f-109" unitRef="shares">6958575</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-8" decimals="INF" id="f-110" unitRef="shares">6958575</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-11"
      decimals="INF"
      id="f-111"
      unitRef="shares">296596</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="c-11"
      decimals="INF"
      id="f-112"
      unitRef="shares">296596</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue contextRef="c-4" decimals="-3" id="f-113" unitRef="usd">5000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-5" decimals="-3" id="f-114" unitRef="usd">4000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="c-4" decimals="-3" id="f-115" unitRef="usd">2980729000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="c-5" decimals="-3" id="f-116" unitRef="usd">2473698000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-4" decimals="-3" id="f-117" unitRef="usd">-1967879000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-5" decimals="-3" id="f-118" unitRef="usd">-1431283000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-4" decimals="-3" id="f-119" unitRef="usd">34093000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-5" decimals="-3" id="f-120" unitRef="usd">-7637000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-121" unitRef="usd">1046948000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-5" decimals="-3" id="f-122" unitRef="usd">1034782000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-4" decimals="-3" id="f-123" unitRef="usd">1399526000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-5" decimals="-3" id="f-124" unitRef="usd">1448598000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-12" decimals="-3" id="f-125" unitRef="usd">4983000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-13" decimals="-3" id="f-126" unitRef="usd">26082000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-14" decimals="-3" id="f-127" unitRef="usd">38905000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-15" decimals="-3" id="f-128" unitRef="usd">53977000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-16" decimals="-3" id="f-129" unitRef="usd">192000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-17" decimals="-3" id="f-130" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-18" decimals="-3" id="f-131" unitRef="usd">238000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-19" decimals="-3" id="f-132" unitRef="usd">316000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-20" decimals="-3" id="f-133" unitRef="usd">5175000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-21" decimals="-3" id="f-134" unitRef="usd">26082000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-135" unitRef="usd">39143000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-22" decimals="-3" id="f-136" unitRef="usd">54293000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-20" decimals="-3" id="f-137" unitRef="usd">14687000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-21" decimals="-3" id="f-138" unitRef="usd">12079000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-1" decimals="-3" id="f-139" unitRef="usd">56678000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-22" decimals="-3" id="f-140" unitRef="usd">32444000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-20" decimals="-3" id="f-141" unitRef="usd">121062000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-21" decimals="-3" id="f-142" unitRef="usd">74600000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-1" decimals="-3" id="f-143" unitRef="usd">379331000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-22" decimals="-3" id="f-144" unitRef="usd">216087000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-20" decimals="-3" id="f-145" unitRef="usd">41628000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-21" decimals="-3" id="f-146" unitRef="usd">37757000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-1" decimals="-3" id="f-147" unitRef="usd">142932000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-22" decimals="-3" id="f-148" unitRef="usd">100998000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:CostsAndExpenses contextRef="c-20" decimals="-3" id="f-149" unitRef="usd">177377000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-21" decimals="-3" id="f-150" unitRef="usd">124436000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-1" decimals="-3" id="f-151" unitRef="usd">578941000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-22" decimals="-3" id="f-152" unitRef="usd">349529000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-20" decimals="-3" id="f-153" unitRef="usd">-172202000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-21" decimals="-3" id="f-154" unitRef="usd">-98354000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-3" id="f-155" unitRef="usd">-539798000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-22" decimals="-3" id="f-156" unitRef="usd">-295236000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-20" decimals="-3" id="f-157" unitRef="usd">9952000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-21" decimals="-3" id="f-158" unitRef="usd">2679000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-159" unitRef="usd">3005000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-22" decimals="-3" id="f-160" unitRef="usd">9347000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-20" decimals="-3" id="f-161" unitRef="usd">-162250000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-21" decimals="-3" id="f-162" unitRef="usd">-95675000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-163" unitRef="usd">-536793000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-22" decimals="-3" id="f-164" unitRef="usd">-285889000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-20" decimals="-3" id="f-165" unitRef="usd">3000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-21" decimals="-3" id="f-166" unitRef="usd">167000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-167" unitRef="usd">-156000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-22" decimals="-3" id="f-168" unitRef="usd">-1134000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="c-20" decimals="-3" id="f-169" unitRef="usd">-162253000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-21" decimals="-3" id="f-170" unitRef="usd">-95842000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-171" unitRef="usd">-536637000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-22" decimals="-3" id="f-172" unitRef="usd">-284755000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-20"
      decimals="2"
      id="f-173"
      unitRef="usdPerShare">-0.36</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-20"
      decimals="2"
      id="f-174"
      unitRef="usdPerShare">-0.36</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-21"
      decimals="2"
      id="f-175"
      unitRef="usdPerShare">-0.34</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-21"
      decimals="2"
      id="f-176"
      unitRef="usdPerShare">-0.34</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-177"
      unitRef="usdPerShare">-1.27</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-178"
      unitRef="usdPerShare">-1.27</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-22"
      decimals="2"
      id="f-179"
      unitRef="usdPerShare">-1.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-22"
      decimals="2"
      id="f-180"
      unitRef="usdPerShare">-1.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-20" decimals="0" id="f-181" unitRef="shares">446988046</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-20" decimals="0" id="f-182" unitRef="shares">446988046</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-21" decimals="0" id="f-183" unitRef="shares">282583048</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-21" decimals="0" id="f-184" unitRef="shares">282583048</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="0" id="f-185" unitRef="shares">422642653</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-186" unitRef="shares">422642653</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-22" decimals="0" id="f-187" unitRef="shares">253447099</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-22" decimals="0" id="f-188" unitRef="shares">253447099</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss contextRef="c-20" decimals="-3" id="f-189" unitRef="usd">-162253000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-21" decimals="-3" id="f-190" unitRef="usd">-95842000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-191" unitRef="usd">-536637000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-23" decimals="-3" id="f-192" unitRef="usd">-284755000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-20" decimals="-3" id="f-193" unitRef="usd">-9527000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-21" decimals="-3" id="f-194" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-3" id="f-195" unitRef="usd">41730000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-22" decimals="-3" id="f-196" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-20" decimals="-3" id="f-197" unitRef="usd">-9527000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-21" decimals="-3" id="f-198" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-3" id="f-199" unitRef="usd">41730000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-22" decimals="-3" id="f-200" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-20" decimals="-3" id="f-201" unitRef="usd">-171780000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-21" decimals="-3" id="f-202" unitRef="usd">-95842000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-1" decimals="-3" id="f-203" unitRef="usd">-494907000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-22" decimals="-3" id="f-204" unitRef="usd">-284755000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-24"
      decimals="INF"
      id="f-205"
      unitRef="shares">432830642</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-24" decimals="-3" id="f-206" unitRef="usd">4000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-25" decimals="-3" id="f-207" unitRef="usd">2681111000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-26" decimals="-3" id="f-208" unitRef="usd">-1805589000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-27" decimals="-3" id="f-209" unitRef="usd">43620000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-28" decimals="-3" id="f-210" unitRef="usd">919146000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-29" decimals="-3" id="f-211" unitRef="usd">-162253000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-20" decimals="-3" id="f-212" unitRef="usd">-162253000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-30" decimals="-3" id="f-213" unitRef="usd">-9527000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-20" decimals="-3" id="f-214" unitRef="usd">-9527000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="c-31"
      decimals="INF"
      id="f-215"
      unitRef="shares">2871306</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-32" decimals="-3" id="f-216" unitRef="usd">-401000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-29" decimals="-3" id="f-217" unitRef="usd">-37000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-20" decimals="-3" id="f-218" unitRef="usd">-438000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-32" decimals="-3" id="f-219" unitRef="usd">25244000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-20" decimals="-3" id="f-220" unitRef="usd">25244000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-31"
      decimals="INF"
      id="f-221"
      unitRef="shares">52243578</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-31" decimals="-3" id="f-222" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-32" decimals="-3" id="f-223" unitRef="usd">254460000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-20" decimals="-3" id="f-224" unitRef="usd">254461000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="c-31"
      decimals="INF"
      id="f-225"
      unitRef="shares">3854975</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="c-32" decimals="-3" id="f-226" unitRef="usd">20315000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="c-20" decimals="-3" id="f-227" unitRef="usd">20315000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-33"
      decimals="INF"
      id="f-228"
      unitRef="shares">491800501</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-33" decimals="-3" id="f-229" unitRef="usd">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-34" decimals="-3" id="f-230" unitRef="usd">2980729000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-35" decimals="-3" id="f-231" unitRef="usd">-1967879000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-36" decimals="-3" id="f-232" unitRef="usd">34093000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-233" unitRef="usd">1046948000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-37"
      decimals="INF"
      id="f-234"
      unitRef="shares">396802394</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-37" decimals="-3" id="f-235" unitRef="usd">4000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-38" decimals="-3" id="f-236" unitRef="usd">2473698000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-39" decimals="-3" id="f-237" unitRef="usd">-1431283000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-40" decimals="-3" id="f-238" unitRef="usd">-7637000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-5" decimals="-3" id="f-239" unitRef="usd">1034782000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-41" decimals="-3" id="f-240" unitRef="usd">-536637000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-241" unitRef="usd">-536637000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-42" decimals="-3" id="f-242" unitRef="usd">41730000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-3" id="f-243" unitRef="usd">41730000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="c-43"
      decimals="INF"
      id="f-244"
      unitRef="shares">11645465</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-44" decimals="-3" id="f-245" unitRef="usd">3772000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-41" decimals="-3" id="f-246" unitRef="usd">41000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-1" decimals="-3" id="f-247" unitRef="usd">3813000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-44" decimals="-3" id="f-248" unitRef="usd">87460000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-1" decimals="-3" id="f-249" unitRef="usd">87460000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-43"
      decimals="INF"
      id="f-250"
      unitRef="shares">79497667</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-43" decimals="-3" id="f-251" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-44" decimals="-3" id="f-252" unitRef="usd">395484000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-1" decimals="-3" id="f-253" unitRef="usd">395485000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="c-43"
      decimals="INF"
      id="f-254"
      unitRef="shares">3854975</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="c-44" decimals="-3" id="f-255" unitRef="usd">20315000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="c-1" decimals="-3" id="f-256" unitRef="usd">20315000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-33"
      decimals="INF"
      id="f-257"
      unitRef="shares">491800501</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-33" decimals="-3" id="f-258" unitRef="usd">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-34" decimals="-3" id="f-259" unitRef="usd">2980729000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-35" decimals="-3" id="f-260" unitRef="usd">-1967879000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-36" decimals="-3" id="f-261" unitRef="usd">34093000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-262" unitRef="usd">1046948000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-45"
      decimals="INF"
      id="f-263"
      unitRef="shares">280968276</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-45" decimals="-3" id="f-264" unitRef="usd">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-46" decimals="-3" id="f-265" unitRef="usd">1740981000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-47" decimals="-3" id="f-266" unitRef="usd">-1156535000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-48" decimals="-3" id="f-267" unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-49" decimals="-3" id="f-268" unitRef="usd">584449000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-50" decimals="-3" id="f-269" unitRef="usd">-95842000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-21" decimals="-3" id="f-270" unitRef="usd">-95842000</us-gaap:NetIncomeLoss>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="c-51"
      decimals="INF"
      id="f-271"
      unitRef="shares">2689679</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-52" decimals="-3" id="f-272" unitRef="usd">732000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-21" decimals="-3" id="f-273" unitRef="usd">732000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-52" decimals="-3" id="f-274" unitRef="usd">18252000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-21" decimals="-3" id="f-275" unitRef="usd">18252000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-51"
      decimals="INF"
      id="f-276"
      unitRef="shares">2466324</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-52" decimals="-3" id="f-277" unitRef="usd">16968000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-21" decimals="-3" id="f-278" unitRef="usd">16968000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-53"
      decimals="INF"
      id="f-279"
      unitRef="shares">286124279</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-53" decimals="-3" id="f-280" unitRef="usd">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-54" decimals="-3" id="f-281" unitRef="usd">1776933000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-55" decimals="-3" id="f-282" unitRef="usd">-1252377000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-56" decimals="-3" id="f-283" unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-57" decimals="-3" id="f-284" unitRef="usd">524559000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-58"
      decimals="INF"
      id="f-285"
      unitRef="shares">234270384</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-58" decimals="-3" id="f-286" unitRef="usd">2000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-59" decimals="-3" id="f-287" unitRef="usd">1431056000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-60" decimals="-3" id="f-288" unitRef="usd">-967622000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-61" decimals="-3" id="f-289" unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-62" decimals="-3" id="f-290" unitRef="usd">463436000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-23" decimals="-3" id="f-291" unitRef="usd">-284755000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-22" decimals="-3" id="f-292" unitRef="usd">-284755000</us-gaap:NetIncomeLoss>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="c-63"
      decimals="INF"
      id="f-293"
      unitRef="shares">7827268</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-64" decimals="-3" id="f-294" unitRef="usd">5586000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-22" decimals="-3" id="f-295" unitRef="usd">5586000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-64" decimals="-3" id="f-296" unitRef="usd">50904000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-22" decimals="-3" id="f-297" unitRef="usd">50904000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-63"
      decimals="INF"
      id="f-298"
      unitRef="shares">44026627</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-63" decimals="-3" id="f-299" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-64" decimals="-3" id="f-300" unitRef="usd">289387000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-22" decimals="-3" id="f-301" unitRef="usd">289388000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-53"
      decimals="INF"
      id="f-302"
      unitRef="shares">286124279</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-53" decimals="-3" id="f-303" unitRef="usd">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-54" decimals="-3" id="f-304" unitRef="usd">1776933000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-55" decimals="-3" id="f-305" unitRef="usd">-1252377000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-56" decimals="-3" id="f-306" unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-57" decimals="-3" id="f-307" unitRef="usd">524559000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-308" unitRef="usd">-536637000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-22" decimals="-3" id="f-309" unitRef="usd">-284755000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-1" decimals="-3" id="f-310" unitRef="usd">64223000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-22" decimals="-3" id="f-311" unitRef="usd">23543000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-3" id="f-312" unitRef="usd">87460000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-22" decimals="-3" id="f-313" unitRef="usd">50904000</us-gaap:ShareBasedCompensation>
    <us-gaap:TangibleAssetImpairmentCharges contextRef="c-1" decimals="-3" id="f-314" unitRef="usd">5956000</us-gaap:TangibleAssetImpairmentCharges>
    <us-gaap:TangibleAssetImpairmentCharges contextRef="c-22" decimals="-3" id="f-315" unitRef="usd">108000</us-gaap:TangibleAssetImpairmentCharges>
    <us-gaap:OperatingLeaseExpense contextRef="c-1" decimals="-3" id="f-316" unitRef="usd">17019000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense contextRef="c-22" decimals="-3" id="f-317" unitRef="usd">11155000</us-gaap:OperatingLeaseExpense>
    <us-gaap:GainLossOnSaleOfBusiness contextRef="c-1" decimals="-3" id="f-318" unitRef="usd">-4502000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness contextRef="c-22" decimals="-3" id="f-319" unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff contextRef="c-1" decimals="-3" id="f-320" unitRef="usd">22082000</us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff>
    <us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff contextRef="c-22" decimals="-3" id="f-321" unitRef="usd">0</us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff>
    <us-gaap:OtherNoncashIncomeExpense contextRef="c-1" decimals="-3" id="f-322" unitRef="usd">-6655000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense contextRef="c-22" decimals="-3" id="f-323" unitRef="usd">650000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="c-1" decimals="-3" id="f-324" unitRef="usd">-33775000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="c-22" decimals="-3" id="f-325" unitRef="usd">4173000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <rxrx:IncreaseDecreaseInPrepaidDataAssets contextRef="c-1" decimals="-3" id="f-326" unitRef="usd">-29601000</rxrx:IncreaseDecreaseInPrepaidDataAssets>
    <rxrx:IncreaseDecreaseInPrepaidDataAssets contextRef="c-22" decimals="-3" id="f-327" unitRef="usd">-2930000</rxrx:IncreaseDecreaseInPrepaidDataAssets>
    <rxrx:IncreaseDecreaseInAccruedDataLiability contextRef="c-1" decimals="-3" id="f-328" unitRef="usd">20258000</rxrx:IncreaseDecreaseInAccruedDataLiability>
    <rxrx:IncreaseDecreaseInAccruedDataLiability contextRef="c-22" decimals="-3" id="f-329" unitRef="usd">0</rxrx:IncreaseDecreaseInAccruedDataLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="c-1" decimals="-3" id="f-330" unitRef="usd">-30014000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="c-22" decimals="-3" id="f-331" unitRef="usd">-22374000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-1" decimals="-3" id="f-332" unitRef="usd">-7035000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-22" decimals="-3" id="f-333" unitRef="usd">-1687000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <rxrx:IncreaseDecreaseInAccruedDevelopmentExpense contextRef="c-1" decimals="-3" id="f-334" unitRef="usd">-4210000</rxrx:IncreaseDecreaseInAccruedDevelopmentExpense>
    <rxrx:IncreaseDecreaseInAccruedDevelopmentExpense contextRef="c-22" decimals="-3" id="f-335" unitRef="usd">-2623000</rxrx:IncreaseDecreaseInAccruedDevelopmentExpense>
    <us-gaap:IncreaseDecreaseInOtherAccruedLiabilities contextRef="c-1" decimals="-3" id="f-336" unitRef="usd">-23246000</us-gaap:IncreaseDecreaseInOtherAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccruedLiabilities contextRef="c-22" decimals="-3" id="f-337" unitRef="usd">-5001000</us-gaap:IncreaseDecreaseInOtherAccruedLiabilities>
    <rxrx:IncreaseDecreaseInLeaseLiability contextRef="c-1" decimals="-3" id="f-338" unitRef="usd">-16124000</rxrx:IncreaseDecreaseInLeaseLiability>
    <rxrx:IncreaseDecreaseInLeaseLiability contextRef="c-22" decimals="-3" id="f-339" unitRef="usd">-11121000</rxrx:IncreaseDecreaseInLeaseLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-3" id="f-340" unitRef="usd">-325735000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-22" decimals="-3" id="f-341" unitRef="usd">-243744000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-1" decimals="-3" id="f-342" unitRef="usd">5225000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-22" decimals="-3" id="f-343" unitRef="usd">12397000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="c-1" decimals="-3" id="f-344" unitRef="usd">2158000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="c-22" decimals="-3" id="f-345" unitRef="usd">3000000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested contextRef="c-1" decimals="-3" id="f-346" unitRef="usd">-4438000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested contextRef="c-22" decimals="-3" id="f-347" unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:PaymentsToAcquireInvestments contextRef="c-1" decimals="-3" id="f-348" unitRef="usd">3806000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments contextRef="c-22" decimals="-3" id="f-349" unitRef="usd">0</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="-3" id="f-350" unitRef="usd">-15627000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-22" decimals="-3" id="f-351" unitRef="usd">-15397000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-1" decimals="-3" id="f-352" unitRef="usd">395484000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-22" decimals="-3" id="f-353" unitRef="usd">289387000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions contextRef="c-1" decimals="-3" id="f-354" unitRef="usd">3300000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions contextRef="c-22" decimals="-3" id="f-355" unitRef="usd">6433000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities contextRef="c-1" decimals="-3" id="f-356" unitRef="usd">6258000</us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities>
    <us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities contextRef="c-22" decimals="-3" id="f-357" unitRef="usd">2339000</us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities>
    <rxrx:PaymentsToAcquireIntangibleAssetsFinancialActivities contextRef="c-1" decimals="-3" id="f-358" unitRef="usd">3000000</rxrx:PaymentsToAcquireIntangibleAssetsFinancialActivities>
    <rxrx:PaymentsToAcquireIntangibleAssetsFinancialActivities contextRef="c-22" decimals="-3" id="f-359" unitRef="usd">0</rxrx:PaymentsToAcquireIntangibleAssetsFinancialActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-3" id="f-360" unitRef="usd">389526000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-22" decimals="-3" id="f-361" unitRef="usd">293481000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-1" decimals="-3" id="f-362" unitRef="usd">15957000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-22" decimals="-3" id="f-363" unitRef="usd">66000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="-3" id="f-364" unitRef="usd">64121000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-22" decimals="-3" id="f-365" unitRef="usd">34406000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-5" decimals="-3" id="f-366" unitRef="usd">603024000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-62" decimals="-3" id="f-367" unitRef="usd">401425000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="-3" id="f-368" unitRef="usd">667145000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-57" decimals="-3" id="f-369" unitRef="usd">435831000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:StockIssued1 contextRef="c-1" decimals="-3" id="f-370" unitRef="usd">20315000</us-gaap:StockIssued1>
    <us-gaap:StockIssued1 contextRef="c-22" decimals="-3" id="f-371" unitRef="usd">0</us-gaap:StockIssued1>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="c-1" decimals="-3" id="f-372" unitRef="usd">29000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="c-22" decimals="-3" id="f-373" unitRef="usd">236000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <rxrx:PurchaseOfAnEquityInvestmentNonCash contextRef="c-1" decimals="-3" id="f-374" unitRef="usd">4438000</rxrx:PurchaseOfAnEquityInvestmentNonCash>
    <rxrx:PurchaseOfAnEquityInvestmentNonCash contextRef="c-22" decimals="-3" id="f-375" unitRef="usd">0</rxrx:PurchaseOfAnEquityInvestmentNonCash>
    <us-gaap:NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1 contextRef="c-1" decimals="-3" id="f-376" unitRef="usd">0</us-gaap:NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1>
    <us-gaap:NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1 contextRef="c-22" decimals="-3" id="f-377" unitRef="usd">6000000</us-gaap:NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1>
    <us-gaap:NatureOfOperations contextRef="c-1" id="f-378">Description of the Business &lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Recursion Pharmaceuticals, Inc. (&#x201c;Recursion&#x201d; or the &#x201c;Company&#x201d;) is a clinical stage TechBio company decoding biology and chemistry to industrialize drug discovery. The Recursion Operating System (OS), a platform built across diverse technologies, enables the Company to map and navigate trillions of biological and chemical relationships within the Recursion Data Universe, one of the world&#x2019;s largest proprietary biological and chemical datasets. The Company integrates physical and digital components as iterative loops of atoms and bits scaling wet lab biology and chemistry data organized into virtuous cycles with computational tools to rapidly translate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;in silico &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;hypotheses into validated insights and novel chemistry.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2025, the Company had an accumulated deficit of $2.0 billion. The Company expects to incur substantial operating losses in future periods and will require additional capital to advance its drug candidates. The Company does not expect to generate significant revenue until the Company successfully completes significant drug development milestones or in collaboration&#160;with third parties, which the Company expects will take a number of years. In order to commercialize its drug candidates, the Company or its partners need to complete clinical development and comply with comprehensive regulatory requirements. The Company is subject to a number of risks and uncertainties similar to those of other companies of the same size within the biotechnology industry, such as the uncertainty of clinical trial outcomes, uncertainty of additional funding and a history of operating losses. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has funded its operations to date primarily through the issuance of Class A common stock (see Note 8, &#x201c;Common Stock&#x201d; for additional details). Additionally, the Company has received payments from its strategic partnerships (see Note 9, &#x201c;Collaborative Development Contracts&#x201d; for additional details). Recursion will likely be required to raise additional capital. As of September&#160;30, 2025, the Company did not have any unconditional outstanding commitments for additional funding. If the Company is unable to access additional funds when needed, it may not be able to continue the development of its products or the Company could be required to delay, scale back or abandon some or all of its development programs and other operations. The Company&#x2019;s ability to access capital when needed is not assured and, if not achieved on a timely basis, could materially harm its business, financial condition and results of operations. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Recursion believes that the Company&#x2019;s existing cash and cash equivalents will be sufficient to fund the Company&#x2019;s operating expenses and capital expenditures for at least the next 12 months.&lt;/span&gt;&lt;/div&gt;</us-gaap:NatureOfOperations>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-4" decimals="-8" id="f-379" unitRef="usd">-2000000000.0</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock contextRef="c-1" id="f-380">Basis of Presentation&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited interim condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC). Accordingly, certain information and footnote disclosures normally included in annual financial statements prepared in accordance with generally accepted accounting principles in the United States (U.S. GAAP) have been condensed or omitted. These unaudited interim condensed consolidated financial statements should be read in conjunction with the Company&#x2019;s audited consolidated financial statements and notes for the year ended December&#160;31, 2024. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;It is management&#x2019;s opinion that these condensed consolidated financial statements include all normal and recurring adjustments necessary for a fair statement of the financial position, results of operations and cash flows for the periods presented. Revenue and net loss for any interim period are not necessarily indicative of future or annual results.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2025, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2025-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounting for internal-use software costs (Topic 350)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The new standard amends specific aspects of the accounting for internal-use software costs including the criteria for capitalizing software costs. It also amends the related disclosure requirements. This standard will be effective for Recursion starting the annual period ending &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December&#160;15, 2028 and for interim reporting periods within that annual reporting period. Early adoption is permitted. The amendments can be applied on a prospective, modified prospective or retrospective basis. Recursion is currently assessing the impact of adopting this guidance on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2024, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2024-03, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Disaggregation of Income Statement Expenses (Topic 220)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The standard requires new disclosures in the notes to the financial statements about certain caption expenses presented on the face of the Income Statement including information on: purchases of inventory; employee compensation; depreciation and intangible asset amortization. Recursion must also disclose a qualitative description of the amounts remaining in expense captions that are not separately disaggregated. This standard will be effective for Recursion starting the annual period ending December 31, 2027 and for interim reporting periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The amendments can be applied on a prospective or retrospective basis. Recursion is currently assessing the impact of adopting this guidance on its consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the FASB issued ASU No. 2023-09, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740)&lt;/span&gt;. The new standard updates disclosure requirements for Accounting Standards Codification (ASC) 740 primarily by requiring additional information in the income tax rate reconciliation and additional disclosures about income taxes paid. This standard will be effective for Recursion starting the annual period ending December 31, 2025. The amendments can be applied on a prospective or retrospective basis. The Company is in process of evaluating the impact of adoption of ASU 2023-09 on the Company's consolidated financial statements and disclosures. We do not expect the adoption of this ASU to have a material impact on our consolidated financial statements.</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c-1" id="f-381">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited interim condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC). Accordingly, certain information and footnote disclosures normally included in annual financial statements prepared in accordance with generally accepted accounting principles in the United States (U.S. GAAP) have been condensed or omitted. These unaudited interim condensed consolidated financial statements should be read in conjunction with the Company&#x2019;s audited consolidated financial statements and notes for the year ended December&#160;31, 2024. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;It is management&#x2019;s opinion that these condensed consolidated financial statements include all normal and recurring adjustments necessary for a fair statement of the financial position, results of operations and cash flows for the periods presented. Revenue and net loss for any interim period are not necessarily indicative of future or annual results.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c-1" id="f-382">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2025, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2025-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounting for internal-use software costs (Topic 350)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The new standard amends specific aspects of the accounting for internal-use software costs including the criteria for capitalizing software costs. It also amends the related disclosure requirements. This standard will be effective for Recursion starting the annual period ending &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December&#160;15, 2028 and for interim reporting periods within that annual reporting period. Early adoption is permitted. The amendments can be applied on a prospective, modified prospective or retrospective basis. Recursion is currently assessing the impact of adopting this guidance on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2024, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2024-03, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Disaggregation of Income Statement Expenses (Topic 220)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The standard requires new disclosures in the notes to the financial statements about certain caption expenses presented on the face of the Income Statement including information on: purchases of inventory; employee compensation; depreciation and intangible asset amortization. Recursion must also disclose a qualitative description of the amounts remaining in expense captions that are not separately disaggregated. This standard will be effective for Recursion starting the annual period ending December 31, 2027 and for interim reporting periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The amendments can be applied on a prospective or retrospective basis. Recursion is currently assessing the impact of adopting this guidance on its consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the FASB issued ASU No. 2023-09, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740)&lt;/span&gt;. The new standard updates disclosure requirements for Accounting Standards Codification (ASC) 740 primarily by requiring additional information in the income tax rate reconciliation and additional disclosures about income taxes paid. This standard will be effective for Recursion starting the annual period ending December 31, 2025. The amendments can be applied on a prospective or retrospective basis. The Company is in process of evaluating the impact of adoption of ASU 2023-09 on the Company's consolidated financial statements and disclosures. We do not expect the adoption of this ASU to have a material impact on our consolidated financial statements.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <rxrx:SupplementalBalanceSheetAndIncomeStatementInformationTextBlock contextRef="c-1" id="f-383">Supplemental Financial Information &lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Tempus agreement&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;November 2023&lt;/span&gt;&lt;span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, Recursion entered into a &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;five&lt;/span&gt;&lt;span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;-year agreement &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(the Tempus Agreement) &lt;/span&gt;&lt;span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;with Tempus AI, Inc. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;Tempus&#x201d;) t&lt;/span&gt;&lt;span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;o purchase access to their records of patient-centric multimodal oncology data and use rights for therapeutic development purposes. This data will be used to improve the training of Recursion&#x2019;s artificial intelligence and machine learning models and is expected to accelerate Recursion&#x2019;s drug discovery process. Recursion is making annual payments, ranging between &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$22.0&#160;million&lt;/span&gt;&lt;span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$42.0&#160;million&lt;/span&gt;&lt;span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, up to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$160.0&#160;million&lt;/span&gt;&lt;span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in aggregate, to Tempus in cash or equity at the Company&#x2019;s option. The equity value is determined by using the &lt;span style="-sec-ix-hidden:f-388"&gt;seven&lt;/span&gt;-trading day period dollar volume-weighted average price (VWAP) for Recursion Class A common stock ending on the day immediately preceding the date that is &lt;span style="-sec-ix-hidden:f-389"&gt;five&lt;/span&gt; business days prior to the payment date.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Recursion is expensing the record purchases based on a contractually agreed price as &#x201c;Research and Development&#x201d; expenses in the Condensed Consolidated Statements of Operations as the records are downloaded. To the extent that the Recursion payments to Tempus are greater than or less than the records purchased amount, Recursion records the applicable amount to &#x201c;Prepaid data assets&#x201d; or &#x201c;Accrued data liability&#x201d; on the Condensed Consolidated Balance Sheet, respectively. The expense for the record purchases was $49.9 million and $2.9 million for the nine months ended September 30, 2025 and 2024. There was no expense recorded for the three months ended September 30, 2025 and 2024&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accrued Expenses and Other Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:69.660%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.521%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued early discovery expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional fees&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Materials received not invoiced&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued license fees&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued other expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expense and other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restructuring&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2025, Recursion announced a reduction in personnel program to help streamline the Company's operating strategy and post-integration efficiencies. These changes resulted in a workforce reduction of approximately 20%. The Company estimates that it will incur approximately $9.5 million in charges for the workforce reduction, consisting of severance payments and employee benefits. Recursion expects to incur all of these expenses in the year ending December&#160;31, 2025. Recursion records these costs in &#x201c;General and Administrative&#x201d; on the Condensed Consolidated Statement of Operations as incurred. The following summarizes the activity related to these restructuring actions and the related accrual as of September&#160;30, 2025:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:77.588%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.212%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,717)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of September 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Income, Net&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.490%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.408%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine months ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(833)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(553)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,821)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(967)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three and nine months ended September 30, 2025 and 2024, interest income primarily related to earnings on cash and cash equivalents in money market funds. Interest expense primarily related to the Company&#x2019;s supercomputer financing lease. Interest income, net was included in &#x201c;Other income (loss), net&#x201d; on the Condensed Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;</rxrx:SupplementalBalanceSheetAndIncomeStatementInformationTextBlock>
    <rxrx:LicenseAgreementTerm contextRef="c-65" id="f-384">P5Y</rxrx:LicenseAgreementTerm>
    <rxrx:LicenseAgreementAnnualPayments contextRef="c-66" decimals="-5" id="f-385" unitRef="usd">22000000</rxrx:LicenseAgreementAnnualPayments>
    <rxrx:LicenseAgreementAnnualPayments contextRef="c-67" decimals="-5" id="f-386" unitRef="usd">42000000</rxrx:LicenseAgreementAnnualPayments>
    <rxrx:LicenseAgreementAggregatePayments contextRef="c-67" decimals="-5" id="f-387" unitRef="usd">160000000</rxrx:LicenseAgreementAggregatePayments>
    <rxrx:LicenseAgreementIncreaseDecreaseAccruedLiabilities contextRef="c-1" decimals="-5" id="f-390" unitRef="usd">49900000</rxrx:LicenseAgreementIncreaseDecreaseAccruedLiabilities>
    <rxrx:LicenseAgreementIncreaseDecreaseAccruedLiabilities contextRef="c-22" decimals="-5" id="f-391" unitRef="usd">2900000</rxrx:LicenseAgreementIncreaseDecreaseAccruedLiabilities>
    <rxrx:LicenseAgreementIncreaseDecreaseAccruedLiabilities contextRef="c-21" decimals="-5" id="f-392" unitRef="usd">0</rxrx:LicenseAgreementIncreaseDecreaseAccruedLiabilities>
    <rxrx:LicenseAgreementIncreaseDecreaseAccruedLiabilities contextRef="c-20" decimals="-5" id="f-393" unitRef="usd">0</rxrx:LicenseAgreementIncreaseDecreaseAccruedLiabilities>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="c-1" id="f-394">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accrued Expenses and Other Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:69.660%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.521%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued early discovery expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional fees&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Materials received not invoiced&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued license fees&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued other expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expense and other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-395" unitRef="usd">24056000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-396" unitRef="usd">50853000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <rxrx:AccruedDevelopmentCostsCurrent contextRef="c-4" decimals="-3" id="f-397" unitRef="usd">2497000</rxrx:AccruedDevelopmentCostsCurrent>
    <rxrx:AccruedDevelopmentCostsCurrent contextRef="c-5" decimals="-3" id="f-398" unitRef="usd">5812000</rxrx:AccruedDevelopmentCostsCurrent>
    <rxrx:AccruedEarlyDiscoveryExpensesCurrent contextRef="c-4" decimals="-3" id="f-399" unitRef="usd">7840000</rxrx:AccruedEarlyDiscoveryExpensesCurrent>
    <rxrx:AccruedEarlyDiscoveryExpensesCurrent contextRef="c-5" decimals="-3" id="f-400" unitRef="usd">3095000</rxrx:AccruedEarlyDiscoveryExpensesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="c-4" decimals="-3" id="f-401" unitRef="usd">1956000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="c-5" decimals="-3" id="f-402" unitRef="usd">787000</us-gaap:AccruedProfessionalFeesCurrent>
    <rxrx:MaterialsReceivedNotInvoiced contextRef="c-4" decimals="-3" id="f-403" unitRef="usd">1206000</rxrx:MaterialsReceivedNotInvoiced>
    <rxrx:MaterialsReceivedNotInvoiced contextRef="c-5" decimals="-3" id="f-404" unitRef="usd">1590000</rxrx:MaterialsReceivedNotInvoiced>
    <rxrx:AccruedLicenseFeeCurrent contextRef="c-4" decimals="-3" id="f-405" unitRef="usd">3000000</rxrx:AccruedLicenseFeeCurrent>
    <rxrx:AccruedLicenseFeeCurrent contextRef="c-5" decimals="-3" id="f-406" unitRef="usd">3000000</rxrx:AccruedLicenseFeeCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-407" unitRef="usd">12547000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-408" unitRef="usd">16735000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-409" unitRef="usd">53102000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-410" unitRef="usd">81872000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent contextRef="c-68" decimals="2" id="f-411" unitRef="number">0.20</us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1 contextRef="c-4" decimals="-5" id="f-412" unitRef="usd">9500000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock contextRef="c-1" id="f-413">The following summarizes the activity related to these restructuring actions and the related accrual as of September&#160;30, 2025:&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:77.588%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.212%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,717)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of September 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:RestructuringReserve contextRef="c-5" decimals="-3" id="f-414" unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges contextRef="c-1" decimals="-3" id="f-415" unitRef="usd">8516000</us-gaap:RestructuringCharges>
    <us-gaap:PaymentsForRestructuring contextRef="c-1" decimals="-3" id="f-416" unitRef="usd">7717000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve contextRef="c-4" decimals="-3" id="f-417" unitRef="usd">799000</us-gaap:RestructuringReserve>
    <us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock contextRef="c-1" id="f-418">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Income, Net&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.490%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.408%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine months ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(833)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(553)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,821)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(967)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock>
    <us-gaap:InvestmentIncomeNonoperating contextRef="c-20" decimals="-3" id="f-419" unitRef="usd">5540000</us-gaap:InvestmentIncomeNonoperating>
    <us-gaap:InvestmentIncomeNonoperating contextRef="c-21" decimals="-3" id="f-420" unitRef="usd">3826000</us-gaap:InvestmentIncomeNonoperating>
    <us-gaap:InvestmentIncomeNonoperating contextRef="c-1" decimals="-3" id="f-421" unitRef="usd">16541000</us-gaap:InvestmentIncomeNonoperating>
    <us-gaap:InvestmentIncomeNonoperating contextRef="c-22" decimals="-3" id="f-422" unitRef="usd">11138000</us-gaap:InvestmentIncomeNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-20" decimals="-3" id="f-423" unitRef="usd">833000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-21" decimals="-3" id="f-424" unitRef="usd">553000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-1" decimals="-3" id="f-425" unitRef="usd">1821000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-22" decimals="-3" id="f-426" unitRef="usd">967000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestIncomeExpenseNonoperatingNet contextRef="c-20" decimals="-3" id="f-427" unitRef="usd">4707000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet contextRef="c-21" decimals="-3" id="f-428" unitRef="usd">3273000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet contextRef="c-1" decimals="-3" id="f-429" unitRef="usd">14720000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet contextRef="c-22" decimals="-3" id="f-430" unitRef="usd">10171000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="c-1" id="f-431">Acquisitions&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;RE Ventures I&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2025, Recursion acquired Rallybio&#x2019;s interest in the joint venture, RE Ventures I, such that Recursion now owns 100% of the interest in RE Ventures I for total consideration of $20.2 million. Recursion determined that this &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;transaction met the criteria for as an asset acquisition since the lead asset, ENPP1 (Rec-102), an inhibitor program for the treatment of hypophosphatasia (HPP), represented substantially all of the fair value of the gross assets acquired. For the three months ended September 30, 2025, Recursion recorded an expense of $20.2 million, representing an acquired in-process research and development (IPR&amp;amp;D) asset with no alternative future use, to &#x201c;Research and Development&#x201d; on the Condensed Consolidated Statements of Operations. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subsequent to closing, in August 2025, Recursion issued additional consideration as part of a required milestone payment related to the RE Ventures I transaction for the initiation of an additional preclinical study. This included the settlement of the previously recorded contingent consideration liability. As a result, Recursion recorded an additional expense of $2.4 million acquired IPR&amp;amp;D, which was recorded to &#x201c;Research and Development&#x201d; on the Condensed Consolidated Statements of Operations. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the total consideration transferred at acquisition date:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:79.016%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.784%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recursion Class A common stock&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration liability&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transactions costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the consideration transferred for the milestone:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:79.016%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.784%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recursion Class A common stock&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the agreement, Rallybio is eligible to receive additional milestone payments under certain conditions. Milestone payment obligations that are incurred prior to regulatory approval of the compound will be expensed as acquired IPR&amp;amp;D when recognized.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Sale of Exscientia GmbH&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2025, Recursion completed the sale of its Austrian operations (Exscientia GmbH) to a newly formed company, Alpha Biotechnology GmbH (Alpha). As part of the sale, Recursion obtained a 49% equity interest in Alpha. Recursion entered into this transaction as part of focusing its efforts and moderating spend. Alpha is a company leveraging a patient-tissue platform for the development of precision therapeutics for the treatment of hematological and solid cancers. For the nine months ended September 30, 2025, Recursion recorded a loss on the disposal of Exscientia GmbH of $4.5 million, which was classified as &#x201c;Other income (loss), net&#x201d; on the Condensed Consolidated Statement of Operations. Recursion also recorded a $4.4 million investment on the Condensed Consolidated Balance Sheet within &#x201c;Other assets, non-current&#x201d; related to its 49% equity interest in Alpha, which was determined to be an equity method investment.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Exscientia plc&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2024, Recursion acquired all of the outstanding equity interests of Exscientia plc (&#x201c;Exscientia&#x201d;), a United Kingdom based public company that was registered on the Nasdaq Global Select Market. Exscientia is a drug design company utilizing its artificial intelligence platform to efficiently design and develop differentiated medicines for diseases with high unmet patient needs. Their focus is on utilizing their platform to develop best in class molecules with improvements to known or likely points of failure to improve the probability of developmental success. The Company believes the combination of the Recursion and Exscientia platforms and pipelines will position it to be a leader of the AI-enabled drug discovery and development space.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The acquisition of Exscientia was accounted for as a business combination using the acquisition method of accounting. The consideration transferred of approximately $630.1 million consisted of $616.9 million in Recursion Class A shares and $13.2 million related to the portion of Exscientia share based awards that were replaced with Recursion share based awards that is attributable to pre-combination service. Approximately 102.1 million Recursion Class A shares were issued in exchange for Exscientia ordinary shares using a fixed exchange ratio of one Exscientia ordinary share converts to 0.7729 Recursion Class A shares (the &#x201c;Exchange Ratio&#x201d;). In addition, Recursion replaced all outstanding Exscientia share based awards with Recursion share based awards wherein the vesting schedule and other applicable terms were carried over except for the exercise price of share options which were adjusted using the 0.7729 exchange ratio. This included Exscientia&#x2019;s stock options and restricted stock units. Recursion used $6.04, the Company&#x2019;s share price on November&#160;20, 2024 to calculate the consideration transferred. See Note 10, &#x201c;Stock-Based Compensation&#x201d; for additional information on the Exscientia share based awards.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the nine months ended September 30, 2025, Recursion updated the deferred tax liabilities from the acquisition, which were incomplete as of December&#160;31, 2024. As a result, Recursion adjusted the provisional deferred tax liabilities to reflect the additional information obtained about the facts and circumstances that existed as of the acquisition date. As a result, deferred tax liabilities and goodwill increased by $6.0 million. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the fair value of assets acquired and liabilities assumed as of the acquisition date:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:79.427%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.373%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:112%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;277,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Other receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;48,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;12,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;61,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;20,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Intangible assets, technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;182,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Intangible assets, indefinite-lived&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;129,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;1,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Other assets, non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;(40,780)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;(21,679)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;(120,905)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;(23,077)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;(1,572)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Total identifiable net assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;526,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;103,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Total assets acquired and liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;630,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Acquired contract liabilities in the scope of ASC 606 are an exception to the ASC 805 fair value measurement principle and were measured as if Recursion had originated the acquired contract. Two acquired customer contracts had contract liabilities and for each contract Recursion reassessed the identification of performance obligations, determination of transaction price, allocation of transaction price and measure of progress for each performance obligation as if Recursion has been party to the original contract and recognized the resulting contract liability as a liability assumed. No contract assets in the scope of ASC 606 were acquired.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The intangible assets of Exscientia consist of the Exscientia artificial intelligence platform and four clinical stage oncology in process research and development (IPR&amp;amp;D) assets. The operating system is a critical tool used for both designing molecules for fulfilling collaboration agreements and Exscientia&#x2019;s own research and development projects. The fair value of each intangible asset was valued based on the present value of future discounted cash flows prepared under the multi-period excess earnings method with the significant inputs being the estimates of future revenues, future expenses, the discount rate of 10.5% and probabilities of technological and regulatory success. The platform asset is being amortized on a straight line basis ove&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;r a six year useful life. The IPR&amp;amp;D assets &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;have been assigned an indefinite useful life and will be tested for impairme&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;nt prospectively and, if regulatory approval is achieved, will be assigned a useful life and amortization will commence.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill was calculated based on the excess of the consideration transferred over net assets acquired. The goodwill recognized represents the assembled workforce, future research and development projects enabled by the platform that do not yet have sufficient substance to meet the definition of in-process research and development assets and expected synergies such as the integration of Recursion and Exscientia platforms. The goodwill is not deductible for tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Recursion&#x2019;s consolidated statement of operations for the nine months ended September 30, 2025 includes $16.8 million of revenue and $139.4 million of operating loss from Exscientia operations. As the business combination occurred in November 2024, Recursion is still finalizing the allocation of the purchase price to assets acquired and liabilities assumed. The preliminary purchase price allocation reflected in the September&#160;30, 2025 balance sheet is based on the current best estimate of management and subject to change. The Company will finalize the amounts recognized as the information necessary to complete the analysis is obtained and management estimates are further refined. The primary areas subject to finalization are the valuation of intangible assets, right-of-use assets, property and equipment and the valuation of tax assets and liabilities. The Company expects to finalize the purchase price allocation soon but will do so no later than one year from the acquisition date. External specialists have been engaged to assist with certain elements of applying the acquisition method of accounting.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Pro forma financial information &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following pro forma summary presents consolidated revenue and earnings of Recursion as if the Exscientia business combination had occurred on January&#160;1, 2023&lt;/span&gt;&lt;span style="color:#008080;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:51.484%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.795%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.797%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Three months ended September 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Nine months ended September 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:112%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;32,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;75,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Operating loss&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;(202,645)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;(512,213)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The pro forma amounts have been calculated after converting the Exscientia financial information to U.S. GAAP, applying Recursion accounting policies and applying the acquisition method of accounting at January&#160;1, 2023. The pro forma financial information is not necessarily indicative of what the consolidated results of operations would have been had the acquisition been completed on January&#160;1, 2023. In addition, the pro forma financial information is not a projection of the future results of operations of the combined company nor does it reflect the expected realization of any cost savings or synergies associated with the acquisition.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <rxrx:AssetAcquisitionEquityOwnershipPercentage contextRef="c-69" decimals="2" id="f-432" unitRef="number">1</rxrx:AssetAcquisitionEquityOwnershipPercentage>
    <us-gaap:AssetAcquisitionConsiderationTransferred contextRef="c-70" decimals="-5" id="f-433" unitRef="usd">20200000</us-gaap:AssetAcquisitionConsiderationTransferred>
    <us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment contextRef="c-71" decimals="-5" id="f-434" unitRef="usd">20200000</us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment>
    <us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment contextRef="c-72" decimals="-3" id="f-435" unitRef="usd">2400000</us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment>
    <us-gaap:AssetAcquisitionTableTextBlock contextRef="c-1" id="f-436">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the total consideration transferred at acquisition date:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:79.016%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.784%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recursion Class A common stock&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration liability&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transactions costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AssetAcquisitionTableTextBlock>
    <us-gaap:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable contextRef="c-70" decimals="-3" id="f-437" unitRef="usd">7815000</us-gaap:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable>
    <us-gaap:AssetAcquisitionConsiderationTransferredContingentConsideration contextRef="c-70" decimals="-3" id="f-438" unitRef="usd">11875000</us-gaap:AssetAcquisitionConsiderationTransferredContingentConsideration>
    <us-gaap:AssetAcquisitionConsiderationTransferredTransactionCost contextRef="c-70" decimals="-3" id="f-439" unitRef="usd">292000</us-gaap:AssetAcquisitionConsiderationTransferredTransactionCost>
    <us-gaap:PaymentsToAcquireProductiveAssets contextRef="c-70" decimals="-3" id="f-440" unitRef="usd">171000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:AssetAcquisitionConsiderationTransferred contextRef="c-70" decimals="-3" id="f-441" unitRef="usd">20153000</us-gaap:AssetAcquisitionConsiderationTransferred>
    <us-gaap:AssetAcquisitionContingentConsiderationTableTextBlock contextRef="c-1" id="f-442">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the consideration transferred for the milestone:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:79.016%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.784%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recursion Class A common stock&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AssetAcquisitionContingentConsiderationTableTextBlock>
    <rxrx:AssetAcquisitionContingentConsiderationEquityInterestIssuedAndIssuable contextRef="c-72" decimals="-3" id="f-443" unitRef="usd">12500000</rxrx:AssetAcquisitionContingentConsiderationEquityInterestIssuedAndIssuable>
    <rxrx:AssetAcquisitionContingentConsiderationCashPaid contextRef="c-72" decimals="-3" id="f-444" unitRef="usd">1768000</rxrx:AssetAcquisitionContingentConsiderationCashPaid>
    <us-gaap:AssetAcquisitionConsiderationTransferredContingentConsideration contextRef="c-72" decimals="-3" id="f-445" unitRef="usd">14268000</us-gaap:AssetAcquisitionConsiderationTransferredContingentConsideration>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-73" decimals="2" id="f-446" unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:GainLossOnSaleOfBusiness contextRef="c-74" decimals="-5" id="f-447" unitRef="usd">-4500000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:EquityMethodInvestments contextRef="c-75" decimals="-5" id="f-448" unitRef="usd">4400000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-73" decimals="2" id="f-449" unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="c-76" decimals="-5" id="f-450" unitRef="usd">630100000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable contextRef="c-76" decimals="-5" id="f-451" unitRef="usd">616900000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <rxrx:BusinessCombinationConsiderationTransferredEquityInterestsIssuable contextRef="c-76" decimals="-5" id="f-452" unitRef="usd">13200000</rxrx:BusinessCombinationConsiderationTransferredEquityInterestsIssuable>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued contextRef="c-76" decimals="-5" id="f-453" unitRef="shares">102100000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <rxrx:BusinessCombinationEquityInterestIssuedOrIssuableSharesOfAcquirerStockPerShareOfAcquireeStockOutstanding
      contextRef="c-77"
      decimals="INF"
      id="f-454"
      unitRef="shares">0.7729</rxrx:BusinessCombinationEquityInterestIssuedOrIssuableSharesOfAcquirerStockPerShareOfAcquireeStockOutstanding>
    <rxrx:BusinessCombinationEquityInterestIssuedOrIssuableSharesOfAcquirerStockPerShareOfAcquireeStockOutstanding
      contextRef="c-77"
      decimals="INF"
      id="f-455"
      unitRef="shares">0.7729</rxrx:BusinessCombinationEquityInterestIssuedOrIssuableSharesOfAcquirerStockPerShareOfAcquireeStockOutstanding>
    <us-gaap:SharePrice
      contextRef="c-78"
      decimals="2"
      id="f-456"
      unitRef="usdPerShare">6.04</us-gaap:SharePrice>
    <us-gaap:GoodwillAcquiredDuringPeriod contextRef="c-79" decimals="-5" id="f-457" unitRef="usd">6000000.0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes contextRef="c-79" decimals="-5" id="f-458" unitRef="usd">6000000.0</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock contextRef="c-1" id="f-459">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the fair value of assets acquired and liabilities assumed as of the acquisition date:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:79.427%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.373%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:112%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;277,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Other receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;48,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;12,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;61,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;20,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Intangible assets, technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;182,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Intangible assets, indefinite-lived&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;129,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;1,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Other assets, non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;(40,780)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;(21,679)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;(120,905)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;(23,077)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;(1,572)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Total identifiable net assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;526,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;103,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Total assets acquired and liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;630,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents contextRef="c-80" decimals="-3" id="f-460" unitRef="usd">277104000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <rxrx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables contextRef="c-80" decimals="-3" id="f-461" unitRef="usd">48408000</rxrx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther contextRef="c-80" decimals="-3" id="f-462" unitRef="usd">12843000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment contextRef="c-80" decimals="-3" id="f-463" unitRef="usd">61961000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rxrx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets contextRef="c-80" decimals="-3" id="f-464" unitRef="usd">20271000</rxrx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="c-80" decimals="-3" id="f-465" unitRef="usd">182000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets contextRef="c-80" decimals="-3" id="f-466" unitRef="usd">129000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets contextRef="c-80" decimals="-3" id="f-467" unitRef="usd">1934000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets contextRef="c-80" decimals="-3" id="f-468" unitRef="usd">930000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable contextRef="c-80" decimals="-3" id="f-469" unitRef="usd">40780000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <rxrx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities contextRef="c-80" decimals="-3" id="f-470" unitRef="usd">21679000</rxrx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue contextRef="c-80" decimals="-3" id="f-471" unitRef="usd">120905000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities contextRef="c-80" decimals="-3" id="f-472" unitRef="usd">23077000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther contextRef="c-80" decimals="-3" id="f-473" unitRef="usd">1572000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet contextRef="c-80" decimals="-3" id="f-474" unitRef="usd">526438000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:Goodwill contextRef="c-80" decimals="-3" id="f-475" unitRef="usd">103686000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet contextRef="c-80" decimals="-3" id="f-476" unitRef="usd">630124000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <rxrx:NumberOfAcquiredCustomerContractsWithContractLiabilities
      contextRef="c-80"
      decimals="INF"
      id="f-477"
      unitRef="contract">2</rxrx:NumberOfAcquiredCustomerContractsWithContractLiabilities>
    <rxrx:NumberOfInProcessResearchAndDevelopmentAssets
      contextRef="c-80"
      decimals="INF"
      id="f-478"
      unitRef="inprocessresearchanddevelopmentasset">4</rxrx:NumberOfInProcessResearchAndDevelopmentAssets>
    <rxrx:FiniteLivedIntangibleAssetDiscountRate contextRef="c-76" decimals="3" id="f-479" unitRef="number">0.105</rxrx:FiniteLivedIntangibleAssetDiscountRate>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-81" id="f-480">P6Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual contextRef="c-79" decimals="-5" id="f-481" unitRef="usd">16800000</us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual>
    <us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual contextRef="c-79" decimals="-5" id="f-482" unitRef="usd">-139400000</us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock contextRef="c-1" id="f-483">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following pro forma summary presents consolidated revenue and earnings of Recursion as if the Exscientia business combination had occurred on January&#160;1, 2023&lt;/span&gt;&lt;span style="color:#008080;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:51.484%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.795%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.797%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Three months ended September 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Nine months ended September 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:112%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;32,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;75,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Operating loss&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;(202,645)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;(512,213)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:BusinessAcquisitionsProFormaRevenue contextRef="c-82" decimals="-3" id="f-484" unitRef="usd">32048000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue contextRef="c-83" decimals="-3" id="f-485" unitRef="usd">75643000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss contextRef="c-82" decimals="-3" id="f-486" unitRef="usd">-202645000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss contextRef="c-83" decimals="-3" id="f-487" unitRef="usd">-512213000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:LesseeFinanceLeasesTextBlock contextRef="c-1" id="f-489">Leases &lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has entered into various long-term real estate operating leases primarily related to office, research and development and operating activities and an equipment financing lease related to the supercomputer. The Company&#x2019;s leases have remaining terms from under one year to eight years and some of those leases include options that provide Recursion with the ability to extend the lease term, generally for 5 years. The options are included in the lease term when it is reasonably certain that the option will be exercised. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the nine months ended September 30, 2025, Recursion entered into lease modifications and terminations resulting in a decrease to the right-of-use asset and lease liability of $10.1&#160;million.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;This impact included the lease surrender of the Vienna facilities of Exscientia GmbH in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;March 2025&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which resulted in a $5.2 million reduction to both the right-of-use asset and lease liability. In connection with this surrender, the Company also incurred a lease termination fee of $5.2 million, which was classified as &#x201c;Other income (loss), net&#x201d; on the Condensed Consolidated Statement of Operations. Additionally, the Company entered into a lease modification related to the Schrodinger leases to decrease the lease terms, which now ended during the second quarter of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2025&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This resulted in a decrease to both the right-of-use asset and lease liability by $4.9 million. As a part of the lease modifications and termination, Recursion recorded leasehold impairments of $6.0 million. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;nine months ended September 30, 2024,&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Recursion entered into operating lease modifications and additions resulting in an increase to the right-of-use asset and lease liability of $19.5 million. The modifications had &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;no impact to the Condensed Consolidated Statements of Operations. For the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;nine months ended September 30, 2024,&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Recursion entered into finance lease additions resulting in an increase to the right-of-use asset and lease liability of $29.3 million. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases were:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:63.666%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.835%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.199%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amount included in the measurement of lease liabilities: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from financing leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows from financing leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets additions, modifications and termination:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,084)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeFinanceLeasesTextBlock>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="c-1" id="f-488">Leases &lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has entered into various long-term real estate operating leases primarily related to office, research and development and operating activities and an equipment financing lease related to the supercomputer. The Company&#x2019;s leases have remaining terms from under one year to eight years and some of those leases include options that provide Recursion with the ability to extend the lease term, generally for 5 years. The options are included in the lease term when it is reasonably certain that the option will be exercised. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the nine months ended September 30, 2025, Recursion entered into lease modifications and terminations resulting in a decrease to the right-of-use asset and lease liability of $10.1&#160;million.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;This impact included the lease surrender of the Vienna facilities of Exscientia GmbH in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;March 2025&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which resulted in a $5.2 million reduction to both the right-of-use asset and lease liability. In connection with this surrender, the Company also incurred a lease termination fee of $5.2 million, which was classified as &#x201c;Other income (loss), net&#x201d; on the Condensed Consolidated Statement of Operations. Additionally, the Company entered into a lease modification related to the Schrodinger leases to decrease the lease terms, which now ended during the second quarter of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2025&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This resulted in a decrease to both the right-of-use asset and lease liability by $4.9 million. As a part of the lease modifications and termination, Recursion recorded leasehold impairments of $6.0 million. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;nine months ended September 30, 2024,&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Recursion entered into operating lease modifications and additions resulting in an increase to the right-of-use asset and lease liability of $19.5 million. The modifications had &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;no impact to the Condensed Consolidated Statements of Operations. For the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;nine months ended September 30, 2024,&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Recursion entered into finance lease additions resulting in an increase to the right-of-use asset and lease liability of $29.3 million. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases were:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:63.666%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.835%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.199%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amount included in the measurement of lease liabilities: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from financing leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows from financing leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets additions, modifications and termination:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,084)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm contextRef="c-84" id="f-490">P1Y</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm contextRef="c-85" id="f-491">P8Y</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:LesseeOperatingLeaseRenewalTerm contextRef="c-4" id="f-492">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <rxrx:LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications contextRef="c-1" decimals="-5" id="f-493" unitRef="usd">-10100000</rxrx:LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications>
    <rxrx:IncreaseDecreaseInOperatingLeaseRightOfUseAssets contextRef="c-1" decimals="-5" id="f-494" unitRef="usd">-10100000</rxrx:IncreaseDecreaseInOperatingLeaseRightOfUseAssets>
    <rxrx:IncreaseDecreaseInOperatingLeaseRightOfUseAssets contextRef="c-86" decimals="-5" id="f-495" unitRef="usd">-5200000</rxrx:IncreaseDecreaseInOperatingLeaseRightOfUseAssets>
    <rxrx:LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications contextRef="c-86" decimals="-5" id="f-496" unitRef="usd">-5200000</rxrx:LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications>
    <rxrx:TerminationOfLeaseFee contextRef="c-87" decimals="-5" id="f-497" unitRef="usd">5200000</rxrx:TerminationOfLeaseFee>
    <rxrx:IncreaseDecreaseInOperatingLeaseRightOfUseAssets contextRef="c-88" decimals="-5" id="f-498" unitRef="usd">-4900000</rxrx:IncreaseDecreaseInOperatingLeaseRightOfUseAssets>
    <rxrx:LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications contextRef="c-88" decimals="-5" id="f-499" unitRef="usd">-4900000</rxrx:LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications>
    <us-gaap:ImpairmentOfLeasehold contextRef="c-88" decimals="-5" id="f-500" unitRef="usd">6000000.0</us-gaap:ImpairmentOfLeasehold>
    <rxrx:IncreaseDecreaseInOperatingLeaseRightOfUseAssets contextRef="c-22" decimals="-5" id="f-501" unitRef="usd">19500000</rxrx:IncreaseDecreaseInOperatingLeaseRightOfUseAssets>
    <rxrx:LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications contextRef="c-22" decimals="-5" id="f-502" unitRef="usd">19500000</rxrx:LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications>
    <rxrx:LesseeFinanceLeaseIncreaseDecreaseInFinanceLeaseLiabilityDueToLeaseModifications contextRef="c-22" decimals="-5" id="f-503" unitRef="usd">29300000</rxrx:LesseeFinanceLeaseIncreaseDecreaseInFinanceLeaseLiabilityDueToLeaseModifications>
    <rxrx:IncreaseDecreaseInRightOfUseAssetsForFinanceLeases contextRef="c-22" decimals="-5" id="f-504" unitRef="usd">29300000</rxrx:IncreaseDecreaseInRightOfUseAssetsForFinanceLeases>
    <us-gaap:LeaseCostTableTextBlock contextRef="c-1" id="f-505">&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases were:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:63.666%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.835%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.199%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amount included in the measurement of lease liabilities: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from financing leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows from financing leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets additions, modifications and termination:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,084)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeasePayments contextRef="c-1" decimals="-3" id="f-506" unitRef="usd">14756000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c-22" decimals="-3" id="f-507" unitRef="usd">10742000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability contextRef="c-1" decimals="-3" id="f-508" unitRef="usd">1368000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability contextRef="c-22" decimals="-3" id="f-509" unitRef="usd">379000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeasePrincipalPayments contextRef="c-1" decimals="-3" id="f-510" unitRef="usd">6174000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments contextRef="c-22" decimals="-3" id="f-511" unitRef="usd">2261000</us-gaap:FinanceLeasePrincipalPayments>
    <rxrx:IncreaseDecreaseInOperatingLeaseRightOfUseAssets contextRef="c-1" decimals="-3" id="f-512" unitRef="usd">-10084000</rxrx:IncreaseDecreaseInOperatingLeaseRightOfUseAssets>
    <rxrx:IncreaseDecreaseInOperatingLeaseRightOfUseAssets contextRef="c-22" decimals="-3" id="f-513" unitRef="usd">19455000</rxrx:IncreaseDecreaseInOperatingLeaseRightOfUseAssets>
    <rxrx:IncreaseDecreaseInRightOfUseAssetsForFinanceLeases contextRef="c-1" decimals="-3" id="f-514" unitRef="usd">0</rxrx:IncreaseDecreaseInRightOfUseAssetsForFinanceLeases>
    <rxrx:IncreaseDecreaseInRightOfUseAssetsForFinanceLeases contextRef="c-22" decimals="-3" id="f-515" unitRef="usd">29342000</rxrx:IncreaseDecreaseInRightOfUseAssetsForFinanceLeases>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock contextRef="c-1" id="f-516">Goodwill and Intangible Assets &lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the changes in the carrying amount of goodwill: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:82.964%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.836%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of September 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No goodwill impairment was recorded during the three and nine months ended September 30, 2025 and 2024.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible Assets, Net&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes intangible assets:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.268%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.888%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.326%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.408%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.350%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net carrying amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Definite-lived technology intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57,806)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,544)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Definite-lived licensed intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,679)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,088)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;385,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63,485)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;362,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26,632)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;335,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense was $13.4 million and $37.4 million during the three and nine months ended September 30, 2025, respectively. Amortization expense was $4.1 million and $11.3 million during the three and nine months ended September 30, 2024, respectively. Amortization expense was included in &#x201c;Research and Development&#x201d; and &#x201c;Cost of Revenue&#x201d; in the Condensed Consolidated Statements of Operations. No indefinite-lived intangible asset impairment charges were recorded during the three and nine months ended September 30, 2025 and 2024.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock contextRef="c-1" id="f-517">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the changes in the carrying amount of goodwill: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:82.964%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.836%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of September 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill contextRef="c-5" decimals="-3" id="f-518" unitRef="usd">148873000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod contextRef="c-1" decimals="-3" id="f-519" unitRef="usd">5947000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss contextRef="c-1" decimals="-3" id="f-520" unitRef="usd">-7222000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill contextRef="c-4" decimals="-3" id="f-521" unitRef="usd">162042000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-21" decimals="INF" id="f-522" unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-20" decimals="INF" id="f-523" unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-1" decimals="INF" id="f-524" unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-22" decimals="INF" id="f-525" unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock contextRef="c-1" id="f-527">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes intangible assets:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.268%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.888%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.326%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.408%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.350%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net carrying amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Definite-lived technology intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57,806)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,544)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Definite-lived licensed intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,679)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,088)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;385,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63,485)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;362,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26,632)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;335,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="c-1" id="f-526">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes intangible assets:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.268%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.888%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.326%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.408%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.350%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net carrying amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Definite-lived technology intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57,806)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,544)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Definite-lived licensed intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,679)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,088)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;385,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63,485)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;362,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26,632)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;335,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-89" decimals="-3" id="f-528" unitRef="usd">236443000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-89" decimals="-3" id="f-529" unitRef="usd">57806000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-89" decimals="-3" id="f-530" unitRef="usd">178637000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-90" decimals="-3" id="f-531" unitRef="usd">224362000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-90" decimals="-3" id="f-532" unitRef="usd">24544000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-90" decimals="-3" id="f-533" unitRef="usd">199818000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-91" decimals="-3" id="f-534" unitRef="usd">11508000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-91" decimals="-3" id="f-535" unitRef="usd">5679000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-91" decimals="-3" id="f-536" unitRef="usd">5829000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-92" decimals="-3" id="f-537" unitRef="usd">9350000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-92" decimals="-3" id="f-538" unitRef="usd">2088000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-92" decimals="-3" id="f-539" unitRef="usd">7262000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c-4" decimals="-3" id="f-540" unitRef="usd">137878000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c-4" decimals="-3" id="f-541" unitRef="usd">137878000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c-5" decimals="-3" id="f-542" unitRef="usd">128775000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c-5" decimals="-3" id="f-543" unitRef="usd">128775000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill contextRef="c-4" decimals="-3" id="f-544" unitRef="usd">385829000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-4" decimals="-3" id="f-545" unitRef="usd">63485000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-4" decimals="-3" id="f-546" unitRef="usd">322344000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill contextRef="c-5" decimals="-3" id="f-547" unitRef="usd">362487000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-5" decimals="-3" id="f-548" unitRef="usd">26632000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-5" decimals="-3" id="f-549" unitRef="usd">335855000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-20" decimals="-5" id="f-550" unitRef="usd">13400000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-1" decimals="-5" id="f-551" unitRef="usd">37400000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-21" decimals="-5" id="f-552" unitRef="usd">4100000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-22" decimals="-5" id="f-553" unitRef="usd">11300000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill contextRef="c-20" decimals="INF" id="f-554" unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill contextRef="c-21" decimals="INF" id="f-555" unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill contextRef="c-1" decimals="INF" id="f-556" unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill contextRef="c-22" decimals="INF" id="f-557" unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c-1" id="f-558">Commitments and Contingencies&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contract Obligations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the normal course of business, the Company enters into contracts with clinical research organizations, drug manufacturers and other vendors&#160;for preclinical and clinical research studies, research and development supplies and other services and products for operating purposes. These contracts generally provide for termination on notice and are cancellable contracts.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Indemnification&lt;/span&gt;&lt;span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has agreed to indemnify its officers and directors for certain events or occurrences, while the officer or director is or was serving at the Company&#x2019;s request in such capacity. The Company purchases directors and officers liability insurance coverage that provides for reimbursement to the Company for covered obligations and this is intended to limit the Company&#x2019;s exposure and enable it to recover a portion of any amount it pays under its indemnification obligations. The Company had no liabilities recorded for these agreements as of September&#160;30, 2025 and December&#160;31, 2024, as no amounts were probable. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Employee Agreements &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has signed employment agreements with certain key employees pursuant to which, if their employment is terminated following a change of control of the Company, the employees are entitled to receive certain benefits, including accelerated vesting of equity incentives. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Legal Matters&lt;/span&gt;&lt;span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may, from time to time, be involved in various legal proceedings arising in the normal course of business. An unfavorable resolution of any such matter could materially affect the Company&#x2019;s future financial position, results of operations or cash flows. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In &lt;/span&gt;&lt;span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;April 2024&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, a putative class action complaint was filed in the U.S. District Court for the District of New Jersey against Exscientia plc, Andrew Hopkins, Ben R. Taylor and David Nicholson (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Campanile v. Exscientia plc, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Case No. 1:24-cv-05692). In &lt;/span&gt;&lt;span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;June 2024&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, a separate complaint was filed against the same defendants in the U.S. District Court for the District of New Jersey (Case 1:24-cv-07181). Both complaints allege that the defendants violated federal securities laws by, among other things, making materially false and misleading statements regarding Exscientia&#x2019;s business, operations and prospects. The complaints seek unspecified compensatory damages, as well as an award of reasonable attorneys&#x2019; fees and other costs, on behalf of persons and/or entities which purchased Exscientia securities between &lt;/span&gt;&lt;span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;March 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;February 2024&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The cases were consolidated and plaintiffs filed an amended complaint on November 11, 2024 against Exscientia plc, Andrew Hopkins and David Nicholson, and the Company moved to dismiss on January 21, 2025. On &lt;/span&gt;&lt;span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;October&#160;7, 2025&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, that motion to dismiss was granted and the District Court dismissed the plaintiff&#x2019;s claims without prejudice; permitting leave to re-file the complaint within 30 days. As of &lt;/span&gt;&lt;span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;September&#160;30, 2025&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the Company had no liability recorded for these events as an unfavorable outcome was not probable.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2021, the Company entered into a lease agreement for laboratory and office space (the Industry Lease) with Industry Office SLC, LLC (the landlord). In March 2023, the Company sent a letter to the landlord detailing numerous construction delays and irregularities, deficiencies and deviations from applicable structural drawings and/or non-conforming conditions with applicable building codes (collectively, the Claims). On June&#160;23, 2023, the landlord filed a lawsuit against the Company (Industry Office SLC, LLC v. Recursion Pharmaceuticals, Inc., Case No. 230904627) amended in October 2023, in the Third District Court for Salt Lake County, State of Utah (the Court), alleging anticipatory repudiation, breach of contract and breach of the implied covenant of good faith and fair dealing and seeks monetary damages and attorney&#x2019;s fees. As of September&#160;30, 2025, the Company had no liability recorded for these events as an unfavorable outcome was not probable. In September 2023, the Company filed claims in the Court against the landlord alleging, among other things, breach of contract and fraudulent misrepresentation (the Counterclaims). In October 2023, the landlord filed an answer and denied the Company&#x2019;s allegations asserted in the Counterclaims. In &lt;/span&gt;&lt;span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;October 2025&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the Company filed a motion for summary judgment against the Claims and in favor of a number of its Counterclaims, which remains pending. The Company is unable to estimate the possible amount or range of damages associated with the Counterclaims.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Pledged Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2025, assets pledged as collateral against finance leases totaled $19.5 million. Assets pledged as collateral are Lab Equipment reported in &#x201c;Property and Equipment, net&#x201d; on the Condensed Consolidated Balance Sheet. As of September&#160;30, 2025, the liabilities associated with collateral pledged were solely comprised of a finance lease and had a carrying value of $20.5 million. The collateral pledged under the lease agreement may only be operated by the Company within the continental United States and must maintain a good title. The assets cannot be sold, disposed of or repledged by the Company.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LossContingencyAccrualAtCarryingValue contextRef="c-4" decimals="INF" id="f-559" unitRef="usd">0</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue contextRef="c-5" decimals="INF" id="f-560" unitRef="usd">0</us-gaap:LossContingencyAccrualAtCarryingValue>
    <rxrx:DurationOfTimeForPlaintiffToRefileClaim contextRef="c-93" id="f-561">P30D</rxrx:DurationOfTimeForPlaintiffToRefileClaim>
    <us-gaap:LossContingencyAccrualAtCarryingValue contextRef="c-4" decimals="INF" id="f-562" unitRef="usd">0</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue contextRef="c-4" decimals="INF" id="f-563" unitRef="usd">0</us-gaap:LossContingencyAccrualAtCarryingValue>
    <rxrx:FinanceLeasesAssetsPledgedAsCollateral contextRef="c-4" decimals="-5" id="f-564" unitRef="usd">19500000</rxrx:FinanceLeasesAssetsPledgedAsCollateral>
    <us-gaap:FinanceLeaseLiability contextRef="c-4" decimals="-5" id="f-565" unitRef="usd">20500000</us-gaap:FinanceLeaseLiability>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c-1" id="f-566">Common Stock &lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each share of Class A common stock entitles the holder to one vote per share and each share of Class B common stock entitles the holder to 10 votes per share on all matters submitted to a vote of the Company&#x2019;s stockholders. Common stockholders are entitled to receive dividends, as may be declared by the Company&#x2019;s Board of Directors. As of September&#160;30, 2025 and December&#160;31, 2024, no dividends had been declared. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;At-The-Market Offering (Citi)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In &lt;/span&gt;&lt;span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;February 2025&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, following the termination of the Jefferies Sales Agreement, the Company entered into a Sales Agreement (the Citi Sales Agreement) with Citigroup Capital Markets Inc. (Citi) to provide for the offering, issuance and sale of up to an aggregate amount of $500 million of its Class A common stock from time to time in &#x201c;at-the-market&#x201d; offerings (the Citi ATM Offering). The Citi ATM Offering was made under a prospectus supplement dated February&#160;28, 2025 and related prospectus filed with the Securities and Exchange Commission pursuant to the Company&#x2019;s automatically effective shelf registration statement on Form S-3 (Registration No. 333-284878). &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the nine months ended September 30, 2025, the Company sold 74.6&#160;million shares and received net proceeds of $358.2 million under the agreement. As of&#160;September&#160;30, 2025, an amount of $136.4 million remained available for future sales under the Sales Agreement. The remaining amount was fully utilized during October 2025, see Note 15, &#x201c;Subsequent Events&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d; for additional details.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;At-The-Market Offering (Jefferies)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In &lt;/span&gt;&lt;span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;August 2023&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the Company entered into an Open Market Sales Agreement (the &#x201c;Jefferies Sales Agreement&#x201d;) with Jefferies LLC ( &#x201c;Jefferies&#x201d;), to provide for the offering, issuance and sale of up to an aggregate amount of $300.0 million of its Class A common stock from time to time in &#x201c;at-the-market&#x201d; (ATM) offerings. In &lt;/span&gt;&lt;span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;February 2025&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the Company terminated the Jefferies Sales Agreement. In total, the Company sold 26.8&#160;million shares and received net proceeds of $199.1 million under the agreement through its termination. Of the total sales and net proceeds, the Company sold 4.9&#160;million shares and received net proceeds of $36.9 million under the agreement in 2025,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;prior to its termination. The Company paid Jefferies a commission of up to 3% of the aggregate gross proceeds received from all sales of Class A common stock. The Jefferies ATM Offering was made under a prospectus supplement dated August&#160;8, 2023 and related prospectus filed with the Securities and Exchange Commission pursuant to the Company&#x2019;s automatically effective shelf registration statement on Form S-3ASR (Registration No. 333-264845). &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Public Offering of Common Stock&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2024, the Company closed its public offering of Class A common stock and issued 35.4&#160;million shares at a price of $6.50 per share for net proceeds of approximately $216.4 million, after deducting transaction costs of $13.6 million. In connection with the public offering of Class A common stock, the Company entered into an underwriting agreement for the offering and sale of 30.8&#160;million shares. The Company also granted the Underwriters a 30 day option from the date of the underwriting agreement to purchase up to an additional 4.6&#160;million shares of Class A Common Stock, which was exercised in full. The public offering was made pursuant to the Company's effective registration statement on Form S-3 (File No. 333-264845) and a related prospectus supplement and accompanying prospectus dated June&#160;26, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Valence Acquisition Exchangeable Shares&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In &lt;/span&gt;&lt;span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;May 2023&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, in connection with the acquisition of Valence, the Company entered into an agreement to issue up to 5.9&#160;million shares of Class A common stock (the &#x201c;Exchangeable Shares&#x201d;), that may be issued upon exchange, retraction or redemption of exchangeable shares of a subsidiary of Recursion. Each exchangeable share of the subsidiary of Recursion entitles the holder to exchange those shares on a one-for-one basis for Recursion&#x2019;s Class A common stock. The shares are entitled to receive dividends economically equivalent to dividends declared by Recursion, are non-voting and are subject to customary adjustments for stock splits or other reorganizations. In addition, the Company may require all outstanding exchangeable shares to be exchanged into an equal number of Class A common stock upon the occurrence of certain events and at any time following the seventh anniversary of the closing of the Valence acquisition. The exchangeable shares are substantially the economic equivalent of the Class A shares and classified as common stock within the Company&#x2019;s stockholders&#x2019; equity. The Company&#x2019;s calculation of weighted-average shares outstanding includes the exchangeable shares. As of September&#160;30, 2025, 5.0&#160;million Exchangeable shares have been redeemed for Class A shares.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Registration Rights Agreements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Tempus agreement&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In &lt;/span&gt;&lt;span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;November 2023&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, in connection with the Tempus Agreement, the Company agreed to prepare and file a registration statement (or a prospectus supplement to an effective registration statement on Form S-3ASR that will become automatically effective upon filing with the SEC pursuant to Rule 462(e)) with the SEC, for resale of the shares of Class A common stock issued or issuable under the Tempus Agreement. A prospectus supplement to a registration statement (File No. 333-264845) was subsequently filed in December 2023 to register shares issued to Tempus for the initial license fee under the Tempus Agreement for resale. In December 2024, a prospectus supplement to a registration statement (File No. 333-264845) was filed to register shares issued to Tempus in payment for the 2024 annual fee. Such registration statement (File No. 333-264845) expired.  A new registration statement (333-284878) was filed in February 2025 and a prospectus supplement covering all shares that have been issued under the Tempus Agreement and remained held by Tempus was filed in May 2025.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;After registration of any shares issued to Tempus under the Tempus Agreement, the Company has agreed to use commercially reasonable efforts to keep such registration statement effective until such date that all shares issued to Tempus covered by such registration statement have been sold or are able to be publicly sold by relying on Rule 144 of the Securities Act without registration.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2024, in connection with the acquisition of Exscientia, the Company filed a Registration Statement on Form S-8 (File No. 333-283347) to register the shares of Class A common stock issuable upon exercise or settlement, as applicable, of Recursion stock options and RSUs issued under the assumed Exscientia plans and the Inducement awards. The Company has agreed to use commercially reasonable efforts to maintain the effectiveness of such registration statement as long as such Recursion stock options and RSUs issued under the assumed Exscientia plans remain outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2023, in connection with the acquisition of Valence, the Company entered into a Registration Agreement providing for the registration for resale of the shares of Class A common stock and Exchange Shares issued or issuable in such transaction. A registration statement on Form S-3ASR (File No. 333-272281) was filed to register the shares for resale by the holders. The registration statement must remain effective for a period of not less than three years. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Class A and B Common Shares Authorization&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2021, the Company&#x2019;s Board of Directors authorized two classes of common stock, Class A and Class B. The rights of the holders of Class A and B common stock are identical, except with respect to voting and conversion. Each share of Class A common stock is entitled to one vote per share. Each share of Class B common stock is entitled to 10 votes per share and is convertible at any time into one share of Class A common stock.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All Class B common stock is held by Christopher Gibson, Ph.D., the Company&#x2019;s Chief Executive Officer (CEO), or his affiliates. As of September&#160;30, 2025, Dr. Gibson and his affiliates held outstanding shares of Class B common &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;stock representing approximately 12% of the voting power of the Company&#x2019;s outstanding shares. This voting power may increase over time as Dr. Gibson vests in and exercises equity awards outstanding. If all the exchangeable equity awards held by Dr. Gibson had been fully vested, exercised and exchanged for shares of Class B common stock as of September&#160;30, 2025, Dr. Gibson and his affiliates would hold approximately 13% of the voting power of the Company&#x2019;s outstanding shares. As a result, Dr. Gibson will be able to significantly influence any action requiring the approval of Recursion stockholders, including the election of the Board of Directors; the adoption of amendments to the Company&#x2019;s certificate of incorporation and bylaws; and the approval of any merger, consolidation, sale of all or substantially all of the Company&#x2019;s assets, or other major corporate transaction.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <rxrx:CommonStockVotePerShare contextRef="c-6" decimals="INF" id="f-567" unitRef="vote">1</rxrx:CommonStockVotePerShare>
    <rxrx:CommonStockVotePerShare contextRef="c-9" decimals="INF" id="f-568" unitRef="vote">10</rxrx:CommonStockVotePerShare>
    <us-gaap:DividendsStock contextRef="c-94" decimals="INF" id="f-569" unitRef="usd">0</us-gaap:DividendsStock>
    <us-gaap:DividendsStock contextRef="c-1" decimals="INF" id="f-570" unitRef="usd">0</us-gaap:DividendsStock>
    <rxrx:SaleOfStockValueAuthorized contextRef="c-95" decimals="-6" id="f-571" unitRef="usd">500000000</rxrx:SaleOfStockValueAuthorized>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c-96" decimals="-5" id="f-572" unitRef="shares">74600000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-96" decimals="-5" id="f-573" unitRef="usd">358200000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <rxrx:SaleOfStockValueRemainingAuthorized contextRef="c-97" decimals="-5" id="f-574" unitRef="usd">136400000</rxrx:SaleOfStockValueRemainingAuthorized>
    <rxrx:SaleOfStockValueAuthorized contextRef="c-98" decimals="-5" id="f-575" unitRef="usd">300000000.0</rxrx:SaleOfStockValueAuthorized>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c-99" decimals="-5" id="f-576" unitRef="shares">26800000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-99" decimals="-5" id="f-577" unitRef="usd">199100000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c-100"
      decimals="-5"
      id="f-578"
      unitRef="shares">4900000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-100" decimals="-5" id="f-579" unitRef="usd">36900000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <rxrx:SaleOfStockPercentageOfCommission contextRef="c-99" decimals="2" id="f-580" unitRef="number">0.03</rxrx:SaleOfStockPercentageOfCommission>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c-101"
      decimals="-5"
      id="f-581"
      unitRef="shares">35400000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-102"
      decimals="2"
      id="f-582"
      unitRef="usdPerShare">6.50</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-101" decimals="-5" id="f-583" unitRef="usd">216400000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c-101" decimals="-5" id="f-584" unitRef="usd">13600000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c-103"
      decimals="-5"
      id="f-585"
      unitRef="shares">30800000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <rxrx:SaleOfStockUnderwritersOptionPeriodFromTheDateOfTheAgreement contextRef="c-104" id="f-586">P30D</rxrx:SaleOfStockUnderwritersOptionPeriodFromTheDateOfTheAgreement>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c-105"
      decimals="-5"
      id="f-587"
      unitRef="shares">4600000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <rxrx:BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares
      contextRef="c-106"
      decimals="-5"
      id="f-588"
      unitRef="shares">5900000</rxrx:BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares>
    <rxrx:CommonStockConversionRatio
      contextRef="c-107"
      decimals="INF"
      id="f-589"
      unitRef="number">1</rxrx:CommonStockConversionRatio>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="c-108"
      decimals="-5"
      id="f-590"
      unitRef="shares">5000000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <rxrx:RegistrationRightsAgreementTerm contextRef="c-109" id="f-591">P3Y</rxrx:RegistrationRightsAgreementTerm>
    <rxrx:NumberOfClassesOfCommonStockAuthorized
      contextRef="c-110"
      decimals="INF"
      id="f-592"
      unitRef="class">2</rxrx:NumberOfClassesOfCommonStockAuthorized>
    <rxrx:CommonStockVotePerShare contextRef="c-6" decimals="INF" id="f-593" unitRef="vote">1</rxrx:CommonStockVotePerShare>
    <rxrx:CommonStockVotePerShare contextRef="c-9" decimals="INF" id="f-594" unitRef="vote">10</rxrx:CommonStockVotePerShare>
    <rxrx:CommonStockConversionRatio contextRef="c-6" decimals="INF" id="f-595" unitRef="number">1</rxrx:CommonStockConversionRatio>
    <rxrx:AffiliatedHoldersOwnershipPercentage contextRef="c-111" decimals="2" id="f-596" unitRef="number">0.12</rxrx:AffiliatedHoldersOwnershipPercentage>
    <rxrx:AffiliatedHoldersPotentialOwnershipPercentageWhenOutstandingEquityAwardsVest contextRef="c-111" decimals="2" id="f-597" unitRef="number">0.13</rxrx:AffiliatedHoldersPotentialOwnershipPercentageWhenOutstandingEquityAwardsVest>
    <us-gaap:CollaborativeArrangementDisclosureTextBlock contextRef="c-1" id="f-598">Collaborative Development Contracts &lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Sanofi&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Description&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In &lt;/span&gt;&lt;span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;January 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the Company and Sanofi entered into a collaboration agreement to develop an AI-driven pipeline of precision-engineered medicines. The research is focused on up to 15 novel small molecule candidates across oncology and immunology and utilizes the Company&#x2019;s AI platform. The Company is leading small molecule drug design and lead optimization activities with Sanofi assuming responsibility for preclinical and clinical development, manufacturing and commercialization.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Pricing&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company received a $100.0 million non-refundable upfront payment. In &lt;/span&gt;&lt;span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;April 2025&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, Recursion received a $7.0 million payment related to the achievement of a milestone for one of the performance obligations. The Company has also received multiple other milestone payments related to this agreement totaling approximately $30.0 million. These related to the advancement of several of the discovery programs within the collaboration and the addition of an existing Company program into the collaboration. Recursion is eligible for additional milestone payments based on performance progress of the collaboration and tiered royalties ranging from high-single-digits to mid-teens. Recursion could earn a maximum of $555.0 million from all research milestones and $1.8 billion from all development and regulatory milestones.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Accounting&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In &lt;/span&gt;&lt;span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;November 2024&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, Recursion acquired Exscientia as part of an acquisition. See Note 4, &#x201c;Acquisitions&#x201d; for additional information. As such, the initial Recursion accounting analysis for this transaction was done as of the business combination date as if Recursion had originated the contract. This agreement represents a transaction with a customer and therefore is accounted for in accordance with ASC 606. Recursion has determined that it has at least eight performance obligations related to the small molecule projects. These performance obligations are for performing research and development services for Sanofi to design small molecules and perform lead optimization activities. The performance obligations also include potential licenses related to the intellectual property. The Company concluded that licenses within the contract are not distinct from the research and development services as they are interrelated due to the fact that the research and development services significantly impact the potential licenses. Any additional services are considered customer options and will be considered as separate contracts for accounting purposes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has determined the transaction price to be $152.9 million, for the initial performance obligations, comprised of the upfront payment, several milestones that have been achieved and estimated additional target exercises. Prior to the three months ended June 30, 2025, Recursion had fully constrained the $7.0 million variable consideration milestone. Recursion is now recognizing the milestone as part of the transaction price over the completion period for the related performance obligation. Recursion has fully constrained the amounts of remaining variable consideration to be received from potential milestones considering the stage of development and the risks associated with the remaining development required to achieve each milestone. Recursion will re-evaluate the transaction price each reporting period. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The transaction price was generally allocated to the performance obligations based on the estimated relative stand-alone selling price of each performance obligation as determined using an expected cost plus margin approach. The milestone fees were allocated to related performance obligation as the terms of the variable consideration related specifically to Recursion&#x2019;s efforts to satisfy the related performance obligation. The Company recognizes revenue over time based on costs incurred relative to total expected costs to perform the research and development services. Recursion determined that this method provides a faithful depiction of the transfer of control to the &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;customer. This method of recognizing revenue requires the Company to make estimates of total costs to provide the services required under the performance obligations. Significant inputs used to determine the total costs included the number of projects to be performed, the number of substitutions related to those projects, length of time required, service hours performed by Company employees and materials costs. A significant change in these estimates could have a material effect on the timing and amount of revenue recognized in future periods. Recursion is unable to estimate the completion date of the performance obligations due to the current stage of work.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Merck KGaA (Merck)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Description&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In &lt;/span&gt;&lt;span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;September 2023&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the Company and Merck entered into a collaboration agreement to discover novel small molecule drug candidates across oncology, neuroinflammation and immunology. The collaboration utilizes the Company&#x2019;s AI platform and the Company is performing drug design and discovery while Merck will be assuming responsibility for the preclinical and clinical development.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Pricing&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company received a $20.1 million non-refundable upfront payment. Recursion is eligible for additional milestone payments based on performance progress of the collaboration and tiered royalties from the mid-single-digits to low-double-digits. The Company could earn a maximum of $73.0 million for discovery, development and sales milestones per project.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Accounting&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In &lt;/span&gt;&lt;span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;November 2024&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, Recursion acquired Exscientia as part of an acquisition. See Note 4, &#x201c;Acquisitions&#x201d; for additional information. As such, the initial Recursion accounting analysis for this transaction was done as of the business combination date as if Recursion had originated the contract. This agreement represents a transaction with a customer and therefore is accounted for in accordance with ASC 606. Recursion has determined that it has three performance obligations related to each project in the partnership. These performance obligations are for performing research and development services for Merck to design small molecules and perform lead optimization activities. The performance obligations also include potential licenses related to the intellectual property. The Company concluded that licenses within the contract are not distinct from the research and development services as they are interrelated due to the fact that the research and development services significantly impact the potential licenses. Any additional services are considered customer options and will be considered as separate contracts for accounting purposes. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has determined the transaction price to be $20.1 million, for the initial performance obligations, comprised of the upfront payment. Recursion will fully constrain the amounts of remaining variable consideration to be received from potential milestones considering the stage of development and the risks associated with the remaining development required to achieve each milestone. Recursion will re-evaluate the transaction price each reporting period. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The transaction price was allocated to the performance obligations based on the estimated relative stand-alone selling price of each performance obligation as determined using an expected cost plus margin approach. The Company recognizes revenue over time based on costs incurred relative to total expected costs to perform the research and development services. Recursion determined that this method provides a faithful depiction of the transfer of control to the customer. This method of recognizing revenue requires the Company to make estimates of total costs to provide the services required under the performance obligations. Significant inputs used to determine the total costs included the number of projects to be performed, the number of substitutions related to those projects, length of time required, service hours performed by Company employees and materials costs. A significant change in these estimates could have a material effect on the timing and amount of revenue recognized in future periods. Recursion was unable to estimate the completion date of the performance obligations due to the current stage of work.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Roche and Genentech&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Description&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2021, Recursion entered into a collaboration and license agreement with Roche and Genentech (collectively referred to as Roche). Recursion is constructing, using the Company&#x2019;s imaging technology and proprietary machine-learning algorithms, unique maps of the inferred relationships amongst perturbation &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;phenotypes in a given cellular context with the goal to discover and develop therapeutic small molecule programs in a gastrointestinal cancer indication and in key areas of neuroscience. Roche and Recursion will collaborate to select certain novel inferences with respect to small molecules or targets generated from the Phenomaps for further validation and optimization as collaboration programs. Roche and Recursion may also combine sequencing datasets from Roche with Recursion&#x2019;s Phenomaps and collaborate to generate new algorithms to produce multi-modal maps from which additional collaboration programs may be initiated. For every collaboration program that successfully identifies potential therapeutic small molecules or validates a target, Roche will have an option to obtain an exclusive license to develop and commercialize such potential therapeutic small molecules or to exploit such target in the applicable exclusive field.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Pricing&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2022, Recursion received a $150.0 million non-refundable upfront payment from the Company&#x2019;s collaboration with Roche. In September 2024, Recursion received a $30.0 million milestone payment (the &#x201c;acceptance fee&#x201d;), which was an acceptance fee related to the first accepted neuroscience Phenomap. Recursion is eligible for additional milestone payments based on performance progress of the collaboration. Each of the Phenomaps requested by Roche and created by Recursion may be subject to either an initiation fee, acceptance fee or both. Such fees could exceed $250.0 million for 16 accepted Phenomaps. In addition, for a period of time after Roche&#x2019;s acceptance of certain Phenomaps, Roche will have the option to obtain, subject to payment of an exercise fee, rights to use outside the collaboration the raw images generated in the course of creating those Phenomaps. If Roche exercises its external use option for all 12 eligible Phenomaps, Roche&#x2019;s associated exercise fee payments to Recursion could exceed $250.0 million. Under the collaboration, Roche may initiate up to 40 programs, each of which, if successfully developed and commercialized, could yield more than $300.0&#160;million in development, commercialization and net revenue milestones for Recursion, as well as tiered royalties on net revenue.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Accounting&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;This agreement represents a transaction with a customer and therefore is accounted for in accordance with ASC 606. Recursion has determined that it has three performance obligations, one related to gastrointestinal cancer and two in neuroscience. These performance obligations are for performing research and development services for Roche to identify targets and medicines. The performance obligations also include potential licenses related to the intellectual property. The Company concluded that licenses within the contract are not distinct from the research and development services as they are interrelated due to the fact that the research and development services significantly impact the potential licenses. Any additional services are considered customer options and will be considered as separate contracts for accounting purposes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has determined the transaction price to be $180.0 million, comprised of the upfront payment and the acceptance fee. Prior to the three months ended September 30, 2024, Recursion had fully constrained the $30.0 million variable consideration acceptance fee. As a result of Roche&#x2019;s acceptance of the neuroscience Phenomap, Recursion is now recognizing the acceptance fee as part of the transaction price over the completion period of one of the neuroscience performance obligations. Recursion has fully constrained the remaining amounts of variable consideration to be received from potential milestones considering the stage of development and the risks associated with the remaining development required to achieve each milestone. Recursion will re-evaluate the transaction price each reporting period. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The transaction price was generally allocated to the performance obligations based on the estimated relative stand-alone selling price of each performance obligation as determined using an expected cost plus margin approach. The acceptance fee was allocated to one of the neuroscience performance obligations as the terms of the variable consideration related specifically to Recursion&#x2019;s efforts to satisfy this performance obligation. The Company recognizes revenue over time based on costs incurred relative to total expected costs to perform the research and development services. Recursion determined that this method provides a faithful depiction of the transfer of control to the customer. This method of recognizing revenue requires the Company to make estimates of total costs to provide the services required under the performance obligations. Significant inputs used to determine the total costs included the length of time required, service hours performed by Company employees and materials costs. A significant change in these estimates could have a material effect on the timing and amount of revenue recognized in future periods. Recursion has estimated the completion of the performance obligations by 2026.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Additional Revenue Disclosures&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Of the revenue recognized during the three and nine months ended September 30, 2025, $4.5 million and $36.6 million was included in the unearned revenue balance as of December&#160;31, 2024, respectively. Of the revenue recognized during the three and nine months ended September 30, 2024, $4.1 million and $29.0 million was included in the unearned revenue balance as of December&#160;31, 2023, respectively. Revenue recognized was from the upfront and variable consideration payments received from the related contracts, which decreased the aggregate unearned revenue recognized. As of September&#160;30, 2025, the Company had $5.6 million of costs incurred to fulfill a contract on its Condensed Consolidated Balance Sheet within &#x201c;Other Current Assets.&#x201d;&lt;/span&gt;&lt;/div&gt;Unearned revenue was classified as short-term and long-term on the Condensed Consolidated Balance Sheets based on the Company&#x2019;s estimate of revenue that will be recognized during the next twelve months.</us-gaap:CollaborativeArrangementDisclosureTextBlock>
    <rxrx:ContractWithCustomerNumberOfNovelSmallMoleculeCandidates
      contextRef="c-112"
      decimals="INF"
      id="f-599"
      unitRef="candidate">15</rxrx:ContractWithCustomerNumberOfNovelSmallMoleculeCandidates>
    <us-gaap:ContractWithCustomerLiability contextRef="c-113" decimals="-5" id="f-600" unitRef="usd">100000000.0</us-gaap:ContractWithCustomerLiability>
    <rxrx:CollaborativeArrangementMilestonePaymentReceived contextRef="c-114" decimals="-5" id="f-601" unitRef="usd">7000000.0</rxrx:CollaborativeArrangementMilestonePaymentReceived>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="c-114" decimals="-5" id="f-602" unitRef="usd">30000000.0</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiability contextRef="c-115" decimals="-5" id="f-603" unitRef="usd">555000000.0</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability contextRef="c-116" decimals="-8" id="f-604" unitRef="usd">1800000000</us-gaap:ContractWithCustomerLiability>
    <rxrx:RevenuePerformanceObligationNumberOfObligations
      contextRef="c-117"
      decimals="INF"
      id="f-605"
      unitRef="performance_obligation">8</rxrx:RevenuePerformanceObligationNumberOfObligations>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-118" decimals="-5" id="f-606" unitRef="usd">152900000</us-gaap:RevenueRemainingPerformanceObligation>
    <rxrx:CollaborativeArrangementMilestonePaymentReceived contextRef="c-114" decimals="-5" id="f-607" unitRef="usd">7000000.0</rxrx:CollaborativeArrangementMilestonePaymentReceived>
    <us-gaap:ContractWithCustomerLiability contextRef="c-119" decimals="-5" id="f-608" unitRef="usd">20100000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability contextRef="c-120" decimals="-5" id="f-609" unitRef="usd">73000000.0</us-gaap:ContractWithCustomerLiability>
    <rxrx:RevenuePerformanceObligationNumberOfObligations
      contextRef="c-121"
      decimals="INF"
      id="f-610"
      unitRef="performance_obligation">3</rxrx:RevenuePerformanceObligationNumberOfObligations>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-122" decimals="-5" id="f-611" unitRef="usd">20100000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:ContractWithCustomerLiability contextRef="c-123" decimals="-5" id="f-612" unitRef="usd">150000000.0</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="c-124" decimals="-5" id="f-613" unitRef="usd">30000000.0</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <rxrx:RevenueRemainingPerformanceObligationVariableConsiderationAmount contextRef="c-125" decimals="-5" id="f-614" unitRef="usd">250000000.0</rxrx:RevenueRemainingPerformanceObligationVariableConsiderationAmount>
    <rxrx:ContractWithCustomerMaximumAcceptedProduct
      contextRef="c-125"
      decimals="INF"
      id="f-615"
      unitRef="phenomap">16</rxrx:ContractWithCustomerMaximumAcceptedProduct>
    <rxrx:ContractWithCustomerMaximumAcceptedProduct
      contextRef="c-126"
      decimals="INF"
      id="f-616"
      unitRef="phenomap">12</rxrx:ContractWithCustomerMaximumAcceptedProduct>
    <rxrx:RevenueRemainingPerformanceObligationVariableConsiderationAmount contextRef="c-126" decimals="-5" id="f-617" unitRef="usd">250000000.0</rxrx:RevenueRemainingPerformanceObligationVariableConsiderationAmount>
    <rxrx:RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated
      contextRef="c-127"
      decimals="INF"
      id="f-618"
      unitRef="program">40</rxrx:RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated>
    <rxrx:RevenueRemainingPerformanceObligationVariableConsiderationAmount contextRef="c-127" decimals="-5" id="f-619" unitRef="usd">300000000</rxrx:RevenueRemainingPerformanceObligationVariableConsiderationAmount>
    <rxrx:RevenuePerformanceObligationNumberOfObligations
      contextRef="c-128"
      decimals="INF"
      id="f-620"
      unitRef="performance_obligation">3</rxrx:RevenuePerformanceObligationNumberOfObligations>
    <rxrx:RevenuePerformanceObligationNumberOfObligations
      contextRef="c-129"
      decimals="INF"
      id="f-621"
      unitRef="performance_obligation">1</rxrx:RevenuePerformanceObligationNumberOfObligations>
    <rxrx:RevenuePerformanceObligationNumberOfObligations
      contextRef="c-130"
      decimals="INF"
      id="f-622"
      unitRef="performance_obligation">2</rxrx:RevenuePerformanceObligationNumberOfObligations>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-123" decimals="-5" id="f-623" unitRef="usd">180000000.0</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="c-124" decimals="-5" id="f-624" unitRef="usd">30000000.0</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="c-20" decimals="-5" id="f-625" unitRef="usd">4500000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="c-1" decimals="-5" id="f-626" unitRef="usd">36600000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="c-21" decimals="-5" id="f-627" unitRef="usd">4100000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="c-22" decimals="-5" id="f-628" unitRef="usd">29000000.0</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerAssetNetCurrent contextRef="c-4" decimals="-5" id="f-629" unitRef="usd">5600000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c-1" id="f-630">Stock-Based Compensation &lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2021, the Board of Directors and the stockholders of the Company adopted the 2021 Equity Incentive Plan (the 2021 Plan). The Company may grant stock options, restricted stock units (RSUs), stock appreciation rights, restricted stock awards and other forms of stock-based compensation. As of September&#160;30, 2025, 13.3&#160;million shares of Class A common stock were available for grant in the 2021 plan. In November 2024, the Board of Directors and the stockholders of the Company adopted the 2024 Inducement Equity Incentive Plan (the 2024 Plan) as part of the Exscientia acquisition. See Note 4, &#x201c;Acquisitions&#x201d; for additional information. As of September&#160;30, 2025, 11.3&#160;million shares of Class A common stock were available for grant in the 2024 plan.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the classification of stock-based compensation expense for employees and non-employees within the Condensed Consolidated Statements of Operations: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:51.259%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.109%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.109%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:3.177%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.782%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.964%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Options &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock options are primarily granted to executive leaders at the Company, generally vest over four years and expire no later than 10 years from the date of grant.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock option activity during the nine months ended September 30, 2025 was as follows: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:37.642%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.367%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.499%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;(in thousands except share data and per share amounts)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Exercise&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Price &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Remaining&#160;Contractual Life (in years) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic Value &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,941,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.9&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,340,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,305,626)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,519,592)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding as of September 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,457,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.2&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable as of September 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,189,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.9&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of options granted to employees is calculated on the grant date using the Black-Scholes option valuation model. The weighted-average grant-date fair values of stock options granted during the nine months ended September 30, 2025 and 2024 were $4.47 and $5.88, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following weighted-average assumptions were used to calculate the grant-date fair value of stock options: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.2&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2025, $36.7 million of unrecognized compensation cost related to stock options is expected to be recognized as expense over approximately the next three years. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;RSUs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity awards granted to employees primarily consist of RSUs and generally vest over four years. The weighted-average grant-date fair value of RSUs generally is determined based on the number of units granted and the quoted price of Recursion&#x2019;s common stock on the date of grant.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes Recursion&#x2019;s RSU activity during the nine months ended September 30, 2025: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.133%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.783%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.784%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-average grant date fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,304,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,980,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,742,946)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,898,723)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding as of September 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,642,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair market value of RSUs vested was $50.8 million during the nine months ended September 30, 2025. As of September&#160;30, 2025, $188.1 million of unrecognized compensation cost related to RSUs is expected to be recognized as expense over approximately the next three years.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-131"
      decimals="-5"
      id="f-631"
      unitRef="shares">13300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-132"
      decimals="-5"
      id="f-632"
      unitRef="shares">11300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="c-1" id="f-633">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the classification of stock-based compensation expense for employees and non-employees within the Condensed Consolidated Statements of Operations: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:51.259%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.109%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.109%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:3.177%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.782%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.964%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-133" decimals="-3" id="f-634" unitRef="usd">964000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-134" decimals="-3" id="f-635" unitRef="usd">1153000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-135" decimals="-3" id="f-636" unitRef="usd">4727000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-136" decimals="-3" id="f-637" unitRef="usd">2600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-137" decimals="-3" id="f-638" unitRef="usd">14906000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-138" decimals="-3" id="f-639" unitRef="usd">9194000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-139" decimals="-3" id="f-640" unitRef="usd">46795000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-140" decimals="-3" id="f-641" unitRef="usd">25141000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-141" decimals="-3" id="f-642" unitRef="usd">9174000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-142" decimals="-3" id="f-643" unitRef="usd">7396000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-143" decimals="-3" id="f-644" unitRef="usd">34911000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-144" decimals="-3" id="f-645" unitRef="usd">21470000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-20" decimals="-3" id="f-646" unitRef="usd">25044000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-21" decimals="-3" id="f-647" unitRef="usd">17743000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-1" decimals="-3" id="f-648" unitRef="usd">86433000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-22" decimals="-3" id="f-649" unitRef="usd">49211000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-145" id="f-650">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="c-145" id="f-651">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c-1" id="f-652">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock option activity during the nine months ended September 30, 2025 was as follows: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:37.642%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.367%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.499%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;(in thousands except share data and per share amounts)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Exercise&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Price &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Remaining&#160;Contractual Life (in years) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic Value &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,941,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.9&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,340,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,305,626)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,519,592)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding as of September 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,457,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.2&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable as of September 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,189,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.9&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-5" decimals="INF" id="f-653" unitRef="shares">21941495</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-5"
      decimals="2"
      id="f-654"
      unitRef="usdPerShare">5.40</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-94" id="f-655">P7Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-5" decimals="-3" id="f-656" unitRef="usd">62685000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="c-1" decimals="INF" id="f-657" unitRef="shares">3340822</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-658"
      unitRef="usdPerShare">7.08</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="c-1" decimals="INF" id="f-659" unitRef="shares">2305626</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-660"
      unitRef="usdPerShare">8.81</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c-1" decimals="INF" id="f-661" unitRef="shares">4519592</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-662"
      unitRef="usdPerShare">1.08</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="c-1" decimals="-3" id="f-663" unitRef="usd">24350000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-4" decimals="INF" id="f-664" unitRef="shares">18457099</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-4"
      decimals="2"
      id="f-665"
      unitRef="usdPerShare">6.52</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-1" id="f-666">P7Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-4" decimals="-3" id="f-667" unitRef="usd">20246000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="c-4" decimals="INF" id="f-668" unitRef="shares">10189094</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="c-4"
      decimals="2"
      id="f-669"
      unitRef="usdPerShare">6.64</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="c-1" id="f-670">P5Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="c-4" decimals="-3" id="f-671" unitRef="usd">14363000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-1"
      decimals="2"
      id="f-672"
      unitRef="usdPerShare">4.47</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-22"
      decimals="2"
      id="f-673"
      unitRef="usdPerShare">5.88</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="c-1" id="f-674">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following weighted-average assumptions were used to calculate the grant-date fair value of stock options: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.2&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-145" id="f-675">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-146" id="f-676">P6Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c-145" decimals="2" id="f-677" unitRef="number">0.66</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c-146" decimals="2" id="f-678" unitRef="number">0.65</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c-145" decimals="3" id="f-679" unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c-146" decimals="3" id="f-680" unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c-145" decimals="3" id="f-681" unitRef="number">0.040</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c-146" decimals="3" id="f-682" unitRef="number">0.042</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions contextRef="c-4" decimals="-5" id="f-683" unitRef="usd">36700000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-1" id="f-684">P3Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-147" id="f-685">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock contextRef="c-1" id="f-686">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes Recursion&#x2019;s RSU activity during the nine months ended September 30, 2025: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.133%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.783%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.784%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-average grant date fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,304,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,980,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,742,946)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,898,723)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding as of September 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,642,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-148"
      decimals="INF"
      id="f-687"
      unitRef="shares">27304229</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-148"
      decimals="2"
      id="f-688"
      unitRef="usdPerShare">7.47</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-147"
      decimals="INF"
      id="f-689"
      unitRef="shares">14980106</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-147"
      decimals="2"
      id="f-690"
      unitRef="usdPerShare">5.86</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-147"
      decimals="INF"
      id="f-691"
      unitRef="shares">6742946</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-147"
      decimals="2"
      id="f-692"
      unitRef="usdPerShare">7.62</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-147"
      decimals="INF"
      id="f-693"
      unitRef="shares">4898723</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-147"
      decimals="2"
      id="f-694"
      unitRef="usdPerShare">7.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-149"
      decimals="INF"
      id="f-695"
      unitRef="shares">30642666</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-149"
      decimals="2"
      id="f-696"
      unitRef="usdPerShare">6.61</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="c-147" decimals="-5" id="f-697" unitRef="usd">50800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions contextRef="c-149" decimals="-5" id="f-698" unitRef="usd">188100000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-147" id="f-699">P3Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c-1" id="f-700">Income Taxes &lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company did not record any U.S. income tax expense during the three and nine months ended September 30, 2025 and 2024. The Company has historically incurred operating losses and maintains a full valuation allowance against its U.S. net deferred tax assets. Foreign taxes were insignificant during the three and nine months ended September 30, 2025 and 2024. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The U.S. net operating losses (NOLs) and tax credit carry-forwards are subject to review and possible adjustment by the Internal Revenue Service (&#x201c;IRS&#x201d;) and may become subject to annual limitation due to ownership changes that occur under Section 382 of the Internal Revenue Code, as amended and similar state provisions. These ownership changes may limit the amount of carryforwards that can be utilized annually to offset future taxable income. In general, an ownership change, as defined by Section 382, results from transactions increasing the ownership of certain shareholders or public groups in the stock of a corporation by more than 50% over a three-year period. As of December&#160;31, 2024, the Company completed a Section 382 study and did not identify ownership changes that would subject its NOLs or tax credit carry-forwards to Section 382 limitations. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company files income tax returns in the United States, Canada and United Kingdom. The Company files state income tax returns in multiple states in the United States among others Utah, California and Massachusetts. The &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Company is not currently under examination in any of these jurisdictions. The Company is subject to income tax examinations for all US federal and state returns filed since the 2016 tax year, Canadian income tax returns since the 2021 tax year, and UK income tax returns since the 2021 tax year.&lt;/span&gt;&lt;/div&gt;In July 2025, congress approved the One Big Beautiful Bill Act (OBBBA), which extends, with modifications, many of the expiring provisions of the Tax Cuts and Jobs Act (TCJA) and makes additional changes to tax laws and regulations. OBBBA includes a broad array of changes including new and modified incentives for business investment and Inflation Reduction Act (IRA) tax credits and various limits on business tax deductions. It also impacts the deduction of research and development costs and property, plant and equipment costs. This act did not have a material impact on Recursion&#x2019;s consolidated balance sheet and statement of operations. The Company will continue to monitor the impact of this Act in future periods.</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations contextRef="c-21" decimals="INF" id="f-701" unitRef="usd">0</us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations contextRef="c-22" decimals="INF" id="f-702" unitRef="usd">0</us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations contextRef="c-20" decimals="INF" id="f-703" unitRef="usd">0</us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations contextRef="c-1" decimals="INF" id="f-704" unitRef="usd">0</us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:EarningsPerShareTextBlock contextRef="c-1" id="f-705">Net Loss Per Share&lt;span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three and nine months ended September 30, 2025 and 2024, Recursion calculated net loss per share of Class A, Class B and the Exchangeable common stock. Basic net loss per share is computed using the weighted-average number of shares outstanding during the period. Diluted net loss per share is computed using the weighted-average number of shares and the effect of potentially dilutive securities outstanding during the period. Potentially dilutive securities consist of stock options and other contingently issuable shares. For periods presented in which the Company reports a net loss, all potentially dilutive shares are anti-dilutive and as such are excluded from the calculation. &lt;/span&gt;&lt;span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;nine months ended September 30, 2025 and 2024&lt;/span&gt;&lt;span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the Company reported a net loss and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;therefore basic and diluted loss per share were the same.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The rights, including the liquidation and dividend rights, of the holders of the Company&#x2019;s Class A, Class B and the Exchangeable common stock are identical, except with respect to voting. As a result, the undistributed earnings for each period are allocated based on the contractual participation rights of the Class A, Class B and the Exchangeable common stock as if the earnings for the period had been distributed. As the liquidation and dividend rights are identical, the undistributed earnings are allocated on a proportionate basis and the resulting amount per share for Class A, Class B and the Exchangeable common stock was the same during the three and nine months ended September 30, 2025 and 2024.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables set forth the computation of basic and diluted net loss per share of Class A, Class B and Exchangeable common stock:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:42.028%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.057%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.057%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.408%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.373%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.377%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands, except share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(162,253)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(95,842)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(536,637)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(284,755)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446,988,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282,583,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;422,642,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253,447,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss per share, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company excluded the following potential common shares from the computation of diluted net loss per share for the periods indicated because including them would have had an anti-dilutive effect: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:41.736%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.204%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.204%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.408%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.373%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.375%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Stock based compensation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,675,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,869,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,696,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,098,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Tempus agreement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,582,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,694,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,582,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,694,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Contingent stock relating to RE Ventures I transaction&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;421,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,508,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,564,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,700,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,793,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c-1" id="f-706">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables set forth the computation of basic and diluted net loss per share of Class A, Class B and Exchangeable common stock:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:42.028%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.057%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.057%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.408%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.373%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.377%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands, except share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(162,253)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(95,842)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(536,637)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(284,755)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446,988,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282,583,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;422,642,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253,447,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss per share, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss contextRef="c-20" decimals="-3" id="f-707" unitRef="usd">-162253000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-21" decimals="-3" id="f-708" unitRef="usd">-95842000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-709" unitRef="usd">-536637000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-22" decimals="-3" id="f-710" unitRef="usd">-284755000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-20" decimals="0" id="f-711" unitRef="shares">446988046</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-20" decimals="0" id="f-712" unitRef="shares">446988046</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-21" decimals="0" id="f-713" unitRef="shares">282583048</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-21" decimals="0" id="f-714" unitRef="shares">282583048</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-715" unitRef="shares">422642653</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="0" id="f-716" unitRef="shares">422642653</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-22" decimals="0" id="f-717" unitRef="shares">253447099</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-22" decimals="0" id="f-718" unitRef="shares">253447099</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-20"
      decimals="2"
      id="f-719"
      unitRef="usdPerShare">-0.36</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-20"
      decimals="2"
      id="f-720"
      unitRef="usdPerShare">-0.36</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-21"
      decimals="2"
      id="f-721"
      unitRef="usdPerShare">-0.34</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-21"
      decimals="2"
      id="f-722"
      unitRef="usdPerShare">-0.34</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-723"
      unitRef="usdPerShare">-1.27</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-724"
      unitRef="usdPerShare">-1.27</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-22"
      decimals="2"
      id="f-725"
      unitRef="usdPerShare">-1.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-22"
      decimals="2"
      id="f-726"
      unitRef="usdPerShare">-1.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="c-1" id="f-727">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company excluded the following potential common shares from the computation of diluted net loss per share for the periods indicated because including them would have had an anti-dilutive effect: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:41.736%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.204%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.204%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.408%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.373%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.375%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Stock based compensation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,675,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,869,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,696,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,098,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Tempus agreement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,582,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,694,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,582,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,694,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Contingent stock relating to RE Ventures I transaction&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;421,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,508,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,564,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,700,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,793,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-150" decimals="0" id="f-728" unitRef="shares">6675698</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-151" decimals="0" id="f-729" unitRef="shares">5869795</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-152" decimals="0" id="f-730" unitRef="shares">8696773</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-153" decimals="0" id="f-731" unitRef="shares">8098979</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-154" decimals="0" id="f-732" unitRef="shares">6582331</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-155" decimals="0" id="f-733" unitRef="shares">6694934</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-156" decimals="0" id="f-734" unitRef="shares">6582331</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-157" decimals="0" id="f-735" unitRef="shares">6694934</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-158" decimals="0" id="f-736" unitRef="shares">1250621</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-159" decimals="0" id="f-737" unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-160" decimals="0" id="f-738" unitRef="shares">421455</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-161" decimals="0" id="f-739" unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-20" decimals="0" id="f-740" unitRef="shares">14508650</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-21" decimals="0" id="f-741" unitRef="shares">12564729</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-1" decimals="0" id="f-742" unitRef="shares">15700559</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-22" decimals="0" id="f-743" unitRef="shares">14793913</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="c-1" id="f-744">Fair Value Measurements&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value hierarchy consists of the following three levels:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1 &#x2014; Valuations based on unadjusted quoted prices in active markets for identical assets that the company has the ability to access;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2 &#x2014; Valuations based on quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-based valuations in which all significant inputs are observable in the market; and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3 &#x2014; Valuations using significant inputs that are unobservable in the market and include the use of judgment by the company's management about the assumptions market participants would use in pricing the asset or liability.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is required to maintain a cash balance in a collateralized account to secure the Company&#x2019;s credit cards. Additionally, the Company holds restricted cash related to an outstanding letter of credit issued by J.P. Morgan, which was obtained to secure certain Company obligations relating to tenant improvements. Recursion also holds restricted cash as required by a lease agreement.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the Company&#x2019;s assets and liabilities that are measured at fair value on a recurring basis:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.727%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.741%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.744%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.745%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of fair value measurement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;436,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;436,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;667,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;667,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.098%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.297%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.204%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.452%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of fair value measurement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bank deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;603,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;603,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the financial instruments that are recognized at fair value on the Condensed Consolidated Balance Sheet, the Company has certain financial instruments that are recognized at amortized cost or some basis other than fair value. The carrying amount of these instruments are considered to be representative of their approximate fair values. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the Company&#x2019;s financial instruments that are not measured at fair value: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:26.531%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.443%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.443%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.992%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.443%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.448%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Book values&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair values&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes payable and financing lease liabilities, current&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes payable and financing lease liabilities, non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="c-1" id="f-745">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the Company&#x2019;s assets and liabilities that are measured at fair value on a recurring basis:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.727%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.741%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.744%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.745%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of fair value measurement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;436,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;436,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;667,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;667,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.098%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.297%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.204%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.452%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of fair value measurement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bank deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;603,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;603,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-162" decimals="-3" id="f-746" unitRef="usd">436675000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-163" decimals="-3" id="f-747" unitRef="usd">436675000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-164" decimals="-3" id="f-748" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-165" decimals="-3" id="f-749" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-166" decimals="-3" id="f-750" unitRef="usd">223161000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-167" decimals="-3" id="f-751" unitRef="usd">223161000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-168" decimals="-3" id="f-752" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-169" decimals="-3" id="f-753" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure contextRef="c-170" decimals="-3" id="f-754" unitRef="usd">7309000</rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure>
    <rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure contextRef="c-171" decimals="-3" id="f-755" unitRef="usd">7309000</rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure>
    <rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure contextRef="c-172" decimals="-3" id="f-756" unitRef="usd">0</rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure>
    <rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure contextRef="c-173" decimals="-3" id="f-757" unitRef="usd">0</rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-170" decimals="-3" id="f-758" unitRef="usd">667145000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-171" decimals="-3" id="f-759" unitRef="usd">667145000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-172" decimals="-3" id="f-760" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-173" decimals="-3" id="f-761" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-174" decimals="-3" id="f-762" unitRef="usd">198050000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-175" decimals="-3" id="f-763" unitRef="usd">198050000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-176" decimals="-3" id="f-764" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-177" decimals="-3" id="f-765" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-178" decimals="-3" id="f-766" unitRef="usd">235812000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-179" decimals="-3" id="f-767" unitRef="usd">235812000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-180" decimals="-3" id="f-768" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-181" decimals="-3" id="f-769" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-182" decimals="-3" id="f-770" unitRef="usd">160487000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-183" decimals="-3" id="f-771" unitRef="usd">160487000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-184" decimals="-3" id="f-772" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-185" decimals="-3" id="f-773" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure contextRef="c-186" decimals="-3" id="f-774" unitRef="usd">8675000</rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure>
    <rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure contextRef="c-187" decimals="-3" id="f-775" unitRef="usd">8675000</rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure>
    <rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure contextRef="c-188" decimals="-3" id="f-776" unitRef="usd">0</rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure>
    <rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure contextRef="c-189" decimals="-3" id="f-777" unitRef="usd">0</rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-186" decimals="-3" id="f-778" unitRef="usd">603024000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-187" decimals="-3" id="f-779" unitRef="usd">603024000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-188" decimals="-3" id="f-780" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-189" decimals="-3" id="f-781" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock contextRef="c-1" id="f-782">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the Company&#x2019;s financial instruments that are not measured at fair value: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:26.531%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.443%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.443%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.992%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.443%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.448%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Book values&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair values&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes payable and financing lease liabilities, current&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes payable and financing lease liabilities, non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent contextRef="c-190" decimals="-3" id="f-783" unitRef="usd">8919000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent contextRef="c-191" decimals="-3" id="f-784" unitRef="usd">8425000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent contextRef="c-192" decimals="-3" id="f-785" unitRef="usd">8919000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent contextRef="c-193" decimals="-3" id="f-786" unitRef="usd">8425000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations contextRef="c-190" decimals="-3" id="f-787" unitRef="usd">11902000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations contextRef="c-191" decimals="-3" id="f-788" unitRef="usd">19022000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations contextRef="c-192" decimals="-3" id="f-789" unitRef="usd">11902000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations contextRef="c-193" decimals="-3" id="f-790" unitRef="usd">19022000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-194" decimals="-3" id="f-791" unitRef="usd">20821000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-195" decimals="-3" id="f-792" unitRef="usd">27447000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-196" decimals="-3" id="f-793" unitRef="usd">20821000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-197" decimals="-3" id="f-794" unitRef="usd">27447000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c-1" id="f-795">Segment Information&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Segment loss&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Recursion operates as a single operating segment that is managed on a consolidated basis. The Company&#x2019;s chief operating decision maker is its Chief Executive Officer. The Company&#x2019;s chief operating decision maker uses segment net loss to evaluate the performance of its segment, analyze financial trends, compare the budget to the actual operating results and make resource allocation decisions. Segment net loss represents the Company&#x2019;s consolidated net loss. All corporate costs, global function support costs, overhead costs and other shared costs are included within this segment. Other segment items primarily include general and administrative expenses including facilities, information technology, professional fees (including auditing, tax and legal) and insurance.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents Recursion&#x2019;s segment net loss: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.508%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.408%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.598%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:112%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;26,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;39,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;54,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Significant segment expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Salaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;55,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;235,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;156,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Consumables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;19,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;92,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;54,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Platform&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;8,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;36,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;13,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Discovery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;3,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;58,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;19,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Clinical development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;9,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;33,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;31,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;6,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;64,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;22,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Other segment items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;22,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;57,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;52,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Loss from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;539,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Other non-operating income (loss), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;(167)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;1,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Total segment loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;162,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;95,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;536,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;284,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Supplemental asset information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Total expenditures for additions to long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;4,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;5,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;12,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Additional Segment Disclosures&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Recursion&#x2019;s revenues are attributed to the following geographic areas based on the location the services are performed: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:25.361%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.882%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.882%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.408%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.882%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.885%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:112%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United Kingdom&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Recursion generates revenue primarily from a single service, research and development services, therefore, the Company does not report additional information on revenue from external customers.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Recursion&#x2019;s long-lived assets are attributed to the following geographic areas based on their location: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.829%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.935%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:112%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;United Kingdom&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;2,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="c-1" id="f-796">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents Recursion&#x2019;s segment net loss: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.508%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.408%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.598%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:112%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;26,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;39,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;54,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Significant segment expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Salaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;55,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;235,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;156,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Consumables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;19,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;92,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;54,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Platform&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;8,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;36,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;13,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Discovery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;3,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;58,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;19,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Clinical development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;9,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;33,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;31,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;6,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;64,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;22,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Other segment items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;22,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;57,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;52,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Loss from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;539,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Other non-operating income (loss), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;(167)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;1,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Total segment loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;162,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;95,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;536,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;284,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Supplemental asset information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Total expenditures for additions to long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;4,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;5,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;12,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-198" decimals="-3" id="f-797" unitRef="usd">5175000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-199" decimals="-3" id="f-798" unitRef="usd">26082000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-200" decimals="-3" id="f-799" unitRef="usd">39143000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-201" decimals="-3" id="f-800" unitRef="usd">54293000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:LaborAndRelatedExpense contextRef="c-198" decimals="-3" id="f-801" unitRef="usd">68600000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense contextRef="c-199" decimals="-3" id="f-802" unitRef="usd">55515000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense contextRef="c-200" decimals="-3" id="f-803" unitRef="usd">235190000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense contextRef="c-201" decimals="-3" id="f-804" unitRef="usd">156171000</us-gaap:LaborAndRelatedExpense>
    <rxrx:ConsumableExpense contextRef="c-198" decimals="-3" id="f-805" unitRef="usd">8928000</rxrx:ConsumableExpense>
    <rxrx:ConsumableExpense contextRef="c-199" decimals="-3" id="f-806" unitRef="usd">19419000</rxrx:ConsumableExpense>
    <rxrx:ConsumableExpense contextRef="c-200" decimals="-3" id="f-807" unitRef="usd">92725000</rxrx:ConsumableExpense>
    <rxrx:ConsumableExpense contextRef="c-201" decimals="-3" id="f-808" unitRef="usd">54176000</rxrx:ConsumableExpense>
    <rxrx:PlatformFeeExpense contextRef="c-198" decimals="-3" id="f-809" unitRef="usd">14377000</rxrx:PlatformFeeExpense>
    <rxrx:PlatformFeeExpense contextRef="c-199" decimals="-3" id="f-810" unitRef="usd">8330000</rxrx:PlatformFeeExpense>
    <rxrx:PlatformFeeExpense contextRef="c-200" decimals="-3" id="f-811" unitRef="usd">36934000</rxrx:PlatformFeeExpense>
    <rxrx:PlatformFeeExpense contextRef="c-201" decimals="-3" id="f-812" unitRef="usd">13102000</rxrx:PlatformFeeExpense>
    <rxrx:DiscoveryExpense contextRef="c-198" decimals="-3" id="f-813" unitRef="usd">37049000</rxrx:DiscoveryExpense>
    <rxrx:DiscoveryExpense contextRef="c-199" decimals="-3" id="f-814" unitRef="usd">3375000</rxrx:DiscoveryExpense>
    <rxrx:DiscoveryExpense contextRef="c-200" decimals="-3" id="f-815" unitRef="usd">58716000</rxrx:DiscoveryExpense>
    <rxrx:DiscoveryExpense contextRef="c-201" decimals="-3" id="f-816" unitRef="usd">19115000</rxrx:DiscoveryExpense>
    <rxrx:ClinicalDevelopmentExpense contextRef="c-198" decimals="-3" id="f-817" unitRef="usd">10814000</rxrx:ClinicalDevelopmentExpense>
    <rxrx:ClinicalDevelopmentExpense contextRef="c-199" decimals="-3" id="f-818" unitRef="usd">9050000</rxrx:ClinicalDevelopmentExpense>
    <rxrx:ClinicalDevelopmentExpense contextRef="c-200" decimals="-3" id="f-819" unitRef="usd">33338000</rxrx:ClinicalDevelopmentExpense>
    <rxrx:ClinicalDevelopmentExpense contextRef="c-201" decimals="-3" id="f-820" unitRef="usd">31966000</rxrx:ClinicalDevelopmentExpense>
    <us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization contextRef="c-198" decimals="-3" id="f-821" unitRef="usd">18708000</us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization contextRef="c-199" decimals="-3" id="f-822" unitRef="usd">6637000</us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization contextRef="c-200" decimals="-3" id="f-823" unitRef="usd">64223000</us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization contextRef="c-201" decimals="-3" id="f-824" unitRef="usd">22982000</us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-198" decimals="-3" id="f-825" unitRef="usd">18901000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-199" decimals="-3" id="f-826" unitRef="usd">22110000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-200" decimals="-3" id="f-827" unitRef="usd">57815000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-201" decimals="-3" id="f-828" unitRef="usd">52017000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:OperatingIncomeLoss contextRef="c-198" decimals="-3" id="f-829" unitRef="usd">-172202000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-199" decimals="-3" id="f-830" unitRef="usd">-98354000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-200" decimals="-3" id="f-831" unitRef="usd">-539798000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-201" decimals="-3" id="f-832" unitRef="usd">-295236000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-198" decimals="-3" id="f-833" unitRef="usd">9952000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-199" decimals="-3" id="f-834" unitRef="usd">2679000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-200" decimals="-3" id="f-835" unitRef="usd">3005000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-201" decimals="-3" id="f-836" unitRef="usd">9347000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-198" decimals="-3" id="f-837" unitRef="usd">3000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-199" decimals="-3" id="f-838" unitRef="usd">167000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-200" decimals="-3" id="f-839" unitRef="usd">-156000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-201" decimals="-3" id="f-840" unitRef="usd">-1134000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="c-198" decimals="-3" id="f-841" unitRef="usd">-162253000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-199" decimals="-3" id="f-842" unitRef="usd">-95842000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-200" decimals="-3" id="f-843" unitRef="usd">-536637000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-201" decimals="-3" id="f-844" unitRef="usd">-284755000</us-gaap:NetIncomeLoss>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c-198" decimals="-3" id="f-845" unitRef="usd">39000</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c-199" decimals="-3" id="f-846" unitRef="usd">4248000</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c-200" decimals="-3" id="f-847" unitRef="usd">5283000</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c-201" decimals="-3" id="f-848" unitRef="usd">12633000</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock contextRef="c-1" id="f-849">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Recursion&#x2019;s revenues are attributed to the following geographic areas based on the location the services are performed: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:25.361%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.882%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.882%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.408%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.882%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.885%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:112%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United Kingdom&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Recursion&#x2019;s long-lived assets are attributed to the following geographic areas based on their location: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.829%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.935%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:112%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;United Kingdom&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;2,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-202" decimals="-3" id="f-850" unitRef="usd">1110000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-203" decimals="-3" id="f-851" unitRef="usd">26082000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-204" decimals="-3" id="f-852" unitRef="usd">22393000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-205" decimals="-3" id="f-853" unitRef="usd">54293000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-206" decimals="-3" id="f-854" unitRef="usd">4065000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-207" decimals="-3" id="f-855" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-208" decimals="-3" id="f-856" unitRef="usd">16750000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-209" decimals="-3" id="f-857" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-20" decimals="-3" id="f-858" unitRef="usd">5175000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-21" decimals="-3" id="f-859" unitRef="usd">26082000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-860" unitRef="usd">39143000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-22" decimals="-3" id="f-861" unitRef="usd">54293000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NoncurrentAssets contextRef="c-210" decimals="-3" id="f-862" unitRef="usd">66571000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-211" decimals="-3" id="f-863" unitRef="usd">78471000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-212" decimals="-3" id="f-864" unitRef="usd">42655000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-213" decimals="-3" id="f-865" unitRef="usd">56332000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-214" decimals="-3" id="f-866" unitRef="usd">2480000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-215" decimals="-3" id="f-867" unitRef="usd">2631000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-216" decimals="-3" id="f-868" unitRef="usd">0</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-217" decimals="-3" id="f-869" unitRef="usd">3629000</us-gaap:NoncurrentAssets>
    <us-gaap:SubsequentEventsTextBlock contextRef="c-1" id="f-870">Subsequent Events&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Roche and Genentech&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October&#160;27, 2025, Recursion received notice that Roche accepted the second neuroscience Phenomap under the December 2021 collaboration and license agreement which resulted in a $30 million milestone which is an acceptance fee accounted for as variable consideration under ASC 606. See Note 9, &#x201c;Collaborative Development Contracts&#x201d; for additional information on the collaboration with Roche. This milestone payment was fully constrained variable consideration at September&#160;30, 2025 due to the uncertainty of the development. The variable consideration is no longer constrained and will be recognized as &#x201c;Operating Revenue&#x201d; in the Condensed Consolidated Statements of Operations as part of the transaction price over the completion period of the neuroscience performance obligation. The amount to be earned over the remaining estimated completion period will be recorded in &#x201c;Unearned Revenue&#x201d; and &#x201c;Unearned Revenue, Non-Current&#x201d; on the Consolidated Balance Sheet, classified as short-term and long-term based on the Company&#x2019;s estimate of revenue that will be recognized during the next twelve months.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;At-The-Market Offering (Citi)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2025, Recursion&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;sold 25.3 million shares and received net proceeds of $133.5 million under the Sales Agreement. Pursuant to its terms, the Sales Agreement has completed and no amount remained available for future sales. In total, the Company sold 99.9 million shares and received net proceeds of $491.7 million under the agreement.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="c-218" decimals="-5" id="f-871" unitRef="usd">30000000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c-219"
      decimals="-5"
      id="f-872"
      unitRef="shares">25300000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-219" decimals="-5" id="f-873" unitRef="usd">133500000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c-220"
      decimals="-5"
      id="f-874"
      unitRef="shares">99900000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-220" decimals="-5" id="f-875" unitRef="usd">491700000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c-1" id="f-876">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c-20" id="f-877">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c-20" id="f-878">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:MtrlTermsOfTrdArrTextBlock contextRef="c-221" id="f-879">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 31, 2025, Blake Borgeson, a member of our Board of Directors, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the potential sale of up to 3,868,000 shares of the Company&#x2019;s Class A common stock, a majority of which will not execute absent a significant increase in the market price of the Company&#x2019;s Class A common stock. The plan is effective until no later than December&#160;01, 2026&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;</ecd:MtrlTermsOfTrdArrTextBlock>
    <ecd:TrdArrAdoptionDate contextRef="c-221" id="f-880">August 31, 2025</ecd:TrdArrAdoptionDate>
    <ecd:TrdArrIndName contextRef="c-221" id="f-881">Blake Borgeson</ecd:TrdArrIndName>
    <ecd:TrdArrIndTitle contextRef="c-221" id="f-882">a member of our Board of Directors</ecd:TrdArrIndTitle>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-221" id="f-883">true</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:TrdArrSecuritiesAggAvailAmt
      contextRef="c-222"
      decimals="INF"
      id="f-884"
      unitRef="shares">3868000</ecd:TrdArrSecuritiesAggAvailAmt>
    <ecd:MtrlTermsOfTrdArrTextBlock contextRef="c-223" id="f-885">&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 22, 2025, Najat Khan, Chief R&amp;amp;D Officer, Chief &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Officer, and a member of our Board of Directors, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;299,317&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; shares of the Company&#x2019;s Class A common stock until December 22, 2026.&lt;/span&gt;&lt;/div&gt;</ecd:MtrlTermsOfTrdArrTextBlock>
    <ecd:TrdArrAdoptionDate contextRef="c-223" id="f-886">September 22, 2025</ecd:TrdArrAdoptionDate>
    <ecd:TrdArrIndName contextRef="c-223" id="f-887">Najat Khan</ecd:TrdArrIndName>
    <ecd:TrdArrIndTitle contextRef="c-223" id="f-888">Chief R&amp;D Officer, Chief Commercial Officer, and a member of our Board of Directors</ecd:TrdArrIndTitle>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-223" id="f-889">true</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:TrdArrSecuritiesAggAvailAmt
      contextRef="c-224"
      decimals="INF"
      id="f-890"
      unitRef="shares">299317</ecd:TrdArrSecuritiesAggAvailAmt>
    <ecd:TrdArrExpirationDate contextRef="c-223" id="f-891">December 22, 2026</ecd:TrdArrExpirationDate>
    <ecd:MtrlTermsOfTrdArrTextBlock contextRef="c-225" id="f-892">&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 30, 2025, Ben Taylor, Chief Financial Officer and President of Recursion UK, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;defense&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of Rule 10b5-1(c) for the sale of up to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;293,321&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; shares of the Company&#x2019;s Class A common stock until December 29, 2026.&lt;/span&gt;&lt;/div&gt;</ecd:MtrlTermsOfTrdArrTextBlock>
    <ecd:TrdArrAdoptionDate contextRef="c-225" id="f-893">September 30, 2025</ecd:TrdArrAdoptionDate>
    <ecd:TrdArrIndName contextRef="c-225" id="f-894">Ben Taylor</ecd:TrdArrIndName>
    <ecd:TrdArrIndTitle contextRef="c-225" id="f-895">Chief Financial Officer and President of Recursion UK</ecd:TrdArrIndTitle>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-225" id="f-896">true</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:TrdArrSecuritiesAggAvailAmt
      contextRef="c-226"
      decimals="INF"
      id="f-897"
      unitRef="shares">293321</ecd:TrdArrSecuritiesAggAvailAmt>
    <ecd:TrdArrExpirationDate contextRef="c-225" id="f-898">December 29, 2026</ecd:TrdArrExpirationDate>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
